Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.6245032926946711,-2.5487438787524876,0.0,0.0,0.0,54/87,20.53%,RPL41;RPS12;RPL3;RPS24;RPS14;RPL27A;RPL8;RPS19;RPL34;RPS13;RPL21;RPL7;RPL18;RPL27;RPL35A;RPL38;RPS15;RPS3;RPL39;RPS7;RPS4X;RPL11;RPL30;RPS23;RPL36;RPLP1;RPS29;RPL37;RPS9;RPS5;RPL4;RPL18A;RPL26;RPL6;RPL36A;RPL29;RPL13A;RPL7A;RPL19;RPS20;RPL14;RPL13;RPL32;RPL5;RPSA;RPLP0;RPS6;RPL22;ZFAND2B;RPS21;RPL37A;RPLP2;RPL17;RPL23
prerank,protein targeting to ER (GO:0045047),-0.6103143745502879,-2.5354577199971566,0.0,0.0,0.0,78/99,31.20%,RPL41;RPS12;RPL3;RPS24;RPS14;RPL27A;RPL8;RPS19;RPL34;RPS13;RPL21;RPL7;RPL18;RPL27;RPL35A;RPL38;RPS15;RPS3;RPL39;RPS7;RPS4X;RPL11;RPL30;RPS23;RPL36;RPLP1;RPS29;RPL37;RPS9;RPS5;RPL4;RPL18A;RPL26;RPL6;RPL36A;RPL29;RPL13A;RPL7A;RPL19;RPS20;RPL14;RPL13;RPL32;RPL5;RPSA;RPLP0;RPS6;RPL22;ZFAND2B;RPS21;RPL37A;SGTB;RPLP2;SPCS1;RPL17;RPL23;RPL28;RPL31;CHMP4B;CHMP4A;EDEM1;RPS10;SGTA;RPS11;RPS27;RPS16;SRPRA;RPL10;RPL15;RPL12;RPL9;RPS8;SEC61G;GET3;SEC63;RPS27A;RPL10A;RPS17
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.6068695455345342,-2.479330587785958,0.0,0.0,0.0,54/91,20.53%,RPL41;RPS12;RPL3;RPS24;RPS14;RPL27A;RPL8;RPS19;RPL34;RPS13;RPL21;RPL7;RPL18;RPL27;RPL35A;RPL38;RPS15;RPS3;RPL39;RPS7;RPS4X;RPL11;RPL30;RPS23;RPL36;RPLP1;RPS29;RPL37;RPS9;RPS5;RPL4;RPL18A;RPL26;RPL6;RPL36A;RPL29;RPL13A;RPL7A;RPL19;RPS20;ARL6IP1;RPL14;RPL13;RPL32;RPL5;RPSA;RPLP0;RPS6;RPL22;RPS21;RPL37A;RPLP2;RPL17;RPL23
prerank,cytoplasmic translation (GO:0002181),-0.594412608159326,-2.4557562888669087,0.0,0.0,0.0,53/91,20.53%,RPL41;RPS12;RPL3;RPS24;RPS14;RPL27A;RPL8;RPS19;RPL34;RPS13;RPL21;RPL7;RPL18;RPL27;RPL35A;RPL38;RPS15;RPS3;RPL39;RPS7;RPS4X;RPL11;RPL30;RPS23;RPL36;RPLP1;RPS29;RPL37;RPS9;RPS5;EIF4A1;RPL4;RPL18A;RPL26;RPL6;RPL36A;RPL29;RPL13A;RPL7A;RPL19;RPS20;RPL14;RPL13;RPL32;RPL5;RPSA;RPLP0;RPS6;RPL22;RPS21;RPL37A;RPL17;RPL23
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.5650540443497492,-2.342613117736235,0.0,0.0,0.0,58/110,20.53%,RPL41;RPS12;RPL3;RPS24;RPS14;RPL27A;RPL8;RPS19;RPL34;RPS13;RPL21;RPL7;RPL18;RPL27;RPL35A;RPL38;RPS15;RPS3;RPL39;RPS7;RPS4X;RPL11;RPL30;RPS23;PABPC1;PNRC2;RPL36;RPLP1;RPS29;RPL37;PPP2R2A;RPS9;RBM8A;RPS5;RPL4;RPL18A;RPL26;RPL6;RPL36A;RPL29;RPL13A;RPL7A;RPL19;RPS20;RPL14;RPL13;RPL32;RPL5;RPSA;SMG7;RPLP0;RPS6;RPL22;RPS21;RPL37A;RPLP2;RPL17;RPL23
prerank,peptide biosynthetic process (GO:0043043),-0.5306303818602872,-2.3160232152745874,0.0,0.0,0.0,77/153,23.09%,RPL41;RPS12;RPL3;RPS24;RPS14;RPL27A;RPL8;RPS19;RPL34;WARS1;RPS13;RPL21;RPL7;RPL18;RPL27;GGT5;RPL35A;RPL38;RPS15;RPS3;RPL39;RPS7;RPS4X;RPL11;MRRF;RPL30;RPS23;RPL36;RPLP1;RPS29;RPL37;RPS9;RPS5;YARS2;RPL4;RPL18A;RPL26;RPL6;RPL36A;RPL29;MRPS18A;RPL13A;MRPS5;GGTA1;RPL7A;RPL19;RPS20;RPL14;EEF1A1;RPL13;RPL32;MRPS12;RPL5;RPSA;MRPS33;RPLP0;MRPL55;RPS6;RPS6KB2;RPL22;MRPS18B;MRPL42;RPS21;GGT1;RPL37A;RPLP2;MRPS21;MRPS7;RPL17;RPL23;PCSK1;MRPL34;EIF4EBP2;RPL28;PABPC4;RPL31;EEF1A2
prerank,extracellular structure organization (GO:0043062),0.6383434838992278,2.162996542690284,0.0,0.0010129429390048602,0.001,54/204,5.48%,ITGA9;ADAMTS6;COL4A4;ADAMTS12;COL4A5;ADAMTSL3;LAMA1;COL4A6;FBN1;COL1A2;COL1A1;DDR2;FBLN5;COL4A3;THSD4;COL22A1;ELN;ADAMTS10;ADAMTS5;LOXL1;MATN3;LUM;SPARC;COL5A1;COL8A2;LOX;DAG1;DCN;BGN;LAMA2;FBN2;SERPINE1;COL11A1;HSPG2;ITGA11;ADAMTS2;ADAMTSL2;RECK;LAMC1;ITGA3;MMP2;MFAP5;MMP19;NID1;NID2;COL13A1;TGFBR1;VTN;COL9A2;ITGB8;MMP11;SMOC2;ECM2;ITGB5
prerank,external encapsulating structure organization (GO:0045229),0.6352090089480403,2.15318937955038,0.0,0.0005064714695024301,0.001,53/205,5.48%,ITGA9;ADAMTS6;COL4A4;ADAMTS12;COL4A5;ADAMTSL3;LAMA1;COL4A6;FBN1;COL1A2;COL1A1;DDR2;FBLN5;COL4A3;THSD4;COL22A1;ELN;ADAMTS10;ADAMTS5;LOXL1;MATN3;LUM;SPARC;COL5A1;COL8A2;LOX;DAG1;DCN;BGN;LAMA2;FBN2;SERPINE1;COL11A1;HSPG2;ITGA11;ADAMTS2;ADAMTSL2;RECK;LAMC1;ITGA3;MMP2;MFAP5;MMP19;NID1;NID2;COL13A1;VTN;COL9A2;ITGB8;MMP11;SMOC2;ECM2;ITGB5
prerank,translation (GO:0006412),-0.4686539159832339,-2.1485472452703887,0.0,0.0012520675528782748,0.009,91/208,23.09%,RPL41;RPS12;RPL3;RPS24;RPS14;RPL27A;RPL8;RPS19;RPL34;WARS1;RPS13;RPL21;RPL7;RPL18;RPL27;EEF2;RPL35A;RPL38;RPS15;RPS3;RPL39;RPS7;RPS4X;RPL11;WARS2;MRRF;RPL30;RPS23;RPL36;RPLP1;RPS29;RPL37;NOA1;GTPBP1;LARS1;RPS9;YARS1;RPS5;GFM2;YARS2;RPL4;RPL18A;RPL26;RPL6;RPL36A;RPL29;MRPS18A;QARS1;RPL13A;MRPS5;RPL7A;RPL19;RPS20;RPL14;EEF1A1;RPL13;EEF1B2;RPL32;MRPS12;RPL5;KARS1;NDUFA7;RPSA;FASTKD2;MRPS33;FARS2;RPLP0;AIMP1;MRPL55;MRPL57;RPS6;RPS6KB2;RPL22;MRPS18B;MRPL42;MARS2;RPS21;RPL37A;RPLP2;MRPS21;AIMP2;MRPS7;RPL17;RPL23;MRPL34;EIF4EBP2;TARS1;RPL28;PABPC4;RPL31;EEF1A2
prerank,heme catabolic process (GO:0042167),-0.8145359406025195,-2.1256888281186725,0.0,0.0015148471627416163,0.014,4/14,3.20%,ABCG2;HMOX2;SLCO2B1;ABCC1
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.8145359406025195,-2.1256888281186725,0.0,0.0015148471627416163,0.014,4/14,3.20%,ABCG2;HMOX2;SLCO2B1;ABCC1
prerank,retinoid metabolic process (GO:0001523),0.6763233360710137,2.022713981936985,0.0,0.0151941440850729,0.038,15/71,7.28%,ALDH1A1;RBP4;GPC6;AKR1B1;CYP26B1;LRP1;HSPG2;DHRS3;RBP1;APOE;APOA1;CYP1B1;ALDH1A2;SDC1;ADH1A
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.7168216393263983,2.0066642418473686,0.0,0.016460322758828975,0.055,15/43,8.95%,IGF1;NELL1;BMP6;DDR2;FBN2;IL6R;BMPR1A;CCN1;WNT4;YAP1;RUNX2;ACVR1;WWTR1;BMP2;CCN4
prerank,extracellular matrix organization (GO:0030198),0.5827590411961142,2.0035401580762975,0.0,0.01397861255826707,0.057,68/276,7.81%,ITGA9;ADAMTS6;COL4A4;ADAMTS12;COL4A5;ADAMTSL3;LAMA1;COL4A6;FBN1;COL1A2;COL1A1;DDR2;FBLN5;COL4A3;THSD4;COL22A1;ELN;ADAMTS10;ADAMTS5;LOXL1;MATN3;LUM;GSN;SPARC;COL5A1;COL8A2;LOX;DAG1;DCN;BGN;LAMA2;FBN2;SERPINE1;COL11A1;HSPG2;ITGA11;DPT;ADAMTS2;ADAMTSL2;RECK;LAMC1;ITGA3;MMP2;MFAP5;MMP19;NID1;NID2;GAS6;COL13A1;TGFBR1;VTN;COL9A2;SH3PXD2B;ITGB8;MMP11;SMOC2;COL20A1;ECM2;ITGB5;CYP1B1;ADAMTS9;SERPINH1;TNC;SMOC1;TIMP2;COLQ;SCUBE1;FLRT2
prerank,diterpenoid metabolic process (GO:0016101),0.6939021801195485,2.0011464582120584,0.0,0.011986491444890843,0.057,10/55,4.30%,ALDH1A1;RBP4;GPC6;AKR1B1;LRP1;HSPG2;DHRS3;RBP1;APOE;APOA1
prerank,regulation of exocytosis (GO:0017157),-0.5772019844186332,-1.97395367891801,0.0,0.03233116658765678,0.256,20/46,19.34%,STXBP6;IL1RAPL1;RAB27A;STXBP5L;RAB21;RAB3C;RIMS2;SYT1;CADPS;RAB12;RAB8B;RAB27B;LGI3;NSF;CPLX1;CFTR;RAB15;RAB3A;CLASP1;ANXA1
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.8276435370126595,1.9536342843562249,0.0016420361247947454,0.03675535807246206,0.184,3/18,0.46%,IGF1;IGFBP2;IGF2
prerank,regulation of activated T cell proliferation (GO:0046006),0.7440367025655324,1.9451944525245537,0.0,0.03988462822331637,0.225,3/30,0.46%,IGF1;IGFBP2;IGF2
prerank,skeletal system development (GO:0001501),0.5997297969705698,1.9435000950241008,0.0,0.037028691881399886,0.231,28/148,5.51%,IGF1;RBP4;BMP6;FBN1;COL1A2;IGF2;COL1A1;GJA1;TRPS1;CDH11;MATN3;AHSG;SOX5;GLI2;SULF2;FGFR1;ANKH;FGFR2;GNAS;COL13A1;TGFBR1;NPR3;COL9A2;SULF1;SH3PXD2B;ITGB8;CREB3L2;TBX3
prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.8802402096390904,1.9428392970174286,0.0,0.03373099986886184,0.233,5/13,4.05%,LTBP1;GREM2;FBN1;FBN2;FSTL1
prerank,collagen fibril organization (GO:0030199),0.6304010681009652,1.9380603034403037,0.0,0.034163802760982104,0.261,22/88,6.32%,COL4A4;COL4A5;COL4A6;COL1A2;COL1A1;DDR2;COL4A3;COL22A1;LOXL1;LUM;COL5A1;COL8A2;LOX;COL11A1;DPT;ADAMTS2;COL13A1;TGFBR1;COL9A2;COL20A1;CYP1B1;SERPINH1
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.8329376519101711,1.9332438170548625,0.0016233766233766235,0.03444005992616524,0.282,9/17,9.52%,IGF1;NRP1;DOCK4;PDGFRB;VTN;IGFBP5;DOCK5;CCN4;S100A11
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.7189104651814889,-1.9093541725117535,0.0,0.07436522435277025,0.521,7/15,6.83%,KCNJ2;ATP1A1;KCNJ3;KCND3;KCNN2;KCNQ1;ATP1B1
prerank,positive regulation of nuclear division (GO:0051785),0.7575137159269864,1.9035810578510188,0.0,0.058127340961355814,0.448,13/25,13.24%,IGF1;IGF2;TGFA;EPGN;PDGFRB;PHIP;CD28;NPM2;SIRT2;DRD3;RGCC;INSR;EGF
prerank,negative regulation of reproductive process (GO:2000242),0.8308305587032978,1.9024321518509621,0.0,0.055277743242836644,0.456,3/17,4.15%,IGF1;GJA1;SULF1
prerank,regulation of epithelial cell proliferation (GO:0050678),0.6045752960869151,1.8974997972214154,0.0,0.05692739317207313,0.488,18/85,8.59%,IGF1;TCF7L2;BMP6;MTSS1;ANGPT1;TGFBR3;MCC;TGFA;LAMC1;EPGN;FGFR2;YAP1;NUPR1;SFRP1;ZFP36L1;NR1D1;OSR1;EGFR
prerank,primary alcohol metabolic process (GO:0034308),0.7441409724196261,1.8895472784265968,0.0015174506828528073,0.06349886048886717,0.544,5/25,7.28%,IGF1;RBP4;DHRS3;CYP1B1;ADH1A
prerank,eye development (GO:0001654),0.6545092476057689,1.8720881056493504,0.0,0.08139294439297876,0.642,12/54,6.98%,RBP4;LAMA1;FBN1;PBX1;COL5A1;FBN2;SHROOM2;SH3PXD2B;CPAMD8;SKI;CACNA1C;SMOC1
prerank,negative regulation of peptidase activity (GO:0010466),0.6610011531442509,1.867278160151764,0.0027397260273972603,0.0848058338377958,0.679,13/47,7.13%,TIMP3;LRP1;AHSG;SERPINE1;SERPING1;VTN;FETUB;SERPIND1;SERPINF1;CST3;SERPINH1;CRB2;TIMP2
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.8181366677096596,1.8626521376343639,0.0,0.08673990325057405,0.704,6/16,5.13%,IGF1;IGFBP2;CILP;IGFBP4;PHIP;IGFBP5
prerank,regulation of phospholipase activity (GO:0010517),0.8913836723368795,1.8616269610911362,0.0,0.08377038105570193,0.709,4/10,3.02%,PDPK1;LRP1;FGFR1;FGFR2
prerank,cardiac muscle cell membrane repolarization (GO:0099622),-0.7734766563911228,-1.859578187130056,0.0,0.13276553347742592,0.743,6/11,6.83%,KCNJ2;ATP1A1;KCNJ3;KCND3;KCNQ1;ATP1B1
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.783791968832622,1.8589591891652808,0.0,0.08335073326668564,0.717,5/19,4.68%,DAPK2;CAMK1D;RIPOR2;CCL19;MCU
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.5324076846688661,-1.8548080570526446,0.0,0.1308678128559694,0.765,22/46,17.45%,GRM7;MEF2C;SHANK3;GRM3;CDH2;NLGN1;PTK2B;GRIK1;TSHZ3;NRXN1;GRM5;OPHN1;CDK5;SYT1;TPRG1L;GRM8;HOMER1;NLGN3;CACNG3;CACNG4;GRM1;DGKZ
prerank,positive regulation of neutrophil migration (GO:1902624),0.7910409030137945,1.8543483169110375,0.0031746031746031746,0.08651453556318782,0.748,5/18,4.68%,DAPK2;CAMK1D;RIPOR2;CCL19;MCU
prerank,chloride transport (GO:0006821),-0.48807489296049483,-1.8536555774576196,0.0,0.12367645050097624,0.774,27/74,14.00%,SLC4A10;SLC12A2;SLC26A7;SLC12A7;CLIC4;GABRG3;ANO1;ANO4;CLCN3;CLIC5;GABRA2;GABRB3;GLRA1;GABRB1;GABRG2;SLC1A1;GLRA2;SLC12A6;CLIC1;GABRB2;SLC4A8;GABRA3;SLC26A6;ANO3;ANO2;CFTR;SLC12A5
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.6097320330946526,1.8507034059036966,0.0,0.08821411768811889,0.767,15/74,6.31%,IGF1;TCF7L2;EYA2;GDNF;AR;EYA1;SERPINE1;BCL2;SH3RF1;CFLAR;TGFBR1;RFFL;ACVR1;PHIP;SRC
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.7945810523248166,1.8468586287189328,0.0016260162601626016,0.09108045259885367,0.79,5/17,4.68%,DAPK2;CAMK1D;RIPOR2;CCL19;MCU
prerank,cell junction assembly (GO:0034329),-0.46169964101659056,-1.8439266263160914,0.0,0.13081787283961527,0.808,28/100,6.25%,PKP4;DNM3;FN1;ADGRL3;SHANK3;CTNND2;CLDN5;CDH2;GPM6A;ITGA6;NLGN1;LIMS2;CDH1;ACTB;SPOCK2;KIRREL3;TJP1;GJC1;NRCAM;MYO9A;DNER;CDH12;CDH6;NRXN1;CDH8;CDH9;OPHN1;CDK5
prerank,cellular response to zinc ion (GO:0071294),-0.7115634480251967,-1.8431386550714148,0.00468384074941452,0.12428509445029207,0.812,10/15,5.93%,GLRA1;MT1B;MT1G;MT1E;MT1A;MT1H;MT1M;MT1X;MT1F;GLRA2
prerank,regulation of stress fiber assembly (GO:0051492),0.6028088861242867,1.839321842111329,0.0,0.09951151432783745,0.835,21/74,7.54%,NRP1;PHLDB2;CCN2;ROCK2;PPM1E;PIK3R1;CGNL1;ARHGAP6;DLC1;TPM1;ARHGAP28;ARHGEF10L;TGFBR1;ASAP3;APOA1;SFRP1;CDC42;ALMS1;ARHGEF18;LPAR1;CARMIL1
prerank,actin cytoskeleton reorganization (GO:0031532),0.6256641901654719,1.8359520492119001,0.001314060446780552,0.10086574111859932,0.85,13/63,5.11%,NRP1;AUTS2;PHACTR1;NRK;ANTXR1;GSN;NEDD9;PARVA;KIT;DTNBP1;THSD7A;MCU;PTK7
prerank,regulation of osteoblast proliferation (GO:0033688),0.7805686350776746,1.8303260935003043,0.0,0.106208942974917,0.874,7/17,8.75%,NELL1;MN1;CCN1;FGFR2;NPR3;SFRP1;BMP2
prerank,glutamate receptor signaling pathway (GO:0007215),-0.5604312126281633,-1.82797221658626,0.003115264797507788,0.1422365106965836,0.877,20/37,19.53%,GRM7;GRID2;GRM3;GRIA4;PTK2B;GRIK1;GRIK2;GRIN2A;GRM5;GRIN2B;GRIN3A;GRIA2;GRM8;HOMER1;APP;CDK5R1;HOMER3;GRM1;GRIN1;DAGLB
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.6160509301742731,1.8225530089861939,0.0,0.1165246145190948,0.906,18/65,10.36%,LTBP1;PDPK1;FBN1;SMAD3;LDLRAD4;FBN2;ADAMTSL2;NKX2-1;PMEPA1;TGFBR1;SLC2A10;SMURF2;SKI;EMILIN1;SPRY2;LEMD3;FAM89B;SPRED3
prerank,neuron cell-cell adhesion (GO:0007158),-0.6911155398167717,-1.8132555500153555,0.004830917874396135,0.15992457903800777,0.916,9/14,21.03%,NLGN1;NRXN3;NCAM2;CNTN4;NRXN1;RET;NLGN3;CDK5R1;ASTN1
prerank,regulation of smooth muscle cell migration (GO:0014910),0.7526714727668818,1.8129479040796055,0.0,0.13238116340787653,0.936,11/20,11.07%,IGF1;NRP1;LRP1;SERPINE1;BMPR1A;PDGFRB;VTN;IGFBP5;CCN4;S100A11;IGFBP3
prerank,synapse assembly (GO:0007416),-0.48039559280560573,-1.8099988347588318,0.0,0.15760674898073018,0.921,18/67,6.25%,DNM3;ADGRL3;GRID2;SHANK3;CDH2;GPM6A;NLGN1;CDH1;SPOCK2;KIRREL3;NRCAM;GABRA2;GABRB3;DNER;NRXN1;GABRG2;LRRTM3;CDK5
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.6016744131042877,1.8095973808254373,0.0,0.13428246894741094,0.943,29/74,15.86%,EPHA3;PHLDB2;COL1A1;SMAD3;LDLRAD4;DAG1;OLFM1;NKX2-1;TGFBR1;AXIN2;SFRP1;PDPN;CRB2;WWTR1;DAB2;BMP2;SPRY2;USF3;FOXA1;SPRED3;RGCC;VASN;PTEN;MDK;HPN;GLIPR2;SPRED1;BMP5;SDHAF2
prerank,positive regulation of protein processing (GO:0010954),0.7504209944923321,1.8088216145042368,0.00463678516228748,0.13161723091327665,0.945,3/19,1.20%,CCBE1;CLEC3B;GSN
prerank,positive regulation of phospholipase activity (GO:0010518),0.7287873462618052,1.80744971042449,0.0031446540880503146,0.1299732408610611,0.949,11/22,10.16%,PDPK1;FGFR1;FGFR2;KIT;PDGFRA;PDGFRB;NTF3;AGTR1;NTRK3;ARL1;FGF2
prerank,regulation of glucose import (GO:0046324),0.6893667133737666,1.8054119859479998,0.0014814814814814814,0.13054685816932332,0.952,11/30,12.55%,IGF1;ENPP1;PID1;PIK3R1;PRKAG2;APPL2;OSBPL8;CREBL2;RHOQ;SELENOS;INSR
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.7459045240467774,1.8042320146223092,0.006097560975609756,0.12873313057176472,0.953,5/21,5.13%,IGF1;GJA1;BMPR1A;MMP2;IGFBP5
prerank,negative regulation of endopeptidase activity (GO:0010951),0.63257174963419,1.800931197305444,0.0027434842249657062,0.13159575839014567,0.954,13/47,7.13%,TIMP3;AHSG;SERPINE1;SERPING1;RECK;VTN;FETUB;MT3;SERPIND1;SERPINF1;SERPINH1;CRB2;TIMP2
prerank,membrane repolarization during action potential (GO:0086011),-0.716396768563099,-1.8000350923013246,0.0,0.1678396554633327,0.937,5/13,6.83%,KCNJ2;ATP1A1;KCND3;KCNQ1;ATP1B1
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.7260866410365389,-1.795054275310134,0.009111617312072893,0.16893637389390942,0.946,6/12,10.38%,PDE4D;CAV1;GJD3;CAMK2D;CALM1;CALM3
prerank,ribosomal large subunit biogenesis (GO:0042273),-0.4939735792717415,-1.7940348806308604,0.0,0.1628952533441634,0.949,23/54,21.54%,NSA2;RPL3;RPL7;RPL35A;PAK1IP1;RPL11;MAK16;RPL26;RPL6;MALSU1;RPL7A;NVL;PPAN;SNU13;RPL14;RPL5;RPLP0;NPM1;RRP15;NOP16;RPF1;RRS1;RPF2
prerank,regulation of bone mineralization (GO:0030500),0.6257332197998897,1.7932354132466288,0.0026845637583892616,0.14459760454294376,0.963,18/55,9.40%,NELL1;BMP6;DDR2;ENPP1;SLC8A1;ADGRV1;AHSG;FBN2;BMPR1A;CCN1;ANKH;KL;WNT4;ACVR1;BCOR;OSR1;BMP2;TRPM4
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.8027088213314534,1.7916680056951524,0.007067137809187279,0.14411166570058334,0.966,3/13,4.03%,IGF1;CCL19;SLC2A10
prerank,regulation of smooth muscle contraction (GO:0006940),-0.6241180382397592,-1.7915712656812763,0.0026595744680851063,0.16021625768424996,0.951,7/20,16.47%,PLCE1;CAV1;KCNB2;CHRM3;ADRB2;CHRM2;CTTN
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.7661149304781764,-1.7886329461468804,0.0,0.15840973187526616,0.964,3/10,1.90%,CAV1;ANK3;KCNAB1
prerank,regulation of osteoblast differentiation (GO:0045667),0.5834117977502603,1.7876300422432825,0.0,0.14823620220542175,0.973,27/82,15.02%,IGF1;NELL1;BMP6;DDR2;FBN2;IL6R;BMPR1A;CCN1;FGFR2;WNT4;YAP1;RUNX2;ACVR1;SKI;SMOC1;WWTR1;BMP2;CCN4;TRPM4;DNAI3;REST;TMEM64;LRP3;TMEM119;TWIST2;BMP4;SUFU
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.667300775575772,1.7817530554298961,0.007204610951008645,0.15757755925493555,0.982,12/34,13.24%,IGF1;IGF2;TGFA;EPGN;PDGFRB;PHIP;CD28;DRD3;ANAPC5;RGCC;INSR;EGF
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.7320489241808518,1.7787049754057271,0.004491017964071856,0.16034886724446937,0.985,8/23,5.92%,NREP;TGFBR3;SMAD3;ITGA3;SMURF2;ENG;DKK3;BCL9
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.724547249204634,1.7774373336786062,0.006153846153846154,0.15560732958236564,0.987,4/21,1.86%,EYA2;GDNF;EYA1;BCL2
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),0.724547249204634,1.7774373336786062,0.006153846153846154,0.15560732958236564,0.987,4/21,1.86%,EYA2;GDNF;EYA1;BCL2
prerank,establishment of endothelial barrier (GO:0061028),-0.5793851112102699,-1.7761010644113295,0.0,0.17517259776468982,0.978,13/29,10.46%,PDE4D;PECAM1;RAP1A;F11R;PPP1R16B;TJP2;TJP1;RDX;PDE2A;RAP1B;ROBO4;SOX18;MSN
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.6980814481611345,1.7712279832411733,0.0030721966205837174,0.16720625537340691,0.99,5/26,2.08%,EYA2;GDNF;EYA1;BCL2;FGFR1
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.6638675769203938,1.7694368095316888,0.0014326647564469914,0.16805644215307905,0.99,12/33,6.96%,TCF7L2;PDPK1;ANGPT1;SERPINE1;YAP1;GAS6;NUPR1;SEMA5A;CAST;NEUROD1;CDH5;NFE2L2
prerank,regulation of steroid metabolic process (GO:0019218),0.7054977855005772,1.7674321320728483,0.004418262150220913,0.1692515101861676,0.99,6/23,6.58%,RORA;EPHX2;APOE;STAR;GNB3;NR5A1
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.6343693163692214,1.7666291888145795,0.00423728813559322,0.16810448687745871,0.99,9/46,6.81%,IGF1;TCF7L2;OGN;ELN;IL6R;PDGFRB;IGFBP5;VIP;IL12B
prerank,neurotransmitter uptake (GO:0001504),0.8161791465123601,1.7662507603977688,0.00865051903114187,0.1653036668546229,0.99,4/12,4.20%,SLC1A3;GLUL;ATP1A2;SLC22A2
prerank,response to copper ion (GO:0046688),-0.6293665232256521,-1.7626740035065307,0.010554089709762533,0.1943166036338779,0.985,8/20,4.62%,MT1B;MT1G;MT1E;MT1A;MT1H;MT1M;MT1X;MT1F
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.613140650109261,1.7626340977154245,0.0,0.17055426735494328,0.99,9/49,7.07%,IGF1;GHR;IL31RA;LYN;IL6R;KIT;PIBF1;IL12B;TSLP
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.6906309166204411,1.7616159972715106,0.0,0.16996769070403997,0.991,10/30,5.92%,NREP;TGFBR3;SMAD3;ITGA3;FSTL1;TWSG1;SMURF2;ENG;DKK3;BCL9
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.8453873690381327,1.7606852329620912,0.0,0.16879681135576985,0.991,5/10,4.70%,LYN;GAS6;CCL19;RAPGEF2;AXL
prerank,cellular response to copper ion (GO:0071280),-0.6746113733739783,-1.7589377359158365,0.009925558312655087,0.19501853830818855,0.989,8/16,4.62%,MT1B;MT1G;MT1E;MT1A;MT1H;MT1M;MT1X;MT1F
prerank,positive regulation of T cell proliferation (GO:0042102),0.5941236420889054,1.7513147713965318,0.002699055330634278,0.1894004679676538,0.993,6/55,7.09%,IGF1;IGFBP2;IGF2;CCL19;IL12B;CD28
prerank,regulation of neuroinflammatory response (GO:0150077),0.7311562032265746,1.7484107159500633,0.012598425196850394,0.1939201338037189,0.994,5/19,8.68%,IGF1;DAGLA;NUPR1;NR1D1;CD200
prerank,positive regulation of biomineral tissue development (GO:0070169),0.6468158880810633,1.7423411386100853,0.005706134094151213,0.20568475301076045,0.997,11/40,4.67%,NELL1;BMP6;SLC8A1;ADGRV1;FBN2;BMPR1A;CCN1;KL;WNT4;WNT6;ACVR1
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.5096169240426545,1.7402318821249276,0.0,0.20737192945738384,0.997,57/248,13.39%,IGFBP2;TCF7L2;LYPD6;WLS;BICC1;LRRK1;COL1A1;RNF220;DAAM2;CDK14;TBL1XR1;RBMS3;MCC;ZEB2;IGFBP4;LGR4;DACT1;NKD1;KANK1;GLI3;FGFR2;APOE;SEMA5A;TMEM170B;TLE1;SMURF2;PRICKLE1;PSME4;AXIN2;MLLT3;SFRP1;PTK7;DKK3;USP47;ZNRF3;ADGRA2;LRRK2;WWTR1;STK4;DAB2;EGFR;BMP2;PRKN;TRPM4;STK11;INVS;DDX3X;LZTS2;JADE1;TMEM64;WNK1;GLI1;BTRC;UBAC2;KLHL12;EGF;TNKS2
prerank,positive regulation of protein secretion (GO:0050714),0.5860015563022193,1.7388363252824415,0.0012610340479192938,0.2078190567951062,0.997,9/69,4.68%,IGF1;TCF7L2;RBP4;BMP6;WLS;SLC30A8;MYO18A;MYH10;MCU
prerank,myoblast differentiation (GO:0045445),0.7783037242614648,1.7365858132825067,0.0034965034965034965,0.21031227771088407,0.997,5/14,7.40%,IGF1;TCF7L2;EPAS1;SDC1;DDX17
prerank,retinol metabolic process (GO:0042572),0.7728873445916846,1.7341785716939107,0.0034965034965034965,0.21254030790347592,0.998,4/14,7.28%,RBP4;DHRS3;CYP1B1;ADH1A
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.7535792908550115,1.7313961736429437,0.00338409475465313,0.2167173953467467,0.999,8/17,14.65%,ADRA1B;ADCY9;RAPGEF2;ADRA2C;ADRB3;DRD3;ADRA2A;AKAP13
prerank,regulation of membrane repolarization (GO:0060306),-0.6791629284590965,-1.7307612877714678,0.004739336492890996,0.2585171700151171,0.999,7/13,14.78%,CAV1;KCNJ2;NEDD4L;KCNQ1;AKAP6;CASQ2;CACNA2D1
prerank,positive regulation of stress fiber assembly (GO:0051496),0.6140852669301928,1.7294845649973292,0.008759124087591242,0.218160439422623,0.999,15/44,11.51%,NRP1;CCN2;ROCK2;PPM1E;TPM1;ARHGEF10L;TGFBR1;APOA1;SFRP1;CDC42;LPAR1;CARMIL1;SYNPO2L;ARHGEF10;RGCC
prerank,defense response to tumor cell (GO:0002357),0.8208662274443131,1.728635131008186,0.001763668430335097,0.2167191418000898,0.999,3/10,1.83%,DAPK1;RBMS3;DLEC1
prerank,regulation of protein processing (GO:0070613),0.6929998731505718,1.7281527208238552,0.019834710743801654,0.21449481873976686,0.999,8/21,15.32%,CCBE1;RUNX1;LRRK2;RNF139;SNX12;CLN3;GAS1;NLRC4
prerank,positive regulation of glycogen metabolic process (GO:0070875),0.79388263122699,1.726588845367949,0.011764705882352941,0.21515234780250003,0.999,2/13,0.46%,IGF1;IGF2
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.5151519374372613,-1.7263241159651241,0.0,0.2621954182763026,1.0,10/37,3.96%,HMCN1;GRID2;CADM1;NLGN1;IL1RAPL1;TENM2;TENM3;TENM4;PTPRD;NECTIN1
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.5260222345740713,1.7224207360400159,0.0,0.22344234957699272,0.999,28/152,6.62%,LYPD6;WLS;LRRK1;COL1A1;RNF220;DAAM2;TBL1XR1;ZEB2;LGR4;DACT1;SULF2;SALL1;KANK1;MACF1;FGFR2;SEMA5A;LBX2;SULF1;SMURF2;PSME4;AXIN2;SFRP1;PTK7;USP47;SKI;ADGRA2;LRRK2;WNT5B
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.5479927813941506,1.7204789884932143,0.0,0.22541145839542528,0.999,23/113,10.16%,IGF1;TCF7L2;NRP1;BMP6;AREG;TGFA;LAMC1;EPGN;FGFR2;VASH2;YAP1;TGFBR1;SEMA5A;NOTCH2;SFRP1;VIP;AKT3;OSR1;EGFR;BMP2;ITGB3;ARNT;FGF2
prerank,angiogenesis involved in wound healing (GO:0060055),-0.720015452947206,-1.7201755340293656,0.006880733944954129,0.27088713370883116,1.0,7/11,9.51%,ADIPOR2;CD34;KDR;PRCP;GATA2;MCAM;VEGFA
prerank,positive regulation of bone mineralization (GO:0030501),0.653298844641437,1.719965031717549,0.007132667617689016,0.22367338466979628,0.999,10/35,4.67%,NELL1;BMP6;SLC8A1;ADGRV1;FBN2;BMPR1A;CCN1;KL;WNT4;ACVR1
prerank,regulation of small molecule metabolic process (GO:0062012),0.6700817004476721,1.7185095849684862,0.005917159763313609,0.2244282514707283,0.999,7/28,10.76%,PDK1;RORA;EPHX2;APOE;GNB3;PRKN;NCOR2
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.6295754734064319,-1.7183952545411707,0.01020408163265306,0.26730071559888413,1.0,10/18,23.02%,SHANK3;NLGN1;PTK2B;TSHZ3;NRXN1;NLGN3;CACNG3;CACNG4;RELN;CCL2
prerank,regulation of mitotic nuclear division (GO:0007088),0.5959156863724601,1.71792854209609,0.005298013245033113,0.22278697237575548,0.999,15/55,13.24%,IGF1;IGF2;TGFA;OBSL1;EPGN;PDGFRB;TOM1L2;PHIP;CD28;DRD3;L3MBTL1;RGCC;NME6;INSR;EGF
prerank,positive regulation of dendrite extension (GO:1903861),-0.6272930573088249,-1.7139654797884598,0.014563106796116505,0.27042050668102235,1.0,6/17,7.82%,SMURF1;RIMS1;NEDD4L;RIMS2;SYT1;ITSN2
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.8032143122718283,1.7133287077333739,0.009157509157509158,0.23181497083520047,0.999,3/10,4.30%,NELL1;EPHA4;CDK5RAP3
prerank,regulation of dendrite extension (GO:1903859),-0.619204483152607,-1.712056176060804,0.012285012285012284,0.26697705742837796,1.0,6/18,7.82%,SMURF1;RIMS1;NEDD4L;RIMS2;SYT1;ITSN2
prerank,cAMP biosynthetic process (GO:0006171),0.8337178810022584,1.7108803826391505,0.0054446460980036296,0.23542849149015857,0.999,5/10,3.53%,ADCY1;ADCY2;ADCY7;ADCY5;ADCY9
prerank,lung development (GO:0030324),0.6443976360566533,1.70730604315864,0.005780346820809248,0.24206442119533286,0.999,14/33,14.89%,RBP4;ERRFI1;GLI2;ITGA3;NKX2-1;FGFR2;PDPN;CEBPA;DNAAF1;FGF2;RCN3;CCDC40;ABCA3;BMP4
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),0.8001109311864614,1.705291252697621,0.01718213058419244,0.2445187187549901,0.999,2/12,0.46%,IGF1;IGF2
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.5266265417722087,1.7047710289476572,0.001160092807424594,0.24283900097448458,0.999,21/129,6.60%,LYPD6;WLS;LRRK1;COL1A1;RNF220;DAAM2;TBL1XR1;ZEB2;LGR4;DACT1;KANK1;FGFR2;SEMA5A;SMURF2;PSME4;AXIN2;SFRP1;PTK7;USP47;ADGRA2;LRRK2
prerank,regulation of glycogen biosynthetic process (GO:0005979),0.6929235245271891,1.7028670131402903,0.012084592145015106,0.24559009695132905,0.999,3/24,0.63%,IGF1;IGF2;ENPP1
prerank,positive regulation of behavior (GO:0048520),-0.7140755879020143,-1.7006514081456872,0.017114914425427872,0.2908315605342549,1.0,3/10,1.44%,MEF2C;SGIP1;NLGN1
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.5909855636352204,1.7005101716197184,0.008391608391608392,0.24889650621520773,0.999,16/51,11.51%,NRP1;CCN2;ROCK2;PPM1E;TPM1;ARHGEF10L;TGFBR1;APOA1;SYNPO2;SFRP1;CDC42;LPAR1;CARMIL1;SYNPO2L;ARHGEF10;RGCC
prerank,sympathetic nervous system development (GO:0048485),0.7555095845103543,1.6988472674658972,0.008403361344537815,0.2504400122395616,0.999,3/15,3.20%,NRP1;GDNF;ASCL1
prerank,regulation of AMPA receptor activity (GO:2000311),-0.5754543724030665,-1.698812589777222,0.014204545454545454,0.28758600503444104,1.0,12/25,22.69%,MEF2C;SHANK3;NLGN1;SHANK1;ADRB2;GSG1L;NLGN3;CACNG3;CACNG4;SHISA9;MINK1;RELN
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),0.7991815278083729,1.6967693970173512,0.013769363166953529,0.2535022986825321,0.999,3/11,1.19%,IGF1;GHR;PIK3R1
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.6705769788014196,1.6959004214308944,0.018957345971563982,0.25292001227672,0.999,7/24,9.69%,CCBE1;RORA;SULF2;SULF1;CYP1B1;EIF2AK3;ARNT
prerank,protein oxidation (GO:0018158),0.808967289913804,1.694852077771724,0.0034482758620689655,0.2528201684172643,0.999,3/11,4.30%,LOXL1;LOX;APOA1
prerank,sulfur compound catabolic process (GO:0044273),0.6218580421090303,1.6885511674129194,0.009859154929577466,0.26869914214918794,1.0,11/38,8.04%,FMOD;OGN;LUM;DCN;BGN;GALNS;CHAC2;NUDT7;DPEP1;OMD;CSPG5
prerank,response to histamine (GO:0034776),-0.7248014134866197,-1.688524422008674,0.009433962264150943,0.30984034646504416,1.0,6/10,11.62%,DIAPH1;GABRB3;GABRB1;GABRG2;GABRB2;HRH1
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.677600441337691,1.687647778451163,0.013719512195121951,0.2682905991821748,1.0,8/22,14.45%,SH3D19;TIMP3;APOE;SNX33;TIMP2;ADRA2A;PTPN3;SNX9
prerank,positive regulation of ATP metabolic process (GO:1903580),0.6454316783931516,1.6852861633151013,0.008759124087591242,0.2718563771731685,1.0,6/32,5.19%,IGF1;ZBTB20;PID1;PFKFB4;NUPR1;PRKAA2
prerank,inorganic anion transmembrane transport (GO:0098661),-0.45382911706147855,-1.6801200072006337,0.0,0.32625947657163257,1.0,26/63,14.00%,SLC12A2;SLC12A7;SLC26A2;GABRG3;ANO1;ANO4;CLCN3;SLC5A6;GABRA2;GABRB3;GLRA1;GABRB1;GABRG2;SLC1A1;GLRA2;SLC12A6;GABRB2;SLC37A3;SLC4A8;SLC25A30;GABRA3;ANO3;ANO2;CFTR;SLC25A11;SLC12A5
prerank,positive regulation of microtubule polymerization (GO:0031116),-0.547446773302193,-1.6798654692006763,0.011976047904191617,0.31859627696397363,1.0,12/28,18.88%,OCLN;NAV3;MET;RPS3;MECP2;PAK1;FES;GIT1;DCTN1;CDK5RAP2;CDK5R1;CLASP1
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.568541961040152,1.6789699344891114,0.00655307994757536,0.28810814837085796,1.0,12/63,6.42%,IGF1;TCF7L2;AR;FGFR1;SH3RF1;SP100;CFLAR;TGFBR1;ACVR1;PHIP;SRC;PML
prerank,negative regulation of protein catabolic process (GO:0042177),0.6138780139562363,1.677320907485434,0.005594405594405594,0.28990915079590907,1.0,13/40,14.42%,NELL1;TIMP3;CDK5RAP3;SNRNP70;CST3;TIMP2;SIRT2;IRAK3;EGFR;SNX12;PTPN3;BANP;FLNA
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.6586172302489316,1.6772699429917206,0.017241379310344827,0.28662667520483953,1.0,7/26,9.69%,CCBE1;RORA;SULF2;SULF1;CYP1B1;EIF2AK3;ARNT
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.7468909728237774,1.6769631145078454,0.010067114093959731,0.28423178868476373,1.0,4/14,8.68%,IGF1;LDLR;NR1D1;CD200
prerank,epidermis development (GO:0008544),0.5794553884529154,1.675911624998481,0.004016064257028112,0.2841776080159333,1.0,5/56,4.52%,SVEP1;CCN2;FGFR2;TGM5;EDAR
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.5694523181527998,1.6755071564504536,0.002680965147453083,0.2822035742022965,1.0,9/57,7.07%,IGF1;GHR;IL31RA;LYN;IL6R;KIT;PIBF1;IL12B;TSLP
prerank,modulation of chemical synaptic transmission (GO:0050804),-0.4147470579431345,-1.6748882657266018,0.0,0.3256588466452114,1.0,33/107,11.61%,GRM7;SLC12A2;GRID2;MEF2C;MCTP1;GRM3;CDH2;NRG3;NLGN1;RIMS1;NGF;GRIK1;GRIK2;PXK;DLGAP2;GRM5;OPHN1;CDK5;RIMS2;SYT1;TMEM108;CLSTN2;LRP8;SLC4A8;TPRG1L;LRRC4C;BCR;SYN3;GRID1;CLSTN3;GRM8;CX3CR1;HOMER1
prerank,activation of protein kinase B activity (GO:0032148),0.6504039760530426,1.6738567817460959,0.008888888888888889,0.2838657479408961,1.0,8/29,8.16%,IGF1;PDPK1;GAS6;MT3;NTF3;OSBPL8;ADRA2C;NTRK3
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.7649011311887707,1.6737893485792665,0.010380622837370242,0.2808924914004488,1.0,1/12,0.15%,RBP4
prerank,cellular biogenic amine catabolic process (GO:0042402),0.8022917630149914,1.6730095112289478,0.02033271719038817,0.28011248739947725,1.0,7/10,11.58%,SMOX;SLC44A1;COMT;HNMT;ALDH7A1;LRTOMT;SARDH
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.7012009448585212,1.6710343608081586,0.012403100775193798,0.28294501721499493,1.0,8/19,8.90%,ROBO1;CCBE1;DCN;SMOC2;IL12B;MYO1C;CD63;SPRY2
prerank,ERK1 and ERK2 cascade (GO:0070371),0.673511595566873,1.6705718979127795,0.01584786053882726,0.2813779320566109,1.0,7/21,9.62%,IGF1;APOA1;MT3;CTSH;ZFP36L1;MAP2K1;ITGAV
prerank,regulation of sodium ion transmembrane transport (GO:1902305),-0.5469488238469435,-1.6703654195150355,0.008450704225352112,0.33090754236402936,1.0,7/27,7.81%,UTRN;NEDD4L;YWHAH;CAMK2D;FGF12;NOS1;ATP2B4
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.7207941286689955,-1.6694947382457603,0.020642201834862386,0.3253305823913716,1.0,7/10,23.02%,KDR;IL33;NAMPT;JAK2;NOD2;TLR4;CCL2
prerank,melanosome transport (GO:0032402),-0.6021600204425167,-1.6685886955185294,0.0234375,0.3127354156689216,1.0,8/18,19.54%,RAB27A;RAB11A;RAB27B;ARL6;MLPH;BLOC1S5;BBS7;MREG
prerank,pigment granule transport (GO:0051904),-0.6021600204425167,-1.6685886955185294,0.0234375,0.3127354156689216,1.0,8/18,19.54%,RAB27A;RAB11A;RAB27B;ARL6;MLPH;BLOC1S5;BBS7;MREG
prerank,eye morphogenesis (GO:0048592),0.7071867858588249,1.6680208103630543,0.011725293132328308,0.2865321494236651,1.0,8/19,5.82%,FBN1;COL5A1;FBN2;NKD1;SHROOM2;MFAP5;RARG;SKI
prerank,rRNA processing (GO:0006364),-0.3846667588519429,-1.667793298359253,0.0,0.3079074408320654,1.0,65/172,20.65%,NSA2;RPL41;RPL3;RPS24;RPS14;RPL27A;RPL8;RPS19;RPL34;RPL21;RPL7;RPL18;RIOK1;RPL27;RPL35A;RPL38;RPS15;RPL39;RPS7;RPL11;WDR36;RPL30;RPL36;RPLP1;RPL37;MAK16;RPS9;UTP4;RPL4;RPL18A;RPL26;RPL6;RPL36A;RPL29;RPL13A;LSM6;RPL7A;NVL;RPL19;RRP1;SNU13;POP4;RPL14;RPL13;RPL32;RPL5;NOL9;PRKDC;RPLP0;MPHOSPH10;KRR1;RPS6;RPL22;UTP15;RRP36;IMP4;FCF1;EXOSC5;RRP15;RRP12;RPL37A;RPLP2;RPL17;RPL23;RPF1
prerank,response to iron ion (GO:0010039),0.7661620824530115,1.6668546868573197,0.010968921389396709,0.287277083095006,1.0,4/12,6.50%,BMP6;BCL2;SLC11A2;ACO1
prerank,cell-matrix adhesion (GO:0007160),0.5382479288635331,1.6656211518069766,0.003658536585365854,0.2883475357842993,1.0,25/95,11.26%,ITGBL1;ADAMTS12;FBLN5;ACTN2;DLC1;ITGA11;RHOD;ITGA3;NID2;COL13A1;VTN;ITGB8;ECM2;ITGB5;ADAMTS9;SRC;EMILIN1;VCL;CD63;ITGB6;ITGB3;ITGAV;LYVE1;TRIP6;SGCE
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.69431525220752,1.6655370474054814,0.016286644951140065,0.28554439390989084,1.0,9/21,9.77%,BMP6;CILP;BMPR1A;TGFBR1;SLC2A10;WWTR1;DAB2;RBPMS;FAM89B
prerank,diol biosynthetic process (GO:0034312),-0.6372346253633265,-1.6652630269367132,0.011627906976744186,0.3082713976179189,1.0,6/15,10.72%,ACER3;ACER2;GCH1;DHFR;SPTLC2;SPR
prerank,determination of bilateral symmetry (GO:0009855),-0.5457918620299241,-1.6641765734313276,0.01652892561983471,0.3040467617417016,1.0,11/25,23.28%,NOTCH1;TBX1;ZIC3;GALNT11;DNAH11;STIL;ARL6;CITED2;BBS7;DLL1;ODAD3
prerank,positive regulation of protein maturation (GO:1903319),0.7636768730387063,1.6637410248475035,0.022887323943661973,0.2883754562950434,1.0,1/11,0.21%,CCBE1
prerank,regulation of potassium ion transmembrane transport (GO:1901379),-0.45708046921526196,-1.6628200620044387,0.00398406374501992,0.30161804153840027,1.0,19/54,15.08%,CAV1;DPP10;FHL1;KCNIP4;KCNJ2;KCNAB1;NEDD4L;KCNJ3;KCNMA1;KCNN2;KCNQ1;AKAP6;KCNMB2;DPP6;KCNJ15;GNB1;KCNJ10;GNG2;CACNA1D
prerank,organic anion transport (GO:0015711),-0.43641980762653765,-1.6627691637762758,0.0,0.29551692552447834,1.0,19/76,13.10%,SLC4A10;ABCG2;SLC26A7;LRRC8C;ABCC4;SLCO2A1;SLCO1C1;LRRC8D;SLCO2B1;CA4;SLC22A6;SLC39A8;ABCC6;SLC4A8;SLC26A6;SLC52A3;SLC35A2;SLC25A4;CFTR
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.5155560926098004,1.6618474468757753,0.001182033096926714,0.2919963063968091,1.0,21/121,7.07%,IGF1;NRP1;BMP6;IGF2;ANGPT1;GHR;IL31RA;LYN;NEDD9;EPHA4;IL6R;IL34;KIT;GAS6;VTN;ACVR1;NTF3;PIBF1;SRC;IL12B;TSLP
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.7099358198828619,1.6609653917220777,0.02159468438538206,0.2918196521551274,1.0,4/16,9.32%,PDK1;RORA;GNB3;PRKN
prerank,modulation by symbiont of entry into host (GO:0052372),-0.6288367970958377,-1.6605182101300477,0.005141388174807198,0.29562706109625936,1.0,9/16,21.76%,CAV1;TRIM14;HS3ST5;TRIM25;EXOC2;TRIM68;TRIM6;TRIM62;NECTIN2
prerank,positive regulation of cell differentiation (GO:0045597),0.48236333738548576,1.6597251424290254,0.0,0.29297348624837566,1.0,47/237,8.95%,IGF1;TCF4;NELL1;BMP6;RIN2;COL1A1;GJA1;DDR2;CCN2;GDNF;SMAD3;AR;SOX5;FBN2;FGFR1;IL6R;SP7;BMPR1A;OLFM1;CCN1;ZEB1;MEDAG;WNT4;RIPOR2;ASCL1;YAP1;RUNX2;TGFBR1;CSF1;RAPGEF2;NEUROD4;ACVR1;NEUROD1;AXIN2;SFRP1;PDPN;ZFP36L1;ADRA2C;CDC42;CRB2;AGTR1;WWTR1;PPP1R13L;DAB2;CREBL2;BMP2;CCN4
prerank,keratan sulfate catabolic process (GO:0042340),0.7794957648712539,1.6589158672511677,0.015410958904109588,0.2925800431642454,1.0,5/11,7.97%,FMOD;OGN;LUM;GALNS;OMD
prerank,proteoglycan metabolic process (GO:0006029),0.6639386538915659,1.6559361108182022,0.020771513353115726,0.29890754432458116,1.0,5/26,4.15%,IGF1;ADAMTS12;GAL3ST3;SULF2;SULF1
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.7365332523055845,1.6559007273789437,0.01576182136602452,0.29607437011340115,1.0,2/15,0.75%,IGF1;ROCK2
prerank,melanocyte differentiation (GO:0030318),0.7657837409408483,1.6542899813995495,0.015517241379310345,0.29818507766955565,1.0,5/11,6.52%,ENPP1;LRMDA;MITF;KIT;SLC24A5
prerank,regulation of trans-synaptic signaling (GO:0099177),-0.5133827575500091,-1.652734869746771,0.024024024024024024,0.3109634974328483,1.0,13/33,11.17%,GRID2;NRG3;NLGN1;NGF;GRIK1;GRIK2;PXK;LRP8;SLC4A8;LRRC4C;BCR;GRID1;CX3CR1
prerank,regulation of cell differentiation (GO:0045595),0.5012233108839745,1.652621651891064,0.0,0.3004195815576224,1.0,27/148,7.78%,EPHA3;PHLDB2;IGF2;CCN2;NREP;TRPS1;GDNF;AR;DAG1;RUNX1;FGFR1;FGFR2;RUNX2;TGFBR1;CSF1;CDK5RAP3;NEUROD4;NTF3;NEUROD1;GNB3;BCL6;ZFP36L1;SIK1;SMOC1;DDX17;PPP1R13L;NR1D1
prerank,regulation of protein autophosphorylation (GO:0031952),0.6120791784522045,1.6516284687678973,0.008645533141210375,0.3003089132185541,1.0,10/36,13.63%,EPHA7;ENPP1;ERRFI1;PDGFD;ENG;DDX3X;IMPACT;PPP2R5D;RAP2A;MVP
prerank,respiratory tube development (GO:0030323),0.6435727488349999,1.648675285320697,0.010416666666666666,0.30655250701734,1.0,12/28,14.89%,RBP4;GLI2;ITGA3;NKX2-1;FGFR2;PDPN;CEBPA;DNAAF1;FGF2;CCDC40;ABCA3;BMP4
prerank,ethanol metabolic process (GO:0006067),0.7668750400718434,1.6458662489976035,0.013816925734024179,0.31300874725378885,1.0,3/12,8.58%,ALDH1A1;ADH1A;ALDH2
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.753132076076122,1.6455997476465902,0.01652892561983471,0.31100136143795093,1.0,5/13,10.16%,PDPK1;IGF2;FGFR1;AKT3;FGF2
prerank,activation of adenylate cyclase activity (GO:0007190),0.6201219205037335,1.6455568739022557,0.01741654571843251,0.30837666492177046,1.0,8/35,6.09%,ADCY1;ADCY2;ADCY7;LGR4;ADCY5;ADCY9;LHCGR;ADRB3
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.7942093278312197,1.6446273180657944,0.023423423423423424,0.3083635572244435,1.0,2/10,2.73%,RUNX1;SH3RF1
prerank,triglyceride catabolic process (GO:0019433),-0.5740060434776454,-1.6423855505273537,0.015748031496062992,0.3328399272321317,1.0,10/19,37.14%,PNPLA3;PNPLA2;FABP7;FABP3;LIPH;LIPC;LPL;FABP4;FABP12;FABP5
prerank,negative regulation of interleukin-1 production (GO:0032692),0.6655734397117913,1.6422271504898585,0.0189873417721519,0.3130084122858857,1.0,3/23,4.30%,IGF1;GAS6;APOA1
prerank,glycosaminoglycan catabolic process (GO:0006027),0.5686616913232916,1.6417084711465786,0.005471956224350205,0.3118519637614166,1.0,14/55,10.16%,GPC6;FMOD;OGN;CEMIP;LUM;DCN;BGN;HSPG2;GALNS;SDC1;OMD;CSPG5;LYVE1;FGF2
prerank,regulation of multicellular organism growth (GO:0040014),0.7287113004426867,1.6415214306931278,0.024793388429752067,0.3096939754041701,1.0,2/15,1.00%,IGF1;GHR
prerank,acylglycerol metabolic process (GO:0006639),-0.4939508010553241,-1.6413746560192526,0.022388059701492536,0.32902355524707017,1.0,16/37,20.81%,CAV1;MGLL;ABHD2;DGKB;DGKH;DGKK;PGS1;PLAAT3;PNPLA3;DGKG;DGKQ;PNPLA2;ABHD6;DGKZ;LYPLA2;DGKI
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.6456145060128593,1.63746991634704,0.012012012012012012,0.3198873801377348,1.0,5/26,2.86%,ERRFI1;CBLB;AREG;TGFA;EPGN
prerank,rRNA metabolic process (GO:0016072),-0.3826996224178208,-1.6363076810873867,0.0,0.3374781408930962,1.0,78/160,28.34%,RPL41;RPL3;RPS24;RPS14;RPL27A;RPL8;RPS19;RPL34;RPL21;RPL7;RPL18;RPL27;RPL35A;RPL38;RPS15;RPL39;RPS7;RPL11;WDR36;RPL30;RPL36;RPLP1;RPL37;NIFK;RPS9;UTP4;RPL4;RPL18A;RPL26;RPL6;RPL36A;RPL29;RPL13A;RPL7A;NVL;RPL19;RRP1;SNU13;POP4;RPL14;RPL13;DEDD2;RPL32;RPL5;NOL9;RPLP0;MPHOSPH10;KRR1;RPS6;RPL22;UTP15;RRP36;IMP4;FCF1;EXOSC5;RRP12;RPL37A;RPLP2;RPL17;RPL23;RPF1;WDR46;RPL28;RPL31;NOL8;PDCD11;EXOSC4;NOP56;RPS27;NOLC1;NOC4L;RPS16;PIH1D1;RPL10;RPL15;WDR18;RPL12;RPL9
prerank,activation of protein kinase activity (GO:0032147),0.5222446238744772,1.6355712862776286,0.0024125452352231603,0.32332963967700823,1.0,28/106,12.55%,IGF1;PDPK1;ADCY1;NRK;ANGPT1;ADCY2;GHR;ADCY7;ADCY5;GAS6;ADCY9;MT3;NTF3;OSBPL8;ADRA2C;PIBF1;TLR6;NTRK3;STK4;PRRC1;MAP4K4;ITGB3;STK11;TAOK3;ADRA2A;TNFSF15;STRADA;INSR
prerank,lipid phosphorylation (GO:0046834),-0.6941409435193434,-1.6345211666595831,0.015909090909090907,0.33665674802452966,1.0,7/10,20.81%,DGKB;DGKH;DGKK;DGKG;DGKQ;DGKZ;DGKI
prerank,respiratory system development (GO:0060541),0.6337905881565188,1.6343282069674057,0.016034985422740525,0.3239685878424091,1.0,15/32,16.71%,RBP4;GLI2;ITGA3;NKX2-1;FGFR2;PDPN;CEBPA;DNAAF1;FGF2;CCDC40;ABCA3;BMP4;SPEF2;SMCHD1;SHH
prerank,positive regulation of signal transduction (GO:0009967),0.479104981105941,1.633003242613074,0.0,0.3258070873473768,1.0,51/238,9.69%,IGF1;NRP1;ROBO1;CCBE1;BMP6;PTGIS;WLS;IGF2;ESM1;MN1;PIK3R1;SASH1;DACT1;SULF2;SALL1;KANK1;MACF1;FGFR2;YAP1;GAS6;MAML3;TGFBR1;SMO;VTN;SULF1;MT3;AXL;NTF3;PHIP;SFRP1;SMOC2;CUX2;SKI;ENHO;SRC;LRRK2;ING5;TSLP;TRAF7;MYO1C;CD63;RBPJ;NTRK3;DRD3;TEDC1;BMP2;ZMIZ1;KAT2B;ITGB3;ITGAV;ARNT
prerank,positive regulation of phosphorylation (GO:0042327),0.47947700282726213,1.6312867440869898,0.0,0.3291383581722767,1.0,47/240,10.17%,IGF1;EPHA3;NRP1;EPHA7;ZBTB20;IGF2;DDR2;ROCK2;ANGPT1;AR;LYN;FGFR1;EPHA4;LEPR;IL34;PELI2;EPHA8;CCN1;FGFR2;KIT;FGFR4;PFKFB4;GAS6;PDGFRA;PDGFRB;MT3;AXL;AXIN2;PRKAA2;MUSK;SLCO3A1;ROR1;ENG;LRRK2;NTRK3;STK4;DAB2;DSCAM;ARRB1;EGFR;EPHB2;BMP2;ITGB3;LMO4;ARNT;FGF2;RYK
prerank,anterograde trans-synaptic signaling (GO:0098916),-0.37043881898131703,-1.630729489453519,0.0,0.34085831762266194,1.0,84/224,23.35%,GRM7;DLG2;SLC12A7;EXOC4;UNC13B;GRM3;GRIA4;RIT2;NLGN1;GABRG3;KCND2;GRIK1;GRIK2;GRIN2A;SDCBP;GABRA2;GABRB3;SYPL1;AMPH;GLRA1;GABRB1;NRXN1;GABRG2;PRKACB;SLC1A1;LRP6;CHRM3;GLRA2;GRM5;CDK5;SLC12A6;GRIN2B;PRKAR1A;SYT1;CAMK4;HCRTR2;GABRB2;GRIA2;PRKAR2B;PAFAH1B1;HTR2A;RPS6KA1;GABRA3;KCNQ3;PRKAR1B;CALM1;PRKAR2A;HOMER1;HRH1;CPLX1;SYN2;PCDHB14;SLC12A5;GPR176;CHRM2;PLP1;GIPC1;NLGN3;GRM1;CACNA1A;SYNJ2BP;APBA2;SLC1A2;SYN1;KIF5A;KCNIP2;GRIN1;CACNB3;GABRA4;GABRG1;GAD1;PNOC;NPY5R;HAP1;CAMKK1;GABARAP;KCNC4;PTCHD1;MAPK1;GABRR2;MINK1;GLRA3;SYT5;CHRM1
prerank,camera-type eye development (GO:0043010),0.6606146268735299,1.6306452788549206,0.015384615384615385,0.32854804226622636,1.0,7/25,6.66%,LAMA1;FBN1;FBN2;SHROOM2;CYP1B1;SKI;CACNA1C
prerank,intestinal absorption (GO:0050892),-0.6451964028459332,-1.6296822759617127,0.029197080291970802,0.3381104087585041,1.0,5/13,10.28%,F11R;TJP2;KCNQ1;SLC26A6;UGCG
prerank,outflow tract septum morphogenesis (GO:0003148),0.6555505007899668,1.6267369447965652,0.0243161094224924,0.33902614168445305,1.0,7/24,5.69%,NRP1;ROBO1;BMPR1A;PARVA;FGFR2;ACVR1;ENG
prerank,energy reserve metabolic process (GO:0006112),0.6883968189780447,1.6258585087688788,0.016051364365971106,0.338945652450782,1.0,9/19,10.93%,PID1;PHKB;LEPR;PRKAG2;MT3;ADRB3;GFPT1;PYGM;PPP1R3C
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.6511787247749485,1.6241351581148158,0.027993779160186624,0.3419300067274942,1.0,5/23,6.34%,TGFBR3;TPM1;FGFR2;ADAMTS9;TNNC1
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.6305107773284837,1.6223941695617137,0.016129032258064516,0.3451848131499142,1.0,13/29,15.86%,LDLRAD4;NKX2-1;SFRP1;SPRY2;USF3;FOXA1;SPRED3;VASN;PTEN;HPN;SPRED1;BMP5;SDHAF2
prerank,regulation of Wnt signaling pathway (GO:0030111),0.5142360779444219,1.6222422380578014,0.0058823529411764705,0.34291765079894926,1.0,25/108,9.32%,WLS;TRABD2B;DAAM2;CDK14;LRP1;DACT1;SULF2;RUNX1;SALL1;NKD1;KANK1;ITGA3;MACF1;FGFR2;MDFI;TLE1;SULF1;SFRP1;PTK7;SKI;LRRK2;TCF7L1;BMP2;CBY1;PRKN
prerank,tight junction assembly (GO:0120192),-0.4612570883022835,-1.622121466774705,0.0035971223021582736,0.3540642022630518,1.0,9/49,4.01%,MPP7;OCLN;PECAM1;CLDN5;ESAM;F11R;LSR;CLDN11;RAMP2
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.6857073639075554,1.6216161326931737,0.022435897435897436,0.33961504206950344,1.0,4/20,5.19%,IGF1;ZBTB20;PFKFB4;PRKAA2
prerank,positive regulation of glycolytic process (GO:0045821),0.6857073639075554,1.6216161326931737,0.022435897435897436,0.33961504206950344,1.0,4/20,5.19%,IGF1;ZBTB20;PFKFB4;PRKAA2
prerank,protein secretion (GO:0009306),0.5506146526941229,1.6192063048680978,0.012228260869565218,0.3450416022152415,1.0,19/56,16.11%,WLS;STEAP3;ABCA1;SLC30A8;NEUROD1;TVP23B;VIP;FAM3B;ARFGAP3;LTBP2;MIA2;MIA3;RCN3;MTTP;CYB5R4;TVP23A;TANGO2;MAFA;GOLPH3
prerank,regulation of macrophage cytokine production (GO:0010935),-0.6345089031808664,-1.6190645250734061,0.01904761904761905,0.35669053956594343,1.0,8/13,20.01%,SEMA7A;PLCG2;TGFB2;TGFB1;GPRC5B;SIRT1;CUEDC2;TGFB3
prerank,positive regulation of dendrite development (GO:1900006),-0.6879930628238697,-1.6187306579300655,0.02528735632183908,0.3517508123083284,1.0,8/10,20.83%,COBL;LRP8;PTN;ALK;ZDHHC15;PACSIN1;VLDLR;DAB2IP
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.6387090384120789,1.6183127876347432,0.02962962962962963,0.34535072403389727,1.0,5/27,5.01%,IGF1;DDR2;GAS6;PDGFRA;LIG4
prerank,positive regulation of ossification (GO:0045778),0.6062594393877503,1.6173912373896886,0.016853932584269662,0.34606026730786804,1.0,10/39,4.67%,NELL1;BMP6;SLC8A1;ADGRV1;FBN2;BMPR1A;CCN1;KL;WNT4;ACVR1
prerank,negative regulation of receptor binding (GO:1900121),-0.7089642126797489,-1.6172390197196795,0.01762114537444934,0.35062760632186213,1.0,3/10,6.54%,B2M;ADAM15;ATP2A3
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.6639864717988226,1.616869799587404,0.02821316614420063,0.3451351762021521,1.0,4/23,5.19%,IGF1;ZBTB20;PFKFB4;PRKAA2
prerank,phosphate ion homeostasis (GO:0055062),0.756053671786798,1.614450733986853,0.03148148148148148,0.3509847283651841,1.0,2/10,3.09%,ENPP1;FGFR4
prerank,bicarbonate transport (GO:0015701),-0.5351311365376681,-1.6142252234716714,0.016574585635359115,0.3531811171334836,1.0,7/25,13.10%,SLC4A10;SLC26A7;CA4;SLC39A8;SLC4A8;SLC26A6;CFTR
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.5260374977377232,1.6128642905770325,0.010165184243964422,0.35350946960037277,1.0,14/86,6.81%,IGF1;NRP1;EPHA7;BMP6;IGF2;ANGPT1;GHR;IL6R;VTN;ACVR1;NTF3;SFRP1;SRC;IL12B
prerank,lipid oxidation (GO:0034440),-0.6592932429927305,-1.6125735865794757,0.026252983293556086,0.35263652402812007,1.0,4/12,16.45%,ADIPOR2;PLA2G7;PPARGC1A;ACOX1
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.5822156330763947,1.6122228020549378,0.016506189821182942,0.35307864772417163,1.0,7/43,5.13%,IGF1;GJA1;IL6R;BMPR1A;MMP2;PDGFRB;IGFBP5
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.7283105574715764,1.6110148771441721,0.03633217993079585,0.35202746374357136,1.0,2/12,6.10%,IGF1;LMCD1
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),0.7283105574715764,1.6110148771441721,0.03633217993079585,0.35202746374357136,1.0,2/12,6.10%,IGF1;LMCD1
prerank,adherens junction organization (GO:0034332),-0.45648360552607997,-1.610710468747244,0.0037174721189591076,0.3519701009757817,1.0,18/48,12.65%,CADM2;CDH2;CADM1;CDH1;ACTB;TJP1;NECTIN1;RAMP2;CDH12;CDH6;CDH8;CDH9;CDH13;JUP;CDH10;CSK;PVR;PAK2
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.7794425266589238,1.61041451227054,0.022727272727272728,0.3513950811616422,1.0,6/10,13.24%,AREG;TGFA;EPGN;HBEGF;ADRA2A;EGF
prerank,neurotransmitter secretion (GO:0007269),-0.47062576735411066,-1.6101612646420218,0.007067137809187279,0.34794652972512596,1.0,21/44,22.90%,RIMS1;LIN7A;HSPA8;NRXN1;CDK5;RIMS2;LIN7C;SYT1;NAAA;SYN3;PCLO;CPLX1;SYN2;RAB3A;STX1A;DVL1;SYN1;GAD1;OTOF;STXBP2;SNPH
prerank,cellular response to BMP stimulus (GO:0071773),0.5457680362321039,1.6099897526216016,0.005188067444876783,0.35017731008047,1.0,19/66,15.57%,BMP6;ADAMTS12;TGFBR3;SMAD3;BMPR1A;RUNX2;ACVR1;SFRP1;ENG;RGMA;BMP2;SMAD1;BMP15;USP9Y;PDCD4;USP9X;HIVEP1;BMP4;BMP5
prerank,bicellular tight junction assembly (GO:0070830),-0.46803893522250845,-1.607884336758981,0.0071174377224199285,0.34849641612395016,1.0,12/46,12.65%,MPP7;OCLN;PECAM1;CLDN5;ESAM;F11R;CLDN11;RAMP2;PDCD6IP;PATJ;STRN;PAK2
prerank,chordate embryonic development (GO:0043009),0.5602038844003838,1.607737190222967,0.013054830287206266,0.3550255690822933,1.0,12/55,6.06%,RBP4;IGF2;COL1A1;ARNT2;DACT1;SULF2;FGFR1;FGFR2;TGFBR1;SULF1;LIG4;ALDH1A2
prerank,microtubule anchoring at centrosome (GO:0034454),0.761329234290911,1.607519010014411,0.030560271646859084,0.35317702629745884,1.0,2/10,2.59%,CCDC68;NINL
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.5987755222448309,1.6073887852422626,0.019635343618513323,0.3511535521883515,1.0,6/37,5.13%,IGF1;GJA1;TPM1;BMPR1A;MMP2;IGFBP5
prerank,regulation of extracellular matrix organization (GO:1903053),0.6891914867939595,1.606297633635109,0.04091653027823241,0.35226874054138735,1.0,6/15,4.03%,DDR2;LRP1;RUNX1;AEBP1;FGFR4;SLC2A10
prerank,negative regulation of cell development (GO:0010721),0.6471024220653883,1.6060916301435726,0.02138157894736842,0.3506270107538571,1.0,3/25,4.42%,IGF1;FBN1;APPL2
prerank,positive regulation of protein export from nucleus (GO:0046827),0.692948224894255,1.6060403825350076,0.03041144901610018,0.3483679591060881,1.0,4/15,12.16%,TCF7L2;GAS6;RBM22;YWHAE
prerank,regulation of axon guidance (GO:1902667),0.7631163857412329,1.6043211387508003,0.032758620689655175,0.351686802609115,1.0,2/10,0.51%,NRP1;MYCBP2
prerank,C4-dicarboxylate transport (GO:0015740),-0.6182878957941333,-1.6041481892407048,0.030303030303030304,0.3545922761201934,1.0,11/14,30.26%,LRRC8D;SLC25A13;SLC25A12;SLC1A1;SLC25A30;SLC25A11;SLC1A2;SLC25A22;SLC25A10;LRRC8E;SLC25A14
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.6710695049663562,1.6002352447725543,0.03403565640194489,0.36230748779296434,1.0,2/19,4.30%,IGF1;APOA1
prerank,chloride transmembrane transport (GO:1902476),-0.4579368077563136,-1.5978408300939804,0.0,0.36742472584489105,1.0,21/48,14.00%,SLC12A2;SLC12A7;GABRG3;ANO1;ANO4;CLCN3;GABRA2;GABRB3;GLRA1;GABRB1;GABRG2;SLC1A1;GLRA2;SLC12A6;GABRB2;SLC4A8;GABRA3;ANO3;ANO2;CFTR;SLC12A5
prerank,supramolecular fiber organization (GO:0097435),0.46302711747954606,1.5966767240928592,0.0,0.3715088817245444,1.0,52/334,7.67%,COL4A4;COL4A5;MFAP4;COL4A6;COL1A2;COL1A1;DDR2;FBLN5;RHOH;COL4A3;COL22A1;LOXL1;LUM;GSN;COL5A1;COL8A2;CGNL1;FIGN;LOX;COL11A1;HSPG2;BFSP1;DPT;RHOD;ADAMTS2;TPM1;TMOD4;SHROOM2;NCKAP5;RHOBTB1;COL13A1;TGFBR1;COL9A2;MYO1B;APOA1;CLIP4;COL20A1;RHOBTB3;DES;CYP1B1;DYNC1H1;CST3;CDC42;SERPINH1;EMILIN1;RHOBTB2;LTBP2;LTBP3;SNCAIP;CENPJ;CARMIL1;MYO1C
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.6382443001033828,1.5960615844560517,0.027906976744186046,0.37116830084576063,1.0,5/23,4.68%,DAPK2;CAMK1D;RIPOR2;CCL19;MCU
prerank,positive regulation of glucose transmembrane transport (GO:0010828),0.6279988655188322,1.595414649861502,0.020895522388059702,0.3709206690942562,1.0,7/26,12.55%,IGF1;PIK3R1;OSBPL8;CREBL2;BRAF;RHOQ;INSR
prerank,T cell differentiation (GO:0030217),0.5732046394012567,1.5934135727498016,0.02442528735632184,0.3749982289725259,1.0,11/40,9.43%,RHOH;LEPR;GLI3;KIT;LIG4;ZFP36L1;TCF7;CD28;NHEJ1;GPR89A;GPR89B
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.5237184083199781,1.5924874570434702,0.011523687580025609,0.37553350111543754,1.0,10/77,6.31%,IGF1;TCF7L2;AR;BCL2;SH3RF1;CFLAR;TGFBR1;ACVR1;PHIP;SRC
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.6088036957445905,-1.5913155157305952,0.027906976744186046,0.38185605328369965,1.0,5/13,13.49%,ELOVL7;ELOVL5;TECR;TECRL;HACD2
prerank,mRNA destabilization (GO:0061157),0.5842073813358668,1.5909974483337015,0.01812688821752266,0.3780343032955835,1.0,14/38,20.48%,POLR2D;ROCK2;ZFP36L1;CPEB3;TUT7;METTL14;TUT4;PLEKHN1;RC3H2;RC3H1;METTL3;YTHDF2;FTO;ZFP36L2
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.6860780235228389,1.5909253165744315,0.01901743264659271,0.3757488660341231,1.0,4/18,2.08%,PDPK1;IGF2;COL4A3;FGFR1
prerank,cardiac conduction system development (GO:0003161),0.6422339106869457,1.5902521152061344,0.025396825396825397,0.37567027933976344,1.0,9/24,14.89%,GJA1;GJB6;BMPR1A;NOTCH2;MSC;SMAD1;CACNA1G;GATA6;BMP4
prerank,protein kinase B signaling (GO:0043491),0.6287995380763435,1.5890173622015995,0.0296875,0.37746828488335943,1.0,5/23,7.37%,IGF1;GAS6;MT3;ZFP36L1;SIRT2
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.5384546767317053,1.5887745607284205,0.01856763925729443,0.3759122151782587,1.0,13/62,9.89%,IGF1;ROBO1;AUTS2;LYN;NOTCH2;APOA1;LPAR1;ALS2;ARRB1;MAP4K4;RAPGEF1;MAPRE2;SYNPO2L
prerank,negative regulation of proteolysis (GO:0045861),0.5880118902529587,1.5858966752864923,0.03058103975535168,0.38322147610236734,1.0,13/34,16.32%,TIMP3;DNAJC1;EPHA4;CST3;LRRK2;TIMP2;SNX12;F2;CLN3;TM4SF20;PTPN3;GAS1;AKT1
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.5872126031535702,1.5856002863063927,0.01881331403762663,0.38186666594231317,1.0,4/39,4.68%,TCF7L2;RBP4;SLC30A8;MCU
prerank,hematopoietic stem cell differentiation (GO:0060218),0.7354766713539866,1.584887420767371,0.05693950177935943,0.38184126374298305,1.0,5/10,11.48%,SP7;MLLT3;SFRP1;BATF;UFL1
prerank,neurotransmitter biosynthetic process (GO:0042136),0.7086648181630377,1.5832380580289185,0.0224,0.38479802984784,1.0,3/14,4.20%,MOXD1;DAGLA;SLC22A2
prerank,regulation of biomineral tissue development (GO:0070167),0.6198568458822009,1.5816053582612202,0.03134796238244514,0.3877117743679223,1.0,6/26,3.44%,DDR2;ENPP1;ROCK2;AHSG;ANKH;GAS6
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.7319642660984537,1.5815228895594944,0.03315881326352531,0.38563738125385644,1.0,4/12,6.81%,LYN;IL34;CSF1;IL12B
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.4787184064043173,1.5808759473276286,0.005753739930955121,0.38566404168491786,1.0,25/150,7.09%,TCF7L2;PDPK1;IGF2;ANGPT1;PIK3R1;AREG;TGFA;FGFR1;EPGN;KL;FGFR2;KIT;FGFR4;GAS6;PDGFRA;PDGFRB;TGFBR1;SEMA5A;CCL19;AXL;OSBPL8;FRS2;ENG;SRC;CD28
prerank,potassium ion homeostasis (GO:0055075),-0.5359546282872237,-1.5802516086056055,0.01881720430107527,0.410194266502382,1.0,7/23,6.83%,SLC12A2;SLC12A7;KCNJ2;ATP1A1;KCNMA1;SLC12A6;ATP1B1
prerank,anterior/posterior axis specification (GO:0009948),0.694338296198196,1.5801600970514227,0.04666666666666667,0.3857089064327775,1.0,3/15,5.82%,WLS;TBX3;SKI
prerank,cAMP metabolic process (GO:0046058),0.7294823495171668,1.579292623615527,0.03356890459363958,0.3862197950222652,1.0,5/13,3.53%,ADCY1;ADCY2;ADCY7;ADCY5;ADCY9
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.6647429720417284,1.5781926170298952,0.03414634146341464,0.3874872865647447,1.0,7/18,11.51%,DDR2;SMAD3;RUNX1;PDPN;EMILIN1;BMP2;RGCC
prerank,Rho protein signal transduction (GO:0007266),0.5425456174747069,1.5779796771159174,0.010854816824966078,0.3859069976545282,1.0,15/53,12.40%,COL1A2;ROCK2;ARHGAP6;RHOD;CTNNAL1;ARHGAP29;CDC42EP4;PDPN;CDC42;AGTR1;NTN1;ARHGEF11;TAX1BP3;ADRA2A;ARHGAP5
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.4813964809447238,1.576886611426885,0.003468208092485549,0.38736626225777526,1.0,32/138,8.61%,EPHA3;EPHA7;MTSS1;DDR2;ANGPTL1;IL31RA;LYN;NEDD9;FGFR1;EPHA4;GFRA2;EPHA8;FGFR2;KIT;FGFR4;PDGFRA;PDGFRB;CD7;POLR1G;CSF1;AXL;NTF3;FRS2;GUCY2C;MUSK;ROR1;SRC;BDKRB2;GUCY2D;NTRK3;EGFR;EPHB2
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.5623495543304898,1.5765542182014436,0.025956284153005466,0.3860870971360832,1.0,6/43,2.39%,IGF2;ENPP1;PID1;AHSG;OGT;KANK1
prerank,carbohydrate homeostasis (GO:0033500),0.520896558549192,1.5756894643412518,0.01673101673101673,0.3866820292332906,1.0,14/67,12.77%,TCF7L2;RBP4;LEPR;SLC30A8;FGFR4;APPL2;MCU;NEUROD1;PRKAA2;CEBPA;STK11;ADRA2A;INSR;CYB5R4
prerank,endoplasmic reticulum tubular network organization (GO:0071786),-0.6020687970008841,-1.5755689296236255,0.04358974358974359,0.4200825758523598,1.0,7/15,18.22%,REEP1;RTN3;TMEM33;ATL2;ARL6IP1;ZFYVE27;REEP2
prerank,cardiac muscle tissue development (GO:0048738),0.5510002015325792,1.5726033341743642,0.02837837837837838,0.39451461834926127,1.0,17/50,15.57%,RBP4;GJA1;GJB6;BMPR1A;NOTCH2;MSC;ADAMTS9;SIK1;BMP2;CBY1;SMAD1;CSRP3;CACNA1G;AKAP13;GATA6;BMP4;BMP5
prerank,signal release from synapse (GO:0099643),-0.4583506099034196,-1.571132555631662,0.010273972602739725,0.4281561582387129,1.0,20/43,22.90%,RIMS1;LIN7A;HSPA8;NRXN1;CDK5;LIN7C;SYT1;NAAA;SYN3;PCLO;CPLX1;SYN2;RAB3A;STX1A;DVL1;SYN1;GAD1;OTOF;STXBP2;SNPH
prerank,purine nucleotide catabolic process (GO:0006195),-0.6138906586863652,-1.5700027537664916,0.035175879396984924,0.4262265949953264,1.0,7/13,18.51%,NT5E;NT5C2;NT5C1A;GDA;NT5C;PNP;GPX1
prerank,renal system development (GO:0072001),0.5476219413524238,1.5692646384602853,0.0107095046854083,0.4036695395997043,1.0,10/52,7.25%,RBP4;GLI2;SULF2;SALL1;WNT4;TGFBR1;SULF1;GREB1L;AGTR1;IFT27
prerank,regulation of MAPK cascade (GO:0043408),0.4733527368299468,1.56739265211717,0.0,0.40767732956122193,1.0,33/157,11.32%,IGF1;EPHA7;IGF2;ADRA1B;NRK;ROCK2;TGFBR3;KSR1;DAG1;LYN;FGFR1;PELI2;EPHA8;CCN1;FGFR2;KIT;LBH;ROR1;ADRA2C;ADRB3;LPAR1;MAP2K1;TRAF7;NTRK3;STK4;EGFR;BMP2;MAP4K4;FGF2;RYK;TAOK3;GSDME;ADRA2A
prerank,response to organophosphorus (GO:0046683),-0.5930703381039186,-1.5671850233640516,0.031413612565445025,0.4296992931816358,1.0,6/16,13.12%,TRPC3;ABCC9;P2RX7;TRIM16;DGKQ;TYMS
prerank,dorsal/ventral pattern formation (GO:0009953),0.662039292003139,1.5655917436947078,0.018433179723502304,0.41138872799227844,1.0,6/20,5.05%,GLI2;BMPR1A;WNT8B;MDFI;ACVR1;SFRP1
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.6612739142150514,1.5636311483773089,0.04411764705882353,0.4159664649636872,1.0,2/17,1.34%,BMP6;SASH1
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.5245211113067537,-1.5630134800691162,0.03359173126614987,0.4374603710952811,1.0,5/24,5.29%,MEF2C;CDH2;SPAG9;CDON;TCF3
prerank,cellular response to organonitrogen compound (GO:0071417),-0.3901054799182085,-1.562944880843907,0.005847953216374269,0.43186128542388136,1.0,28/99,13.10%,SLIT2;MEF2C;RAP1A;CDH1;ACTB;DIAPH1;SH3BP4;GABRB3;P2RX7;GLRA1;GABRB1;GABRG2;PDE2A;KCNQ1;GLRA2;AKAP6;SPAAR;RAP1B;TAF1;INPP5K;GABRB2;LARS1;IPO5;SLC26A6;JUP;HRH1;MTOR;CFTR
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.6669766965065675,1.5629374096106206,0.04194630872483222,0.41591091754083076,1.0,2/17,3.47%,IGF1;APOE
prerank,chemical synaptic transmission (GO:0007268),-0.3434387195571485,-1.5615183760435563,0.0,0.43111211946802175,1.0,101/284,23.35%,GRM7;DLG2;GRID2;SLC12A7;EXOC4;UNC13B;GRM3;GRIA4;RIT2;NLGN1;GABRG3;RIMS1;KCND2;LIN7A;GRIK1;GRIK2;GRIN2A;HSPA8;SDCBP;GABRA2;GABRB3;SYPL1;AMPH;GLRA1;GABRB1;DLGAP2;NRXN1;GABRG2;PRKACB;SLC1A1;CDH8;LRP6;CHRM3;GLRA2;GRM5;CDK5;LIN7C;SLC12A6;GRIN2B;PRKAR1A;SYT1;CAMK4;HCRTR2;GABRB2;NAAA;GRIA2;PRKAR2B;PAFAH1B1;HTR2A;RPS6KA1;GABRA3;KCNQ3;SYN3;GRID1;PRKAR1B;CALM1;PRKAR2A;HOMER1;HRH1;CPLX1;SYN2;PCDHB14;SLC1A4;SLC12A5;GPR176;CHRM2;PLP1;GIPC1;NLGN3;RAB3A;STX1A;CBLN2;GRM1;CACNA1A;SYNJ2BP;APBA2;SLC1A2;DVL1;SYN1;KIF5A;KCNIP2;GRIN1;CACNB3;GABRA4;GABRG1;GAD1;PNOC;NPY5R;HAP1;CAMKK1;GABARAP;KCNC4;PTCHD1;MAPK1;GABRR2;MINK1;STXBP2;SNPH;GLRA3;SYT5;CHRM1
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.7246743169051171,1.5613829562994517,0.04891304347826087,0.4190035605772872,1.0,2/11,5.54%,PDK1;CYP1B1
prerank,positive regulation of cell cycle process (GO:0090068),0.5015263289160814,1.5601710171195462,0.009852216748768473,0.4211907791432905,1.0,16/91,8.20%,IGF1;IGF2;SVIL;TGFA;EPGN;PDGFRB;PHIP;MAP3K20;DYNC1H1;CDC42;INO80;CD28;NPM2;SIRT2;UBXN2B;DRD3
prerank,positive regulation of glucose import (GO:0046326),0.645334847787299,1.5595074083332068,0.03605015673981191,0.42107868207459015,1.0,6/21,12.55%,IGF1;PIK3R1;OSBPL8;CREBL2;RHOQ;INSR
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.5210472546484819,1.558810311830867,0.022929936305732482,0.42126045848903226,1.0,14/66,6.05%,ROBO1;MTSS1;TGFBR3;SPARC;MCC;NR2F2;FGFR2;NFIB;APOE;NUPR1;SULF1;SFRP1;CASK;ATOH8
prerank,regulation of epidermal cell differentiation (GO:0045604),0.6329955960566883,1.558606675253356,0.03770491803278689,0.41957103880150487,1.0,7/21,14.94%,ERRFI1;ROCK2;RUNX1;ZFP36L1;CTSL;BMP4;SFRP4
prerank,cellular response to ketone (GO:1901655),0.579289677483035,1.5581944438864535,0.037091988130563795,0.41869050228273413,1.0,8/35,7.20%,ADCY1;ROCK2;ADCY2;AR;ADCY5;SFRP1;SRC;SPHK2
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.5030488558411531,1.5575727533233519,0.01338199513381995,0.4183565042236411,1.0,24/95,10.36%,PDPK1;NREP;TGFBR3;SMAD3;LDLRAD4;ZEB2;ADAMTSL2;ITGA3;NKX2-1;PMEPA1;TGFBR1;SLC2A10;SMURF2;ENG;DKK3;SKI;BCL9;EMILIN1;DAB2;SPRY2;LEMD3;FAM89B;STK11;SPRED3
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.4641494199090269,-1.5564014061962643,0.013559322033898305,0.4420936704890199,1.0,16/39,20.17%,RPS24;RPS14;RPS19;RIOK1;RPS15;RPS7;UTP4;RPS5;METTL17;LSM6;SNU13;RPSA;RPS6;RRP36;NPM1;MRPS7
prerank,myofibril assembly (GO:0030239),0.5657682480384815,1.5563890540703842,0.02361111111111111,0.42032727868966885,1.0,12/42,10.12%,ACTN2;OBSL1;TPM1;TMOD4;TNNT1;PDGFRA;CFLAR;PDGFRB;CSRP2;CSRP3;SYNPO2L;TNNT3
prerank,wound healing (GO:0042060),0.526039098528411,1.5558693841245212,0.016645326504481434,0.4196923741495218,1.0,14/62,10.48%,IGF1;SMAD3;TPM1;PPP3CA;MACF1;PPL;PDGFRA;CFLAR;TGFBR1;FUT10;ITGB3;MIA3;FGF2;ANXA6
prerank,endothelial cell development (GO:0001885),-0.4985342690704372,-1.554863395313668,0.027624309392265192,0.4412699845049974,1.0,12/25,10.46%,PDE4D;PECAM1;RAP1A;PPP1R16B;MET;RDX;PDE2A;COL15A1;RAP1B;ROBO4;SOX18;MSN
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.6114803872308693,-1.554402885939357,0.039119804400977995,0.4367813884781313,1.0,8/13,23.02%,KDR;IL33;NAMPT;JAK2;EDN1;NOD2;TLR4;CCL2
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.4630551693035181,1.5542767424605641,0.0022197558268590455,0.42297447412166383,1.0,44/186,15.28%,IGFBP2;TCF7L2;BICC1;TRABD2B;RBMS3;MCC;LRP1;IGFBP4;DACT1;NKD1;GLI3;MDFI;APOE;TMEM170B;TLE1;PRICKLE1;PSME4;RNF213;AXIN2;MLLT3;SFRP1;DKK3;ZNRF3;WWTR1;STK4;DAB2;BMP2;CBY1;PRKN;STK11;TAX1BP3;INVS;LZTS2;JADE1;TMEM64;GLI1;UBAC2;KLHL12;TSC2;MDK;AMFR;CXXC4;SFRP4;GRB10
prerank,axonal fasciculation (GO:0007413),0.706764006451849,1.5536051580177734,0.0564373897707231,0.4229280526667511,1.0,6/12,11.55%,EPHA3;EPHA4;SEMA5A;ARHGAP35;EPHB2;EPHB3
prerank,negative regulation of cell migration (GO:0030336),0.4786289912930844,1.5535172052668955,0.008018327605956471,0.4209316711000834,1.0,27/137,7.43%,ROBO1;PHLDB2;GJA1;MCC;LDLRAD4;LRP1;DAG1;MITF;SERPINE1;DLC1;PODN;TPM1;EPHA4;BMPR1A;KANK1;RECK;NKX2-1;DPYSL3;SULF1;SFRP1;IGFBP5;CYP1B1;ENG;VCL;ATP1B2;DPEP1;AFDN
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.6389698573743575,1.5526704298643608,0.03912363067292645,0.4215343282466151,1.0,7/21,6.94%,ADCY1;ADCY2;ADCY7;ADCY5;ADCY9;GUCY2C;GUCY2D
prerank,iron ion transport (GO:0006826),0.5522301236120883,1.552353182025165,0.024896265560165973,0.4205099329313018,1.0,6/47,6.47%,ATP6V0A4;CP;STEAP3;SCARA5;HEPH;SLC11A2
prerank,regulation of catabolic process (GO:0009894),-0.5563934338333477,-1.5519697401354449,0.03299492385786802,0.4390757450364383,1.0,4/18,4.22%,FAP;ZDHHC2;NEDD4L;FAF1
prerank,positive regulation of MAPK cascade (GO:0043410),0.45349358321470445,1.5514873794067892,0.0,0.42131001549960256,1.0,48/245,11.32%,IGF1;NRP1;ROBO1;IGF2;ADRA1B;CCN2;ROCK2;ANGPT1;PDGFD;KSR1;FGFR1;IL34;PELI2;EPHA8;EPGN;FGFR2;KIT;FGFR4;GAS6;PDGFRA;APOE;PDGFRB;CCL19;NOTCH2;RAPGEF2;MT3;ROR1;ADRA2C;ADRB3;CCL4;LRRK2;LPAR1;MAP2K1;TRAF7;MTURN;NTRK3;SLC30A10;ARRB1;EGFR;BMP2;SPRY2;FGF2;RYK;CARD9;BRAF;TAOK3;GSDME;ADRA2A
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.3570760976485703,-1.5496650291092362,0.0,0.44116917965717145,1.0,71/168,20.53%,RPL41;RPS12;RPL3;RPS24;RPS14;RPL27A;RPL8;RPS19;CNOT6L;RPL34;RPS13;RPL21;RPL7;RPL18;RPL27;CSDE1;RPL35A;RPL38;RPS15;RPS3;RPL39;RPS7;RPS4X;RPL11;PAN3;RPL30;RPS23;PABPC1;PNRC2;RPL36;RPLP1;RPS29;RPL37;PPP2R2A;RPS9;RBM8A;RPS5;RPL4;PNLDC1;RPL18A;RPL26;RPL6;RPL36A;RPL29;RPL13A;RPL7A;THRAP3;RPL19;RPS20;RPL14;RPL13;DIS3L2;RPL32;RPL5;RPSA;SMG7;RPLP0;NBAS;RPS6;RPL22;AGO1;EXOSC5;CNOT7;RPS21;DDX5;DCP2;RPL37A;RPLP2;TENT2;RPL17;RPL23
prerank,regulation of plasminogen activation (GO:0010755),0.721109029271577,1.5495145758094782,0.04745762711864407,0.4260269177631274,1.0,7/12,15.64%,CLEC3B;SERPINE1;RUNX1;PLGRKT;CTSZ;HPN;MELTF
prerank,muscle cell differentiation (GO:0042692),-0.48613949746537055,-1.5485827931103862,0.026785714285714284,0.43922122578529915,1.0,8/32,6.41%,NEBL;SYNE1;MRTFB;SGCZ;MEF2C;TBX1;KDM1A;HEY2
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.6653296641272173,1.5465079625988127,0.05226480836236934,0.4341536417482955,1.0,2/16,0.75%,IGF1;ROCK2
prerank,regulation of histone modification (GO:0031056),0.7154759935145687,1.546127193470035,0.030664395229982964,0.4332576247048726,1.0,6/13,14.64%,IGF2;NNMT;HPF1;MTHFR;SETD5;AKAP8L
prerank,positive regulation of kinase activity (GO:0033674),0.48663171282879397,1.5456412254724785,0.014319809069212411,0.43265649943443485,1.0,31/107,12.55%,EPHA3;EPHA7;DDR2;FGFR1;EPHA4;EPHA8;CCN1;FGFR2;KIT;FGFR4;PRKAG2;GAS6;PDGFRA;PDGFRB;CCL19;CSF1;RAPGEF2;AXL;MUSK;ROR1;ALS2;NTRK3;EGFR;EPHB2;LMO4;RYK;MRNIP;EPHB3;F2;DUSP19;INSR
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.6792161229104485,1.5444450387391673,0.053833605220228384,0.434340629708089,1.0,2/15,3.63%,MOXD1;SMOX
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.6803557459329974,1.5430450291905888,0.043333333333333335,0.43691262646254303,1.0,4/16,3.56%,NRP1;PDGFD;PDGFRA;PDGFRB
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.44021599411800005,1.54230616586878,0.0,0.43695698134486416,1.0,68/390,10.17%,IGF1;EPHA3;NRP1;POLR2D;ATP6V0A4;EPHA7;COL4A6;IGF2;MTSS1;COL1A1;DDR2;ROCK2;ANGPT1;GHR;ANGPTL1;PIK3R1;PDGFD;IL31RA;LYN;SULF2;NEDD9;FGFR1;EPHA4;GFRA2;EPHA8;MMP2;KL;FGFR2;KIT;FGFR4;RBFOX2;PDGFRA;EFNB2;PDGFRB;ANGPT2;CD7;SULF1;POLR1G;CSF1;RAPGEF2;AXL;NTF3;PHIP;FRS2;MUSK;ROR1;CDC42;SRC;BDKRB2;EFNA2;SIRT2;EIF2AK3;FLRT2;NTRK3;AAMP;FOXC2;ZNF106;EGFR;EPHB2;HNRNPA1;EFNB1;RAPGEF1;ITGB3;POLR2C;ITGAV;ATP6V1E1;FGF2;RYK
prerank,detection of mechanical stimulus (GO:0050982),-0.550707594928544,-1.5422516391768077,0.03414634146341464,0.45482569051042065,1.0,3/19,1.56%,PIEZO2;CDH2;PIEZO1
prerank,regulation of acute inflammatory response (GO:0002673),0.6490150235279692,1.5414960018690709,0.04597701149425287,0.4374946365051694,1.0,2/18,2.52%,PTGES;OSMR
prerank,metal ion homeostasis (GO:0055065),-0.4694342351753516,-1.5410253080229712,0.014336917562724014,0.4533527931046752,1.0,7/40,6.66%,TMTC2;SLC12A2;SLC12A7;CAV1;ANK3;LETM1;SLC12A6
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.6455880552567007,1.540253384641759,0.058823529411764705,0.4394956823754287,1.0,2/20,4.81%,IGF1;NEUROD1
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.670635312923751,1.54015510798448,0.07308970099667775,0.4376266262698659,1.0,1/15,0.01%,IGF1
prerank,epithelial structure maintenance (GO:0010669),0.7132727345764374,1.539772859194669,0.05017921146953405,0.43656837757308475,1.0,2/11,8.41%,RBP4;PIWIL4
prerank,regulation of gastrulation (GO:0010470),0.6867958305857926,1.5391611356880652,0.04568527918781726,0.43659836617787307,1.0,4/14,7.89%,PHLDB2;DAG1;CRB2;OSR1
prerank,sphingolipid catabolic process (GO:0030149),-0.5869688199081308,-1.5388512298794483,0.027707808564231738,0.4549276976834427,1.0,4/15,3.32%,ACER3;ENPP2;ACER2;PPT1
prerank,embryonic organ morphogenesis (GO:0048562),0.5631632963450506,1.5385643788324328,0.025210084033613446,0.4365734413045309,1.0,9/42,5.00%,RBP4;FBN1;FBN2;MFAP5;FGFR2;PDGFRA;ACVR1;NEUROD1;RARG
prerank,cytoskeleton organization (GO:0007010),0.4857156720562998,1.5384503713582105,0.008111239860950173,0.4348539331222523,1.0,28/114,8.37%,SH3D19;MICAL3;RHOH;RHOD;NEDD9;OBSL1;TPM1;MARK1;ANK1;RHOBTB1;APOE;PALLD;CNN2;WDPCP;FGD1;BRWD1;PHIP;FGD4;RHOBTB3;DES;ARHGAP10;RANBP9;RHOBTB2;CSPG5;WTIP;PLD2;MAST2;CAPZB
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.6649884921069413,1.5351729105489484,0.05723905723905724,0.4438509436372509,1.0,5/15,5.93%,DDR2;LRP1;FGFR4;PDPN;CST3
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.7051195338749249,1.534702998848511,0.05779334500875657,0.44328242519629596,1.0,2/11,4.08%,RUNX1;TWSG1
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.4876869187036625,1.5343143729744526,0.013365735115431349,0.4424807472979884,1.0,26/112,9.23%,CILP;COL1A2;CLEC3B;TGFBR3;SMAD3;SOX5;BMPR1A;WNT4;TGFBR1;TWSG1;PDCD5;APOA1;APPL2;ACVR1;SFRP1;ITGB5;PDE3A;CDH5;ENG;ZFP36L1;SKI;SRC;LTBP2;ARHGEF18;ZMIZ1;SMAD1
prerank,"synaptic transmission, GABAergic (GO:0051932)",-0.6429829576666679,-1.534184221880132,0.05429864253393665,0.46524177305283926,1.0,7/10,20.75%,GABRG3;GABRA2;GABRG2;GABRB2;GABRA3;GABRA4;GABRG1
prerank,potassium ion import across plasma membrane (GO:1990573),-0.4448011969679175,-1.533708675838998,0.003424657534246575,0.46145005628588526,1.0,12/41,14.00%,SLC12A2;SLC12A7;KCNJ2;ATP1A1;KCNJ3;ABCC9;SLC12A6;ATP1B1;KCNJ15;ATP1A3;KCNJ10;SLC12A5
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.6326548782736622,-1.533534932685906,0.051094890510948905,0.4568481483564604,1.0,3/11,6.57%,SLIT2;CCN3;RIN3
prerank,sensory perception of sound (GO:0007605),0.5109181516755402,1.5328771417743103,0.012224938875305624,0.44511329913017394,1.0,18/88,11.08%,ATP6V0A4;COL1A1;CEMIP;COL4A3;ADGRV1;EYA1;GRXCR1;COL11A1;EML2;KIT;RIPOR2;ROR1;USH2A;ALDH7A1;TIMM9;LRTOMT;COL11A2;GSDME
prerank,membrane lipid biosynthetic process (GO:0046467),-0.4114691089998624,-1.532232706814776,0.008438818565400843,0.4555556348011718,1.0,13/58,11.40%,SGMS1;CERT1;ACER3;SGMS2;ELOVL7;ACER2;DEGS2;SPNS2;ELOVL5;DEGS1;ST8SIA6;SPTLC2;SPTSSB
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.6173128837543621,1.5309392600928753,0.0334855403348554,0.4495006644901139,1.0,4/26,7.79%,IGF1;FHL2;LMCD1;RCAN1
prerank,positive regulation of secretion (GO:0051047),-0.623437367181855,-1.5297020662007443,0.05152224824355972,0.4586091581831476,1.0,6/11,30.75%,NPR1;GPLD1;ACSL3;XBP1;AQP1;SCIN
prerank,regulation of heart rate by cardiac conduction (GO:0086091),-0.4652758016503304,-1.5274354953874973,0.020905923344947737,0.4611461110139368,1.0,11/38,15.08%,CAV1;KCNJ2;CTNNA3;KCNJ3;KCND3;CAMK2D;KCNQ1;JUP;DSG2;CACNA2D1;CACNA1D
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.5087358126600151,-1.5269577308091649,0.023529411764705882,0.4576049838760445,1.0,11/26,18.88%,OCLN;NAV3;MET;RPS3;PAK1;FES;DCTN1;TRPV4;CDK5RAP2;CDK5R1;CLASP1
prerank,myeloid cell activation involved in immune response (GO:0002275),-0.5419915824815379,-1.5268746655119332,0.060209424083769635,0.45304052416600943,1.0,7/18,14.50%,PLCG2;DYSF;LBP;FCER1G;IFI35;SBNO2;KARS1
prerank,smooth muscle cell differentiation (GO:0051145),-0.6199744214954406,-1.5263980416922418,0.03803131991051454,0.44949521145387483,1.0,6/12,14.87%,MRTFB;MEF2C;HEY2;APLNR;HEY1;EDNRB
prerank,regulation of endopeptidase activity (GO:0052548),0.5185095480880272,1.5250417394705942,0.023778071334214,0.4681236581433266,1.0,13/59,10.92%,TIMP3;AHSG;SERPINE1;SERPING1;VTN;FETUB;SERPIND1;SERPINF1;SERPINH1;CRB2;TIMP2;PICALM;APH1B
prerank,positive regulation of axon extension (GO:0045773),0.6123894332677633,1.5222523104809755,0.04833836858006042,0.47572005084471647,1.0,6/22,8.65%,NRP1;MACF1;SEMA5A;GOLGA4;DSCAM;NTN1
prerank,regulation of amyloid-beta formation (GO:1902003),0.5701519029959491,1.5196788377616404,0.04227405247813411,0.482598354226353,1.0,4/34,3.47%,IGF1;ROCK2;EPHA4;APOE
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.4581161938531507,1.5196303402728593,0.006818181818181818,0.48054675699341315,1.0,32/161,12.90%,IGFBP2;TCF7L2;BICC1;RBMS3;MCC;IGFBP4;DACT1;NKD1;GLI3;APOE;TMEM170B;TLE1;PRICKLE1;PSME4;AXIN2;MLLT3;SFRP1;DKK3;ZNRF3;WWTR1;STK4;DAB2;BMP2;PRKN;STK11;INVS;LZTS2;JADE1;TMEM64;GLI1;UBAC2;KLHL12
prerank,artery development (GO:0060840),0.6160840970319179,1.519304126300854,0.042105263157894736,0.4795884350374917,1.0,5/23,5.69%,NRP1;ROBO1;TGFBR1;SLC2A10;ENG
prerank,regulation of smoothened signaling pathway (GO:0008589),0.5358166610729698,1.5189192700716072,0.03038309114927345,0.47871401924331075,1.0,23/50,18.67%,RORA;ZIC1;GLI3;FGFR2;MGRN1;SMO;FBXL17;SFRP1;TULP3;TEDC1;IFT81;GLIS2;TTC23;PTCH2;GLI1;BTRC;SUFU;GAS1;SHH;INTU;HHIP;EVC;PDCL
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.5525016043921632,1.5173236211638375,0.03576751117734724,0.4823615603781899,1.0,11/40,8.75%,TCF7L2;COL1A1;SMAD3;OLFM1;TGFBR1;AXIN2;PDPN;CRB2;WWTR1;DAB2;BMP2
prerank,catecholamine metabolic process (GO:0006584),0.671636560008835,1.5168255751347068,0.05985915492957746,0.4819424521858858,1.0,5/14,10.20%,COMT;SNCAIP;DRD3;PRKN;LRTOMT
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.5476145586525665,-1.5165872778469616,0.05291005291005291,0.47794566967327123,1.0,8/18,11.31%,SHANK3;NLGN1;PTK2B;RIMS1;NRXN1;RIMS2;SHANK1;PRKCZ
prerank,odontogenesis (GO:0042476),0.5690129662109873,1.516166443442619,0.034023668639053255,0.48212846179474705,1.0,9/35,8.75%,COL1A2;GLI2;FGFR2;WNT6;AXIN2;BCOR;OSR1;AQP6;BMP2
prerank,positive regulation of ERBB signaling pathway (GO:1901186),-0.49282504049611414,-1.51566179112997,0.04424778761061947,0.4760305768257309,1.0,7/25,10.18%,AFAP1L2;CCDC88A;BCAR3;CBL;HIP1R;ARAP1;SHKBP1
prerank,embryonic limb morphogenesis (GO:0030326),0.5758399737400508,1.5155004633793379,0.03768115942028986,0.4823818446984599,1.0,11/34,8.17%,CYP26B1;SALL1;GLI3;WDPCP;RARG;TBX3;MAP3K20;SKI;CACNA1C;OSR1;AFF3
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.6355642555200295,1.5148754536190923,0.047619047619047616,0.4821883396795895,1.0,2/19,3.47%,IGF1;APOE
prerank,negative regulation of lipid catabolic process (GO:0050995),-0.5637654483661442,-1.5147303630595301,0.038860103626943004,0.4743256417216596,1.0,5/17,10.27%,PDE3B;SORL1;MFSD2A;ALK;GPLD1
prerank,response to amyloid-beta (GO:1904645),0.545213045402653,1.5138508920648304,0.0371900826446281,0.4837304442411678,1.0,7/44,7.75%,IGF1;GJA1;LRP1;EPHA4;MMP2;CACNB1;TLR6
prerank,GPI anchor metabolic process (GO:0006505),-0.5070766047344566,-1.5128542388704804,0.040983606557377046,0.4756664255648989,1.0,11/26,18.79%,DPM1;PIGP;PGAP2;GPLD1;PIGB;PIGL;DPM3;PIGU;DPM2;PIGO;PIGV
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.6213142374394247,1.511987483856559,0.05245901639344262,0.48835659757080946,1.0,2/22,0.75%,IGF1;ROCK2
prerank,negative regulation of stress fiber assembly (GO:0051497),0.6089980419307489,1.511542287109222,0.05030487804878049,0.48777724579775994,1.0,6/24,2.15%,PHLDB2;PIK3R1;CGNL1;ARHGAP6;DLC1;ARHGAP28
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.5676061607261421,1.5106107762515033,0.030791788856304986,0.4889408037047192,1.0,11/34,14.42%,NRP1;NEDD9;APOA1;CDC42;DOCK5;CARMIL1;CSPG5;MYADM;P4HB;MDK;FLNA
prerank,chondrocyte differentiation (GO:0002062),0.5771022423979004,1.51049066734889,0.033236994219653176,0.48727485619376715,1.0,11/32,8.75%,SOX5;SULF2;RUNX1;NFIB;RUNX2;SULF1;CREB3L2;WNT5B;EIF2AK3;OSR1;BMP2
prerank,sprouting angiogenesis (GO:0002040),0.5338917055370828,1.5098566454619213,0.03929539295392954,0.4872791013056904,1.0,12/51,6.38%,NRP1;ROBO1;CCBE1;ESM1;ANGPT1;RECK;PARVA;EFNB2;SEMA5A;RNF213;ENG;ADGRA2
prerank,sphingolipid metabolic process (GO:0006665),-0.370987269174257,-1.5094386012425987,0.011235955056179775,0.48227225126555817,1.0,22/108,13.61%,ST6GALNAC3;SGMS1;CERT1;ESYT2;ACER3;ENPP2;SGMS2;ELOVL7;ACER2;DEGS2;PPT1;SPNS2;ELOVL5;HEXB;DEGS1;UGCG;SPTLC2;TECR;SPTSSB;ORMDL3;HACD2;ARV1
prerank,cell-cell junction organization (GO:0045216),-0.3898421593782694,-1.5093914946636364,0.016129032258064516,0.4775956033007384,1.0,27/79,14.09%,PKP4;CTNND2;OCLN;CADM2;CLDN5;CDH2;CADM1;LIMS2;CDH1;TJP2;TJP1;GJC1;TGFB2;NECTIN1;CDH12;CDH6;CDH8;CDH9;CDH13;JUP;CDH10;CSK;TGFB1;CXADR;PVR;TRPV4;DSG2
prerank,nucleotide catabolic process (GO:0009166),-0.5564551487583891,-1.5076511236445915,0.03636363636363636,0.47822782165727923,1.0,8/16,23.84%,NT5E;NT5C2;NT5C1A;GDA;NT5C;PNP;GPX1;VCP
prerank,regulation of chromatin organization (GO:1902275),0.6661908373517067,1.5053439520867797,0.056856187290969896,0.5013223428958219,1.0,7/14,15.18%,IGF2;HPF1;MLLT3;SETD1A;SETD5;TLK1;METTL4
prerank,inositol lipid-mediated signaling (GO:0048017),0.5301406883922581,1.5048017485829288,0.036061026352288486,0.5011944348900597,1.0,9/50,6.84%,IGF1;PIK3R1;FGFR1;OGT;PDGFRA;PDGFRB;PLCD1;ADAP2;PLCB4
prerank,negative regulation of cellular protein localization (GO:1903828),0.5678276634413827,1.5041571111499348,0.04052098408104197,0.5013583097103229,1.0,9/34,10.55%,ROCK2;ACTN2;LEPROT;RIPOR2;SNX33;UBXN2B;PICALM;COMMD1;TAX1BP3
prerank,positive regulation of proteolysis (GO:0045862),0.513874282542724,1.503658663269684,0.021828103683492497,0.5008542404770394,1.0,8/55,6.72%,CCBE1;SH3D19;OGT;FGFR4;ASPH;APOE;CTSH;SNX33
prerank,response to glucose (GO:0009749),0.5318746400103859,1.501256336699951,0.028925619834710745,0.5069823071052902,1.0,7/46,5.19%,TCF7L2;ZBTB20;NKX6-1;SLC30A8;GAS6;NEUROD1;PRKAA2
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.6894721739410901,1.500895797360642,0.050488599348534204,0.5059454347572816,1.0,2/13,1.04%,ERRFI1;CBLB
prerank,embryonic organ development (GO:0048568),0.5156792686426162,1.5004503197044214,0.03238341968911917,0.5054541977474465,1.0,13/61,4.81%,RBP4;TEAD1;GDNF;PBX1;GLI2;SALL1;BMPR1A;GLI3;FGFR2;KIT;COL13A1;RARB;NEUROD1
prerank,regulation of glucose metabolic process (GO:0010906),0.5573728141400515,1.49992849930299,0.04824561403508772,0.5053292146988714,1.0,5/34,5.45%,PDK1;RORA;OGT;SLC45A3;GNB3
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.48535379376106236,1.4993524203888728,0.01699029126213592,0.5052911334506235,1.0,23/95,11.93%,GPC6;FMOD;OGN;CEMIP;ANGPT1;LUM;UST;DCN;BGN;HSPG2;PXYLP1;ST3GAL3;DSE;HS6ST1;SDC1;B4GALT1;OMD;CSPG5;EXT1;ABCC5;NDST1;CHST15;GALNT5
prerank,Golgi ribbon formation (GO:0090161),0.6829527671849278,1.4990083729593027,0.06239737274220033,0.504488323832817,1.0,4/13,8.91%,OPTN;MYO18A;STX16;TRIP11
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),-0.5809695174480544,-1.4981592715410452,0.05398457583547558,0.5058857559591807,1.0,8/15,17.75%,TEC;PTK2B;KDR;BMX;AATK;MAPK3;IGF1R;TXK
prerank,regulation of protein export from nucleus (GO:0046825),0.593364942181265,1.4978732381064128,0.058823529411764705,0.5066970408291832,1.0,6/23,12.16%,TCF7L2;SP100;GAS6;RBM22;IFI27;YWHAE
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),-0.5315593936526104,-1.4962073950418324,0.05614973262032086,0.5078950572939334,1.0,8/19,12.63%,CSGALNACT1;EXTL3;NDST3;XYLT1;HS6ST3;HS3ST5;HS6ST2;UGDH
prerank,regulation of postsynaptic membrane potential (GO:0060078),-0.45349804619975564,-1.4960986536565315,0.03470031545741325,0.5033672735903225,1.0,10/34,9.47%,GRID2;MEF2C;GABRG3;GRIN2A;GABRA2;GLRA1;GABRG2;GRIN2B;GSK3A;GABRA3
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),0.7028285884020393,1.4951767020034608,0.05913978494623656,0.5142444291264255,1.0,6/11,8.34%,NKD1;LBX2;MLLT3;SFRP1;WNT5B;DAB2
prerank,positive regulation of endothelial cell migration (GO:0010595),0.48332989690548084,1.4944177767916007,0.023399014778325122,0.5148620135138536,1.0,18/84,10.16%,NRP1;PDPK1;RIN2;ROCK2;ANGPT1;SPARC;SASH1;PLPP3;FGFR1;SEMA5A;SMOC2;ATOH8;AKT3;AAMP;FOXC2;ANXA3;ITGB3;FGF2
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.5161668004828296,1.4943920607971737,0.023004059539918808,0.512830733679668,1.0,14/56,10.50%,BMP6;LDLRAD4;BMPR1A;INHBE;PMEPA1;TGFBR1;TWSG1;ACVR1;ENG;EMILIN1;DAB2;RBPMS;BMP2;BMP15
prerank,regulation of fibroblast proliferation (GO:0048145),0.5300015862141602,1.494202316160286,0.041278295605858856,0.5113603841832469,1.0,7/45,5.82%,IGF1;DDR2;GAS6;PDGFRA;LIG4;SFRP1;SKI
prerank,glucose homeostasis (GO:0042593),0.4792605618116884,1.4940942239967392,0.02781289506953224,0.5096145105559677,1.0,20/83,15.80%,TCF7L2;RBP4;PIK3R1;LEPR;SLC30A8;FGFR4;APPL2;MCU;NEUROD1;PRKAA2;CEBPA;NR1D1;STK11;ADRA2A;INSR;CYB5R4;SLC2A4;FOXK2;PIK3R2;LRRC8A
prerank,amide transport (GO:0042886),-0.4881175551870034,-1.4937107538188301,0.034666666666666665,0.5069575148731805,1.0,6/26,6.74%,CERT1;ABCG2;PLTP;SLC5A6;SLC38A5;PLEKHA3
prerank,negative regulation of myeloid cell differentiation (GO:0045638),-0.5135747676957896,-1.4934738222292094,0.03260869565217391,0.5030201080285212,1.0,5/20,6.07%,ZBTB16;CDK6;PTK2B;HOXA5;MEIS2
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.6935363086095232,1.492911232558792,0.06655574043261231,0.511722997444402,1.0,2/13,0.18%,NRP1;PLXNA2
prerank,cardiac muscle contraction (GO:0060048),0.5529444952098606,1.492063425130115,0.05037037037037037,0.5126400852779208,1.0,8/34,9.65%,SLC8A1;GSN;ATP1A2;TPM1;TNNC1;MYL4;GAA;CSRP3
prerank,regulation of kinase activity (GO:0043549),0.48642300363925706,1.4917165974696556,0.029850746268656716,0.5118861848064601,1.0,22/89,10.58%,EPHA3;EPHA7;LDB2;DDR2;FGFR1;EPHA4;EPHA8;FGFR2;KIT;FGFR4;PDGFRA;PDGFRB;TSPYL2;AXL;MUSK;ROR1;NTRK3;EGFR;EPHB2;LMO4;RYK;RBL2
prerank,regulation of gene expression by genetic imprinting (GO:0006349),0.7003511990783876,1.4915594638591054,0.07948243992606285,0.5104043127352466,1.0,3/10,8.77%,IGF2;DNMT3A;PCGF3
prerank,positive regulation of natural killer cell activation (GO:0032816),0.6767982966835226,1.4907352928455182,0.07903780068728522,0.5113973129880747,1.0,6/13,17.96%,GAS6;AXL;IL12B;ZBTB1;IL23A;IL18
prerank,regulation of transforming growth factor beta production (GO:0071634),0.6226360737675353,1.490355268461284,0.06456953642384106,0.510755119762559,1.0,6/18,9.62%,LTBP1;SMAD3;ITGB8;ITGB6;CD200;ITGAV
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.6867287485803362,1.4902613726794987,0.065,0.5091253800026228,1.0,6/11,10.55%,ACTN2;LEPROT;SNX33;PICALM;COMMD1;TAX1BP3
prerank,cellular zinc ion homeostasis (GO:0006882),-0.48792594955020263,-1.490207196859236,0.05013927576601671,0.5092495482619489,1.0,10/26,4.62%,SLC39A10;SLC39A8;MT1B;MT1G;MT1E;MT1A;MT1H;MT1M;MT1X;MT1F
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.705269088011365,1.4901495396636188,0.08736059479553904,0.5075247687338256,1.0,3/10,4.42%,ENPP1;PID1;APPL2
prerank,C-terminal protein amino acid modification (GO:0018410),-0.6090905688889618,-1.4899073188541097,0.060133630289532294,0.5056072914072062,1.0,7/11,30.00%,AGBL4;GPLD1;ATG7;TTL;AGTPBP1;LCMT1;AGBL1
prerank,positive regulation of phosphatase activity (GO:0010922),-0.5184772667991269,-1.4895587833526702,0.036827195467422094,0.5021837467463247,1.0,10/21,12.39%,MEF2C;ITGA1;HSP90AB1;PPP1R15B;CALM1;MTMR9;GPLD1;CALM3;PLEK;MTOR
prerank,axon guidance (GO:0007411),0.44673862240945966,1.4893760349168712,0.0054288816503800215,0.5083164727127604,1.0,41/201,10.37%,EPHA3;NRP1;ROBO1;PLXNA2;EPHA7;LAMA1;RHOH;GDNF;PIK3R1;DAG1;SEMA3D;LAMA2;GLI2;EPHA4;GFRA2;EPHA8;NFIB;EFNB2;SMO;PALLD;SEMA5A;NOTCH2;NCAM1;LRTM1;FRS2;SRC;ALCAM;RANBP9;EFNA2;ARHGAP35;SPTAN1;DSCAM;EPHB2;NTN1;EFNB1;GFRA4;SLIT3;SLIT1;RYK;PTPRM;NEXN
prerank,regulation of protein kinase B signaling (GO:0051896),0.44194248496021366,1.4884655105195104,0.0044444444444444444,0.5095102983194446,1.0,41/193,13.85%,TCF7L2;PDPK1;IGF2;ANGPT1;PIK3R1;AREG;DAG1;TGFA;FGFR1;EPGN;KL;FGFR2;KIT;FGFR4;GAS6;PDGFRA;PDGFRB;TGFBR1;SEMA5A;CCL19;AXL;OSBPL8;FRS2;ENG;SRC;CD28;GRM2;NTRK3;DRD3;EGFR;SPRY2;FGF2;HBEGF;RCN3;PHLPP2;INSR;MUL1;EGF;TSC2;PTEN;FLT3LG
prerank,bone development (GO:0060348),0.545641655921905,1.4884279181794264,0.033946251768033946,0.5076319671215261,1.0,8/39,5.82%,GJA1;CYP26B1;SULF2;FGFR2;GNAS;SULF1;SH3PXD2B;SKI
prerank,regulation of developmental growth (GO:0048638),0.5719562981229431,1.487743028115273,0.054252199413489736,0.5080087593745669,1.0,5/29,5.36%,IGF1;GHR;OLFM1;APOE;MUSK
prerank,cellular response to amyloid-beta (GO:1904646),0.554959739411437,1.4864688134118336,0.049635036496350364,0.5105153276417385,1.0,6/35,7.75%,IGF1;GJA1;LRP1;EPHA4;CACNB1;TLR6
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.650195473049603,1.4861649935129062,0.07899159663865546,0.5096324820980794,1.0,7/15,6.62%,DAAM2;DACT1;LBX2;RNF213;SFRP1;ZNRF3;WNT5B
prerank,cellular response to interleukin-6 (GO:0071354),0.584821236739113,1.485927704798458,0.05076923076923077,0.5084895031095947,1.0,6/26,6.86%,PTGIS;PID1;IL6R;YAP1;SRC;CEBPA
prerank,apical junction assembly (GO:0043297),-0.42137508049444544,-1.4852694379965097,0.011538461538461539,0.5121019527007137,1.0,13/53,12.65%,MPP7;OCLN;PECAM1;CLDN5;ESAM;F11R;CLDN11;RAMP2;PDCD6IP;PATJ;WDR1;STRN;PAK2
prerank,embryonic digestive tract development (GO:0048566),0.6500973895298124,1.4842359424319587,0.07258064516129033,0.5128228954983525,1.0,6/18,3.68%,GLI2;SALL1;GLI3;FGFR2;PDGFRA;RARB
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.5220832425384218,-1.4839383593219475,0.05080213903743316,0.511971550360713,1.0,9/20,14.43%,RPS6KA5;DIP2B;NOS1;PPARGC1A;BRD7;RPS6KA4;TADA2A;MAPK3;DIP2A
prerank,negative regulation of signaling receptor activity (GO:2000272),0.5856456932233912,1.482231788164285,0.05803571428571429,0.5180579783508934,1.0,3/25,2.56%,ERRFI1;CBLB;SLC6A9
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.4488023447744023,1.482018295632756,0.005611672278338945,0.5168337593382268,1.0,36/166,12.58%,IGF1;SAMD4A;IGF2;SMAD3;ZEB2;PLD1;GLI2;SLC6A9;NOS1AP;NNMT;FGFR4;PDGFRB;CCL19;APOA1;SLC45A3;SLC25A37;LDLR;STAR;SMOC2;CPEB3;CD28;NPM2;SREBF1;TLR6;NR1D1;LPGAT1;EGFR;METTL14;ARNT;FGF2;EIF6;DDX3X;RGCC;GLI1;INSR;NMD3
prerank,ketone body metabolic process (GO:1902224),0.7100897102236077,1.481433583741193,0.06216696269982238,0.5168483353355943,1.0,4/10,3.16%,SLC27A5;ACSS3;OXCT1;HMGCLL1
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.5949939629433754,1.4812729218670957,0.058823529411764705,0.5154377476849522,1.0,10/23,16.85%,GJA1;GDNF;SMO;LBX2;WNT5B;FGF2;EGF;MDK;BMP4;LIF
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.5226934363286303,1.4812702649197853,0.05135520684736091,0.5134891688790963,1.0,6/46,4.26%,TCF7L2;PIK3R1;SMAD3;ZIC1;GAS6;NEDD4
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.5341644798203539,1.4806806589361594,0.04992867332382311,0.5136805652871966,1.0,13/41,13.99%,AREG;TGFA;NEDD9;EPHA4;IL34;EPGN;GAS6;SRC;HBEGF;ADRA2A;NOX4;EGF;DLG4
prerank,endothelial cell proliferation (GO:0001935),-0.5507757541600267,-1.4804423896211358,0.05897435897435897,0.5195297802224291,1.0,9/17,18.89%,TEK;BMPER;CD34;ACVRL1;THAP1;PRKX;ERN1;BMPR2;ITGB1BP1
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.5812928237920099,1.479873808856183,0.0589171974522293,0.5147616077663908,1.0,2/25,0.72%,PDPK1;CEMIP
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.6497099093619655,1.4795598373328258,0.07119205298013245,0.5139983563600542,1.0,5/15,14.45%,SH3D19;APOE;SNX33;ADRA2A;SNX9
prerank,regulation of actin filament-based process (GO:0032970),0.4965286403689566,1.4793208223640641,0.02849740932642487,0.5128968538170131,1.0,14/70,7.95%,EPHA3;RHOH;ROCK2;LRP1;DLC1;RHOD;ARHGAP18;RHOBTB1;PDGFRB;CNN2;IQGAP2;RHOBTB3;RHOBTB2;ARHGAP35
prerank,aorta development (GO:0035904),0.6654280202243037,1.4791450601652694,0.08482871125611746,0.511521121848919,1.0,4/14,6.17%,ROBO1;LRP1;PDGFRB;ADAMTS9
prerank,retinoic acid metabolic process (GO:0042573),0.6510317310401231,1.4779991972285622,0.0946843853820598,0.5139034693623138,1.0,3/14,7.28%,CYP26B1;ALDH1A2;ADH1A
prerank,myotube cell development (GO:0014904),0.7063909330907857,1.4768907178322495,0.06782608695652174,0.5158608151215451,1.0,2/10,5.82%,IGF1;SKI
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.7034369697682139,1.4761881869534805,0.09352517985611511,0.5162880782789624,1.0,3/10,3.05%,LYN;PIGR;KIT
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),0.6614871575607085,1.4758136650511862,0.07142857142857142,0.5157363725013133,1.0,5/13,8.73%,BMP6;BMPR1A;TGFBR1;DAB2;RBPMS
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.48030992213616547,1.474854761557548,0.02857142857142857,0.5173883326370334,1.0,17/88,12.73%,NELL1;SAMD4A;DAPK1;DNAJC1;APOE;CDK5RAP3;IGF2BP2;IGFBP5;CST3;CPEB3;EIF2AK3;RNF139;DDX3X;F2;CLN3;LARP1;TM4SF20
prerank,regulation of transmembrane transport (GO:0034762),-0.4604144761612734,-1.474247021964876,0.039755351681957186,0.5360117198668538,1.0,7/31,3.19%,OCLN;SLC2A1;KCNJ2;ACTB;CTTNBP2NL;NEDD4L;KCNJ3
prerank,regulation of cell migration (GO:0030334),0.4227373840478046,1.471879428141863,0.0,0.5260746779438259,1.0,83/382,11.32%,IGF1;ROBO1;PLXNA2;LDB2;PHACTR1;COL1A1;CEMIP;ROCK2;AMOTL2;PDGFD;SYNE2;SASH1;LDLRAD4;DAG1;MITF;SEMA3D;SERPINE1;DLC1;RHOD;PODN;NEDD9;TPM1;EPHA4;DOCK10;NKD1;KANK1;RECK;PPP3CA;CCN1;NKX2-1;MACF1;KIT;MYLK;PDGFRA;PDGFRB;TGFBR1;SMO;DPYSL3;SEMA5A;SULF1;CSF1;RFFL;APPL2;ACVR1;NTF3;SFRP1;CTSH;IGFBP5;TBCCD1;PDPN;CXCL16;CYP1B1;CDH5;ENG;SRC;BEX4;WNT5B;VCL;DPEP1;AFDN;CARMIL1;MYO1C;PARD6B;NTRK3;DAB2;EGFR;EPHB2;BMP2;MAP4K4;SPRY2;ACTN4;CAMK2B;MYADM;LMO4;MIA3;FAM89B;FGF2;NEXN;DNAI3;TRIP6;AMOTL1;HBEGF;ADRA2A
prerank,embryonic eye morphogenesis (GO:0048048),0.7050736927011094,1.4704128771593845,0.07557117750439367,0.5293470975416231,1.0,4/11,5.00%,FBN1;FBN2;MFAP5;RARG
prerank,positive regulation of regulated secretory pathway (GO:1903307),-0.5434415978948428,-1.4700057083918177,0.04834605597964377,0.5463871478756349,1.0,8/17,18.69%,NLGN1;RAB27A;SLC4A8;CACNA1H;RAB15;RAB3A;STX1A;SYT4
prerank,negative regulation of sprouting angiogenesis (GO:1903671),-0.6089321719559142,-1.4695387307589687,0.08009153318077804,0.5430585943599868,1.0,4/11,3.18%,SEMA6A;THBS1;EPN2;KLF2
prerank,positive regulation of DNA binding (GO:0043388),0.5586963585506702,1.4687516140263688,0.06896551724137931,0.5335247253246609,1.0,7/31,13.24%,IGF1;NEUROD1;SKI;SIRT2;PRKN;NIBAN2;EGF
prerank,ribosomal large subunit assembly (GO:0000027),-0.49950139809356386,-1.4670566157297702,0.04057971014492753,0.5473765901143532,1.0,11/24,27.97%,RPL3;RPL11;RPL6;PPAN;RPL5;FASTKD2;RPLP0;RRS1;RPF2;DDX28;RPL10
prerank,ganglion development (GO:0061548),0.6883921688459205,1.4665385748427668,0.08185053380782918,0.5394321954960918,1.0,2/11,3.20%,NRP1;ASCL1
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.5544582908092647,1.466295709600868,0.05547445255474453,0.5384100323498341,1.0,8/35,6.49%,IRAG1;ADCY1;ADCY2;KSR1;APOE;RAPGEF2;PDE3A;PDE7B
prerank,pancreas development (GO:0031016),0.6695336281304722,1.4658076484219982,0.08047945205479452,0.5383755544277296,1.0,3/12,7.53%,TCF7L2;NKX6-1;DNAAF1
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.6752547566565293,1.4651445148244038,0.09375,0.5388135479677382,1.0,8/12,28.51%,INSIG2;KDELR3;INSIG1;RER1;HSPA5;OS9;KDELR2;TAPT1
prerank,negative regulation of cartilage development (GO:0061037),0.6766389906372645,1.4645013948729573,0.09298245614035087,0.5392771711404846,1.0,3/13,4.35%,ADAMTS12;TGFBR1;CHADL
prerank,regulation of actomyosin structure organization (GO:0110020),0.6709633248054958,1.4644853531931754,0.08635578583765112,0.537450342778356,1.0,4/13,6.66%,ROCK2;ASAP3;CDC42;ALMS1
prerank,cation transport (GO:0006812),-0.3331235444302614,-1.464074454555543,0.0,0.5531605911464015,1.0,29/167,7.91%,TRPM3;PIEZO2;SLC6A6;SLC12A2;SLC47A1;KCNB2;KCNJ2;PIEZO1;ANO1;KCNK5;KCNAB1;NEDD4L;SLC9B2;SLC7A1;KCNJ3;SCN1A;KCNMA1;KCND3;SLC5A6;ABCC9;SLC38A5;KCNN2;SCN3A;SLC1A1;ATP1B1;KCNMB2;NDFIP2;SCN2A;TRPM7
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.5595868086188708,1.46363997888475,0.07526881720430108,0.538589607409961,1.0,6/30,9.62%,IGF1;LYN;NOTCH2;SRC;RAPGEF1;ITGAV
prerank,integrin-mediated signaling pathway (GO:0007229),0.4860053687233985,1.4621295534515077,0.03337612323491656,0.5420559772403832,1.0,16/73,9.62%,ITGBL1;NRP1;FYB1;PLPP3;ITGA11;NEDD9;FBLN1;APOA1;ITGB8;ITGB5;CDC42;SRC;DAB2;ITGB6;ITGB3;ITGAV
prerank,cellular response to growth factor stimulus (GO:0071363),0.44949306974660036,1.4619679109725972,0.013605442176870748,0.5407556920533637,1.0,27/151,9.36%,NRP1;BMP6;ADAMTS12;PDPK1;CILP;CLEC3B;SMAD3;SOX5;BMPR1A;WNT4;RUNX2;TGFBR1;PDCD5;RAPGEF2;APPL2;ACVR1;SFRP1;PDE3A;ZFP36L1;ACAP2;SIRT2;NTRK3;EGFR;BMP2;STAT5B;SPRY2;RAPGEF1
prerank,protein localization to synapse (GO:0035418),-0.5755943416238726,-1.4615187963203629,0.0683371298405467,0.5577159247568046,1.0,5/12,10.52%,NLGN1;NRXN1;SHANK1;ZDHHC15;PCLO
prerank,sarcomere organization (GO:0045214),0.5780156641671137,1.4605195699196005,0.05637982195845697,0.5438974169770208,1.0,7/27,10.12%,ACTN2;TPM1;TNNT1;CSRP2;CSRP3;SYNPO2L;TNNT3
prerank,positive regulation of insulin secretion (GO:0032024),0.5476705897627905,1.460456052761471,0.047619047619047616,0.5422480513620045,1.0,5/36,5.31%,TCF7L2;RBP4;SLC30A8;MCU;BAIAP3
prerank,regulation of cardiac muscle cell contraction (GO:0086004),-0.4751618040116726,-1.459912990347335,0.05341246290801187,0.5586594485773934,1.0,8/27,14.09%,PDE4D;CAV1;PDE4B;CTNNA3;CAMK2D;JUP;RYR2;DSG2
prerank,regulation of stem cell proliferation (GO:0072091),0.6278817534026914,1.4593284633232928,0.08866995073891626,0.5441922027535383,1.0,4/17,5.78%,GJA1;YAP1;FBLN1;ZFP36L1
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.5881685384258905,1.4580610251251975,0.0904836193447738,0.5471114387966423,1.0,2/25,4.81%,IGF1;NEUROD1
prerank,ceramide catabolic process (GO:0046514),-0.55127700706372,-1.456962025788894,0.06598984771573604,0.5643509003109507,1.0,7/14,25.09%,ACER3;ACER2;HEXB;HEXA;NEU1;GLA;NEU2
prerank,positive regulation of signaling receptor activity (GO:2000273),0.5433016898286132,1.4569488659162997,0.05043227665706052,0.5494118959476669,1.0,10/36,13.49%,NRP1;AREG;TGFA;EPGN;ADRA2C;EPHB2;HBEGF;ADRA2A;EGF;NCOA3
prerank,response to prostaglandin E (GO:0034695),0.6891252523750873,1.4562510220884373,0.08347826086956522,0.5499933260529607,1.0,3/10,5.05%,TGFBR3;CCL19;SFRP1
prerank,diacylglycerol metabolic process (GO:0046339),-0.49352498673131445,-1.4559300807137632,0.05,0.5635982609281164,1.0,10/23,17.45%,PLCE1;DGKB;DGKH;LIPE;DGKK;PGS1;DGKG;DGKQ;PNPLA2;DGKZ
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),-0.5876561026924475,-1.4559218984971347,0.07207207207207207,0.5589945674831139,1.0,3/12,3.55%,PODXL;PROM1;IQGAP1
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.6815777442650962,1.455212162834796,0.08907563025210084,0.5517185588734048,1.0,4/12,3.18%,MYCBP2;GLI2;EPHA4;NFIB
prerank,regulation of chondrocyte differentiation (GO:0032330),0.5880560599417602,1.4545684509328594,0.07796101949025487,0.5520883555991114,1.0,5/24,4.35%,ADAMTS12;TRPS1;SOX5;TGFBR1;CHADL
prerank,BMP signaling pathway (GO:0030509),0.492614122179091,1.452927251468903,0.032509752925877766,0.5559957949575727,1.0,17/62,15.57%,BMP6;TGFBR3;SMAD3;BMPR1A;RUNX2;ACVR1;ENG;RGMA;BMP2;SMAD1;BMP15;USP9Y;PDCD4;USP9X;HIVEP1;BMP4;BMP5
prerank,cyclooxygenase pathway (GO:0019371),0.7095817736248222,1.4528133345150338,0.07747747747747748,0.5544938622830219,1.0,2/10,1.91%,PTGIS;PTGES
prerank,regulation of cellular catabolic process (GO:0031329),0.4912572433212829,1.4527642407943724,0.042105263157894736,0.5528008192783291,1.0,19/62,20.99%,DAPK2;ITPR1;DAPK1;NUPR1;LRRK2;MTMR3;WDR91;PRKN;LONP2;RRAGD;USP10;PIK3R2;TPCN2;PIP4K2C;ATM;WDR41;PSAP;GPR137B;DDIT3
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.485745397011031,1.4521508923381068,0.044444444444444446,0.5532741920767855,1.0,13/72,6.31%,IGF1;PIK3R1;PDGFD;DCN;LYN;FGFR1;KIT;PDGFRA;PDGFRB;NEDD4;NTF3;ROR1;SRC
prerank,replicative senescence (GO:0090399),0.6690484119995559,1.4513050737235167,0.0880281690140845,0.5546184429109152,1.0,2/12,2.11%,SERPINE1;PLA2R1
prerank,carbohydrate derivative transport (GO:1901264),-0.5382579435529498,-1.4511562006031895,0.07142857142857142,0.5723351213280246,1.0,8/18,14.56%,PLTP;SLC15A2;LBP;NPC2;MFSD2A;ABCG1;SCARB1;VLDLR
prerank,embryonic digit morphogenesis (GO:0042733),0.6203070821882488,1.4506500290725486,0.0992,0.5550961070511267,1.0,6/18,7.89%,SALL1;GLI3;WDPCP;TBX3;MAP3K20;OSR1
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.605594888255833,-1.4502016423620028,0.07042253521126761,0.571308551444248,1.0,5/11,10.72%,NOS3;GCH1;DHFR;CALM1;SPR
prerank,positive regulation of transferase activity (GO:0051347),0.4450095932438298,1.4495388596519174,0.01834862385321101,0.5571186164526731,1.0,25/142,10.31%,EPHA3;EPHA7;IGF2;DDR2;ARRDC4;FGFR1;EPHA4;EPHA8;FGFR2;KIT;FGFR4;PDGFRA;PDGFRB;CHTF8;AXL;MUSK;ROR1;PARM1;NTRK3;EGFR;EPHB2;CD200;LMO4;RYK;PARN
prerank,actin filament bundle assembly (GO:0051017),0.543415803383932,1.449485876732723,0.06986899563318777,0.5555321197303245,1.0,8/33,5.80%,CALD1;RHOD;NEDD9;SHROOM2;DPYSL3;MYO1B;FSCN3;LIMA1
prerank,cell chemotaxis (GO:0060326),0.49063451719753215,1.4493163868983494,0.06524633821571238,0.5542903995338674,1.0,12/60,7.51%,NRP1;DOCK4;PARVA;XCR1;KIT;PDGFRA;PDGFRB;SEMA5A;ACKR2;CCR9;AGTR1;LPAR1
prerank,substrate-dependent cell migration (GO:0006929),0.6422306701641856,1.4486809454821026,0.0920353982300885,0.5548061743484974,1.0,3/14,2.61%,NRP1;ITGA11;EPHA8
prerank,phospholipid transport (GO:0015914),-0.3996331646520271,-1.4482663612382793,0.043137254901960784,0.5740067525330034,1.0,21/52,17.77%,PITPNC1;ATP8A1;ATP8B1;ATP11C;PLTP;ABCC1;PITPNA;ATP11B;TNFAIP8L3;NPC2;ATP11A;MFSD2A;ABCG1;OSBPL2;SCARB1;PCTP;SCARB2;PITPNB;ATP10A;PRELID2;ABCB4
prerank,tRNA aminoacylation for protein translation (GO:0006418),-0.424049251930106,-1.4478301003777319,0.0410958904109589,0.5710432786692057,1.0,16/42,22.19%,WARS1;WARS2;LARS1;TARS3;YARS1;YARS2;QARS1;TARS2;KARS1;FARS2;AIMP1;NARS2;MARS2;AIMP2;AARS2;TARS1
prerank,regulation of endothelial cell migration (GO:0010594),0.46884805698713566,1.4474534818740294,0.028465346534653466,0.5573344895380348,1.0,20/85,10.32%,NRP1;RIN2;ROCK2;ANGPT1;SPARC;GLUL;SASH1;DCN;NR2F2;SP100;APOE;SMOC2;ATOH8;ADAMTS9;AAMP;FOXC2;ANXA3;ITGB3;FGF2;PTPRM
prerank,central nervous system neuron differentiation (GO:0021953),-0.44462659540552674,-1.4472602443180291,0.07507507507507508,0.5686708985091078,1.0,8/33,11.81%,GRID2;MDGA2;MAP2;SPOCK1;LRP6;OPHN1;ZC4H2;ATP7A
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.6762963546929585,1.4467289165632626,0.09557522123893805,0.5582110058966978,1.0,4/12,9.03%,ROCK2;APOE;RANBP9;PICALM
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.5461332672765605,1.4466661541553723,0.06437125748502993,0.5566632870533809,1.0,8/31,8.12%,TGFBR3;TPM1;BMPR1A;FGFR2;TGFBR1;ENG;TNNC1;RBPJ
prerank,regulation of receptor binding (GO:1900120),0.6834177796640996,1.4463868284973445,0.10091743119266056,0.555826127572709,1.0,1/10,0.07%,GREM2
prerank,negative regulation of multicellular organismal process (GO:0051241),0.43575179950997855,1.4456893593434732,0.012114537444933921,0.5567481874814513,1.0,45/199,15.86%,ALDH1A1;ROBO1;GJA1;ROCK2;ADAMTS5;MCC;LDLRAD4;LGR4;WWC2;IL17D;TNNT1;NKX2-1;NFIB;ACOT11;GAS6;NPR3;TWSG1;APOA1;SFRP1;NR1D1;RBPJ;FOXC2;EGFR;BMP2;SPRY2;USF3;STK11;FOXA1;SPRED3;ADM;RGCC;VASN;MAP2K6;SYT11;PTEN;PTPN23;MDK;HPN;NR1H3;BMP4;ASB1;SPRED1;BMP5;CHSY1;SDHAF2
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.6982206178329573,1.4455993213566085,0.08566433566433566,0.5552463057944479,1.0,5/11,11.10%,GRK3;ADRB3;DRD3;ARRB1;ADM
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.43066550483608607,1.4446465362197554,0.014285714285714285,0.5568873658138648,1.0,46/182,14.19%,IGF1;ROBO1;CILP;SLC24A3;ROCK2;RBMS3;RUNX1;BMPR1A;OLFM1;OPTN;WNT4;YAP1;APOE;SMO;NOTCH2;SLC2A10;ITGB8;LDLR;SFRP1;PRKAA2;ENG;TNRC6B;ATOH8;EMILIN1;CD28;MAP2K1;TET1;TNRC6A;BMP2;PICALM;SNX12;PRKN;MYADM;PARP14;FGF2;TTBK1;RBL2;TCEAL1;REST;TERF2;LRP3;CCDC3;MYCN;DLG4;ZNF148;SETDB1
prerank,sensory perception of mechanical stimulus (GO:0050954),0.48480814627308144,1.4445659108328623,0.03209876543209877,0.5554141451610783,1.0,17/85,11.08%,ATP6V0A4;COL1A1;CEMIP;COL4A3;ADGRV1;EYA1;GRXCR1;COL11A1;EML2;RIPOR2;ROR1;USH2A;ALDH7A1;TIMM9;LRTOMT;COL11A2;GSDME
prerank,keratan sulfate biosynthetic process (GO:0018146),0.5840548666140754,1.4439361347907687,0.08282208588957055,0.5558176482051332,1.0,6/26,7.97%,FMOD;OGN;LUM;ST3GAL3;B4GALT1;OMD
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.5203571940558596,1.4433026263614281,0.062146892655367235,0.5563831037453701,1.0,15/43,14.24%,ERRFI1;CBLB;AREG;TGFA;EPGN;CDC42;EPS15;EGFR;SPRY2;HBEGF;EPS15L1;PTPN3;EGF;MVP;GPRC5A
prerank,peptidyl-tyrosine modification (GO:0018212),0.5009190669919312,1.4431509112353955,0.040214477211796246,0.5551184561096222,1.0,11/56,3.56%,EPHA3;DDR2;LYN;FGFR1;EPHA4;FGFR2;KIT;FGFR4;TPST1;PDGFRA;PDGFRB
prerank,protein homotrimerization (GO:0070207),0.6281685010174781,1.4420785917890337,0.10445205479452055,0.5553451674585164,1.0,4/14,9.20%,SLC1A5;SCARA5;MLKL;CLYBL
prerank,protein trimerization (GO:0070206),0.6281685010174781,1.4420785917890337,0.10445205479452055,0.5553451674585164,1.0,4/14,9.20%,SLC1A5;SCARA5;MLKL;CLYBL
prerank,autonomic nervous system development (GO:0048483),0.6353320269558373,1.440899965449707,0.08019639934533551,0.5577716142592642,1.0,3/17,3.20%,NRP1;GDNF;ASCL1
prerank,C21-steroid hormone metabolic process (GO:0008207),0.5996990647012654,1.4408612275006654,0.0949367088607595,0.55614695331996,1.0,4/20,10.90%,AKR1B1;STAR;HSD3B2;TSPO
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.5864394989429291,-1.440421126829848,0.1026252983293556,0.5881782965200832,1.0,7/11,25.88%,UQCRH;CYCS;UQCR10;UQCR11;UQCRQ;UQCRC1;UQCRFS1
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),-0.5723061954540584,-1.4403923419564508,0.07363420427553444,0.5837471090697058,1.0,9/14,30.24%,ENTPD1;ENTPD2;ENTPD6;ENTPD3;ADPRM;NUDT16;NUDT9;ENTPD5;NUDT1
prerank,ribosome biogenesis (GO:0042254),-0.32694447051678494,-1.4402613018471488,0.011904761904761904,0.5796912248345274,1.0,69/187,21.54%,RPL41;RPL3;RPS24;RPS14;RPL27A;RPL8;RPS19;RPL34;RPL21;RPL7;RPL18;RIOK1;RPL27;RPL35A;RPL38;RPS15;RPL39;RPS7;PAK1IP1;RPL11;WDR36;RPL30;RPL36;RPLP1;RPL37;RPS9;UTP4;RPL4;METTL17;RPL18A;RPL26;RPL6;RPL36A;RPL29;MALSU1;RPL13A;RPL7A;NVL;RPL19;RRP1;SNU13;POP4;RPL14;RPL13;RPL32;RPL5;NOL9;RPLP0;MPHOSPH10;KRR1;RPS6;RPL22;UTP15;RRP36;IMP4;FCF1;EXOSC5;NPM1;RRP12;RPL37A;NOP16;RPLP2;URB2;RPL17;RPL23;RPF1;WDR46;RRS1;RPF2
prerank,sensory organ development (GO:0007423),0.5094923240547057,1.440111497044218,0.04582210242587601,0.5570806310924604,1.0,7/51,6.98%,RBP4;PBX1;SHROOM2;ASCL1;SH3PXD2B;CPAMD8;SMOC1
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.6500711848442778,1.4399880796605586,0.10186757215619695,0.5558185152350095,1.0,3/13,6.76%,PTGIS;NNMT;PARP16
prerank,keratan sulfate metabolic process (GO:0042339),0.5574956827010406,1.4398806252954515,0.08430232558139535,0.55449503132494,1.0,7/31,7.97%,FMOD;OGN;LUM;ST3GAL3;GALNS;B4GALT1;OMD
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.4580278860084971,1.4398409170015696,0.027544910179640718,0.5528755458753555,1.0,17/102,8.83%,PDPK1;ADCY1;ENPP1;TBC1D4;ADCY2;PIK3R1;ADCY7;ADCY5;ADCY9;INSIG2;CPEB1;ZFP36L1;LHCGR;SRC;TRARG1;SLC30A10;KAT2B
prerank,Golgi organization (GO:0007030),0.44869527747932825,1.439812518259606,0.024676850763807285,0.5512723099837252,1.0,40/112,19.66%,OBSL1;USP6NL;LMAN2L;OPTN;RAB30;MYO18A;GORASP2;ARHGAP21;TMED1;GOLGB1;LMAN1;CDC42;STX16;ZW10;LRRK2;UBXN2B;GOSR2;TRIP11;ARL1;TMED4;PLEKHM2;TJAP1;GOLPH3L;GORASP1;GOLGA8B;GOLGA5;TANGO2;ATP8B2;TBC1D20;BAG5;HACE1;HUWE1;CUL7;GOLPH3;ARFGEF1;TMED10;CSNK1A1;SEC16B;HTT;NSFL1C
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.6677287911870433,1.4390724100519845,0.0919931856899489,0.5521474041827876,1.0,5/12,8.04%,UST;DCN;BGN;DSE;CSPG5
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.5107771035838075,1.4389734848222742,0.04801097393689986,0.5508483132290172,1.0,16/47,15.64%,NRP1;NEDD9;KANK1;FBLN1;APOA1;PDPN;CDC42;DOCK5;CARMIL1;CSPG5;ACTN4;MYADM;P4HB;MDK;FLNA;MELTF
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.6522462823450117,1.4385949243901321,0.0986159169550173,0.5504771801798094,1.0,3/14,4.35%,ADAMTS12;TGFBR1;CHADL
prerank,negative regulation of cell differentiation (GO:0045596),0.43072065990997005,1.43732754597049,0.015783540022547914,0.5532428744147124,1.0,50/181,16.01%,ADAMTS12;IGF2;RORA;ENPP1;RUNX1T1;ADGRV1;SMAD3;COL5A1;LDLRAD4;ABCA1;NKX2-1;ASCL1;YAP1;TGFBR1;CHADL;SFRP1;TBX3;SKI;WWTR1;USH2A;SIRT2;OSR1;EGFR;SPRY2;METTL14;TRPM4;ITGB3;ITGAV;USF3;ANKRD26;FOXA1;SPRED3;REST;TMEM64;LRP3;VASN;PDCD4;PAF1;COL5A2;PTEN;HPN;TWIST2;NR1H3;BMP4;SUFU;SPRED1;BMP5;RIOX1;SDHAF2;TRIO
prerank,cellular response to glucagon stimulus (GO:0071377),0.6292294481206459,1.4359498046045422,0.09369676320272573,0.5565675016013604,1.0,5/17,3.53%,ADCY1;ADCY2;ADCY7;ADCY5;ADCY9
prerank,dermatan sulfate metabolic process (GO:0030205),0.6513306943885587,1.4352449590746097,0.1026936026936027,0.5573304136126468,1.0,5/13,8.04%,UST;DCN;BGN;DSE;CSPG5
prerank,cellular response to cadmium ion (GO:0071276),-0.47798315471473196,-1.4352392145453536,0.060941828254847646,0.5935086933670398,1.0,11/24,13.80%,MT1B;MT1G;MT1E;MT1A;MT1H;MT1M;MT1X;MT1F;MAPK8;JUN;MAPK3
prerank,regulation of cellular respiration (GO:0043457),-0.5242581301706477,-1.4351598018113148,0.08401084010840108,0.5892853829763767,1.0,9/17,28.95%,CBFA2T3;PRDM16;NOA1;PNPT1;IL10RB;IFNAR1;VCP;IFNLR1;NOS2
prerank,protein localization to cell periphery (GO:1990778),-0.3356232470673239,-1.4349513258722624,0.0,0.5855868690584379,1.0,30/133,8.93%,CAV1;DPP10;KCNB2;KCNIP4;RAP1A;SMURF1;F11R;CDH1;ANK3;BSG;EFR3B;LIN7A;ZDHHC2;RAMP2;SPTBN1;RDX;LRP6;EMP2;TTC7A;RAB3C;LIN7C;ATP1B1;EHD4;RAB12;GAK;RAB8B;INPP5K;RAB11A;MAP7;ARL3
prerank,regulation of execution phase of apoptosis (GO:1900117),0.6773625623347285,1.4345247538758685,0.0855614973262032,0.5580734146308287,1.0,3/11,7.37%,PTGIS;DLC1;SIRT2
prerank,regulation of focal adhesion assembly (GO:0051893),0.49624926521865487,1.4343158597458994,0.05121293800539083,0.5571643819469051,1.0,10/54,6.79%,EPHA3;NRP1;PHLDB2;ROCK2;ARHGAP6;DLC1;MACF1;SFRP1;SRC;VCL
prerank,regulation of steroid biosynthetic process (GO:0050810),0.6607357643619531,1.4340897905590035,0.11672473867595819,0.5562821020135549,1.0,5/11,8.75%,FGFR4;WNT4;STAR;NR5A1;BMP2
prerank,branched-chain amino acid catabolic process (GO:0009083),0.5895191629310585,1.4332930918249192,0.07739938080495357,0.5558002787768338,1.0,13/20,26.46%,IVD;BCKDHB;DBT;ECHS1;ALDH6A1;ACADSB;MCCC2;BCKDK;DLD;HIBADH;HIBCH;ACAD8;BCAT2
prerank,branched-chain amino acid metabolic process (GO:0009081),0.5895191629310585,1.4332930918249192,0.07739938080495357,0.5558002787768338,1.0,13/20,26.46%,IVD;BCKDHB;DBT;ECHS1;ALDH6A1;ACADSB;MCCC2;BCKDK;DLD;HIBADH;HIBCH;ACAD8;BCAT2
prerank,regulation of sequestering of calcium ion (GO:0051282),-0.5778148114373266,-1.4329741584359978,0.09382151029748284,0.5880190952482659,1.0,7/12,23.45%,UBASH3B;PTK2B;DIAPH1;CASQ2;RYR2;MTLN;CASQ1
prerank,response to interleukin-6 (GO:0070741),0.6880162310547902,1.4320666909960147,0.1045045045045045,0.558433030504477,1.0,2/10,0.91%,PTGIS;PID1
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.5971615960941599,1.4318274864624194,0.10031347962382445,0.5575754927931144,1.0,6/19,3.57%,RBP4;TGFBR3;RUNX1;BMPR1A;FGFR2;TGFBR1
prerank,thyroid hormone generation (GO:0006590),0.6849345775011189,1.4313972826361412,0.10677966101694915,0.5574093130949319,1.0,4/10,15.56%,CPQ;SLC5A5;DIO2;TG
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.6474539522935702,1.4303418386904228,0.09771986970684039,0.5592072510083202,1.0,3/13,7.99%,GAL3ST3;B3GALT1;B3GALNT1
prerank,activation of protein kinase A activity (GO:0034199),0.634876511562708,1.4302724988459046,0.09914529914529914,0.5577770293630262,1.0,5/16,3.53%,ADCY1;ADCY2;ADCY7;ADCY5;ADCY9
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.5385154002199546,-1.4299419610038095,0.09798994974874371,0.5948155587873724,1.0,2/16,3.00%,CLDN5;CLDN11
prerank,protein localization to membrane (GO:0072657),-0.3264637819800331,-1.4293384548908359,0.0,0.5927905645654133,1.0,41/187,10.09%,DLG2;CAV1;DPP10;SHANK3;KCNB2;KCNIP4;RAP1A;SMURF1;NLGN1;F11R;CDH1;ANK3;BSG;EFR3B;LIN7A;ZDHHC2;RAMP2;SPTBN1;NRXN1;RDX;LRRC7;LRP6;EMP2;TTC7A;RAB3C;ITGA4;LIN7C;ATP1B1;EHD4;RAB12;NUP54;GAK;RAB8B;INPP5K;RAB11A;MAP7;PTN;ARL3;JUP;ZDHHC15;SCRIB
prerank,response to ATP (GO:0033198),-0.5217732209369291,-1.4292822864683963,0.08816120906801007,0.5886910901540233,1.0,5/18,12.50%,TRPC3;ABCC9;P2RX7;TAF1;DGKQ
prerank,maturation of LSU-rRNA (GO:0000470),-0.4830368172873486,-1.4272790089875922,0.08206686930091185,0.5916583726665154,1.0,11/26,21.67%,NSA2;RPL7;MAK16;NIFK;RPL7A;SNU13;RPL7L1;RRP15;RPF1;RPF2;ZNHIT3
prerank,positive regulation of cell migration (GO:0030335),0.41962006423152537,1.4272023285691344,0.0106951871657754,0.5666985020195078,1.0,51/253,9.77%,IGF1;NRP1;COL1A1;DDR2;CEMIP;ROCK2;PDGFD;SYNE2;SEMA3D;RHOD;NEDD9;PPP3CA;CCN1;KIT;MYLK;PDGFRA;PDGFRB;TGFBR1;SMO;VTN;SEMA5A;CSF1;INSL3;RAPGEF2;SMURF2;ACVR1;NTF3;CTSH;PDPN;CXCL16;CDH5;SRC;WNT5B;DOCK5;RAB25;CARMIL1;MYO1C;NTRK3;DAB2;EGFR;EPHB2;BMP2;MAP4K4;SPRY2;CCN4;SYDE1;ACTN4;MYADM;S100A11;MIA3;FAM89B
prerank,regulation of dendritic spine development (GO:0060998),-0.49302197671962095,-1.426807028198514,0.07309941520467836,0.5891042891760657,1.0,8/19,10.77%,MEF2C;SHANK3;PPFIA2;NLGN1;GRIN3A;TANC2;SHANK1;KIF1A
prerank,platelet degranulation (GO:0002576),0.4459403559417287,1.4264412964534043,0.03329369797859691,0.5676834335972062,1.0,21/118,9.58%,IGF1;IGF2;CLEC3B;ACTN2;TIMP3;SPARC;AHSG;SERPINE1;LYN;SERPING1;GAS6;APOA1;APLP2;PHACTR2;TLN1;VCL;NHLRC2;CD63;ACTN4;ISLR;ITGB3
prerank,proteoglycan biosynthetic process (GO:0030166),0.5400072698726263,1.4257875963373032,0.07983193277310924,0.5682285037312044,1.0,3/31,2.15%,IGF1;GAL3ST3;PXYLP1
prerank,positive chemotaxis (GO:0050918),0.6081963460069431,1.4257772597735219,0.10613598673300166,0.5666355687168119,1.0,3/17,3.78%,NRP1;ANGPT1;SEMA5A
prerank,cardiac left ventricle morphogenesis (GO:0003214),-0.5644700435092881,-1.4255850558705956,0.09255079006772009,0.5894664479642424,1.0,8/13,21.72%,NOTCH1;HEY2;GSK3A;TGFBR2;RYR2;CPE;FOXF1;NPY5R
prerank,positive regulation of response to stimulus (GO:0048584),-0.4203656353004759,-1.4255010298297375,0.04693140794223827,0.5855413789843505,1.0,20/40,35.07%,IFIH1;B2M;IL15;TGFB2;HOMER1;CGAS;SIRT1;CD80;ABI3;DHX9;HMGA2;NSMCE1;FMR1;ACOX2;IER5;FCGR2B;ARG2;ANKLE1;GATA3;HMGA1
prerank,ncRNA processing (GO:0034470),-0.32270889126849606,-1.4253108958430558,0.013157894736842105,0.5821242180256385,1.0,72/200,21.20%,RPL41;RPL3;RPS24;RPS14;RPL27A;RPL8;RPS19;INTS6;RPL34;RPL21;RPL7;RPL18;RPL27;RPL35A;RPL38;RPS15;RPL39;RPS7;LIN28B;RPL11;WDR36;RPL30;RPL36;RPLP1;RPL37;RPS9;UTP4;RPL4;RPL18A;RPL26;RPL6;RPL36A;RPL29;RPL13A;ADAR;RPL7A;NVL;RPL19;RRP1;SNU13;POP4;RPL14;RPL13;HNRNPA2B1;RPL32;RPL5;KARS1;NOL9;RPP21;MRPL44;FARS2;RPLP0;INTS8;MPHOSPH10;SRRT;KRR1;RPS6;RPL22;AGO1;UTP15;RRP36;IMP4;FCF1;EXOSC5;RRP12;RPL37A;RPLP2;RPL17;RPL23;RPF1;INTS1;WDR46
prerank,fatty acid elongation (GO:0030497),-0.5522273322505256,-1.425180039112334,0.10120481927710843,0.578530119454294,1.0,4/13,13.49%,ELOVL7;ELOVL5;TECR;HACD2
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.5198698479808098,-1.4249994393725123,0.08771929824561403,0.5752158710772931,1.0,5/17,10.26%,PODXL;PIEZO1;TGFB2;RET;SKAP1
prerank,actin filament bundle organization (GO:0061572),0.5366410079265986,1.424536008017317,0.06911764705882353,0.5691359365957076,1.0,8/33,5.80%,CALD1;RHOD;NEDD9;SHROOM2;DPYSL3;MYO1B;FSCN3;LIMA1
prerank,amino acid import across plasma membrane (GO:0089718),0.5736313008623489,1.4243404241716586,0.09188361408882083,0.568196582005258,1.0,6/24,4.20%,SLC1A3;SLC7A2;SLC1A5;SLC6A9;SLC6A13;SLC22A2
prerank,manganese ion transport (GO:0006828),-0.5557641989484787,-1.4238593567025395,0.10204081632653061,0.5754329774055739,1.0,6/14,6.02%,TRPC3;TRPC4;SLC39A8;TRPC5;ATP2C1;TRPC1
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.5098037772884361,1.4231342123398159,0.06741573033707865,0.5707948057011969,1.0,11/45,10.50%,BMP6;BMPR1A;INHBE;TGFBR1;TWSG1;ACVR1;ENG;DAB2;RBPMS;BMP2;BMP15
prerank,visual system development (GO:0150063),0.5314540854875575,1.4223681426672077,0.08467153284671533,0.5717509847123783,1.0,5/37,6.98%,RBP4;PBX1;SH3PXD2B;CPAMD8;SMOC1
prerank,"synaptic transmission, glutamatergic (GO:0035249)",-0.5300887291108316,-1.4221710187215972,0.07529411764705882,0.5772612667785023,1.0,7/18,9.66%,GRID2;UNC13B;GRIK1;GRIK2;CDH8;GRIA2;GRID1
prerank,regulation of cellular component movement (GO:0051270),0.49821434638756296,1.4219265837068842,0.0649171270718232,0.5717264726475483,1.0,16/49,14.03%,MYCBP2;ROCK2;TGFBR3;LYN;ARHGAP18;SP100;TGFBR1;PDPN;MEMO1;EGFR;ZSWIM6;ACTN4;HBEGF;EGF;IGBP1;ETS1
prerank,NAD biosynthetic process (GO:0009435),0.5803273727385688,1.421612554872999,0.08346709470304976,0.5712274645316693,1.0,4/20,6.77%,PTGIS;NNMT;PARP16;KYNU
prerank,gland development (GO:0048732),0.4854803300570648,1.4214273149824528,0.06640625,0.5702666735185025,1.0,18/59,11.64%,TGFBR3;PRKCSH;GLI2;SALL1;ARID5B;NKX2-1;FGFR2;WNT4;TGFBR1;CDK5RAP3;TBX3;DKK3;CEBPA;ARHGAP35;ZBTB1;PHF2;EPHB3;NKX2-8
prerank,histone H3-K4 methylation (GO:0051568),0.5629899401496401,1.4209724321599755,0.06134969325153374,0.5701804005439886,1.0,10/26,20.54%,OGT;SETD1A;WDR82;SETD4;KMT2A;WDR5;SETD1B;TET3;CXXC1;RBBP5
prerank,response to cadmium ion (GO:0046686),-0.4655457722375843,-1.4198145854647515,0.06340057636887608,0.5812442064655394,1.0,11/26,13.80%,MT1B;MT1G;MT1E;MT1A;MT1H;MT1M;MT1X;MT1F;MAPK8;JUN;MAPK3
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.505862630500334,1.4196386342788119,0.06938775510204082,0.5731363147119511,1.0,9/48,6.94%,ADCY1;AMPD3;ADCY2;ADCY7;ADCY5;NUDT2;ADCY9;GUCY2C;GUCY2D
prerank,leukocyte cell-cell adhesion (GO:0007159),-0.4683396931397414,-1.4196149699889449,0.08130081300813008,0.5779551344011358,1.0,5/24,10.46%,PECAM1;F11R;NT5E;ITGA4;MSN
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.47594051581651764,1.4193586504997955,0.052429667519181586,0.5724300787877438,1.0,15/67,8.61%,EPHA3;DDR2;GHR;LYN;FGFR1;EPHA4;FGFR2;KIT;FGFR4;PDGFRA;PDGFRB;PIBF1;SRC;EGFR;EPHB2
prerank,hippo signaling (GO:0035329),0.565412257872598,1.4190865392241145,0.08346456692913386,0.5717620619821743,1.0,9/26,12.73%,AMOTL2;TEAD1;YAP1;WWTR1;DCHS1;STK4;AMOTL1;YWHAE;TEAD3
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.6569344729422263,1.41834491688876,0.10714285714285714,0.5728903656406055,1.0,2/13,3.11%,ENPP1;TPST1
prerank,regulation of insulin secretion (GO:0050796),0.44942964139754676,1.418187887357881,0.04004854368932039,0.5718275693820881,1.0,13/101,7.78%,TCF7L2;RBP4;ITPR1;RAPGEF4;ADCY5;SLC30A8;MCU;CDK16;NEUROD1;SFRP1;ADRA2C;CACNA1C;NR1D1
prerank,B cell homeostasis (GO:0001782),0.6791419786819126,1.4177660414008266,0.09615384615384616,0.5717129172330838,1.0,4/10,2.92%,LYN;DOCK10;DOCK11;GAPT
prerank,negative regulation of DNA metabolic process (GO:0051053),-0.4732449643090643,-1.4170977622675254,0.0700280112044818,0.5824158884449081,1.0,9/24,17.83%,DACH1;ACVRL1;RPS3;MSH3;SUB1;ZRANB3;DFFA;BMPR2;CDKN1A
prerank,Ras protein signal transduction (GO:0007265),0.4332114854727647,1.4164522533904385,0.02957906712172924,0.5744317581622379,1.0,32/137,15.56%,IGF1;COL1A2;RHOH;ROCK2;KSR1;PLD1;ARHGAP6;RHOD;CTNNAL1;CCNA2;RRAS2;ARHGAP29;CDC42EP4;RAPGEF2;MRAS;PDPN;AGTR1;NTN1;ARHGEF11;RAPGEF1;FGF2;TAX1BP3;ADRA2A;ARHGAP5;RAP2A;WASF1;SETDB1;EPS8L1;PLK2;RAPGEF6;HACE1;RASSF1
prerank,positive regulation of T cell cytokine production (GO:0002726),-0.5014134098597243,-1.4159592233106537,0.07588075880758807,0.5824933591521569,1.0,12/20,31.67%,DENND1B;B2M;CD55;PRKCZ;CD81;FZD5;TRAF2;MAP3K7;MALT1;TRAF6;NLRP3;IL1R1
prerank,apoptotic cell clearance (GO:0043277),0.5408216401358881,1.4153449871424642,0.07946026986506746,0.5767837781212979,1.0,8/30,9.62%,RHOH;LRP1;RHOBTB1;GAS6;TXNDC5;RHOBTB2;ITGB3;ITGAV
prerank,anion transport (GO:0006820),-0.4419847875258614,-1.4148496641680035,0.06769230769230769,0.5824472688165337,1.0,6/33,3.99%,ABCG2;SLC26A7;LRRC8C;LRRC8D;SLCO2B1;SLC22A6
prerank,renal water homeostasis (GO:0003091),0.5877147993016848,1.41476998469855,0.0880503144654088,0.5772989090214348,1.0,5/23,3.53%,ADCY1;ADCY2;ADCY7;ADCY5;ADCY9
prerank,purine ribonucleotide transport (GO:0015868),-0.5320072859054925,-1.4147437244522996,0.08483290488431877,0.5789997855949403,1.0,5/16,12.87%,LRRC8C;ABCC4;LRRC8D;ABCC6;SLC25A4
prerank,endocrine system development (GO:0035270),0.5865309879579246,1.4138320804660647,0.07882534775888717,0.578989229743452,1.0,6/21,5.73%,GLI2;SALL1;NKX2-1;WNT4;TGFBR1;DKK3
prerank,regulation of pH (GO:0006885),0.6628051602634671,1.4136112080444043,0.10112359550561797,0.5781336943415039,1.0,1/11,0.20%,ATP6V0A4
prerank,protein autophosphorylation (GO:0046777),0.42741964366916585,1.4133456701665537,0.02088167053364269,0.5775472266593618,1.0,35/157,13.77%,STK17B;DAPK2;PDPK1;DDR2;DAPK1;LYN;GRK5;FGFR1;EPHA4;EPHA8;FGFR2;KIT;FGFR4;PDGFRA;PDGFRB;MUSK;SRC;ULK2;LRRK2;SIK1;EIF2AK3;OXSR1;STK4;EGFR;CAMK2B;STK11;NEK6;TAOK3;EPHB3;MAP3K13;INSR;ACVR1B;STK16;MARK2;CDK12
prerank,macrophage activation involved in immune response (GO:0002281),-0.5568993293995083,-1.4133183196399564,0.07729468599033816,0.5803583157392576,1.0,6/13,13.00%,PLCG2;DYSF;LBP;IFI35;CX3CR1;SBNO2
prerank,regulation of tissue remodeling (GO:0034103),0.6023390721172319,1.412991768652872,0.10063897763578275,0.577224839995386,1.0,5/18,6.81%,DDR2;RUNX1;LEPR;CST3;IL12B
prerank,muscle contraction (GO:0006936),0.44223323917380947,1.412714801006745,0.0234192037470726,0.5765444265315668,1.0,23/126,7.31%,ROCK2;ACTN2;CALD1;SLC8A1;SNTB1;TPM1;TMOD4;TNNT1;MYL10;MYH13;ASPH;MYLK;LTB4R;MYL12A;TLN1;ITGB5;DES;SMTN;BDKRB2;TNNC1;VCL;MYL4;DTNA
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.5943372011074868,1.41256630988119,0.09364548494983277,0.5755282333550229,1.0,5/19,9.16%,RHOH;GAS6;AXL;ZMIZ1;ZBTB1
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.6027465644203502,1.412301816963677,0.11642743221690591,0.5748258499489183,1.0,6/17,11.96%,NRP1;ROBO1;EFNB2;MIA3;FGF2;NR4A1
prerank,positive regulation of endopeptidase activity (GO:0010950),0.5491439789922807,1.4121087300196915,0.1042296072507553,0.5739543320215533,1.0,6/26,10.92%,ROCK2;LYN;EPHA4;PICALM;TTBK1;APH1B
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.6566363126546,1.4113596972188525,0.10214168039538715,0.5749573629136343,1.0,5/13,10.85%,PGM3;SLC35A3;GFPT1;UAP1;RENBP
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.41705202868219704,1.41115047658583,0.017185821697099892,0.574112031149078,1.0,38/214,10.63%,NRP1;EPHA7;CCN2;ANGPT1;TIMP3;TGFBR3;PDGFD;LYN;CCN1;FGFR2;FGFR4;GAS6;PDGFRA;APOE;PDGFRB;CCL19;NOTCH2;FBLN1;RAPGEF2;MT3;ROR1;CCL4;RANBP9;EMILIN1;MAP2K1;TRAF7;MTURN;NTRK3;SLC30A10;ARRB1;EGFR;EPHB2;BMP2;SPRY2;FGF2;SPRED3;CARD9;BRAF
prerank,glycerophospholipid catabolic process (GO:0046475),-0.4761802015955502,-1.411085634815215,0.08423913043478261,0.5845511342831702,1.0,13/27,27.23%,GPCPD1;ENPP2;PLA2G7;INPP5F;PNPLA8;PLA2G4C;PNPLA6;PLA2G4F;PLA2G4E;GDPD1;LIPC;PLA2G4B;PLA2G5
prerank,establishment of vesicle localization (GO:0051650),-0.5123450004824733,-1.4101173477925304,0.08791208791208792,0.5844678263019719,1.0,8/18,23.33%,LIMK2;RAB27A;CDK5;RAB11A;TESK1;SYNJ1;KIF5A;TMEM230
prerank,morphogenesis of a polarized epithelium (GO:0001738),-0.5680025406056833,-1.4100298943083813,0.0945054945054945,0.5810083927658672,1.0,5/12,17.62%,ACTB;LAMA5;SCRIB;FUZ;ACTG1
prerank,glycoprotein biosynthetic process (GO:0009101),0.4671611767262622,1.4098963765246741,0.06012269938650307,0.5770098749726474,1.0,11/79,8.29%,IGF1;GAL3ST2;GAL3ST3;GALNTL5;B3GALT1;ST3GAL5;ST3GAL3;LARGE1;FUT10;B3GALNT1;ALG5
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.6516504324354053,1.4097314693889353,0.11805555555555555,0.5759924862276966,1.0,4/12,8.90%,ADAMTS12;DCN;IL12B;SPRY2
prerank,digestive tract development (GO:0048565),0.5459500773863408,1.4095788882412825,0.08142857142857143,0.5749453288177264,1.0,14/33,15.65%,GLI2;SALL1;GLI3;FGFR2;KIT;SMO;RARB;CLMP;DNAAF1;EPHB3;CCDC40;GLI1;GATA6;NPY
prerank,cellular response to nitrogen compound (GO:1901699),0.5920652359435611,1.4091722889257972,0.08025682182985554,0.5747924448524299,1.0,8/20,19.34%,ROCK2;RIOK3;DDI1;RTF2;TIMELESS;EPG5;ATRX;HSF1
prerank,negative regulation of fat cell differentiation (GO:0045599),0.5257240538584601,1.409147698308862,0.08540372670807453,0.5733634194372456,1.0,7/34,7.37%,RORA;ENPP1;RUNX1T1;SMAD3;YAP1;WWTR1;SIRT2
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.4909891261872817,1.4088700810207357,0.05859375,0.572847443945868,1.0,10/57,8.20%,ADCY1;ADCY2;ADCY7;ADCY5;ADCY9;INSL3;HTR1A;MTNR1A;LPAR1;DRD3
prerank,UV protection (GO:0009650),0.6651406267191424,1.408401822732165,0.11713286713286714,0.573052369667813,1.0,1/10,0.34%,MFAP4
prerank,ribosome assembly (GO:0042255),-0.4008617144717591,-1.408123165996817,0.04316546762589928,0.5835972816232183,1.0,17/47,21.54%,RPL3;RPS14;RPS19;RPS15;RPL11;RPS5;RPL6;PPAN;RPL5;RPSA;RPLP0;MTERF3;NPM1;C1QBP;MRPS7;RRS1;RPF2
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.44316875133470146,1.4079324262942692,0.022300469483568074,0.5731172350090928,1.0,28/122,14.46%,IGF1;SAMD4A;IGF2;AR;PLD1;GLI2;SLC6A9;FGFR4;PDGFRB;CCL19;SLC25A37;SMOC2;CPEB3;CD28;NPM2;EGFR;METTL14;FGF2;EIF6;DDX3X;RGCC;GLI1;INSR;NMD3;EGF;MTPN;PLXNB2;NSUN5
prerank,actin filament depolymerization (GO:0030042),0.686117372149239,1.4079185745573686,0.11267605633802817,0.5716596789060191,1.0,2/11,1.20%,MICAL3;GSN
prerank,artery morphogenesis (GO:0048844),0.5514779263150825,1.40771490595962,0.09530791788856305,0.5708292378081797,1.0,7/30,6.17%,NRP1;LRP1;BMPR1A;PDGFRB;TGFBR1;ENG;ADAMTS9
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.5968596678070932,1.4074293711799464,0.11092985318107668,0.568805809265891,1.0,5/19,18.79%,POLR2D;POLR2C;TERF2;ATRX;POLR2L
prerank,regulation of DNA recombination at telomere (GO:0072695),0.5968596678070932,1.4074293711799464,0.11092985318107668,0.568805809265891,1.0,5/19,18.79%,POLR2D;POLR2C;TERF2;ATRX;POLR2L
prerank,zinc ion homeostasis (GO:0055069),-0.45920282881690716,-1.4073729948529554,0.07331378299120235,0.582332040256291,1.0,10/28,4.62%,SLC39A10;SLC39A8;MT1B;MT1G;MT1E;MT1A;MT1H;MT1M;MT1X;MT1F
prerank,regulation of glycolytic process (GO:0006110),0.47643119269215384,1.4066192139529843,0.05370843989769821,0.5701206887088057,1.0,17/68,14.43%,IGF1;ZBTB20;OGT;PRKAG2;PFKFB4;NUP107;NUPR1;PRKAA2;NUP42;NCOR1;ARNT;EIF6;NUP98;RAE1;INSR;HDAC4;NUP214
prerank,glycoprotein catabolic process (GO:0006516),0.5957099211045316,1.4063610292392201,0.11755485893416928,0.5694396860198413,1.0,5/17,16.22%,ADAMTS12;ADAMTS9;NGLY1;CTSL;NEU4
prerank,cellular response to glucose starvation (GO:0042149),0.5080076120025363,1.406355244549552,0.07511045655375552,0.5679880715131864,1.0,24/41,26.65%,PRKAG2;PRKAA2;NUAK1;SIK1;EIF2AK3;BRSK1;MTMR3;HNRNPA1;IMPACT;PIK3R4;ITFG2;SESN2;TBL2;FOXO3;BECN1;PRKAG1;SZT2;CPEB4;HSPA5;PMAIP1;PRKAG3;SH3GLB1;RRP8;SESN3
prerank,cGMP-mediated signaling (GO:0019934),0.6326124175432054,1.405498264289783,0.1232876712328767,0.5695618483183814,1.0,3/13,5.63%,IRAG1;APOE;PDE3A
prerank,adrenergic receptor signaling pathway (GO:0071875),0.5925485431196287,1.40549307651018,0.10815307820299501,0.5680991267657,1.0,7/20,11.32%,ADRA1B;ADCY9;RAPGEF2;ADRA2C;ADRB3;DRD3;ADRA2A
prerank,response to retinoic acid (GO:0032526),0.4910958279786035,1.4049922560885213,0.0651890482398957,0.5682661967145749,1.0,10/59,6.62%,EPHA3;RBP4;LYN;WNT8B;ASCL1;WNT6;RARG;CTSH;PTK7;WNT5B
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.5922771382754106,1.4046794096918207,0.11235955056179775,0.5677519200226369,1.0,6/17,18.14%,NKX6-1;ATOH8;FGF2;BMP4;SFRP4;AHI1
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),-0.44745481715141566,-1.4043645545729255,0.07228915662650602,0.5888059845174988,1.0,14/30,25.99%,ACKR3;RPS3;KDM1A;PTTG1IP;TPT1;SIRT1;BCL2L1;CD44;CLU;SNAI2;TWIST1;CCAR2;MIF;SNAI1
prerank,blood vessel morphogenesis (GO:0048514),0.49896636843690423,1.4028939890765433,0.06477732793522267,0.5723619828288996,1.0,10/54,5.69%,NRP1;CCBE1;LAMA1;TGFBR3;LOX;EFNB2;TGFBR1;ITGB8;CYP1B1;ENG
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.6636689199147588,1.4026780919606041,0.1335676625659051,0.5716641669722096,1.0,2/11,7.37%,NRP1;SIRT2
prerank,B cell receptor signaling pathway (GO:0050853),-0.4355633812300535,-1.4019376037833866,0.0634441087613293,0.5933608997485076,1.0,12/32,16.27%,MEF2C;TEC;VAV3;PLCG2;CD38;BMX;NFATC2;PLEKHA1;BCAR1;BLNK;PTPRC;BTK
prerank,negative regulation of cell junction assembly (GO:1901889),0.55227712819136,1.4011731759204806,0.10283159463487332,0.5753283921882184,1.0,4/25,1.84%,PHLDB2;ROCK2;ARHGAP6;DLC1
prerank,regulation of phospholipase C activity (GO:1900274),0.6161516129088505,1.400556323413864,0.1174496644295302,0.5760148870153271,1.0,7/15,10.16%,FGFR1;KIT;PDGFRA;PDGFRB;NTF3;NTRK3;FGF2
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.6481410521554652,1.4004808321573585,0.13099630996309963,0.5748053694914491,1.0,5/11,14.16%,GAS6;CCL19;AXL;SELENOS;MERTK
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),-0.43564347333338255,-1.4003997928971543,0.06962025316455696,0.5949558871314631,1.0,11/34,15.07%,PTPRB;PTPRJ;UBASH3B;PTPN12;DUSP22;PTPN2;PTPRT;DUSP7;PTPN22;DUSP8;PTPN6
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.4627345433704913,1.4003783704074064,0.0535031847133758,0.573683814616803,1.0,9/84,7.86%,IGF1;SAMD4A;DAPK1;APOE;IGF2BP2;IGFBP5;CPEB3;EIF2AK3;RNF139
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.513202823800268,-1.4003567116672664,0.09669811320754718,0.5913855119974503,1.0,9/16,26.94%,ACKR3;RPS3;TPT1;BCL2L1;CLU;SNAI2;CCAR2;SNAI1;NACC2
prerank,T cell differentiation in thymus (GO:0033077),0.6196170292115507,1.4003054535190238,0.138353765323993,0.5724454382023006,1.0,3/14,5.78%,GLI3;LIG4;ZFP36L1
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.5023955772783945,1.3997386773765685,0.0743801652892562,0.5728421377521002,1.0,9/46,9.86%,ALDH1A1;ADAMTS5;LGR4;ACOT11;NPR3;NR1D1;RBPJ;FOXC2;STK11
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.4033118860607702,1.398833926298777,0.004149377593360996,0.5743538786404023,1.0,82/348,14.98%,IGF1;ROBO1;BMP6;SLC24A3;GJA1;ROCK2;ANGPT1;PID1;GSN;SMAD3;RBMS3;AR;MITF;OLFM1;NOS1AP;NKX2-1;EPHX2;FGFR4;DTNBP1;YAP1;GAS6;TGFBR1;SMO;WNT6;RESF1;SLC2A10;TLE1;PDCD5;CSF1;SLC22A2;MT3;NTF3;ITGB8;CTSH;MUSK;CDH5;CUX2;TNRC6B;NR5A1;EMILIN1;NFE2L2;CD28;AFDN;EIF2AK3;MAP2K1;CD63;TLR6;OSR1;RBPJ;NTRK3;TNRC6A;ARRB1;EPHB2;BMP2;SPRY2;SMAD1;PRKN;ITCH;FGF2;PPHLN1;TTBK1;BRAF;DDX3X;RGCC;DNAJA4;C1QTNF1;TERF2;LRP3;HMGN5;INSR;TMEM119;MYCN;EGF;MTPN;PDCL3;ETS1;SETDB1;HPN;TADA3;BMP4;SFRP4;FUBP3
prerank,axon extension (GO:0048675),0.563441419278496,1.39878546481776,0.0984375,0.5730775324566946,1.0,7/23,10.12%,NRP1;AUTS2;SEMA5A;ALCAM;ULK2;SLIT3;SLIT1
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.4630936213595792,1.398703782130917,0.056320400500625784,0.5718782812721378,1.0,20/75,14.89%,NRP1;PDPK1;IGF2;FGFR1;VASH2;TGFBR1;SEMA5A;VIP;AKT3;AGTR1;BMP2;ITGB3;ARNT;FGF2;FGFBP1;NR4A1;EGF;PDCL3;MDK;BMP4
prerank,cellular amide metabolic process (GO:0043603),0.45034947461272,1.398521398117976,0.03822441430332922,0.5711133554656904,1.0,21/102,14.87%,CPXM2;PCCA;PLPP3;AEBP1;NNMT;ACOT11;ACOT6;ACOT2;CPXM1;PCCB;SMPD2;MTHFR;ALDH1L1;ABCB9;NSMAF;NAPEPLD;FOLR2;ACSF2;CERK;THOP1;VNN1
prerank,regulation of neuroblast proliferation (GO:1902692),-0.5312419571727076,-1.39765408494663,0.0954653937947494,0.5965756226643633,1.0,7/15,11.43%,KDM1A;TAFA1;PTN;DISC1;VEGFA;CX3CR1;NF1
prerank,negative regulation of bone mineralization (GO:0030502),0.6320978950038441,1.3970628656433601,0.12678571428571428,0.5745799429967593,1.0,4/13,9.40%,ENPP1;AHSG;BCOR;TRPM4
prerank,adenine nucleotide transport (GO:0051503),-0.5216839667523173,-1.397040909635784,0.0835509138381201,0.5950340768101511,1.0,5/17,12.87%,LRRC8C;ABCC4;LRRC8D;ABCC6;SLC25A4
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.5643193891450017,1.3967937003612234,0.09937888198757763,0.5741129908105318,1.0,7/24,6.96%,PDPK1;ANGPT1;SERPINE1;GAS6;SEMA5A;CDH5;NFE2L2
prerank,embryonic skeletal system development (GO:0048706),0.518001212895906,1.3966929792738114,0.08579465541490858,0.5730355766102704,1.0,6/35,4.15%,RBP4;COL1A1;SULF2;PDGFRA;SLC2A10;SULF1
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.5503419070889235,-1.3961735904384815,0.10588235294117647,0.594502752684936,1.0,9/13,29.36%,KDM1A;PTTG1IP;SIRT1;CD44;SNAI2;TWIST1;MIF;SNAI1;PSMD10
prerank,cortical cytoskeleton organization (GO:0030865),0.5042403135927545,1.3961658195018127,0.0856353591160221,0.5732658250764155,1.0,13/41,16.62%,RHOH;ROCK2;RHOD;RHOBTB1;RHOBTB3;RHOBTB2;FMNL1;RHOQ;LLGL1;RND3;ARF6;EPB41L3;RHOG
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.6780076551891395,1.3954493134443666,0.1319796954314721,0.5742689599236374,1.0,7/10,22.41%,CPEB1;CPEB3;PAF1;CDC73;HSF1;LEO1;NCBP2
prerank,gonad development (GO:0008406),0.5011156718870274,1.3938711273919393,0.08104395604395605,0.578094976481232,1.0,8/41,6.58%,AR;NR2F2;SALL1;KIT;WNT4;NUP107;LHCGR;NR5A1
prerank,negative regulation of cell motility (GO:2000146),0.44233874035541565,1.3934274948587053,0.0441527446300716,0.5781155118973752,1.0,22/108,7.43%,ROBO1;LDLRAD4;DAG1;MITF;SERPINE1;DLC1;PODN;TPM1;EPHA4;KANK1;RECK;NKX2-1;DPYSL3;SULF1;FBLN1;SFRP1;IGFBP5;CYP1B1;ENG;VCL;DPEP1;AFDN
prerank,positive regulation of epithelial cell migration (GO:0010634),0.4434984787149439,1.3930844870498171,0.06781750924784218,0.5779086526276143,1.0,21/92,10.75%,NRP1;RIN2;ROCK2;ANGPT1;SPARC;SASH1;INSL3;CTSH;SMOC2;ATOH8;SRC;DOCK5;RAB25;AAMP;FOXC2;ANXA3;MAP4K4;MAPRE2;ITGB3;FGF2;CAPN7
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.6766481117803352,1.3930434645316792,0.12478031634446397,0.5766454945688179,1.0,2/10,1.78%,ADGRV1;GRXCR1
prerank,negative regulation of transposition (GO:0010529),0.6039865496021501,1.3929532333925363,0.11774461028192372,0.5755384429066158,1.0,7/16,17.50%,UBR2;TUT7;PIWIL4;SPOCD1;TUT4;MYBL1;DDX4
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.5141614765485586,1.3920598559032509,0.0898716119828816,0.5770733470864347,1.0,5/40,9.32%,IGF1;MOAP1;PDCD5;BCL2L11;PRKN
prerank,lipid homeostasis (GO:0055088),0.4796881134572106,1.390317498789755,0.08344549125168237,0.5813020174408954,1.0,14/57,16.30%,ZBTB20;ABCA1;RBP1;APOE;APOA1;PRKAA2;CEBPA;TLCD1;NR1D2;DDX3X;RCN3;DGAT2;NR1H3;THADA
prerank,positive regulation by host of viral transcription (GO:0043923),-0.5031963699357976,-1.3897572285756097,0.09866666666666667,0.613049651541719,1.0,6/15,16.95%,LEF1;CHD1;SNW1;JUN;EP300;TFAP4
prerank,sodium ion transport (GO:0006814),0.4469352894157911,1.3896067748579986,0.061124694376528114,0.5822371605136345,1.0,9/85,4.52%,SLC24A3;SCN7A;NALCN;SLC8A1;SLC8A3;ATP1A2;SLC6A9;SLC6A13;SLC24A1
prerank,inner dynein arm assembly (GO:0036159),0.6651088574857716,1.388724967366498,0.1303538175046555,0.5838033320020823,1.0,5/11,15.90%,CFAP73;DNAAF1;DNAI3;CCDC40;DNAAF5
prerank,toxin transport (GO:1901998),0.661255415388147,1.3887164530204652,0.12567324955116696,0.5824300443290055,1.0,3/10,4.20%,ANTXR1;ANTXR2;SLC22A2
prerank,regulation of interleukin-2 production (GO:0032663),-0.40950967978804864,-1.388534828063128,0.03322259136212625,0.6134314624405063,1.0,20/43,27.14%,PDE4D;PDE4B;CD34;PLCG2;NAV3;SPTBN1;RPS3;TNFAIP3;CD80;PTPRC;HOMER3;PNP;CD86;ANXA1;TRAF2;MAP3K7;MALT1;CARD11;TRAF6;PRNP
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.4202340383317917,1.3879410978595685,0.024746906636670417,0.5835351020461945,1.0,44/173,15.17%,SEC24D;AREG;TGFA;DYNLL1;LMAN2L;ANK1;SEC31A;GAS6;TMED1;GOLGB1;YIF1B;DYNC1H1;LMAN1;ZW10;ARFGAP3;DCTN6;MIA2;TRAPPC4;COPB1;SPTAN1;COG8;CAPZB;COPZ2;GOSR2;TRIP11;BCAP31;MIA3;TMED4;KDELR3;ERGIC2;TRAPPC6B;ERGIC3;GORASP1;F2;COPA;DYNC1I2;CTSZ;KLHL12;USO1;SEC23A;ARF4;BET1L;TBC1D20;ERGIC1
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),-0.4803978641507223,-1.3877916152434213,0.0777479892761394,0.612191474048983,1.0,10/21,27.25%,PDE4D;CAV1;INPP5K;DDIT4;NLRP2B;RACK1;NCK2;RASSF2;DMTN;MLXIPL
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.5509637427172925,-1.3876763338169398,0.10024449877750612,0.6088859663181595,1.0,4/13,14.06%,TMSB4X;HEY2;TAF1;HEY1
prerank,response to sterol (GO:0036314),0.6383376440432456,1.387298471133158,0.1528776978417266,0.5843399469853574,1.0,2/11,3.57%,RORA;TGFBR1
prerank,positive regulation of wound healing (GO:0090303),0.5194778613520198,1.3865676849147341,0.10089020771513353,0.5853339008417632,1.0,11/36,11.76%,PLPP3;SERPINE1;KANK1;MYLK;VTN;INSL3;SMOC2;FOXC2;HBEGF;ADRA2A;F2
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.541605041922558,1.386350916566554,0.10229007633587786,0.5846316865417955,1.0,5/28,4.42%,ENPP1;PID1;AHSG;KANK1;APPL2
prerank,maintenance of blood-brain barrier (GO:0035633),-0.4499981781776492,-1.3852831411799313,0.07476635514018691,0.6141031275153384,1.0,12/30,5.15%,SLC12A2;OCLN;PECAM1;CLDN5;JAM2;ESAM;F11R;ACTB;TJP2;LSR;TJP1;SLC1A1
prerank,regulation of nitric-oxide synthase activity (GO:0050999),-0.4232081372740888,-1.384986898425647,0.07384615384615385,0.6114572369037767,1.0,14/36,11.16%,CAV1;NOSTRIN;NOS3;DDAH1;GCH1;NOSIP;DDAH2;ATP2B4;CYGB;DHFR;CALM1;S100A1;SPR;SCARB1
prerank,RNA stabilization (GO:0043489),0.5224163902041511,1.3844404119729634,0.09335219236209336,0.5897800253887847,1.0,9/33,12.41%,GDNF;TENT5A;PHAX;AXIN2;VIP;TENT5D;NSUN2;PARN;LARP1
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.5457542520896332,1.3844266678568027,0.11010558069381599,0.5884288503238043,1.0,6/27,2.15%,PHLDB2;PIK3R1;CGNL1;ARHGAP6;DLC1;ARHGAP28
prerank,prostanoid biosynthetic process (GO:0046457),0.6259457281149737,1.3844234777423887,0.1276595744680851,0.5870553805297247,1.0,3/15,5.18%,PTGIS;PTGES;PLA2G4A
prerank,neuromuscular junction development (GO:0007528),0.5610414826772411,1.384143855814338,0.13112164296998421,0.5866584159492053,1.0,7/24,6.60%,PDZRN3;PPFIBP2;UNC13C;NEDD4;MUSK;CACNB1;LRRK2
prerank,histone H3-K4 trimethylation (GO:0080182),0.6544571764093148,1.3839138639996518,0.13286713286713286,0.5859803568133326,1.0,6/11,19.25%,OGT;SETD1A;WDR82;KMT2A;SETD1B;TET3
prerank,regulation of blood circulation (GO:1903522),0.5153871489036426,1.3837250069161056,0.10678210678210678,0.5853220792204219,1.0,6/34,6.90%,CELF2;TPM1;DMPK;DES;BDKRB2;AGTR1
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.5617917294194232,1.3831202337646276,0.1186161449752883,0.5859448898103347,1.0,12/21,24.16%,LRRK2;EIF2AK3;BCL2L11;PRKN;CREB3;SELENOS;TMBIM6;CREB3L1;DDIT3;OPA1;TXNDC12;PMAIP1
prerank,cell projection organization (GO:0030030),0.5429519707190669,1.3821298156204036,0.12349397590361445,0.5879201097844176,1.0,7/30,8.04%,RHOH;GSN;PARVA;CDC42;NPHP1;ATP1B2;CSPG5
prerank,muscle filament sliding (GO:0030049),0.5099314260086495,1.3813029032391628,0.08201438848920864,0.5877889304991079,1.0,8/38,13.02%,ACTN2;TPM1;TNNT1;DES;TNNC1;MYL4;TNNT3;TPM2
prerank,actin-myosin filament sliding (GO:0033275),0.5099314260086495,1.3813029032391628,0.08201438848920864,0.5877889304991079,1.0,8/38,13.02%,ACTN2;TPM1;TNNT1;DES;TNNC1;MYL4;TNNT3;TPM2
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.5328842103168981,1.3807879956396465,0.10494752623688156,0.5881821999154887,1.0,6/29,8.75%,TGFBR3;TPM1;FGFR2;ENG;TNNC1;BMP2
prerank,negative regulation of interleukin-2 production (GO:0032703),-0.4977063058410161,-1.3795231219635558,0.10421836228287841,0.6265692213487015,1.0,5/18,16.80%,CD34;NAV3;TNFAIP3;PTPRC;HOMER3
prerank,regulation of cellular protein catabolic process (GO:1903362),0.5821503451134317,1.3794578685537089,0.11831442463533225,0.591226487239488,1.0,3/18,4.30%,NELL1;DACT1;CDK5RAP3
prerank,triglyceride biosynthetic process (GO:0019432),0.5817057708847502,1.3793549776968173,0.11345218800648298,0.5902166436831521,1.0,7/18,21.74%,AGMO;LPGAT1;MOGAT3;DGAT2;GK;LPIN3;LPIN2
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),-0.3577759019891875,-1.3786027254114617,0.023809523809523808,0.6260546844393781,1.0,24/75,16.30%,PLCE1;RGS5;MGLL;RGS3;KCTD8;GIT2;NMT2;RGS6;CRY1;FNTA;RGS12;SYP;FNTB;CALM1;EDN1;RGS16;PLEK;RGS4;GIT1;DGKQ;RGS11;PDE6A;METAP2;GPER1
prerank,aorta morphogenesis (GO:0035909),0.5967597025484718,1.3785703520568335,0.1281645569620253,0.5915167614986037,1.0,7/17,8.12%,LRP1;BMPR1A;MYLK;PDGFRB;ENG;ADAMTS9;RBPJ
prerank,regulation of epithelial cell differentiation (GO:0030856),-0.500886408790961,-1.3785459939438438,0.0784313725490196,0.6226469576945701,1.0,8/17,21.88%,CAV1;KLF7;APOLD1;MAFG;PRKX;CEACAM1;DLL1;DSPP
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.5684612309037146,-1.3775310810605927,0.10551558752997602,0.6228618719718457,1.0,6/11,23.78%,NOTCH1;GSK3A;ATP2B4;FOXO1;MLIP;RGS2
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.5181685560080955,-1.377360526220452,0.10462287104622871,0.6199093955049827,1.0,7/16,6.66%,GUCY1B1;NOS3;GUCY1A1;DDAH1;KCNC2;NOS1;DDAH2
prerank,positive regulation of cellular senescence (GO:2000774),-0.5678284351553883,-1.3769350614713647,0.11778290993071594,0.6179586088068264,1.0,5/10,20.17%,B2M;CGAS;SIRT1;ABI3;HMGA2
prerank,transferrin transport (GO:0033572),0.5214876738039415,1.376710333526585,0.1025260029717682,0.5962284362581955,1.0,2/33,0.82%,ATP6V0A4;STEAP3
prerank,acylglycerol homeostasis (GO:0055090),0.5710124243872079,1.376591822425101,0.13344051446945338,0.5952581201560734,1.0,3/20,4.30%,RORA;APOE;APOA1
prerank,regulation of lipid biosynthetic process (GO:0046890),0.5292604378324726,1.3759054679009708,0.09598853868194843,0.5962857434275276,1.0,9/32,10.42%,ZBTB20;PRKAG2;APOE;APOA1;PRKAA2;STAR;NR5A1;CREBL2;EIF6
prerank,negative regulation of inflammatory response (GO:0050728),0.41099822378940337,1.3755473156890792,0.035555555555555556,0.5960557738460831,1.0,21/182,7.78%,IGF1;PTGIS;RORA;ADCY1;ADCY2;LYN;ADCY7;ADCY5;APOE;ADCY9;INSL3;APOA1;MVK;VIP;CDH5;LHCGR;ADRB3;SRC;CD247;DPEP1;NR1D1
prerank,regulation of cell size (GO:0008361),-0.477390080089804,-1.3752994958492244,0.08620689655172414,0.619799230328457,1.0,9/23,12.78%,VAV3;RDX;RAP1GAP2;LARS1;EDN1;MSN;PLEK;MTOR;DEPTOR
prerank,cholesterol homeostasis (GO:0042632),0.468915732333719,1.3750281726815927,0.09454061251664447,0.5964553346317094,1.0,10/64,7.78%,RORA;CYP7B1;ABCA1;EPHX2;FGFR4;APOE;APOA1;LDLR;LIMA1;NR1D1
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.3878050007496329,1.374664312241553,0.005045408678102927,0.5964212618706144,1.0,90/509,11.79%,IGF1;TCF7L2;PDPK1;WLS;IGF2;ADRA1B;GJA1;ROCK2;ANGPT1;PIK3R1;PDGFD;ADGRV1;KSR1;SASH1;AREG;TGFA;DCN;LYN;BCL2;FGFR1;PELI2;EPHA8;NOS1AP;EPGN;KL;FGFR2;KIT;FGFR4;GAS6;PDGFRA;CFLAR;PDGFRB;TGFBR1;NUPR1;SEMA5A;CCL19;NEDD4;CDK5RAP3;RAPGEF2;EDAR;AXL;NTF3;OSBPL8;FRS2;ROR1;ENG;ADRA2C;ADRB3;CCL4;SRC;RNF31;IL12B;CD28;DDX60;SPHK2;LPAR1;TRAF7;NMI;TLR6;NTRK3;BCL2L11;EGFR;BMP2;RUNDC3A;SPRY2;BCAP31;ACTN4;PRKN;GPR89A;LTBR;ITGAV;SLC38A9;SLC20A1;TMED4;FGF2;RYK;CXXC5;CARD9;NEK6;TRIP6;DDX3X;GSDME;HBEGF;LAMTOR2;ADRA2A;P2RX5;TNIP2;IKBKE;RRAGD;TBK1
prerank,cellular response to sterol (GO:0036315),0.6165727844307365,1.3740165636358386,0.12953367875647667,0.59718944742213,1.0,3/13,3.86%,RORA;SMO;INSIG2
prerank,positive regulation of cellular catabolic process (GO:0031331),0.42242105948189956,1.37360153689255,0.05178365937859609,0.5972407603594864,1.0,20/132,11.48%,IGF1;ZBTB20;SH3D19;DAPK1;DCN;DACT1;OPTN;PFKFB4;APOE;APOA1;PRKAA2;LRRK2;SNX33;DXO;ARNT;STK11;ITCH;RNF152;ADRA2A;UFL1
prerank,cellular potassium ion homeostasis (GO:0030007),-0.5403313852901757,-1.3728702572979552,0.11163895486935867,0.6248399988095774,1.0,5/13,6.83%,SLC12A2;KCNJ2;ATP1A1;KCNMA1;ATP1B1
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.6641965130453995,1.3725082420569963,0.13028169014084506,0.5994865518586624,1.0,9/11,26.97%,ZFP36L1;PAF1;ZC3H3;CDC73;LEO1;PAPOLA;NCBP2;AHCYL1;NCBP1
prerank,entry into host (GO:0044409),-0.5436731203265222,-1.3724430732628536,0.11822660098522167,0.6228618719718457,1.0,4/13,5.14%,CDH1;MET;CBL;PPIA
prerank,positive regulation of cell junction assembly (GO:1901890),-0.3846517835422089,-1.3722655578673548,0.04263565891472868,0.6200608992424418,1.0,17/56,10.85%,TEK;CNTNAP2;GRID2;CAV1;PTPRJ;CLDN5;NLGN1;IL1RAPL1;KDR;PTPRD;EPHB1;NRXN1;MYOC;CLSTN2;VEGFA;ACE2;CLSTN3
prerank,hepaticobiliary system development (GO:0061008),0.5635728650048211,1.3721631573951505,0.1392,0.5992001358085896,1.0,8/20,11.64%,TGFBR3;PRKCSH;ARID5B;WNT4;CDK5RAP3;CEBPA;PHF2;NKX2-8
prerank,sterol homeostasis (GO:0055092),0.4659276077482259,1.3720117288847256,0.09933774834437085,0.5983403974906512,1.0,10/65,7.78%,RORA;CYP7B1;ABCA1;EPHX2;FGFR4;APOE;APOA1;LDLR;LIMA1;NR1D1
prerank,cardiac muscle cell development (GO:0055013),0.5611656478264719,1.371934007342178,0.10759493670886076,0.5972669610843265,1.0,5/20,3.56%,PDLIM5;SLC8A1;OBSL1;PDGFRA;PDGFRB
prerank,smooth muscle contraction (GO:0006939),0.6233603108031474,1.3714475299151323,0.13518197573656845,0.5975685030124877,1.0,5/14,6.32%,ROCK2;SLC8A1;MYLK;SMTN;BDKRB2
prerank,response to muramyl dipeptide (GO:0032495),-0.5584798652846056,-1.371377910590367,0.11910669975186104,0.6196557229219112,1.0,7/12,16.10%,NOD1;ARHGEF2;VIM;PTPN22;NOD2;ERBIN;IRF5
prerank,regulation of embryonic development (GO:0045995),0.5139511125687299,1.3711270713598671,0.12859304084720122,0.5973385423247858,1.0,8/34,12.55%,PHLDB2;DAG1;WDPCP;CRB2;TRIP12;RBM19;NIBAN2;INSR
prerank,negative regulation of gene expression (GO:0010629),0.3985674579084453,1.370852122283251,0.01053740779768177,0.5968552424576792,1.0,68/302,15.16%,IGF1;ROBO1;SAMD4A;CILP;SLC24A3;ROCK2;DAPK1;RBMS3;LGR4;RUNX1;BMPR1A;OLFM1;WNT4;YAP1;DNMT3A;APOE;SMO;NOTCH2;SLC2A10;TWSG1;IGF2BP2;ITGB8;SFRP1;IGFBP5;PRKAA2;ENG;TNRC6B;ATOH8;EMILIN1;CPEB3;CD28;EIF2AK3;MAP2K1;DXO;RNF139;NCOR1;TNRC6A;BMP2;KAT2B;PICALM;SNX12;PRKN;MYADM;PARP14;RBBP7;FGF2;PHF1;PPHLN1;TTBK1;RBL2;NCOR2;TCEAL1;DDX3X;RGCC;REST;TERF2;LRP3;LARP1;CCDC3;MYCN;SYT11;ENC1;ZNF148;SETDB1;NUDT16L1;BMP4;ASB1;TMBIM6
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.5615722395791168,1.3706219240674014,0.10510046367851623,0.5963583638747437,1.0,6/22,9.03%,ROCK2;LYN;EPHA4;RANBP9;SLC2A13;PICALM
prerank,negative regulation of protein autophosphorylation (GO:0031953),0.6539959051281327,1.3704524160354097,0.14025500910746813,0.5955678686750323,1.0,5/10,13.63%,ENPP1;ERRFI1;ENG;IMPACT;MVP
prerank,regulation of signal transduction (GO:0009966),0.4092757530692351,1.3699974640748436,0.03222222222222222,0.5957580292253087,1.0,30/190,8.35%,IGFBP2;RORA;GDNF;SLC8A3;GRK3;IGFBP4;GRK5;DHRS3;RUNX1;ZIC1;OGT;ITGA3;FGFR2;SP100;DTNBP1;SEMA5A;IRAK2;FBXL17;SULF1;NCAM1;TSPYL2;ACVR1;IGFBP5;USP20;SRC;LRRK2;WWTR1;CD63;TULP3;TCF7L1
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.4517514683066096,1.3698854571113916,0.07341772151898734,0.594845163050984,1.0,19/87,9.23%,FMOD;COL1A2;TGFBR3;SMAD3;BMPR1A;TGFBR1;TWSG1;APOA1;APPL2;ACVR1;ITGB5;CDH5;ENG;SKI;SRC;LTBP2;ARHGEF18;ZMIZ1;SMAD1
prerank,nucleoside diphosphate metabolic process (GO:0009132),-0.5277721903303152,-1.3696906506424378,0.1295843520782396,0.6219476421970483,1.0,6/15,16.69%,ENTPD1;AK5;ENTPD2;ENTPD6;AK7;ENTPD3
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.5376819104343653,1.3693050147727166,0.11450381679389313,0.5954234432845799,1.0,4/27,2.39%,ENPP1;PID1;AHSG;KANK1
prerank,androgen receptor signaling pathway (GO:0030521),0.643560181248322,1.3691058118037696,0.1415929203539823,0.5947796572155862,1.0,4/11,8.78%,AR;PMEPA1;DDX17;ZMIZ1
prerank,arachidonic acid metabolic process (GO:0019369),0.5224072596694367,1.3686003467614314,0.11475409836065574,0.5951893121208294,1.0,7/35,7.06%,PTGIS;PTGES;DAGLA;EPHX2;PLA2G4A;CYP1B1;ALOXE3
prerank,glycerolipid metabolic process (GO:0046486),-0.5652055989106073,-1.3683519266173632,0.13272311212814644,0.6232778668798128,1.0,5/11,17.45%,DGKB;PNPLA3;DGKG;DGKQ;DGKZ
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.4625427261049411,1.3683142595963795,0.06809078771695594,0.5921774523915783,1.0,21/61,19.98%,SEC24D;AREG;TGFA;SEC31A;LMAN1;TRAPPC4;GOSR2;TRAPPC9;TRAPPC10;TRAPPC6B;GORASP1;CTSZ;KLHL12;USO1;SEC23A;TBC1D20;SEC24A;TMED10;SEC16B;TRAPPC1;TRAPPC3
prerank,vesicle coating (GO:0006901),0.4625427261049411,1.3683142595963795,0.06809078771695594,0.5921774523915783,1.0,21/61,19.98%,SEC24D;AREG;TGFA;SEC31A;LMAN1;TRAPPC4;GOSR2;TRAPPC9;TRAPPC10;TRAPPC6B;GORASP1;CTSZ;KLHL12;USO1;SEC23A;TBC1D20;SEC24A;TMED10;SEC16B;TRAPPC1;TRAPPC3
prerank,COPII vesicle coating (GO:0048208),0.4625427261049411,1.3683142595963795,0.06809078771695594,0.5921774523915783,1.0,21/61,19.98%,SEC24D;AREG;TGFA;SEC31A;LMAN1;TRAPPC4;GOSR2;TRAPPC9;TRAPPC10;TRAPPC6B;GORASP1;CTSZ;KLHL12;USO1;SEC23A;TBC1D20;SEC24A;TMED10;SEC16B;TRAPPC1;TRAPPC3
prerank,regulation of cardiac conduction (GO:1903779),0.4714575249959588,1.3681522961486066,0.0847913862718708,0.5913784999775402,1.0,7/54,4.12%,ITPR1;SLC8A1;SLC8A3;ATP1A2;DMPK;ASPH;STIM1
prerank,negative regulation of metabolic process (GO:0009892),0.479412468879845,1.3675338570310074,0.0801068090787717,0.5920147199531088,1.0,9/54,9.86%,ALDH1A1;ADAMTS5;LGR4;ACOT11;NPR3;NR1D1;RBPJ;FOXC2;STK11
prerank,phospholipid homeostasis (GO:0055091),0.6462232515152624,1.3672751377606858,0.16089965397923875,0.5915586763788383,1.0,4/11,12.18%,ABCA1;APOA1;TLCD1;RCN3
prerank,prostaglandin biosynthetic process (GO:0001516),0.5933261567908946,1.3671446291232494,0.13921901528013583,0.5907400263742546,1.0,3/18,5.18%,PTGIS;PTGES;PLA2G4A
prerank,calcium-mediated signaling (GO:0019722),0.4433086368973476,1.3670907599244957,0.0625,0.5896438874683323,1.0,19/93,9.40%,RCAN2;PDPK1;SLC8A1;DMPK;PPP3CA;XCR1;ADGRL1;MCTP2;MCU;ACKR2;CCR9;LRRK2;CACNA1C;AGTR1;EIF2AK3;RCAN1;EGFR;BCAP31;TRPM4
prerank,glycerolipid catabolic process (GO:0046503),-0.4852324697047444,-1.3669243154204855,0.1096938775510204,0.6246463502318939,1.0,10/19,24.06%,GPCPD1;MGLL;ABHD2;PLA2G4C;ABHD6;PNPLA6;LYPLA2;PLA2G4F;PLA2G4E;GDPD1
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.616854024123806,1.3668295049923738,0.1323283082077052,0.5892393413661383,1.0,2/13,2.48%,RUNX1;GLI3
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.48335267543187815,1.3661458540302551,0.0957004160887656,0.5902919554444082,1.0,13/48,14.42%,NRP1;NEDD9;OBSL1;APOA1;CUX2;CDC42;DOCK5;CARMIL1;CSPG5;MYADM;P4HB;MDK;FLNA
prerank,regulation of ion transmembrane transport (GO:0034765),-0.41309539143464025,-1.365317058137104,0.06645569620253164,0.6264556199874188,1.0,16/33,26.27%,KCNJ2;NEDD4L;KCNJ3;P2RX7;KCNQ1;CHRM3;AKAP6;KCNJ15;KCNJ10;CASQ2;ANO6;KCNJ8;KCNJ6;KCNJ13;KCNJ16;WWP2
prerank,positive regulation of binding (GO:0051099),0.443178747898155,1.3650915176760172,0.07800511508951406,0.5926646888613842,1.0,14/84,9.32%,IGF1;TCF7L2;LRP1;DACT1;APOE;VTN;RAPGEF2;SKI;DERL1;LRRK2;SIRT2;STK4;BMP2;PRKN
prerank,COPII-coated vesicle budding (GO:0090114),0.45764926994675537,1.3642205506682732,0.06754966887417219,0.5943253712719411,1.0,23/68,19.98%,SEC24D;AREG;TGFA;SEC31A;LMAN1;TRAPPC4;GOSR2;MIA3;SEC23B;TRAPPC9;TRAPPC10;TRAPPC6B;GORASP1;CTSZ;KLHL12;USO1;SEC23A;TBC1D20;SEC24A;TMED10;SEC16B;TRAPPC1;TRAPPC3
prerank,high-density lipoprotein particle assembly (GO:0034380),0.6525501997551251,1.3638049403580144,0.16498316498316498,0.5944552621448437,1.0,3/10,4.30%,ABCA1;APOE;APOA1
prerank,negative regulation of signal transduction (GO:0009968),0.3983013123388598,1.3636682821480057,0.019251336898395723,0.5936662858909928,1.0,62/249,16.39%,ADAMTS12;CILP;TRABD2B;ENPP1;PID1;CYP26B1;LRP1;AHSG;DCN;LYN;LGR4;BCL2;DACT1;SULF2;NKD1;LEPROT;KANK1;GLI3;MDFI;MGRN1;SLC2A10;TLE1;SULF1;NEDD4;ACVR1;SFRP1;IGFBP5;DKK3;LRRK2;EMILIN1;IL12B;CBLN1;TULP3;IRAK3;ARRB1;EGFR;NTN1;BMP2;CBY1;SPRY2;GLIS2;FGF2;TAX1BP3;IGFBP3;PTCH2;NIBAN2;BTRC;NDRG4;EGF;TSC2;PTEN;FSTL3;CXXC4;SFRP4;SUFU;TMBIM6;GRB10;BMP5;CD47;PIP4K2C;AKT1;KANK2
prerank,positive regulation of cell motility (GO:2000147),0.4074465982297012,1.3632680589902,0.03303964757709251,0.5936210453711765,1.0,44/205,11.54%,IGF1;COL1A1;CEMIP;ROCK2;PDGFD;SYNE2;SEMA3D;RHOD;NEDD9;PPP3CA;CCN1;KIT;MYLK;PDGFRA;PDGFRB;TGFBR1;SMO;SEMA5A;CCL19;CSF1;ACVR1;NTF3;CTSH;PDPN;CXCL16;CDH5;WNT5B;CARMIL1;MYO1C;NTRK3;DAB2;EGFR;EPHB2;NTN1;BMP2;MAP4K4;SPRY2;ACTN4;MYADM;FAM89B;TRIP6;HBEGF;ADRA2A;CCDC25
prerank,negative regulation of receptor internalization (GO:0002091),-0.5513781275714092,-1.3626421379165699,0.12826603325415678,0.6322658441102373,1.0,4/12,6.57%,ANKRD13A;SDCBP;MTMR2;RIN3
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.5091857136480228,-1.3625171450939497,0.10594315245478036,0.6292912240560229,1.0,8/17,18.91%,ATP5F1A;ATP5F1E;ATP5ME;ATP5MG;ATP5F1C;ATP5MF;ATP5PD;VPS9D1
prerank,regulation of keratinocyte proliferation (GO:0010837),0.5471547774777631,1.3619470483109364,0.1346749226006192,0.5964520688008808,1.0,8/22,15.84%,AREG;FGFR2;NOTCH2;ZFP36L1;CASK;KLF9;MDK;EPPK1
prerank,organophosphate catabolic process (GO:0046434),-0.5644156096822615,-1.361247462384941,0.12555066079295155,0.6303155383174989,1.0,1/11,0.91%,ENPP2
prerank,regulation of macromolecule metabolic process (GO:0060255),0.412580219328783,1.3610557600254667,0.03712035995500562,0.598018858878019,1.0,15/170,5.78%,IGF1;NELL1;ROCK2;SLC8A1;GDNF;C1D;AFF1;PRDM5;ASCL1;ZNF462;APOE;IGF2BP2;LDLR;GNB3;ZFP36L1
prerank,cell projection assembly (GO:0030031),0.5632917650778404,1.3607194580923205,0.125,0.5978709102724264,1.0,4/22,6.15%,RHOH;GSN;PARVA;CDC42
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.6124696409368887,1.3605376562920082,0.11872909698996656,0.5972362641125882,1.0,7/14,17.53%,SEC24D;SEC31A;MIA3;SEC23B;SEC23A;TBC1D20;SEC24A
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),-0.47280653977855047,-1.3604726783491203,0.07479224376731301,0.6295505486359059,1.0,12/23,27.53%,MBOAT1;PLAAT3;PNPLA8;PLA2G4C;LPCAT3;PLA2G4F;PLA2G4E;ABHD4;PLA2G4B;PLA2G5;LPCAT4;MBOAT2
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.4525045343764093,1.3599744858575784,0.08751608751608751,0.5977085353963605,1.0,12/72,10.90%,POLR2D;FGFR1;KL;FGFR2;FGFR4;RBFOX2;FRS2;FLRT2;HNRNPA1;POLR2C;FGF2;FGFBP1
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),0.5909156040654949,1.3599324592569464,0.13517915309446255,0.5965704128866761,1.0,4/16,3.02%,IGF1;TGFBR3;BMPR1A;FGFR2
prerank,regulation of sodium ion transport (GO:0002028),-0.4299834912891039,-1.359897063434535,0.08333333333333333,0.6282786119237044,1.0,11/34,9.72%,NKAIN2;ATP1A1;ANK3;YWHAH;NKAIN1;P2RX7;NKAIN3;FGF12;NOS1;ATP2B4;WNK2
prerank,dendritic cell differentiation (GO:0097028),0.5524987465882005,1.359509321618404,0.1346749226006192,0.5967122086175749,1.0,5/22,6.84%,LYN;GAS6;CCL19;AXL;BATF
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.49690590923186195,-1.3591428554126919,0.12718204488778054,0.6277147930610573,1.0,8/18,24.57%,JAM2;SLC39A8;ITGA4;CX3CR1;ROCK1;VCAM1;SELP;ITGB7
prerank,regulation of ion transmembrane transporter activity (GO:0032412),-0.40477164241483704,-1.3586498654152326,0.05787781350482315,0.62620316957381,1.0,6/39,5.85%,UTRN;FHL1;NEDD4L;YWHAH;FGF12;CHRM3
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.4217871479082823,1.3579089702154388,0.04823529411764706,0.6005801994293504,1.0,32/138,15.02%,POLR2D;RORA;CCN2;TBL1XR1;TEAD1;AR;THRB;YAP1;MAML3;RARB;NOTCH2;RARG;GTF2E1;GTF2H5;NR5A1;WWTR1;DR1;NR1D1;RBPJ;NCOR1;KAT2B;POLR2C;NR1D2;NCOR2;NR4A1;MNAT1;TEAD3;GTF2E2;TAF9;NRBF2;NR1H3;RXRA
prerank,connective tissue development (GO:0061448),0.5052384466927512,1.3576581088536357,0.10826210826210826,0.600155002942285,1.0,11/35,10.81%,SOX5;SULF2;ARID5B;SULF1;SH3PXD2B;ITGB8;CREB3L2;TRIP11;PGRMC2;COL11A2;SLC39A13
prerank,gene expression (GO:0010467),-0.2835892442734172,-1.3575593205309002,0.0,0.6266648299594884,1.0,121/348,20.78%,BICD1;NUP93;RPL41;RPS12;TAF1B;RPL3;RPS24;RPS14;RPL27A;RPL8;RPS19;NUP35;RPL34;WARS1;RPS13;RPL21;RPL7;NUP153;RPL18;RPL27;NUP160;EIF4E;RPL35A;RPL38;RPS15;RPS3;SORL1;RPL39;APOBEC1;RPS7;GALNT2;RPS4X;RNGTT;RPL11;ELAVL4;MRRF;HNRNPK;RPL30;RPS23;NUP54;BAZ2A;PWP1;RPL36;RPLP1;RPS29;RPL37;RPS9;RBM8A;ALYREF;HHEX;HNRNPD;CHTOP;RPS5;YARS2;PTMA;RPL4;RPL18A;RPL26;SNRNP40;RPL6;RPL36A;RPL29;MRPS18A;RPL13A;PAX8;ADAR;MRPS5;RPL7A;RPL19;THAP1;RPS20;RPL14;EEF1A1;RPL13;DEDD2;HNRNPA2B1;DUSP11;RPL32;MRPS12;CLP1;RPL5;YTHDC1;TSPAN17;RPSA;SRSF7;NOL9;FASTKD2;SEC13;ADARB2;MRPL44;MRPS33;SMG7;RPLP0;NUP155;MPHOSPH10;MRPL55;DDX19B;RPS6;RPS6KB2;RPL22;RANBP2;GLE1;DHX38;NUP88;MRPS18B;POLR2E;MRPL42;RPS21;MCM3AP;TASP1;RPL37A;RPLP2;MRPS21;THOC6;SRSF4;MRPS7;RPL17;RPL23;NUP62;MRPL34;SLBP
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.4810965140882289,1.3575257264562925,0.10298102981029811,0.5993238717307531,1.0,10/46,9.62%,NRP1;ATRNL1;ANTXR1;PIK3R1;PARVA;LAMC1;USH2A;ATRN;ITGB3;ITGAV
prerank,liver development (GO:0001889),0.5147826804881578,1.3574669668782493,0.1161764705882353,0.5982906574020382,1.0,11/32,12.42%,TGFBR3;PRKCSH;ARID5B;WNT4;CDK5RAP3;CEBPA;DNAAF1;PHF2;CEBPB;NKX2-8;CCDC40
prerank,cellular response to fatty acid (GO:0071398),0.6221501387470629,1.356943711638498,0.15789473684210525,0.598722526957792,1.0,1/12,0.91%,PID1
prerank,multivesicular body organization (GO:0036257),-0.4265090263972906,-1.3567509889957956,0.11960132890365449,0.6260830030266864,1.0,17/31,31.51%,RAB27A;RAB11A;PDCD6IP;VPS37B;VPS37A;VPS28;VPS36;VPS4A;CHMP2B;VPS37C;SNF8;CHMP4B;CHMP4A;HGS;MVB12A;CHMP4C;STAM2
prerank,action potential (GO:0001508),-0.3961089626449167,-1.3564986862138395,0.06273062730627306,0.623683665516473,1.0,11/44,7.82%,KCNJ2;ANK3;KCND2;SCN1A;YWHAH;SCN3A;KCNQ1;GNA14;AKAP6;KCNMB2;SCN2A
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.42232679161869957,1.3564878529776754,0.05827505827505827,0.5990210374531978,1.0,34/128,15.57%,BMP6;COL1A2;TGFBR3;SMAD3;BMPR1A;RUNX2;TGFBR1;TWSG1;APOA1;SMURF2;APPL2;ACVR1;ITGB5;CDH5;ENG;SKI;SRC;LTBP2;ARHGEF18;RGMA;BMP2;ZMIZ1;SMAD1;BMP15;USP9Y;PDCD4;ACVR1B;USP9X;HIVEP1;COL3A1;BMP4;PARD3;TGFBRAP1;BMP5
prerank,neuron projection extension (GO:1990138),0.5067764007514605,1.355777542753955,0.1273006134969325,0.600089490060622,1.0,5/32,6.43%,NRP1;AUTS2;SEMA5A;ALCAM;ULK2
prerank,lung epithelium development (GO:0060428),0.6494112315467311,1.3555855207673666,0.1478102189781022,0.5994251038846214,1.0,4/10,14.89%,ERRFI1;ASCL1;RCN3;BMP4
prerank,growth hormone receptor signaling pathway (GO:0060396),0.5981280677150823,1.3554213880725434,0.1505016722408027,0.5986824881957741,1.0,3/14,1.77%,GHR;PIK3R1;LYN
prerank,negative regulation of cellular component organization (GO:0051129),0.44923771891143705,1.3552599232530365,0.08640406607369759,0.5979926247807792,1.0,17/74,14.37%,EPHA3;BMP6;AR;APOA1;CDC42;SRC;SNX33;CARMIL1;IRAK3;SPRY2;DDX3X;DNAJA4;IMPACT;TERF2;SYT11;RIOK3;RTEL1
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.4407615513325257,1.3546377796022064,0.07329192546583851,0.5987609073982116,1.0,15/87,7.95%,EPHA3;RHOH;ROCK2;LRP1;DLC1;RHOD;ARHGAP18;RHOBTB1;PDGFRA;PDGFRB;NOTCH2;IQGAP2;RHOBTB3;RHOBTB2;ARHGAP35
prerank,regulation of hemopoiesis (GO:1903706),0.6446755195848981,1.3539898046295082,0.14689265536723164,0.5996106443848178,1.0,2/10,2.77%,RUNX1;IL17D
prerank,regulation of establishment of cell polarity (GO:2000114),0.5925093686736183,1.3536398929668556,0.13846153846153847,0.5994439842170265,1.0,5/16,5.68%,ROCK2;GSN;KANK1;RIPOR2;CDH5
prerank,skin development (GO:0043588),0.4573874538199895,1.3532971925475,0.07926023778071334,0.5993766234030036,1.0,7/65,4.03%,COL1A2;COL1A1;ERRFI1;TXNIP;COL5A1;ITGA3;SLC2A10
prerank,epithelial cell migration (GO:0010631),0.5022967482192716,1.3532460019008792,0.11159420289855072,0.5983068448247189,1.0,7/37,6.38%,NRP1;ZEB2;KANK1;KIT;FSTL1;CYP1B1;ADGRA2
prerank,regulation of cation channel activity (GO:2001257),-0.33955457842605385,-1.352940075356055,0.0425531914893617,0.6327524288351237,1.0,29/89,20.31%,DLG2;PDE4D;MEF2C;GRIA4;NLGN1;PTK2B;ANK3;KCNAB1;GRIN2A;CAMK2D;FGF12;LRRC7;NOS1;GRIN2B;STAC;GRIA2;SHANK1;CALM1;HOMER1;APP;GSG1L;CACNG3;CACNG4;HPCA;AHNAK;CTSS;GRIN1;CACNB3;FKBP1A
prerank,synaptic vesicle localization (GO:0097479),-0.5516773784741879,-1.3527101721420263,0.13895781637717122,0.6303190514138873,1.0,6/13,23.33%,NLGN1;RAB27A;CDK5;SYNJ1;KIF5A;TMEM230
prerank,vasodilation (GO:0042311),-0.5357227616879692,-1.351345844557345,0.12276214833759591,0.6314433234654758,1.0,6/13,16.30%,NOS3;KLF2;KCNMA1;NOS1;ADRB2;GPER1
prerank,positive regulation of developmental process (GO:0051094),0.4098269598129044,1.351120493532345,0.037694013303769404,0.6038817922953782,1.0,40/164,14.20%,PHLDB2;GJA1;CCN2;GDNF;AR;DAG1;SOX5;DCN;FGFR1;BMPR1A;APOE;ADGRL1;SMURF2;NEUROD4;ACVR1;MCU;NEUROD1;SRC;CPEB3;PPP1R13L;KMT5B;BMP2;SYDE1;CAMK2B;PRKN;TRPM4;KRT10;CEBPB;RBM19;REST;NIBAN2;MAP3K13;INSR;ACVR1B;MUL1;TMEM119;NCOA3;DLG4;HMCES;MDK
prerank,positive regulation of T cell differentiation (GO:0045582),0.5087916169370306,1.351017917812994,0.09610027855153204,0.6030053400343267,1.0,11/36,16.71%,RHOH;GLI2;GLI3;BCL6;IL12B;ZMIZ1;ZBTB1;MDK;VNN1;IL23A;SHH
prerank,ion homeostasis (GO:0050801),-0.4302054679980355,-1.350905265816641,0.08571428571428572,0.6298929268743422,1.0,8/30,9.72%,SLC4A10;FHL1;NEDD4L;CAMK2D;UNC80;KLHL3;SLC4A8;WNK2
prerank,T cell proliferation (GO:0042098),-0.5175673531131065,-1.3506552231093298,0.11971830985915492,0.6276360629979616,1.0,8/13,37.51%,CADM1;MSN;PIK3CG;DOCK8;LILRB1;TNFRSF4;CRTAM;LMBR1L
prerank,regulation of fat cell differentiation (GO:0045598),0.4438014025485618,1.349978360983042,0.08781127129750983,0.6050183849687539,1.0,19/74,12.28%,RORA;ENPP1;RUNX1T1;SMAD3;MEDAG;YAP1;SFRP1;GNB3;ZFP36L1;WWTR1;SIRT2;NR1D1;CREBL2;BMP2;TRPM4;ANKRD26;CEBPB;TMEM64;LRP3
prerank,sterol metabolic process (GO:0016125),0.46201944441585374,1.3494122430461328,0.11543624161073826,0.6056402104485785,1.0,9/60,7.22%,CYP26B1;CYP7B1;ABCA1;PRKAG2;APOE;INSIG2;APOA1;CYP1B1;CYP27A1
prerank,sodium ion transmembrane transport (GO:0035725),0.44168164626163836,1.3492621081753122,0.07644110275689223,0.6048751206270785,1.0,10/84,4.52%,SLC24A3;SCN7A;NALCN;SLC8A1;SLC8A3;ATP1A2;SLC6A9;SLC6A13;SLC9A9;SLC24A1
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.6443454414142729,1.348916825159783,0.18932874354561102,0.6034996763743727,1.0,1/10,2.64%,TULP1
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.6443454414142729,1.348916825159783,0.18932874354561102,0.6034996763743727,1.0,1/10,2.64%,TULP1
prerank,actin filament network formation (GO:0051639),-0.5588488925720356,-1.3487111914133463,0.1461187214611872,0.6311240026675881,1.0,5/11,10.45%,COBL;PLS3;SPIRE1;FHOD3;PLS1
prerank,response to interleukin-1 (GO:0070555),0.4449256827185333,1.3483136664830324,0.0781456953642384,0.6042749441111264,1.0,17/73,18.49%,ADAMTS12;PTGIS;CCL19;IRAK2;SFRP1;CCL4;SRC;NR1D1;IRAK3;USP10;IGBP1;HDAC4;TAF9;CD47;CX3CL1;RC3H1;PRKCA
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.5257737007372145,1.347592769652321,0.15396578538102643,0.6054297518537199,1.0,2/23,3.56%,IGF1;EFNB2
prerank,positive regulation of gene expression (GO:0010628),0.38545925881993126,1.3469967206039548,0.005112474437627812,0.6060996330528465,1.0,97/442,14.98%,IGF1;ROBO1;BMP6;SAMD4A;SLC24A3;GJA1;ROCK2;ANGPT1;PID1;PIK3R1;GSN;SMAD3;RBMS3;AR;MITF;PLD1;PLA2R1;OLFM1;NOS1AP;NKX2-1;EPHX2;FGFR4;DTNBP1;HNRNPLL;YAP1;GAS6;TGFBR1;SMO;WNT6;SLC2A10;TLE1;PDCD5;POLR1G;CSF1;SLC22A2;MT3;ITGB8;CTSH;MUSK;CDH5;CUX2;TNRC6B;NR5A1;EMILIN1;CPEB3;BATF;NFE2L2;CD28;SPHK2;AFDN;EIF2AK3;MAP2K1;MYO1C;TLR6;OSR1;RBPJ;NTRK3;TNRC6A;EGFR;EPHB2;RBM22;BMP2;KAT2B;SPRY2;METTL14;SMAD1;PRKN;NFAM1;FGF2;BAZ1B;PHF2;EIF6;TTBK1;CARD9;BRAF;TENT4A;DDX3X;ADRA2A;RGCC;DNAJA4;C1QTNF1;TERF2;LRP3;HMGN5;TMEM119;MYCN;EGF;GLMN;PDCL3;ETS1;PLXNB2;HPN;NSUN5;TADA3;BMP4;SFRP4;FUBP3
prerank,presynapse assembly (GO:0099054),-0.5068325883622541,-1.3465886592596392,0.11029411764705882,0.634764668953461,1.0,7/16,18.25%,NLGN1;IL1RAPL1;PTPRD;LRRTM3;PCLO;NLGN3;DVL1
prerank,regulation of programmed necrotic cell death (GO:0062098),0.550189965254883,1.3460998272038907,0.14173228346456693,0.6076855302988364,1.0,4/20,3.58%,OGT;MLKL;CFLAR;NUPR1
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.4315204827848497,1.3460454676456062,0.06801909307875895,0.6066607347421834,1.0,19/101,11.51%,ROBO1;CEMIP;PDGFD;FGFR1;IL34;EPGN;KIT;PDGFRB;RAPGEF2;SRC;LRRK2;PARP16;MAP2K1;EGFR;TELO2;FGF2;DDX3X;ADRA2A;RGCC
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.5658588200000807,-1.3459417924439656,0.12984054669703873,0.6339348955391633,1.0,5/10,19.80%,SEC14L1;RNF125;TKFC;UFD1;C1QBP
prerank,peptide metabolic process (GO:0006518),0.44486278970441406,1.345541406705201,0.07954545454545454,0.6070525077239717,1.0,12/75,9.74%,CPXM2;CPQ;AEBP1;CPXM1;GSTM4;GSTM2;DPEP1;NAALADL1;SEC11C;APEH;GSTT1;ABCB9
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),-0.31501826455603416,-1.3433263512573486,0.009433962264150943,0.6397922683453998,1.0,37/159,10.61%,ADGRL3;HMCN1;GRID2;PECAM1;CLDN5;CDH2;CADM1;NLGN1;CDH1;IL1RAPL1;TENM2;BSG;KIRREL3;TENM3;CLDN11;LRFN5;TENM4;PTPRD;TGFB2;NECTIN1;CDH12;ATP2C1;CNTN4;CDH6;NTNG1;CDH8;PTPRT;CDH9;CDH13;CNTN6;LRRC4C;ROBO4;TGFBR2;CDH10;FAT2;EMB;UNC5D
prerank,regulation of immunoglobulin production (GO:0002637),0.544569833185483,1.3431338474546701,0.14285714285714285,0.6136260769811351,1.0,1/23,0.15%,RBP4
prerank,regulation of protein secretion (GO:0050708),0.4202951115150617,1.3428376302319363,0.06761565836298933,0.6133876962176287,1.0,12/119,6.81%,IGF1;BMP6;ITPR1;DNAJC1;RAPGEF4;APOE;MYO18A;MYH10;NEUROD1;ADRA2C;CACNA1C;IL12B
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.4933156357896905,1.3424802434333576,0.12133891213389121,0.6133746866573273,1.0,10/37,15.55%,DYNLL1;WDR35;IFT43;IFT27;TRIP11;IFT81;DYNC2I1;DYNLRB2;IFT22;IFT74
prerank,regulation of GTPase activity (GO:0043087),-0.3051037717524084,-1.3422593297237926,0.0,0.640350162659993,1.0,45/177,11.96%,PKP4;DOCK9;CHN2;EFNA5;FGD5;LRCH1;PLXNA4;RAP1A;ITGA6;ARHGAP44;F11R;VAV3;CAV2;SH3BP4;RABGAP1;RAP1GDS1;SIPA1L1;BCAR3;NET1;SNX13;RGS6;RASIP1;PRKG1;RDX;TBC1D15;TGM2;ARHGAP27;ERBB2;EZH2;CCL14;EPHA5;NGEF;CHN1;TBC1D30;ARAP1;RASGRF1;RGS7;LARS1;PLXND1;RGS16;ADAP1;AGRN;NF1;EVI5;CD40
prerank,sulfur compound biosynthetic process (GO:0044272),0.4270024192106934,1.3419481593292855,0.0794392523364486,0.6139623575855564,1.0,20/104,11.73%,FMOD;OGN;ANGPT1;LUM;UST;DCN;BGN;ST3GAL3;DSE;CHAC2;GSTM4;GSTM2;B4GALT1;OMD;CSPG5;MGST1;GSTT1;CDO1;LIAS;CHST15
prerank,Wnt signaling pathway (GO:0016055),0.43030232981050864,1.3418880769859691,0.07577639751552795,0.6129293983068276,1.0,14/92,6.62%,TCF7L2;WLS;PLPP3;WNT8B;FZD2;WNT4;WNT6;FZD1;RARG;SFRP1;BCL9;TCF7;LRRK2;WNT5B
prerank,negative regulation of vascular permeability (GO:0043116),-0.5432385646586738,-1.3408728483633559,0.1399548532731377,0.641754180158609,1.0,8/12,9.51%,SLIT2;PTPRJ;CLDN5;RAMP2;SH3GL2;PDE2A;DDAH1;VEGFA
prerank,negative regulation of protein binding (GO:0032091),-0.34942888084132495,-1.3407687088121019,0.04128440366972477,0.6390386917693538,1.0,26/71,21.96%,CAV1;MAP2;ACTB;B2M;ADAM15;KDM1A;SORL1;CTNNBIP1;ITGA4;ATP2A3;DISC1;GTF2F1;MAPK8;ADRB2;RALB;CARD16;PPP1CA;ZFPM1;RACK1;CDKN1A;DVL1;EFHB;ITGB1BP1;ROCK1;STYX;GSK3B
prerank,positive regulation of phospholipase C activity (GO:0010863),0.4968243927411569,1.3405825950420893,0.11637931034482758,0.6158357396050854,1.0,10/40,10.16%,ARHGAP6;FGFR1;KIT;PDGFRA;PDGFRB;NTF3;LPAR1;NTRK3;EGFR;FGF2
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.640545846732071,1.3403458033255253,0.1712707182320442,0.6154061909798068,1.0,8/10,26.51%,VTN;MT3;ITGB3;ARNT;GRB10;PRKCB;PRKD2;ITGA5
prerank,regulation of leukocyte activation (GO:0002694),0.5818442109258756,1.339624794161674,0.18090452261306533,0.6165537809785931,1.0,7/14,22.37%,LYN;MYO18A;CD200;CD33;PJA2;GPR137B;LCK
prerank,modified amino acid transport (GO:0072337),0.6049938461676908,1.3396088566941986,0.14776632302405499,0.6154119121382338,1.0,5/15,12.63%,SLC16A12;SLC6A13;PDPN;MGST1;FOLR2
prerank,protein O-linked glycosylation via serine (GO:0018242),-0.5689337464513143,-1.3394250116034139,0.15034168564920272,0.640482143426259,1.0,8/10,38.45%,GALNT13;GALNT2;GALNT3;POGLUT3;GALNT4;MGAT5B;GALNT16;POGLUT1
prerank,tRNA modification (GO:0006400),0.45785246398263674,1.3388419794625481,0.11588541666666667,0.6165981556060763,1.0,21/62,19.90%,TRMT44;PUS3;ADAT2;TRMO;NSUN2;BCDIN3D;TRMT9B;TRMT13;URM1;TRMT112;THUMPD3;THUMPD2;OSGEP;ELP5;THADA;DTWD1;ALKBH1;PUSL1;ANKRD16;TRUB1;METTL1
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.5893352870808826,1.3382541980385765,0.1490066225165563,0.6172811694670042,1.0,6/15,14.15%,DACT1;ACVR1;SKI;LEMD3;ACVR1B;FSTL3
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),-0.3631145882214032,-1.3377644752047941,0.06521739130434782,0.6432844849454603,1.0,21/59,15.19%,HMCN1;PECAM1;CDH2;CADM1;CDH1;BSG;KIRREL3;TENM3;NECTIN1;CNTN4;PTPRT;CDH13;CNTN6;ROBO4;FAT2;EMB;PVR;IGSF11;DSG2;CEACAM1;PLXNB3
prerank,positive regulation of histone methylation (GO:0031062),0.5277870703146933,1.3376767611278202,0.14173228346456693,0.617992778817917,1.0,11/24,22.99%,AUTS2;OGT;TET1;PHF1;PAF1;KMT2A;WDR5;DNMT3B;JARID2;DNMT1;BRCA1
prerank,positive regulation of cell projection organization (GO:0031346),0.4185509640876684,1.3371867790686018,0.060786650774731825,0.6183646528858495,1.0,29/115,14.29%,EPHA3;ROBO1;PLXNA2;CAMK1D;LYN;OBSL1;TIAM2;APOE;DPYSL3;RAPGEF2;FZD1;PTK7;ROR1;CUX2;ATP1B2;CARMIL1;ARHGAP35;NTRK3;CAMK2B;RAPGEF1;PLXNC1;MAP3K13;NDRG4;MARK2;PLXNA1;DLG4;MDK;CHODL;PLXNB2
prerank,regulation of cAMP-mediated signaling (GO:0043949),-0.46145078981464216,-1.3371349079275328,0.12181303116147309,0.6425433980947834,1.0,11/24,13.51%,PDE4D;PDE3B;PDE2A;PRKAR1A;PRKAR2B;PRKAR1B;PRKAR2A;CGAS;PEX5L;UBE2B;APLNR
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.4952072310195742,-1.3368507956064302,0.11311053984575835,0.6404725827106156,1.0,11/18,34.43%,CHRM3;AGRN;GNB1;CHRM2;RGS10;GNA11;CDK5R1;CHRM1;GNAQ;HRH3;CHRM5
prerank,negative regulation of lipid metabolic process (GO:0045833),-0.4504231823290704,-1.336787115600894,0.13314447592067988,0.6376942678431727,1.0,6/22,16.30%,PDE3B;APOD;PPP2R5A;ALK;CEACAM1;GPER1
prerank,response to glucagon (GO:0033762),0.5697850507365467,1.3358087629090052,0.152428810720268,0.6217622628614495,1.0,5/19,3.53%,ADCY1;ADCY2;ADCY7;ADCY5;ADCY9
prerank,MAPK cascade (GO:0000165),0.38357347619384713,1.3350765338610235,0.028361344537815126,0.6228395962576856,1.0,52/295,11.59%,IGF1;NRK;ANGPT1;ACTN2;GDNF;PIK3R1;KSR1;AREG;TGFA;IL31RA;FGFR1;GFRA2;EPGN;KL;FGFR2;KIT;FGFR4;PDGFRA;PDGFRB;ABHD17C;APOA1;RAPGEF2;NCAM1;MT3;RASA3;PSME4;FRS2;CTSH;MRAS;MAP3K20;ZFP36L1;RANBP9;LRRK2;MAP2K1;ARAF;SPTAN1;RGL1;EGFR;MAP3K8;ARL2;MAP4K4;CAMK2B;ITGAV;GFRA4;FGF2;FGF13;BRAF;TAOK3;HBEGF;LAMTOR2;KBTBD7;TNIP2
prerank,positive regulation of integrin activation (GO:0033625),-0.5727243794312449,-1.3350423348582445,0.13670886075949368,0.6404618072120244,1.0,5/11,10.69%,PIEZO1;RASIP1;RAP1B;SKAP1;PLEK
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.6338746889772893,1.3349216149947924,0.16666666666666666,0.6221600118210501,1.0,4/10,12.58%,GHR;LYN;STAT5B;STAT6
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),-0.43808859831667646,-1.334517026386341,0.125,0.6392675157628925,1.0,8/26,10.72%,ACER3;ACER2;NOS3;GCH1;NOS1;DDAH2;SPTLC2;SPR
prerank,canonical Wnt signaling pathway (GO:0060070),0.444897142777437,1.3341921759700837,0.1073738680465718,0.6233233297638151,1.0,14/68,8.35%,TCF7L2;PLPP3;WNT8B;FZD2;WNT4;WNT6;FZD1;RARG;SFRP1;BCL9;TCF7;LRRK2;WNT5B;TCF7L1
prerank,negative regulation of cellular catabolic process (GO:0031330),0.455376851372387,1.33413372063448,0.10738255033557047,0.6223405652338545,1.0,10/63,7.37%,NELL1;TIMP3;BCL2;LEPR;NUPR1;CDK5RAP3;MT3;CST3;TIMP2;SIRT2
prerank,positive regulation of cell aging (GO:0090343),-0.5317762532557142,-1.3341013255947773,0.1523809523809524,0.6376785199350423,1.0,5/11,20.17%,B2M;CGAS;SIRT1;ABI3;HMGA2
prerank,negative regulation of transforming growth factor beta production (GO:0071635),-0.567724552969358,-1.3340923053169038,0.14318706697459585,0.634757860033386,1.0,4/10,15.58%,FN1;HSP90AB1;TSKU;CDH3
prerank,sphingoid biosynthetic process (GO:0046520),-0.5609108666759044,-1.3337355537790982,0.1337719298245614,0.6301037900420248,1.0,3/11,10.37%,ACER3;ACER2;SPTLC2
prerank,sphingosine biosynthetic process (GO:0046512),-0.5609108666759044,-1.3337355537790982,0.1337719298245614,0.6301037900420248,1.0,3/11,10.37%,ACER3;ACER2;SPTLC2
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.5390698373892983,1.333528928992798,0.14985163204747776,0.6231178187446399,1.0,4/22,8.75%,SASH1;GADD45B;RELL1;BMP2
prerank,positive regulation of cation transmembrane transport (GO:1904064),-0.3954414874720274,-1.3331660981531674,0.07042253521126761,0.629205048549079,1.0,15/41,13.63%,KCNJ2;ANK3;KCNJ3;KCNMA1;KCNN2;KCNQ1;NOS1;AKAP6;STAC;KCNMB2;ACE2;KCNJ15;GNB1;KCNJ10;GNG2
prerank,striated muscle contraction (GO:0006941),0.4639792286995161,1.3329915614747057,0.1262135922330097,0.6236499388259449,1.0,11/53,10.12%,SLC8A1;ATP1A2;TPM1;TNNT1;TNNC1;MYL4;DTNA;GAA;ARHGEF11;CSRP3;TNNT3
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.642269506243257,1.332513900238147,0.1693121693121693,0.6227818286726251,1.0,2/10,6.15%,CDC42EP4;CDC42
prerank,regulation of pseudopodium assembly (GO:0031272),0.642269506243257,1.332513900238147,0.1693121693121693,0.6227818286726251,1.0,2/10,6.15%,CDC42EP4;CDC42
prerank,response to purine-containing compound (GO:0014074),-0.5003530064629883,-1.3318064215099121,0.1501416430594901,0.6307996906889319,1.0,6/17,15.47%,TRPC3;ABCC9;P2RX7;DGKQ;RYR2;P2RY6
prerank,regulation of actin filament-based movement (GO:1903115),-0.5687451560699239,-1.331037101288915,0.15931372549019607,0.6304059863072213,1.0,2/10,1.19%,PDE4D;PDE4B
prerank,negative regulation of protein phosphorylation (GO:0001933),0.407153971914567,1.330341305240397,0.06064073226544622,0.6285540282096252,1.0,35/150,13.79%,PDPK1;ENPP1;ERRFI1;PID1;PPM1E;LDLRAD4;PTPN13;PLPP3;LYN;DTNBP1;PMEPA1;PRKAG2;FBLN1;CDK5RAP3;NTF3;SFRP1;ENG;LRRK2;EMILIN1;WWTR1;SIRT2;NTRK3;DNAJC3;EPHB2;SPRY2;PRKN;MYADM;SPRED3;IGFBP3;IMPACT;DUSP19;TSC2;MVP;CNKSR3;PTEN
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),-0.43024890841461055,-1.3300066190043631,0.093841642228739,0.6309066711354663,1.0,14/29,27.53%,LPCAT1;PLAAT3;PNPLA8;PLA2G4C;MBOAT7;LPCAT3;LPCAT2;PLA2G4F;PLA2G4E;DBI;PLA2G4B;PLA2G5;LPCAT4;MBOAT2
prerank,purine-containing compound salvage (GO:0043101),0.6240497872443368,1.3294781615449789,0.13298791018998274,0.6302641608089863,1.0,2/12,2.79%,AMPD3;ADK
prerank,cartilage development (GO:0051216),0.47630666235421854,1.3294756691971776,0.10899182561307902,0.6290908779082814,1.0,14/49,10.71%,SOX5;SULF2;RUNX1;NFIB;RUNX2;SULF1;ITGB8;CREB3L2;WNT5B;OSR1;BMP2;TRIP11;FGF2;COL11A2
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.42711065954722,1.329190767670547,0.09213759213759214,0.6288247140729214,1.0,14/100,6.31%,IGF1;PIK3R1;PDGFD;PTPN13;DCN;LYN;FGFR1;KIT;PDGFRA;PDGFRB;NEDD4;NTF3;ROR1;SRC
prerank,epithelial to mesenchymal transition (GO:0001837),0.46563437307611244,1.3289853313718365,0.13728323699421965,0.6282844970568778,1.0,11/47,8.75%,ROCK2;TGFBR3;FGFR1;OLFM1;WNT4;TGFBR1;TBX3;ENG;DDX17;RBPJ;BMP2
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.4965129140861759,1.3288040750752272,0.12116991643454039,0.6276800322486228,1.0,10/36,11.71%,VAMP5;MACF1;OPTN;GORASP2;GOLGA4;TRARG1;AFDN;GGA2;GOLPH3L;GORASP1
prerank,negative regulation of immune system process (GO:0002683),0.5770321601910802,1.3280315246494212,0.14869281045751634,0.6289449639951314,1.0,4/16,14.04%,LYN;IL17D;CD200;COL3A1
prerank,filopodium assembly (GO:0046847),-0.4924908886879149,-1.3279416663097532,0.15384615384615385,0.6346417408651756,1.0,3/16,3.37%,DNM3;FGD5;SPATA13
prerank,regulation of heart contraction (GO:0008016),0.4237313849464519,1.3276026395362468,0.08958837772397095,0.6291073582109253,1.0,11/90,6.93%,CELF2;ITPR1;SLC8A1;SLC8A3;ATP1A2;TPM1;DMPK;ASPH;STIM1;DES;ATP1B2
prerank,positive regulation of MAP kinase activity (GO:0043406),0.45152845967373184,1.3271054432959288,0.10751295336787564,0.6295007323394812,1.0,16/66,13.24%,ROBO1;PDGFD;SASH1;FGFR1;IL34;EPGN;KIT;PDGFRB;LRRK2;TLR6;EGFR;FGF2;TAOK3;ADRA2A;DUSP19;EGF
prerank,positive regulation of histone modification (GO:0031058),-0.41776636522188165,-1.3269776524056003,0.10576923076923077,0.6348854303092634,1.0,11/33,13.80%,RPS6KA5;KDM1A;NOS1;CTBP1;PPARGC1A;BRD7;RPS6KA4;CHTOP;TADA2A;APLNR;MAPK3
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.5342877343762108,1.3269485493412758,0.1470113085621971,0.6288176869701376,1.0,7/25,13.65%,NRP1;AR;SRC;DSCAM;EGFR;EGF;GLMN
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.5046709324197499,-1.3263976184662785,0.10732984293193717,0.6339678465910783,1.0,7/16,17.21%,ATP5F1A;ATP5F1E;ATP5ME;ATP5MG;ATP5F1C;ATP5MF;ATP5PD
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.4127819898022293,1.3259482037677444,0.07455621301775148,0.6307877054221875,1.0,17/110,8.20%,ADRA1B;ADCY1;ADCY2;ABCA1;ADCY7;LGR4;ADCY5;GNAS;ADCY9;ADGRL1;RAPGEF2;VIP;ADRA2C;LHCGR;ADRB3;LPAR1;DRD3
prerank,positive regulation of cellular component movement (GO:0051272),0.5266127896524179,1.3259043569951088,0.1494435612082671,0.6297621657086999,1.0,10/24,14.03%,LYN;TGFBR1;CCL19;PDPN;NTN1;ACTN4;STK11;CCDC25;TUBB2B;ETS1
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.6289309178881061,1.3251545262553774,0.18683274021352314,0.6309625304858096,1.0,4/11,8.75%,TGFBR3;TGFBR1;ACVR1;BMP2
prerank,reverse cholesterol transport (GO:0043691),0.6029908794133865,1.3249298342088456,0.1635434412265758,0.6305709704550974,1.0,3/13,4.30%,ABCA1;APOE;APOA1
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),0.5817950786640972,1.3248793526129379,0.17003367003367004,0.6295756910583644,1.0,7/14,22.99%,AUTS2;KMT2E;KMT2A;WDR5;DNMT3B;DNMT1;BRCA1
prerank,regulation of trophoblast cell migration (GO:1901163),0.5948259490285184,1.3242148458372005,0.16363636363636364,0.6305764949449466,1.0,4/14,12.87%,GJA1;SMURF2;SYDE1;ACVR1B
prerank,protein prenylation (GO:0018342),-0.57055322796477,-1.3239729076287052,0.15776699029126215,0.6391158292946144,1.0,6/10,22.82%,FNTA;FNTB;PTAR1;CHML;PGGT1B;RCE1
prerank,monocarboxylic acid transport (GO:0015718),-0.37798474324900005,-1.323466806736499,0.06882591093117409,0.6380510622354032,1.0,11/51,7.50%,ABCG2;ATP8B1;ABCC4;SLCO2A1;SLCO1C1;SLC16A6;SLCO2B1;SLC5A6;SLC16A9;SLC16A1;SLC16A4
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.5125141774531152,1.3231579532955233,0.13210445468509985,0.6328221870919264,1.0,6/29,8.35%,TCF7L2;TLE1;AXIN2;BCL9;TCF7;TCF7L1
prerank,cardiocyte differentiation (GO:0035051),0.6370128809582715,1.3230078030802797,0.18294849023090587,0.6321171338744224,1.0,6/10,14.70%,SIK1;BMP2;EEF1AKMT4-ECE2;CBY1;AKAP13;GATA6
prerank,establishment of protein localization to extracellular region (GO:0035592),0.4784042561109701,1.3227247422717368,0.13056379821958458,0.6317843410478596,1.0,13/39,17.58%,STEAP3;ABCA1;TVP23B;ARFGAP3;LTBP2;MIA2;MIA3;RCN3;MTTP;TVP23A;TANGO2;GOLPH3;COPG1
prerank,membrane repolarization (GO:0086009),-0.48936438284696193,-1.3226189787484925,0.13730569948186527,0.6381650413413334,1.0,5/15,6.83%,KCNJ2;ATP1A1;KCND3;KCNQ1;ATP1B1
prerank,regulation of neurotransmitter transport (GO:0051588),-0.48013411965456854,-1.3220766563959119,0.12561576354679804,0.6370416882240801,1.0,3/16,1.86%,MEF2C;MCTP1;RIMS1
prerank,female gonad development (GO:0008585),0.55543083156285,1.3219002509878712,0.1485623003194888,0.6332461677520183,1.0,7/19,11.09%,NR2F2;KIT;NUP107;LHCGR;NR5A1;EIF2B4;CEBPB
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.41964104584288187,1.3212282911583928,0.09155766944114149,0.6341317472479953,1.0,11/108,4.20%,ROBO1;COL4A3;UACA;GSN;DAPK1;SMAD3;DLC1;CASP12;CFLAR;PDCD5;SLC22A2
prerank,transition metal ion homeostasis (GO:0055076),0.5162986420074702,1.3210326315333385,0.1457725947521866,0.6335856973018693,1.0,8/28,9.32%,CP;MT3;HEPH;NEO1;CYBRD1;PICALM;COMMD1;PRKN
prerank,calcium ion import across plasma membrane (GO:0098703),0.5988205944250333,1.3207323129810205,0.16243654822335024,0.6333902836932491,1.0,3/14,4.52%,SLC8A1;SLC8A3;SLC24A1
prerank,inorganic cation import across plasma membrane (GO:0098659),-0.34291236601860764,-1.3207289998885408,0.046296296296296294,0.6386556291439103,1.0,21/75,14.78%,SLC12A2;SLC12A7;SLC9A2;KCNJ2;SLC24A2;SLC39A10;ATP1A1;KCNJ3;SLC9A6;ABCC9;SLC39A8;SLC12A6;ATP1B1;ATP2B4;SLC9A7;KCNJ15;ATP1A3;KCNJ10;TRPV4;SLC12A5;CACNA2D1
prerank,cellular macromolecule biosynthetic process (GO:0034645),-0.279023922368048,-1.3207202274521186,0.027777777777777776,0.6359153957896551,1.0,143/306,31.20%,RAD17;RPL41;RPS12;TAF1B;RPL3;RPS24;RPS14;RPL27A;RPL8;RPS19;RPL34;WARS1;RPS13;RPL21;RPL7;RPL18;RPL27;B4GALT5;EEF2;RPL35A;RPL38;RPS15;RPS3;RPL39;RPS7;RPS4X;RPL11;MRRF;RPL30;RPS23;BAZ2A;PWP1;RPL36;RPLP1;RPS29;RPL37;DBF4;GTPBP1;RPS9;RPS5;ALAS1;RMI1;TOPBP1;ORC4;YARS2;PTMA;RPL4;RPL18A;RAD1;RPL26;RPL6;RPL36A;RPL29;MRPS18A;RPL13A;PAX8;MRPS5;RPL7A;RPL19;FAM111A;TYMS;THAP1;RPS20;INHA;RPL14;EEF1A1;RPL13;EEF1B2;RPL32;MRPS12;RPL5;RPSA;MCM8;HUS1;MRPS33;RPLP0;MRPL55;INHBA;RPS6;RPS6KB2;RPL22;NBN;MRPS18B;POLR2E;MRPL42;MCM3;RPS21;RPL37A;RPLP2;MRPS21;ALAS2;MRPS7;RPL17;RPL23;MRPL34;HELB;DTX1;EIF4EBP2;RPL28;PABPC4;MCM5;RPL31;EEF1A2;ST3GAL4;EXO1;RPS10;HOXD3;E2F1;RPS11;POLR2B;ORC5;RPS27;EEF2K;RHNO1;POLR2J;RPS16;NFKBIB;TOPORS;RPL10;RPL15;SET;RPL12;RPL9;RPS8;DONSON;MRPL28;GRWD1;MEF2A;CDK1;CDC6;PIF1;FEN1;MRPL43;TICRR;MRPS14;POLA1;RPS27A;POLD2;RNPS1;RPL10A;XAB2;TERT;RPS17
prerank,acylglycerol catabolic process (GO:0046464),-0.42347782229968356,-1.3196988324528538,0.10932475884244373,0.636554845752093,1.0,13/30,27.50%,MGLL;ABHD2;LIPE;PNPLA3;PNPLA2;ABHD6;FABP7;LYPLA2;FABP3;LIPH;LIPC;FAAH;LPL
prerank,monocarboxylic acid metabolic process (GO:0032787),0.41342165909510065,1.3196309772033044,0.07367149758454106,0.6357544941587826,1.0,14/117,7.28%,IGF1;PCCA;CYP26B1;ABAT;ACOT11;ACOT6;PDHA1;CPT1C;ACOT2;PCCB;ALDH1A2;HOGA1;KYNU;ADH1A
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.5167527870819769,1.319158769168069,0.1458966565349544,0.6360550290207558,1.0,8/29,8.71%,ZBTB20;APOE;APOA1;SLC45A3;LDLR;SREBF1;LPGAT1;CREBL2
prerank,dopamine metabolic process (GO:0042417),0.5593204351546274,1.3191423901405894,0.1757679180887372,0.634967387840625,1.0,6/18,10.20%,MOXD1;COMT;SNCAIP;DRD3;PRKN;LRTOMT
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.54118267349556,1.3189130389757313,0.16211878009630817,0.6346160386458183,1.0,4/21,6.79%,EPHA3;ROCK2;MACF1;VCL
prerank,response to insulin (GO:0032868),0.43217592474887956,1.318384624708752,0.10559796437659033,0.6351188598940688,1.0,14/80,12.55%,PDPK1;ENPP1;TBC1D4;PIK3R1;OGT;INSIG2;CPEB1;ZFP36L1;TRARG1;KAT2B;EIF6;RHOQ;SELENOS;INSR
prerank,positive regulation of lipid localization (GO:1905954),0.6183178893019308,1.3179843198277423,0.17198581560283688,0.63521324949208,1.0,2/11,11.60%,LRP1;IKBKE
prerank,positive regulation of cell population proliferation (GO:0008284),0.3771978559766287,1.317466474270096,0.0182370820668693,0.635734948131968,1.0,54/423,8.95%,IGF1;TCF7L2;BMP6;IGF2;ESM1;GJA1;DDR2;PID1;TGFBR3;GDNF;PDGFD;AREG;AR;TGFA;IL31RA;LYN;BCL2;GRK5;FGFR1;IL6R;BMPR1A;IL34;OSMR;CCN1;LAMC1;EPGN;FGFR2;FGFR4;YAP1;GAS6;PDGFRA;EFNB2;PDGFRB;TGFBR1;CSF1;NTF3;HTR1A;PHIP;LIG4;SFRP1;CTSH;TBX3;VIP;TSLP;WWTR1;RAB25;IL13RA1;OSR1;TET1;RBPJ;NTRK3;EGFR;BMP2;CCN4
prerank,activin receptor signaling pathway (GO:0032924),0.5855131896692518,1.3167491242726925,0.1567291311754685,0.6369095788194273,1.0,3/15,4.67%,SMAD3;TGFBR1;ACVR1
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.6317926481052066,1.3167054410782453,0.17777777777777778,0.6359295494325021,1.0,4/11,10.85%,PGM3;GFPT1;UAP1;RENBP
prerank,peptidyl-lysine trimethylation (GO:0018023),0.5245580229354798,1.3166768378790834,0.1654357459379616,0.6348809121117935,1.0,10/26,19.25%,OGT;KMT5B;SETD1A;WDR82;SETD5;SETD4;KMT2A;EEF2KMT;SETD1B;TET3
prerank,sodium-independent organic anion transport (GO:0043252),-0.5605875849856838,-1.3164623057212799,0.17567567567567569,0.6448338145004464,1.0,3/10,2.67%,SLCO2A1;SLCO1C1;SLCO2B1
prerank,regulation of MAP kinase activity (GO:0043405),0.42354995309125615,1.3163095297553002,0.0929951690821256,0.6349658901380412,1.0,20/92,13.77%,ROBO1;PDGFD;KSR1;LYN;FGFR1;IL34;EPGN;KIT;APOE;PDGFRB;CDK5RAP3;LRRK2;IRAK3;EGFR;SPRY2;FGF2;ADRA2A;DUSP19;EGF;CDK12
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.5415770547318601,1.3155541778009332,0.16693418940609953,0.6362018016179231,1.0,10/21,22.99%,MT3;SIRT2;SLC30A10;PRKN;SLC18A2;ABCD2;SIRT5;AATF;HDAC6;BRCA1
prerank,regulation of synapse organization (GO:0050807),0.5134273717300935,1.3153157683021213,0.16691285081240767,0.6358556571521693,1.0,9/26,12.62%,PDLIM5;EPHA4;ABHD17C;NEDD4;CAMK2B;SETD5;MDGA1;CLN3;SLITRK2
prerank,negative regulation of transmembrane transport (GO:0034763),-0.5607944096934406,-1.3143729633462025,0.14705882352941177,0.648943948683293,1.0,3/10,7.80%,THBS1;CTTNBP2NL;INPP5K
prerank,excitatory postsynaptic potential (GO:0060079),-0.4593026386504314,-1.3140900150581398,0.13705583756345177,0.6471061205129318,1.0,5/19,7.65%,GRID2;MEF2C;GRIN2A;GRIN2B;GSK3A
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.41508100170013795,1.3140216102470197,0.08246225319396051,0.6389593948991257,1.0,27/118,10.41%,PHLDB2;PDLIM5;SH3D19;HECW2;PID1;GDNF;SPARC;DAG1;KIF13B;EPHA4;FGFR2;SP100;VASH2;NEDD4;PHIP;SFRP1;BCL6;ADGRA2;CRB2;LRRK2;BRSK1;ARHGAP35;WTIP;CAPZB;STAT2;FGF2;PDZD8
prerank,peptide catabolic process (GO:0043171),0.5274954324683845,1.3138031070541343,0.15031645569620253,0.6385613725432437,1.0,5/23,7.92%,CPQ;CHAC2;CTSH;DPEP1;NAALADL1
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.5961390784182694,1.3136687581670972,0.17900172117039587,0.6378936824373318,1.0,2/12,2.08%,LYN;RUNX1
prerank,myotube differentiation (GO:0014902),0.5653087102392024,1.3136344888045233,0.15262321144674085,0.6368544938481523,1.0,2/17,0.94%,IGF1;ADAMTS5
prerank,tRNA wobble base modification (GO:0002097),0.5770666725110198,1.3135814367247198,0.1744186046511628,0.6358882581568668,1.0,6/14,19.90%,ADAT2;TRMT9B;URM1;ALKBH1;DPH3;ELP4
prerank,axonogenesis (GO:0007409),0.3867851052694295,1.3127682495887287,0.03322615219721329,0.6373504383482471,1.0,39/237,10.37%,EPHA3;NRP1;ROBO1;EPHA7;LAMA1;AUTS2;GDNF;PIK3R1;DAG1;SEMA3D;LAMA2;GLI2;EPHA4;GFRA2;EPHA8;FGFR2;EFNB2;PALLD;SEMA5A;NOTCH2;NCAM1;LRTM1;FRS2;SRC;ULK2;RANBP9;EFNA2;BRSK1;ARHGAP35;SPTAN1;PARD6B;DSCAM;EPHB2;EFNB1;GFRA4;SLIT3;SLIT1;RYK;NEXN
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),-0.4728015852938249,-1.3125685629073893,0.12894736842105264,0.6493517002415454,1.0,11/18,31.55%,TMEM14A;HIP1R;GSK3A;BAK1;ZNF205;ACAA2;GSK3B;FZD9;CHCHD10;BID;BAX
prerank,protein autoubiquitination (GO:0051865),0.4537729127853972,1.311688932582067,0.1358839050131926,0.6396681533437771,1.0,15/61,15.28%,RNF220;SH3RF3;SH3RF1;RNF213;BFAR;RNF10;RNF185;PRKN;ITCH;RNF181;ERCC8;RAD18;RNFT1;AMFR;RNF13
prerank,calcium ion import into cytosol (GO:1902656),0.5847611378166728,1.3105500706605282,0.1777408637873754,0.6423331041172284,1.0,3/15,4.52%,SLC8A1;SLC8A3;SLC24A1
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.5452515070197522,1.3101698171337774,0.18421052631578946,0.6424158236944847,1.0,6/20,12.16%,ACTN2;HECW2;NEDD4;OSR1;ADRA2A;YWHAE
prerank,sensory perception (GO:0007600),0.47511323448962334,1.31016912450755,0.125,0.6413003404236056,1.0,6/45,7.25%,ADGRV1;TRPA1;PTGES;GNAS;ALOXE3;USH2A
prerank,kidney development (GO:0001822),0.44723756901689793,1.3095927882368616,0.125,0.6420176551095093,1.0,12/65,7.89%,GDNF;GLI2;SULF2;SALL1;WNT4;TGFBR1;SULF1;GREB1L;CTSH;AGTR1;IFT27;OSR1
prerank,cristae formation (GO:0042407),-0.431912234852276,-1.3088933974550476,0.12285714285714286,0.6587143762588719,1.0,8/27,17.21%,LETM1;ATP5F1A;ATP5F1E;ATP5ME;ATP5MG;ATP5F1C;ATP5MF;ATP5PD
prerank,alanine transport (GO:0032328),-0.5592594618599379,-1.3084504039080826,0.14870689655172414,0.657437330357214,1.0,3/10,13.96%,SLC6A6;SLC36A4;SLC1A4
prerank,positive regulation of protein polymerization (GO:0032273),-0.3525172646127871,-1.3082896020039603,0.07112970711297072,0.6552863639650642,1.0,17/65,19.35%,OCLN;BAIAP2L1;PTK2B;NAV3;MET;RPS3;PAK1;FES;DCTN1;TPPP3;CDK5RAP2;CTTN;CDK5R1;PRKCE;NCK2;CLASP1;LMOD1
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.6078713186971294,1.3076869862796177,0.16607142857142856,0.6469510308925651,1.0,6/12,18.68%,DPYSL3;DPYD;CTPS2;CDA;ALDH6A1;DPYSL2
prerank,visual perception (GO:0007601),0.42800163194623264,1.3069501133362247,0.09725685785536159,0.6481783311770546,1.0,8/84,4.52%,COL1A1;ADGRV1;COL11A1;EML2;DHRS3;TULP1;ZIC2;SLC24A1
prerank,histone deacetylation (GO:0016575),0.4660408294537674,1.306810078820817,0.1436388508891929,0.6474962196115523,1.0,18/43,23.32%,TBL1XR1;PRDM5;MIDEAS;SIRT2;MTA2;MTA3;BRMS1L;HDAC8;REST;HDAC4;SUDS3;ELK4;MIER3;BRMS1;SMARCAD1;HDAC6;HDAC5;SFPQ
prerank,protein O-linked glycosylation (GO:0006493),0.4158815941702528,1.3066767811100009,0.11097708082026538,0.6467727988213188,1.0,11/96,5.89%,TMTC1;GXYLT2;GALNT15;GALNT14;GALNT18;TMTC4;OGT;PGM3;ST3GAL3;LARGE1;LARGE2
prerank,positive regulation of phagocytosis (GO:0050766),0.4579579435928534,1.3064977129309672,0.12129380053908356,0.6462715426642952,1.0,9/47,7.45%,CAMK1D;AHSG;TULP1;GAS6;MYO18A;APOA1;APPL2;C4B;IL15RA
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.5709396415735046,-1.3062993635317277,0.1542056074766355,0.6592710035297898,1.0,6/10,26.25%,ATP5F1A;ATP5MG;ATP5F1C;ATP5PD;VPS9D1;ATP5MC2
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.39829309520842365,1.3059100351202029,0.06947608200455581,0.6469694398652606,1.0,27/151,10.63%,NRP1;CCN2;ANGPT1;PDGFD;FGFR2;FGFR4;GAS6;PDGFRA;APOE;PDGFRB;CCL19;NOTCH2;RAPGEF2;MT3;ROR1;CCL4;MAP2K1;MTURN;NTRK3;SLC30A10;ARRB1;EGFR;BMP2;SPRY2;FGF2;CARD9;BRAF
prerank,dicarboxylic acid transport (GO:0006835),0.5148468680473938,1.3055747754723983,0.1731066460587326,0.6468674458082408,1.0,4/28,5.39%,SLC1A3;GJA1;SLC13A3;PDPN
prerank,negative regulation of biomineral tissue development (GO:0070168),0.5405939208616825,1.3053147164703638,0.16193656093489148,0.6465247067505233,1.0,5/21,5.94%,ENPP1;ROCK2;AHSG;GAS6;BCOR
prerank,positive regulation of nervous system process (GO:0031646),-0.46851716993631903,-1.3042665633024018,0.1554959785522788,0.6630617484999465,1.0,5/18,11.80%,UNC13B;RIMS1;TENM4;RIMS2;ATPSCKMT
prerank,miRNA metabolic process (GO:0010586),0.5404888859024854,1.3040946379308604,0.17684887459807075,0.6493622219049909,1.0,10/20,22.16%,SND1;DDX17;TUT7;PARN;BCDIN3D;TUT4;PRKRA;TENT4B;DICER1;DROSHA
prerank,catecholamine biosynthetic process (GO:0042423),0.6078674115696111,1.3036529918890896,0.20433996383363473,0.6496006524981304,1.0,1/11,0.53%,MOXD1
prerank,neutrophil migration (GO:1990266),-0.35619663572425536,-1.303199670697766,0.08130081300813008,0.663999991270722,1.0,10/58,12.13%,PECAM1;PDE4B;BSG;TGFB2;PPIA;CCL14;FCER1G;EDN1;CKLF;CXADR
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.5297790486285529,1.303187007863321,0.1664025356576862,0.6499538877177216,1.0,6/24,9.89%,PID1;LEPR;MT3;ADRB3;GFPT1;COQ10B
prerank,blood vessel endothelial cell migration (GO:0043534),0.5376508337387312,1.3026561502594427,0.1618320610687023,0.6505384848868475,1.0,7/22,11.96%,NRP1;ROBO1;EFNB2;CDH5;MIA3;FGF2;NR4A1
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.5137529892018418,-1.3018219454752706,0.14918414918414918,0.6657327562077204,1.0,4/13,10.72%,NOS3;GCH1;CALM1;SPR
prerank,alpha-amino acid metabolic process (GO:1901605),0.47099224258638156,1.3011390743007751,0.12535211267605634,0.654118651408006,1.0,9/45,8.63%,ASPG;GLUL;PYCR1;MTHFR;ASPA;PYCR3;DPEP1;MMUT;ALDH18A1
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.5693154270376084,1.3009314908961087,0.16666666666666666,0.6536761144739821,1.0,5/17,6.93%,GJA1;SLC8A1;ATP1A2;CACNA1C;ATP1B2
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.5382262107769444,1.3006561936556482,0.16693944353518822,0.6534373209251876,1.0,4/18,8.68%,ADCY1;CAMK1D;CRTC3;CD200
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.5039691513416857,-1.3006303833321662,0.17422434367541767,0.6668750275687382,1.0,8/14,11.74%,PRKAR1A;ATP2B4;PKIB;PRKAR2B;PRKAR1B;PRKAR2A;ADRB2;SIRT1
prerank,regulation of neutrophil migration (GO:1902622),0.6193231668464256,1.3003781828327783,0.20550458715596331,0.653192489902308,1.0,1/10,0.70%,RHOH
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.4378680581369538,1.299010672508407,0.13026315789473683,0.6564399776473401,1.0,10/69,7.37%,IGF1;PIK3R1;FGFR1;OGT;PDGFRA;PDGFRB;PLCD1;ZFP36L1;PLCB4;SIRT2
prerank,regulation of lipid kinase activity (GO:0043550),0.6215345099001928,1.2988831338434423,0.20430107526881722,0.6557117291824794,1.0,6/11,15.73%,PIK3R1;WDR81;WDR91;RBL2;F2;PIK3R2
prerank,amino sugar biosynthetic process (GO:0046349),0.6067862756988893,1.2986751643381989,0.20238095238095238,0.6552583166288296,1.0,4/12,10.85%,PGM3;GFPT1;UAP1;RENBP
prerank,bile acid and bile salt transport (GO:0015721),-0.43016098355314797,-1.2985921414172685,0.11621621621621622,0.6708226193119496,1.0,4/24,2.67%,ATP8B1;ABCC4;SLCO1C1;SLCO2B1
prerank,positive regulation of translational initiation (GO:0045948),0.543406001721887,1.2979017118121374,0.1986863711001642,0.6566419597785901,1.0,4/18,12.41%,POLR2D;CDC123;DDX3X;LARP1
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.5792613843454824,1.297277329168805,0.16750418760469013,0.6574814100625164,1.0,2/14,6.93%,ACTN2;ATP1B2
prerank,regulation of secretion by cell (GO:1903530),-0.3595216608928164,-1.29704209112245,0.11065573770491803,0.6732952431191054,1.0,20/54,19.34%,MEF2C;MCTP1;RIMS1;STXBP5L;RAB21;RAB3C;RIMS2;VAMP8;SYT1;RAB12;RAB8B;LGI3;NSF;CPLX1;RAB15;RAB3A;RIC1;ARFIP1;SYN1;ANXA1
prerank,protein polyglutamylation (GO:0018095),-0.5321328922997423,-1.2970285681068205,0.15575620767494355,0.6706392439725911,1.0,2/11,1.61%,TTLL7;TTLL5
prerank,acute-phase response (GO:0006953),0.5986525315474175,1.2968550175587126,0.17398945518453426,0.6576997849730235,1.0,2/12,2.21%,AHSG;IL6R
prerank,cGMP metabolic process (GO:0046068),-0.5204137960928954,-1.2968113135367925,0.1517412935323383,0.6686381545046138,1.0,5/12,8.35%,GUCY1B1;GUCY1A1;PDE2A;NPR1;PDE9A
prerank,macrophage activation (GO:0042116),-0.39970218841519145,-1.2967689479806501,0.10726643598615918,0.6661311007014471,1.0,16/34,25.49%,CD93;PLCG2;DYSF;LBP;JAK2;FOXP1;IFI35;SBNO2;APP;TLR4;CLU;AGER;AIF1;TREM2;IFNGR1;TMEM106A
prerank,negative regulation of blood pressure (GO:0045776),-0.504774014208403,-1.2967258979093566,0.17164179104477612,0.6635703071833287,1.0,3/13,6.37%,NOS3;PRCP;NOS1
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.5913018218225164,1.295085644277339,0.19759450171821305,0.6620351537176805,1.0,4/12,16.18%,IL12B;ZBTB1;CARD9;IL23A
prerank,regulation of endothelial cell chemotaxis (GO:2001026),-0.49061360716479185,-1.295057563272154,0.17804878048780487,0.6664129550194617,1.0,5/15,4.18%,TMSB4X;THBS1;NOTCH1;MET;FGF1
prerank,transport across blood-brain barrier (GO:0150104),0.4203996840560801,1.294917007149558,0.11069182389937107,0.6614483626937102,1.0,23/83,12.55%,SLC1A3;SLC24A3;SLC7A2;SLC1A5;LRP1;SLC16A12;ATP1A2;SLC13A3;LEPR;SLC6A9;SLC6A13;SLC44A1;SLC2A10;SLC22A2;SLCO3A1;ATP1B2;SLC2A13;SLC5A3;SLC29A1;ABCC5;SLC5A5;LRP3;INSR
prerank,secretory granule organization (GO:0033363),0.6175729632672654,1.2947970547286574,0.19823008849557522,0.660721948333919,1.0,3/10,9.55%,ABCA1;DTNBP1;BLOC1S1
prerank,negative regulation of response to wounding (GO:1903035),0.540643885415901,1.2946659567223624,0.17111459968602827,0.6600299172707399,1.0,8/19,15.84%,SERPINE1;EPHA4;PTPRS;CASK;FGF2;MDK;CERS2;EPPK1
prerank,regulation of mitochondrial depolarization (GO:0051900),0.6275117669729242,1.29460779751982,0.17572463768115942,0.6591335612998142,1.0,4/10,6.60%,DCN;BCL2;SRC;LRRK2
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.5338234522704776,-1.2944442761539028,0.1642156862745098,0.6658689902295255,1.0,4/12,6.92%,UNC13B;RIMS1;RIMS2;SYT1
prerank,cellular response to decreased oxygen levels (GO:0036294),0.44184395112418295,1.294417356512603,0.11696658097686376,0.658604094947607,1.0,10/65,7.37%,PTGIS;RORA;SLC8A3;MT3;SFRP1;CPEB1;EPAS1;ZFP36L1;NDRG1;SIRT2
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.4138970021329869,1.2942635080129044,0.11455847255369929,0.6580010360341587,1.0,20/104,10.36%,PDPK1;CILP;SMAD3;LDLRAD4;ADAMTSL2;BMPR1A;NKX2-1;PMEPA1;TGFBR1;SLC2A10;SMURF2;ACVR1;SKI;EMILIN1;BMP2;SPRY2;LEMD3;SMAD1;FAM89B;SPRED3
prerank,plasma membrane tubulation (GO:0097320),-0.5131745983121447,-1.2941591842987736,0.15476190476190477,0.6641446095381645,1.0,8/13,23.57%,FNBP1L;CAVIN2;BIN3;PACSIN2;PACSIN1;EHD2;CHMP4A;BIN2
prerank,T cell activation (GO:0042110),0.42694392525804203,1.2936239064377242,0.13359273670557717,0.6590430745247842,1.0,14/69,14.20%,RHOH;KIF13B;LEPR;PPP3CA;KIT;CCL19;CD7;CD28;NHEJ1;GPR89A;GPR89B;IFNK;DDOST;MDK
prerank,vascular transport (GO:0010232),0.42376288325977074,1.2928492543995687,0.11224489795918367,0.6603803893071734,1.0,23/81,12.55%,SLC1A3;SLC24A3;SLC7A2;SLC1A5;LRP1;SLC16A12;ATP1A2;SLC13A3;LEPR;SLC6A9;SLC6A13;SLC44A1;SLC2A10;SLC22A2;SLCO3A1;ATP1B2;SLC2A13;SLC5A3;SLC29A1;ABCC5;SLC5A5;LRP3;INSR
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.46881715473795327,1.2927935000885973,0.14937759336099585,0.6594675039064322,1.0,4/38,7.67%,BMP6;SASH1;DDX60;NMI
prerank,lipid translocation (GO:0034204),-0.4453370506832374,-1.2926733666186414,0.1276595744680851,0.6664016345829814,1.0,6/21,7.23%,ATP8A1;ATP8B1;ATP11C;ABCC1;ATP11B;ATP11A
prerank,organophosphate ester transport (GO:0015748),-0.4427327512880717,-1.2922698655631284,0.1457142857142857,0.6650310071952562,1.0,10/24,17.09%,PITPNC1;PLTP;PITPNA;TNFAIP8L3;NPC2;OSBPL2;SCARB1;PCTP;PITPNB;PRELID2
prerank,receptor signaling pathway via STAT (GO:0097696),0.5187699890252512,1.2917696577920306,0.18335901386748846,0.661611414904401,1.0,7/25,13.57%,GHR;IL31RA;NMI;STAT5B;STAT2;STAT6;STAT4
prerank,presynaptic endocytosis (GO:0140238),-0.4275632933973217,-1.29167022371085,0.1452991452991453,0.6642924787455695,1.0,11/24,24.83%,NLGN1;AMPH;OPHN1;CDK5;SYT1;PACSIN1;NLGN3;STX1A;SYNJ1;SYT5;SNCG
prerank,positive regulation of multicellular organismal process (GO:0051240),0.37760514510074533,1.2916419933666863,0.0472193074501574,0.6608821663372578,1.0,69/308,15.28%,ADRA1B;COL1A1;GJA1;GHR;GDNF;SMAD3;LRP1;SOX5;NKX6-1;ABCA1;SERPINE1;PLA2R1;LEPR;OGT;ACSL1;BMPR1A;OLFM1;GNAS;GAS6;APOE;TGFBR1;SMO;SMURF2;APPL2;ACVR1;AXIN2;PDPN;VIP;EPAS1;DYNC1H1;ADRB3;CRB2;ALMS1;IL12B;BATF;CD28;WWTR1;DAB2;KMT5B;BMP2;SYDE1;TRPM4;NFAM1;FGF2;CARD9;MFAP2;CEBPB;ADRA2A;RBM19;RGCC;REST;NIBAN2;MAP3K13;STAT6;ACVR1B;DECR1;TMEM119;EGF;NCOA3;GLMN;DIO2;G0S2;HMCES;MDK;BMP4;CNOT3;GLIPR2;IL4R;GRB10
prerank,contractile actin filament bundle assembly (GO:0030038),0.5753745947789991,1.2908939650126634,0.20364238410596028,0.661056161780595,1.0,5/15,13.28%,PHACTR1;ITGB5;SRC;ARRB1;TNFAIP1
prerank,stress fiber assembly (GO:0043149),0.5753745947789991,1.2908939650126634,0.20364238410596028,0.661056161780595,1.0,5/15,13.28%,PHACTR1;ITGB5;SRC;ARRB1;TNFAIP1
prerank,alcohol catabolic process (GO:0046164),0.6385516515731192,1.290763303016485,0.19964028776978418,0.6603958329091228,1.0,3/10,7.22%,APOE;MT3;CYP27A1
prerank,protein K48-linked deubiquitination (GO:0071108),-0.4347788625511313,-1.2907134461327512,0.12011173184357542,0.6648769884284309,1.0,7/23,11.50%,OTUD7B;MINDY2;MINDY1;OTUD7A;OTUD4;YOD1;TNFAIP3
prerank,neuromuscular process controlling balance (GO:0050885),-0.5218126885437898,-1.2902273682153147,0.1642512077294686,0.6638890801099435,1.0,4/12,9.86%,PCDH15;NRXN1;PAFAH1B1;SHANK1
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.4633173005384302,1.2902206975168677,0.15006821282401092,0.6610755974924976,1.0,6/43,13.46%,IGF1;GAS6;IRAK3;CD33;SELENOS;SYT11
prerank,negative chemotaxis (GO:0050919),0.4967807112619002,1.2897944248362996,0.15453194650817237,0.6612623270758881,1.0,10/33,10.12%,ROBO1;EPHA7;SEMA3D;APOA1;LRTM1;NTN1;ITGB3;ITGAV;SLIT3;SLIT1
prerank,purine ribonucleotide metabolic process (GO:0009150),0.4357030879486123,1.2893410702794967,0.1203104786545925,0.6616096004074211,1.0,8/68,6.60%,ENPP1;AMPD3;TPST1;ACOT11;ACOT6;ACOT2;RAB23;LRRK2
prerank,nucleosome assembly (GO:0006334),-0.4026649207884836,-1.2889902653598366,0.1282051282051282,0.6654145114067819,1.0,17/31,31.97%,NAP1L4;HIRA;NAP1L2;H3-3A;CHAF1A;NAA60;RSF1;HMGB2;NPM1;CABIN1;NASP;ASF1A;HAT1;ASF1B;GRWD1;NAP1L3;NAP1L1
prerank,positive regulation of protein phosphorylation (GO:0001934),0.36781167844955354,1.2889765842654968,0.040123456790123455,0.6617045644742364,1.0,46/348,8.90%,IGF1;NRP1;BMP6;IGF2;DDR2;CEMIP;ROCK2;ANGPT1;GHR;PDGFD;LYN;IL6R;LEPR;BMPR1A;IL34;PELI2;CCN1;INHBE;PRKAG2;GAS6;TGFBR1;VTN;CCL19;TWSG1;CSF1;RAPGEF2;MT3;ACVR1;NTF3;AXIN2;MUSK;SLCO3A1;ENG;SRC;LRRK2;ARAF;ALS2;NTRK3;STK4;DAB2;ARRB1;EGFR;CREBL2;RBPMS;BMP2;SPRY2
prerank,protein localization to plasma membrane (GO:0072659),-0.3025647488553086,-1.2888175755837727,0.031007751937984496,0.6634358965691793,1.0,27/129,8.24%,DPP10;KCNB2;KCNIP4;RAP1A;SMURF1;F11R;CDH1;ANK3;BSG;EFR3B;ZDHHC2;CCDC88A;RAMP2;SPTBN1;RDX;LRP6;EMP2;TTC7A;RAB3C;ATP1B1;EHD4;RAB12;GAK;RAB8B;INPP5K;RAB11A;MAP7
prerank,ceramide metabolic process (GO:0006672),-0.37325287841025045,-1.2883799385040557,0.09187279151943463,0.6624016130651704,1.0,6/49,2.87%,ST6GALNAC3;SGMS1;ACER3;SGMS2;ACER2;DEGS2
prerank,oligosaccharide biosynthetic process (GO:0009312),0.539754160796617,1.2881764134751317,0.20534223706176963,0.6631383383356041,1.0,5/20,10.18%,ST6GALNAC5;B3GALT1;ST3GAL3;B4GALT1;ST6GALNAC6
prerank,regulation of keratinocyte differentiation (GO:0045616),0.5180167988466597,1.287911596145204,0.185126582278481,0.662952334768021,1.0,4/24,5.78%,ERRFI1;ROCK2;RUNX1;ZFP36L1
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.4906727635801954,1.2877427467573554,0.18303571428571427,0.662350317583807,1.0,4/33,7.37%,IGF1;PIK3R1;ZFP36L1;SIRT2
prerank,membrane assembly (GO:0071709),-0.40092373336384207,-1.287593632003653,0.12951807228915663,0.6623934584763971,1.0,9/34,10.28%,NLGN1;IL1RAPL1;ANK3;PTPRD;SPTBN1;NRXN1;EMP2;GAK;UGCG
prerank,positive regulation of mRNA metabolic process (GO:1903313),-0.5037799625459948,-1.2875538814256222,0.17233560090702948,0.6599618561211722,1.0,5/13,21.44%,PRR5L;GTPBP1;PNPT1;CNOT7;CNOT8
prerank,inhibitory synapse assembly (GO:1904862),-0.5353291559484393,-1.2874857402412005,0.1558139534883721,0.657717647725872,1.0,4/11,8.12%,GABRA2;GABRB3;GABRG2;GABRB2
prerank,synaptic vesicle exocytosis (GO:0016079),-0.38970403542487925,-1.2870204507205698,0.11458333333333333,0.6568265840042227,1.0,15/40,25.18%,UNC13B;RIMS1;STX3;CDK5;RIMS2;SYT1;PCLO;CPLX1;RAB3A;STX1A;RIMS3;OTOF;SNPH;SYT5;SNAP29
prerank,prostaglandin metabolic process (GO:0006693),0.5182932655670803,1.286970853331024,0.16614420062695925,0.6637027234790733,1.0,3/26,5.18%,PTGIS;PTGES;PLA2G4A
prerank,nucleic acid metabolic process (GO:0090304),0.43676627298985304,1.2862353056098124,0.10824742268041238,0.6649530692648045,1.0,23/69,20.82%,POLR2D;ENPP1;RBFOX2;POLG;DXO;RECQL5;HNRNPR;METTL14;HNRNPA1;POLR2C;DNASE1L1;DNASE2;WTAP;LSM8;HNRNPC;KPNA2;METTL3;DDX1;POLR2L;HNRNPU;HNRNPH1;EXD2;DDX24
prerank,regulation of actin filament depolymerization (GO:0030834),0.5971216252115427,1.2853250267163485,0.2082616179001721,0.6667310741989839,1.0,3/12,5.80%,PLEKHH2;SEMA5A;LIMA1
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.42257341246812524,1.2842394127374552,0.1220715166461159,0.6690439412947341,1.0,12/78,9.03%,EPHA3;PDPK1;PID1;PIK3R1;AR;LRP1;ITGA3;PTPN9;DAB2;EGFR;EPHB2;PICALM
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.41334102855863647,1.2836626924919305,0.12995049504950495,0.6697886647353593,1.0,19/87,15.81%,POLR2D;FGFR1;KL;FGFR2;FGFR4;RBFOX2;FRS2;SFRP1;ZFP36L1;FLRT2;HNRNPA1;POLR2C;FGF2;FGFBP1;NR4A1;TIAL1;DSTYK;SPRED1;FIBP
prerank,mononuclear cell differentiation (GO:1903131),0.5180042553991897,1.2833442927044139,0.17746913580246915,0.6697170946532995,1.0,4/24,4.70%,IL31RA;LYN;GAS6;AXL
prerank,regulation of nervous system process (GO:0031644),0.543310857275211,1.2829615324490353,0.1970684039087948,0.6698363864643287,1.0,2/18,1.31%,ROCK2;SLC8A3
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.46791310083018534,1.282955729707894,0.18088235294117647,0.6687907365785687,1.0,5/41,4.52%,ITPR1;SLC8A1;SLC8A3;CCL19;SLC24A1
prerank,negative regulation of T cell differentiation (GO:0045581),0.6085639762208245,1.282915512892568,0.21693121693121692,0.6678530876320883,1.0,4/10,14.89%,GLI3;IRF1;MDK;BMP4
prerank,ribosomal small subunit assembly (GO:0000028),-0.4830288981799258,-1.2822674470210753,0.16666666666666666,0.6693606284125206,1.0,7/16,20.17%,RPS14;RPS19;RPS15;RPS5;RPSA;PRKDC;MRPS7
prerank,regulation of cell morphogenesis (GO:0022604),0.4926556327660528,1.2821704881717686,0.1687116564417178,0.6691147328960422,1.0,8/30,10.41%,SH3D19;SPARC;MACF1;PHIP;PDPN;WTIP;CAPZB;PDZD8
prerank,negative regulation of wound healing (GO:0061045),0.5004063542471288,1.2820866576823864,0.16909620991253643,0.6683336510236028,1.0,6/28,5.86%,PHLDB2;SERPINE1;APOE;VTN;TFPI;CASK
prerank,negative regulation of macrophage activation (GO:0043031),0.5537311909654041,1.2816840046504574,0.21666666666666667,0.6684782294306124,1.0,7/16,17.51%,IL31RA;LDLR;NR1D1;CD200;SYT11;NR1H3;CX3CL1
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.46693770967999026,1.2815623428414928,0.15459610027855153,0.6678254385794252,1.0,6/41,13.46%,IGF1;GAS6;IRAK3;CD33;SELENOS;SYT11
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.4502045366951446,1.2809638415583666,0.14854111405835543,0.6687404547659783,1.0,12/52,18.30%,POLR2D;SAMD4A;TUT7;EXOSC1;PARN;EXOSC7;TUT4;RC3H2;CNOT3;DCP1A;PATL1;RC3H1
prerank,sulfur amino acid metabolic process (GO:0000096),0.5128635067779211,1.2806589168115587,0.16820987654320987,0.6686061471724363,1.0,7/24,13.12%,MTR;MTHFR;DPEP1;MMUT;CDO1;SMS;NOX4
prerank,ureteric bud morphogenesis (GO:0060675),0.5583972166467803,1.280647610577482,0.1895424836601307,0.6675915112297078,1.0,6/16,16.71%,GDNF;SALL1;BMP2;FGF2;BMP4;SHH
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),-0.5068383806970967,-1.2805399610214565,0.17590361445783131,0.6724698058515444,1.0,8/13,16.79%,PTPRT;JAK2;MGAT5;HES1;CRLF2;PTPRC;PIGU;JAK3
prerank,protein O-linked mannosylation (GO:0035269),0.5445871949980899,1.2803369613277324,0.17109634551495018,0.6675293968042028,1.0,4/18,5.89%,TMTC1;TMTC4;LARGE1;LARGE2
prerank,actomyosin structure organization (GO:0031032),0.4319408907289138,1.2802901841958239,0.1346153846153846,0.6666196533809273,1.0,16/75,10.12%,PHACTR1;ROCK2;ACTN2;TPM1;TMOD4;TNNT1;MYO18A;MYH10;FRMD6;CSRP2;ITGB5;SRC;ARRB1;CSRP3;SYNPO2L;TNNT3
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.47763207246446976,-1.2799187089295043,0.1725067385444744,0.6717619106917176,1.0,8/17,26.80%,COX4I1;COX6A1;COX5B;CYCS;COX5A;COX6C;COX8A;AFG1L
prerank,regulation of cytoskeleton organization (GO:0051493),0.40635315985559345,1.2792993814162918,0.09564164648910412,0.6687404897703996,1.0,13/108,5.50%,EPHA3;PHLDB2;RHOH;ROCK2;LRP1;DLC1;RHOD;ARHGAP18;RHOBTB1;PDGFRB;IQGAP2;PRKAA2;RHOBTB3
prerank,inorganic anion transport (GO:0015698),-0.3560096166650051,-1.2792443410199974,0.1111111111111111,0.6713550150743719,1.0,10/53,9.96%,SLC4A10;SLC26A7;CLIC4;ANO1;ANO4;CLIC5;GLRA1;CLIC1;SLC25A30;SLC26A6
prerank,transcription preinitiation complex assembly (GO:0070897),-0.5232043993180967,-1.2787451495298119,0.18433179723502305,0.6704624104823531,1.0,7/12,22.93%,TAF1B;TAF1;TBP;GTF2A2;BDP1;POLR1E;GTF2B
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.4870898979222361,-1.2783634553218415,0.18357487922705315,0.6693221708040906,1.0,5/14,11.74%,SEMA7A;PLCG2;CAMK4;GPRC5B;SIRT1
prerank,positive regulation of filopodium assembly (GO:0051491),0.5133752655505175,1.2779250112237879,0.17873651771956856,0.6720021729692461,1.0,6/24,6.15%,NRP1;PIK3R1;DOCK11;RIPOR2;DPYSL3;CDC42
prerank,positive regulation of receptor internalization (GO:0002092),0.5147744295780937,1.2772090112807368,0.17729393468118196,0.6732246329230382,1.0,8/22,18.14%,ANGPT1;NTF3;CD63;ARRB1;INSR;EGF;SFRP4;AHI1
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.43703906660715436,1.2770440077820202,0.157543391188251,0.6726919346490999,1.0,14/55,15.38%,PID1;PDGFRB;MT3;CYP1B1;AGTR1;SPHK2;SIRT2;PRKN;DCXR;EIF6;F2;NOXO1;ARF4;PIKFYVE
prerank,protein localization to cell-cell junction (GO:0150105),-0.4788791374171354,-1.2769876914384448,0.18085106382978725,0.6712045212314381,1.0,6/15,2.91%,MPP7;F11R;ACTB;TJP2;LSR;TJP1
prerank,cellular iron ion homeostasis (GO:0006879),0.439357636706529,1.2767044694206735,0.13581890812250333,0.6726760291241545,1.0,7/55,6.50%,BMP6;CP;SCARA5;HEPH;CYBRD1;SLC11A2;ACO1
prerank,cellular response to mechanical stimulus (GO:0071260),-0.3624921949104872,-1.2763441863756186,0.1,0.6706563267036386,1.0,11/46,14.60%,PIEZO2;F11R;PIEZO1;CRADD;MAP3K1;PDE2A;MAPK8;CASP8;CD40;MAPK3;BAK1
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.397934143647444,-1.2763206455023515,0.1534090909090909,0.6682954828502287,1.0,11/31,15.04%,PPP1R13B;YWHAH;YWHAQ;HIP1R;GSK3A;MAPK8;CASP8;YWHAG;BBC3;BAK1;ZNF205
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.5304133376307162,1.2756908547650527,0.2064,0.6748496397205516,1.0,8/20,9.91%,RUNX2;CHD6;MT3;NFE2L2;RBPJ;BMP2;SMAD1;CREB3
prerank,anion transmembrane transport (GO:0098656),0.42881394342400875,1.2751683717546438,0.15306122448979592,0.6754680426284967,1.0,9/67,6.08%,SLC1A3;SLC7A2;SLC16A12;SLC13A3;SLC13A4;SLC6A9;SLC6A13;SFXN2;SLC35A3
prerank,ephrin receptor signaling pathway (GO:0048013),0.41295225890911486,1.275130216582435,0.14127764127764128,0.6745463002903432,1.0,13/82,9.02%,EPHA3;EPHA7;ROCK2;LYN;EPHA4;EPHA8;MMP2;EFNB2;CDC42;SRC;EFNA2;EPHB2;EFNB1
prerank,negative regulation of RNA splicing (GO:0033119),-0.4480482234462895,-1.2749362794091132,0.1784841075794621,0.6702104900208244,1.0,11/19,30.81%,RPS13;PTBP2;PTBP3;SRSF12;SRSF7;RBMX;C1QBP;SRSF4;PCBP4;U2AF2;RNPS1
prerank,water-soluble vitamin metabolic process (GO:0006767),0.42969840051598224,1.2744224307859942,0.13618677042801555,0.6756986954992992,1.0,11/68,8.24%,ENPP1;MMAB;PCCA;NNMT;MTR;PCCB;MTHFR;PDXK;MMUT;CYB5A;ALDH1L1
prerank,acidic amino acid transport (GO:0015800),0.5467848411283285,1.2743413783236333,0.20234113712374582,0.674913875884232,1.0,3/17,3.80%,SLC1A3;GJA1;SLC6A13
prerank,regulation of DNA binding (GO:0051101),0.45512773107303756,1.27433498920859,0.16223776223776223,0.6739020409027494,1.0,7/44,9.32%,IGF1;SP100;MDFI;SMO;SKI;SIRT2;PRKN
prerank,protein kinase A signaling (GO:0010737),-0.5185406445256383,-1.273954569454574,0.17209302325581396,0.6708917458015237,1.0,3/12,7.60%,RDX;PRKACB;MYOM1
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.4460648550516128,1.2738181605935224,0.15384615384615385,0.6744688351232623,1.0,8/52,8.61%,EPHA3;PDPK1;PIK3R1;LRP1;ITGA3;PTPN9;EGFR;EPHB2
prerank,negative regulation of cell projection organization (GO:0031345),0.45507744372297865,1.2733699459010555,0.16326530612244897,0.6748362785884835,1.0,16/48,15.93%,EPHA4;KANK1;APOE;EFNB2;DPYSL3;RAPGEF2;MT3;PTPRS;DENND5A;LPAR1;PTPN9;SPRY2;GORASP1;PTEN;BAG5;STX1B
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.47338210781264106,1.273029097237703,0.16546762589928057,0.6749229481028594,1.0,2/37,0.40%,EPHA3;PHLDB2
prerank,protein ADP-ribosylation (GO:0006471),0.5030033695562741,1.2721051521487443,0.17371601208459214,0.6767312000418395,1.0,10/28,19.03%,ART4;PARP11;HPF1;PARP16;SIRT2;PARP14;TNKS2;ARF4;PARP12;SIRT5
prerank,skeletal system morphogenesis (GO:0048705),0.46153626029940575,1.2720977329198946,0.15352697095435686,0.6757103824369607,1.0,14/42,18.20%,CYP26B1;FBN2;FGFR1;FGFR2;PDGFRA;TGFBR1;SKI;DYNC2I1;SFRP4;HOXC4;SPEF2;ANKRD11;HHIP;SOX11
prerank,SNARE complex assembly (GO:0035493),-0.5391158301290498,-1.2718435793499652,0.1966824644549763,0.6750640812466332,1.0,2/10,6.64%,STXBP6;VAMP8
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",-0.41744353848910554,-1.2710941907713071,0.1527777777777778,0.6750877986014256,1.0,6/25,7.65%,GRID2;MEF2C;GRIN2A;GLRA1;GRIN2B;GSK3A
prerank,ceramide transport (GO:0035627),-0.5220446172173477,-1.270832847576387,0.19248826291079812,0.6734906146586486,1.0,3/12,6.74%,CERT1;PLTP;PLEKHA3
prerank,cellular response to peptide (GO:1901653),0.442958522969703,1.2703092555990902,0.1581081081081081,0.6802816524912777,1.0,8/56,7.75%,IGF1;GJA1;LRP1;EPHA4;CACNB1;ZFP36L1;SRC;TLR6
prerank,positive regulation of protein kinase activity (GO:0045860),0.38891386673267797,1.2702342625636427,0.10981308411214953,0.6794839764288608,1.0,35/148,14.45%,DDR2;NRK;NEDD9;EPHA4;IL6R;IL34;CCN1;PRKAG2;GAS6;CCL19;CSF1;RAPGEF2;NAB2;SRC;PARP16;IL12B;MAP2K1;ALS2;STK4;MAP4K4;ITGB3;TELO2;STK11;TTBK1;MRNIP;TAOK3;DDX3X;ADRA2A;STRADA;DUSP19;INSR;NOX4;MARK2;DLG4;SNX9
prerank,positive regulation of protein localization to membrane (GO:1905477),0.40617649114668664,1.2699417082231512,0.12302070645554203,0.6793809833675672,1.0,14/98,9.32%,EPHA3;PDPK1;CEMIP;PIK3R1;LRP1;BCL2;ITGA3;PDCD5;MYO1C;PTPN9;EGFR;EPHB2;SLC5A3;PRKN
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.4881840308467087,-1.2698903547840745,0.16911764705882354,0.6741054471585421,1.0,8/15,19.53%,GRM7;GRM3;GRM5;GRM8;HOMER1;HOMER3;GRM1;DAGLB
prerank,positive regulation of hydrolase activity (GO:0051345),-0.3036391754560066,-1.2697408076576882,0.0546875,0.6721811976758956,1.0,32/137,11.96%,PKP4;DOCK9;RAP1A;ITGA6;F11R;CAV2;RAP1GDS1;BCAR3;NET1;SNX13;RGS6;TGM2;ARHGAP27;RPS3;ERBB2;EZH2;FNTA;CCL14;TBC1D30;ARAP1;RASGRF1;RGS7;LARS1;MAPK8;CALM1;MTMR9;RGS16;CALM3;AGRN;NF1;EVI5;CD40
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.5351014556566338,1.2689439805309057,0.18270799347471453,0.6814750656255478,1.0,6/19,17.30%,AMPD3;ADK;POLL;CDA;AMPD2;DCK
prerank,lipid transport (GO:0006869),-0.3223829864543207,-1.2683752625569678,0.06134969325153374,0.6742140437566088,1.0,29/97,17.09%,PITPNC1;CERT1;ATP8A1;ATP8B1;PLTP;ABCC4;SLCO2A1;SLCO1C1;SLCO2B1;PPARD;PITPNA;TNFAIP8L3;SPNS2;LBP;PLEKHA3;NPC2;MFSD2A;ABCG1;OSBPL2;UGCG;SCARB1;PCTP;CEACAM1;ABCD3;ABCC3;MFSD2B;PITPNB;OSBP;PRELID2
prerank,regulation of angiogenesis (GO:0045765),0.3784882650998571,1.2683737733081546,0.09010989010989011,0.6821809477823428,1.0,28/192,6.63%,PDPK1;PTGIS;COL4A3;ROCK2;SPARC;GLUL;SASH1;DCN;SERPINE1;HSPG2;RUNX1;SP100;VASH2;ISM1;THBS2;SEMA5A;STIM1;SULF1;ITGB8;SFRP1;CTSH;SMOC2;CYP1B1;CDH5;SERPINF1;ADGRA2;PML;EMILIN1
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.6168604338614814,1.2682637053476358,0.2146690518783542,0.6815172179346426,1.0,3/10,7.54%,ACTN2;SEMA5A;CARMIL1
prerank,apical protein localization (GO:0045176),-0.5367255771684022,-1.2679244267834844,0.19318181818181818,0.6732802222431709,1.0,3/10,2.24%,ATP8B1;ACTB;MAL
prerank,positive regulation of axonogenesis (GO:0050772),0.4629841282949634,1.2666329580426654,0.17189631650750342,0.6856627610965546,1.0,11/43,14.29%,ROBO1;PLXNA2;MACF1;TIAM2;GOLGA4;NTN1;PLXNC1;MAP3K13;PLXNA1;CHODL;PLXNB2
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),-0.32453363368248944,-1.2664536875349135,0.09482758620689655,0.6753906210684476,1.0,24/75,18.55%,MEF2C;MAP2;ACTB;ANK3;NRCAM;KLF7;CNTN4;NTNG1;BTBD3;OPHN1;CDK5;DCDC2;MFSD2A;NEFH;DCC;APBB1;LMTK2;APP;MAP1B;RAB3A;SHTN1;UNK;DVL1;BRSK2
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.4447173690413467,1.2662615542539954,0.16937669376693767,0.6857853215855729,1.0,8/52,8.61%,EPHA3;PDPK1;PIK3R1;LRP1;ITGA3;PTPN9;EGFR;EPHB2
prerank,cellular modified amino acid catabolic process (GO:0042219),0.5530403539564279,1.2661045114840521,0.2120689655172414,0.6852261057974053,1.0,5/15,11.58%,GGACT;CHAC2;HOGA1;DPEP1;SARDH
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.3839313707938264,1.2659249400991508,0.09615384615384616,0.6847540033167087,1.0,36/166,15.02%,POLR2D;RORA;CCN2;TBL1XR1;TEAD1;AR;THRB;YAP1;MAML3;RARB;NOTCH2;POLR1G;RARG;GTF2E1;BRF1;GTF3C1;GTF2H5;NR5A1;WWTR1;NR1D1;RBPJ;NCOR1;KAT2B;POLR2C;TFAM;NR1D2;NCOR2;POLRMT;NR4A1;MNAT1;TEAD3;GTF2E2;TAF9;NRBF2;NR1H3;RXRA
prerank,sulfur compound transport (GO:0072348),-0.41455433614265363,-1.2653359295581759,0.1565934065934066,0.6765532915544566,1.0,7/27,9.96%,SLC6A6;ABCG2;SLC26A7;LRRC8D;SLC5A6;SLC25A30;SLC26A6
prerank,iron ion homeostasis (GO:0055072),0.4313111519420351,1.2651205838066473,0.14456233421750664,0.6862223828906202,1.0,8/58,6.50%,BMP6;CP;SCARA5;HEPH;NEO1;CYBRD1;SLC11A2;ACO1
prerank,pinocytosis (GO:0006907),0.5928763913450046,1.2647281282786564,0.25432525951557095,0.6864604790291179,1.0,3/10,7.54%,AHSG;SNX33;CARMIL1
prerank,positive regulation of neuroblast proliferation (GO:0002052),-0.5397282485232328,-1.2645152827459676,0.21247113163972287,0.6768392167351981,1.0,4/10,11.17%,KDM1A;DISC1;VEGFA;CX3CR1
prerank,purine-containing compound catabolic process (GO:0072523),-0.49134886546003276,-1.2639586850682776,0.20293398533007334,0.6762778175059123,1.0,7/13,18.51%,NT5E;NT5C2;NT5C1A;GDA;NT5C;PNP;GPX1
prerank,heart trabecula morphogenesis (GO:0061384),0.5371118854535086,1.2636990136502766,0.19594594594594594,0.6886447770499652,1.0,6/18,8.12%,RBP4;TGFBR3;BMPR1A;TGFBR1;ENG;RBPJ
prerank,limb development (GO:0060173),0.4971795351515701,1.2626952511948863,0.19083969465648856,0.690767945517151,1.0,6/28,8.83%,SALL1;GLI3;MAP3K20;ZNRF3;SMOC1;KAT2B
prerank,muscle organ development (GO:0007517),0.4325595853561552,1.2626085246458636,0.16032608695652173,0.6900034058380579,1.0,13/54,14.36%,IGF1;LAMA2;ITGA11;VAMP5;LARGE1;MRAS;SMTN;CHD2;HBEGF;SGCE;COL6A3;CHODL;TCF12
prerank,negative regulation of cell activation (GO:0050866),0.5621642803960689,1.262474367041928,0.21105527638190955,0.6893726797635195,1.0,8/14,12.06%,PDGFRA;APOE;LDLR;EMILIN1;NR1D1;CD200;F2;C1QTNF1
prerank,negative regulation of mitochondrion organization (GO:0010823),0.48894992153868283,1.2624641970103134,0.1849112426035503,0.6883815291685458,1.0,1/33,0.01%,IGF1
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.3570424264872059,1.262104696991639,0.015045135406218655,0.688416822854486,1.0,157/834,15.85%,IGF1;TCF7L2;TCF4;BMP6;LDB2;AUTS2;NFIA;IGF2;RORA;TBL1XR1;PID1;TEAD1;CDK8;GDNF;PIK3R1;PBX1;SMAD3;ARNT2;AR;ZEB2;MITF;DCN;GLIS3;NKX6-1;SERPINE1;NR2F2;GLI2;RUNX1;SALL1;SP7;OGT;BMPR1A;GLI3;PPP3CA;CCN1;NKX2-1;FGFR2;THRB;NFIB;ASCL1;SSBP3;ZNF462;YAP1;MAML3;RUNX2;MLXIP;RARB;NFIX;MEOX2;CRTC3;RLF;IRF1;RFX5;ACVR1;NEUROD1;NCOA2;KLF15;PHIP;RARG;BRD8;TBX3;EPAS1;HLF;ENG;SKI;BCL9;ATOH8;INO80;SMARCA1;MED14;NR5A1;CEBPA;ATAD2B;NFE2L2;WWTR1;RNF10;SREBF1;SIRT2;DDX17;DR1;ZBTB38;MED16;NR1D1;OSR1;TET1;RBPJ;DAB2;FOXC2;ARRB1;EGFR;RGMA;BMP2;ZMIZ1;KAT2B;STAT5B;MZF1;CCNK;SMAD1;PRKN;GLIS2;CSRP3;ARNT;CREB3L4;CREB3;RNASEL;FOXA1;FGF2;ZSCAN21;NR1D2;DDX3X;CEBPB;RGCC;TNIP2;NKX2-8;TBK1;HDAC8;REST;NR4A1;RHOQ;GLI1;STAT6;ZNF513;RIPK2;MYCN;SMARCD2;NPAS2;HELZ2;NCOA3;KMT2A;CDK12;HDAC4;TAF9;MED19;ARF4;HIVEP1;ETS1;FSTL3;TCF12;TCERG1;AKAP8L;GATA6;NR1H3;BMP4;FUBP3;HOXC4;RXRA;TNFRSF1A;FOXK2;SS18;SMARCB1;BMP5;CAMTA2;MTF1;TFCP2;PIK3R2;POGZ;ZBTB17
prerank,regulation of histone methylation (GO:0031060),0.5724037012698123,1.2617250686892225,0.20347826086956522,0.6885347930252308,1.0,5/13,12.72%,NNMT;MTHFR;TET1;NSD1;PAF1
prerank,homeostasis of number of cells (GO:0048872),-0.5122566544120968,-1.2615655498528935,0.17371937639198218,0.6815363280651705,1.0,5/12,14.21%,NOTCH1;NOS3;CCN3;CX3CR1;LPCAT3
prerank,peptidyl-amino acid modification (GO:0018193),0.6062453727164433,1.2613913061761248,0.22037037037037038,0.6885472113472043,1.0,3/10,6.62%,FKBP7;APOA1;TTLL4
prerank,neuron projection fasciculation (GO:0106030),0.5893131287718889,1.2604872931688278,0.2204585537918871,0.6903318678533567,1.0,5/10,11.55%,EPHA4;SEMA5A;ARHGAP35;EPHB2;EPHB3
prerank,protein deacetylation (GO:0006476),0.45374522413460044,1.2602065822765347,0.18493150684931506,0.6902082302092895,1.0,10/41,14.90%,TBL1XR1;PRDM5;MIDEAS;SIRT2;MTA2;MTA3;BRMS1L;HDAC4;FLNA;SUDS3
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.44566340551659533,1.2601370165711072,0.16666666666666666,0.6894326046093611,1.0,12/48,14.79%,ROBO1;DCST1;GAS6;RFFL;APOA1;IRAK3;STAT2;PARP14;SLIT3;MUL1;CCDC3;NR1H3
prerank,positive regulation of B cell proliferation (GO:0030890),-0.3937978639322928,-1.2599621053974932,0.1661631419939577,0.6841930338493866,1.0,10/29,17.03%,MEF2C;VAV3;CD38;TFRC;NFATC2;CD40;CD81;GPR183;PTPRC;CD320
prerank,protein depolymerization (GO:0051261),0.5058311196425361,1.2598484587432437,0.1908284023668639,0.6893719126865789,1.0,3/27,2.81%,MICAL3;GSN;NCKAP5
prerank,synaptic vesicle transport (GO:0048489),-0.5305849879087438,-1.2597567482842715,0.20631067961165048,0.6825078077312174,1.0,5/11,23.33%,RAB27A;CDK5;SYNJ1;KIF5A;TMEM230
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.5145104536002837,1.2597337968416136,0.20684039087947884,0.688695279600375,1.0,9/20,14.89%,TGFBR3;OLFM1;TGFBR1;TBX3;ENG;RBPJ;BMP2;PDCD4;BMP4
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),-0.4832752093285956,-1.259649820748093,0.16985645933014354,0.6804872805824667,1.0,6/14,16.55%,THBS1;ECSCR;ITGA4;CD40;GPER1;ANO6
prerank,positive regulation of keratinocyte differentiation (GO:0045618),-0.5317599270817258,-1.259500873524378,0.22850678733031674,0.6785835786698373,1.0,3/10,9.89%,PRKCH;MED1;TRIM16
prerank,negative regulation of cell-substrate adhesion (GO:0010812),-0.3728133725630037,-1.259482216466011,0.13099041533546327,0.676318531783701,1.0,13/39,16.19%,EFNA5;ACER2;THBS1;NOTCH1;SPOCK1;ADAM15;FZD4;MYOC;NEXMIF;SPRY4;HOXA7;CORO1C;RASA1
prerank,positive regulation of lymphocyte migration (GO:2000403),-0.5009815734405743,-1.2592716718470678,0.17067833698030635,0.6746729460573341,1.0,4/12,26.01%,JAM2;APP;AIF1;DOCK8
prerank,cellular amino acid catabolic process (GO:0009063),0.4065405595775557,1.2592113482676641,0.13544303797468354,0.689316607724622,1.0,14/87,8.29%,GLUL;IVD;ABAT;HMGCLL1;BCKDHB;PHYKPL;TDO2;DDO;HOGA1;ASPA;HNMT;KYNU;DBT;ALDH7A1
prerank,proteolysis (GO:0006508),0.3676958886824293,1.2585461327437122,0.07105538140020899,0.6903466430367058,1.0,49/252,18.25%,CPXM2;ADAMTS12;TRABD2B;ADAM33;ADGRV1;CPQ;OGT;AEBP1;MMP2;MMP19;VASH2;ENDOU;CPXM1;CTSH;CTSF;MMEL1;ADAMTS9;SPRTN;PRSS48;CLPX;ECE2;EEF1AKMT4-ECE2;APEH;ATG4A;HTRA1;LONP2;CAPN7;CLPP;APH1B;CASP7;RSPRY1;CPA2;CLN3;CTSZ;CTSL;SENP6;HPN;THOP1;SUFU;DPP3;CUL7;LONP1;PSEN2;UBE3A;PSMB5;MMP14;ST14;YME1L1;CASP1
prerank,negative regulation of response to external stimulus (GO:0032102),0.39860296336106016,1.2576174299913634,0.13237063778580024,0.6922974854418054,1.0,25/105,15.04%,PTGIS;RORA;SERPINE1;EPHA4;APOE;APOA1;MVK;PTPRS;CDH5;CASK;MAPKBP1;SIRT2;NMI;NR1D1;DRD3;IRAK3;ITCH;FGF2;TNFAIP6;SELENOS;MUL1;PTEN;NR1H3;CERS2;TNFRSF1A
prerank,cellular response to metal ion (GO:0071248),-0.3002840320959862,-1.2575388605495237,0.062111801242236024,0.6776148236588388,1.0,22/123,4.62%,DLG2;SLC12A2;MEF2C;CPNE8;CLIC4;NLGN1;CDH1;ANK3;PLCG2;B2M;IQGAP1;CAMK2D;CPNE3;GLRA1;MT1B;MT1G;MT1E;MT1A;MT1H;MT1M;MT1X;MT1F
prerank,small GTPase mediated signal transduction (GO:0007264),0.400560397769309,1.2575004149211177,0.13818181818181818,0.6916501932316917,1.0,17/103,9.05%,IGF1;RIN2;KSR1;PLD1;CCNA2;ARHGAP18;TIAM2;RRAS2;RAPGEF2;MRAS;ARHGAP32;ARHGEF18;PLD2;RGL1;NTN1;RUNDC3A;ARFIP2
prerank,positive regulation of DNA metabolic process (GO:0051054),0.4221110385931748,1.256643138298704,0.15019762845849802,0.6932143124973318,1.0,14/61,14.37%,EYA2;EYA1;FGFR4;PDGFRB;SMOC2;PML;EGFR;FGF2;PPP1R10;RGCC;ERCC8;USP9X;NPAS2;RTEL1
prerank,regulation of microtubule-based process (GO:0032886),0.4733971973285416,1.2560653252786584,0.16400580551523947,0.694044841825073,1.0,5/36,7.72%,EPHA3;PHLDB2;MACF1;PRKAA2;MEMO1
prerank,cAMP-mediated signaling (GO:0019933),0.508260442672126,1.2553456864823862,0.18138801261829654,0.6953129745597646,1.0,6/24,6.49%,ADCY1;ADCY2;KSR1;RAPGEF2;PDE3A;PDE7B
prerank,regulation of gene expression (GO:0010468),0.3528613190568696,1.2534472756234416,0.01001001001001001,0.7002001240858181,1.0,175/903,15.63%,IGF1;NELL1;ROBO1;BMP6;CILP;NFIA;IGF2;RORA;SLC24A3;GJA1;RHOH;ROCK2;ANGPT1;PID1;SLC8A1;GDNF;ATXN1;GSN;SMAD3;ARNT2;RBMS3;AR;C1D;MITF;LYN;RUNX1;WWC2;AFF1;BMPR1A;OLFM1;NOS1AP;SON;NKX2-1;EPHX2;FGFR4;PRDM5;DTNBP1;WNT4;ASCL1;HNRNPLL;ZNF462;YAP1;NUP107;GAS6;APOE;TGFBR1;SMO;WNT6;NOTCH2;SLC2A10;TLE1;PDCD5;OGG1;CSF1;SLC22A2;ZC3H7B;MSC;MT3;IGF2BP2;ITGB8;NCOA2;SFRP1;CTSH;PRKAA2;DENND4A;MUSK;GNB3;SNRNP70;BCL6;CDH5;ENG;CUX2;ZFP36L1;TNRC6B;TCF7;ATOH8;APBB2;NAB2;PML;NR5A1;EMILIN1;IL12B;CEBPA;NFE2L2;CD28;WWTR1;SAP30;REXO4;AFDN;ZBTB38;EIF2AK3;MAP2K1;TLR6;OSR1;WTIP;RBPJ;NTRK3;AFF3;TULP3;TCF7L1;TNRC6A;EPHB2;CREBL2;BMP2;ZBTB4;SPRY2;CCN4;PICALM;NONO;SNX12;MZF1;SMAD1;PRKN;GTF2IRD1;MYADM;NSD1;PARP14;FGF2;ACTR8;ZSCAN21;PHF1;RNF6;TTBK1;NR1D2;RBL2;BRAF;TCEAL1;DDX3X;CEBPB;IFNK;RGCC;DNAJA4;REST;C1QTNF1;TERF2;LRP3;LARP1;HMGN5;INSR;ZNF513;ACVR1B;TRIP4;CCDC3;TMEM119;MYCN;EGF;TAF5L;GLMN;HDAC4;PDCL3;ETS1;ZNF148;SETDB1;ZNF219;HPN;YAF2;TADA3;CLK4;AFF4;BMP4;SFRP4;ERMAP;FUBP3;SUFU;MYCBP;FOXK2;METTL4;CLK3;SAP30L;GPBP1;FADS1;TGFBRAP1;PSPC1;SLC38A2;MYT1
prerank,regulation of systemic arterial blood pressure (GO:0003073),-0.47803879099014185,-1.2528710921009416,0.19444444444444445,0.6904391383239499,1.0,4/16,7.65%,PRCP;KLK2;DDAH1;GSK3A
prerank,regulation of response to interferon-gamma (GO:0060330),-0.47447032752029766,-1.2526273045963747,0.17857142857142858,0.6888215562767076,1.0,4/14,14.62%,PTPN2;HSP90AB1;JAK2;CDC37
prerank,fat cell differentiation (GO:0045444),0.4332849714295845,1.2525367844303075,0.16986301369863013,0.7020592670781578,1.0,8/57,8.89%,TCF7L2;PID1;OSBPL8;FAM120B;WNT5B;CEBPA;ALOXE3;CBY1
prerank,extracellular matrix assembly (GO:0085029),0.5091662883363524,1.2522445835710798,0.23214285714285715,0.7019826882056236,1.0,5/23,6.88%,MFAP4;FBLN5;GAS6;EMILIN1;LTBP3
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.4572944251479444,1.2520486956400265,0.1739766081871345,0.7015305147901326,1.0,13/39,13.63%,ERRFI1;AREG;TGFA;EPGN;CDC42;EPS15;EGFR;SPRY2;HBEGF;EPS15L1;PTPN3;EGF;MVP
prerank,aortic valve morphogenesis (GO:0003180),0.48209965200689875,1.2519078051778532,0.18838304552590268,0.7009477183389261,1.0,3/30,0.85%,ROBO1;ROCK2;ELN
prerank,response to UV-B (GO:0010224),0.5790828349141646,1.2517470249073224,0.22968197879858657,0.7004544336929837,1.0,3/12,9.86%,MFAP4;IL12B;STK11
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.555192574365961,1.2509690040927677,0.23140495867768596,0.7018642159055363,1.0,5/15,8.04%,UST;DCN;BGN;DSE;CSPG5
prerank,ventricular septum development (GO:0003281),0.4677128200653195,1.2506311043526672,0.1908831908831909,0.7019066951361645,1.0,6/37,4.67%,ROBO1;TGFBR3;SALL1;BMPR1A;TGFBR1;ACVR1
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.4446760228940745,1.2506103345486972,0.1755829903978052,0.7009535988476538,1.0,9/51,9.23%,GREM2;FBN1;BMPR1A;FSTL1;SMURF2;SKI;BMP2;LEMD3;SMAD1
prerank,T cell migration (GO:0072678),-0.4837989720283119,-1.250054375668484,0.20050125313283207,0.6947969914418602,1.0,4/13,14.25%,SLC12A2;S1PR1;MSN;GPR183
prerank,transcription by RNA polymerase II (GO:0006366),0.36331919219378284,1.2488806583447312,0.06962025316455696,0.7052586105265619,1.0,92/305,21.89%,POLR2D;RORA;CCN2;TBL1XR1;TEAD1;AR;SOX5;GLIS3;PRRX1;MAF;THRB;YAP1;MAML3;HSF2BP;RARB;NOTCH2;NFIX;PHAX;RARG;MLLT3;GTF2E1;GTF2H5;NR5A1;WWTR1;PMF1;SNAPC1;MED16;NR1D1;RBPJ;NCOR1;KAT2B;TRIP11;ZBTB1;CCNK;POLR2C;RPAP2;WDR33;NR1D2;MBD1;NCOR2;INTS4;NKX2-8;TTF2;NR4A1;MNAT1;PAF1;TEAD3;TAF5L;GTF2E2;CDK12;TAF9;NELFE;ELL2;ADRM1;NRBF2;SNAPC5;AFF4;SNAPC4;PCF11;NR1H3;RXRA;TFCP2;COPS2;TFDP1;SP1;GTF2I;TSC22D1;ELOF1;CCNT2;LSM10;CPSF2;CDC73;POLR2L;FIP1L1;TAF2;PAX1;MAML2;GTF2A1;ELP4;DEAF1;NFE2L3;LEO1;TAF8;MLLT1;IRF9;SCAF8;NOCT;ERCC3;MED23;CCNT1;PAPOLA;RPAP1
prerank,positive regulation of biosynthetic process (GO:0009891),0.44750461246634526,1.2482209986006985,0.18270571827057183,0.7062900870856929,1.0,13/40,16.32%,ZBTB20;RUNX1;WNT4;APOE;APOA1;TLR6;CREBL2;SLC5A3;RGCC;F2;MTPN;BMP4;AKT1
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.40749025487041535,1.2480780046408038,0.15809768637532134,0.7057150236724476,1.0,19/86,10.50%,BMP6;ZEB2;BMPR1A;CCN1;INHBE;TGFBR1;SLC2A10;TWSG1;SULF1;ACVR1;CDH5;ENG;CRB2;RBPJ;DAB2;RBPMS;BMP2;STK11;BMP15
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.467950675437604,1.2468353747451135,0.19271623672230653,0.7087021218156564,1.0,7/31,12.80%,PYCR1;STAR;HSD3B2;PYCR3;SRD5A1;LIAS;MOCS1
prerank,cellular response to insulin stimulus (GO:0032869),0.3860059899988547,1.2466545657818782,0.13953488372093023,0.7082583853202468,1.0,14/124,8.83%,ATP6V0A4;PDPK1;IGF2;ENPP1;TBC1D4;PIK3R1;INSIG2;PHIP;CPEB1;ZFP36L1;TRARG1;FOXC2;ZNF106;KAT2B
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.542900645694464,1.2466138131930602,0.2348111658456486,0.7063588761327223,1.0,4/16,6.31%,PHLDB2;ARHGAP6;DLC1;SRC
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.542900645694464,1.2466138131930602,0.2348111658456486,0.7063588761327223,1.0,4/16,6.31%,PHLDB2;ARHGAP6;DLC1;SRC
prerank,regulation of melanin biosynthetic process (GO:0048021),0.5924541943946373,1.2461700445568897,0.2423146473779385,0.7067330262273097,1.0,2/10,4.33%,ZEB2;RAPGEF2
prerank,protein destabilization (GO:0031648),0.4630486620638123,1.2459148801745545,0.2,0.7065521602257239,1.0,10/32,13.02%,GSN;CTSH;DERL1;FBXL3;NR1D1;RNF139;PRKN;BTRC;PEX2;MUL1
prerank,regulation of cellular response to heat (GO:1900034),-0.316944921932483,-1.2458058481384369,0.05429864253393665,0.7062866692914018,1.0,30/77,25.02%,CD34;NUP93;HSPA8;NUP35;CAMK2D;NUP153;NUP160;HSP90AB1;NUP54;BAG4;CAMK2G;SIRT1;MTOR;DNAJB6;MAPK3;SEC13;NUP155;EP300;HIKESHI;RANBP2;NUP88;HSPH1;NUP62;AKT1S1;GSK3B;NUP85;MAPK1;DNAJB1;CCAR2;NUP43
prerank,positive regulation of chemotaxis (GO:0050921),0.4480282382014281,1.245777563590337,0.1717877094972067,0.7059666301435759,1.0,9/43,10.16%,NRP1;IL6R;PDGFRB;SEMA5A;CCL19;SMOC2;NTRK3;DSCAM;FGF2
prerank,response to progesterone (GO:0032570),-0.4443017654810649,-1.245677211481101,0.1928020565552699,0.7043866756525896,1.0,4/18,3.96%,CAV1;THBS1;ABHD2;TGFB2
prerank,sensory perception of light stimulus (GO:0050953),0.40596737696402174,1.2456572754757973,0.13432835820895522,0.7053354115956731,1.0,8/87,4.52%,COL1A1;ADGRV1;COL11A1;EML2;DHRS3;TULP1;ZIC2;SLC24A1
prerank,acetylcholine receptor signaling pathway (GO:0095500),-0.4481519151316833,-1.2456306795660586,0.18156424581005587,0.7022154996270688,1.0,9/20,26.46%,CHRM3;AGRN;GNB1;CHRM2;RGS10;GNA11;CDK5R1;CHRM1;LY6G6D
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.602078596430071,1.2450633172965024,0.2577132486388385,0.7061544727485197,1.0,4/10,7.89%,HECW2;ATP1A2;NEDD4;OSR1
prerank,L-glutamate transmembrane transport (GO:0015813),0.6004086385307217,1.2444326196435975,0.24225865209471767,0.7070198643217341,1.0,1/10,0.18%,SLC1A3
prerank,positive regulation of interleukin-2 production (GO:0032743),-0.4100885491599003,-1.2439005752791548,0.15846994535519127,0.7052202768827788,1.0,15/25,27.09%,PDE4D;PDE4B;PLCG2;SPTBN1;RPS3;CD80;PTPRC;PNP;CD86;ANXA1;TRAF2;MAP3K7;MALT1;CARD11;TRAF6
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.5852152228111233,1.2435169836840647,0.23198594024604569,0.7089243315217301,1.0,3/11,11.59%,COLEC12;RFTN1;TNIP2
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.5268319544556768,-1.2431388289797587,0.2191142191142191,0.7054952185980109,1.0,3/10,10.26%,PODXL;PIEZO1;SKAP1
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.3535074330050544,1.242974746056872,0.029116465863453816,0.7096820898687628,1.0,109/572,15.02%,TCF7L2;BMP6;LDB2;IGF2;FHL2;TBL1XR1;TRPS1;ATXN1;SMAD3;AR;ZEB2;MITF;GLIS3;NKX6-1;NR2F2;DACT1;GLI2;RUNX1;WWC2;SALL1;KCNIP3;CBX7;GLI3;AEBP1;ARID5B;ZEB1;NKX2-1;FGFR2;THRB;PRDM5;SP100;MDFI;FOXP2;NFIB;ASCL1;YAP1;DNMT3A;JDP2;RARB;NFIX;MXI1;NEDD4;SMURF2;ZHX2;RARG;ETV6;TBX3;BCL6;CUX2;SKI;BCOR;CPEB3;MBD2;SAP30;SIRT2;DR1;NR1D1;OSR1;MTA2;RBPJ;DAB2;FOXC2;NCOR1;MTA3;BMP2;JAZF1;ZBTB4;BRMS1L;ZBTB1;MZF1;PRKN;GTF2IRD1;HEXIM2;GLIS2;NSD1;IFI27;ZKSCAN3;CXXC5;NR1D2;NCOR2;ZNF177;CEBPB;BHLHE41;SPDEF;HDAC8;REST;PER3;IMPACT;TCF25;PHF21A;PEX2;PAF1;USP9X;IGBP1;HDAC4;HIVEP1;FRK;ZNF148;ZNF219;TCERG1;HSBP1;GATA6;NR1H3;BMP4;SUDS3;UBE2D1;ZNF25;SUFU;RXRA
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.41920633662492635,-1.2428952980419918,0.14857142857142858,0.703983533979805,1.0,7/24,13.91%,PDE4D;CAMK2D;NOS1;AKAP6;CALM1;CALM3;CASQ2
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.43202352380741227,-1.24252268736703,0.18206521739130435,0.7029431851964936,1.0,6/21,15.93%,PRKCH;SLC39A10;RPS3;FOXP1;CD81;PTPRC
prerank,regulation of cell adhesion (GO:0030155),0.38116629067929814,1.2420979982971374,0.1395076201641266,0.7113694532304441,1.0,30/129,14.29%,PLXNA2;EPHA7;ROCK2;ANGPT1;LYN;RHOD;TPM1;EPHA4;EPHA8;PPP3CA;RIPOR2;SEMA5A;FBLN1;NUAK1;SRC;IL12B;DSCAM;EPHB2;RSU1;MYADM;ITGAV;MIA3;EPHB3;PLXNC1;SIPA1;DACT2;P4HB;PLXNA1;MDK;PLXNB2
prerank,regulation of chemotaxis (GO:0050920),0.4767141938708618,1.2416293363257824,0.21397379912663755,0.711791588824314,1.0,7/30,9.23%,MYCBP2;PDGFRA;EFNB2;PDGFRB;CCL19;ADGRA2;ZSWIM6
prerank,regulation of cholesterol esterification (GO:0010872),0.6029318352873327,1.240588691360074,0.24912891986062718,0.7140352693263964,1.0,3/10,6.90%,APOE;APOA1;AGTR1
prerank,regulation of membrane depolarization (GO:0003254),-0.44720209791237653,-1.2405760091029798,0.20884520884520885,0.7066328495806632,1.0,3/18,4.03%,FHL1;NEDD4L;CAMK2D
prerank,phospholipid catabolic process (GO:0009395),-0.4192111071579049,-1.240499905728167,0.16847826086956522,0.7046705746907422,1.0,9/24,26.89%,GPCPD1;ENPP2;PLA2G4C;SMPDL3A;PNPLA6;PLA2G4F;PLA2G4E;GDPD1;PLA2G4B
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.44480834716432816,1.240259184708889,0.18679775280898878,0.7141190972480678,1.0,12/45,11.25%,PDPK1;PIK3R1;AREG;TGFA;EPGN;PIGR;SRC;SLC30A10;AAMP;EGFR;BRAF;HBEGF
prerank,focal adhesion assembly (GO:0048041),0.5152271817118017,1.2402321018199407,0.21044546850998463,0.71321666511185,1.0,4/21,6.31%,ACTN2;DLC1;RHOD;SRC
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.5792476788138693,1.2401334973564198,0.24786324786324787,0.712547353874138,1.0,6/13,18.63%,APOE;DKK3;BMP2;REST;BMP5;ERLIN1
prerank,negative regulation of ossification (GO:0030279),0.5018574560533459,1.2401292077884416,0.21339563862928349,0.7115662787452355,1.0,6/23,9.40%,ENPP1;AHSG;SFRP1;BCOR;RBPJ;TRPM4
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.46876203115198595,1.2396806107774887,0.20114942528735633,0.712053741031213,1.0,4/35,3.78%,NRP1;PLXNA2;SEMA3D;SEMA5A
prerank,GPI anchor biosynthetic process (GO:0006506),-0.39247954638287497,-1.239534632840492,0.18413597733711048,0.7051603037380789,1.0,10/30,18.79%,DPM1;PIGP;PGAP2;PIGB;PIGL;DPM3;PIGU;DPM2;PIGO;PIGV
prerank,multivesicular body assembly (GO:0036258),-0.39410863656951234,-1.2392953234309565,0.18421052631578946,0.7036520917834816,1.0,16/30,31.51%,RAB11A;PDCD6IP;VPS37B;VPS37A;VPS28;VPS36;VPS4A;CHMP2B;VPS37C;SNF8;CHMP4B;CHMP4A;HGS;MVB12A;CHMP4C;STAM2
prerank,response to hexose (GO:0009746),0.5000528148031261,1.2385745431403965,0.22585669781931464,0.7144544363207171,1.0,7/25,16.07%,TCF7L2;SLC30A8;NEUROD1;EIF2B4;SELENOS;EIF2B3;MAFA
prerank,carbohydrate biosynthetic process (GO:0016051),0.5143733600419369,1.2384036841516777,0.24584717607973422,0.7139953404006646,1.0,5/21,10.18%,ST6GALNAC5;B3GALT1;ST3GAL3;B4GALT1;ST6GALNAC6
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.5706650727049791,1.2381588484629238,0.2462809917355372,0.7138156909352071,1.0,2/12,2.59%,CCDC68;NINL
prerank,intestinal lipid absorption (GO:0098856),0.5782518789242501,1.2381571226171404,0.23943661971830985,0.7128326384155684,1.0,2/11,5.80%,LDLR;LIMA1
prerank,regulation of cell communication by electrical coupling (GO:0010649),-0.4906789573473224,-1.2379195926760223,0.21658986175115208,0.7058171849640239,1.0,7/13,13.91%,PDE4D;CAV1;ANK3;CAMK2D;CALM1;CALM3;CASQ2
prerank,ncRNA transcription (GO:0098781),0.5470826427976596,1.2375336918944742,0.23725834797891038,0.7137605048281065,1.0,5/13,9.76%,POLR1G;BRF1;GTF3C1;USPL1;RPAP2
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.5309164018380872,1.2375188828914876,0.22022838499184338,0.712826414198155,1.0,5/17,11.33%,SLC8A1;ATP1A2;CACNA1C;TRPM4;CACNA1G
prerank,RNA metabolic process (GO:0016070),0.3856339338435842,1.237247747179132,0.1351039260969977,0.7126130419846288,1.0,41/127,22.41%,POLR2D;CELF2;RBMS1;ATXN1;RBFOX2;SND1;DDX17;RBMS2;HNRNPR;RBPMS;METTL14;HNRNPA1;POLR2C;RNASEL;PARN;DDX3X;WTAP;EXOSC7;MTREX;RBM39;RBM5;RBM6;RNASEH2C;LSM8;SYNCRIP;HNRNPC;PAPOLG;ALKBH1;METTL3;POLR2L;DICER1;FTO;HNRNPU;AGO4;HNRNPH1;DDX24;PAPOLA;RBM4;SIDT2;DROSHA;NCBP2
prerank,regulation of Rho protein signal transduction (GO:0035023),0.41579097788637004,1.2372143707430288,0.15723270440251572,0.7117249622806738,1.0,13/72,8.59%,NRP1;ROBO1;ABCA1;DLC1;KANK1;ITGA3;RIPOR2;APOE;APOA1;ARHGEF18;LPAR1;ARHGAP35;ARRB1
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.5813741695337844,1.2364792369949813,0.25136612021857924,0.7120348814841608,1.0,4/10,15.04%,SMPD2;SPHK2;NSMAF;TNFRSF1A
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.5813741695337844,1.2364792369949813,0.25136612021857924,0.7120348814841608,1.0,4/10,15.04%,SMPD2;SPHK2;NSMAF;TNFRSF1A
prerank,cholesterol efflux (GO:0033344),0.521524153134404,1.2361026320218116,0.2336448598130841,0.7121822559096351,1.0,3/20,4.30%,ABCA1;APOE;APOA1
prerank,purine nucleotide metabolic process (GO:0006163),-0.407630220264703,-1.2356893649764202,0.19020172910662825,0.7106651602252492,1.0,9/24,19.04%,NT5E;NT5C2;PRPS2;NT5C1A;GDA;NT5C;PNP;GPX1;FHIT
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.4955255830078119,-1.2355590304783681,0.21105527638190955,0.7087835743774471,1.0,5/12,14.09%,CAV1;CTNNA3;JUP;RYR2;DSG2
prerank,cellular response to hexose stimulus (GO:0071331),0.49363623050010996,1.2353322134033156,0.2171875,0.7136335640526623,1.0,3/23,5.19%,ZBTB20;GAS6;PRKAA2
prerank,negative regulation of hemostasis (GO:1900047),0.5783276664425065,1.235120225947524,0.22641509433962265,0.7133376973207864,1.0,4/12,5.43%,SERPINE1;APOE;VTN;TFPI
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.4946001883310069,1.234963552873104,0.22610015174506828,0.7128751989466211,1.0,2/24,3.58%,EPHA7;NUPR1
prerank,transport along microtubule (GO:0010970),0.5432091502174663,1.2344352373705805,0.25084175084175087,0.7136024085182846,1.0,5/13,17.58%,ARHGAP21;CDC42;APBA1;DYNC1I2;COPG1
prerank,regulation of cellular pH (GO:0030641),-0.40017406356298196,-1.2343371616483545,0.1781609195402299,0.7104960560138208,1.0,6/29,9.96%,SLC4A10;SLC9A2;SLC9A6;SLC4A8;SLC9A7;SLC26A6
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.40603894254219947,1.233620244256562,0.17374517374517376,0.7151680756249763,1.0,15/80,12.16%,EPHA7;UACA;DAPK1;SH3RF1;GAS6;PDCD5;MT3;USP47;SRC;DPEP1;BCAP31;CARD9;DDX3X;REST;YWHAE
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.5665460653805903,1.2335283598389999,0.23978685612788633,0.7144748230276878,1.0,3/12,10.90%,AKR1B1;STAR;TSPO
prerank,engulfment of apoptotic cell (GO:0043652),0.5482384596500522,1.232684994424872,0.26166666666666666,0.7161644206881073,1.0,3/15,6.75%,RHOH;RHOBTB1;RHOBTB2
prerank,acyl-CoA biosynthetic process (GO:0071616),-0.4554332384553774,-1.232653801927793,0.1984732824427481,0.7134404577293286,1.0,9/16,29.90%,PPT1;ACSS1;HSD17B8;DIP2A;PPT2;ACACA;SCD5;CBR4;MLYCD
prerank,smoothened signaling pathway (GO:0007224),0.4742023688914902,1.2326213851878947,0.20512820512820512,0.7153809861724433,1.0,8/32,12.48%,GLI2;GLI3;SMO;B9D1;IFT27;EVC2;PTCH2;GLI1
prerank,phasic smooth muscle contraction (GO:0014821),0.5874487347424676,1.232544079078601,0.24701873935264054,0.7146326160193367,1.0,1/10,1.17%,GDNF
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.5853665012870047,1.2324631875517273,0.24915824915824916,0.7129626253021897,1.0,2/12,7.79%,FHL2;RCAN1
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.5853665012870047,1.2324631875517273,0.24915824915824916,0.7129626253021897,1.0,2/12,7.79%,FHL2;RCAN1
prerank,positive regulation of vasculature development (GO:1904018),0.3946708042994417,1.2323984837387052,0.16480793060718713,0.7122096126765023,1.0,13/94,5.68%,PDPK1;PTGIS;SASH1;SERPINE1;RUNX1;VASH2;SEMA5A;STIM1;ITGB8;CTSH;SMOC2;CYP1B1;CDH5
prerank,cellular response to lipid (GO:0071396),0.369202429776866,1.231892102559222,0.1277533039647577,0.7128046698124186,1.0,20/191,7.78%,EPHA3;RORA;ADCY1;ROCK2;PID1;ADCY2;AR;SERPINE1;LYN;ATP1A2;ADCY5;WNT8B;WNT6;AXL;SFRP1;PTK7;TFPI;WNT5B;SPHK2;NR1D1
prerank,T cell mediated immunity (GO:0002456),-0.4941546923137935,-1.231690067945963,0.21963824289405684,0.7141134709430933,1.0,3/13,6.57%,CADM1;EMP2;CD55
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.35319645550350365,1.231502543405008,0.0539714867617108,0.7130409366868398,1.0,102/476,16.77%,IGF1;TCF4;COL1A1;RORA;TBL1XR1;TEAD1;SMAD3;ARNT2;AR;MITF;IL31RA;NR2F2;GLI2;RUNX1;SALL1;ZIC1;GLI3;NKX2-1;FZD2;SP100;WNT4;NFIB;YAP1;APOE;RUNX2;TGFBR1;LBH;RLF;IRF1;ZIC2;MT3;ACVR1;NEUROD1;CREB3L2;FZD1;PHIP;MLLT3;SFRP1;ARID1B;ATXN7L3;ATOH8;SMARCA1;PML;MED14;ING5;RNF10;SMARCC2;MAP2K1;MED16;NR1D1;RAI1;FOXC2;EGFR;ARHGEF11;CREBL2;BMP2;ZMIZ1;PICALM;BICRAL;GLIS2;NSD1;ZKSCAN3;FGF2;TFAM;RNF6;NR1D2;CEBPB;NFE2;REST;NIBAN2;GLI1;HMGN5;BTRC;ZNF318;TRIP4;MYCN;NPAS2;EGF;KMT2E;KMT2A;HDAC4;ETS1;YAF2;TADA3;GATA6;NR1H3;PHF8;BMP4;FUBP3;RXRA;FOXK2;CDKN1C;DYRK1A;DYRK1B;AKT1;CREB5;ZNF423;PCBD2;RHOG;ATF5;SHH;SP1
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.5257234079750286,1.2314582389542477,0.22547332185886404,0.7122227810229025,1.0,9/18,24.16%,PIK3R1;RNF185;BCL2L11;TMEM259;RNFT1;DDIT3;BAG6;ATXN3;PMAIP1
prerank,positive regulation of vascular permeability (GO:0043117),0.5597022743147837,1.2313968612273944,0.23519163763066203,0.7114353745039946,1.0,4/12,7.30%,BMP6;ANGPT1;PDE3A;TJP3
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),-0.45162219690300454,-1.231217081851306,0.1806282722513089,0.7134612694453223,1.0,6/18,8.29%,RAP1A;NLGN1;RIMS1;RIMS2;RAP1B;SLC4A8
prerank,positive regulation of stem cell differentiation (GO:2000738),0.5320231839552507,1.2312123622081765,0.22758620689655173,0.7110506395401059,1.0,3/16,6.88%,SOX5;SP7;LTBP3
prerank,positive regulation of monooxygenase activity (GO:0032770),0.4949328067990194,1.2311598913451887,0.22570532915360503,0.7102669103364868,1.0,4/26,3.68%,GDNF;NOS1AP;APOE;NPR3
prerank,positive regulation of RNA metabolic process (GO:0051254),0.4445606820110012,1.2307810228318572,0.18634423897581792,0.7105076990170334,1.0,15/45,15.60%,PIK3R1;HNRNPLL;BUD23;MAP2K1;DXO;EGFR;RBM22;DIMT1;WDR43;NMD3;MYCN;TRMT112;BMP4;DYRK1A;SLC38A2
prerank,blood circulation (GO:0008015),0.4361217893249854,1.230481974731118,0.20388349514563106,0.7104138034742216,1.0,7/49,6.90%,COL4A3;ROCK2;ELN;SERPING1;MEOX2;BDKRB2;AGTR1
prerank,second-messenger-mediated signaling (GO:0019932),0.4028855347593855,1.2301658687223358,0.16769420468557336,0.7103647278088403,1.0,14/82,7.79%,RCAN2;PDPK1;XCR1;APOE;MCTP2;INPP5A;MCU;NEUROD1;ACKR2;CCR9;LRRK2;AGTR1;EIF2AK3;RCAN1
prerank,regulation of potassium ion transport (GO:0043266),-0.38806020306437083,-1.2299024849738642,0.14596273291925466,0.7155846051853023,1.0,8/31,6.37%,DPP10;FHL1;KCNIP4;PTK2B;ANK3;KCNAB1;KCNN2;NOS1
prerank,regulation of mesenchymal cell proliferation (GO:0010464),-0.5110167321201513,-1.229774895039725,0.22195704057279236,0.7138023599595011,1.0,5/11,10.23%,TBX1;LRP5;CTNNBIP1;TGFBR2;PDGFA
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.43465598975480324,1.2297380473210724,0.20249653259361997,0.7107406523793008,1.0,5/47,6.83%,PTGIS;ROCK2;WNT4;RAPGEF2;SIK1
prerank,positive regulation of lipid metabolic process (GO:0045834),0.5117055802612618,1.2295679534222002,0.23197492163009403,0.7103370119658708,1.0,5/22,11.76%,ZBTB20;APOE;APOA1;CREBL2;F2
prerank,regulation of endocytic recycling (GO:2001135),0.5796615310933002,1.229223777395764,0.25906735751295334,0.7103635655476195,1.0,2/11,3.62%,ACTN2;ATP9A
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),-0.4407830194927541,-1.2290878427314202,0.20810810810810812,0.7137141542862194,1.0,7/19,21.81%,HIPK2;SNW1;DDIT4;SIRT1;DYRK2;EP300;MSH2
prerank,fibrinolysis (GO:0042730),0.5474524225087299,1.228653726916388,0.2637931034482759,0.7111719224229188,1.0,2/13,11.76%,SERPINE1;F2
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.42440167551897234,1.228532534295743,0.188,0.7106190502770757,1.0,9/59,8.46%,TCF7L2;CDK8;MITF;RUNX2;TNRC6B;MED14;MED8;MED16;TNRC6A
prerank,leukocyte tethering or rolling (GO:0050901),-0.4598768705533031,-1.2280180135409327,0.21158690176322417,0.7149552759993149,1.0,7/17,24.57%,JAM2;ITGA4;CX3CR1;ROCK1;VCAM1;SELP;ITGB7
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.3837678235044395,-1.2279559080101403,0.19745222929936307,0.7129647661491207,1.0,10/32,21.81%,PPP1R13B;HIPK2;SNW1;DDIT4;SIRT1;DYRK2;EP300;FHIT;DDX5;MSH2
prerank,ribonucleoprotein complex biogenesis (GO:0022613),-0.33990519746892284,-1.2278435227250122,0.14666666666666667,0.7110649702555579,1.0,23/57,21.54%,RPS24;RPS19;RPL7;RIOK1;RPL35A;RPL38;RPS15;RPS7;PAK1IP1;RPL11;METTL17;RPL26;MALSU1;NVL;RPL14;RPL5;RPS6;RRP36;NPM1;NOP16;URB2;RRS1;RPF2
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.4693216317319583,1.227819659585455,0.19696969696969696,0.7119421211417611,1.0,3/32,5.72%,PDPK1;CEMIP;GSTM2
prerank,histone H3-K36 demethylation (GO:0070544),0.5859862815331783,1.2264860558804473,0.27191413237924866,0.7150239762983092,1.0,5/10,21.12%,KDM7A;PHF8;RIOX1;KDM4A;KDM4C
prerank,positive regulation of stem cell proliferation (GO:2000648),0.5257187988336278,1.2264474155533605,0.233387358184765,0.7142036158419637,1.0,2/17,6.88%,GJA1;LTBP3
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.5141554820100814,1.226399442852673,0.23462783171521034,0.7134134431624717,1.0,6/20,15.26%,TGFBR1;EPAS1;ZMIZ1;PRKN;ITCH;DCUN1D2
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.4982016892094292,-1.2260393847792965,0.2357142857142857,0.7145780529881063,1.0,3/13,6.96%,SLC4A10;GRIK2;SYP
prerank,regulation of dendritic spine morphogenesis (GO:0061001),-0.38178906687023667,-1.2257124896170817,0.18095238095238095,0.7134250952290596,1.0,13/31,12.38%,SHANK3;PPFIA2;NLGN1;ARHGAP44;SIPA1L1;SRCIN1;CDK5;NGEF;TANC2;LRP8;ZDHHC15;KIF1A;ABI3
prerank,lipoprotein transport (GO:0042953),0.5836440707459166,1.2256535714273358,0.27171903881700554,0.7146379075662117,1.0,2/10,9.69%,LRP1;MIA3
prerank,regulation of transposition (GO:0010528),0.5454940860303444,1.2249756705923425,0.25287356321839083,0.7157393577868796,1.0,5/13,17.50%,UBR2;PIWIL4;SPOCD1;MYBL1;DDX4
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.4201428871764269,1.2247412704322838,0.20077720207253885,0.7155112542627072,1.0,25/62,23.90%,POLR2D;MLLT3;GTF2H5;CCNK;POLR2C;MNAT1;PAF1;CDK12;NELFE;ADRM1;AFF4;ELOF1;CCNT2;CDC73;POLR2L;ELP4;LEO1;MLLT1;ERCC3;CCNT1;NCBP2;CDK7;ERCC2;ELOC;CDK13
prerank,regulation of lipid metabolic process (GO:0019216),0.40195396944173417,1.2244457074491568,0.17245657568238212,0.7155174025921565,1.0,27/88,20.05%,RORA;TBL1XR1;FGFR4;PRKAG2;C1QTNF2;CHD9;NCOA2;MVK;GNB3;SREBF1;NR1D1;NCOR1;IDI1;NR1D2;NCOR2;CCDC3;HELZ2;FASN;CERS2;RXRA;HMGCS1;SP1;CARM1;NCOA6;SCD;ABCA7;PSAP
prerank,RNA modification (GO:0009451),0.4348412527830955,1.2240010574590496,0.1953727506426735,0.715858972736932,1.0,17/54,19.90%,PUS3;ADAT2;NSUN2;FTSJ3;PARN;BCDIN3D;TRMT9B;URM1;NSUN5;NSUN4;ELP5;DTWD1;ALKBH1;METTL3;ANKRD16;TRUB1;METTL1
prerank,positive regulation of calcium ion import (GO:0090280),0.5568052724525996,1.2239084094275403,0.2638146167557932,0.7152304025266212,1.0,2/12,7.20%,PDGFRB;SPHK2
prerank,regulation of monooxygenase activity (GO:0032768),-0.41086029788297584,-1.2236712868447746,0.1881720430107527,0.7179280241220624,1.0,9/23,10.72%,CAV1;NOSTRIN;NOS3;DDAH1;NOSIP;DDAH2;CYGB;CALM1;SPR
prerank,triglyceride homeostasis (GO:0070328),0.48852086699376873,1.2224956615992881,0.23974763406940064,0.7185282967854839,1.0,3/26,4.30%,RORA;APOE;APOA1
prerank,protein mono-ADP-ribosylation (GO:0140289),0.5801896294287555,1.22224639936308,0.23986486486486486,0.7183350224411219,1.0,7/11,29.33%,PARP11;PARP16;PARP14;PARP12;PARP10;PARP9;PARP6
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.4420705171579922,1.221770321986835,0.21052631578947367,0.7188505201109971,1.0,4/38,2.69%,PTGIS;ROCK2;SMAD3;NOS1AP
prerank,negative regulation of smooth muscle cell migration (GO:0014912),0.5470130695340019,1.221524348347491,0.26262626262626265,0.7186494260887796,1.0,5/14,5.13%,LRP1;SERPINE1;TPM1;BMPR1A;IGFBP5
prerank,microtubule-based transport (GO:0099111),0.5613544403849837,1.221014417807432,0.2429078014184397,0.7192828879254888,1.0,6/13,19.55%,CCDC40;DYNC1I2;CABYR;SPEF2;HTT;ROPN1L
prerank,regulation of leukocyte chemotaxis (GO:0002688),0.5139494374703901,1.220850145198842,0.24165341812400637,0.7188754875203999,1.0,3/18,2.21%,CAMK1D;LYN;IL6R
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.5575769731019969,1.220764886563395,0.2504317789291883,0.7181804800612036,1.0,4/12,6.85%,DOCK4;TPM1;IGFBP5;DOCK5
prerank,negative regulation of cell division (GO:0051782),0.582361344882475,1.2203987855339622,0.25383304940374785,0.7183560692171156,1.0,1/11,1.01%,TXNIP
prerank,relaxation of muscle (GO:0090075),0.5539991976448564,1.2201738615757411,0.26559714795008915,0.7180810077924983,1.0,4/13,5.72%,SLC8A1;GSN;ATP1A2;GSTM2
prerank,neuron development (GO:0048666),-0.29264479927482634,-1.2198972101827124,0.08130081300813008,0.7277967048491675,1.0,33/141,9.28%,FRY;CNTNAP2;MEF2C;GPM6A;MAP2;PBX3;NLGN1;PPP1R9A;TENM2;ETV1;TENM3;GPM6B;PPT1;TENM4;STX3;TGFB2;SH3GL2;MYT1L;CNTN4;B4GALT5;MYOC;OPHN1;VSX1;CDK5;EPHA5;TMEM108;RP1;RAB11A;RASGRF1;ULK1;ALK;ARL3;BTG2
prerank,regulation of cation transmembrane transport (GO:1904062),-0.3977136444122121,-1.2195574508185363,0.1697530864197531,0.7266436816163562,1.0,8/29,11.81%,DPP10;KCNIP4;KCNAB1;KCNN2;FGF12;ATP2B4;HOMER1;DPP6
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.33881238839273514,-1.2189513097532936,0.14225941422594143,0.7262820598454764,1.0,21/57,22.69%,DLG2;MEF2C;GRIA4;NLGN1;PTK2B;GRIN2A;DLGAP2;LRRC7;GRIN2B;GRIA2;SHANK1;LYNX1;APP;GSG1L;CACNG3;CACNG4;GRIN1;SHISA9;BEGAIN;MINK1;RELN
prerank,positive regulation of cellular process (GO:0048522),0.34663030860201427,1.2188315464873924,0.05443548387096774,0.7211199598817218,1.0,70/565,8.16%,IGF1;BMP6;IGF2;ESM1;CCN2;CAMK1D;GDNF;COLEC12;PDGFD;AREG;AR;LRP1;AHSG;TGFA;IL31RA;LYN;BCL2;GRK5;RHOD;TPM1;FGFR1;EPHA4;IL6R;IL34;OSMR;TULP1;PPP3CA;EPGN;FGFR2;FGFR4;GAS6;PDGFRA;EFNB2;PDGFRB;TGFBR1;NUPR1;CSF1;APOA1;MT3;NEUROD4;NTF3;NEUROD1;HTR1A;AXIN2;PHIP;SFRP1;CTSH;SLC30A2;PRKAA2;PDPN;CXCL16;TBX3;VIP;DYNC1H1;USP47;ZFP36L1;CDC42;INO80;SMC5;IL12B;TSLP;WWTR1;RNF10;RAB25;IL13RA1;SIRT2;IL15RA;PPP1R13L;TET1;NTRK3
prerank,lipoprotein localization (GO:0044872),0.5708055304614822,1.218681046677482,0.2730627306273063,0.7206788783086627,1.0,2/11,9.69%,LRP1;MIA3
prerank,in utero embryonic development (GO:0001701),0.4898680948945791,1.2185100240321778,0.23042168674698796,0.7202363247629756,1.0,5/25,5.01%,IGF2;ARNT2;FGFR2;TGFBR1;LIG4
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.3431045625510947,1.2185081116250716,0.018018018018018018,0.719313175098599,1.0,235/1082,18.29%,IGF1;TCF7L2;TCF4;BMP6;LDB2;AUTS2;NFIA;IGF2;COL1A1;RORA;TBL1XR1;PID1;TEAD1;CDK8;GDNF;PIK3R1;PBX1;SMAD3;ARNT2;AR;ZEB2;MITF;DCN;GLIS3;NKX6-1;IL31RA;SERPINE1;NR2F2;GLI2;RUNX1;SALL1;ZIC1;SP7;OGT;BMPR1A;GLI3;PPP3CA;CCN1;NKX2-1;FZD2;FGFR2;THRB;SP100;WNT4;NFIB;ASCL1;SSBP3;ZNF462;YAP1;MAML3;APOE;RUNX2;TGFBR1;MLXIP;RARB;LBH;NFIX;MEOX2;CRTC3;RLF;IRF1;ZIC2;MT3;RFX5;ACVR1;NEUROD1;CREB3L2;NCOA2;FZD1;KLF15;PHIP;RARG;MLLT3;SFRP1;ARID1B;BRD8;ATXN7L3;TBX3;EPAS1;HLF;ENG;SKI;BCL9;ATOH8;INO80;SMARCA1;PML;MED14;NR5A1;CEBPA;ING5;ATAD2B;NFE2L2;WWTR1;RNF10;SREBF1;SIRT2;DDX17;DR1;ZBTB38;EIF2AK3;SMARCC2;MAP2K1;MED16;NR1D1;RAI1;OSR1;TET1;RBPJ;DAB2;FOXC2;ARRB1;EGFR;RGMA;ARHGEF11;CREBL2;BMP2;ZMIZ1;KAT2B;STAT5B;PICALM;BICRAL;MZF1;CCNK;SMAD1;PRKN;GLIS2;CSRP3;NSD1;ARNT;CREB3L4;CREB3;RNASEL;FOXA1;ZKSCAN3;FGF2;ZSCAN21;TFAM;RNF6;NR1D2;DDX3X;CEBPB;NFE2;RGCC;TNIP2;NKX2-8;TBK1;HDAC8;REST;NR4A1;RHOQ;WDR43;NIBAN2;GLI1;HMGN5;STAT6;ZNF513;BTRC;RIPK2;ZNF318;TRIP4;MYCN;SMARCD2;NPAS2;EGF;KMT2E;HELZ2;NCOA3;KMT2A;HDAC4;TAF9;MED19;ARF4;HIVEP1;ETS1;FSTL3;TCF12;YAF2;TCERG1;TADA3;AKAP8L;GATA6;NR1H3;PHF8;BMP4;FUBP3;HOXC4;RXRA;TNFRSF1A;FOXK2;SS18;CDKN1C;DYRK1A;SMARCB1;BMP5;CAMTA2;MTF1;TFCP2;DYRK1B;PIK3R2;POGZ;ZBTB17;NCOA7;AKT1;CREB5;PLAG1;ZNF423;PCBD2;RHOG;ATF5;SHH;TFDP1;SP1;LIF;MYBL1;PRPF6;EFCAB7;IRF2;ABHD14B;FOXJ3;ATM;CX3CL1;TNIP1;ELOF1;ELF1;CCNT2;KAT5;FOXO3;IL18;AHI1;NFIL3;RFXANK;SOX11;WAC;TRIM45
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.5354353079232983,1.2184541218712814,0.24390243902439024,0.7185302285803884,1.0,5/14,17.96%,IL17D;IL12B;CARD9;IL23A;IL18
prerank,positive regulation of vasoconstriction (GO:0045907),0.5451473040103487,1.2183256047523179,0.26588628762541805,0.7179674619426768,1.0,2/13,9.40%,ADRA1B;TRPM4
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),-0.3796555509223474,-1.217615769749355,0.17404129793510326,0.7285873835943337,1.0,10/33,11.49%,MEF2C;THBS1;NOTCH1;ACVRL1;MECP2;ATP2B4;JUP;VASH1;KLF4;TGFB1
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.5005317223240031,1.2169015434965404,0.24879614767255218,0.7213749013569887,1.0,3/19,4.18%,CAMK1D;IL34;CSF1
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.36037938400214004,1.2168478323516194,0.12784398699891658,0.7206234097541646,1.0,38/208,15.04%,PDPK1;WLS;RORA;GJA1;RHOH;PELI2;OPTN;CFLAR;CCL19;TLE1;EDAR;ROR1;RNF31;MAPKBP1;SPHK2;LPAR1;TLR6;NR1D1;PRKN;GPR89A;LTBR;SLC20A1;TMED4;CXXC5;CARD9;NEK6;UFL1;TNIP2;IKBKE;TBK1;RIPK2;USP10;MUL1;RIOK3;FLNA;AKAP13;PLK2;TNFRSF1A
prerank,steroid catabolic process (GO:0006706),-0.5215640111484456,-1.2165226704345902,0.23927765237020315,0.730034399340099,1.0,5/10,28.47%,YWHAH;SPP1;HSD11B1;HSD17B11;HSD17B14
prerank,DNA replication-independent nucleosome organization (GO:0034724),-0.5050626019633955,-1.2159559988324533,0.24700239808153476,0.7296687654544838,1.0,7/11,27.58%,HIRA;H3-3A;CABIN1;NASP;ASF1A;HAT1;ASF1B
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.4692055182680643,1.2153476274506725,0.21720116618075802,0.7242904241244802,1.0,5/29,7.55%,GDNF;TENT5A;AXIN2;VIP;TENT5D
prerank,regulation of postsynapse organization (GO:0099175),-0.39429982380355066,-1.2152367105985702,0.20795107033639143,0.7298258735044131,1.0,13/28,12.38%,SHANK3;PPFIA2;ARHGAP44;IL1RAPL1;SIPA1L1;SRCIN1;CDK5;TANC2;ABHD17B;ZDHHC15;KIF1A;HOMER1;ABI3
prerank,response to fatty acid (GO:0070542),0.5076380191779942,1.2151998348263275,0.24870466321243523,0.7238420473099768,1.0,1/17,0.91%,PID1
prerank,regulation of lymphocyte migration (GO:2000401),-0.5274435365342838,-1.2149269975116346,0.24776785714285715,0.7286612469718156,1.0,3/10,10.46%,JAM2;STK10;MSN
prerank,pseudouridine synthesis (GO:0001522),0.5451045476689077,1.2139477540903136,0.27330173775671407,0.7267278467567199,1.0,5/13,18.89%,PUS3;RPUSD2;TRUB2;PUSL1;TRUB1
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),0.5542028760976482,1.2137334983756587,0.2578947368421053,0.7264437561637539,1.0,1/13,0.46%,IGF2
prerank,protein neddylation (GO:0045116),-0.47910660181465414,-1.2131406219519538,0.25970873786407767,0.7321779589641882,1.0,3/13,10.96%,RBX1;UBA3;DCUN1D4
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.49699061532415983,1.21308861045815,0.2392638036809816,0.7274732233585527,1.0,5/21,14.96%,SAMD4A;TUT7;PARN;TUT4;CNOT3
prerank,negative regulation of actin filament polymerization (GO:0030837),-0.4122249867517115,-1.2129838916241553,0.21921921921921922,0.73051185779598,1.0,6/22,6.51%,SLIT2;TMSB4X;KANK3;CYRIB;TMSB10;HIP1R
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),0.5661166980201486,1.212079214544318,0.2578947368421053,0.7295747227394155,1.0,1/12,0.46%,IGF2
prerank,regulation of ossification (GO:0030278),0.45167886091903214,1.2120480878197415,0.2482468443197756,0.7287411919738007,1.0,8/36,8.75%,DDR2;ENPP1;AHSG;ANKH;ACVR1;SFRP1;RBPJ;BMP2
prerank,glucan catabolic process (GO:0009251),0.5285419033243033,1.2116693148512347,0.2669902912621359,0.7288893769891112,1.0,7/15,16.45%,PHKB;GAA;AGL;PYGM;PYGB;PHKA1;PHKA2
prerank,cellular response to cytokine stimulus (GO:0071345),0.3426628578731891,1.211250179537455,0.07921810699588477,0.7291793322903873,1.0,48/416,8.86%,GREM2;ADAMTS12;PTGIS;COL1A2;RORA;PID1;GHR;PIK3R1;DAPK1;SMAD3;PTPN13;IL31RA;BCL2;IL6R;LEPR;IL34;OSMR;ZEB1;MMP2;PTPN20;KIT;RIPOR2;GAS6;NUMBL;DPYSL3;CCL19;IRAK2;CSF1;IRF1;AXL;SFRP1;BCL6;ZFP36L1;TCF7;CCL4;SDC1;IL12B;BATF;CEBPA;NFE2L2;IL13RA1;NR1D1;OXSR1;PTPN9;IRAK3;BCL2L11;STAT5B;CNTFR
prerank,regulation of T cell differentiation (GO:0045580),0.4578490629989934,1.2109748591097187,0.22448979591836735,0.7291104442412546,1.0,5/33,9.16%,RHOH;RUNX1;TCF7;ZMIZ1;ZBTB1
prerank,post-translational protein modification (GO:0043687),0.3504859537506312,1.2109430360884101,0.08472803347280335,0.7282804260338007,1.0,83/332,20.64%,LTBP1;CP;FBN1;SPSB1;MATN3;AHSG;PRKCSH;IGFBP4;OBSL1;CCN1;LAMC1;GAS6;APOE;FSTL1;FBXL19;CSF1;APOA1;APLP2;PSME4;SERPIND1;IGFBP5;EPAS1;CST3;TNC;CUL4B;STT3A;CUL5;FBXL3;RCN1;DNAJC3;COMMD1;FN3KRP;MIA3;RBBP7;ASB12;BMP15;IGFBP3;PDIA6;FBXO9;FBXO11;KBTBD7;DCAF8;ERCC8;FBXO4;FBXL12;FEM1C;ITIH2;GPS1;BTRC;COPS3;P4HB;FSTL3;ASB6;WDR5;BMP4;ASB1;SENP8;MELTF;CUL7;KTN1;COPS2;HRC;KCTD7;PSMB5;LAMB2;PSMC2;CALU;CKAP4;FN3K;PSMD1;RABGGTA;ASB13;PSMD4;MXRA8;PRSS23;PSME3;FBXL18;FEM1B;HIF3A;DCAF11;DCAF6;RBBP5;PSMA3
prerank,metal ion export (GO:0070839),-0.3772343975799576,-1.2108649735998234,0.17891373801916932,0.7350078247324776,1.0,9/31,11.88%,KCNK5;ATP1A1;KCND3;KCNQ1;ATP1B1;ATP2B4;SLC40A1;ATP7A;ATP1A3
prerank,smooth muscle tissue development (GO:0048745),0.5879697655415306,1.2108306895363037,0.27886323268206037,0.7277140266410961,1.0,6/10,18.98%,MYLK;SMO;ENG;BMP4;SHH;EFEMP2
prerank,DNA biosynthetic process (GO:0071897),-0.45398696879477546,-1.2104696706673228,0.23425692695214106,0.7340865477028662,1.0,9/16,31.18%,PPIA;POLH;SIRT1;TYMS;POLD4;WRNIP1;POLA1;POLD2;TERT
prerank,regulation of dopamine secretion (GO:0014059),0.4870802775170918,1.2094743278186162,0.25413533834586466,0.7309179643708591,1.0,7/25,13.46%,GDNF;DTNBP1;SYT9;DRD3;PRKN;SYT11;SYT12
prerank,modulation by symbiont of host process (GO:0044003),-0.5148815445774708,-1.2092916569936698,0.24178403755868544,0.7354544673033107,1.0,6/10,33.34%,B2M;HGS;UBC;RPS27A;TLR2;PGK1
prerank,positive regulation of protein binding (GO:0032092),0.41134281902901965,1.2091498138672818,0.22950819672131148,0.7309579493817885,1.0,11/56,9.32%,TCF7L2;LRP1;DACT1;APOE;VTN;RAPGEF2;DERL1;LRRK2;STK4;BMP2;PRKN
prerank,cellular response to increased oxygen levels (GO:0036295),-0.506480303268902,-1.2090956879194024,0.22004357298474944,0.7339501334975604,1.0,4/11,21.84%,CAV1;FOXO1;ATP6V0A2;ATG7
prerank,ventricular septum morphogenesis (GO:0060412),0.480577620116182,1.208788249027636,0.22796352583586627,0.7311261994702808,1.0,5/27,4.67%,ROBO1;TGFBR3;BMPR1A;TGFBR1;ACVR1
prerank,negative regulation of blood coagulation (GO:0030195),0.43807919308043886,1.208742005451702,0.21857142857142858,0.7303508993033124,1.0,6/38,5.43%,SERPINE1;SERPING1;PDGFRA;APOE;VTN;TFPI
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.42682058731206174,-1.2084530021575706,0.20161290322580644,0.7339453542199044,1.0,6/19,14.93%,SLCO1C1;KLF2;MAPK8;KLF4;PAX8;APP
prerank,histone modification (GO:0016570),0.37805716798369965,1.208323978425567,0.18906064209274673,0.7306842972415821,1.0,16/109,10.19%,TBL1XR1;EYA2;EYA1;CCNA2;PRDM5;MIDEAS;MT3;BRD8;ATXN7L3;SIRT2;UBE2U;MTA2;MTA3;BRMS1L;NSD1;BAZ1B
prerank,negative regulation of defense response (GO:0031348),0.3989230526750601,1.2081130565632048,0.20275344180225283,0.7304204915296669,1.0,17/77,15.04%,PTGIS;RORA;APOE;APOA1;MVK;CDH5;MAPKBP1;SIRT2;NMI;NR1D1;IRAK3;ITCH;TNFAIP6;SELENOS;MUL1;NR1H3;TNFRSF1A
prerank,response to muscle stretch (GO:0035994),0.532901027955667,1.2079756035738756,0.2557726465364121,0.7299259230881463,1.0,2/15,1.20%,SLC8A1;GSN
prerank,regulation of axonogenesis (GO:0050770),0.42402785171383145,1.207842923425076,0.22679045092838196,0.7294287989210222,1.0,14/51,14.29%,ROBO1;PLXNA2;KIF13B;EPHA4;TIAM2;BRSK1;ARHGAP35;EPHB3;PLXNC1;MARK2;PLXNA1;PTEN;CHODL;PLXNB2
prerank,protein phosphorylation (GO:0006468),0.341609976205308,1.2077086682003166,0.06307222787385554,0.7289001152668746,1.0,77/479,12.87%,EPHA3;STK17B;DAPK2;PDPK1;PDK1;DDR2;NRK;ROCK2;CDK14;CAMK1D;TGFBR3;CDK8;DAPK1;GRK3;LYN;GRK5;FGFR1;EPHA4;BMPR1A;DMPK;MARK1;EPHA8;CCNA2;FGFR2;KIT;FGFR4;PRKAG2;GAS6;PDGFRA;PDGFRB;TGFBR1;ACVR1;CDK16;PRKAA2;MUSK;MAP3K20;NUAK1;SRC;ULK2;GTF2H5;LRRK2;AKT3;SIK1;EIF2AK3;BRSK1;MAP2K1;OXSR1;MAST2;STK4;IRAK3;EGFR;EPHB2;BMP2;MAP4K4;CAMK2B;VRK3;STK11;RNASEL;RYK;BAZ1B;TTBK1;NEK6;BRAF;TAOK3;IGFBP3;EPHB3;IKBKE;TBK1;TLK1;STRADA;WNK1;MAP3K13;INSR;MAP4K5;GRK4;MAP2K6;ACVR1B
prerank,ncRNA metabolic process (GO:0034660),0.4396338402925066,1.207287823956297,0.21120689655172414,0.7292282047755287,1.0,11/37,18.89%,TDRD1;DDX17;TUT7;PIWIL4;PARN;BCDIN3D;TUT4;PRKRA;TENT4B;DDX4;DICER1
prerank,amino acid transport (GO:0006865),0.4242004215026933,1.2067490154210487,0.2153846153846154,0.7299581397021508,1.0,8/49,9.72%,SLC7A11;SLC7A2;SLC1A5;SLC7A13;PDPN;SLC38A6;SLC38A9;SLC43A1
prerank,regulation of mitochondrial fusion (GO:0010635),0.5658033433152079,1.2066630646829666,0.27807486631016043,0.7293214295895514,1.0,4/11,15.20%,PID1;PRKN;MUL1;HUWE1
prerank,meiosis I (GO:0007127),0.4976557783787621,1.2066399394744531,0.26073131955484896,0.7284817005440739,1.0,8/23,17.50%,HSF2BP;BCL2L11;ZSCAN21;SYCP3;SGO1;MYBL1;FOXJ3;DDX4
prerank,response to cytokine (GO:0034097),0.36847706987062323,1.2058795705764962,0.1559633027522936,0.7299256789331012,1.0,28/141,14.07%,PID1;TIMP3;SMAD3;PTPN13;BCL2;IL6R;OSMR;PTPN20;SP100;DPYSL3;IRAK2;CXCL16;ALDH1A2;SRC;PML;KYNU;TIMP2;PTPN9;AFF3;IRAK3;IKBKE;TBK1;DDOST;IGBP1;HDAC4;TAF9;COL3A1;PTPN23
prerank,regulation of cilium assembly (GO:1902017),-0.3245886197445219,-1.205459242961215,0.13733905579399142,0.7414009404220355,1.0,17/62,14.22%,LIMK2;RABGAP1;CCDC88A;TBC1D1;TBC1D8;TBC1D14;TBC1D15;DCDC2;KCTD17;TBC1D30;CEP97;TESK1;EVI5;DYNLT2B;ATG3;TBC1D5;SDCCAG8
prerank,positive regulation of cytoplasmic transport (GO:1903651),-0.4973019748718777,-1.204331689412611,0.25118483412322273,0.7430154983920705,1.0,5/11,10.46%,RDX;MTMR2;SORL1;RAB21;MSN
prerank,regulation of water loss via skin (GO:0033561),-0.4543753963424207,-1.2041717677251222,0.2379746835443038,0.7392303610361672,1.0,4/15,11.25%,LSR;MET;UGCG;HRNR
prerank,establishment of skin barrier (GO:0061436),-0.4543753963424207,-1.2041717677251222,0.2379746835443038,0.7392303610361672,1.0,4/15,11.25%,LSR;MET;UGCG;HRNR
prerank,ion transport (GO:0006811),-0.29468127734384536,-1.2040302182217608,0.08280254777070063,0.7375357396460862,1.0,17/111,5.15%,TRPM3;PIEZO2;SLC12A2;SLC26A7;SLC12A7;SLC9A2;SLC24A2;SLC26A2;PIEZO1;ANO1;SLC9A6;ATP11B;GLRA1;GABRB1;KCNN2;SLC15A2;SLC1A1
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.5524989061238256,1.2037663857042267,0.24745762711864408,0.7354541699785844,1.0,5/12,17.96%,IL17D;IL12B;CARD9;IL23A;IL18
prerank,positive regulation of potassium ion transport (GO:0043268),-0.3650059623108706,-1.203654257316752,0.19047619047619047,0.736546879529402,1.0,12/38,13.63%,FHL1;KCNJ2;KCNJ3;KCNMA1;KCNN2;KCNQ1;AKAP6;KCNMB2;KCNJ15;GNB1;KCNJ10;GNG2
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.4778242391530153,-1.2035806350652727,0.22572815533980584,0.7346178558277849,1.0,4/13,4.38%,NR3C2;ESR1;ABHD2;MED1
prerank,amino sugar metabolic process (GO:0006040),-0.5165555418848953,-1.20318878767425,0.2529274004683841,0.733712781848706,1.0,2/10,0.97%,CSGALNACT1;ST6GAL1
prerank,mesenchymal cell differentiation (GO:0048762),0.41994293478495237,1.2029227628815757,0.2141863699582754,0.7371460887442788,1.0,11/51,8.75%,ROCK2;TGFBR3;FGFR1;FGFR2;WNT4;TGFBR1;FBXL17;ENG;DDX17;RBPJ;BMP2
prerank,positive regulation of lipid transport (GO:0032370),0.5581284066263499,1.2027581010613606,0.2792321116928447,0.7367604870213426,1.0,2/12,3.47%,LRP1;APOE
prerank,lipid biosynthetic process (GO:0008610),0.3980857770601365,1.2026204768098825,0.191969887076537,0.7362660579890633,1.0,10/77,7.89%,PAM;ACSL1;MVK;PRKAA2;STAR;HSD3B2;AGPAT3;SREBF1;SRD5A1;DOLPP1
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),-0.3831305873663165,-1.2024222913603,0.195906432748538,0.7339536523802254,1.0,7/30,5.45%,KCNJ2;ATP1A1;NEDD4L;GJC1;SCN1A;FGF12;KCNQ1
prerank,negative regulation of cell population proliferation (GO:0008285),0.3472769636556076,1.202026843122236,0.10684647302904564,0.7372405534834905,1.0,81/351,16.98%,NELL1;RBP4;MTSS1;OGN;COL4A3;MN1;TGFBR3;AR;MCC;LYN;DLC1;PODN;PDS5B;NUPR1;PDCD5;FBLN1;RAPGEF2;APPL2;IRF1;AXIN2;RARG;SFRP1;IGFBP5;PDPN;TBX3;CYP1B1;VIP;SKI;ALDH1A2;PML;IL12B;CEBPA;ING5;P3H3;SIRT2;MAP2K1;NMI;RNF139;CD200;BMP2;KAT2B;S100A11;STK11;INCA1;FGFBP1;IGFBP3;GSDME;IFNK;CGRRF1;RGCC;REST;CD33;NIBAN2;PEX2;NDRG4;NOX4;TSC2;GLMN;PTEN;CLMN;ETS1;FRK;HPN;GATA6;BMP4;SFRP4;RBM5;CDKN1C;PRKRA;BMP5;EPPK1;ZBTB17;SST;SPEG;KANK2;ADAMTS1;SLC16A2;ATF5;TFDP1;TNS2;CDKN2C
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),-0.45722872915586055,-1.2011163621178365,0.23741007194244604,0.73603538214448,1.0,4/14,10.01%,YBX3;ANGEL2;ELAVL4;ELAVL1
prerank,response to peptide hormone (GO:0043434),0.43344980082555384,1.2010505798397737,0.22478386167146974,0.7391596442919149,1.0,14/43,16.32%,ROCK2;TGFBR3;OGT;IGFBP5;ZFP36L1;SRC;STAT5B;STAT2;EIF6;EIF2B4;STAT6;STAT4;EIF2B3;AKT1
prerank,cellular copper ion homeostasis (GO:0006878),-0.4740457905145659,-1.200941713832357,0.2400990099009901,0.7345115180343411,1.0,8/14,27.14%,ATOX1;ARF1;ATP7A;SLC31A1;APP;MT2A;SLC31A2;PRNP
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.40277364487146666,1.2007566514822432,0.21601016518424396,0.7391401125301451,1.0,7/73,4.20%,ROBO1;COL4A3;SMAD3;DLC1;CASP12;CFLAR;SLC22A2
prerank,aortic valve development (GO:0003176),0.45123235449896537,1.2007018890468326,0.23170731707317074,0.738375817655778,1.0,3/34,0.85%,ROBO1;ROCK2;ELN
prerank,epithelial tube morphogenesis (GO:0060562),-0.3811539046835838,-1.2006385059963411,0.18654434250764526,0.7334128553586923,1.0,13/32,13.99%,SLIT2;PODXL;MEF2C;ACVRL1;MET;SOX17;RASIP1;PAK1;RHOB;SCRIB;HES1;PRKX;RYR2
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.52265241867192,1.2001739329662995,0.25562700964630225,0.7390441601637369,1.0,4/16,6.66%,SLC8A1;ATP1A2;GSTM2;CACNA1C
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.5074292017769408,1.1998505040073766,0.27479674796747966,0.7391115233715804,1.0,4/18,6.86%,IL6R;YAP1;SRC;CEBPA
prerank,epithelial cell-cell adhesion (GO:0090136),0.5723683288379968,1.199737238543768,0.2635135135135135,0.7385900031052092,1.0,4/11,6.79%,PLEKHA7;KIT;ITGB5;VCL
prerank,"wound healing, spreading of cells (GO:0044319)",0.47337796648047464,1.1993740095475114,0.28525641025641024,0.7387528736751824,1.0,4/24,7.95%,COL5A1;CCN1;PDPN;ARHGAP35
prerank,striated muscle tissue development (GO:0014706),0.4581729734063788,1.1987252718709878,0.23607038123167157,0.7398098464249833,1.0,4/29,4.38%,RBP4;SVIL;CFLAR;MSC
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.5027399968867567,1.1981809120823657,0.2551834130781499,0.7405648008296773,1.0,4/18,9.03%,ROCK2;EPHA4;SLC2A13;PICALM
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.4748121296204373,1.1981636004855876,0.24132730015082957,0.7397215816004726,1.0,4/27,4.20%,SLC1A3;SLC7A2;SLC6A9;SLC22A2
prerank,regulation of receptor-mediated endocytosis (GO:0048259),-0.36754682303080705,-1.1975814009059833,0.20625,0.7409143148344886,1.0,8/35,7.10%,SGIP1;BICD1;B2M;PPT1;CBL;RAB21;HIP1R;HNRNPK
prerank,response to calcium ion (GO:0051592),-0.29674002418185197,-1.197248505808432,0.11176470588235295,0.739842210336349,1.0,27/102,13.99%,CAV1;MEF2C;CPNE8;CLIC4;NLGN1;TRPC3;THBS1;PLCG2;IQGAP1;KCNMA1;CAMK2D;SLC25A13;CPNE3;SLC25A12;TRPC1;SYT1;KCNMB2;ITPR3;CALM1;GPLD1;CALM3;ADCY8;LGMN;HOMER1;SYT6;CASQ2;RYR2
prerank,negative regulation of hormone secretion (GO:0046888),0.5774147242840282,1.1971071117480006,0.29038112522686027,0.7419401359315124,1.0,1/10,0.60%,GJA1
prerank,regulation of actin filament bundle assembly (GO:0032231),0.4753498079124711,1.1960446252638492,0.24582701062215478,0.7443301165347398,1.0,7/26,9.89%,ROCK2;ASAP3;SYNPO2;CDC42;ALMS1;PRKN;SYNPO2L
prerank,regulation of filopodium assembly (GO:0051489),0.44279396013581884,1.195758004200933,0.25467625899280577,0.7443193011076004,1.0,8/38,8.37%,NRP1;PIK3R1;MYO10;DOCK11;RIPOR2;DPYSL3;CDC42;CAPZB
prerank,response to endoplasmic reticulum stress (GO:0034976),0.37393212511353374,1.195270216486379,0.2028985507246377,0.7448805122625279,1.0,25/107,15.99%,ITPR1;PIK3R1;BCL2;GORASP2;CDK5RAP3;CREB3L2;ERLEC1;DERL1;ATG10;EIF2AK3;RNF185;RNF139;BCL2L11;AIFM1;BCAP31;PRKN;TMEM259;CEBPB;UFL1;RCN3;SELENOS;P4HB;UFC1;PIK3R2;ERP44
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.5787009802383758,1.194933336974795,0.2864963503649635,0.7450623492743852,1.0,5/10,14.79%,APOA1;SLC45A3;LPGAT1;ABCD2;NR1H3
prerank,L-amino acid transport (GO:0015807),0.4708557963616704,1.1949311239521943,0.2492354740061162,0.7441721541613557,1.0,2/28,0.60%,SLC1A3;SLC7A2
prerank,negative regulation of mononuclear cell migration (GO:0071676),-0.48574214838667296,-1.19490016968347,0.2632794457274827,0.7453576899850705,1.0,2/12,2.63%,SLIT2;CCN3
prerank,dicarboxylic acid catabolic process (GO:0043649),0.5430981416564117,1.1948230137736304,0.28449744463373083,0.7436294810265968,1.0,3/13,6.15%,GLUL;DDO;ASPA
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.43512983626535434,1.1945695777034093,0.24118476727785615,0.7435062119524253,1.0,10/39,12.62%,PDPK1;ANGPT1;SERPINE1;GAS6;SEMA5A;CDH5;NFE2L2;RGCC;TNIP2;PDCD4
prerank,aerobic electron transport chain (GO:0019646),-0.3167518703575569,-1.1942871348888406,0.15283842794759825,0.7451411351077146,1.0,31/68,28.83%,COX4I1;NDUFC1;UQCRH;SDHD;COX6A1;COX5B;NDUFA6;NDUFA5;CYCS;NDUFA7;NDUFA8;NDUFB7;NDUFA3;NDUFA10;COX5A;COX6C;NDUFS7;NDUFS1;NDUFS5;UQCR10;NDUFB3;COX8A;UQCR11;UQCRQ;UQCRC1;NDUFAB1;UQCRFS1;AFG1L;NDUFB4;NDUFV2;NDUFV3
prerank,negative regulation of GTPase activity (GO:0034260),-0.41074345306067483,-1.1942556314136636,0.2023121387283237,0.7431386209852021,1.0,4/22,4.83%,LRCH1;F11R;SH3BP4;RDX
prerank,response to axon injury (GO:0048678),0.5192520662412013,1.1942100462682261,0.25354330708661416,0.7436681293997388,1.0,3/18,4.34%,NREP;DPYSL3;MTR
prerank,glycogen catabolic process (GO:0005980),0.5249249755413699,1.1941517883207113,0.25732899022801303,0.7429334528723328,1.0,7/15,16.45%,PHKB;GAA;AGL;PYGM;PYGB;PHKA1;PHKA2
prerank,regulation of mRNA stability (GO:0043488),0.3637665063723687,1.1938378551851074,0.18602029312288612,0.743104170709045,1.0,36/145,20.64%,SAMD4A;ROCK2;GDNF;TENT5A;CSDC2;IGF2BP2;PSME4;AXIN2;VIP;ZFP36L1;TENT5D;EXOSC1;METTL14;PARN;SERBP1;EXOSC7;LARP1;RC3H2;NUP214;MAPKAPK2;AKT1;DCP1A;PSMB5;PSMC2;RC3H1;METTL3;PSMD1;PRKCA;PSMD4;FASTKD3;PSME3;YTHDF2;FTO;HNRNPU;ZFP36L2;PSMA3
prerank,proton transmembrane transport (GO:1902600),0.44202237080826745,1.1934287104403694,0.2481962481962482,0.743491625492354,1.0,2/36,1.81%,ATP6V0A4;ATP1A2
prerank,polyamine metabolic process (GO:0006595),0.5320821130111968,1.1932119152745058,0.271304347826087,0.7431959920170192,1.0,5/13,22.74%,SMOX;SMS;SAT2;SAT1;HDAC6
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.40336996782128853,1.193077264178468,0.20764331210191084,0.7427243747876293,1.0,14/70,13.26%,NRP1;ATRNL1;ANTXR1;PIK3R1;PARVA;LAMC1;USH2A;RAB25;ATRN;ITGB3;ITGAV;EPHB3;DACT2;NTNG2
prerank,negative regulation of cellular component movement (GO:0051271),0.537274116597437,1.1926492056181288,0.27986906710310966,0.7431000168562849,1.0,3/15,4.29%,TGFBR3;SP100;FBLN1
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),0.5212389432678504,1.192579089813236,0.27591973244147155,0.7424449180296981,1.0,5/17,5.86%,ITGA3;FSTL1;TWSG1;SULF1;CASK
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.44536055963498555,1.192391234938918,0.23597122302158274,0.742109732457338,1.0,9/34,10.16%,PIK3R1;EPHA8;KIT;PDGFRA;PDGFRB;CCL19;WDR81;WDR91;FGF2
prerank,regulated exocytosis (GO:0045055),0.3614192675089938,1.19238894229465,0.1750841750841751,0.741240567938755,1.0,22/173,9.58%,IGF1;IGF2;CLEC3B;ACTN2;TIMP3;SPARC;AHSG;SERPINE1;LYN;SERPING1;GAS6;APOA1;APLP2;PHACTR2;TLN1;VCL;NHLRC2;CD63;SYT9;ACTN4;ISLR;ITGB3
prerank,fructose 6-phosphate metabolic process (GO:0006002),-0.4974794007101082,-1.191988374685829,0.24770642201834864,0.7480346032636525,1.0,3/10,8.02%,HK2;PFKL;PFKP
prerank,positive regulation of synapse assembly (GO:0051965),-0.3902296472718094,-1.1919818341014117,0.21084337349397592,0.7459702547867939,1.0,12/27,17.60%,GRID2;NLGN1;IL1RAPL1;PTPRD;EPHB1;NRXN1;CLSTN2;CLSTN3;AGRN;NLGN3;LRRC4B;VSTM5
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.36116114209299244,1.1904921453902215,0.16535433070866143,0.746097437663429,1.0,17/152,7.51%,ADRA1B;ADCY1;ADCY2;ABCA1;ADCY7;LGR4;GRK5;ADCY5;GNAS;ADCY9;ADGRL1;INSL3;VIP;LHCGR;ADRB3;MTNR1A;LPAR1
prerank,regulation of T cell cytokine production (GO:0002724),-0.4500879432897001,-1.1898809864687319,0.24806201550387597,0.7506289493304065,1.0,7/15,27.09%,B2M;CD55;FZD5;TRAF2;MAP3K7;MALT1;TRAF6
prerank,spliceosomal snRNP assembly (GO:0000387),-0.3575391855514955,-1.1897112065016915,0.19934640522875818,0.7491176277484197,1.0,14/38,23.23%,SNRPB;PRMT7;SNRPD1;SRSF12;LSM2;SNUPN;PRPF31;USP4;SNRPD3;COIL;GEMIN8;STRAP;CD2BP2;GEMIN7
prerank,"phagocytosis, engulfment (GO:0006911)",0.44556468020447115,1.1891587189014408,0.24717514124293785,0.7491103551681363,1.0,6/36,7.39%,RHOH;GSN;RHOBTB1;CDC42;RHOBTB2;GULP1
prerank,regulation of phosphorylation (GO:0042325),0.3742893342055195,1.1891236374318181,0.199764982373678,0.7483295987302255,1.0,36/120,19.55%,NRP1;LDB2;SRPX2;AR;LYN;DYNLL1;OGT;PRKAG2;NUP107;PHIP;CDH5;PML;NUP42;SIRT2;DSCAM;EGFR;STAT2;EIF6;NUP98;RAE1;EGF;GLMN;PLXNB2;NUP214;BMP4;SESN2;CDKN1C;FNIP1;CDKN2C;KCTD20;GCK;SEH1L;TPR;CDKN1B;PRKAG1;ROPN1L
prerank,negative regulation of protein processing (GO:0010955),0.5386909662724904,1.1889016056702688,0.28896672504378285,0.7481224935287422,1.0,5/12,15.10%,SERPINE1;LRRK2;SNX12;CTSZ;GAS1
prerank,cell junction organization (GO:0034330),-0.3097024343832636,-1.188450827169795,0.1504424778761062,0.7511209587007946,1.0,27/71,20.01%,CTNND2;OCLN;PPFIA2;LIMS2;ACTB;TJP2;TJP1;MYO9A;TGFB2;PPFIA1;GRM5;OPHN1;RAB8B;AGRN;TGFB1;CXADR;APP;NLGN3;LIMS1;ELFN1;CBLN2;MARVELD2;ACTG1;DVL1;PPFIA4;SH3BP1;TGFB3
prerank,negative regulation of translation (GO:0017148),0.3882527012464141,1.1881343147568777,0.22277227722772278,0.7495179082596363,1.0,10/87,8.95%,SAMD4A;ROCK2;DAPK1;IGF2BP2;IGFBP5;CPEB1;CPEB3;EIF2AK3;RNF139;METTL14
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.4040412522307632,1.1877971550952489,0.23717948717948717,0.7496076728251964,1.0,25/64,23.90%,POLR2D;MLLT3;GTF2H5;CCNK;POLR2C;MNAT1;PAF1;CDK12;NELFE;ADRM1;AFF4;ELOF1;CCNT2;CDC73;POLR2L;ELP4;LEO1;MLLT1;ERCC3;CCNT1;NCBP2;CDK7;ERCC2;ELOC;CDK13
prerank,positive regulation of exocytosis (GO:0045921),-0.3564383443141883,-1.1873616433892138,0.20679012345679013,0.7525300542921086,1.0,14/35,26.47%,RAB27A;SDCBP;CADPS;RAB27B;PDCD6IP;CFTR;RAB15;RAB3A;CLASP1;VPS4A;SNF8;EXPH5;STXBP5;HGS
prerank,relaxation of cardiac muscle (GO:0055119),0.5441205678983688,1.1871923978374035,0.2714535901926445,0.7504318482142903,1.0,4/13,5.72%,SLC8A1;GSN;ATP1A2;GSTM2
prerank,regulation of sprouting angiogenesis (GO:1903670),-0.36244644186039954,-1.187188681813906,0.2080745341614907,0.7509298970068443,1.0,9/33,4.18%,BMPER;SEMA6A;THBS1;PPP1R16B;EPN2;CEMIP2;TJP1;KLF2;FGF1
prerank,positive regulation of protein transport (GO:0051222),0.40370834699439184,1.1870186190165677,0.21773142112125163,0.750041891239654,1.0,4/67,3.85%,IGF1;BMP6;MYO18A;MYH10
prerank,steroid biosynthetic process (GO:0006694),0.4137739036286296,1.1856070938120016,0.23880597014925373,0.7534817761202786,1.0,8/56,7.55%,CYP7B1;SLC27A5;PRKAG2;INSIG2;STAR;HSD3B2;CYP27A1;SRD5A1
prerank,cellular response to acid chemical (GO:0071229),-0.38626026573969097,-1.1855834666859804,0.23410404624277456,0.7541251524491243,1.0,9/27,12.39%,SH3BP4;KLF2;GLRA1;GLRA2;SPAAR;LARS1;VEGFA;IPO5;MTOR
prerank,positive regulation of cellular component organization (GO:0051130),0.37153522502417646,1.185112181355424,0.1941747572815534,0.7540687662958706,1.0,16/107,10.13%,ASAP1;TRABD2B;FRMPD4;AR;LRP1;RUNX1;APOE;TGFBR1;ADGRL1;CCL19;CDH5;LMAN1;DAB2;BCL2L11;CAMK2B;PLEKHM2
prerank,cellular response to purine-containing compound (GO:0071415),0.568292207331981,1.1850013880556836,0.30071174377224197,0.7535106566033006,1.0,2/10,5.72%,SLC8A1;GSTM2
prerank,positive regulation of viral transcription (GO:0050434),0.4748247548283546,1.1845632205437724,0.27522935779816515,0.7539822360133843,1.0,1/25,0.14%,POLR2D
prerank,neural crest cell differentiation (GO:0014033),-0.4219843906226641,-1.1843979041624497,0.24473684210526317,0.7558064274806491,1.0,3/18,5.51%,MEF2C;CDH2;LRP6
prerank,regulation of protein localization to membrane (GO:1905475),0.45519804713739376,1.1842361594973678,0.25413533834586466,0.7540221509671693,1.0,3/28,1.40%,GPC6;GSN;AR
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.5731767973165328,1.1834452215455227,0.29294755877034356,0.7555239276248427,1.0,6/10,24.20%,IVD;ETFDH;ETFA;ETFB;ACADM;ACADVL
prerank,cellular metal ion homeostasis (GO:0006875),0.37833543074397863,1.1833457552022535,0.21325301204819277,0.7549466091092333,1.0,16/102,8.20%,SLC24A3;SLC8A1;SLC8A3;ATP1A2;SLC41A1;DMPK;CCL19;STIM1;ATP13A3;SLC24A1;MT3;CDH5;SLC24A5;ATP1B2;TMEM203;DRD3
prerank,positive regulation of synaptic transmission (GO:0050806),-0.31715439308783355,-1.183307968839308,0.1743119266055046,0.7573224347434822,1.0,25/72,17.32%,SHANK3;SLC24A2;NLGN1;PTK2B;RIMS1;ZDHHC2;GRIK2;TSHZ3;GRIN2A;NRXN1;RIMS2;GRIN2B;SYT1;CLSTN2;CLSTN3;ADCY8;PRKCZ;LGMN;APP;NLGN3;GPER1;LGI1;CACNG3;CACNG4;MPP2
prerank,regulation of cell-cell adhesion (GO:0022407),-0.3573501645411177,-1.1830245473599281,0.23793103448275862,0.7560908325603821,1.0,6/39,2.61%,PTPRG;EFNA5;PODXL;CDH1;ZDHHC2;TENM3
prerank,cellular protein metabolic process (GO:0044267),0.33568105782825797,1.1825992313737772,0.13673469387755102,0.7563717025338415,1.0,36/396,8.43%,LTBP1;IGF1;IGFBP2;PAPPA;CP;FBN1;IGF2;MATN3;LOX;AHSG;PRKCSH;IGFBP4;MSRB3;RRBP1;CCN1;LAMC1;MMP2;GAS6;APOE;FSTL1;CSF1;TGM5;APOA1;APLP2;SERPIND1;CTSH;IGFBP5;CST3;LMCD1;TNC;ADPRH;ARAF;RCN1;UBA7;SEC11C;DNAJC3
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.47645524672443185,1.1824001702064821,0.2708978328173375,0.7560532900389364,1.0,13/25,23.17%,FBXL17;DERL1;RNF185;NGLY1;UGGT2;CLPP;AUP1;LONP1;YME1L1;ZER1;BAG6;HDAC6;ATXN3
prerank,regulation of cell death (GO:0010941),0.38153298130098434,1.1823518758670688,0.2042875157629256,0.755337045310744,1.0,19/94,13.22%,CCN2;LRP1;CCN1;RRAS2;MT3;SLC25A24;AXIN2;CCN5;LRRK2;PARP16;CCN4;PRKN;FGF2;TBK1;RAD18;IMPACT;RIPK2;CTSZ;NPAS2
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.5380098985386165,1.1819537784175878,0.2877442273534636,0.7556118523944358,1.0,4/12,14.79%,ABCA1;ITGB3;ITGAV;NR1H3
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.5595265612894599,1.1819482782083817,0.29347826086956524,0.754751901513705,1.0,7/10,30.76%,SPHK2;KMT2A;SMARCB1;BRCA1;HDAC5;RAPGEF3;SMAD4
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),-0.41990994424711164,-1.180846042572917,0.2604166666666667,0.7611194575180531,1.0,6/20,6.83%,SLC12A2;KCNJ2;ATP1A1;NEDD4L;KCNMA1;ATP1B1
prerank,respiratory electron transport chain (GO:0022904),-0.4716929141399885,-1.180756722321458,0.2722772277227723,0.7593645339830617,1.0,9/14,26.93%,SLC25A13;SLC25A12;PPARGC1A;NDUFA5;SDHB;SLC25A22;ETFRF1;UQCRFS1;GPD2
prerank,receptor clustering (GO:0043113),-0.3962937279474934,-1.1803220621184287,0.2471264367816092,0.7586478501319409,1.0,11/27,18.89%,DLG2;NLGN1;NRXN1;LRRC7;ITGA4;PTN;SCRIB;AGRN;SYNJ2BP;DVL1;ITGB1BP1
prerank,establishment of spindle orientation (GO:0051294),0.4664108273461001,1.1802968951051505,0.2850467289719626,0.7589034305062212,1.0,13/28,23.46%,GJA1;SPDL1;ZW10;UBXN2B;LLGL1;CENPA;HTT;NUMA1;NSFL1C;NDE1;LLGL2;FBXW11;ITGB1
prerank,positive regulation of secretion by cell (GO:1903532),0.3955240684215039,1.1802680845115072,0.24936061381074168,0.7581073882329457,1.0,6/70,5.31%,IGF1;BMP6;DTNBP1;MYO18A;MYH10;BAIAP3
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),-0.4128094908752787,-1.1799607936275551,0.23466666666666666,0.7577888040015802,1.0,13/21,33.67%,KDM1A;DISC1;VEGFA;CX3CR1;DLL4;TOX;LRP2;FZD3;FZD9;DISP3;CTNNB1;NAP1L1;RASSF10
prerank,positive regulation of interferon-gamma production (GO:0032729),-0.34184774281865243,-1.1795988652475269,0.19932432432432431,0.7569812205396714,1.0,11/48,19.92%,PDE4D;PDE4B;SLC7A5;CYRIB;SCRIB;PTPN22;ZFPM1;TLR4;TXK;CD276;FZD5
prerank,cellular response to glucose stimulus (GO:0071333),0.4449992747386853,1.1791594692641727,0.25625920471281294,0.7605220136779602,1.0,3/30,5.19%,ZBTB20;GAS6;PRKAA2
prerank,secretion (GO:0046903),0.5342826880203404,1.1790232661879805,0.31385642737896496,0.7599999623285019,1.0,5/14,8.20%,FBLN5;SLC22A2;VIP;SLC22A4;DRD3
prerank,heart morphogenesis (GO:0003007),0.41856175312683397,1.178846839648878,0.24033149171270718,0.7596241569688075,1.0,11/50,9.89%,TGFBR3;DLC1;BMPR1A;OLFM1;TGFBR1;ACVR1;TBX3;ENG;FLRT2;BMP2;SYNPO2L
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.31267149020627993,-1.1787406944346666,0.16666666666666666,0.757798397840218,1.0,17/67,14.82%,ATP8B1;PODXL;CAV1;PPP1R16B;RABGAP1;TBC1D1;TBC1D8;TBC1D14;RDX;TBC1D15;DCDC2;EVI5;DYNLT2B;ATG3;TBC1D5;SDCCAG8;GAP43
prerank,establishment of mitotic spindle orientation (GO:0000132),0.48071417403259725,1.1772547680116499,0.2863849765258216,0.7636795295046445,1.0,11/23,23.46%,GJA1;SPDL1;ZW10;UBXN2B;CENPA;HTT;NUMA1;NSFL1C;NDE1;FBXW11;ITGB1
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),-0.3547263873471252,-1.176806753341184,0.20298507462686566,0.7619626551356112,1.0,7/39,5.00%,UTRN;ANK3;NEDD4L;HECW1;YWHAH;CAMK2D;FGF12
prerank,limb morphogenesis (GO:0035108),0.4992131394930173,1.176672248419449,0.29264214046822745,0.7645186832139181,1.0,4/20,5.82%,CYP26B1;GLI3;TBX3;SKI
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.5549963045898247,1.1765433707533979,0.2895204262877442,0.7640200798282342,1.0,1/10,0.24%,BMP6
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.4949950903543112,1.1764409041841337,0.28429752066115704,0.763478379172538,1.0,3/19,6.86%,AR;NAB2;CEBPA
prerank,cellular response to retinoic acid (GO:0071300),0.43051823230197317,1.176323885466475,0.2538141470180305,0.7629588557547444,1.0,6/42,6.62%,EPHA3;LYN;WNT8B;WNT6;PTK7;WNT5B
prerank,protein stabilization (GO:0050821),0.3602876859862944,1.1760764891813558,0.18284424379232506,0.7628331554564687,1.0,29/168,15.66%,IGF1;PIK3R1;PLPP3;A1CF;EPHA4;PARVA;ZSWIM7;APOA1;MT3;ATP1B2;STK4;CREBL2;WDR81;PRKN;TELO2;PEX6;TNIP2;PER3;SUGT1;MUL1;USP9X;HYPK;PTEN;TAF9;PDCL3;FLNA;BAG5;PRKRA;LAMP2
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.4843510919005783,1.1760319871828493,0.27844311377245506,0.7620684171756094,1.0,10/21,23.49%,SMO;SFRP1;TEDC1;TTC23;GLI1;SHH;EVC;PDCL;TXNDC15;STK36
prerank,regulation of endothelial cell proliferation (GO:0001936),0.38465068831053323,1.1758478041944291,0.21536523929471033,0.7617319311580403,1.0,19/88,11.96%,NRP1;ANGPT1;SPARC;NR2F2;VASH2;APOE;TGFBR1;SEMA5A;SULF1;VIP;ATOH8;AKT3;BMP2;ITGB3;ARNT;FGF2;PTPRM;RGCC;NR4A1
prerank,peptidyl-lysine dimethylation (GO:0018027),0.5053186564389885,1.1754729742560468,0.3014354066985646,0.7619599893499919,1.0,6/18,17.46%,SETD7;ASH1L;SETD1A;SETD4;KMT2A;SETD1B
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.5216646577232297,1.175165207277282,0.2705061082024433,0.7620210156930843,1.0,8/14,23.52%,LRRK2;PRKN;CREB3;SELENOS;TMBIM6;CREB3L1;OPA1;TXNDC12
prerank,protein mannosylation (GO:0035268),0.4794035170370599,1.1751036767286556,0.266347687400319,0.7613380770357144,1.0,4/22,5.89%,TMTC1;TMTC4;LARGE1;LARGE2
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.39087094250442767,1.1749458481761026,0.22506393861892582,0.7609243509514243,1.0,12/75,6.63%,COL4A3;ROCK2;SPARC;DCN;HSPG2;WNT4;ISM1;THBS2;SULF1;SERPINF1;PML;EMILIN1
prerank,regulation of cartilage development (GO:0061035),0.49433574870985436,1.1748237408791888,0.30063291139240506,0.7603986328809522,1.0,5/18,14.89%,TRPS1;SOX5;BMP2;MDK;BMP4
prerank,membrane organization (GO:0061024),-0.26063309422850905,-1.174283163951945,0.05263157894736842,0.7679336587206442,1.0,36/227,8.99%,DNM3;CERT1;SGCZ;FNBP1L;SGIP1;ACTB;ANK3;RIMS1;EPN2;NUP93;REEP1;REPS2;CCDC88A;TFRC;PPT1;HSPA8;CBL;DYSF;FZD4;SH3GL2;TMEM33;SPTBN1;AMPH;ATP2C1;HIP1R;VAMP8;SUN2;PLEKHA3;SYT1;SYP;ARPC3;GAK;SH3KBP1;PACSIN2;RTP4;OSBPL2
prerank,regulation of histone acetylation (GO:0035065),-0.37288945560305925,-1.1739109848116147,0.24838709677419354,0.7670407998376694,1.0,8/33,13.80%,RPS6KA5;NOS1;CTBP1;PPARGC1A;BRD7;RPS6KA4;TADA2A;MAPK3
prerank,modulation of excitatory postsynaptic potential (GO:0098815),-0.3913258051839246,-1.173501075667208,0.21100917431192662,0.766273417848506,1.0,14/26,19.52%,SHANK3;NLGN1;PTK2B;RIMS1;NRXN1;MTMR2;RIMS2;TMEM108;SHANK1;PRKCZ;APP;NLGN3;TMEM25;GRIN1
prerank,synaptic vesicle recycling (GO:0036465),-0.36561473136735195,-1.1731231145603478,0.2329192546583851,0.7654050035459298,1.0,10/31,18.61%,NLGN1;AMPH;OPHN1;CDK5;SYT1;PACSIN1;NLGN3;RAB3A;STX1A;SYNJ1
prerank,positive regulation of protein modification process (GO:0031401),0.35074364332143815,1.1729484885590598,0.18360655737704917,0.7651126361190619,1.0,37/203,13.68%,IGF2;TRABD2B;ROCK2;ANGPT1;LYN;DLC1;LEPR;IL34;PELI2;CCN1;NOS1AP;NNMT;GAS6;MT3;AXIN2;MUSK;SLCO3A1;CDH5;ENG;LRRK2;ATG10;NTRK3;STK4;DAB2;ARRB1;EGFR;BMP2;ITGB3;FGF2;DDX3X;F2;CAMTA1;INSR;RAP2A;TMEM119;RAB3GAP1;ALG10B
prerank,bone morphogenesis (GO:0060349),0.5326198288521911,1.1721741536000199,0.29354838709677417,0.7666172917263115,1.0,3/14,5.82%,CYP26B1;FGFR2;SKI
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.49416864306176367,-1.1719699749736705,0.28095238095238095,0.767079241041984,1.0,3/10,12.70%,CD55;TGFBR2;CD81
prerank,regulation of bicellular tight junction assembly (GO:2000810),-0.4178924504687234,-1.1719569311639568,0.2349869451697128,0.7651298139642166,1.0,5/19,2.91%,PRKCH;OCLN;CLDN5;F11R;TJP1
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.3287991043059627,1.1717836737532275,0.012,0.7668827909689537,1.0,333/1667,17.25%,IGF1;TCF7L2;TCF4;BMP6;ZBTB20;LDB2;AUTS2;NFIA;IGF2;FHL2;RORA;TBL1XR1;ZFHX4;PID1;TRPS1;TEAD1;CDK8;GDNF;ATXN1;PIK3R1;PBX1;SMAD3;ARNT2;PKNOX2;AR;ZKSCAN2;ZEB2;SOX5;TGFA;MITF;DCN;GLIS3;NKX6-1;SERPINE1;NR2F2;DACT1;GLI2;RUNX1;PRRX1;WWC2;SALL1;KCNIP3;ZIC1;SP7;OGT;IKZF2;BMPR1A;VGLL3;CBX7;MAF;GLI3;AEBP1;PPP3CA;CCN1;ARID5B;ZEB1;NKX2-1;FGFR2;KIT;ARID4A;THRB;PRDM5;SP100;MDFI;FOXP2;NFIB;ASCL1;SSBP3;ZNF462;YAP1;DNMT3A;JDP2;MAML3;APOE;RUNX2;SIX5;MLXIP;RARB;MIDEAS;ZIC4;NFIX;MXI1;LBX2;FBXL19;MEOX2;CRTC3;IKZF4;RLF;MSC;SMURF2;BRWD1;IRF1;ZIC2;NEUROD4;RFX5;ACVR1;ZHX2;ZNF83;NEUROD1;CREB3L2;NCOA2;KLF15;PHIP;RARG;ETV6;ARID1B;BRD8;ATXN7L3;TBX3;SP4;EPAS1;HLF;BCL6;ENG;CUX2;ZBTB8B;SKI;BCL9;TNRC6B;BCOR;TCF7;ATOH8;HES7;INO80;SMARCA1;ZNF483;ZNF23;MED14;GTF2H5;NR5A1;CPEB3;BATF;CEBPA;ATAD2B;NFE2L2;MBD2;WWTR1;SAP30;RNF10;SREBF1;SIRT2;DDX17;DR1;ZBTB38;TSHZ2;ZBTB24;SMARCC2;MED8;MED16;PPP1R13L;NR1D1;RAI1;OSR1;BBX;TET1;MTA2;RBPJ;LIN9;DAB2;TCF7L1;FOXC2;SAFB2;NCOR1;CHD2;MTA3;TNRC6A;KDM5B;HIVEP2;ARRB1;EGFR;RGMA;BMP2;PCGF3;ZMIZ1;JAZF1;KAT2B;STAT5B;ZBTB4;BRMS1L;HOXC5;ZBTB1;MZF1;CCNK;SMAD1;GMEB1;PRKN;GTF2IRD1;HEXIM2;STAT2;GLIS2;CSRP3;NSD1;ARNT;RPAP2;CREB3L4;CREB3;RNASEL;FOXA1;IFI27;ZKSCAN3;FGF2;SP140;BAZ1B;ZSCAN21;PHF2;CXXC5;NR1D2;MED13L;NCOR2;SP5;ZBTB8A;DDX3X;ZNF177;CEBPB;KLF9;CCNL2;MED29;BHLHE41;NFE2;RGCC;TNIP2;SPDEF;NKX2-8;ZBTB37;TBK1;HDAC8;ZFP30;REST;NR4A1;PER3;RHOQ;IMPACT;CCNL1;MNAT1;TCF25;GLI1;CAMTA1;PHF21A;STAT6;ZNF513;RIPK2;PEX2;PAF1;TEAD3;MYCN;SMARCD2;USP9X;NPAS2;HELZ2;IGBP1;NCOA3;KMT2A;HOXC8;EBF1;STAT4;TIAL1;ZNF182;CDK12;HDAC4;PTEN;TAF9;MED19;ARF4;HIVEP1;ETS1;FRK;ZNF148;ZNF383;FSTL3;ZNF219;TWIST2;TCF12;HOXD1;TCERG1;HSBP1;TADA3;AKAP8L;KDM7A;GATA6;NR1H3;PHF8;BMP4;SUDS3;UBE2D1;ZNF25;FUBP3;HOXC4;SUFU;RXRA;TNFRSF1A;FOXK2;SS18;SMARCB1;TSHZ1;HDGFL3;BMP5;CAMTA2;MYT1;MTF1;TFCP2;RNF2;PIK3R2;POGZ;ZBTB17;ZNF585B;ZNF585A;CBX5;MAFA;ZNF276;MXD4;NCOA7;EBF4;KANK2;CREB5;FNIP1;PLAG1;CCNQ;ATF5;SHH;TFDP1;FOXO6;SP1;LIF;MYBL1;BAZ2B;PRPF6;EFCAB7;IRF2;ZSCAN20;CBX6;ABHD14B;KDM3B;FOXJ3
prerank,regulation of wound healing (GO:0061041),0.42675605611742834,1.1717731858534721,0.265474552957359,0.766041825894851,1.0,11/42,11.76%,SERPINE1;KANK1;MYLK;VTN;INSL3;CASK;EPHB2;FGF2;HBEGF;ADRA2A;F2
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.44556527416226793,1.1706025231485258,0.260932944606414,0.7687251464821159,1.0,9/33,13.79%,OGN;TPM1;IGFBP5;VIP;IL12B;IGFBP3;PDCD4;NDRG4;PTEN
prerank,stem cell differentiation (GO:0048863),0.4305246681713698,1.1695852269416245,0.2463768115942029,0.7709022267241609,1.0,10/39,11.48%,SP7;FGFR2;KIT;FBXL17;MLLT3;SFRP1;BATF;OSR1;EEF1AKMT4-ECE2;UFL1
prerank,actin filament capping (GO:0051693),0.4963652595962075,1.1694135579711755,0.294770206022187,0.7696482057012632,1.0,2/18,1.20%,SVIL;GSN
prerank,barbed-end actin filament capping (GO:0051016),0.4963652595962075,1.1694135579711755,0.294770206022187,0.7696482057012632,1.0,2/18,1.20%,SVIL;GSN
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.442328529630273,1.1691285876905164,0.28193832599118945,0.7696153375511633,1.0,7/32,8.81%,PHLDB2;SERPINE1;ARHGAP6;DLC1;CASK;SRC;MAP4K4
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.4686689445445265,1.169070123567643,0.2900641025641026,0.7689148441750154,1.0,4/24,10.48%,ITPR1;CCL19;FGF2;ANXA6
prerank,cellular polysaccharide catabolic process (GO:0044247),0.5011510142154448,1.1689236286259903,0.2914012738853503,0.7684560720874994,1.0,7/16,16.45%,PHKB;GAA;AGL;PYGM;PYGB;PHKA1;PHKA2
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.4998250590598317,1.1687047526313918,0.2905405405405405,0.7682029647285983,1.0,4/17,8.16%,NRP1;NTF3;CDC42;NTRK3
prerank,regulation of cellular biosynthetic process (GO:0031326),0.45701218604278715,1.1686976424029056,0.2682926829268293,0.7673542420913791,1.0,5/28,5.19%,MITF;NOS1AP;FGFR4;PRKAG2;PRKAA2
prerank,sulfate transport (GO:0008272),-0.4439828266192254,-1.1684237289152122,0.2847380410022779,0.774332405976785,1.0,5/14,13.83%,SLC26A7;SLC26A2;SLC25A30;SLC26A6;SLC25A11
prerank,regulation of cardiac muscle contraction (GO:0055117),-0.3569442503336129,-1.1682482975987667,0.20552147239263804,0.7728535508247829,1.0,16/34,27.82%,PDE4D;PDE4B;KCNQ1;NOS1;ATP1B1;CALM1;CALM3;RYR2;CHGA;GJA5;PIK3CG;RGS2;PLN;CALM2;HCN4;SRI
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.4764254910902688,1.1677340001021703,0.27403846153846156,0.7693205205000797,1.0,2/21,4.57%,EPHA7;MT3
prerank,regulation of NMDA receptor activity (GO:2000310),-0.3667034682872604,-1.1673707221684149,0.23885350318471338,0.7735855110443924,1.0,9/32,8.48%,DLG2;MEF2C;GRIA4;NLGN1;PTK2B;GRIN2A;LRRC7;GRIN2B;GRIA2
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),-0.3819015873693228,-1.1669051397256434,0.2225609756097561,0.7730547633635538,1.0,14/27,23.96%,IL1RAPL1;CCDC88A;MBOAT1;NTNG1;GSK3A;EFHC2;DISC1;CAMK2G;HOMER1;BRSK2;FBXO7;GSK3B;TREM2;CTNNA2
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.456437005857649,1.1669038441654154,0.28043143297380585,0.7708699714069738,1.0,10/26,22.08%,LGR4;APPL2;IRF1;IRAK3;GPR108;APPL1;TLR5;SMPDL3B;BIRC2;BIRC3
prerank,regulation of interleukin-4 production (GO:0032673),-0.41243056142392853,-1.1663173424561308,0.2608695652173913,0.7728790486026337,1.0,6/21,18.96%,LEF1;SLC7A5;FCER1G;PRKCZ;ZFPM1;CD86
prerank,positive regulation of B cell activation (GO:0050871),-0.3314522898539813,-1.1659138476118547,0.21132075471698114,0.7721595973734646,1.0,15/50,17.03%,MEF2C;VAV3;CD38;TFRC;NFATC2;SH3KBP1;SHLD1;CD40;CD81;GPR183;NOD2;PTPRC;BTK;CD27;CD320
prerank,response to chemokine (GO:1990868),-0.46555203956906377,-1.1657190591411966,0.2635294117647059,0.7708129833219154,1.0,2/13,0.68%,SLC12A2;LRCH1
prerank,stress granule assembly (GO:0034063),-0.40748435080287426,-1.1650771939266542,0.25405405405405407,0.7707941884160177,1.0,6/20,12.90%,BICD1;CSDE1;RPS23;LSM14A;YTHDF3;G3BP1
prerank,response to molecule of bacterial origin (GO:0002237),-0.31576227613839036,-1.1647145076548095,0.16666666666666666,0.7698689059237522,1.0,19/69,19.92%,NOS3;TNFRSF11A;CYRIB;GGT5;LBP;GCH1;NOS1;JAK2;FOXP1;TNFAIP3;PTPN22;ERBIN;IRF5;TRIM6;TLR4;HMGB2;IFNAR1;GGT1;FZD5
prerank,protein glycosylation (GO:0006486),0.3609291477413174,1.1644925439629086,0.22641509433962265,0.7771173732265073,1.0,26/125,13.98%,GALNTL5;GALNT18;B3GALT1;OGT;ST3GAL5;PGM3;MAN1C1;ST3GAL3;LARGE1;MOGS;LARGE2;FUT10;B4GALT1;STT3A;DOLPP1;TET1;B3GALNT1;GFPT1;ALG5;ALG11;MGAT3;POMT1;DDOST;GALNT6;ALG10B;ALG6
prerank,regulation of cell motility (GO:2000145),0.35708526189737577,1.1637288954450382,0.22847301951779564,0.7785099575589228,1.0,27/121,14.42%,PLXNA2;LDB2;ROCK2;AMOTL2;DOCK10;ARHGAP18;MACF1;CCL19;FBLN1;TBCCD1;BEX4;MEMO1;PARD6B;EGFR;NTN1;LMO4;FGF2;NEXN;AMOTL1;HBEGF;CCDC25;MGAT3;PLXNC1;EGF;PLXNA1;PLXNB2;FLNA
prerank,positive regulation of type 2 immune response (GO:0002830),-0.4522309702133619,-1.1637032796685272,0.26763990267639903,0.7711990847424888,1.0,7/14,30.03%,DENND1B;PRKCZ;CD81;NOD2;CD86;RARA;NLRP3
prerank,regulation of integrin activation (GO:0033623),-0.4464993423202015,-1.1635999726107542,0.25,0.7695663120902544,1.0,5/15,10.69%,PIEZO1;RASIP1;RAP1B;SKAP1;PLEK
prerank,phospholipid biosynthetic process (GO:0008654),-0.3520319836707581,-1.1632502839933476,0.1986754966887417,0.7686981526940849,1.0,5/36,4.46%,SGMS1;SGMS2;CPNE3;LPCAT1;MBOAT1
prerank,negative regulation of nuclear division (GO:0051784),0.5424196425454872,1.1631431673106867,0.3244274809160305,0.7794036933752981,1.0,3/11,14.89%,TOM1L2;NME6;BMP4
prerank,monosaccharide transmembrane transport (GO:0015749),0.5102684145907216,1.1631074558866632,0.3058637083993661,0.7786305124326489,1.0,3/16,9.28%,SLC2A10;SLC45A3;SLC5A3
prerank,regulation of cytoplasmic transport (GO:1903649),0.5501942866271445,1.1630143364240446,0.3117338003502627,0.7780483445885962,1.0,4/11,7.59%,ATP9A;SRC;LRRK2;MAP2K1
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.5032481189735181,1.162760877477097,0.29545454545454547,0.7779851968419105,1.0,4/17,6.31%,AR;ATP1A2;TFPI;SRC
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.4799254867494802,1.1626707228473834,0.30842607313195547,0.7774353920507234,1.0,8/20,21.44%,SLC8A3;MCU;PMPCB;MICU2;YME1L1;PHB2;AFG3L2;STOML2
prerank,regulation of Rac protein signal transduction (GO:0035020),0.4921937427326759,1.162501473753845,0.29194630872483224,0.7770687317891384,1.0,4/16,11.50%,AUTS2;OGT;ALS2;KBTBD7
prerank,B cell activation involved in immune response (GO:0002312),0.5298167178482134,1.162265423507829,0.2916666666666667,0.7769014338982371,1.0,3/13,6.84%,GAPT;LIG4;BATF
prerank,protein auto-ADP-ribosylation (GO:0070213),0.5450442678490501,1.1622561038287846,0.2967409948542024,0.7760599578508098,1.0,6/12,23.91%,PARP11;PARP16;TNKS2;PARP12;PARP10;TNKS
prerank,positive regulation of heart rate (GO:0010460),0.5129313908447237,1.1615763670891082,0.29411764705882354,0.777195859968508,1.0,4/17,11.10%,ADRA1B;TPM1;TRPM4;ADM
prerank,regulation of amyloid-beta clearance (GO:1900221),0.5066352754223136,1.1614077167591623,0.29264214046822745,0.7768210205531455,1.0,2/16,3.47%,LRP1;APOE
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.41915337853266105,1.161081175491975,0.27155172413793105,0.7769004308754529,1.0,5/38,7.78%,RORA;RHOH;TLE1;MAPKBP1;NR1D1
prerank,neuron migration (GO:0001764),0.4058279399051409,1.160662775287381,0.2503401360544218,0.7773701178585612,1.0,7/48,5.49%,NRP1;AUTS2;FGFR1;MARK1;SH3RF1;RAPGEF2;LRP12
prerank,oxoacid metabolic process (GO:0043436),0.46126976008148735,1.1606074680769258,0.2909090909090909,0.7767043644831731,1.0,3/27,5.85%,ENPP1;TPST1;DDO
prerank,cellular response to pH (GO:0071467),-0.430760935606577,-1.1603600429390242,0.2616136919315403,0.7759726520358871,1.0,7/17,26.50%,HYAL1;GPLD1;GPR68;RAB11FIP5;HVCN1;PKD2L1;KCNK4
prerank,phagosome acidification (GO:0090383),0.4613203764320922,1.160181084613542,0.2967032967032967,0.7770441122481513,1.0,1/26,0.20%,ATP6V0A4
prerank,regulation of lamellipodium organization (GO:1902743),0.5189751639162258,1.1601529399134556,0.3092436974789916,0.7762789952118541,1.0,4/14,8.37%,PDPN;CDC42;CARMIL1;CAPZB
prerank,macrophage chemotaxis (GO:0048246),-0.4838320159896552,-1.1601083515958084,0.2847682119205298,0.7747828445555371,1.0,7/10,47.64%,CKLF;EDNRB;CCL2;CXCL17;CCL3;CCL5;LGALS3
prerank,endomembrane system organization (GO:0010256),0.35040155619316943,1.16006028014817,0.18743228602383533,0.775672162373443,1.0,48/178,16.38%,OBSL1;USP6NL;DMPK;LMAN2L;OPTN;SEC31A;RAB30;MYO18A;GORASP2;ARHGAP21;TMED1;GOLGB1;LMAN1;CDC42;ARFGEF2;ZW10;LRRK2;SNX33;UBXN2B;EIF2AK3;RAB22A;ALS2;TLCD1;TRIP11;LEMD3;MIA3;ARL1;TMED4;PLEKHM2;TJAP1;GOLPH3L;GORASP1;GOLGA8B;GOLGA5;TANGO2;HOOK2;ATP8B2;TOR1B;FER1L5;TBC1D20;BAG5;HACE1;HUWE1;LAPTM4B;CUL7;GOLPH3;TOR1AIP2;ARFGEF1
prerank,aspartate family amino acid catabolic process (GO:0009068),0.4849881195999532,1.1599387290063228,0.30413223140495865,0.7751554161733643,1.0,4/19,8.29%,PHYKPL;DDO;ASPA;ALDH7A1
prerank,cellular response to alcohol (GO:0097306),0.42366482916473447,1.1598673808582745,0.26207906295754024,0.7745422744741254,1.0,7/42,7.20%,ADCY1;ADCY2;ADCY7;ADCY5;SMO;SFRP1;SPHK2
prerank,negative regulation of locomotion (GO:0040013),-0.4681154916872513,-1.1595622206558736,0.28365384615384615,0.7745213489514319,1.0,3/12,8.56%,FRMD5;PTPN2;CCDC125
prerank,heart contraction (GO:0060047),0.4193373060949256,1.1595584919795985,0.27167630057803466,0.7746190527655525,1.0,7/41,9.65%,SLC8A1;ATP1A2;TPM1;TNNC1;MYL4;GAA;CSRP3
prerank,myelination (GO:0042552),-0.3310391417384516,-1.1593628237313354,0.2198581560283688,0.773138081676047,1.0,15/46,14.74%,ADGRG6;ACER3;MAL;CMTM8;B4GALT5;MYOC;SCN2A;EIF2B5;DEGS1;TNFRSF21;NF1;MAL2;MALL;PLP1;NFASC
prerank,regulation of primary metabolic process (GO:0080090),0.36189695171603703,1.1586104170316547,0.22941176470588234,0.776599907677486,1.0,40/126,23.42%,ROCK2;TBL1XR1;FGFR4;C1QTNF2;CHD9;APOE;PSME4;NCOA2;LDLR;MVK;SREBF1;NR1D1;NCOR1;IDI1;NR1D2;NCOR2;HELZ2;FASN;CERS2;RXRA;HMGCS1;SP1;PSMB5;PSMC2;OAZ3;PSMD1;CARM1;NCOA6;SCD;PSMD4;ABCA7;PSME3;PSAP;PSMA3;RUBCNL;NFYC;CYP51A1;PSMA2;PSMC5;SREBF2
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.447713131028846,1.1585719527002978,0.28322784810126583,0.7758690015716168,1.0,2/28,1.86%,ITPR1;BCL2
prerank,retrograde axonal transport (GO:0008090),-0.4328123130697575,-1.1580712424053954,0.2554347826086957,0.7751054762338727,1.0,8/16,27.71%,DLG2;TMEM108;PAFAH1B1;KIF1A;KIF5A;HAP1;SOD1;ACTR10
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.4613989509424529,1.1579615036916828,0.2753846153846154,0.7768213055433677,1.0,8/26,17.55%,GAL3ST2;LARGE1;GBGT1;ALG11;ALG6;GOLPH3;GK;TNIP1
prerank,regulation of neuronal synaptic plasticity (GO:0048168),-0.3763933196835208,-1.157642197179529,0.25892857142857145,0.7745091638075801,1.0,5/29,6.96%,SLC4A10;MCTP1;ZDHHC2;GRIK2;SYP
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),-0.35224248077569587,-1.1575331214752278,0.23509933774834438,0.7728739970621908,1.0,16/36,24.79%,SDCBP;RYBP;OPHN1;RPL11;HSP90AB1;AQP11;PSMF1;GIPC1;N4BP1;FHIT;DDRGK1;UBXN1;CAMLG;CCAR2;USP7;PRKCG
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.5051120576501482,1.1573923122519907,0.2962962962962963,0.7776117147010824,1.0,6/16,14.41%,ADCY7;APPL2;F2;PDCD4;ABCD2;CHID1
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.43401235513825537,1.1571121908092792,0.2886297376093295,0.777559222528672,1.0,4/35,3.16%,PAM;SLC27A5;ACSS3;HMGCLL1
prerank,icosanoid metabolic process (GO:0006690),0.42592798029286477,1.1570102446811499,0.28530259365994237,0.7770460157991518,1.0,7/40,7.16%,PTGIS;DAGLA;PLA2G4A;CYP1B1;DPEP1;ALOXE3;DPEP2
prerank,positive regulation of nervous system development (GO:0051962),-0.3405955869681432,-1.1564829834551702,0.18835616438356165,0.7742411303358505,1.0,17/42,16.30%,GRID2;NLGN1;IL1RAPL1;PTPRD;EPHB1;NRXN1;TGM2;SNW1;CLSTN2;CLSTN3;CX3CR1;FAIM;MME;NUMB;NLGN3;LRRC4B;GPER1
prerank,cellular modified amino acid biosynthetic process (GO:0042398),-0.40769077447843055,-1.1559409421620799,0.2864583333333333,0.7742168516013712,1.0,11/20,27.21%,GATM;GCLM;PTDSS1;OPLAH;GAMT;GCLC;GGT1;GGCT;PLSCR1;GSS;PLOD2
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.4337337828629018,1.1558194441238039,0.2822822822822823,0.7796243870532319,1.0,7/34,9.48%,LYN;LGR4;PTPRS;TLR6;NR1D1;IRAK3;RAB7B
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.5097664131789366,1.1556097837106414,0.31333333333333335,0.7793899037239074,1.0,3/14,4.30%,GAS6;RFFL;APOA1
prerank,response to interleukin-4 (GO:0070670),-0.4952221193406116,-1.1555132769439038,0.2909930715935335,0.7736937255437621,1.0,1/10,0.16%,LEF1
prerank,sensory perception of pain (GO:0019233),0.4854033717789208,1.1540198485716016,0.3015625,0.7832186622761961,1.0,4/21,11.71%,TRPA1;PTGES;ALOXE3;NIPSNAP1
prerank,morphogenesis of an epithelial sheet (GO:0002011),-0.49194212620334143,-1.1538021505136131,0.2900232018561485,0.7773450238205133,1.0,7/10,31.21%,NOTCH1;LRP6;LIN7C;DLL4;ARHGAP12;TBX20;PHACTR4
prerank,pyruvate metabolic process (GO:0006090),-0.32170744639607585,-1.1535144375142075,0.2114695340501792,0.7763562392867127,1.0,13/52,12.09%,BSG;GPI;HK2;DLAT;SLC16A1;ME1;PDHX;PFKL;TPI1;PFKFB1;ALDOA;LDHB;ME2
prerank,positive regulation of protein import (GO:1904591),0.4410299254204662,1.153418689379183,0.28417818740399386,0.7841010603717772,1.0,10/30,18.62%,PIK3R1;SMAD3;ZIC1;PDCD5;RBM22;FLNA;PIK3R2;UBR5;EFCAB7;TPR
prerank,protein heterooligomerization (GO:0051291),-0.42207895024655223,-1.1534085944684913,0.2769607843137255,0.7747765304768929,1.0,10/17,27.85%,KCNC2;GRIN2B;CPSF7;MAT2A;HSD17B8;TMEM120A;GRIN1;CBR4;CPSF6;PKD1
prerank,positive regulation of GTPase activity (GO:0043547),-0.26601881149040524,-1.1531890068929278,0.17204301075268819,0.7735220149269603,1.0,44/188,11.96%,PKP4;DOCK9;RAP1A;ITGA6;F11R;CAV2;RABGAP1;RAP1GDS1;SIPA1L1;BCAR3;NET1;SNX13;TBC1D1;RGS6;ARHGEF15;SIPA1L2;TBC1D8;TBC1D14;TBC1D15;TGM2;ARHGAP27;RAP1GAP2;ERBB2;EZH2;TBC1D9;CCL14;NGEF;TBC1D30;ARAP1;RASGRF1;RGS7;CCDC125;LARS1;BCR;RUNDC1;RALGAPA2;SCRIB;RGS16;ARHGAP25;AGRN;RANGAP1;NF1;EVI5;CD40
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.45401585284189977,-1.1530650070153519,0.2702020202020202,0.7719879135404293,1.0,6/14,21.67%,RPL7;NIFK;NOL9;RPL7L1;RPF2;ZNHIT3
prerank,regulation of fatty acid metabolic process (GO:0019217),-0.4244557724140921,-1.1529539241137237,0.27440633245382584,0.7704375436162986,1.0,3/17,2.87%,CAV1;ADIPOR2;PPARD
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.41069693937900004,1.1528596469167032,0.26227208976157085,0.7848688818810639,1.0,13/46,17.55%,TIMP3;LYN;FBLN1;RANBP9;EMILIN1;EPHB2;SPRY2;SPRED3;CNKSR3;PTEN;SPRED1;DUSP4;TNIP1
prerank,regulation of cellular localization (GO:0060341),0.4105454443830023,1.152772271922678,0.27071823204419887,0.7842910124971524,1.0,11/46,9.32%,GSN;LYN;ADCY5;CDK16;DYNC1H1;LRRK2;BRSK1;NR1D1;PARD6G;PARD6B;PRKN
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.4851692321508772,1.1509696311034923,0.2988691437802908,0.7886983297493014,1.0,2/19,3.11%,ENPP1;TPST1
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.4441417837155418,1.1508994779930426,0.29790419161676646,0.7880794197712396,1.0,7/29,13.57%,GHR;IL31RA;NMI;STAT5B;STAT2;STAT6;STAT4
prerank,Golgi localization (GO:0051645),0.5393216710191288,1.150870322642479,0.3166089965397924,0.7873169790502409,1.0,5/11,17.58%,ARHGAP21;TBCCD1;CDC42;UVRAG;COPG1
prerank,regulation of histone H3-K4 methylation (GO:0051569),0.5037430784413552,1.1507031898981688,0.3239669421487603,0.7869261016812332,1.0,7/16,22.99%,AUTS2;BCOR;KMT2A;WDR5;DNMT3B;DNMT1;BRCA1
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.35872376138116596,1.1503981803174281,0.25748502994011974,0.7869099390394312,1.0,13/116,6.97%,ADCY1;ADCY2;LYN;ADCY7;ADCY5;ADCY9;INSL3;VIP;LHCGR;ADRB3;SRC;CD247;DPEP1
prerank,aspartate family amino acid metabolic process (GO:0009066),0.4919850092634019,1.1503107176445082,0.30130293159609123,0.7863162272890899,1.0,3/18,6.15%,ASPG;MTHFR;ASPA
prerank,establishment of melanosome localization (GO:0032401),-0.412784479860821,-1.1501786799646971,0.26273458445040215,0.7772777148311829,1.0,8/19,19.54%,RAB27A;RAB11A;RAB27B;ARL6;MLPH;BLOC1S5;BBS7;MREG
prerank,carboxylic acid transmembrane transport (GO:1905039),0.4197443944141715,1.1501266026810633,0.27696793002915454,0.786054565881251,1.0,10/40,15.60%,SLC7A11;SLC13A3;SLC7A13;SLC38A6;SLC38A9;ABCC5;SLC38A3;SLC7A6;SLC38A10;SLC38A2
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.5023565005926273,1.1499106484630512,0.31727574750830567,0.7858194648513286,1.0,10/16,25.65%,LRRK2;BCAP31;MIA3;UBAC2;SEC16B;SEC16A;HSPA5;PPP1R15A;ANK2;VAPA
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),-0.3927365345365038,-1.1497389757518794,0.2471590909090909,0.7767951359345775,1.0,11/22,31.32%,PTPRJ;PTPN2;PTPN22;CEACAM1;DGKZ;CD300A;DUSP3;PRNP;GPS2;FCGR2B;PHPT1
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.44732832703800973,-1.1494792120017097,0.3034825870646766,0.7756947550619941,1.0,8/16,19.53%,THBS1;PPP1R16B;JCAD;GATA2;VEGFA;APLNR;DLL4;PDCD10
prerank,synaptic membrane adhesion (GO:0099560),0.5067149381663841,1.1494508125986505,0.31605351170568563,0.7862699013026561,1.0,2/14,5.18%,GPC6;PTPRS
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.43229924188480123,1.1490930148882037,0.30618401206636503,0.786553975808871,1.0,2/32,0.72%,PDPK1;CEMIP
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.3045215269643832,-1.1490248009977768,0.20175438596491227,0.7752347967687576,1.0,31/69,28.83%,COX4I1;NDUFC1;UQCRH;SDHD;COX6A1;COX5B;NDUFA6;NDUFA5;CYCS;NDUFA7;NDUFA8;NDUFB7;NDUFA3;NDUFA10;COX5A;COX6C;NDUFS7;NDUFS1;NDUFS5;UQCR10;NDUFB3;COX8A;UQCR11;UQCRQ;UQCRC1;NDUFAB1;UQCRFS1;AFG1L;NDUFB4;NDUFV2;NDUFV3
prerank,regulation of myoblast fusion (GO:1901739),0.5322247245805324,1.1490095913507088,0.3320964749536178,0.7859713676006996,1.0,3/11,11.17%,RIPOR2;CFLAR;CD53
prerank,cellular response to organic substance (GO:0071310),0.3594775493742717,1.1488513045781068,0.2441860465116279,0.7855981983740451,1.0,17/116,8.85%,CLEC3B;PID1;GHR;SMAD3;PTPN13;BMPR1A;PTPN20;TGFBR1;DPYSL3;ACVR1;NCOA2;SFRP1;IGFBP5;CYP1B1;LRRK2;PTPN9;STAT5B
prerank,membrane depolarization during action potential (GO:0086010),0.46007353018298586,1.1487342925249988,0.2996941896024465,0.785093278463301,1.0,3/26,1.81%,SCN7A;SLC8A1;ATP1A2
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.42210411815138194,1.1486440676335263,0.30337078651685395,0.7844990095971317,1.0,6/39,5.69%,NRP1;GDNF;GLI2;SALL1;NKX2-1;ENG
prerank,actin nucleation (GO:0045010),-0.4029385679955196,-1.1483016279282658,0.2757660167130919,0.7757039538792659,1.0,6/21,19.35%,ARPC1B;SPIRE1;ARPC3;ARPC5L;ARPC4;LMOD1
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.5626249507097093,1.1483004981920484,0.31922398589065254,0.7846587201312127,1.0,4/10,13.09%,ATP1A2;ADRA2A;YWHAE;VDAC1
prerank,peptide hormone secretion (GO:0030072),0.4575852540969225,1.1482634598244312,0.30078740157480316,0.7839297527950656,1.0,5/26,5.61%,SLC30A8;CDK16;NEUROD1;VIP;FAM3B
prerank,negative regulation of endocytosis (GO:0045806),0.45426011604546024,1.1472721372709367,0.3058470764617691,0.7859010073087802,1.0,6/24,15.36%,EPHA3;SNX33;PICALM;SYT11;NR1H3;ARF6
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.38940509516692,1.1467796605651277,0.28900949796472186,0.7864446102542135,1.0,18/59,18.49%,PDPK1;ROCK2;TGFBR1;ACVR1;LRRK2;MAP2K1;OXSR1;TTBK1;TBK1;WNK1;ACVR1B;MARK2;DYRK1A;DYRK1B;AKT1;CDK10;DYRK3;PRKCA
prerank,"phototransduction, visible light (GO:0007603)",-0.43974491416907674,-1.1466459347132252,0.3010204081632653,0.7788980485073311,1.0,7/14,33.84%,RP1;GNB1;PDE6A;GNA11;GNAQ;PDE6B;SAG
prerank,regulation of mitotic sister chromatid separation (GO:0010965),0.5082938984836336,1.1466304303354105,0.32941176470588235,0.7860662067161002,1.0,4/15,20.47%,HECW2;NEK6;TPR;CDC23
prerank,positive regulation of lymphocyte proliferation (GO:0050671),-0.31253904364887386,-1.1458223941085304,0.1950207468879668,0.7795756911910231,1.0,23/63,24.61%,MEF2C;VAV3;CD38;SLC7A1;IL15;TFRC;NFATC2;CD40;CD80;CD81;GPR183;PTPRC;JAK3;CD320;NCK2;PNP;CD86;ANXA1;CD276;AIF1;VCAM1;IRS2;MIF
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.5229097634080935,1.1457834572965173,0.313458262350937,0.7876663547105068,1.0,2/13,5.69%,NRP1;ENG
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.46221756014358534,1.1456025398332998,0.31521739130434784,0.787384694706222,1.0,8/23,15.02%,ENPP1;GLI3;MGRN1;TULP3;GLIS2;PTCH2;BTRC;SUFU
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.4837162822946634,1.1454942129578796,0.30615640599001664,0.7868367834746003,1.0,6/20,14.18%,SULF2;SULF1;SMOC2;SPRY2;FGF2;DSTYK
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.3567384395713249,1.1453566468323242,0.2517814726840855,0.7864105126372637,1.0,13/117,6.97%,ADCY1;ADCY2;LYN;ADCY7;ADCY5;ADCY9;INSL3;VIP;LHCGR;ADRB3;SRC;CD247;DPEP1
prerank,regulation of macrophage chemotaxis (GO:0010758),-0.39687829758391563,-1.145246063003992,0.275,0.7796373705750989,1.0,4/21,4.35%,MTUS1;PTK2B;THBS1;CMKLR1
prerank,negative regulation of secretion by cell (GO:1903531),-0.34462442241793434,-1.1451784351910315,0.26101694915254237,0.7779904851783547,1.0,4/38,2.20%,GRM7;STXBP6;IL1RAPL1;NOTCH1
prerank,circulatory system development (GO:0072359),0.3570358115829891,1.145104466498924,0.24182242990654207,0.7863398280673963,1.0,21/118,8.83%,RBP4;FBN1;PDLIM5;HSPG2;GLI2;SALL1;PDLIM2;TGFBR1;SH3PXD2B;ACVR1;CDH5;ADAP2;BCOR;CRB2;CACNA1C;OSR1;NTRK3;FOXC2;BMP2;EEF1AKMT4-ECE2;KAT2B
prerank,regulation of JNK cascade (GO:0046328),0.3620508231397854,1.1448779340910882,0.2573170731707317,0.7862533317591412,1.0,19/101,12.75%,CCN2;TGFBR3;SH3RF3;DACT1;SH3RF1;GADD45B;CCL19;EDAR;MTURN;NCOR1;EGFR;MAP4K4;PRKN;LTBR;ITCH;CARD9;TAOK3;DUSP19;RAP2A
prerank,tRNA methylation (GO:0030488),0.4372245661742695,1.1438499456204247,0.2955223880597015,0.7884001681974396,1.0,10/34,16.30%,TRMT44;TRMO;NSUN2;BCDIN3D;TRMT13;TRMT112;PRORP;THUMPD3;THUMPD2;THADA
prerank,peptidyl-glutamic acid modification (GO:0018200),-0.39022421098058024,-1.1435602915124463,0.26878612716763006,0.7813063835013585,1.0,9/24,27.96%,TTLL7;TTLL5;AGBL4;TTLL3;TTLL8;PARP1;TTLL6;TTLL2;AGTPBP1
prerank,regulation of protein ubiquitination (GO:0031396),0.36450762966091854,1.143546434763188,0.2765957446808511,0.7884603434446845,1.0,22/108,15.20%,MYCBP2;ANGPT1;SASH1;OGT;TGFBR1;CDK5RAP3;PRICKLE1;DERL1;LRRK2;SPRTN;ARRB1;SPRY2;COMMD1;PRKN;UFL1;FBXO4;HDAC8;RIPK2;FANCI;UBE2D1;BAG5;HUWE1
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.3777499568363273,1.1434363669002718,0.2722710163111669,0.787961417875856,1.0,12/80,9.59%,NRP1;AUTS2;PIK3R1;DOCK11;RIPOR2;DPYSL3;CCL19;CDC42EP4;CDC42;ARHGAP35;CROCC;PLEKHM1
prerank,mesenchymal cell development (GO:0014031),-0.416712283920055,-1.1434190675392295,0.27735368956743,0.7798761659127058,1.0,8/18,28.15%,CDH2;NOTCH1;HEY2;SOX8;HEYL;SNAI2;NOLC1;TBX20
prerank,regulation of DNA repair (GO:0006282),0.4086347111691856,1.1432376076096415,0.30014025245441794,0.7877347844027628,1.0,11/44,16.59%,EYA2;EYA1;AXIN2;PML;TRIP12;UBE2V2;EGFR;ERCC8;NPAS2;UBR5;SMCHD1
prerank,regulation of microglial cell activation (GO:1903978),0.49390594628357665,1.142989093800097,0.3102866779089376,0.787582716522853,1.0,5/15,17.51%,LDLR;NR1D1;TTBK1;SYT11;CX3CL1
prerank,regulation of sensory perception of pain (GO:0051930),-0.4718241677274306,-1.142706938099356,0.3055555555555556,0.7802919274694201,1.0,5/11,19.08%,MGLL;CCN3;ATPSCKMT;ZFHX2;ACP3
prerank,microglial cell activation (GO:0001774),-0.38794702549314486,-1.1426677139945018,0.26685393258426965,0.7785600734697911,1.0,8/21,24.16%,JAK2;CX3CR1;APP;CLU;AGER;AIF1;TREM2;IFNGR1
prerank,calcium ion transport (GO:0006816),0.3649239901595925,1.142433013227479,0.2536057692307692,0.788329715066653,1.0,15/113,9.62%,ITPR1;SLC24A3;NALCN;SLC8A1;SLC8A3;TRPA1;GAS6;STIM1;SLC24A1;SLC24A5;CACNA1C;PANX1;ORAI2;TRPM4;ITGAV
prerank,vacuolar acidification (GO:0007035),0.4687902497079913,1.1423762006678713,0.30870279146141216,0.7876502756315112,1.0,1/21,0.20%,ATP6V0A4
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.3772021492293347,1.1423667281421015,0.26032540675844806,0.7868572404656596,1.0,14/80,10.98%,SAMD4A;ROCK2;PLD1;EPHA4;SMPD2;CPEB3;CD28;SPHK2;SLC2A13;METTL14;PICALM;EIF6;NSMAF;DDX3X
prerank,male meiosis I (GO:0007141),0.5046252232230072,1.142329820088784,0.34833333333333333,0.7861480717093545,1.0,6/16,17.50%,HSF2BP;ZSCAN21;SYCP3;MYBL1;FOXJ3;DDX4
prerank,phosphatidylinositol biosynthetic process (GO:0006661),-0.282823585918344,-1.1422313952547065,0.17964071856287425,0.7780284120256128,1.0,40/119,19.28%,PIP5K1B;EFR3B;PLCG2;INPP5D;BMX;PIK3R6;DPM1;MTMR2;SOCS2;TTC7A;INPP4B;PLEKHA3;PIGP;INPP5K;PLEKHA1;INPP5F;PGAP2;MTMR9;IP6K1;PIK3R3;ARF1;PIGB;SACM1L;PIK3R5;MTMR6;ARF3;MBOAT7;PIK3C2B;PIGL;PIK3CA;RAB4A;DPM3;PIGU;DPM2;PITPNM3;INPP5E;PIGO;SYNJ1;PIGV;RUFY1
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),-0.45849343286513855,-1.1421655312618113,0.29931972789115646,0.7764360589459435,1.0,4/12,9.72%,ANK3;NOS1;ATP1B1;WNK2
prerank,defense response to Gram-negative bacterium (GO:0050829),0.4066284713995492,1.1420939280205438,0.2796005706134094,0.7859994965477732,1.0,9/42,16.18%,SERPINE1;IL6R;OPTN;IL12B;CAMP;RNASE7;F2;GSDMD;IL23A
prerank,neuron projection regeneration (GO:0031102),0.5482944633866338,1.1420064855194032,0.34843205574912894,0.7854357445320032,1.0,2/10,4.34%,NREP;MTR
prerank,formation of extrachromosomal circular DNA (GO:0001325),-0.49765222074801513,-1.1416620503453423,0.31839622641509435,0.772545507779251,1.0,3/10,23.32%,NBN;SLX4;EXO1
prerank,telomere maintenance via telomere trimming (GO:0090737),-0.49765222074801513,-1.1416620503453423,0.31839622641509435,0.772545507779251,1.0,3/10,23.32%,NBN;SLX4;EXO1
prerank,t-circle formation (GO:0090656),-0.49765222074801513,-1.1416620503453423,0.31839622641509435,0.772545507779251,1.0,3/10,23.32%,NBN;SLX4;EXO1
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.4765726701574537,1.1412152687031922,0.284329563812601,0.7868822356732962,1.0,4/20,6.66%,SLC8A1;ATP1A2;GSTM2;CACNA1C
prerank,positive regulation of apoptotic process (GO:0043065),0.33118214222850073,1.1409151712879317,0.20464135021097046,0.7869265030633186,1.0,59/293,16.01%,STK17B;EPHA7;DAPK2;PTGIS;DAPK1;DLC1;OLFM1;PLEKHG2;GADD45B;TIAM2;PHLDA1;TGFBR1;NUPR1;MOAP1;SOS2;FGD1;PDCD5;NEUROD1;ING3;RARG;SFRP1;FGD4;MAP3K20;CYP1B1;BCL6;ARHGEF17;SIK1;ING5;SPHK2;SIRT2;ARHGEF18;TRAF7;STK4;BCL2L11;ARHGEF11;BMP2;AIFM1;FOXA1;APH1B;DDX3X;IGFBP3;SPDEF;ADAMTSL4;FGD3;REST;PLEKHN1;PAWR;IFIT2;AKAP13;MTCH2;MTCH1;BMP4;SUDS3;SFRP4;RBM5;NLRC4;ARHGEF19;CASP9;TRIO
prerank,neutrophil chemotaxis (GO:0030593),-0.3210056901618669,-1.1403224367609262,0.22692307692307692,0.7747399037081417,1.0,9/53,12.13%,PDE4B;BSG;TGFB2;PPIA;CCL14;FCER1G;EDN1;CKLF;CXADR
prerank,regulation of hydrolase activity (GO:0051336),-0.2992784168440164,-1.1401956465802219,0.2100456621004566,0.7733322445727495,1.0,18/71,7.22%,CHN2;EFNA5;FGD5;CAV1;PLXNA4;ARHGAP44;VAV3;RABGAP1;SIPA1L1;RASIP1;PRKG1;RDX;TBC1D15;ARHGAP27;EPHA5;NOS1;NGEF;CHN1
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.5250024457930569,1.1399262153709084,0.324459234608985,0.7889420377313422,1.0,3/12,3.81%,DOCK10;DOCK11;NOTCH2
prerank,regulation of cell population proliferation (GO:0042127),0.32156327179461563,1.1397985356901723,0.13152610441767068,0.7885326063172807,1.0,118/691,14.08%,IGF1;TCF7L2;BMP6;IGF2;ESM1;COL4A3;ELN;GDNF;PDGFD;KSR1;AREG;AR;TGFA;IL31RA;LYN;DLC1;BCL2;GRK5;PODN;RUNX1;FGFR1;IL6R;BMPR1A;IL34;OSMR;EPGN;FGFR2;KIT;FGFR4;RBFOX2;YAP1;PDGFRA;PDS5B;EFNB2;PDGFRB;TGFBR1;NUPR1;NPR3;PDCD5;CSF1;RAPGEF2;IRF1;NTF3;HTR1A;AXIN2;PHIP;RARG;SFRP1;CTSH;PDPN;TBX3;CYP1B1;VIP;BCL6;ENG;ZFP36L1;SKI;ALDH1A2;NUAK1;PML;BEX4;CEBPA;AGTR1;ING5;P3H3;TSLP;WWTR1;RAB25;IL13RA1;SIRT2;MAP2K1;NMI;RNF139;TET1;NTRK3;EGFR;CD200;BMP2;KAT2B;STAT5B;TRPM4;S100A11;ITGAV;STAT2;STK11;INCA1;FGF2;CDC123;TSPO;FGFBP1;SETD4;IGFBP3;GSDME;IFNK;HBEGF;ADRA2A;CGRRF1;UFL1;RGCC;REST;CD33;NIBAN2;GLI1;HMGN5;INSR;STAT6;FOLR2;NOX4;EGF;STAT4;TSC2;GLMN;HDAC4;PTEN;FLT3LG;CLMN;ETS1;FRK
prerank,generation of neurons (GO:0048699),0.34187689783329556,1.1396048547960251,0.24804469273743016,0.7882862172775723,1.0,25/190,7.59%,NRP1;AUTS2;RUNX1;FGFR1;MARK1;SH3RF1;WNT8B;FZD2;WNT4;ASCL1;YAP1;RUNX2;WNT6;RAPGEF2;NEUROD4;NEUROD1;FZD1;LRP12;THOC2;ATOH8;HES7;SMARCA1;WNT5B;BRSK1;MAP2K1
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.5532774527096108,1.1395953233934315,0.3207885304659498,0.7875030275231386,1.0,2/10,9.32%,MT3;PRKN
prerank,positive regulation of tissue remodeling (GO:0034105),0.5426508034489261,1.1395711138971698,0.3463687150837989,0.7867674005200708,1.0,2/10,6.81%,ROCK2;IL12B
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.38533794343293604,-1.1388871208595288,0.2810810810810811,0.7737577815809655,1.0,7/23,11.57%,PPP1R13B;YWHAH;YWHAQ;MAPK8;CASP8;YWHAG;BBC3
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.38533794343293604,-1.1388871208595288,0.2810810810810811,0.7737577815809655,1.0,7/23,11.57%,PPP1R13B;YWHAH;YWHAQ;MAPK8;CASP8;YWHAG;BBC3
prerank,AMP metabolic process (GO:0046033),0.5289161370346722,1.1384359654169125,0.3156089193825043,0.7891931282196311,1.0,2/13,3.28%,AMPD3;NUDT2
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.4774135992714581,1.1383894105123566,0.3184931506849315,0.7885125085510045,1.0,1/18,0.43%,FBN1
prerank,negative regulation of cellular process (GO:0048523),0.32453926954691936,1.1376297476613038,0.15532994923857868,0.7898904053128104,1.0,127/521,17.56%,PLXNA2;GJA1;ENPP1;COL4A3;CCN2;ANGPT1;TGFBR3;TXNIP;SMAD3;AR;LYN;DLC1;BCL2;PODN;CCN1;SP100;RIPOR2;PDS5B;NUPR1;SEMA5A;UBR2;PDCD5;FBLN1;APOA1;RAPGEF2;TSPYL2;APPL2;IRF1;MT3;AXIN2;RARG;SFRP1;CCN5;PDPN;CYP1B1;BCL6;SKI;CASK;ALDH1A2;APBB2;PML;EMILIN1;PARP16;CEBPA;ING5;P3H3;SPHK2;SIRT2;EIF2AK3;MAP2K1;NMI;RNF139;PIWIL4;DSCAM;EPHB2;CD200;BMP2;KAT2B;CCN4;PRKN;S100A11;MIA3;STK11;INCA1;RBBP7;SLIT3;FGF2;ANXA6;FGFBP1;DDX3X;IGFBP3;GSDME;IFNK;JADE1;CGRRF1;RGCC;ST7L;SPOCD1;NME6;RAD18;REST;NR4A1;IMPACT;CD33;PLXNC1;NIBAN2;CDA;PDCD4;SIPA1;ACVR1B;DACT2;MUL1;NOX4;NPAS2;SYT11;TSC2;GLMN;PLXNA1;PTEN;CLMN;ETS1;FRK;MDK;PLXNB2;NR1H3;FER1L5;BMP4;SFRP4;RBM5;TMBIM6;SESN2;PRKRA;BMP5;ZBTB17;SST;SPEG;KANK2;ADAMTS1;ATF5;SHH;TNS2;CDKN2C;MYBL1;VPS13C;DDX4;DCBLD2;CDK10
prerank,negative regulation of mRNA processing (GO:0050686),-0.436593570366138,-1.1369412635417124,0.32941176470588235,0.7777058405454634,1.0,9/15,32.67%,SRSF12;SRSF7;RBMX;C1QBP;SRSF4;PCBP4;U2AF2;RNPS1;BARD1
prerank,negative regulation of phosphorylation (GO:0042326),0.370427405607958,1.13690234935361,0.26548672566371684,0.7911853940665805,1.0,23/85,15.46%,PID1;PTPN13;PLPP3;LYN;DYNLL1;NUPR1;FBLN1;CDK5RAP3;LRRK2;WWTR1;NTRK3;NCOR1;EPHB2;PRKN;MYADM;IGFBP3;IMPACT;HDAC4;PTEN;IBTK;BMP4;CDKN1C;NPRL2
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.4216113906913687,1.136749917822352,0.3090909090909091,0.7908279280873789,1.0,3/34,8.61%,RBP4;SPHK2;EPHB2
prerank,nucleoside triphosphate metabolic process (GO:0009141),0.5088972292235548,1.136598081241741,0.33612040133779264,0.7904244913086931,1.0,1/14,0.63%,ENPP1
prerank,cellular component disassembly (GO:0022411),0.3896179118724,1.1363884424469646,0.27023498694516973,0.7902230174816185,1.0,10/53,9.83%,ADAMTS5;GSN;LAMC1;MMP2;MMP19;SH3PXD2B;MMP11;TIMP2;SCUBE1;HTRA1
prerank,potassium ion export across plasma membrane (GO:0097623),-0.45400036992926696,-1.1362820939998381,0.32,0.77795579388569,1.0,3/13,5.45%,KCNK5;KCND3;KCNQ1
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.5016469370879436,1.1358035281551346,0.3284072249589491,0.7911229355684666,1.0,5/15,16.71%,GLI3;IL12B;EBI3;IL23A;SHH
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.4901373163848435,1.1356147988780718,0.3242320819112628,0.790866322341624,1.0,5/16,20.48%,ZFP36L1;CPEB3;PLEKHN1;RC3H1;ZFP36L2
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.3284194252521271,1.135461707259685,0.21101871101871103,0.7905048040603684,1.0,79/327,18.96%,NFIA;IGF2;RORA;RHOH;ATXN1;ARNT2;MITF;WWC2;NUP107;TGFBR1;OGG1;MSC;NCOA2;DENND4A;ENG;TCF7;APBB2;NAB2;PML;CEBPA;WWTR1;SAP30;REXO4;ZBTB38;WTIP;TULP3;TCF7L1;CREBL2;BMP2;ZMIZ1;ZBTB4;NONO;MZF1;ACTN4;GTF2IRD1;NSD1;ACTR8;ZSCAN21;PHF1;RNF6;NR1D2;CEBPB;IFNK;REST;HMGN5;INSR;ACVR1B;TRIP4;TAF5L;ZNF219;YAF2;SUFU;MYCBP;FOXK2;SAP30L;GPBP1;FADS1;TGFBRAP1;PSPC1;MYT1;MAFA;PLAG1;COPS2;ZNF423;ATF5;SP1;ZFAT;MYBL1;SPIN4;IRF2;SRSF10;PPIE;NFIL3;SOX11;GON4L;CARM1;ATRX;CREM;CHD7
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.38416846812003813,-1.13485742474824,0.30523255813953487,0.7805462681613066,1.0,8/25,15.19%,SLIT2;ARHGAP44;LIMK2;TBC1D30;CEP97;TESK1;ABI3;PLXNB3
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.44144493826393494,-1.1343702640915474,0.32242990654205606,0.7802547403535637,1.0,8/14,30.81%,SRSF12;SRSF7;RBMX;C1QBP;SRSF4;PCBP4;U2AF2;RNPS1
prerank,regulation of protein phosphorylation (GO:0001932),0.33130321059818646,1.1342579028414461,0.21855010660980811,0.7930279673950179,1.0,55/256,14.89%,EPHA7;IGF2;ROCK2;ANGPT1;PID1;PTPN13;PLPP3;LYN;LEPR;IL34;PELI2;CCN1;GAS6;FBLN1;CDK5RAP3;TSPYL2;MT3;AXIN2;PHIP;MUSK;SLCO3A1;CDH5;ENG;PML;LRRK2;WWTR1;EIF2AK3;NTRK3;STK4;DAB2;ARRB1;EGFR;EPHB2;BMP2;PRKN;MYADM;ITGB3;STAT2;NSD1;FGF2;IGFBP3;CEBPB;F2;IMPACT;PPP2R5D;INSR;RAP2A;TMEM119;PTEN;PDCL3;PLXNB2;IBTK;AKAP8L;RSPO1;BMP4
prerank,positive regulation of Notch signaling pathway (GO:0045747),0.40938299688095026,1.1338687591716035,0.30737134909596664,0.7932921422893469,1.0,8/39,8.83%,ROBO1;YAP1;MAML3;ENHO;SRC;RBPJ;ZMIZ1;KAT2B
prerank,extracellular matrix disassembly (GO:0022617),0.3904798821186097,1.1336531323533456,0.270481144343303,0.7931095901822743,1.0,13/53,14.33%,ADAMTS5;GSN;LAMC1;MMP2;MMP19;SH3PXD2B;MMP11;TIMP2;SCUBE1;HTRA1;NOXO1;CTSL;HPN
prerank,inorganic cation transmembrane transport (GO:0098662),0.3315801752366344,1.1334297495670969,0.22896698615548455,0.7929562326956348,1.0,30/268,9.62%,SLC1A3;ATP6V0A4;KCNK2;SLC24A3;SCN7A;NALCN;SLC8A1;SLC8A3;TRPA1;ATP1A2;SLC41A1;SCARA5;SLC6A9;SLC30A8;GAS6;SLC6A13;SLC9A9;SLC24A1;SLC30A2;KCNK7;SLC11A2;SLC24A5;CACNA1C;SLC30A10;NNT;KCNQ4;SLC9A5;KCNJ14;TRPM4;ITGAV
prerank,positive regulation of protein dephosphorylation (GO:0035307),-0.34477059315353864,-1.132926621685314,0.24104234527687296,0.7828124990519457,1.0,11/32,12.39%,PPP1R16B;ITGA1;PPIA;HSP90AB1;PPP1R15B;PPP2R5A;SPPL3;CALM1;CALM3;TGFB1;MTOR
prerank,negative regulation of coagulation (GO:0050819),0.5173096723227718,1.132584611340333,0.3213675213675214,0.7944907392474526,1.0,4/14,5.43%,SERPINE1;APOE;VTN;TFPI
prerank,organelle organization (GO:0006996),0.32700369604505686,1.1315907770388918,0.195496417604913,0.7965820256052074,1.0,109/388,19.66%,SH3D19;MICAL3;NEDD9;OBSL1;TPM1;PYROXD2;USP6NL;LMAN2L;MARK1;ANK1;OPTN;SEC31A;APOE;RAB30;MYO18A;PALLD;CNN2;WDPCP;FGD1;GORASP2;BRWD1;ARHGAP21;TMED1;GOLGB1;PHIP;LIG4;FGD4;FAF2;DES;LMAN1;ARHGAP10;CDC42;ZW10;RANBP9;LRRK2;UBXN2B;EPS15;EIF2AK3;CSPG5;WTIP;PLD2;MAST2;CAPZB;TRIP11;WDR81;PRKN;MIA3;RHOT1;ARL1;TMED4;PLEKHM2;LONP2;TJAP1;TFAM;PDZD8;POLRMT;PEX6;GOLPH3L;CFAP410;GORASP1;FGD3;SLC25A36;PEX2;SIPA1;GOLGA8B;GOLGA5;CHMP5;RAB3GAP1;ABCA3;TANGO2;CECR2;MDK;ABCD2;ATP8B2;TOR1B;PEX11B;TBC1D20;BAG5;HACE1;HUWE1;PIKFYVE;AUP1;CUL7;GOLPH3;VPS13D;TOR1AIP2;ARFGEF1;LONP1;RHOU;VPS13C;CAMSAP1;RAB32;TMED10;DYRK3;PRKCI;YME1L1;CSNK1A1;PHB2;ODF2;SEC16B;DPYSL2;CDCA8;SIRT5;HTT;NUMA1;SMPD4;ZFYVE16;PEX7;NSFL1C
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.45814800972538794,1.1310731598253199,0.326984126984127,0.7971758301504318,1.0,5/23,7.40%,GHR;KIT;CYP1B1;TSLP;CENPJ
prerank,positive regulation of immunoglobulin production (GO:0002639),0.43525174525668076,1.1306276052972792,0.2986627043090639,0.7976884634827687,1.0,3/31,8.61%,RBP4;KMT5B;EPHB2
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.5131538330061888,1.1305908058217644,0.3521594684385382,0.796985347985657,1.0,4/13,11.81%,PGM3;LARGE1;RENBP;MGAT3
prerank,regulation of phosphate metabolic process (GO:0019220),0.48889823197343624,1.130300666789385,0.33278688524590166,0.7970551266370344,1.0,3/16,7.37%,SRPX2;GNB3;SIRT2
prerank,regulation of cardiac muscle cell action potential (GO:0098901),-0.3780267686408558,-1.1302165220478053,0.29428571428571426,0.7892005391970666,1.0,9/25,14.09%,CAV1;CTNNA3;CAMK2D;CALM1;JUP;CALM3;CXADR;RYR2;DSG2
prerank,gliogenesis (GO:0042063),-0.4291068929834767,-1.1299349458702859,0.3164251207729469,0.7882391120695729,1.0,3/15,3.96%,CDH2;CDK6;TGFB2
prerank,regulation of cholesterol metabolic process (GO:0090181),0.46603724457744206,1.1298712263778992,0.30866141732283464,0.7975244220713058,1.0,4/20,7.36%,EPHX2;APOE;GNB3;SREBF1
prerank,regulation of mast cell activation (GO:0033003),0.5402458892177658,1.1296328890083518,0.36684303350970016,0.7973423231073771,1.0,2/10,7.07%,LYN;TSLP
prerank,aminoglycan catabolic process (GO:0006026),0.4334181717322479,1.1293991577948128,0.28865979381443296,0.7972615791775765,1.0,3/28,6.56%,GPC6;HSPG2;SDC1
prerank,muscle cell development (GO:0055001),0.43201069491297595,1.1292866848620542,0.29971181556195964,0.7967906987711368,1.0,4/30,6.56%,IGF1;SLC8A1;ENG;SDC1
prerank,lamellipodium organization (GO:0097581),-0.36467932265120806,-1.1290562764205656,0.26875,0.7891035604118838,1.0,9/29,9.32%,PARVB;CCDC88A;ABLIM1;S1PR1;SPATA13;CDH13;SNX1;ABLIM3;ABLIM2
prerank,regulation of collagen biosynthetic process (GO:0032965),0.47059230203978103,1.1290390201959792,0.32063492063492066,0.7967493567949826,1.0,8/19,20.89%,RUNX1;WNT4;EMILIN1;RGCC;F2;BMP4;LARP6;CREB3L1
prerank,negative regulation of endothelial cell proliferation (GO:0001937),0.42328037342150504,1.1289261273297986,0.3057142857142857,0.7962951913757723,1.0,7/35,6.81%,COL4A3;SPARC;NR2F2;APOE;SULF1;ATOH8;IL12B
prerank,positive regulation of protein metabolic process (GO:0051247),0.3549816353905428,1.1288106328566845,0.27144535840188017,0.7958348250842106,1.0,15/110,6.90%,ROCK2;HECW2;DACT1;NKD1;SLC6A9;IL17D;APOE;CSF1;NEDD4;SLC25A37;SMURF2;VIP;RANBP9;IL12B;AGTR1
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.540536632632836,1.1285314826897712,0.3559928443649374,0.7958341491143053,1.0,4/10,9.06%,HECW2;NEDD4;OSR1;COMMD1
prerank,sphingoid metabolic process (GO:0046519),0.5158388410509487,1.1277972002140315,0.3282051282051282,0.7971891348675126,1.0,3/12,10.89%,PLPP3;SPHK2;KDSR
prerank,cortical actin cytoskeleton organization (GO:0030866),0.4670406363123473,1.1276926264913272,0.31001589825119236,0.7966907638996514,1.0,9/20,23.17%,ROCK2;FMNL1;RHOQ;LLGL1;ARF6;FHOD1;LLGL2;NCKAP1L;DLG1
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.37797840203079863,1.1273452349085367,0.2956989247311828,0.7969128716246656,1.0,17/66,17.13%,PIK3R1;SMAD3;ZIC1;YAP1;CDK5RAP3;WWTR1;EIF2AK3;RBM22;F2;NMD3;FLNA;SESN2;PIK3R2;UBR5;AKT1;LIF;EFCAB7
prerank,positive regulation of actin nucleation (GO:0051127),0.5291727001231785,1.1271027466679386,0.3488372093023256,0.7968403579817155,1.0,3/11,16.31%,GSN;WASF1;FCHSD2
prerank,spliceosomal complex assembly (GO:0000245),0.39422233039952964,1.126396992809788,0.29958391123439665,0.7980758265255021,1.0,12/46,18.51%,CELF2;SF1;DDX23;NOL3;SNRPD2;SRSF5;RBM5;PRPF6;SF3B1;SRSF10;KHDC4;DDX1
prerank,phosphorylation (GO:0016310),0.32015593891924315,1.1263920679333408,0.20249221183800623,0.7972930371716601,1.0,66/385,14.16%,STK17B;EPHA7;DAPK2;PDPK1;PDK1;NRK;ROCK2;CDK14;CDK8;DAPK1;GRK3;LYN;GRK5;FGFR1;BMPR1A;DMPK;MARK1;PRKAG2;GAS6;TGFBR1;ACVR1;CDK16;PRKAA2;MAP3K20;NUAK1;LRRK2;AKT3;SIK1;SPHK2;EIF2AK3;BRSK1;MAP2K1;OXSR1;MAST2;STK4;IRAK3;EPHB2;BMP2;MAP4K4;CAMK2B;XYLB;STK11;RNASEL;RYK;TTBK1;NEK6;BRAF;TAOK3;PI4KA;IGFBP3;IKBKE;TBK1;TLK1;STRADA;WNK1;MAP3K13;INSR;MAP4K5;GRK4;ACVR1B;MARK2;PIK3R4;CDK12;CERK;FRK;MERTK
prerank,regulation of protein kinase activity (GO:0045859),0.3570599058623456,1.1263896705775729,0.28361858190709044,0.7965087818973111,1.0,11/106,4.40%,PDPK1;DDR2;PPM1E;CCN1;DTNBP1;PRKAG2;GAS6;CCL19;CSF1;RAPGEF2;TSPYL2
prerank,cardiac muscle cell contraction (GO:0086003),-0.4028913727194746,-1.1248469056527273,0.28746928746928746,0.8003538199872218,1.0,8/19,15.08%,KCNJ2;ATP1A1;SCN1A;CAMK2D;FGF12;PIK3CA;CACNA2D1;CACNA1D
prerank,myoblast fusion (GO:0007520),-0.46667978455750536,-1.1238899375728733,0.3137254901960784,0.8016209854522072,1.0,6/12,13.74%,ADGRB3;JAM2;ADAM12;NOS1;CD81;CACNA1H
prerank,regulation of transport (GO:0051049),0.4198125477383542,1.1235308499202634,0.30484330484330485,0.8040128853690446,1.0,6/36,9.32%,NRP1;LEPR;SLC30A8;LRRK2;RAB25;PRKN
prerank,regulation of inflammatory response (GO:0050727),0.3327652779472609,1.1232819369373468,0.2423580786026201,0.8039769348848307,1.0,40/190,18.25%,ADAMTS12;PTGIS;RORA;AHSG;SERPINE1;PTGES;DAGLA;CASP12;APOE;APOA1;MVK;BCL6;CDH5;IL12B;CEBPA;AGTR1;TSLP;NMI;NR1D1;CD200;CCN4;NR1D2;SETD4;TNFAIP6;UFL1;NAPEPLD;SELENOS;PDCD4;ETS1;MDK;NR1H3;TNFRSF1A;CD47;IL23A;FNDC4;LACC1;CX3CL1;TNIP1;IL18;CASP1
prerank,positive regulation of neurogenesis (GO:0050769),0.3777966342567227,1.1231180615731926,0.3303225806451613,0.8036466189441088,1.0,8/68,5.78%,ROBO1;PLXNA2;OBSL1;TIAM2;NUMBL;LIG4;CUX2;SERPINF1
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.4266742763423579,1.1230999619129158,0.33591331269349844,0.8029073633728295,1.0,11/30,16.71%,SP7;KIT;MLLT3;SFRP1;BATF;UFL1;FSTL3;BMP4;PRRC2C;PLD4;SHH
prerank,glycolipid biosynthetic process (GO:0009247),0.4169392736088298,1.122306323138459,0.3058823529411765,0.8043850082603664,1.0,4/38,4.33%,ST6GALNAC5;ST3GAL5;LARGE1;GBGT1
prerank,phosphatidylcholine catabolic process (GO:0034638),-0.48588541675976016,-1.1222629954744643,0.33403805496828753,0.8049861673602228,1.0,3/10,10.51%,ENPP2;PLA2G7;PNPLA8
prerank,protein transport (GO:0015031),0.3239159591491675,1.1216602194665588,0.23529411764705882,0.8054870151033088,1.0,59/332,16.17%,ATP6V0A4;WLS;RABGAP1L;TBC1D4;STEAP3;TXNIP;LRP1;ARRDC4;ABCA1;VAMP5;USP6NL;LMAN2L;MACF1;OPTN;SEC31A;APOE;TMED1;VPS26C;GOLGA4;RAB23;STXBP3;TVP23B;TOM1;STX16;ARFGAP3;ADPRH;SNX33;LTBP2;MIA2;IFT27;RAB22A;COPZ2;ARFIP2;MIA3;TBC1D2B;ARL1;GGA2;ATP6V1E1;TMED4;ARRDC2;GOLPH3L;STXBP1;RCN3;TLK1;MTTP;COPA;USO1;TVP23A;ARF4;TANGO2;SNX9;IFT22;ARF6;LAMP2;STX1B;ARL5A;SNX31;GOLPH3;RAB19
prerank,homocysteine metabolic process (GO:0050667),0.5297601882618379,1.1214665832260855,0.34929078014184395,0.8052435936479999,1.0,4/11,13.12%,MTHFR;DPEP1;MMUT;NOX4
prerank,cellular response to catecholamine stimulus (GO:0071870),-0.38549519384855885,-1.1213077089645311,0.31016042780748665,0.8061757789350451,1.0,11/23,22.34%,PDE4B;TGM2;KCNQ1;ATP2B4;GNB1;GNG2;MAPK3;RYR2;GABPA;ATF4;MAPK1
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.45091066040751543,1.1212474832136292,0.33169934640522875,0.8050806482815666,1.0,3/24,6.15%,AUTS2;PIK3R1;CDC42
prerank,vasculature development (GO:0001944),0.49423672743158337,1.1212408740470259,0.3349673202614379,0.804304664380798,1.0,5/16,9.86%,ERRFI1;PDGFRA;PDGFRB;CDH5;STK11
prerank,T-helper cell differentiation (GO:0042093),-0.4314861811136035,-1.1211404407349086,0.3137254901960784,0.8049112436559246,1.0,5/14,17.09%,LEF1;FOXP1;ATP7A;GPR183;ZFPM1
prerank,cellular protein modification process (GO:0006464),0.31346044163661707,1.1209977122901593,0.11611611611611612,0.8042168151695236,1.0,157/983,14.16%,LTBP1;STK17B;DAPK2;PDPK1;PDK1;CP;FBN1;SPSB1;NRK;PPM1H;ROCK2;CDK14;LOXL1;PPM1E;MATN3;CDK8;DAPK1;UST;LOX;PTPN13;AHSG;GRK3;PRKCSH;GALNTL5;IGFBP4;LYN;GRK5;OBSL1;ART4;FGFR1;B3GALT1;BMPR1A;DMPK;ST3GAL5;MARK1;PPP3CA;CCN1;LAMC1;PRKAG2;GAS6;APOE;PTPN21;TGFBR1;ST3GAL3;FSTL1;FBXL19;CSF1;LARGE1;TGM5;APOA1;APLP2;MT3;ACVR1;PSME4;CDK16;SERPIND1;IGFBP5;PTPRS;PRKAA2;MAP3K20;EPAS1;CST3;NUAK1;FUT10;TNC;CD247;CUL4B;LRRK2;ADPRH;AKT3;PARP16;ATG10;SIK1;STT3A;CUL5;SIRT2;EIF2AK3;BRSK1;MAP2K1;FBXL3;ARAF;RCN1;OXSR1;PTPN9;B3GALNT1;UBA7;MAST2;ALG5;STK4;IRAK3;DNAJC3;MTMR3;BMP2;MAP4K4;COMMD1;MTMR7;FN3KRP;CAMK2B;KRT10;MIA3;NGLY1;STK11;CTDSP2;RNASEL;PARP14;RBBP7;RYK;ASB12;PTPRM;TTBK1;BMP15;NEK6;BRAF;TAOK3;IGFBP3;PDIA6;FBXO9;FBXO11;UFL1;KBTBD7;DCAF8;IKBKE;ERCC8;FBXO4;TBK1;FBXL12;TLK1;STRADA;WNK1;PPP2R5D;FEM1C;MAP3K13;INSR;ITIH2;GPS1;BTRC;WIPI1;MAP4K5;GRK4;ACVR1B;PTPN3;COPS3;DDOST;TNKS2;P4HB;ENGASE;MARK2;ALG10B;PIK3R4;CDK12;PTEN;JMJD7;ARF4;COL3A1;FRK;FSTL3;MERTK
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.523518986735782,1.1209576733946103,0.36427320490367776,0.8035219713210137,1.0,3/10,8.90%,DCN;IL12B;SPRY2
prerank,regulation of cell communication (GO:0010646),0.4224809608881176,1.120932313303425,0.32988165680473375,0.802800605629244,1.0,4/35,4.40%,SLC8A1;GRK3;GRK5;TSPYL2
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.49596032785470673,1.1206665221348933,0.35748031496062993,0.8027483238701424,1.0,3/15,3.05%,ADGRV1;COL11A1;KIT
prerank,response to metal ion (GO:0010038),0.37290468430801876,1.1206367909836523,0.29365079365079366,0.8020450381252408,1.0,10/67,6.47%,PAM;BCL2;PPP3CA;SLC30A8;SEC31A;NEDD4;MT3;SLC30A2;NDRG1;SLC11A2
prerank,establishment of mitotic spindle localization (GO:0040001),0.4365901179738772,1.120395317197932,0.3373134328358209,0.8019081946389506,1.0,12/28,23.46%,GJA1;SPDL1;ZW10;UBXN2B;CENPA;KPNB1;HTT;NUMA1;NSFL1C;NDE1;FBXW11;ITGB1
prerank,regulation of protein localization to cell surface (GO:2000008),0.42264533851415176,1.1198859974932422,0.3039647577092511,0.8025930851785844,1.0,10/33,19.67%,ACTN2;LEPROT;SNX33;PICALM;COMMD1;TAX1BP3;EGF;BDNF;TM9SF4;ABCA7
prerank,regulation of transferase activity (GO:0051338),0.4839829483996568,1.1191637945614676,0.3570300157977883,0.803849513132764,1.0,1/17,0.36%,LDB2
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.31564249743047323,1.118953273447097,0.1492985971943888,0.8036905134917642,1.0,148/807,15.06%,TCF7L2;BMP6;LDB2;IGF2;FHL2;TBL1XR1;TRPS1;RUNX1T1;ATXN1;SMAD3;AR;ZEB2;MITF;GLIS3;NKX6-1;NR2F2;DACT1;GLI2;RUNX1;WWC2;SALL1;KCNIP3;CBX7;GLI3;AEBP1;ARID5B;ZEB1;NKX2-1;FGFR2;ARID4A;THRB;PRDM5;SP100;MDFI;WNT4;FOXP2;ASCL1;RBFOX2;YAP1;DNMT3A;GAS6;JDP2;RUNX2;RARB;LBH;MIDEAS;NFIX;MXI1;TLE1;IKZF4;SMURF2;IRF1;ZIC2;PRICKLE1;MT3;ZHX2;RARG;SFRP1;ETV6;TBX3;BCL6;CUX2;DKK3;USP47;SKI;BCOR;CBX3;ATOH8;NAB2;PML;CPEB3;CEBPA;MBD2;SAP30;SIRT2;DR1;ZBTB38;SMARCC2;NR1D1;OSR1;MTA2;RBPJ;DAB2;FOXC2;NCOR1;ZMYND15;MTA3;SCML2;BMP2;JAZF1;ZBTB4;BRMS1L;CBY1;NONO;ZBTB1;MZF1;PRKN;GTF2IRD1;HEXIM2;GLIS2;NSD1;PBXIP1;IFI27;ZKSCAN3;CXXC5;NR1D2;MBD1;KDM5C;NCOR2;ZNF177;CEBPB;L3MBTL1;BHLHE41;SPDEF;HDAC8;REST;PER3;IMPACT;NIBAN2;TCF25;PHF21A;PDCD4;BTRC;PEX2;PAF1;ZNF318;L3MBTL2;USP9X;IGBP1;HDAC4;HIVEP1;FRK;ZNF148;ZNF219;TWIST2;FLNA;YAF2;TCERG1;HSBP1;GATA6;NR1H3;BMP4;SUDS3;UBE2D1;ZNF25;SUFU;RXRA;FOXK2
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.45463978296239105,-1.1188725645978475,0.33638443935926776,0.810176605380049,1.0,5/11,33.79%,ITM2A;BACE2;NECAB2;ITM2C;NECAB3
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.31321058125880125,1.1182544414674505,0.071,0.804932534554781,1.0,324/1645,17.25%,IGF1;TCF7L2;TCF4;ZBTB20;NFIA;IGF2;COL1A1;RORA;RHOH;CDK14;TBL1XR1;ZFHX4;TRPS1;RUNX1T1;TEAD1;ATXN1;PBX1;SMAD3;ARNT2;PKNOX2;AR;ZKSCAN2;ZEB2;SOX5;TGFA;MITF;GLIS3;NKX6-1;IL31RA;NR2F2;GLI2;RUNX1;PRRX1;WWC2;SALL1;ZIC1;SP7;OGT;IKZF2;VGLL3;MAF;GLI3;ARID5B;ZEB1;NKX2-1;FZD2;KIT;ARID4A;PRDM5;SP100;WNT4;FOXP2;NFIB;ASCL1;RBFOX2;YAP1;NUP107;GAS6;JDP2;APOE;RUNX2;SIX5;TGFBR1;MLXIP;LBH;MIDEAS;ZIC4;NFIX;MXI1;LBX2;TLE1;FBXL19;OGG1;MEOX2;IKZF4;RLF;MSC;SMURF2;BRWD1;IRF1;ZIC2;PRICKLE1;MT3;NEUROD4;RFX5;ACVR1;ZHX2;ZNF83;CDK16;NEUROD1;CREB3L2;NCOA2;FZD1;KLF15;PHIP;MLLT3;SFRP1;ETV6;DENND4A;ARID1B;ATXN7L3;TBX3;SP4;EPAS1;HLF;BCL6;ENG;CUX2;ZBTB8B;DKK3;USP47;BCOR;TCF7;CBX3;ATOH8;HES7;APBB2;NAB2;SMARCA1;ZNF483;PML;ZNF23;MED14;NR5A1;BATF;CEBPA;ING5;NFE2L2;MBD2;WWTR1;SAP30;RNF10;SREBF1;SIRT2;DDX17;REXO4;ZBTB38;TSHZ2;ZBTB24;SMARCC2;MAP2K1;MED8;MED16;PPP1R13L;NR1D1;RAI1;OSR1;BBX;WTIP;RBPJ;LIN9;TULP3;TCF7L1;FOXC2;SAFB2;NCOR1;ZMYND15;CHD2;MTA3;KDM5B;HIVEP2;ARRB1;EGFR;ARHGEF11;CREBL2;SCML2;BMP2;PCGF3;ZMIZ1;STAT5B;ZBTB4;CBY1;HOXC5;PICALM;NONO;ZBTB1;BICRAL;MZF1;CCNK;SMAD1;GMEB1;GTF2IRD1;HEXIM2;STAT2;GLIS2;NSD1;ARNT;CREB3L4;CREB3;FOXA1;PBXIP1;ZKSCAN3;FGF2;SP140;BAZ1B;ACTR8;ZSCAN21;PHF1;PHF2;TFAM;RNF6;NR1D2;MBD1;KDM5C;MED13L;NCOR2;SETD5;SP5;ZBTB8A;ZNF177;CEBPB;KLF9;IFNK;CCNL2;MED29;L3MBTL1;BHLHE41;NFE2;SPDEF;NKX2-8;ZBTB37;ZFP30;REST;NR4A1;CCNL1;MNAT1;NIBAN2;GLI1;CAMTA1;HMGN5;INSR;STAT6;PDCD4;BTRC;TEAD3;ZNF318;ACVR1B;TRIP4;L3MBTL2;MYCN;SMARCD2;NPAS2;EGF;KMT2E;KMT2A;HOXC8;EBF1;TAF5L;STAT4;TIAL1;ZNF182;HDAC4;HIVEP1;ETS1;ZNF148;ZNF383;FSTL3;ZNF219;TWIST2;TCF12;HOXD1;YAF2;TADA3;KDM7A;GATA6;NR1H3;PHF8;BMP4;SUDS3;ZNF25;FUBP3;HOXC4;SUFU;RXRA;MYCBP;FOXK2;METTL4;CDKN1C;DYRK1A;SAP30L;SMARCB1;GPBP1;TSHZ1;FADS1;TGFBRAP1;HDGFL3;PSPC1;CAMTA2;MYT1;MTF1;TFCP2;DYRK1B;RIOX1;ZBTB17;ZNF585B;ZNF585A;CBX5;MAFA;ZNF276;SCMH1;MXD4;NCOA7;EBF4;AKT1;CREB5;PLAG1;ZNF423;CCNQ;PCBD2;RHOG;ATF5;SHH;TFDP1;FOXO6;SP1;ZFAT;MYBL1;BAZ2B;SPIN4;TIMELESS;IRF2;ZSCAN20;KDM3B;FOXJ3
prerank,positive regulation of protein ubiquitination (GO:0031398),0.37046934796607306,1.1182504512303104,0.29161451814768463,0.8041600816022466,1.0,15/80,15.26%,MYCBP2;ANGPT1;ARRDC4;CDK5RAP3;PRICKLE1;DERL1;LRRK2;SPRTN;COMMD1;FBXO4;RIPK2;FANCI;UBE2D1;HUWE1;DCUN1D2
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.27615614969946767,-1.1182467730265666,0.21875,0.8103553622169605,1.0,33/114,23.95%,TMSB4X;PTK2B;TNFRSF11A;ST18;NFKBIA;TNFRSF11B;AIM2;JAK2;BAG4;TRAF5;EIF5A;CARD14;CD40;PSMF1;TRAF1;TXNDC17;PSMB8;PSMA4;PSMB10;PSMB2;LIMS1;CD27;PSMC4;PSMA6;PSMD9;PSMD11;PSMD5;TRAF2;COMMD7;CHUK;TNFRSF12A;PSMA8;PSMB1
prerank,regulation of cell junction assembly (GO:1901888),-0.3683841054330762,-1.1177537010906742,0.27823691460055094,0.8100746643419013,1.0,7/27,2.91%,PRKCH;MEF2C;OCLN;CLDN5;RAP1A;F11R;TJP1
prerank,negative regulation of neurogenesis (GO:0050768),-0.3537514825826831,-1.1174036527258366,0.29411764705882354,0.8093766215764219,1.0,12/34,18.53%,NOTCH1;B2M;YWHAH;SORL1;GDI1;ARHGDIA;PTN;NF1;LINGO1;MAG;MCF2;RTN4R
prerank,positive regulation of cell development (GO:0010720),0.42590275666578853,1.1172872182272062,0.30851063829787234,0.8060982137671922,1.0,5/31,5.78%,NKX6-1;NUMBL;LIG4;PDE3A;SERPINF1
prerank,regulation of viral life cycle (GO:1903900),-0.37928648818245114,-1.1168775318103834,0.28342245989304815,0.80922269806707,1.0,10/21,21.76%,TRIM14;PPIA;HS3ST5;TRIM25;TRIM68;TYRO3;TRIM6;TRIM62;VPS4A;NECTIN2
prerank,positive regulation of catalytic activity (GO:0043085),0.41348747247856943,1.1167800027853387,0.31977559607293127,0.8067414885110207,1.0,6/37,9.28%,IGF2;FGFR4;APOA1;MT3;NHEJ1;SLC5A3
prerank,protein localization to cell junction (GO:1902414),-0.3836956066550696,-1.1166817438552543,0.3150684931506849,0.8080481229084421,1.0,8/22,12.65%,NLGN1;TJP2;TJP1;NECTIN1;HEG1;SHANK1;PCLO;PAK2
prerank,mesonephros development (GO:0001823),-0.45998925357484,-1.1165570734635886,0.29782608695652174,0.8066568323238626,1.0,3/11,11.76%,ZBTB16;FGF1;PAX8
prerank,divalent inorganic cation homeostasis (GO:0072507),-0.3696077180126861,-1.1165290089559556,0.28353658536585363,0.8049535234036789,1.0,3/25,1.79%,TMTC2;CAV1;ANK3
prerank,covalent chromatin modification (GO:0016569),0.4970969575419919,1.1164339119160724,0.3528399311531842,0.8069578392284505,1.0,4/14,11.48%,MT3;MBD2;SETD5;UFL1
prerank,positive regulation of supramolecular fiber organization (GO:1902905),-0.27973974950666414,-1.1158657409289972,0.233502538071066,0.8051796386764015,1.0,24/86,19.40%,OCLN;BAIAP2L1;PTK2B;NAV3;MET;RPS3;PAK1;CFL2;EDN1;PLEK;WDR1;FES;DCTN1;TRPV4;CDK5RAP2;APP;CTTN;CDK5R1;PRKCE;NCK2;GPX1;CLASP1;LMOD1;CLU
prerank,regulation of synapse assembly (GO:0051963),0.402131659810042,1.115815588723556,0.32443257676902537,0.8079543950471398,1.0,11/46,12.62%,GPC6;PDLIM5;SRPX2;MUSK;CUX2;EPHB2;SLIT1;SETD5;MDGA1;EPHB3;SLITRK2
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.45242120258287144,1.11551433604172,0.30647709320695105,0.8080344168416429,1.0,6/21,10.48%,SLC8A3;MCU;BCAP31;MICU2;PDZD8;ANXA6
prerank,positive regulation of neuron projection development (GO:0010976),0.36435542156772255,1.1154759580038798,0.31954887218045114,0.8073567867937,1.0,15/85,9.36%,EPHA3;CAMK1D;LYN;APOE;DPYSL3;RAPGEF2;FZD1;PTK7;ROR1;CUX2;ATP1B2;ARHGAP35;NTRK3;CAMK2B;RAPGEF1
prerank,positive regulation of cell-matrix adhesion (GO:0001954),-0.3342983832433188,-1.11532928642083,0.26813880126182965,0.8050922782192217,1.0,12/42,10.26%,UTRN;TEK;PTPRJ;CDK6;PTK2B;KDR;MYOC;EMP2;CDH13;VEGFA;JUP;SKAP1
prerank,mRNA splice site selection (GO:0006376),0.4234734605481951,1.1153105508745138,0.3522012578616352,0.8070181176286192,1.0,6/30,17.99%,CELF2;SF1;NOL3;SRSF5;SRSF10;KHDC4
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.4649017055971809,1.115225061187127,0.33169934640522875,0.8064996767670748,1.0,7/20,19.01%,NR2F2;CEBPA;HEXIM2;INCA1;PTEN;CDKN1C;CDKN1B
prerank,positive regulation of innate immune response (GO:0045089),-0.3527787698700927,-1.1142059963833286,0.30177514792899407,0.8066326226390599,1.0,13/30,27.23%,RPS19;GBP5;LBP;NLRC5;IFI35;UBE2K;TRIM6;TRIM62;DHX9;PLSCR1;POLR3C;SLC15A4;PLA2G5
prerank,regulation of cell-matrix adhesion (GO:0001952),-0.303416615469596,-1.1141831549969572,0.2711864406779661,0.804931489787699,1.0,17/64,11.43%,UTRN;EFNA5;CDK6;ACER2;PTK2B;THBS1;LIMCH1;GPM6B;ADAM15;MYOC;EMP2;CDH13;NEXMIF;JUP;SKAP1;PEAK1;NF1
prerank,negative regulation of protein depolymerization (GO:1901880),0.45740931260597634,1.1140148011520838,0.34328358208955223,0.8091258884906268,1.0,8/24,21.33%,PLEKHH2;LIMA1;KATNB1;FGF13;HDGFL3;CAMSAP1;ATXN7;TAOK1
prerank,"base-excision repair, AP site formation (GO:0006285)",0.47952612422709284,1.1139801485564702,0.35008665511265163,0.8084185046982343,1.0,4/17,12.17%,OGG1;NEIL1;MBD4;TERF2
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.3690000130445301,1.113943954002321,0.3025,0.807724219441414,1.0,18/76,17.55%,MYCBP2;ANGPT1;CDK5RAP3;PRICKLE1;DERL1;LRRK2;SPRTN;COMMD1;FBXO4;RIPK2;MUL1;HDAC4;FANCI;UBE2D1;HUWE1;DCUN1D2;UBE3A;TNIP1
prerank,positive regulation of metabolic process (GO:0009893),0.35845038488469916,1.1139170565635754,0.3024096385542169,0.8070244356020871,1.0,22/103,15.28%,GJA1;CAMK1D;LEPR;OGT;ACSL1;GNAS;APPL2;EPAS1;DYNC1H1;ADRB3;ALMS1;MFAP2;CEBPB;INSR;STAT6;DECR1;DIO2;G0S2;FASN;CNOT3;IL4R;GRB10
prerank,somite development (GO:0061053),0.526956697932642,1.11371670735423,0.37291280148423006,0.8068119784981197,1.0,5/11,21.14%,SMO;MEOX2;SHH;SOX11;PPP2R3A
prerank,import into cell (GO:0098657),0.40103753428018457,1.1135535503179386,0.33152909336941816,0.8064965887307001,1.0,9/41,9.97%,SLC1A3;GLUL;ATP1A2;SLC6A13;SLC22A2;SLC11A2;SLC22A4;SLC5A3;SLC29A1
prerank,negative regulation of chemokine production (GO:0032682),-0.4351287512910306,-1.1134792972106136,0.33251833740831294,0.8054150829456432,1.0,4/14,14.23%,APOD;SIRPA;KLF4;SIGIRR
prerank,inositol phosphate-mediated signaling (GO:0048016),-0.40278486444696837,-1.1134183491917409,0.3237597911227154,0.8038852592655962,1.0,6/19,11.62%,PLCE1;NFATC2;NFATC3;NFATC1;EDN1;HRH1
prerank,cellular glucose homeostasis (GO:0001678),0.3976718978727095,1.1133875766064802,0.3485714285714286,0.8061671957281362,1.0,5/41,7.78%,ZBTB20;PIK3R1;GAS6;PRKAA2;NR1D1
prerank,tRNA aminoacylation (GO:0043039),-0.3378892251516772,-1.113149661827863,0.30743243243243246,0.8028617042869006,1.0,12/37,22.19%,WARS1;WARS2;LARS1;YARS1;YARS2;QARS1;KARS1;FARS2;AIMP1;MARS2;AIMP2;TARS1
prerank,negative regulation of angiogenesis (GO:0016525),0.36527930741965114,1.1130216698840762,0.31337579617834393,0.8064757819869107,1.0,13/84,6.63%,COL4A3;ROCK2;SPARC;DCN;SERPINE1;HSPG2;ISM1;THBS2;SULF1;SERPINF1;ADAMTS9;PML;EMILIN1
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.508238530902004,1.1128856614424802,0.37349397590361444,0.8060906585642763,1.0,2/12,2.01%,CYP26B1;DHRS3
prerank,heart process (GO:0003015),-0.43771576113081034,-1.1126789573879776,0.3316953316953317,0.8026896744011299,1.0,1/14,0.35%,SGCZ
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.35394732638496945,-1.112378904703315,0.3047619047619048,0.8017996097123827,1.0,16/30,25.67%,SDCBP;RYBP;RPL11;HSP90AB1;USP14;GIPC1;N4BP1;SVIP;FHIT;DDRGK1;STYX;UBXN1;CAMLG;CCAR2;USP7;SGTA
prerank,regulation of defense response (GO:0031347),0.36398224089203496,1.1122267528953473,0.32054455445544555,0.807154306156888,1.0,9/76,6.90%,ADAMTS12;AHSG;PTGES;CASP12;APOE;APPL2;IRF1;BCL6;AGTR1
prerank,positive regulation of neuron death (GO:1901216),0.3980430729075435,1.112077683540825,0.34163208852005533,0.8067915863839399,1.0,5/46,9.03%,EPHA7;EFNB2;NUPR1;TLR6;PICALM
prerank,granulocyte chemotaxis (GO:0071621),-0.30757546327354285,-1.1118228698217953,0.25,0.8017694350218472,1.0,9/55,12.13%,PDE4B;BSG;TGFB2;PPIA;CCL14;FCER1G;EDN1;CKLF;CXADR
prerank,negative regulation of viral transcription (GO:0032897),-0.42387384629081404,-1.1117568935924182,0.3325242718446602,0.8002324719270164,1.0,7/13,27.84%,TRIM14;TRIM11;TRIM62;IFITM3;TRIM13;MID2;UBP1
prerank,chromosome organization (GO:0051276),0.35812665589430914,1.1117141353992368,0.2850182704019488,0.8070276333410511,1.0,17/99,12.95%,TCF7L2;SETD7;BRWD1;AXIN2;LIG4;MTHFR;CUL4B;TOP2B;TCF7L1;POLE3;PHF1;CENPH;L3MBTL1;RAE1;HDAC8;GPS1;COPS3
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.510022360244927,1.11170116540982,0.35688405797101447,0.806290958687574,1.0,4/13,14.78%,OGG1;NEIL1;MBD4;UPP2
prerank,melanosome localization (GO:0032400),-0.386695685328829,-1.1112853068015527,0.3133514986376022,0.7999963713338484,1.0,8/21,19.54%,RAB27A;RAB11A;RAB27B;ARL6;MLPH;BLOC1S5;BBS7;MREG
prerank,nuclear pore organization (GO:0006999),-0.42994884445543025,-1.1111384199323275,0.31116389548693585,0.7987205812607908,1.0,4/14,7.43%,NUP93;NUP35;NUP153;NUP54
prerank,embryonic heart tube development (GO:0035050),-0.42699371348294335,-1.110670470564235,0.3112244897959184,0.798365697162349,1.0,6/14,16.88%,SOX17;TBX2;SOX18;HES1;RYR2;CITED2
prerank,negative regulation of epithelial cell migration (GO:0010633),0.41979704900744924,1.1101775880071139,0.3407079646017699,0.8098454610549706,1.0,11/33,15.84%,MCC;DCN;NR2F2;SP100;APOE;ADAMTS9;PTPRM;DNAJA4;PTEN;PTPN23;EPPK1
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.5121454218943798,1.11006455022365,0.37340619307832423,0.8093781371119082,1.0,2/12,3.64%,GDNF;SMO
prerank,cardiac ventricle morphogenesis (GO:0003208),0.3996559412321019,1.1100472824559369,0.32132564841498557,0.8086567785758894,1.0,7/41,8.12%,TGFBR3;TPM1;BMPR1A;FGFR2;ENG;TNNC1;RBPJ
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.48342862481702975,1.1095610884614162,0.3579638752052545,0.8092102080365929,1.0,6/16,24.20%,APPL2;NCOR1;ERLIN1;BRCA1;ERLIN2;ACADVL
prerank,regulation of endocytosis (GO:0030100),0.37603821883172306,1.1093822462548226,0.3284182305630027,0.8089240873394891,1.0,10/61,9.17%,EPHA3;LRP1;APOE;CCL19;SRC;SNX33;STON1;DAB2;PICALM;SNX12
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.4909018579051613,1.1087177061615605,0.3564356435643564,0.8100510460462963,1.0,3/15,3.57%,FGFR2;PDGFRA;TGFBR1
prerank,steroid hormone biosynthetic process (GO:0120178),0.43040169802662953,1.1086519832804032,0.3363774733637747,0.8094549194394346,1.0,5/29,10.90%,AKR1B1;STAR;HSD3B2;SRD5A1;TSPO
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),-0.4747767563432044,-1.1085180891561806,0.3390928725701944,0.8032414655416977,1.0,5/10,13.51%,PDE4D;PDE3B;PDE2A;UBE2B;APLNR
prerank,positive regulation of cardiocyte differentiation (GO:1905209),-0.45680398791247645,-1.1079547497710092,0.34831460674157305,0.8031857621918997,1.0,4/11,16.30%,MEF2C;TGFB2;TGFB1;GPER1
prerank,apoptotic process (GO:0006915),-0.2414185895094439,-1.1074727957113364,0.18181818181818182,0.8028505786583728,1.0,50/203,15.78%,EFNA5;ZBTB16;SEMA6A;ELMO1;PTK2B;MAL;FAP;EGLN3;PLAGL1;PPARD;TNFRSF19;PAK5;TBX1;ADAM15;TRPC5;SIAH1;BCL2L13;CIT;PPIA;NFKBIA;DPF2;PRUNE2;HK2;MAGI3;CDK5;RHOB;SCN2A;JAK2;RFK;TGFBR2;YARS1;DDIT4;CASP8;DCC;CYFIP2;TNFRSF21;BBC3;MTOR;ERBB3;BCL2L1;PAEP;BNIP1;PIK3CA;BAK1;APP;ARHGEF6;FASTKD2;FOXO1;DAP;IAPP
prerank,RNA destabilization (GO:0050779),0.4661432928682074,1.107389491254133,0.3443708609271523,0.8123494835960836,1.0,10/18,27.72%,ROCK2;DXO;METTL14;METTL3;YTHDF2;FTO;METTL16;GIGYF2;ZC3H18;PUM1
prerank,ventricular cardiac muscle cell action potential (GO:0086005),-0.4089283379290267,-1.1069004617724387,0.33756345177664976,0.8028765773808046,1.0,4/17,21.49%,NEDD4L;KCNQ1;RYR2;KCNJ8
prerank,regulation of protein import into nucleus (GO:0042306),0.41115997298186635,1.106599047607476,0.33482142857142855,0.8138165997707616,1.0,12/36,18.62%,PIK3R1;SMAD3;ZIC1;RAB23;RBM22;FLNA;BMP4;SUFU;PIK3R2;UBR5;EFCAB7;TPR
prerank,calcium ion homeostasis (GO:0055074),0.3578909880358948,1.1064746616028271,0.28976572133168926,0.8134142829987986,1.0,13/95,9.65%,SLC24A3;SLC8A1;SLC8A3;DMPK;CCL19;STIM1;ATP13A3;SLC24A1;CDH5;SLC24A5;TMEM203;DRD3;CSRP3
prerank,lymphocyte chemotaxis (GO:0048247),0.4148335402383017,1.106389515123549,0.31516936671575846,0.8128593964664791,1.0,5/34,6.11%,CYP7B1;GAS6;CCL19;CXCL16;CCL4
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.4771964666786043,1.1063110185135467,0.38304552590266877,0.8123170478248332,1.0,4/18,8.20%,DAAM2;IL34;SLC45A3;DRD3
prerank,stabilization of membrane potential (GO:0030322),0.484409038409888,1.1061682885665651,0.3494983277591973,0.811955547124468,1.0,2/16,6.18%,KCNK2;KCNK7
prerank,nucleic acid-templated transcription (GO:0097659),0.4042505794171233,1.1059998001083102,0.3333333333333333,0.8116482424674848,1.0,6/42,11.64%,POLR2D;THRB;CREBL2;POLR3A;POLR2C;NKX2-8
prerank,lamellipodium assembly (GO:0030032),-0.36642657140553314,-1.1058553249069256,0.308411214953271,0.8043528954183753,1.0,8/26,9.32%,PARVB;CCDC88A;ABLIM1;S1PR1;SPATA13;CDH13;ABLIM3;ABLIM2
prerank,synaptic vesicle endocytosis (GO:0048488),-0.351223612052712,-1.105755203021651,0.3051948051948052,0.8030291280884415,1.0,13/33,18.61%,DNM3;NLGN1;AMPH;OPHN1;CDK5;SYT1;GAK;ITSN2;PACSIN1;NLGN3;DNM1;STX1A;SYNJ1
prerank,cell differentiation in hindbrain (GO:0021533),-0.4617026408277264,-1.1056811920224165,0.3491686460807601,0.8015774041423285,1.0,3/11,11.81%,GRID2;OPHN1;ATP7A
prerank,organelle fission (GO:0048285),-0.3619240780676169,-1.1056493084956007,0.3128834355828221,0.7999944313889007,1.0,6/24,16.18%,DNM3;WASHC5;MTFR1;CORO1C;DNM1;MTFR2
prerank,response to organic cyclic compound (GO:0014070),0.3863476185031111,1.1051012271410332,0.31866666666666665,0.8134905600206939,1.0,11/52,10.00%,WNT8B;FGFR4;SFRP1;IGFBP5;CYP1B1;STRN3;LRRK2;KYNU;DRD3;STAT5B;FOXA1
prerank,phospholipid translocation (GO:0045332),-0.3576383146509213,-1.1050067751704185,0.3395061728395062,0.8003923666254952,1.0,8/28,7.78%,ATP8A1;ATP8B1;ATP11C;ABCC1;ATP11B;P2RX7;ATP11A;MFSD2A
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),-0.37716946663674605,-1.1046934082466886,0.3264781491002571,0.7980600582486809,1.0,12/22,37.36%,ZDHHC2;ZDHHC15;ZDHHC14;ZDHHC18;ZDHHC8;ZDHHC24;CLIP3;ZDHHC22;ZDHHC6;ZDHHC12;ZDHHC19;ZDHHC21
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),-0.37716946663674605,-1.1046934082466886,0.3264781491002571,0.7980600582486809,1.0,12/22,37.36%,ZDHHC2;ZDHHC15;ZDHHC14;ZDHHC18;ZDHHC8;ZDHHC24;CLIP3;ZDHHC22;ZDHHC6;ZDHHC12;ZDHHC19;ZDHHC21
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),-0.4028201443204902,-1.1044389130893169,0.32587064676616917,0.7971705866903784,1.0,3/17,6.48%,ANK3;KCNAB1;AKAP6
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.3712850696028416,1.1042901820317064,0.3201058201058201,0.8150175131895705,1.0,10/67,9.62%,NRP1;ROCK2;PIK3R1;SULF1;AXL;CDC42;SRC;AAMP;ITGB3;ITGAV
prerank,B cell differentiation (GO:0030183),-0.32580751938901575,-1.1041894293747083,0.29642857142857143,0.796264533131925,1.0,28/46,36.43%,PTPRJ;TPD52;PLCG2;TCF3;PTPN2;ITGA4;HHEX;BLNK;PTPRC;JAK3;ADGRG3;MSH2;KLF6;VCAM1;DCAF1;CEBPG;IRF2BP2;GPS2;FLT3;CR2;LYL1;IL11;MS4A1;ZBTB7A;CLCF1;SYVN1;IL4;CD79A
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.45257667369707216,1.104165581501379,0.36075949367088606,0.8146109985308256,1.0,10/23,26.87%,EPHX2;GSTM4;GSTM2;ALOXE3;FADS1;CYP1A1;ALOX12;HPGD;LTA4H;ACOT7
prerank,regulation of ERBB signaling pathway (GO:1901184),-0.4158630522174972,-1.1041235514128138,0.3421686746987952,0.7948257292046713,1.0,6/15,14.14%,MVB12B;PTPN12;ERBB2;CDH13;LGMN;CEACAM1
prerank,regulation of ion transport (GO:0043269),-0.2884248901446975,-1.103935635331722,0.24598930481283424,0.7937161585945948,1.0,14/76,6.92%,NKAIN2;KCNJ2;ATP1A1;ANK3;NEDD4L;B2M;KCNJ3;PXK;YWHAH;NKAIN1;P2RX7;NKAIN3;NOS1;SYT1
prerank,endothelial cell differentiation (GO:0045446),-0.45573997191933524,-1.1037405177386066,0.3260340632603406,0.792695863377094,1.0,6/12,19.43%,TIE1;KDR;ACVRL1;SOX18;BMPR2;ACVR2B
prerank,blood vessel diameter maintenance (GO:0097746),-0.3416032378240762,-1.1033178179725167,0.29042904290429045,0.792285410135679,1.0,14/34,20.26%,EDNRA;NOS3;KLF2;NOS1;NPR1;KCNMB2;GCLM;ACE2;EDN1;EDNRB;GPER1;GCLC;ITGB1BP1;ROCK1
prerank,protein lipidation (GO:0006497),-0.3031295532074453,-1.10318786551567,0.2647058823529412,0.7910694746639195,1.0,19/59,18.79%,ZDHHC2;DPM1;PIGP;ZDHHC16;PGAP2;ZDHHC15;GPLD1;UGCG;ZDHHC14;PIGB;WDR45B;ZDHHC5;PIGL;DPM3;WIPI2;PIGU;DPM2;PIGO;PIGV
prerank,snRNA transcription (GO:0009301),0.37040071504181776,1.1029056299217832,0.34993773349937735,0.8173630785694461,1.0,25/70,24.68%,POLR2D;PHAX;GTF2E1;SNAPC1;CCNK;USPL1;POLR2C;RPAP2;INTS4;GTF2E2;TAF9;ELL2;SNAPC5;SNAPC4;SP1;CCNT2;POLR2L;GTF2A1;TAF8;CCNT1;NCBP2;CDK7;INTS7;NABP2;ICE1
prerank,protein-containing complex assembly (GO:0065003),0.3210366457359138,1.102444161919075,0.2751605995717345,0.8178957827187889,1.0,79/259,22.80%,TCF7L2;TEAD1;SEC24D;AREG;TGFA;MITF;PLEKHA7;LAMC1;SEC31A;YAP1;TLE1;SH3PXD2B;MCU;AXIN2;LMAN1;BCL9;TCF7;PML;CD247;ZW10;RANBP9;LRRK2;TRAPPC4;AFDN;PARD6B;TCF7L1;GOSR2;PICALM;TSPAN4;CDC123;TRAPPC9;TRAPPC10;TRAPPC6B;GORASP1;FANCC;MNAT1;CTSZ;KLHL12;NOL3;USO1;WASF1;KMT2A;SEC23A;LLGL1;DLG4;SNX9;COL16A1;TBC1D20;TNFRSF1A;PARD3;GSDMD;TAPBP;CX3CL1;SEC24A;KAT5;DARS1;TMED10;CDC73;CSNK1A1;SEC16B;HSF1;MDM4;TRAPPC1;TRAPPC3;AFG3L2;RBBP5;HGSNAT;LEO1;TLE3;CAPZA1;OPA1;STOML2;TLE4;IL1RAP;SEC16A;SLC9A1;FANCA;NAPA;NCKAP1L
prerank,calcium ion transmembrane transport (GO:0070588),0.3569588167733507,1.1022531777608588,0.32503113325031135,0.8176844092071558,1.0,14/86,9.91%,SLC24A3;NALCN;SLC8A1;SLC8A3;TRPA1;GAS6;SLC24A1;MCU;SLC24A5;CACNA1C;PMPCB;TRPM4;ITGAV;MICU2
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.52929240594823,1.1020209586072238,0.37842778793418647,0.8175455815346864,1.0,3/10,15.28%,LYN;MAP2K1;RNF13
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.3413509689833579,1.1016764293029855,0.29782359679266895,0.8177399192432429,1.0,26/136,16.10%,TCF7L2;PTGIS;SP100;MDFI;GAS6;NUPR1;IRAK2;CDK5RAP3;CYP1B1;SIK1;MTURN;IRAK3;ARRB1;CD200;COMMD1;GLIS2;ITCH;UFL1;BTRC;HDAC4;FLNA;SFRP4;SUFU;EGLN1;RNF2;NWD1
prerank,regulation of coagulation (GO:0050818),-0.45947692259724493,-1.1010677499436379,0.3615023474178404,0.7959099166284512,1.0,2/11,5.27%,CAV1;HS3ST5
prerank,regulation of proteolysis (GO:0030162),0.38501220081427057,1.1010634320881316,0.3255172413793103,0.8187279496622473,1.0,14/48,16.71%,DNAJC1;OGT;FGFR4;ASPH;CST3;RNF139;ITCH;F2;CLN3;BTRC;TM4SF20;SPOP;AKT1;SHH
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.4715780639193412,1.1010044599502484,0.34890965732087226,0.8181303449431273,1.0,5/18,7.95%,DLC1;KANK1;ITGA3;RIPOR2;ARHGAP35
prerank,membrane lipid metabolic process (GO:0006643),0.4480879914393293,1.1006603731962958,0.3624382207578254,0.8183217007073212,1.0,4/22,7.20%,AGMO;CYP1B1;ALOXE3;SPHK2
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),0.4931080756621154,1.1006485953290919,0.3553299492385787,0.8175914127429164,1.0,1/14,0.14%,NRP1
prerank,positive regulation of protein import into nucleus (GO:0042307),0.42780858364102,1.1005437622790795,0.34009360374414976,0.8171277580886597,1.0,9/28,18.62%,PIK3R1;SMAD3;ZIC1;RBM22;FLNA;PIK3R2;UBR5;EFCAB7;TPR
prerank,nervous system development (GO:0007399),0.31432072931745797,1.100297428431815,0.24288617886178862,0.8170592034882322,1.0,65/429,10.49%,NELL1;ROBO1;LDB2;TEAD1;FARP1;GDNF;ATXN1;GSN;ADGRV1;ARNT2;ZEB2;DACT1;RBFOX1;OBSL1;ZIC1;DAGLA;GFRA2;WNT8B;ASCL1;RBFOX2;YAP1;TGFBR1;NUMBL;SMO;SEMA5A;NOTCH2;ZIC4;FBXL17;WDPCP;MTR;ZIC2;IGF2BP2;AXL;NTF3;NEUROD1;LIG4;NAV2;TBX3;ALDH1A2;FUT10;ATXN10;NAB2;ADGRA2;PMP22;FGF11;WWTR1;DCHS1;LPAR1;APBA1;CSPG5;CBLN1;SH3GL1;DSCAM;NHEJ1;EPHB2;CNTFR;PRKN;MARCKSL1;GLIS2;GFRA4;FGF2;FGF13;RYK;NRSN1;PCDHB3
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.43538101712368926,-1.0990021110595531,0.34813084112149534,0.8004045367738648,1.0,6/14,19.53%,THBS1;NOTCH1;KLF4;DLL4;ITGB1BP1;PDCD10
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.41367086201842124,1.0989646786806735,0.3361945636623748,0.8201351397684187,1.0,8/35,8.78%,AR;PMEPA1;RBFOX2;YAP1;NEDD4;SRC;DDX17;ZMIZ1
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.3487912097511384,1.0989333512895618,0.3175182481751825,0.8194698962581483,1.0,13/94,11.60%,ITPR1;PDK1;BCL2;MOAP1;CYP1B1;PML;CUL5;BCL2L11;AIFM1;STK11;DDX3X;CEBPB;IKBKE
prerank,embryonic hemopoiesis (GO:0035162),-0.43976785010609726,-1.0985284047072952,0.35853658536585364,0.8001432913099092,1.0,4/12,9.69%,KITLG;KDR;TAL1;TGFBR2
prerank,aminoglycan biosynthetic process (GO:0006023),0.3888944842244001,1.0979952372172594,0.3428184281842818,0.8213481209476464,1.0,10/49,11.93%,GPC6;HSPG2;PXYLP1;B3GALT1;HS6ST1;SDC1;B3GALNT1;EXT1;NDST1;GALNT5
prerank,neuron apoptotic process (GO:0051402),-0.3963971041554777,-1.0978292431166246,0.31283422459893045,0.8006040275767751,1.0,8/19,14.93%,TRPC5;SIAH1;CIT;CDK5;SCN2A;TNFRSF21;ERBB3;APP
prerank,membrane protein intracellular domain proteolysis (GO:0031293),-0.37869556484176625,-1.0978189780448775,0.3223350253807107,0.7989959781207935,1.0,9/20,30.27%,ADAM10;TGFB1;MBTPS2;ADAM9;RHBDD1;APH1A;MBTPS1;TRAF6;NCSTN
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.32681848183883117,-1.09757184979294,0.3106796116504854,0.7980093207173019,1.0,18/37,25.67%,SDCBP;HIPK2;RYBP;RPS7;RPL11;HSP90AB1;TAF1;RPL5;GIPC1;N4BP1;FHIT;RPL23;DDRGK1;UBXN1;CAMLG;CCAR2;USP7;SGTA
prerank,regulation of cell growth (GO:0001558),-0.24967146503099416,-1.097320782316347,0.21348314606741572,0.7971513719010013,1.0,49/204,14.57%,PLCE1;SLIT2;PTPRJ;FHL1;ADAM10;NRG3;SPOCK1;SH3BP4;CCN3;ACVRL1;NET1;PAK5;TFRC;PPT1;ADAM15;OSGIN2;SDCBP;SOX17;TGFB2;CAMK2D;ERBB2;SOCS2;NPR1;AKAP6;NDRG3;MFSD2A;EGLN2;SERTAD3;HYAL1;WFDC1;SGK1;RPS6KA1;CCDC85B;LTBP4;OGFR;MINAR1;BCAR1;TGFB1;SLC25A33;SIRT1;MTOR;ATAD3A;FAM107A;SERTAD2;SUPV3L1;APBB1;CEACAM1;H3-3A;DERL2
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),-0.4408381882624294,-1.097163943143705,0.3448275862068966,0.7960578904864151,1.0,6/12,30.28%,RAD17;TOPBP1;HUS1;HUS1B;CDC6;TICRR
prerank,epithelial cell development (GO:0002064),0.46746780346954325,1.097065209617227,0.34394904458598724,0.8232191023893385,1.0,5/20,12.99%,BFSP1;WNT5B;RAB25;LRTOMT;DACT2
prerank,neuron projection organization (GO:0106027),-0.4154294726517529,-1.0969080620725304,0.32367149758454106,0.7952093367271639,1.0,9/15,27.14%,PLS1;ARF1;LGMN;ATP1A3;DCTN1;APP;GSK3B;PICK1;PRNP
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.4203399349351996,-1.0968113657795684,0.34413965087281795,0.7938645086376431,1.0,4/15,15.96%,ARPC1B;ARPC3;ARPC5L;ARPC4
prerank,RNA methylation (GO:0001510),0.38075754973998643,1.096708004242409,0.3444592790387183,0.8234184049010073,1.0,18/60,19.90%,TRMT44;BUD23;TRMO;NSUN2;METTL14;DIMT1;FTSJ3;WTAP;BCDIN3D;TRMT13;TRMT112;NSUN5;THUMPD3;THUMPD2;NSUN4;THADA;METTL3;METTL1
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.4967294835636797,1.0966871222443164,0.37583892617449666,0.8227216341610344,1.0,3/13,9.87%,MOAP1;BCL2L11;RHOT1
prerank,vesicle organization (GO:0016050),-0.31971094590275606,-1.0965956137193016,0.29285714285714287,0.792911886654984,1.0,11/46,16.17%,CAV1;FNBP1L;CD34;CAV2;DNAJC13;ALS2CL;WASHC5;EXOC8;AKTIP;SRGN;DNM1
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),-0.41712574354921167,-1.0957731053670507,0.3283208020050125,0.793759883679169,1.0,9/15,35.37%,RAD17;MDC1;HUS1;FANCD2;ATF2;HUS1B;NEK11;RAD9A;EME1
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.4361906584490258,1.0956977735515716,0.3306581059390048,0.8247276460617933,1.0,2/23,3.24%,CEMIP;PRKAG2
prerank,protein localization to condensed chromosome (GO:1903083),0.510361340771044,1.095696181018982,0.3681506849315068,0.8239701017629331,1.0,4/12,9.45%,SPDL1;ZW10;CHAMP1;MTBP
prerank,positive regulation of response to external stimulus (GO:0032103),0.3368847359862733,1.0951002466049524,0.3055555555555556,0.8248339168906232,1.0,29/128,18.49%,BMP6;SASH1;SERPINE1;OPTN;PDGFRB;CCL19;IL12B;CEBPA;AGTR1;TSLP;DDX60;NMI;CCN4;SETD4;IFNK;F2;NAPEPLD;PDCD4;ETS1;MDK;RIOK3;TNFRSF1A;CD47;IL23A;CX3CL1;TNIP1;IL18;DHX58;PRKCA
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.44825313667247907,1.0949797620751005,0.34831460674157305,0.8244243528944749,1.0,2/23,1.04%,ERRFI1;CBLB
prerank,actin polymerization or depolymerization (GO:0008154),0.3905508025211728,1.094896095054391,0.3484848484848485,0.8238969781838,1.0,4/50,1.79%,MICAL3;SVIL;GSN;ARHGAP6
prerank,JNK cascade (GO:0007254),-0.3274992263633226,-1.0948568050911527,0.29152542372881357,0.7948919310303235,1.0,20/40,30.87%,NOD1;TNFRSF19;MAPK10;MAPK8;MAP4K3;ARHGEF6;NOD2;TAB1;MAP3K11;UBE2V1;MINK1;MAP3K7;MAP2K4;TRAF6;GPS2;PTGER4;UBC;RPS27A;MAP3K10;IKBKG
prerank,glucose catabolic process to pyruvate (GO:0061718),-0.3729402763258459,-1.0948350734332055,0.362116991643454,0.7917785837678878,1.0,6/24,9.82%,GPI;HK2;PFKL;TPI1;PFKP;ALDOA
prerank,canonical glycolysis (GO:0061621),-0.3729402763258459,-1.0948350734332055,0.362116991643454,0.7917785837678878,1.0,6/24,9.82%,GPI;HK2;PFKL;TPI1;PFKP;ALDOA
prerank,B cell activation (GO:0042113),-0.29335020372547593,-1.0948088436939007,0.2863247863247863,0.7902934322745913,1.0,23/68,23.49%,MEF2C;PTPRJ;TPD52;PLCG2;TCF3;PTPN2;ITGA4;HHEX;CASP8;CD40;BLNK;GPR183;PTPRC;BTK;JAK3;ADGRG3;CD86;MSH2;KLF6;VCAM1;DCAF1;MALT1;CEBPG
prerank,regulation of intracellular protein transport (GO:0033157),-0.3451621243457038,-1.094765508067662,0.3,0.7888394164329529,1.0,12/32,27.49%,PRR5L;PTPN14;KIF20B;TGFB1;UHMK1;PDCD10;PLK3;TENM1;CEP131;GCC2;RAB29;LCP1
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.32268607287523954,1.0947598717706073,0.28055260361317746,0.8234908966485883,1.0,34/260,9.22%,NRP1;ASAP1;MTSS1;ACTN2;GSN;DYNLL1;RHOD;PARVA;KIT;MYLK;WDPCP;FGD1;RAPGEF2;DZIP1L;RAB23;FGD4;CYS1;CPLANE1;PIBF1;TTC39C;B9D1;WDR35;VCL;PMP22;IFT43;CENPJ;DNAAF1;CARMIL1;FBF1;EMP3;NTN1;MAP4K4;ARFIP2;IFT81
prerank,vasculogenesis (GO:0001570),-0.34089809315913294,-1.0947032776758137,0.3067484662576687,0.7874337749426051,1.0,12/32,13.51%,CAV1;KDR;NOTCH1;SOX17;RASIP1;RAMP2;HEY2;SOX18;VEGFA;TGFBR2;TGFB1;APLNR
prerank,axonal transport of mitochondrion (GO:0019896),-0.4430760584516402,-1.0945152359773678,0.358974358974359,0.7864259486064609,1.0,7/11,39.31%,SYBU;HIF1A;TRAK2;HAP1;ACTR10;MAPT;NEFL
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.43824724611547144,1.094490497115467,0.35118110236220473,0.823518881930035,1.0,3/24,3.78%,NRP1;SEMA3D;SEMA5A
prerank,positive regulation of lamellipodium organization (GO:1902745),0.4150109581834654,1.094403354852429,0.3439878234398782,0.8229928625981813,1.0,5/32,7.54%,AUTS2;PIK3R1;CDC42;SRC;CARMIL1
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.44517370685940083,1.0934909662508023,0.37519142419601836,0.8248071587211127,1.0,3/22,5.68%,RUNX1;IRF1;BCL6
prerank,positive regulation of acute inflammatory response (GO:0002675),0.48878944406201835,1.0933836535018553,0.38617200674536256,0.8243692066746516,1.0,1/14,2.52%,OSMR
prerank,negative regulation of cellular metabolic process (GO:0031324),0.40024321969506427,1.0927438051422846,0.34609929078014184,0.8254277963136442,1.0,8/37,9.62%,OPTN;APOE;MT3;SIRT2;NCOR1;PRKN;ITGB3;ITGAV
prerank,brain development (GO:0007420),0.3369091883693148,1.0925988581014698,0.3283410138248848,0.8250364581989146,1.0,14/136,4.48%,EPHA7;ATXN1;PBX1;ARNT2;HSPG2;ZIC1;PCDH18;SHROOM2;NKX2-1;NFIB;CDK5RAP3;SYNJ2;RAPGEF2;ZIC2
prerank,cellular response to chemokine (GO:1990869),-0.31957964619044515,-1.0925692590294394,0.2789115646258503,0.7905419542492587,1.0,5/46,6.29%,SLC12A2;LRCH1;PTK2B;ACKR3;CCL14
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.37852674954077054,1.092493611840056,0.3256756756756757,0.824577256313593,1.0,8/60,8.46%,TCF7L2;CDK8;RUNX2;TNRC6B;MED14;MED8;MED16;TNRC6A
prerank,regulation of vasoconstriction (GO:0019229),0.4215809118592955,1.092225256572059,0.34782608695652173,0.8245549964100285,1.0,5/27,11.10%,ADRA1B;BDKRB2;AGTR1;TRPM4;ADM
prerank,synaptic vesicle cycle (GO:0099504),-0.34350031119533325,-1.0918617197368177,0.32228915662650603,0.7911563023449755,1.0,7/30,16.85%,NLGN1;RIMS1;CDK5;PCLO;CPLX1;RAB3A;STX1A
prerank,heart development (GO:0007507),0.3327315785452532,1.0917578230286327,0.3182844243792325,0.825105390569524,1.0,24/150,9.89%,RBP4;FBN1;PDLIM5;TGFBR3;DLC1;GLI2;SALL1;PDLIM2;TGFBR1;SH3PXD2B;ACVR1;ADAP2;BCOR;CACNA1C;SCUBE1;FLRT2;OSR1;NTRK3;FOXC2;BMP2;EEF1AKMT4-ECE2;KAT2B;CSRP3;SYNPO2L
prerank,positive regulation of signaling (GO:0023056),-0.3308981240108575,-1.0917316709517135,0.2979452054794521,0.7899530994593176,1.0,12/37,12.19%,RIMS1;GRIK2;RIMS2;SYT1;CLSTN2;INPP5F;EDN1;SCRIB;CLSTN3;NSF;HOMER1;CD80
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.3498059944565869,1.0916996728131974,0.316043425814234,0.8245013562835846,1.0,16/107,8.27%,SLC24A3;SLC8A1;SLC8A3;SLC41A1;DMPK;SLC30A8;CCL19;STIM1;ATP13A3;SLC24A1;MT3;CDH5;SLC24A5;TMEM203;DRD3;SLC30A10
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.4634534549964875,-1.0916269075156224,0.37850467289719625,0.7886856219954916,1.0,4/10,5.72%,PTPRJ;APOD;PTPN12;PTPN2
prerank,positive regulation of neuron differentiation (GO:0045666),0.3997918739410049,1.0911519474064473,0.34054834054834054,0.8252548618754664,1.0,9/40,12.08%,TCF4;FGFR1;ZEB1;ASCL1;NEUROD1;ADRA2C;BMP2;REST;IMPACT
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.4927705049274802,1.091108685849039,0.38448275862068965,0.8246112001832878,1.0,4/14,10.16%,SULF2;SULF1;SPRY2;FGF2
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.43723754272861187,1.0907728611935383,0.36097560975609755,0.8247632110450736,1.0,5/24,9.50%,NRP1;PIK3R1;SFRP1;MAP4K4;MAPRE2
prerank,sulfation (GO:0051923),0.5130907561525253,1.0906437018969357,0.3765112262521589,0.8243532226209352,1.0,1/11,1.33%,UST
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.5094085074532788,1.0905919433805844,0.3824561403508772,0.8237461744737834,1.0,3/10,6.96%,PYCR1;LRRK2;NFE2L2
prerank,regulation of protein kinase C signaling (GO:0090036),0.4843833179610186,1.0905478482724136,0.36650082918739635,0.8231310361877062,1.0,3/14,9.40%,ADGRV1;SPHK2;MYADM
prerank,cellular glucan metabolic process (GO:0006073),0.5105127271430988,1.0903795412575152,0.37300177619893427,0.8228687423460633,1.0,5/11,16.23%,PHKB;PRKAG2;PYGM;PPP1R3C;PHKA1
prerank,regulation of acrosome reaction (GO:0060046),-0.45517368225776167,-1.090236773525505,0.36091954022988504,0.7912533965029354,1.0,2/10,13.74%,GLRA1;CACNA1H
prerank,secondary alcohol metabolic process (GO:1902652),0.3948205222324551,1.0894518798400945,0.3338129496402878,0.824709881297792,1.0,8/42,15.41%,ABCA1;APOE;APOA1;CYP27A1;IDH2;LCAT;RXRA;OSBPL5
prerank,regulation of epithelial cell migration (GO:0010632),0.38067279641324603,1.0889359837615902,0.35771276595744683,0.8253871577710743,1.0,9/51,7.28%,GLUL;SASH1;MCC;MACF1;INSL3;CTSH;SRC;DOCK5;RAB25
prerank,negative regulation of programmed cell death (GO:0043069),0.31184322031465883,1.0887986978056645,0.28147389969293757,0.8250218748640714,1.0,71/355,17.06%,IGF1;FHL2;ANGPT1;GDNF;PIK3R1;IL31RA;BCL2;GRK5;SON;SH3RF1;ASCL1;GAS6;CFLAR;NUPR1;MYO18A;NOTCH2;TXNDC5;FSTL1;MT3;AXL;PHIP;SFRP1;CTSH;PRKAA2;PDPN;TBX3;VIP;USP47;BFAR;ARHGAP10;SRC;DPEP1;TSLP;CD28;ARAF;OSR1;DAB2;DNAJC3;EGFR;MAP4K4;SPRY2;ITCH;BRAF;DDX3X;CLN3;ANXA5;NIBAN2;HMGN5;RIPK2;NOL3;VDAC1;HYPK;TAF9;HSPA9;ARF4;TM7SF3;DSTYK;HPN;FLNA;PLK2;GATA6;BMP4;TMBIM6;GOLPH3;AKT1;KANK2;ATF5;SHH;PIM1;PSEN2;GLO1
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.4539779614944939,1.0887487409701906,0.3627760252365931,0.8244074475518886,1.0,9/20,24.20%,WNT4;SIK1;BMP2;BMP5;ERLIN1;SLC27A1;BRCA1;ERLIN2;ACADVL
prerank,epithelium development (GO:0060429),0.34910174470322386,1.08818729059567,0.3407755581668625,0.8252193802546273,1.0,24/107,18.30%,ERRFI1;DAG1;DACT1;SALL1;FGFR2;WNT4;SMO;CNN3;MEOX2;ALDH1A2;VCL;OSR1;BMP2;RCN3;NDRG4;VDAC1;GSTK1;GATA6;KANK2;SHH;TIMELESS;AHI1;SOX11;FN3K
prerank,cellular response to drug (GO:0035690),-0.3612624418396312,-1.0880697586551997,0.3242424242424242,0.7960432731550562,1.0,7/25,10.27%,MEF2C;PDE4B;ACER2;TFRC;KCNQ1;AIM2;GPLD1
prerank,phosphatidylserine metabolic process (GO:0006658),-0.3409983387370192,-1.0880428850225077,0.34551495016611294,0.7945807452544499,1.0,13/32,27.53%,SERINC5;MBOAT1;PLA1A;PLAAT3;PTDSS1;LPCAT3;PLA2G4F;PLA2G4E;PLSCR1;PLA2G4B;PLA2G5;LPCAT4;MBOAT2
prerank,cell differentiation in spinal cord (GO:0021515),-0.4664400820913021,-1.0879484248913778,0.36423841059602646,0.7933179356122999,1.0,2/10,9.30%,MDGA2;ZC4H2
prerank,regulation of ruffle assembly (GO:1900027),-0.3702635512958763,-1.0873698770511186,0.3323615160349854,0.7935103540070464,1.0,4/23,7.20%,CAV1;NLGN1;RDX;EPS8L2
prerank,rRNA 3'-end processing (GO:0031125),0.5245596209174923,1.0873457798400867,0.39344262295081966,0.8267422882747855,1.0,7/10,27.34%,ERI3;ERI1;EXOSC7;EXOSC2;ERI2;EXOSC8;EXOSC9
prerank,negative regulation of type I interferon production (GO:0032480),-0.32369802586990787,-1.0873307846394251,0.3087248322147651,0.7921010769615896,1.0,12/40,19.26%,IFIH1;RNF125;SIRPA;TRIM25;NLRC5;YY1;REL;TNFAIP3;RELB;PCBP2;UFD1;TAX1BP1
prerank,positive regulation of angiogenesis (GO:0045766),0.34557798123244704,1.0871028936786518,0.33496332518337407,0.82666181996066,1.0,13/108,5.68%,PDPK1;PTGIS;SASH1;SERPINE1;RUNX1;VASH2;SEMA5A;STIM1;ITGB8;CTSH;SMOC2;CYP1B1;CDH5
prerank,heterocycle biosynthetic process (GO:0018130),0.48084088161504496,1.0869169954952562,0.38636363636363635,0.8264319711736555,1.0,4/14,12.80%,PYCR1;PYCR3;LIAS;MOCS1
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.426251005645358,1.0868091259026424,0.363905325443787,0.8260331046806432,1.0,11/29,22.16%,SMAD3;ZC3H7B;TUT7;SMAD1;TUT4;PRKRA;METTL3;DICER1;AGO4;SMAD2;DROSHA
prerank,long-chain fatty acid import into cell (GO:0044539),0.526255138550592,1.0864511514247217,0.38738738738738737,0.8262547340316992,1.0,2/10,2.35%,SLC27A5;ACSL1
prerank,sphingolipid biosynthetic process (GO:0030148),-0.2866838737517935,-1.0862594444443276,0.2807017543859649,0.7937813840020076,1.0,9/71,5.34%,SGMS1;CERT1;ACER3;SGMS2;ELOVL7;ACER2;DEGS2;SPNS2;ELOVL5
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.4852432180506656,1.086256877462701,0.3920552677029361,0.8260467831979148,1.0,5/12,22.37%,MIA3;WNK1;MDK;AKT1;LCK
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.25618154682894345,-1.0859308337457587,0.2,0.7932772708833219,1.0,42/149,21.79%,PRKCH;CAV1;NOD1;RPS6KA5;TNFRSF11A;TFRC;TRIM14;PPIA;NFKBIA;RPS3;ARHGEF2;RBCK1;AIM2;TRIM25;ALK;RPS6KA4;TRAF5;CX3CR1;PRKCZ;RTKN2;CARD14;CD40;TRAF1;TRIM68;APP;NOD2;CARD16;TAB1;TRIM6;BTK;EP300;TLR4;TRIM62;NPM1;CLU;DHX9;PSMA6;AGER;TRAF2;UBE2V1;DDRGK1;CHUK
prerank,cellular response to hormone stimulus (GO:0032870),0.3668702145934261,1.0858127106349558,0.34127979924717694,0.8265378180338724,1.0,19/69,13.49%,GHR;AR;ATP1A2;THRB;NCOA2;SFRP1;CTSH;BRD8;TFPI;ZFP36L1;LHCGR;SRC;STAT5B;SLIT3;KLF9;ADRA2A;SLC5A5;CTSL;NCOA3
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),-0.41028220933242404,-1.0853777831859877,0.3583959899749373,0.793285568292026,1.0,3/14,9.98%,NOS3;ACE2;EDN1
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),-0.37621533955010356,-1.0853313971049094,0.3324175824175824,0.7919289672328874,1.0,8/21,12.63%,EXTL3;NDST3;HS3ST4;XYLT1;HS6ST3;HS3ST5;HS6ST2;UGDH
prerank,ERBB signaling pathway (GO:0038127),0.36859133699413393,1.0853292466564886,0.3390501319261214,0.8271722900182438,1.0,13/64,11.25%,PDPK1;PIK3R1;AREG;TGFA;EPGN;PIGR;SRC;CUL5;SLC30A10;AAMP;EGFR;BRAF;HBEGF
prerank,regulation of vacuole organization (GO:0044088),0.4578172185472569,1.08485095423738,0.3653250773993808,0.8277140348935657,1.0,8/20,18.10%,NPRL3;ADPRH;ENO2;MTMR3;PIKFYVE;NPRL2;LAPTM4B;ENO3
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.44100633300469133,1.0847408054215892,0.38181818181818183,0.8272907933852994,1.0,8/24,15.28%,VTN;NEDD4;MT3;EMILIN1;ITGB3;ARNT;NIBAN2;GRB10
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.299463532159841,-1.084306907095063,0.3278008298755187,0.7934108960074007,1.0,25/54,30.49%,CAV1;IVNS1ABP;NXN;RPS3;CRY1;RPL11;MINAR1;COPS9;TNFAIP3;RPL5;USP4;N4BP1;VPS28;PRMT3;PRR7;ADGRB1;UBXN1;CAMLG;PRKCG;CAPN3;ISG15;BAG2;U2AF2;CTNNB1;SQSTM1
prerank,regulation of RIG-I signaling pathway (GO:0039535),-0.3761878214140255,-1.0837305330909366,0.35958005249343833,0.7935612176216562,1.0,7/18,24.85%,SEC14L1;RNF125;USP15;UFD1;C1QBP;OASL;PUM2
prerank,Golgi to plasma membrane transport (GO:0006893),-0.3033175221393685,-1.0829577217015982,0.292,0.7943913349995451,1.0,13/47,14.64%,STXBP6;EXOC4;EXOC6;ANK3;EXOC5;SPTBN1;KIF13A;STEAP2;ARL3;NSF;EXOC8;EXOC2;CCDC93
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.3258448236673073,1.0828228993126077,0.33590308370044053,0.8317809458117925,1.0,22/190,8.20%,ITPR1;RORA;RHOH;UACA;CGNL1;DAG1;LYN;BCL2;WWC2;MGRN1;NPRL3;TLE1;UBR2;RFFL;PRKAA2;PDE3A;SRC;MAPKBP1;NMI;NR1D1;WTIP;DRD3
prerank,histone lysine demethylation (GO:0070076),0.4380219621494762,1.0826715285892508,0.39280359820089955,0.8314262775752044,1.0,11/25,23.22%,KDM5B;PHF2;KDM5C;KDM7A;PHF8;RIOX1;KDM3B;KDM4A;KDM5A;KDM4C;KDM3A
prerank,negative regulation of adenylate cyclase activity (GO:0007194),0.4832552356718169,1.0826253798001217,0.3827751196172249,0.8308083889981022,1.0,3/13,8.20%,ADGRV1;GRM2;DRD3
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.43143880098124465,1.0825911189094215,0.3767441860465116,0.830155489778927,1.0,11/24,24.02%,SEC24D;SEC31A;BCAP31;ABCB9;SEC23A;TAPBP;SEC24A;IDE;TAP1;PDIA3;CANX
prerank,protein localization to cell surface (GO:0034394),0.4276552437275968,1.0825527902415362,0.38484848484848483,0.8295199892875704,1.0,6/26,15.36%,FBLN5;ANGPT1;VCL;GGA2;FLNA;ARF6
prerank,regulation of T cell receptor signaling pathway (GO:0050856),-0.3376418014110259,-1.082446584093857,0.3020833333333333,0.7944104777359747,1.0,17/33,34.42%,PTPRJ;RPS3;PTPN2;CD81;PTPN22;CEACAM1;DGKZ;CD300A;NECTIN2;CARD11;DUSP3;RAB29;PRNP;IKBKG;PHPT1;TRAT1;CD226
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.47979995386307883,1.0820455043960029,0.36938435940099834,0.8301301695789083,1.0,8/16,22.93%,AMPD3;NUDT2;GART;AMPD2;PPAT;PFAS;ADSS1;ADSL
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),-0.3671643180169979,-1.0818807400737516,0.35816618911174786,0.7945878179707487,1.0,6/25,9.82%,GPI;HK2;PFKL;TPI1;PFKP;ALDOA
prerank,cell part morphogenesis (GO:0032990),0.4939873009337813,1.0816855070590752,0.3958333333333333,0.8303692032849005,1.0,4/13,13.21%,PID1;CSPG5;NUBPL;WASF1
prerank,macromolecule catabolic process (GO:0009057),-0.36694035721800294,-1.0816138170947704,0.31671554252199413,0.793941185854865,1.0,8/26,12.39%,SMURF1;PPT1;SIAH1;TRIM24;KIF16B;TGFB1;LGMN;MTOR
prerank,mitochondrial fission (GO:0000266),-0.38708511555092806,-1.080613626999672,0.36243386243386244,0.7953875061840062,1.0,4/16,16.18%,DNM3;MTFR1;DNM1;MTFR2
prerank,negative regulation of immune response (GO:0050777),0.3270265290783737,1.0806061908728686,0.3424036281179138,0.8326327987034043,1.0,17/154,8.39%,ADCY1;ADCY2;LYN;ADCY7;ADCY5;ADCY9;INSL3;VIP;LHCGR;ADRB3;SRC;CD247;MAPKBP1;DPEP1;SIRT2;NMI;IRAK3
prerank,intracellular pH reduction (GO:0051452),0.4112143653482217,1.0804987666943566,0.3662182361733931,0.8321681268291302,1.0,4/33,10.04%,ATP6V0A4;GPR89A;GPR89B;ATP6V1E1
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.495490400747049,1.0803414938744247,0.40362438220757824,0.831822814716999,1.0,2/12,7.99%,B3GALT1;B3GALNT1
prerank,gastrulation (GO:0007369),-0.41024254882365796,-1.0790924183603305,0.351010101010101,0.7982964782284205,1.0,4/15,12.63%,GPC3;LRP5;TASOR;UGDH
prerank,intraciliary retrograde transport (GO:0035721),0.5017243080567608,1.0788649851690986,0.398981324278438,0.8351315276463666,1.0,3/12,10.60%,WDR35;IFT43;DYNC2I1
prerank,long-chain fatty acid metabolic process (GO:0001676),0.3661240927635526,1.077628154630415,0.3581699346405229,0.8378239294542109,1.0,9/64,7.06%,DAGLA;ACSL1;EPHX2;ACOT2;GSTM4;PLA2G4A;CYP1B1;GSTM2;ALOXE3
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.3476755213189849,-1.0775316955777543,0.30952380952380953,0.8012978915513355,1.0,10/29,22.16%,CAV1;THBS1;TNFSF10;RET;PAK2;DEDD2;GPER1;INHBA;TRAF2;TNFRSF12A
prerank,chromatin remodeling (GO:0006338),0.34568929548965194,1.0774596135182524,0.3553921568627451,0.8375354345424013,1.0,36/100,23.32%,ARID1B;NPM3;CBX3;INO80;SMARCA1;NPM2;MBD2;DR1;SMARCC2;MTA2;KDM5B;KAT2B;ZBTB1;POLE3;FOXA1;BAZ1B;ACTR8;KDM5C;SMARCD2;HDAC4;CECR2;SMARCB1;HNRNPC;BAZ2B;ATRX;KDM4A;SRCAP;KDM5A;TAF6L;KDM4C;JARID2;NUDT5;SMARCAD1;PBRM1;HDAC5;SMARCE1
prerank,cobalamin metabolic process (GO:0009235),0.4599393642269691,1.0771643315291306,0.3860759493670886,0.8376205917466594,1.0,3/17,8.02%,MMAB;MTR;MMUT
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.37203194901690384,1.0770244752395661,0.36712328767123287,0.8372389117677143,1.0,5/51,4.18%,SERPINE1;IL6R;IL34;GAS6;CSF1
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),-0.3998977108485906,-1.076995031284204,0.3548387096774194,0.8013240242887831,1.0,5/17,17.45%,PTPRJ;PTPN2;PTPN22;CEACAM1;DGKZ
prerank,proteasomal protein catabolic process (GO:0010498),0.3198743768911731,1.0769443449266698,0.33916849015317285,0.8367123055638135,1.0,65/201,23.51%,SPSB1;TBL1XR1;HECW2;FBXL17;FBXL19;NEDD4;RFFL;SMURF2;PSME4;ERLEC1;BFAR;DERL1;PML;CUL4B;NFE2L2;UBE4B;SIRT2;UBXN2B;UBE2U;RNF185;NR1D1;RNF139;ARRB1;UBXN11;PRKN;ITCH;IFI27;KBTBD7;ERCC8;RCN3;FEM1C;BTRC;TNFAIP1;ENC1;APPBP2;HACE1;HUWE1;DDI1;NHLRC3;SPOP;PSMB5;PSMC2;KAT5;RNF34;PSMD1;PSMD4;NSFL1C;PSME3;CCDC47;FEM1B;KCTD13;DCAF11;PSMA3;ZSWIM8;DDIT3;UCHL1;BIRC2;RNF216;BAG6;KLHL20;PSMA2;FBXW11;ATXN3;PSMC5;ARMC8
prerank,central nervous system neuron axonogenesis (GO:0021955),0.4960754814592239,1.0766580452442076,0.3969594594594595,0.8367390604979319,1.0,5/12,16.82%,MYCBP2;ARHGAP35;EPHB2;PTEN;B4GALT6
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),-0.35773515311715015,-1.0764350894025163,0.3472584856396867,0.8014365800120792,1.0,10/25,23.25%,SLC7A5;PLCG2;B2M;CD55;NOD2;TRIM6;FZD5;TRAF2;MAP3K7;MALT1
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.3964090769216305,1.0763937510220825,0.3815789473684211,0.8367737934043943,1.0,4/40,6.60%,PID1;BCL2;PYCR1;LRRK2
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.38443773724987274,1.0762709294422905,0.3780821917808219,0.8363781649165274,1.0,9/49,11.08%,DAPK2;BCL2;NUPR1;SRC;EIF2AK3;BCL2L11;BCAP31;DDX3X;GSDME
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.4350570724066028,-1.076124473106633,0.3811764705882353,0.8008651923578667,1.0,6/12,20.96%,PLCG2;RAB27A;ZNF205;TLR4;GRIN1;ADGRB1
prerank,protein localization to vacuole (GO:0072665),-0.4313692656693474,-1.0758804177818013,0.3620253164556962,0.7999951881368144,1.0,4/13,19.76%,SH3BP4;KPTN;CD81;LMBRD1
prerank,establishment of endothelial intestinal barrier (GO:0090557),-0.448823358781566,-1.0756632200397127,0.4074074074074074,0.7991339461326771,1.0,3/11,2.91%,F11R;TJP2;TJP1
prerank,negative regulation of histone methylation (GO:0031061),0.5251094781111723,1.0753890984460834,0.41818181818181815,0.8380304802043081,1.0,7/10,22.99%,BCOR;PHF1;WDR5;DNMT3B;JARID2;DNMT1;BRCA1
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.45887441798934686,1.0749095133309727,0.3818770226537217,0.8386171489225662,1.0,8/19,26.75%,DNAAF1;CCDC40;CABYR;CFAP53;SPEF2;ROPN1L;ODAD4;NPHP3
prerank,neuron projection morphogenesis (GO:0048812),-0.2523409474207646,-1.0739198957249338,0.2751677852348993,0.8027760184990315,1.0,33/137,15.06%,CNTNAP2;SHANK3;CTNND2;GPM6A;MAP2;NLGN1;ACTB;ANK3;NGF;NRCAM;IQGAP1;SLC9A6;KLF7;EPHB1;CNTN4;NTNG1;BTBD3;CDK5;DCDC2;PAK1;SGK1;SHANK1;NEFH;DCC;KIF20B;ATP7A;PACSIN1;NYAP2;APBB1;DIP2A;LMTK2;APP;MAP1B
prerank,iron ion transmembrane transport (GO:0034755),0.5202935005200768,1.073588262504959,0.4110320284697509,0.8414952382067857,1.0,4/10,10.70%,SCARA5;SLC25A37;SLC11A2;ABCC5
prerank,positive regulation of cation channel activity (GO:2001259),-0.32258994443161204,-1.0734309072962245,0.3504823151125402,0.8026841994884204,1.0,17/40,23.45%,SHANK3;TMSB4X;ANK3;AKAP6;STAC;CALM1;CALM3;ADRB2;ATPSCKMT;P2RY6;NLGN3;CTSS;KCNIP2;HAP1;RELN;CCL2;CASQ1
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),-0.3095029737013271,-1.0733374444089245,0.3079710144927536,0.8014423297796281,1.0,13/44,13.63%,KCNJ2;KCNJ3;KCNMA1;KCNN2;KCNQ1;AKAP6;ATP1B1;KCNMB2;WNK2;KCNJ15;GNB1;KCNJ10;GNG2
prerank,mitochondrion morphogenesis (GO:0070584),0.5078043010215954,1.073253194562194,0.40540540540540543,0.8416836731298141,1.0,3/11,13.21%,PID1;NUBPL;WASF1
prerank,inositol phosphate metabolic process (GO:0043647),-0.3036570568347757,-1.073135438839673,0.2996389891696751,0.8005829982158916,1.0,20/46,26.00%,PLCE1;PLCG2;INPP5D;INPP4B;NUDT4;MINPP1;CALM1;IP6K1;ISYNA1;IPMK;PLCD4;INPP5B;SYNJ1;PLCH1;PPIP5K1;NUDT11;ITPKB;IMPA2;NUDT10;ITPKC
prerank,negative regulation of protein modification process (GO:0031400),0.3491102298722801,1.0729211173625819,0.36523929471032746,0.8418158976544156,1.0,14/79,9.40%,PID1;PTPN13;PLPP3;LYN;FBLN1;CDK5RAP3;PRKAA2;LRRK2;BEX4;WWTR1;NTRK3;EPHB2;PRKN;MYADM
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.41766884639167645,1.0726382921516047,0.37025796661608495,0.8419071249574568,1.0,8/30,10.76%,AR;NCOA2;SFRP1;DAB2;SAFB2;NCOR1;RNF6;NCOR2
prerank,"transcription, DNA-templated (GO:0006351)",0.3209200004493002,1.0722839090044372,0.35313531353135313,0.8421088727262056,1.0,66/207,23.83%,POLR2D;SOX5;GLIS3;MAF;THRB;HSF2BP;NFIX;MLLT3;GTF2E1;BRF1;GTF3C1;GTF2H5;PMF1;MED16;CREBL2;POLR3A;TRIP11;CCNK;POLR2C;TFAM;MBD1;POLRMT;NKX2-8;TTF2;MNAT1;PAF1;TEFM;TAF5L;GTF2E2;TAF9;NELFE;AFF4;FUBP3;TTF1;COPS2;TFDP1;TSC22D1;CCNT2;FOXO3;CDC73;NCOA6;POLR2L;TAF2;PAX1;HSF1;GTF2A1;DEAF1;BRF2;NFE2L3;LEO1;MLLT1;IRF9;GTF3C3;NOCT;ERCC3;CCNT1;RPAP1;NCBP2;POLR1C;CDK7;ERCC2;KLF13;TAF4B;NAT14;ELOC;SETX
prerank,basement membrane organization (GO:0071711),0.4876947990137365,1.071989520501114,0.3996789727126806,0.8421881841446311,1.0,8/14,23.24%,NID1;NID2;FLRT2;NTNG2;HPN;LAMB2;COL4A1;PXDN
prerank,neuropeptide signaling pathway (GO:0007218),-0.3067424424856374,-1.0717105965225562,0.350210970464135,0.803295764847189,1.0,17/58,24.42%,SORCS2;GLRA1;SORL1;GLRA2;HCRTR2;CYSLTR1;CYSLTR2;SORCS1;GPR37;NXPH2;PPY;CPE;SORCS3;PNOC;NMUR2;GLRA3;NXPH4
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.36109465116941447,1.0715390248990422,0.398505603985056,0.8426872069707272,1.0,24/69,24.68%,POLR2D;PHAX;GTF2E1;SNAPC1;CCNK;POLR2C;RPAP2;INTS4;GTF2E2;TAF9;ELL2;SNAPC5;SNAPC4;SP1;CCNT2;POLR2L;GTF2A1;TAF8;CCNT1;NCBP2;CDK7;INTS7;NABP2;ICE1
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.42906974453714863,1.071528956860124,0.38095238095238093,0.8419807788687896,1.0,2/26,3.80%,ITPR1;CCL19
prerank,endoplasmic reticulum membrane organization (GO:0090158),-0.4395143101084036,-1.0712694590052894,0.38461538461538464,0.803044374203921,1.0,4/11,14.21%,ATL2;BNIP1;ARL6IP1;LPCAT3
prerank,regulation of cellular component organization (GO:0051128),-0.25352523603971383,-1.070913714224738,0.28846153846153844,0.8026873189826773,1.0,31/135,14.30%,PLCE1;RAP1A;NRG3;RIT2;SPOCK1;TJP1;NET1;PAK5;TFRC;HSPA8;CAMK2D;SOCS2;OPHN1;HIP1R;RAP1B;RAB5B;CDH13;EGLN2;PACSIN2;WFDC1;SGK1;LTBP4;SSRP1;OGFR;BCAR1;MTOR;ATAD3A;FAM107A;PACSIN1;CEACAM1;RAB4A
prerank,regulation of protein modification process (GO:0031399),0.37995693363299743,1.0707024892041985,0.3681462140992167,0.8436191149673751,1.0,11/50,10.36%,IGF2;LYN;MT3;HPF1;PHIP;CDH5;PML;ATG10;KAT2B;STAT2;SPRED3
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.4745118016375065,1.0704343987741707,0.3968253968253968,0.8436201378535045,1.0,2/15,3.64%,GDNF;SMO
prerank,regulation of adaptive immune response (GO:0002819),0.45863600793427733,1.0702895965105175,0.3827993254637437,0.8432600227824476,1.0,2/18,4.44%,ADCY7;IRF1
prerank,regulation of glucose transmembrane transport (GO:0010827),-0.383435488208567,-1.0702691178379151,0.3491271820448878,0.8030258911377691,1.0,3/18,7.80%,OCLN;SLC2A1;INPP5K
prerank,histone H2A acetylation (GO:0043968),0.46182405269845306,1.0693766636747624,0.3950819672131147,0.8449440204259967,1.0,3/16,7.20%,ING3;BRD8;SPHK2
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.4309475842290689,1.0692070371768383,0.3814756671899529,0.8446809826238627,1.0,9/22,25.91%,ROCK2;PPP4R4;BOD1L1;PTPA;BOD1;NCKAP1L;PPP1R15A;MASTL;STYXL1
prerank,glycine metabolic process (GO:0006544),-0.43748692137174705,-1.0688863134503654,0.38752783964365256,0.8056096815806311,1.0,6/12,33.59%,GCSH;GCAT;SHMT1;AMT;GLYAT;GLDC
prerank,embryonic heart tube morphogenesis (GO:0003143),-0.3025896556302164,-1.0687593736509415,0.33587786259541985,0.8045006311846706,1.0,12/44,14.28%,MEF2C;NOTCH1;SOX17;TBX2;ZIC3;SOX18;TGFBR2;HES1;STIL;APLNR;RYR2;MICAL2
prerank,negative regulation of neuron differentiation (GO:0045665),-0.3706752537401763,-1.0685145704750507,0.3697916666666667,0.803786632557243,1.0,10/22,24.22%,B2M;MED1;CNTN4;HES1;HEY1;DLL1;DTX1;GSK3B;NEPRO;EIF2AK4
prerank,regulation of interleukin-1 beta production (GO:0032651),0.35646365671198577,1.0682963543680575,0.37146529562982006,0.8464065102567436,1.0,5/66,7.75%,IGF1;CCL19;APOA1;PANX1;TLR6
prerank,renal filtration (GO:0097205),0.5189322675502106,1.0681957945696956,0.42397137745974955,0.845930241427343,1.0,3/10,4.15%,SULF2;ITGA3;SULF1
prerank,cellular response to oxidative stress (GO:0034599),0.3380450210082074,1.0679434483154628,0.3595238095238095,0.8458959317632915,1.0,21/118,13.12%,DAPK1;TPM1;PLA2R1;PYCR1;NUDT2;PDGFRA;MT3;SLC25A24;PRKAA2;GPX8;LRRK2;NFE2L2;ERCC6L2;SIRT2;EGFR;ARNT;MGAT3;FANCC;SELENOS;GPX3;NOX4
prerank,response to laminar fluid shear stress (GO:0034616),0.5124836428859338,1.0678657954664883,0.4146341463414634,0.8453850024284004,1.0,2/10,6.96%,ABCA1;NFE2L2
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.34195662600932886,1.0678347798797212,0.3711843711843712,0.8447436326594722,1.0,13/93,10.83%,CCN2;SH3RF3;SASH1;SH3RF1;GADD45B;CCL19;EDAR;RELL1;MTURN;BMP2;LTBR;CARD9;TAOK3
prerank,long-chain fatty acid transport (GO:0015909),0.4113684339552771,1.0676080073937955,0.3965014577259475,0.8445958463224936,1.0,4/30,5.19%,ACSL1;PRKAG2;APOE;PRKAA2
prerank,negative regulation of autophagosome assembly (GO:1902902),0.4851912009615765,1.0671777053114326,0.41391304347826086,0.8450513612802409,1.0,2/13,6.60%,NUPR1;LRRK2
prerank,negative regulation of cyclase activity (GO:0031280),0.47662375650349453,1.0667444830013297,0.39052287581699346,0.8454764011605383,1.0,3/14,8.20%,ADGRV1;GRM2;DRD3
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.48741043242491866,1.0665433903006474,0.4021543985637343,0.8452917216169031,1.0,4/11,14.89%,MAP2K1;EGFR;MYCN;BMP4
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.30749329886335564,1.0664785370000074,0.3432682425488181,0.8447351339184764,1.0,81/366,18.96%,NFIA;IGF2;RORA;RHOH;ATXN1;ARNT2;MITF;WWC2;CCNA2;NUP107;TGFBR1;OGG1;MSC;NCOA2;DENND4A;ENG;TCF7;APBB2;NAB2;PML;CEBPA;WWTR1;SAP30;REXO4;ZBTB38;WTIP;TULP3;TCF7L1;CREBL2;BMP2;ZBTB4;NONO;MZF1;GTF2IRD1;NSD1;ACTR8;ZSCAN21;PHF1;RNF6;NR1D2;EIF2B4;CEBPB;IFNK;REST;HMGN5;INSR;ACVR1B;TRIP4;MTPN;TAF5L;ZNF219;YAF2;SUFU;MYCBP;FOXK2;SAP30L;GPBP1;RBM4B;FADS1;TGFBRAP1;PSPC1;MYT1;MAFA;PLAG1;ZNF423;ATF5;SP1;ZFAT;MYBL1;SPIN4;IRF2;FOXO3;SRSF10;PPIE;NFIL3;SOX11;GON4L;CARM1;ATRX;CREM;CHD7
prerank,cell cycle G2/M phase transition (GO:0044839),0.32786168047472336,1.0657844150629079,0.3778801843317972,0.8459049031741042,1.0,24/130,14.91%,CDK14;DYNLL1;NINL;CCNA2;OPTN;CEP152;PHLDA1;FBXL17;DYNC1H1;ALMS1;CENPJ;BRSK1;FBXL3;FBXL12;YWHAE;MNAT1;DYNC1I2;BTRC;HAUS1;HAUS7;HAUS3;CEP164;AKAP8L;CEP192
prerank,rRNA pseudouridine synthesis (GO:0031118),0.5144152768964183,1.0657298494873617,0.41379310344827586,0.845340912990616,1.0,3/10,17.55%,RPUSD4;RPUSD2;NAF1
prerank,translational elongation (GO:0006414),-0.26743021622974233,-1.06555258301318,0.27932960893854747,0.8110753465997469,1.0,40/101,32.16%,EEF2;GTPBP1;GFM2;MRPL46;MRPS18A;MRPS5;MRPL39;MRPS26;EEF1A1;EEF1B2;MRPS12;MRPL48;MRPL4;MRPL21;MRPL44;MRPS33;MRPL55;MRPL57;RACK1;MRPS18B;MRPL42;MRPS10;MRPS21;MRPS7;MRPL34;MRPL19;MRPL15;EEF1A2;LTN1;MRPS22;MRPL38;MRPS31;EEF2K;MRPL12;MRPL28;MRPL43;MRPS14;MRPL54;MRPL2;AURKAIP1
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.43911270422105636,-1.0649380386732792,0.3923444976076555,0.8114454533613282,1.0,8/12,29.92%,SGTB;CHMP4B;CHMP4A;SGTA;SEC61G;GET3;SEC61A2;SEC63
prerank,modulation by host of viral genome replication (GO:0044827),0.4738411371415138,1.0645895315739953,0.39767054908485855,0.8477332498715436,1.0,4/13,15.01%,CCNK;PRKN;IFI27;TBC1D20
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.4113935877117376,1.0645108301619515,0.3858858858858859,0.8472086207591222,1.0,4/28,7.95%,ARHGAP28;PLEKHG2;ARHGAP18;ARHGAP35
prerank,cGMP biosynthetic process (GO:0006182),-0.439738434430201,-1.06420452782588,0.3878504672897196,0.8121388145267878,1.0,3/10,6.46%,GUCY1B1;GUCY1A1;NPR1
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.46041514825199886,1.0641367390129401,0.38613861386138615,0.847480836490996,1.0,7/16,20.89%,RUNX1;WNT4;RGCC;F2;BMP4;LARP6;CREB3L1
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.37563899099657727,1.0637944431338922,0.3884180790960452,0.8476641270420114,1.0,17/45,21.05%,SMAD3;TOM1L2;BCL6;ZFP36L1;ZW10;ZWINT;RGCC;NME6;PTPN3;PLK2;BMP4;GAS1;CDKN1C;CDKN1B;FOXC1;ZFP36L2;PRCC
prerank,regulation of autophagosome assembly (GO:2000785),0.40538016258692944,1.0637910229538579,0.38799414348462663,0.8469494060738558,1.0,9/33,16.29%,NUPR1;NPRL3;LRRK2;ADPRH;MTMR3;RAB3GAP1;PIKFYVE;NPRL2;PIP4K2C
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.41493824077784225,1.0637279536835296,0.3939393939393939,0.8456672202038841,1.0,6/29,17.18%,ACOT11;ACOT6;ACOT2;ACSF2;ACOT9;OXSM
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.41493824077784225,1.0637279536835296,0.3939393939393939,0.8456672202038841,1.0,6/29,17.18%,ACOT11;ACOT6;ACOT2;ACSF2;ACOT9;OXSM
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.48383383980451256,1.063662282877879,0.41056218057921634,0.8451366683005703,1.0,1/12,1.40%,AR
prerank,Fc-gamma receptor signaling pathway (GO:0038094),-0.2752659267889336,-1.063624916811211,0.2962962962962963,0.8123578580380595,1.0,22/71,19.03%,ELMO1;YES1;ACTB;VAV3;PLCG2;ARPC1B;DOCK1;PAK1;HSP90AB1;ARPC3;WIPF3;WASF2;FCER1G;CYFIP2;PLPP4;MAPK3;PIK3CA;ARPC4;PRKCE;ACTG1;FCGR1A;FGR
prerank,macrophage differentiation (GO:0030225),0.4776514882971411,1.0632728659090454,0.38488576449912126,0.8455267006545854,1.0,3/13,6.15%,IL31RA;CSF1;CDC42
prerank,mitotic sister chromatid cohesion (GO:0007064),0.4652060332244302,1.063132154226546,0.4047244094488189,0.8451645580813592,1.0,6/16,19.20%,PDS5B;POGZ;SGO1;NIPBL;BOD1;NAA50
prerank,negative regulation of protein polymerization (GO:0032272),-0.33398324724079814,-1.0629731021522588,0.3710691823899371,0.8128319991385646,1.0,5/27,6.51%,SLIT2;MAP2;KANK3;CYRIB;HIP1R
prerank,cellular response to interleukin-4 (GO:0071353),-0.45380780317109176,-1.0629282081367488,0.3847926267281106,0.8114667295057598,1.0,1/10,0.16%,LEF1
prerank,cell-cell junction assembly (GO:0007043),0.36687105473553233,1.0627043744316134,0.3745072273324573,0.8455504544981446,1.0,12/63,8.01%,GJA1;CDH11;GJB6;GJB2;TLN2;ARVCF;TLN1;CDH5;VCL;DCHS1;FBF1;PARD6B
prerank,polyol metabolic process (GO:0019751),-0.30245767468534596,-1.0624742100468396,0.3285198555956679,0.8113334506916225,1.0,20/46,26.00%,PLCE1;PLCG2;INPP5D;INPP4B;NUDT4;MINPP1;CALM1;IP6K1;ISYNA1;IPMK;PLCD4;INPP5B;SYNJ1;PLCH1;PPIP5K1;NUDT11;ITPKB;IMPA2;NUDT10;ITPKC
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.4897711961955402,1.062133188659828,0.3862815884476534,0.8464059895644734,1.0,2/11,7.75%,LYN;TLR6
prerank,motor neuron axon guidance (GO:0008045),0.47169365601868496,1.0619184855849075,0.4006849315068493,0.8462411036368223,1.0,4/15,10.12%,RHOH;EPHA4;NTN1;SLIT1
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.3779522675858351,1.0616122984426297,0.39106145251396646,0.8463301633278993,1.0,4/48,2.08%,PDPK1;ANGPT1;SRPX2;FGFR1
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.3728068875542708,-1.0611501795314948,0.37823834196891193,0.813842899435365,1.0,7/20,12.61%,SEMA6D;SEMA6A;SEMA7A;SEMA5B;SEMA3G;SEMA3C;SEMA4B
prerank,photoreceptor cell development (GO:0042461),-0.4089209036523482,-1.060841684442303,0.4020618556701031,0.813284158558692,1.0,5/14,9.51%,RORB;RP1;MFSD2A;ARL3;VEGFA
prerank,ether lipid metabolic process (GO:0046485),0.4682265613091204,1.0607983393643583,0.3996627318718381,0.8478615920395082,1.0,1/14,0.62%,AGMO
prerank,pentose-phosphate shunt (GO:0006098),0.49605762646831036,1.060790739030558,0.3932384341637011,0.8471602337909833,1.0,6/11,31.06%,H6PD;PGD;TALDO1;PGLS;TKT;DERA
prerank,ceramide biosynthetic process (GO:0046513),-0.31337429141687784,-1.0607359835285786,0.33986928104575165,0.8121163731270338,1.0,9/40,11.40%,ST6GALNAC3;SGMS1;ST8SIA4;SGMS2;DEGS2;DEGS1;ST8SIA6;SPTLC2;SPTSSB
prerank,primary miRNA processing (GO:0031053),0.5086560661582822,1.0603277906982782,0.41367521367521365,0.8477174505340572,1.0,5/10,22.16%,SMAD3;SMAD1;METTL3;SMAD2;DROSHA
prerank,positive regulation of cell communication (GO:0010647),-0.3458937599611688,-1.059958558865093,0.36443148688046645,0.8128828860004683,1.0,10/28,12.19%,ANK3;RIMS1;GRIK2;RIMS2;SYT1;CLSTN2;EDN1;CLSTN3;HOMER1;CD80
prerank,glycogen metabolic process (GO:0005977),0.41335599076097307,1.0598230059037317,0.3830104321907601,0.8483517090486735,1.0,10/27,16.45%,PHKB;PRKAG2;NR1D1;GAA;AGL;PYGM;PPP1R3C;PYGB;PHKA1;PHKA2
prerank,response to gamma radiation (GO:0010332),0.4255959261074628,1.0590256797526645,0.36666666666666664,0.8497683633977449,1.0,3/24,5.51%,YAP1;LIG4;MAP3K20
prerank,skeletal muscle organ development (GO:0060538),0.4222623644481508,1.058932543319764,0.39457831325301207,0.8492816456867092,1.0,4/26,4.38%,SVIL;CFLAR;LARGE1;MSC
prerank,positive regulation of epidermal cell differentiation (GO:0045606),-0.400146955845999,-1.058879269386024,0.40097799511002447,0.8144993961878508,1.0,3/15,9.89%,PRKCH;MED1;TRIM16
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.3684237044763823,-1.058756721822907,0.3972972972972973,0.8133602469848447,1.0,11/22,25.46%,AKAP6;STAC;ATP1B1;CALM1;CALM3;RYR2;P2RY6;HAP1;CASQ1;VMP1;CALM2
prerank,cell-substrate junction assembly (GO:0007044),0.398172566292221,1.0585885190685156,0.3818443804034582,0.8494813023828497,1.0,5/33,6.31%,ACTN2;DLC1;RHOD;LAMC1;SRC
prerank,regulation of leukocyte migration (GO:0002685),0.4634474271354358,1.0585581189069242,0.40604026845637586,0.8488470369694952,1.0,1/16,0.70%,RHOH
prerank,purine ribonucleotide catabolic process (GO:0009154),-0.36271426418091646,-1.0584816203908525,0.344311377245509,0.812732209255606,1.0,7/21,11.07%,PDE4D;NT5E;NT5C2;PDE2A;NUDT4;PDE9A;NT5C1A
prerank,lipid catabolic process (GO:0016042),-0.3790375375537771,-1.0578920352586456,0.37333333333333335,0.8130017181734227,1.0,9/18,28.47%,PPT1;LIPE;PLA1A;PLAAT3;HSD11B1;LIPH;LIPC;LPL;HSD17B14
prerank,histone ubiquitination (GO:0016574),0.43604614756407756,1.0575754640142723,0.39368770764119604,0.8507449175442747,1.0,12/21,27.36%,UBR2;ATXN7L3;UBE2U;PAF1;HUWE1;WAC;CDC73;LEO1;RNF20;UBE2E1;RNF40;UBE2N
prerank,mesenchymal to epithelial transition (GO:0060231),0.5107742038482997,1.0575677313937157,0.4298245614035088,0.8500467078508193,1.0,1/10,2.13%,SALL1
prerank,phosphatidylcholine metabolic process (GO:0046470),-0.27777147834048405,-1.057322021134047,0.3607305936073059,0.8131674793154774,1.0,28/70,27.53%,ENPP2;PLA2G7;LPCAT1;MBOAT1;SLC44A5;MFSD2A;PLAAT3;GPLD1;PNPLA8;PLA2G4C;PCTP;MBOAT7;LPCAT3;STARD7;LPCAT2;PCYT1B;PLA2G4F;PLA2G4E;CHKA;DBI;ABHD4;PLAAT1;CHPT1;LIPC;PLA2G4B;PLA2G5;LPCAT4;MBOAT2
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.5014035938500471,1.056840866029121,0.41681574239713776,0.8512486211434266,1.0,1/11,1.20%,GSN
prerank,lipid modification (GO:0030258),-0.31910139166309937,-1.0567018460169233,0.34967320261437906,0.8135291534999467,1.0,15/37,20.81%,DGKB;DGKH;PLA2G7;MBOAT1;PLPPR5;DGKK;PLPPR1;DGKG;DGKQ;PLPP4;MBOAT7;LPCAT3;DGKZ;PLPP6;DGKI
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.3840467912638193,1.0566769247886918,0.3929577464788732,0.8509605948696762,1.0,5/44,7.22%,CYP7B1;SLC27A5;PRKAG2;INSIG2;CYP27A1
prerank,positive regulation of chondrocyte differentiation (GO:0032332),-0.4460312190153214,-1.056508700314266,0.38154613466334164,0.8126258155266048,1.0,3/10,5.23%,ZBTB16;ACVRL1;PKDCC
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),-0.4508224542793213,-1.0564888414419678,0.41839080459770117,0.8112526394729881,1.0,6/10,19.89%,PDE4B;NIPSNAP2;CALM1;CALM3;CACNA2D1;CACNB3
prerank,positive regulation of response to wounding (GO:1903036),0.4264922352002372,1.056480091334122,0.3858858858858859,0.8507555505586721,1.0,8/24,16.38%,KANK1;MYLK;VTN;INSL3;HBEGF;ADRA2A;MDK;ARFGEF1
prerank,establishment of apical/basal cell polarity (GO:0035089),-0.41496937134141815,-1.0564062645204206,0.40865384615384615,0.8100642319900169,1.0,5/14,11.19%,MYO9A;OPHN1;SCRIB;MSN;PATJ
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.4053807346166606,1.0562480530346785,0.39481268011527376,0.8506324295788481,1.0,6/30,11.52%,VAMP5;MACF1;OPTN;GOLGA4;GGA2;GOLPH3L
prerank,regulation of adenylate cyclase activity (GO:0045761),0.4401492426929301,1.0562343421321194,0.3776435045317221,0.8499618635414393,1.0,5/22,8.20%,ADGRV1;STIM1;CACNA1C;GRM2;DRD3
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.5153802395438153,1.0561596638928543,0.4254937163375224,0.8487563318806045,1.0,3/10,12.37%,APOA1;MYADM;WNK1
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.5153802395438153,1.0561596638928543,0.4254937163375224,0.8487563318806045,1.0,3/10,12.37%,APOA1;MYADM;WNK1
prerank,regulation of Ras protein signal transduction (GO:0046578),0.3402257240708505,1.0560563213829555,0.3926829268292683,0.8483109153798427,1.0,11/86,9.36%,IGF1;LYN;DLC1;OGT;KANK1;NOTCH2;DENND4A;ARHGEF18;EPHB2;SPRY2;RAPGEF1
prerank,response to organonitrogen compound (GO:0010243),0.3904612633388531,1.0557462325482745,0.4008746355685131,0.848412064483642,1.0,9/38,12.18%,ERLEC1;DERL1;KYNU;RNF185;RNF139;DRD3;IRAK3;PRKN;RCN3
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.4261465342004521,1.0553874808872892,0.39628482972136225,0.8487168170516255,1.0,5/24,7.40%,GHR;KIT;CYP1B1;PIBF1;CENPJ
prerank,cellular response to alkaloid (GO:0071312),0.4490399806704496,1.0551865695804965,0.4020979020979021,0.8485327535029443,1.0,3/17,10.96%,SLC8A1;GSTM2;CASP7
prerank,epithelial cell morphogenesis (GO:0003382),0.46842807777070594,1.0551018780189634,0.4192495921696574,0.8480214785098995,1.0,3/17,12.99%,COL22A1;RAB25;DACT2
prerank,response to nitric oxide (GO:0071731),0.47153333269718184,1.055087276963944,0.40176991150442476,0.8473541795063063,1.0,4/13,6.97%,CCL19;MTR;MT3;DPEP1
prerank,negative regulation of developmental growth (GO:0048640),0.4042100296076713,1.0548297098588557,0.3924812030075188,0.8473107569003266,1.0,7/30,10.40%,WWC2;NKD1;MT3;PTPRS;ULK2;FGF13;RNF6
prerank,calcium-ion regulated exocytosis (GO:0017156),-0.34592590784746463,-1.0547759198787097,0.37735849056603776,0.8132881748955761,1.0,9/27,23.10%,RIMS1;ARHGAP17;RIMS2;SYT1;SYT6;SYT4;RIMS3;SYT15;SYT5
prerank,mitotic cytokinesis (GO:0000281),0.37778783320264775,1.054756635524867,0.41793103448275865,0.846792510543402,1.0,8/47,9.01%,ROCK2;SON;KIF20A;MYH10;EFHC1;SNX33;SNX18;KLHDC8B
prerank,nuclear migration (GO:0007097),0.4776643028666376,1.0547445140019776,0.4096185737976783,0.8461253710382806,1.0,6/13,23.44%,SYNE2;DYNC1H1;CLMN;CEP120;FBXW11;TMEM201
prerank,regulation of neuron projection development (GO:0010975),0.3218885328556695,1.054391054739088,0.3741573033707865,0.8463377831101471,1.0,27/163,9.36%,EPHA3;PDLIM5;CAMK1D;LYN;KIF13B;EPHA4;KANK1;MARK1;APOE;EFNB2;DPYSL3;RAPGEF2;MT3;FZD1;PTK7;PTPRS;ROR1;LRRK2;ATP1B2;DENND5A;LPAR1;BRSK1;PTPN9;ARHGAP35;NTRK3;CAMK2B;RAPGEF1
prerank,negative regulation of TORC1 signaling (GO:1904262),0.4732036503791301,1.0543694778626742,0.4370629370629371,0.8457032040487956,1.0,7/13,20.41%,STK11;RNF152;CASTOR2;ITFG2;SESN2;ATM;SZT2
prerank,regulation of macrophage migration (GO:1905521),-0.447330335362307,-1.0531996797559655,0.4033816425120773,0.816233548623717,1.0,4/10,12.70%,MTUS1;PTK2B;CX3CR1;CD81
prerank,acute inflammatory response (GO:0002526),0.4233779186271463,1.05261833277473,0.39717425431711145,0.8495805035750779,1.0,2/23,2.21%,AHSG;IL6R
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.3528026444096296,1.0525683808801205,0.3835263835263835,0.8489996336789849,1.0,14/67,9.40%,NRP1;NEDD9;CSF1;APOA1;SFRP1;ECM2;CDC42;PLEKHA2;DOCK5;CARMIL1;CSPG5;ARL2;RSU1;MYADM
prerank,histone H4-K16 acetylation (GO:0043984),0.4478556995316808,1.0524219943006705,0.4428341384863124,0.8486911833461919,1.0,9/19,24.63%,OGT;JADE1;KMT2A;WDR5;MSL2;KANSL1;MEAF6;KANSL3;JADE2
prerank,chromatin assembly or disassembly (GO:0006333),0.5077436248688986,1.0523082071711278,0.4218181818181818,0.84829952855618,1.0,3/11,11.80%,CHAF1B;MTA2;HDAC8
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.32276716097817365,1.0516156769196552,0.3764705882352941,0.8494785403277636,1.0,29/140,9.87%,RHOH;CGNL1;ARHGAP6;SYDE2;DLC1;RHOD;ARHGAP28;PLEKHG2;ARHGAP18;TIAM2;SOS2;ARHGAP29;FGD1;ARHGAP21;FGD4;ARHGAP19;ARHGAP32;ARHGAP10;CDC42;SRC;FAM13A;ARHGEF17;ARHGEF18;ARHGAP35;ARHGAP9;ARHGEF11;SYDE1;ITGAV;RHOT1
prerank,hexose biosynthetic process (GO:0019319),0.3857072270866876,1.0512869165396228,0.40502793296089384,0.8496710794873911,1.0,4/42,8.02%,RBP4;AKR1B1;MDH2;ENO2
prerank,alpha-amino acid catabolic process (GO:1901606),0.4064264831487362,1.0505744314926164,0.40822320117474303,0.8508311502117236,1.0,10/29,22.54%,TDO2;DDO;HOGA1;KYNU;SARDH;ACADSB;PRODH;CBS;KYAT1;FAH
prerank,heart looping (GO:0001947),-0.30726278400715273,-1.050359171191416,0.3613138686131387,0.8230225427880622,1.0,10/40,14.28%,MEF2C;NOTCH1;SOX17;TBX2;ZIC3;SOX18;TGFBR2;STIL;APLNR;MICAL2
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.26970687622546957,-1.0498455364763208,0.33195020746887965,0.8230532183126251,1.0,22/73,19.03%,ELMO1;YES1;ACTB;VAV3;PLCG2;ARPC1B;DOCK1;PAK1;HSP90AB1;ARPC3;WIPF3;WASF2;FCER1G;CYFIP2;PLPP4;MAPK3;PIK3CA;ARPC4;PRKCE;ACTG1;FCGR1A;FGR
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.34600735265405,1.0493704861571014,0.3979591836734694,0.8532475618014357,1.0,14/71,13.35%,ADAMTS12;FBXL17;CTSH;CTSF;CUL4B;NR1D1;CLPX;PRKN;NGLY1;CLPP;RSPRY1;CTSZ;USP9X;CTSL
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.3631782666663446,1.0493574314992835,0.3954727030625832,0.8525753135578165,1.0,25/52,27.13%,SEC31A;TSPYL2;TLN1;PARP16;GFPT1;DNAJC3;GOSR2;CTDSP2;KDELR3;PDIA6;WIPI1;ZBTB17;CUL7;YIF1A;SRPRB;CXXC1;WFS1;ATP6V0D1;HSPA5;EXTL2;ACADVL;SSR1;LMNA;FKBP14;DNAJB9
prerank,natural killer cell activation (GO:0030101),0.42277149195104025,1.0493164979947451,0.4165341812400636,0.8519941363124702,1.0,4/23,11.11%,PBX1;AXL;IL12B;IFNK
prerank,protein ubiquitination (GO:0016567),0.2998893100876468,1.0491989392429129,0.35444330949948927,0.8516203314610138,1.0,120/471,20.85%,MYCBP2;RNF220;SPSB1;PDZRN3;HECW2;SH3RF3;SASH1;ARRDC4;BCL2;PELI2;SH3RF1;MGRN1;FBXL17;UBR2;FBXL19;NEDD4;SMURF2;PSME4;RNF213;EPAS1;BFAR;DERL1;ZNRF3;CUL4B;RNF31;NFE2L2;UBE4B;RNF10;TRIP12;CUL5;UBE2U;DTX4;FBXL3;TRAF7;RNF185;RNF139;UBE2V2;ARRB1;UBOX5;COMMD1;FBXO28;PRKN;ITCH;RNF181;ASB12;RNF6;RNF38;RNF152;MIB1;FBXO9;FBXO11;ERCC8;FBXO4;FBXL12;RAD18;SELENOS;BTRC;PEX2;PAF1;RNFT1;RNF217;KLHL12;MUL1;USP9X;TNFAIP1;TNKS2;RNF19A;ENC1;RC3H2;UBE2E2;AMFR;UBA6;THOP1;UBE2D1;ASB1;HACE1;HUWE1;RNF13;HLTF;DZIP3;CUL7;NHLRC3;SPOP;UBR5;UBE2R2;MSL2;UBR3;UBE3B;RNF138;UBE3A;PSMB5;RNF135;PJA2;PSMC2;DTX3;HERC6;UNKL;KLHL18;WAC;RC3H1;CDC73;RNF34;PSMD1;TRIM47;TRIM41;TRIM32;PSMD4;TRIM26;PSME3;TRIM21;FBXL18;HIF3A;RNF11;KCTD13;ARIH2;CDC23;UBE2T;PSMA3;LEO1;ZSWIM8
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.436020475132886,1.0491616161950996,0.4103852596314908,0.8509968154314477,1.0,4/19,11.51%,BMP6;AFDN;FOXA1;RGCC
prerank,mesenchyme development (GO:0060485),0.4560702159560308,1.0490321982855875,0.42033898305084744,0.8506377374197024,1.0,4/15,14.89%,FGFR2;TGFBR1;BMP2;BMP4
prerank,regulation of myeloid cell differentiation (GO:0045637),-0.2875466115383135,-1.048923764623638,0.36134453781512604,0.8243182186233902,1.0,7/62,2.31%,MEF2C;ZBTB16;CDK6;PTK2B;TNRC6C;THBS1;HOXA5
prerank,triglyceride metabolic process (GO:0006641),0.3686978631768142,1.0484897700393643,0.39783491204330174,0.851354462081756,1.0,3/48,3.47%,AGMO;SLC27A5;APOE
prerank,regulation of Golgi organization (GO:1903358),0.45444680212566463,1.0481194475215991,0.42414355628058725,0.8516568714015096,1.0,3/17,7.59%,USP6NL;RBSN;MAP2K1
prerank,response to X-ray (GO:0010165),0.46746176568774755,1.048007675624445,0.4019933554817276,0.851249228369031,1.0,5/14,20.16%,LIG4;IKBIP;ATM;NIPBL;BRCC3
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.3225724513729974,1.047715857660603,0.3970080552359033,0.8513491375562875,1.0,23/129,14.91%,CDK14;DYNLL1;NINL;CCNA2;OPTN;CEP152;PHLDA1;FBXL17;DYNC1H1;ALMS1;CENPJ;BRSK1;FBXL3;FBXL12;YWHAE;MNAT1;DYNC1I2;BTRC;HAUS1;HAUS7;HAUS3;CEP164;CEP192
prerank,positive regulation of cell growth (GO:0030307),0.3341842394320419,1.0472331061525266,0.41211401425178146,0.8519702511824316,1.0,12/96,8.65%,IGF1;BCL2;MACF1;TGFBR1;GOLGA4;SFRP1;CXCL16;USP47;CDC42;INO80;EGFR;NTN1
prerank,nucleus organization (GO:0006997),-0.29402865273801077,-1.0471203343493463,0.35802469135802467,0.8281134697279641,1.0,12/47,19.82%,SYNE1;NUP93;RPS19;NUP35;SUN2;NUP54;PDCD6IP;PITPNB;NUP155;IRAG2;VPS4A;CHMP2B
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.4175037466746649,1.0470595291276317,0.41363636363636364,0.8517626316582115,1.0,3/28,3.47%,ADCY1;EPHA4;APOE
prerank,regulation of cholesterol transport (GO:0032374),0.43872507113825704,1.0469060591955783,0.43312101910828027,0.8514892534096262,1.0,5/20,18.08%,LRP1;APOA1;TSPO;NR1H3;YJEFN3
prerank,glutamine family amino acid metabolic process (GO:0009064),0.3894100044092765,1.0463136581768306,0.3994252873563218,0.8523646529806438,1.0,5/33,8.63%,GLUL;ART4;PYCR1;PYCR3;ALDH18A1
prerank,regulation of humoral immune response (GO:0002920),0.37344851502398185,1.0462919174082386,0.40860215053763443,0.8517332352366566,1.0,12/44,20.22%,SERPING1;VTN;CFH;C4B;C8G;F2;CFHR2;CXCL13;GATA6;PROS1;PHB2;SUSD4
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.37810779881185996,1.046209446346169,0.4057142857142857,0.8512734546154213,1.0,8/40,8.59%,ANGPT1;SERPINE1;VTN;CCL19;NTF3;CD63;DAB2;ARRB1
prerank,glutathione derivative biosynthetic process (GO:1901687),0.43903768204564675,1.045876688137849,0.4240506329113924,0.8507774396511778,1.0,10/20,27.27%,GSTM4;GSTM2;MGST1;GSTT1;GSTK1;AKR1A1;MGST3;ESD;MGST2;GSTZ1
prerank,glutathione derivative metabolic process (GO:1901685),0.43903768204564675,1.045876688137849,0.4240506329113924,0.8507774396511778,1.0,10/20,27.27%,GSTM4;GSTM2;MGST1;GSTT1;GSTK1;AKR1A1;MGST3;ESD;MGST2;GSTZ1
prerank,positive regulation of histone acetylation (GO:0035066),-0.3579353899405232,-1.0455918867494611,0.4,0.8310206653492245,1.0,7/23,13.80%,RPS6KA5;NOS1;PPARGC1A;BRD7;RPS6KA4;TADA2A;MAPK3
prerank,muscle tissue development (GO:0060537),0.4800508115278626,1.0455406475683549,0.4234875444839858,0.8509682654555301,1.0,6/13,16.71%,SMO;CSRP2;ENG;CSRP3;BMP4;SHH
prerank,steroid metabolic process (GO:0008202),0.35380487433304914,1.0454622709773447,0.41160949868073876,0.8504654128396644,1.0,7/72,7.55%,CYP26B1;CYP7B1;STAR;HSD3B2;CYP1B1;CYP27A1;SRD5A1
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.34723570807780646,1.0447555055882942,0.388,0.8516510662106915,1.0,13/70,16.00%,PDPK1;SMAD3;BCL2;IL6R;MOAP1;ITGAV;IFI27;DDX3X;ACVR1B;G0S2;CASP8AP2;TNFRSF1A;CASP9
prerank,regulation of phagocytosis (GO:0050764),0.35927673427827667,1.0446819137625074,0.39947780678851175,0.8511640587934637,1.0,11/53,16.03%,CAMK1D;AHSG;TULP1;GAS6;APOA1;IL15RA;ITGAV;SYT11;MERTK;FER1L5;CD47
prerank,protein localization to kinetochore (GO:0034501),0.46596196526464295,1.0440127048033156,0.4205298013245033,0.8522251179487889,1.0,4/14,9.45%,SPDL1;ZW10;CHAMP1;MTBP
prerank,ncRNA 3'-end processing (GO:0043628),-0.401729208653916,-1.0436414828404732,0.38618925831202044,0.8351746185077714,1.0,4/14,17.97%,INTS6;PTCD1;INTS8;ELAC2
prerank,regulation of fibrinolysis (GO:0051917),-0.4197164722538713,-1.043391303239181,0.39853300733496333,0.8344210607522434,1.0,3/13,2.59%,THBS1;FAP;THBD
prerank,regulation of protein neddylation (GO:2000434),-0.44706009449458683,-1.0433818673167028,0.4060324825986079,0.8330039177096302,1.0,5/10,15.16%,RPL11;DCUN1D4;COPS9;RPL5;HIF1A
prerank,epiboly involved in wound healing (GO:0090505),0.45384723036855684,1.0432045996630122,0.4444444444444444,0.8536807949409513,1.0,4/16,14.42%,CCN1;PDPN;ARHGAP35;FLNA
prerank,icosanoid biosynthetic process (GO:0046456),0.5037503722078952,1.04314119284628,0.42857142857142855,0.8531655090371283,1.0,6/10,27.00%,PLA2G4A;FADS1;ALOX5AP;LTA4H;MGST3;MGST2
prerank,negative regulation of histone acetylation (GO:0035067),-0.4404672823684608,-1.042729871395969,0.4013761467889908,0.8334257029959748,1.0,4/11,28.27%,CTBP1;SIRT1;THAP7;SET
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.3886945396601565,1.0425362671443705,0.3825701624815362,0.8540801301786547,1.0,9/37,15.34%,CEMIP;PRKAG2;SIRT2;SPRY2;SPRED3;RIPK2;EGF;PARD3;SPRED1
prerank,regulation of MHC class II biosynthetic process (GO:0045346),-0.43434156828401815,-1.0423640635608407,0.4195804195804196,0.8330500207684792,1.0,5/11,35.95%,JAK2;SIRT1;TMEM106A;XBP1;IL4
prerank,carnitine shuttle (GO:0006853),0.48894380715402663,1.0421275127491714,0.43103448275862066,0.8545023255551613,1.0,2/11,5.19%,PRKAG2;PRKAA2
prerank,cardiac muscle cell differentiation (GO:0055007),0.4298885873356285,1.0421010389112035,0.4218009478672986,0.8538855944134023,1.0,5/21,8.89%,SLC8A1;ACVR1;SIK1;BMP2;CBY1
prerank,regulation of osteoclast differentiation (GO:0045670),0.3918812187002651,1.040978535084767,0.4185714285714286,0.8561610663159718,1.0,10/33,21.04%,FBN1;CSF1;IL12B;TCTA;CEBPB;FSTL3;IL23A;CARTPT;GPR137B;PRXL2A
prerank,cellular component assembly (GO:0022607),0.30236386679586086,1.0405084317842777,0.3931987247608927,0.8566962869338876,1.0,45/253,14.45%,RHOH;TEAD1;CALD1;GSN;MITF;RHOD;NEDD9;PARVA;LAMC1;SHROOM2;YAP1;GAS6;DPYSL3;MYO1B;GORASP2;FZD1;FSCN3;CHAF1B;LIMA1;CDC42;PML;CD247;ZW10;RANBP9;PARD6B;SYCE2;TLCD1;CFAP46;PICALM;TEX12;TSPAN4;FLNC;STAG3;FANCC;RHOQ;MNAT1;CCDC40;PAWR;WASF1;KMT2A;ABCA3;LLGL1;DLG4;FLNA;SNX9
prerank,inner mitochondrial membrane organization (GO:0007007),-0.2995484607190366,-1.0402441688721378,0.35546875,0.8380148029707717,1.0,13/47,21.51%,TOMM70;LETM1;ATP5F1A;ATP5F1E;ATP5ME;ATP5MG;ATP5F1C;ATP5MF;MTX3;MTX2;ATP5PD;MTX1;TIMM10
prerank,neuromuscular synaptic transmission (GO:0007274),0.4517469802958835,1.0402292857519686,0.4416403785488959,0.8567486034833736,1.0,6/18,24.26%,ERC2;DTNA;FCHSD2;STAC3;CHRNB2;RIMBP2
prerank,actin filament organization (GO:0007015),0.3193643702817188,1.0397748436759702,0.3974799541809851,0.8572678474335741,1.0,23/151,10.60%,RHOH;SVIL;GSN;CGNL1;RHOD;NEDD9;TPM1;TMOD4;SHROOM2;RHOBTB1;DPYSL3;MYO1B;MCU;RHOBTB3;CDC42;RHOBTB2;CARMIL1;MYO1C;FAT1;MARCKSL1;MPRIP;SHROOM3;EFS
prerank,maturation of 5.8S rRNA (GO:0000460),0.4385818288729662,1.0396782001741907,0.42394822006472493,0.8568245312034032,1.0,5/17,12.90%,C1D;MPHOSPH6;FTSJ3;EIF6;MTREX
prerank,ruffle organization (GO:0031529),0.44868003218966324,1.0396393330648392,0.4230769230769231,0.856232462071615,1.0,4/16,9.05%,TPM1;LIMA1;CARMIL1;ARFIP2
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.34799467499565623,1.0396279203016374,0.39367088607594936,0.8555804677938639,1.0,17/72,23.01%,POLR2D;GTF2H5;CUL4B;POLR2C;ERCC8;MNAT1;GPS1;COPS3;COPS2;PPIE;XPA;POLR2L;RFC5;ERCC3;CDK7;LIG1;ERCC2
prerank,xenobiotic transport (GO:0042908),-0.3793986858127043,-1.0389827591037017,0.4,0.8402771699186743,1.0,5/17,5.07%,SLC47A1;ABCG2;SLC7A5;ABCC1;SLC15A2
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.34416780752338866,1.038648942955218,0.41424802110817943,0.8574403833061163,1.0,12/75,9.96%,SLC8A1;SLC8A3;LYN;NR2F2;APOE;CDK5RAP3;PKIA;CEBPA;IRAK3;SPRY2;HEXIM2;INCA1
prerank,regulation of immune response (GO:0050776),0.3219381306090403,1.0382497103560866,0.4014084507042254,0.8578046502386318,1.0,10/135,6.92%,COL1A2;COL1A1;COLEC12;LYN;ADCY7;APPL2;IRF1;BCL6;CD247;KLRD1
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),-0.41054487904375914,-1.0380661588938873,0.4247191011235955,0.8415005941519302,1.0,2/14,1.66%,ADAM10;PTK2B
prerank,Golgi inheritance (GO:0048313),-0.4331527836912852,-1.0380381389334814,0.3922902494331066,0.8401145019560827,1.0,4/11,29.31%,VRK1;PDCD10;PLK3;CDK1
prerank,negative regulation of neuron projection development (GO:0010977),0.36390722936070824,1.0379038513836663,0.39620081411126185,0.8580622632471866,1.0,10/56,7.92%,EPHA4;KANK1;APOE;EFNB2;DPYSL3;MT3;PTPRS;DENND5A;LPAR1;PTPN9
prerank,bile acid biosynthetic process (GO:0006699),0.418888298602244,1.0374794758374803,0.4143302180685358,0.8585265840563547,1.0,3/24,7.22%,CYP7B1;SLC27A5;CYP27A1
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),-0.4438155489248651,-1.0372901736427371,0.42488262910798125,0.8407782330581979,1.0,5/11,16.32%,NOVA2;PCBP3;PCBP1;RASA1;PCBP2
prerank,telomere maintenance via recombination (GO:0000722),0.5011439723411037,1.0372430233180827,0.4364326375711575,0.8584452925889808,1.0,5/11,20.24%,SMC5;SMC6;TEP1;RAD51D;NSMCE2
prerank,response to ketone (GO:1901654),-0.3424409358792432,-1.0369331880056407,0.38274932614555257,0.8403384633311823,1.0,5/24,3.96%,SLIT2;CAV1;THBS1;ABHD2;TGFB2
prerank,regulation of fatty acid oxidation (GO:0046320),0.4437545108925307,1.036410855027182,0.4318936877076412,0.8599005083408426,1.0,3/16,10.19%,PRKAG2;APPL2;LONP2
prerank,negative regulation of hydrolase activity (GO:0051346),-0.29529652301958864,-1.0361292120449088,0.375,0.8412722681762567,1.0,6/49,6.37%,LRCH1;MAP2;F11R;SH3BP4;RDX;NOS1
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),-0.36175971640486776,-1.0357658909704113,0.40437158469945356,0.8409467453892436,1.0,9/20,18.59%,ENTPD1;NT5E;P2RX7;HSP90AB1;APP;TXN;ANO6;C3AR1;PSTPIP1
prerank,amino acid import (GO:0043090),0.4302852440445362,1.0357393933447405,0.41823899371069184,0.8609918126439573,1.0,5/21,7.62%,SLC1A3;SLC6A13;SLC22A2;SFXN2;SLC22A4
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.4185164510829972,1.0356251313567864,0.4197901049475262,0.8606071278538338,1.0,13/26,25.71%,PRKAG2;APOA1;SLC45A3;PRKAA2;LPGAT1;EIF6;NR1H3;ERLIN1;BRCA1;ERLIN2;PRKAB2;ACADVL;PDK4
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.32962960819829856,-1.035321893590555,0.4166666666666667,0.8408090993852638,1.0,12/29,30.46%,RPS14;RPS19;UTP4;RRP36;RPS21;HELB;WDR46;RRS1;RPS16;RPS8;TSR1;RPP40
prerank,phagosome maturation (GO:0090382),0.38736118170467265,1.0348750232956547,0.41348973607038125,0.8618419909825973,1.0,1/35,0.20%,ATP6V0A4
prerank,glycosphingolipid biosynthetic process (GO:0006688),0.44309993571610473,1.0345005172547952,0.43926788685524126,0.8621320004485371,1.0,3/16,4.22%,ST6GALNAC5;ST3GAL5;LARGE1
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.29401986164436356,1.0344922705190562,0.42190669371196754,0.8614681438289705,1.0,92/497,15.24%,TCF7L2;SAMD4A;ENPP1;RUNX1T1;ATXN1;DAPK1;NR2F2;SALL1;GLI3;ARID5B;ZEB1;NKX2-1;ARID4A;PRDM5;WNT4;FOXP2;ASCL1;RBFOX2;GAS6;RUNX2;LBH;MIDEAS;TLE1;IKZF4;SMURF2;TSPYL2;IRF1;ZIC2;PRICKLE1;MT3;IGF2BP2;ZHX2;SFRP1;IGFBP5;TBX3;BCL6;DKK3;USP47;BCOR;CBX3;ATOH8;PML;CPEB3;CEBPA;MBD2;SIRT2;ZBTB38;EIF2AK3;SMARCC2;NR1D1;RNF139;RBPJ;NCOR1;ZMYND15;MTA3;SCML2;BMP2;ZBTB4;CBY1;NONO;HEXIM2;S100A11;GLIS2;PBXIP1;ZKSCAN3;NR1D2;MBD1;KDM5C;NCOR2;DDX3X;L3MBTL1;BHLHE41;REST;NIBAN2;SELENOS;LARP1;PDCD4;BTRC;ZNF318;L3MBTL2;HDAC4;ENC1;ZNF148;ZNF219;TWIST2;YAF2;GATA6;BMP4;SUDS3;FOXK2;WAPL;CDKN1C
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.36189122655719996,1.0339899768973713,0.4397260273972603,0.8621149314640689,1.0,13/53,21.26%,EYA2;EYA1;PLA2R1;EGFR;SPRED3;ERCC8;NPAS2;SPRED1;SMCHD1;ATM;UIMC1;BRCC3;NSMCE4A
prerank,cellular response to radiation (GO:0071478),-0.3073175674642246,-1.033664312691262,0.3870967741935484,0.8441594017746424,1.0,22/40,35.89%,NET1;RHOB;RAD1;SIRT1;KDM4D;HUS1;RAD51;ECT2;CDKN1A;TANK;RAD51AP1;RHNO1;RRH;OPN1MW3;OPN1MW;FIGNL1;OPN3;GRB2;RAD9A;MAPK14;NSMCE3;EEF1D
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),-0.3427203478280459,-1.0335985240397307,0.4169184290030212,0.8429166140718695,1.0,8/26,13.10%,EFNA5;ANO1;LRP5;KLF7;EPHA5;GPLD1;ADCY8;CFTR
prerank,regulation of blood coagulation (GO:0030193),-0.3414694198594597,-1.0332475761199056,0.3942307692307692,0.8424727195516539,1.0,5/27,2.59%,CAV1;CD34;THBS1;FAP;THBD
prerank,negative regulation of ATP metabolic process (GO:1903579),0.437985925943248,1.0326823957187428,0.43659711075441415,0.8647913988569264,1.0,3/17,8.39%,PID1;NUPR1;NCOR1
prerank,glycolytic process (GO:0006096),-0.3356978859256473,-1.032678301440946,0.391304347826087,0.8426729303933019,1.0,10/28,23.32%,GPI;HK2;PFKL;TPI1;PFKFB1;ALDOA;PKM;PGAM1;PGAM4;ALDOC
prerank,positive regulation of sodium ion transport (GO:0010765),-0.4212534944087298,-1.03242389042377,0.41964285714285715,0.8419399651372489,1.0,2/12,6.37%,ANK3;NOS1
prerank,camera-type eye morphogenesis (GO:0048593),-0.4464668178373859,-1.031796352910797,0.45023696682464454,0.8424242965680202,1.0,5/10,11.43%,TENM3;LRP6;TBX2;VEGFA;NF1
prerank,electron transport chain (GO:0022900),-0.3968942118578283,-1.031667955061315,0.40240963855421685,0.8413679745627187,1.0,7/15,25.88%,PDIA5;PPARGC1A;CYB561;NDUFA5;SDHB;ETFRF1;UQCRFS1
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.443299138603057,1.031382347163917,0.431740614334471,0.8674796776000171,1.0,2/15,2.08%,RAI2;FGFR1
prerank,tetrapyrrole metabolic process (GO:0033013),0.4377857834752794,1.0308494002720086,0.445859872611465,0.8681714980549254,1.0,3/18,8.02%,MMAB;MTR;MMUT
prerank,positive regulation of JNK cascade (GO:0046330),0.3427067348623742,1.0303429879373354,0.41284403669724773,0.8687788804508415,1.0,11/70,12.36%,CCN2;SH3RF3;SH3RF1;GADD45B;CCL19;EDAR;MTURN;LTBR;CARD9;TAOK3;DUSP19
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.42938283206559524,1.0302879023327338,0.4297520661157025,0.8682194172467712,1.0,6/18,20.48%,ZFP36L1;BCL2L11;KLF9;REST;HNRNPU;ZFP36L2
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.37392045181718775,-1.0302461760242376,0.4223918575063613,0.8441233583551814,1.0,7/17,15.93%,ITGA1;HSP90AB1;PPP1R15B;CALM1;CALM3;MTOR;PTPRC
prerank,zinc ion transport (GO:0006829),0.42486776094823203,1.0301331651526622,0.4267515923566879,0.8679440778395536,1.0,5/21,10.81%,SLC30A8;MT3;SLC30A2;SLC30A10;SLC39A13
prerank,positive regulation of BMP signaling pathway (GO:0030513),0.41176213444013315,1.0299548797469011,0.44011976047904194,0.8676803658040495,1.0,7/25,8.12%,BMPR1A;CCN1;SULF1;CDH5;ENG;CRB2;RBPJ
prerank,membrane fusion (GO:0061025),-0.3191824535731674,-1.0298314540166233,0.4228187919463087,0.8439315360631473,1.0,5/33,11.54%,DNM3;RIMS1;DYSF;GCA;NSF
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.4815793256477833,1.029692644134522,0.43392857142857144,0.8676663111983878,1.0,4/10,14.37%,DCLRE1C;DCLRE1A;TERF2;RTEL1
prerank,neural crest cell migration (GO:0001755),0.3888305950555193,1.029620499976165,0.43615494978479197,0.8671749423544963,1.0,4/36,3.78%,NRP1;GDNF;SEMA3D;SEMA5A
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.3575582562525837,1.0295259890261343,0.42668428005284015,0.8667146558486916,1.0,8/52,11.94%,CELF2;RBFOX1;RBFOX2;DDX17;HNRNPA1;SMU1;WTAP;REST
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.3995512748336997,1.0289809072717844,0.44728915662650603,0.8674728566629584,1.0,7/30,14.65%,ROBO1;APOA1;LPAR1;ARRB1;SYNPO2L;COL3A1;AKAP13
prerank,protein modification by small protein conjugation (GO:0032446),0.29575536319578033,1.0289620961956145,0.42045454545454547,0.8668458285231222,1.0,95/361,20.85%,MYCBP2;RNF220;SPSB1;PDZRN3;HECW2;ARRDC4;EYA1;MGRN1;NUP107;FBXL17;UBR2;NEDD4;CDK5RAP3;SMURF2;RNF213;EPAS1;DERL1;ZNRF3;CUL4B;ATG10;NFE2L2;NUP42;CUL5;DTX4;FBXL3;TRAF7;RNF139;UBA7;UBE2V2;ARRB1;COMMD1;PRKN;TRPM4;ITCH;RNF181;ASB12;RNF6;RNF38;RNF152;MIB1;NUP98;FBXO9;FBXO11;UFL1;RAE1;FBXO4;RAD18;SELENOS;BTRC;PEX2;PAF1;URM1;MUL1;USP9X;TNFAIP1;ENC1;AMFR;NUP214;UBA6;UFC1;UBE2D1;ASB1;HACE1;HUWE1;DCUN1D2;HLTF;CUL7;UBE2R2;MSL2;UBR3;RNF138;RNF135;PJA2;DTX3;SEH1L;KLHL18;WAC;CDC73;RNF34;TRIM47;TRIM41;TPR;TRIM32;SUMO1;TRIM26;TRIM21;HIF3A;AAAS;NSMCE2;KCTD13;ARIH2;CDC23;UBE2T;LEO1;ZSWIM8
prerank,histone H2B ubiquitination (GO:0033523),0.49815691593524686,1.0289229416075758,0.466789667896679,0.8662571840238302,1.0,7/10,27.02%,PAF1;WAC;CDC73;LEO1;RNF20;UBE2E1;RNF40
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.3848721063692303,1.0287044238107015,0.42128935532233885,0.866098016395121,1.0,7/35,8.16%,NRP1;PDGFRA;NOTCH2;NTF3;IQGAP2;CDC42;NTRK3
prerank,melanosome organization (GO:0032438),0.4033367799671562,1.0282952745375982,0.4327485380116959,0.8665142911374681,1.0,9/26,19.32%,SHROOM2;DTNBP1;BLOC1S1;AP1M1;PIKFYVE;ABCB6;RAB32;HPS4;SNAPIN
prerank,organic acid transport (GO:0015849),0.3340857372821705,1.0282643214539486,0.422360248447205,0.8659082382058467,1.0,9/94,5.39%,SLC7A11;SLC7A2;SLC1A5;SLC13A3;SLC27A5;ACSL1;SLC6A13;NCOA2;PDPN
prerank,protein localization to lysosome (GO:0061462),-0.33696021953404776,-1.028183011003131,0.41641337386018235,0.847356975266213,1.0,9/28,19.76%,SH3BP4;SORL1;KPTN;NCOA4;CD81;SCARB2;GGA3;VPS4A;LMBRD1
prerank,regulation of autophagy (GO:0010506),0.30459640638290364,1.0281828944398528,0.4326086956521739,0.865464158275385,1.0,51/216,21.22%,DAPK2;ITPR1;DAPK1;DCN;BCL2;LEPR;OPTN;PRKAG2;NUPR1;NEDD4;MT3;PRKAA2;LRRK2;SREBF1;SIRT2;MTMR3;PRKN;SLC38A9;STK11;ATP6V1E1;ZKSCAN3;RNF152;LAMTOR2;UFL1;RRAGD;USP10;VDAC1;PLK2;FOXK2;NPRL2;PIK3R2;TPCN2;PIP4K2C;AKT1;ATM;KAT5;FOXO3;PRKACA;KDM4A;PRKAG1;RHEB;TRIM21;WDR41;PSAP;GPR137B;MLST8;ATP13A2;SNX6;DDIT3;UCHL1;EIF4G2
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),-0.25075580334283687,-1.0281800560326733,0.4010989010989011,0.8459410293440758,1.0,38/100,24.70%,RNF144B;CBFA2T3;RNF144A;SDCBP;RBX1;RYBP;TRIB2;RPL11;HSP90AB1;TAF1;GSK3A;FOXF2;HSPBP1;ZYG11B;GIPC1;RAD23A;COP1;GNA12;N4BP1;RACK1;BBS7;DVL1;RNF14;FHIT;CLU;DDRGK1;GSK3B;GABARAP;UBXN1;RCHY1;CAMLG;USP5;NUB1;CSNK1D;VCP;CCAR2;USP7;DDA1
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.43211106422826717,1.027416758310369,0.43156199677938806,0.8667684565455235,1.0,2/18,6.90%,GDNF;AGTR1
prerank,positive regulation of phospholipid transport (GO:2001140),0.4932995113068932,1.026894222889497,0.43523316062176165,0.8674474266768524,1.0,5/10,22.47%,APOE;APOA1;ABCA3;ABCA7;PRELID1
prerank,regulation of neuron differentiation (GO:0045664),0.3377157349321034,1.0268232627345446,0.4154838709677419,0.8669659910691934,1.0,10/76,6.60%,TCF4;NREP;FGFR1;ZEB1;ASCL1;CDK5RAP3;NTF3;NEUROD1;ADRA2C;LRRK2
prerank,cellular response to estrogen stimulus (GO:0071391),0.45309617426804794,1.026779547780586,0.43243243243243246,0.8664196753735388,1.0,2/14,5.05%,AR;SFRP1
prerank,regulation of fibroblast migration (GO:0010762),0.42598194414182217,1.026027809145304,0.41243862520458263,0.8676346151377082,1.0,5/20,11.90%,DDR2;RFFL;APPL2;FGF2;CLN3
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.26607446505183785,-1.0256789836049107,0.3709677419354839,0.8518580714624328,1.0,21/70,19.03%,ELMO1;YES1;ACTB;VAV3;PLCG2;ARPC1B;DOCK1;PAK1;HSP90AB1;ARPC3;WIPF3;WASF2;CYFIP2;PLPP4;MAPK3;PIK3CA;ARPC4;PRKCE;ACTG1;FCGR1A;FGR
prerank,receptor metabolic process (GO:0043112),-0.28330043900951035,-1.02536946279602,0.40271493212669685,0.8513837981538537,1.0,12/53,12.70%,DNM3;CAV1;SMURF1;ACKR3;TFRC;RAMP2;SNX1;FCER1G;KIF16B;TGFB1;LGMN;CD81
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.44413633313947376,1.0250846007057137,0.4366883116883117,0.86940189789771,1.0,8/17,23.11%,SPDL1;ZW10;CHAMP1;MTBP;CENPA;BOD1;IK;CTCF
prerank,lytic vacuole organization (GO:0080171),0.3916776038078414,1.0242056267223933,0.4163027656477438,0.8709778816484111,1.0,10/32,19.32%,ABCA1;LRRK2;GAA;ZKSCAN3;CLN3;HOOK2;TPCN2;HPS4;TMEM106B;SNAPIN
prerank,regulation of presynapse assembly (GO:1905606),0.435139057383021,1.0240663373284393,0.4326923076923077,0.8700116492266635,1.0,1/18,0.24%,GPC6
prerank,regulation of presynapse organization (GO:0099174),0.435139057383021,1.0240663373284393,0.4326923076923077,0.8700116492266635,1.0,1/18,0.24%,GPC6
prerank,regulation of microtubule polymerization (GO:0031113),-0.30607554395524655,-1.0239704811988701,0.4059040590405904,0.8539726511766444,1.0,11/40,18.88%,OCLN;MAP2;NAV3;MET;RPS3;PAK1;FES;DCTN1;CDK5RAP2;CDK5R1;CLASP1
prerank,error-prone translesion synthesis (GO:0042276),-0.3494362325591427,-1.023946627051328,0.4447592067988669,0.8526185207640488,1.0,2/21,8.38%,REV3L;POLH
prerank,positive regulation of intracellular protein transport (GO:0090316),0.31219218213688504,1.0234826118201588,0.4598623853211009,0.8708475868619405,1.0,8/144,3.44%,TCF7L2;CEMIP;PIK3R1;SMAD3;BCL2;ZIC1;LEPROT;GAS6
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.40048721604829907,1.0229039644009044,0.43452380952380953,0.8716020089265275,1.0,5/27,3.80%,EPHA8;KIT;PDGFRA;PDGFRB;CCL19
prerank,cellular protein-containing complex assembly (GO:0034622),0.3118855669610031,1.02253999441083,0.42390078917700114,0.8719261938391936,1.0,23/160,14.45%,TCF4;FMOD;ANGPT1;SMAD3;NUP107;COX7A2;SPAG1;SRC;EPS15;DNAAF1;ARL2;AIFM1;PICALM;SMAD1;CENPC;NUP98;STXBP1;UVRAG;CCDC40;RAB5IF;NSG2;ADRM1;SNX9
prerank,positive regulation of collagen metabolic process (GO:0010714),0.4364833826816168,1.0225263253362977,0.45264847512038525,0.8712816911444037,1.0,7/17,20.89%,RUNX1;WNT4;RGCC;F2;BMP4;LARP6;CREB3L1
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.34463677148164706,-1.0223329480041865,0.43137254901960786,0.8559400435491777,1.0,6/23,17.75%,PTPN2;HSP90AB1;JAK2;NLRC5;CDC37;TXK
prerank,metal ion transport (GO:0030001),0.335418559254988,1.022210319638216,0.43742098609355246,0.8714416366099007,1.0,9/86,6.99%,ITPR1;SLC8A1;SLC8A3;SLC41A1;SLC30A8;SLC24A1;MT3;CACNA1C;PANX1
prerank,cellular response to interferon-beta (GO:0035458),-0.4099967737341527,-1.0221778941394408,0.44776119402985076,0.8549436228514103,1.0,5/14,16.14%,AIM2;PNPT1;UBE2K;UBE2G2;TRIM6
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.41860437413177004,1.022117923181041,0.43450479233226835,0.8710195979022767,1.0,6/22,15.24%,NR2F2;CEBPA;HEXIM2;INCA1;PTEN;CDKN1C
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.4388911549124997,-1.0216939289343658,0.44646924829157175,0.8548903720152369,1.0,6/10,28.85%,DGKH;GAP43;CHRM1;PICK1;PLPP1;F2R
prerank,glycolipid metabolic process (GO:0006664),-0.298328387992912,-1.0215831133553375,0.44274809160305345,0.8537891785997976,1.0,3/47,0.81%,ST6GALNAC3;ST3GAL6;ESYT2
prerank,postsynaptic membrane organization (GO:0001941),-0.37334841007865355,-1.0211925363041168,0.45202020202020204,0.8534542502964002,1.0,3/17,4.76%,SHANK3;NLGN1;NRXN1
prerank,positive regulation of transport (GO:0051050),0.33004163029987027,1.0211382145810945,0.4254007398273736,0.8729131744012841,1.0,11/85,8.34%,CAMK1D;LRP1;AHSG;TULP1;GAS6;APOE;CCL19;APOA1;DYNC1H1;IL15RA;DAB2
prerank,negative regulation of complement activation (GO:0045916),0.49012342484901444,1.0207632447260018,0.4391080617495712,0.8732061298094825,1.0,1/10,2.27%,SERPING1
prerank,anterograde axonal transport (GO:0008089),-0.3085513381296587,-1.0206387267101344,0.43356643356643354,0.8536660960999707,1.0,14/37,27.59%,DLG2;RAB21;AP3B1;RAB27B;KIF1A;TRAK2;AP3S1;BLOC1S5;KIF5A;KIF4A;HAP1;KIF1B;AP3B2;SOD1
prerank,negative regulation of cation transmembrane transport (GO:1904063),-0.3665302780265801,-1.0205703991254196,0.4427083333333333,0.852438994994255,1.0,4/18,8.82%,CAV1;NEDD4L;CAMK2D;SLC43A2
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.45880913466126827,1.0204914873759727,0.4383116883116883,0.8732201712430847,1.0,3/14,16.18%,CSF1;IL12B;IL23A
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.42649366050624943,-1.0203894316464444,0.45154185022026433,0.8515287820506448,1.0,4/10,23.25%,ESR1;ATF7IP;PSMC4;THRA
prerank,regulation of apoptotic process (GO:0042981),0.2881653680693542,1.0203473664856262,0.4391959798994975,0.8729121751969513,1.0,114/676,15.16%,IGF1;STK17B;DAPK2;FHL2;ANGPT1;STEAP3;ACTN2;GDNF;PIK3R1;DAPK1;IL31RA;BCL2;GRK5;OLFM1;SON;SH3RF1;PLEKHG2;ASCL1;GADD45B;TIAM2;GAS6;PHLDA1;CFLAR;NUPR1;MYO18A;MOAP1;NOTCH2;SOS2;TXNDC5;FSTL1;FGD1;PDCD5;MT3;AXL;NTF3;NEUROD1;ING3;PHIP;RARG;SFRP1;CTSH;FGD4;PRKAA2;PDPN;TBX3;MAP3K20;CYP1B1;VIP;BCL6;USP47;BFAR;ARHGAP10;NDRG1;SRC;ARHGEF17;ING5;DPEP1;TSLP;CD28;SPHK2;ARHGEF18;ARAF;OSR1;STK4;DAB2;DNAJC3;BCL2L11;EGFR;ARHGEF11;BMP2;MAP4K4;SPRY2;AIFM1;ACTN4;PRKN;FOXA1;ITCH;BRAF;APH1B;DDX3X;IGFBP3;FBXO11;SPDEF;ADAMTSL4;FGD3;CLN3;ANXA5;REST;NIBAN2;HMGN5;RIPK2;PLEKHN1;NOL3;PAWR;IFIT2;VDAC1;HYPK;TAF9;HSPA9;ARF4;DSTYK;HPN;FLNA;AKAP13;PLK2;GATA6;MTCH2;MTCH1;BMP4;SUDS3;SFRP4;RBM5;GAS1;TMBIM6
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.3752838951546416,-1.0203053721459279,0.4246913580246914,0.850390919205661,1.0,5/16,19.00%,CELF4;SNW1;THRAP3;RBMX;SF3B4
prerank,regulation of mRNA polyadenylation (GO:1900363),0.44617096796574723,1.0201327349202602,0.45264847512038525,0.8727647568644559,1.0,10/17,27.02%,CPEB1;CPEB3;NELFE;ZC3H3;HSF1;CCNT1;RNF20;NCBP2;NCBP1;RNF40
prerank,regulation of peptide hormone secretion (GO:0090276),0.34501475032630236,1.0193358014932625,0.42133333333333334,0.8741502466743875,1.0,5/67,6.66%,ITPR1;RAPGEF4;NEUROD1;ADRA2C;CACNA1C
prerank,extracellular transport (GO:0006858),0.4624514497588007,1.0192703981407119,0.45517241379310347,0.8736434003305334,1.0,5/13,21.87%,CCDC40;CABYR;SPEF2;ROPN1L;TSG101
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.3733269508652111,1.019055367091076,0.44126074498567336,0.8735323814964974,1.0,5/36,8.46%,TCF7L2;PPP3CA;FZD2;TNRC6B;TNRC6A
prerank,long-term synaptic potentiation (GO:0060291),-0.35730129469692046,-1.0186759984924576,0.4297297297297297,0.853724579573668,1.0,5/21,6.70%,SLC24A2;PTK2B;TSHZ3;GRIN2A;GRIN2B
prerank,7-methylguanosine RNA capping (GO:0009452),0.39509422313648,1.018618480098236,0.42120343839541546,0.8733497549343807,1.0,10/31,23.01%,POLR2D;GTF2H5;POLR2C;MNAT1;CMTR2;POLR2L;ERCC3;NCBP2;CDK7;ERCC2
prerank,7-methylguanosine mRNA capping (GO:0006370),0.39509422313648,1.018618480098236,0.42120343839541546,0.8733497549343807,1.0,10/31,23.01%,POLR2D;GTF2H5;POLR2C;MNAT1;CMTR2;POLR2L;ERCC3;NCBP2;CDK7;ERCC2
prerank,positive regulation of glial cell differentiation (GO:0045687),-0.3668876946077429,-1.0185249741061833,0.42216358839050133,0.8527576671750609,1.0,6/17,11.49%,NOTCH1;TENM4;PTN;ID2;HES1;TGFB1
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.3437657903212572,1.018450494302782,0.4416058394160584,0.8731249403135943,1.0,13/72,10.16%,PLEKHH2;EML2;KANK1;APOE;CHADL;LDLR;CDH5;LIMA1;EMILIN1;PRKN;MYADM;KATNB1;FGF13
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.3347090454331428,1.0183035440582007,0.452970297029703,0.8727792902102596,1.0,19/90,15.28%,GJA1;LEPR;OGT;ACSL1;GNAS;APPL2;EPAS1;DYNC1H1;ADRB3;ALMS1;MFAP2;CEBPB;STAT6;DECR1;DIO2;G0S2;CNOT3;IL4R;GRB10
prerank,cellular response to light stimulus (GO:0071482),-0.26672237717326464,-1.0181280744233412,0.43414634146341463,0.8525430200378005,1.0,26/66,30.05%,PTPRK;KDM1A;TAF1;YY1;RPL26;COPS9;GNB1;BAK1;PDE6A;EP300;N4BP1;RHBDD1;NPM1;PARP1;POLK;TRIAP1;ATF4;SDE2;EIF2AK4;FMR1;RUVBL2;RHNO1;AQP1;RRH;OPN1MW3;OPN1MW
prerank,aminoglycan metabolic process (GO:0006022),0.489145414020809,1.0178278277792392,0.44545454545454544,0.8733221443386706,1.0,1/10,1.37%,GAL3ST3
prerank,regulation of translational initiation (GO:0006446),0.34903901161628426,1.0176066610854007,0.4576271186440678,0.8732118815298994,1.0,19/63,22.41%,POLR2D;EIF2AK3;DNAJC3;EIF4A2;CDC123;DDX3X;CEBPB;EIF5B;IMPACT;LARP1;ALKBH1;DDX1;TPR;CTIF;YTHDF2;MIF4GD;EIF4G2;RBM4;NCBP2
prerank,negative regulation of transport (GO:0051051),0.3580969865938773,1.0176058377733745,0.44712182061579653,0.8725453275929048,1.0,11/51,14.83%,EPHA3;SNX33;SNX12;PRKN;ITGB3;ITGAV;EGF;SYT11;PTEN;NR1H3;FER1L5
prerank,regulation of microtubule-based movement (GO:0060632),-0.42910989392268095,-1.017311823721202,0.45707656612529,0.8535845516846751,1.0,5/11,25.37%,MAP2;NEFH;DYNLT2B;HAP1;CCDC65
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.41565207384799796,1.017024417863839,0.44072948328267475,0.873390688626761,1.0,5/23,13.93%,MOAP1;COX18;BCL2L11;TIMM9;TOMM22
prerank,linoleic acid metabolic process (GO:0043651),0.43795539348806634,1.016529512957164,0.4559068219633943,0.8740018353392202,1.0,3/17,7.06%,ACSL1;GSTM2;ALOXE3
prerank,positive regulation of telomere capping (GO:1904355),-0.370925541761115,-1.0161793711857916,0.450261780104712,0.8554249434420773,1.0,6/17,22.34%,NEK7;PKIB;HNRNPD;MAPK3;PNKP;MAPK1
prerank,hematopoietic stem cell proliferation (GO:0071425),-0.42403176403673104,-1.0156323958944202,0.42792792792792794,0.8556685394447945,1.0,2/11,1.68%,MECOM;CD34
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),0.4397507573072857,1.0156141801987397,0.4626865671641791,0.8757123679362437,1.0,5/16,14.61%,AR;RBFOX2;DDX17;TRIP4;TADA3
prerank,nitrogen compound transport (GO:0071705),0.316015147253025,1.0154921164272046,0.4476409666283084,0.8753449556062183,1.0,12/141,5.62%,SLC7A11;SLC7A2;TXNIP;SLC1A5;ARRDC4;LMAN2L;SLC6A13;SLC44A1;SLC22A2;SLC35F3;PDPN;TOM1
prerank,regulation of mitochondrial fission (GO:0090140),0.41086129340720157,1.015195716523355,0.4298642533936652,0.8754351629747834,1.0,6/24,13.02%,DCN;MCU;LRRK2;PRKN;STAT2;MUL1
prerank,central nervous system neuron development (GO:0021954),-0.3849242740673088,-1.0151820273543963,0.45652173913043476,0.8556421543967483,1.0,5/15,11.81%,MAP2;LHX6;B4GALT5;HSP90AB1;ATP7A
prerank,regulation of cytokinesis (GO:0032465),-0.2642079694655783,-1.0151247678339081,0.44148936170212766,0.854406471582685,1.0,24/78,21.15%,PKP4;CIT;KIF13A;RAB11A;RAB11FIP3;CALM1;CALM3;KIF20B;CDC14A;CSPP1;GIT1;BCL2L1;CETN2;GIPC1;PRPF40A;PRC1;KIF23;PRKCE;ECT2;CUL3;VPS4A;E2F7;FLCN;PLK3
prerank,regulation of p38MAPK cascade (GO:1900744),0.3775442775823976,1.0151218035072427,0.4628099173553719,0.8749597438475165,1.0,4/35,8.75%,SASH1;GADD45B;RELL1;BMP2
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.2870559590314615,-1.0150486053451615,0.42857142857142855,0.8532316141448111,1.0,17/55,23.95%,FHL1;CUL1;RBX1;FBXL7;AVEN;PSMF1;PSMB8;PSMA4;PSMB10;PSMB2;PSMC4;PSMA6;PSMD9;PSMD11;PSMD5;PSMA8;PSMB1
prerank,carbohydrate catabolic process (GO:0016052),-0.30344072788973897,-1.0150110878616412,0.44107744107744107,0.8519738910877396,1.0,13/38,25.09%,GPI;HK2;PFKL;TPI1;PFKFB1;ALDOA;MAN2B1;NEU1;PKM;PGAM1;PGAM4;ALDOC;NEU2
prerank,protein targeting to lysosome (GO:0006622),-0.35331975825566647,-1.0148270823951866,0.4482758620689655,0.8511135396394571,1.0,10/20,26.51%,HSPA8;SORL1;NCOA4;SCARB2;GGA3;CLU;VPS4A;GNPTAB;HGS;GCC2
prerank,mRNA stabilization (GO:0048255),0.36164265743989593,1.014727191175979,0.4383561643835616,0.8752752055046744,1.0,14/40,22.88%,GDNF;TENT5A;AXIN2;VIP;TENT5D;LARP1;MAPKAPK2;SYNCRIP;HNRNPC;HNRNPU;TIRAP;NOCT;MYD88;IGF2BP1
prerank,negative regulation of viral entry into host cell (GO:0046597),0.4690869738673275,1.0143628824647541,0.4497444633730835,0.8755485912363417,1.0,1/12,1.20%,GSN
prerank,cellular response to organic cyclic compound (GO:0071407),0.3140438542662855,1.0141892467760123,0.4570446735395189,0.8753181688725888,1.0,15/141,6.60%,RORA;ADCY1;ROCK2;ADCY2;AR;ATP1A2;ADCY5;RAPGEF2;SFRP1;IGFBP5;TFPI;CYP1B1;PDE3A;ZFP36L1;LRRK2
prerank,regulation of Notch signaling pathway (GO:0008593),-0.2619212564052131,-1.0139754473365576,0.4090909090909091,0.8521455084759162,1.0,23/76,19.60%,NOTCH3;EPN2;NOTCH1;NOS3;CCN3;BEND6;TGFB2;JAG2;GATA2;NOTCH4;SNW1;MFNG;LFNG;GALNT11;HEY1;NOD2;EP300;DLL4;SYNJ2BP;ITGB1BP1;PDCD10;DLL1;EGFL7
prerank,regulation of cellular metabolic process (GO:0031323),0.3578421052540384,1.0139015819261752,0.44851904090267986,0.8754118997526088,1.0,9/45,14.75%,PID1;GNB3;CYP1B1;PRKN;EIF6;NCOR2;ARF4;RSPO1;FASN
prerank,regulation of apoptotic signaling pathway (GO:2001233),0.3763061711318347,1.0137918298570552,0.4577777777777778,0.875032832932137,1.0,5/36,7.65%,DAPK2;BCL2;TGFBR1;ING5;TRAF7
prerank,rRNA methylation (GO:0031167),0.41920075857073025,1.0136148840474626,0.4671875,0.8747871984559326,1.0,6/22,15.16%,BUD23;DIMT1;FTSJ3;TRMT112;NSUN5;NSUN4
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),-0.3204734701993655,-1.0135675099936057,0.43202416918429004,0.8519258945885079,1.0,9/32,13.80%,TAF1B;RRN3;TAF1;TBP;CAVIN1;GTF2H1;TAF1C;UBTF;MAPK3
prerank,negative regulation of potassium ion transport (GO:0043267),-0.40781045428119767,-1.0132159179263907,0.4419134396355353,0.8515973918031116,1.0,4/13,6.37%,CAV1;PTK2B;NEDD4L;NOS1
prerank,response to hydrogen peroxide (GO:0042542),-0.2920399574280065,-1.0129984056735564,0.436241610738255,0.8508760347082559,1.0,14/45,19.53%,NET1;RPS3;SIRPA;RHOB;PLEKHA1;TNFAIP3;SIRT1;APTX;ADAM9;ECT2;GPX1;ANXA1;CAT;PDCD10
prerank,positive regulation of ATPase activity (GO:0032781),0.36748768868833565,1.0127396832529374,0.4334763948497854,0.8763330034407811,1.0,6/41,11.52%,DYNLL1;TPM1;ATP1B2;MYL4;TNNT3;TOR1AIP1
prerank,response to lipopolysaccharide (GO:0032496),-0.23742193577752654,-1.0124059397567509,0.4142857142857143,0.8512369425090285,1.0,30/138,19.52%,MEF2C;PDE4B;NOS3;TNFRSF11A;GGT5;LBP;GCH1;VIM;NOS1;SIRPA;JAK2;FOXP1;MAPK8;SCARB1;CX3CR1;TNFAIP3;CD80;GIT1;SBNO2;PTPN22;NOD2;CARD16;ERBIN;TRIM6;ADAM9;TLR4;HMGB2;IFNAR1;CD86;GGT1
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.42569139051784904,1.0122202564173333,0.46818923327895595,0.8769540075432735,1.0,4/18,5.68%,ROCK2;KANK1;RIPOR2;CDH5
prerank,positive regulation of cellular metabolic process (GO:0031325),0.32107601498349375,1.011750067271968,0.4420289855072464,0.8774683337835966,1.0,19/98,14.94%,ANGPT1;PID1;APOE;PDGFRB;CSF1;APOA1;MT3;NTF3;AGTR1;CD63;ARRB1;DCXR;F2;INSR;EGF;HPN;FASN;NR1H3;SFRP4
prerank,protein processing (GO:0016485),0.3190866582800443,1.0117287819454204,0.46199524940617576,0.8768594529180529,1.0,13/102,11.90%,CPXM2;OGT;AEBP1;CPXM1;CTSH;MMEL1;SPRTN;SEC11C;ECE2;EEF1AKMT4-ECE2;LONP2;APH1B;CLN3
prerank,calcium ion import (GO:0070509),0.3967784541656123,1.0109056308976563,0.4595808383233533,0.8781909256115036,1.0,5/28,11.33%,SLC8A1;MCU;CACNA1C;MICU2;CACNA1G
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.3469114200222729,-1.010889040595044,0.4340659340659341,0.8541722818322793,1.0,15/23,43.72%,CADM1;PIK3R6;PVR;RAET1E;NECTIN2;LILRB1;SLAMF6;CD226;CRTAM;ARRB2;NCR1;CD160;KLRK1;LAMP1;AP1G1
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),-0.39616546181338785,-1.0103804743092473,0.4441687344913151,0.8542732017661078,1.0,3/14,5.21%,TMSB4X;FAF1;NFKBIA
prerank,tRNA wobble uridine modification (GO:0002098),0.4470490721151565,1.0102833170630603,0.4619377162629758,0.8790792805531106,1.0,5/14,20.94%,TRMT9B;URM1;DPH3;ELP4;TRMU
prerank,determination of heart left/right asymmetry (GO:0061371),-0.28799491013873874,-1.0100483802138585,0.4028776978417266,0.8538752359387937,1.0,10/43,14.28%,MEF2C;NOTCH1;SOX17;TBX2;ZIC3;SOX18;TGFBR2;STIL;APLNR;MICAL2
prerank,cholesterol transport (GO:0030301),0.3672920268582975,1.0099656134319064,0.4628330995792426,0.8792352349649206,1.0,6/45,5.80%,ABCA1;APOE;APOA1;LDLR;STAR;LIMA1
prerank,regulation of B cell apoptotic process (GO:0002902),0.4716803657523483,1.0098888574725295,0.4741532976827095,0.8787734179023685,1.0,2/12,5.68%,LYN;BCL6
prerank,B cell proliferation (GO:0042100),0.43024037112454094,1.0097456901036694,0.4677685950413223,0.8784503555883744,1.0,2/17,2.92%,BCL2;GAPT
prerank,regulation of protein localization to cell periphery (GO:1904375),-0.3646170537253782,-1.0096950638604518,0.46965699208443273,0.8535080005377755,1.0,5/18,6.64%,ACTB;ZDHHC2;SPTBN1;CDK5;VAMP8
prerank,myeloid leukocyte differentiation (GO:0002573),0.3435280512271488,1.009402506928457,0.4645669291338583,0.8786376807467822,1.0,10/65,6.86%,IL31RA;RUNX1;KIT;CCL19;CSF1;CDC42;PML;EFNA2;BATF;CEBPA
prerank,O-glycan processing (GO:0016266),0.3488359298505572,1.0084014012945544,0.45157068062827227,0.880490367978338,1.0,4/54,3.69%,GXYLT2;GALNT15;GALNT14;ST3GAL3
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.40079642958688055,1.0078868865992259,0.44992295839753466,0.8811583777052074,1.0,9/23,24.33%,FAF2;LMAN1;DERL1;SELENOS;AUP1;TECPR2;SEC16A;RANGRF;OS9
prerank,positive regulation of chromosome organization (GO:2001252),0.4371484427989062,1.00786266890306,0.4778156996587031,0.880557684805369,1.0,7/15,26.06%,LIG4;PML;PPP1R10;RTEL1;ATRX;MRE11;RAD50
prerank,synaptonemal complex assembly (GO:0007130),0.44127553159974353,1.0076506515990968,0.4543918918918919,0.8797409425257209,1.0,3/15,11.78%,SYCE2;TEX12;STAG3
prerank,synaptonemal complex organization (GO:0070193),0.44127553159974353,1.0076506515990968,0.4543918918918919,0.8797409425257209,1.0,3/15,11.78%,SYCE2;TEX12;STAG3
prerank,histone H3 acetylation (GO:0043966),-0.2992079875387971,-1.0076062937609966,0.4482758620689655,0.8580699167677236,1.0,13/40,18.28%,LEF1;JADE3;TRIM16;KAT2A;TAF10;TADA2A;LDB1;PER1;KAT6A;NAA60;BRCA2;SGF29;YEATS2
prerank,peptide cross-linking (GO:0018149),-0.3309030177580389,-1.007507396303231,0.4662756598240469,0.8569737721615076,1.0,3/25,4.94%,FN1;THBS1;TGM2
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.467443232643597,1.0073855750384573,0.4520547945205479,0.8797337343175408,1.0,6/11,28.84%,SLC30A10;SLC18A2;ABCD2;ABCD1;FYN;PPARA
prerank,regulation of calcium-mediated signaling (GO:0050848),0.3986532790285607,1.0064786371867815,0.46597633136094674,0.8813839420383134,1.0,3/25,6.60%,ITPR1;CCL4;LRRK2
prerank,peptidyl-serine phosphorylation (GO:0018105),0.30434330230259027,1.0062714774031092,0.46757679180887374,0.881264902676662,1.0,43/153,21.35%,PDPK1;ROCK2;CAMK1D;DMPK;MARK1;GAS6;TGFBR1;ULK2;LRRK2;AKT3;EIF2AK3;BRSK1;MAST2;STK4;VRK3;TTBK1;NEK6;IKBKE;TBK1;TLK1;WNK1;MAP3K13;MARK2;PLK2;DYRK1A;PIKFYVE;DYRK1B;MAPKAPK2;AKT1;ATM;CDC7;DYRK3;PRKCI;CSNK1A1;PRKCA;PRKACA;RICTOR;CLSPN;SGK3;SGK2;PKN2;AURKA;PRKCB
prerank,presynapse organization (GO:0099172),-0.4343633142175744,-1.0060401420107017,0.4423963133640553,0.8597764231402829,1.0,4/10,18.25%,NLGN1;LRRTM3;NLGN3;DVL1
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.3683036447342164,1.0060116549319817,0.44755244755244755,0.8813133509594377,1.0,17/42,25.04%,ARID1B;INO80;SMARCA1;MBD2;SMARCC2;MTA2;ACTR8;SMARCD2;CECR2;SMARCB1;HNRNPC;SRCAP;SMARCAD1;PBRM1;SMARCE1;DMAP1;HDAC1
prerank,negative regulation of lyase activity (GO:0051350),0.4409268198082296,1.0058499808203414,0.46798029556650245,0.881059886524343,1.0,3/16,8.20%,ADGRV1;GRM2;DRD3
prerank,axonemal dynein complex assembly (GO:0070286),0.39999358464576307,1.0058389250330413,0.44907407407407407,0.8804303484662973,1.0,9/28,18.76%,SPAG1;CFAP73;DNAAF1;DNAI3;CCDC40;DNAAF5;DNAL1;DNAH8;TTC12
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.35857731115370356,1.0056454216990898,0.4512893982808023,0.8802829160967397,1.0,12/44,16.40%,SH3RF1;GAS6;CAST;MT3;USP47;SRC;DPEP1;DDX3X;YWHAE;IGBP1;AKT1;FNIP1
prerank,cognition (GO:0050890),-0.29200857967194327,-1.004568935515631,0.44776119402985076,0.8626256763176708,1.0,15/42,23.27%,SHROOM4;GRM5;MFSD2A;DOP1B;GPR155;STRA6;NF1;FAM107A;SLC1A4;CBR3;APP;CHMP2B;JAKMIP1;PTCHD1;ST3GAL4
prerank,retina homeostasis (GO:0001895),0.4057107796281446,1.0043813240687063,0.43962848297213625,0.8827624109197869,1.0,4/23,6.93%,TULP1;PIGR;CRB2;ATP1B2
prerank,regulation of protein localization to nucleus (GO:1900180),0.3574284545720736,1.0042902367122208,0.44755244755244755,0.8823389186637719,1.0,13/43,18.62%,GLUL;YAP1;CDK5RAP3;WWTR1;EIF2AK3;BYSL;F2;BMP4;SESN2;AKT1;SHH;LIF;TPR
prerank,negative regulation of axonogenesis (GO:0050771),-0.3286532575084886,-1.0042664724559431,0.44141689373297005,0.8620813667652852,1.0,11/27,18.53%,MAP2;DIP2B;GDI1;ULK1;ARHGDIA;SEMA3G;DCC;LINGO1;MAG;MCF2;RTN4R
prerank,cellular response to hydroxyurea (GO:0072711),0.48022437583586197,1.0037628975465938,0.4753521126760563,0.882969698143799,1.0,4/10,18.74%,DDI1;RTF2;TIMELESS;ATRX
prerank,regulation of axon extension (GO:0030516),0.3691551882003596,1.0037235015890373,0.456973293768546,0.8824148859494658,1.0,9/37,12.45%,OLFM1;MACF1;APOE;MT3;GOLGA4;PTPRS;NTN1;RNF6;MAP3K13
prerank,ameboidal-type cell migration (GO:0001667),-0.2847422120863392,-1.002738949853289,0.45038167938931295,0.8650869573008747,1.0,18/51,16.21%,GPC3;SEMA6D;SEMA6A;SEMA7A;CCN3;ERBB4;TBX1;ITGA4;PKN1;SEMA5B;SEMA3G;FAT2;PKN3;SEMA3C;SEMA4B;PDLIM1;CORO1C;SOX8
prerank,granulocyte differentiation (GO:0030851),-0.3728155990899321,-1.0019265145021232,0.45231607629427795,0.8661093497238619,1.0,3/18,8.31%,LEF1;CBFA2T3;TAL1
prerank,purine-containing compound biosynthetic process (GO:0072522),0.4005207831861077,1.0018792443818683,0.46788990825688076,0.8864567692624813,1.0,7/25,19.42%,AMPD3;ADK;GART;AMPD2;DCK;PRPSAP2;PPAT
prerank,negative regulation of chemotaxis (GO:0050922),0.38048824248669905,1.0017732953114884,0.45949926362297494,0.886068639897849,1.0,4/31,3.78%,ROBO1;SEMA3D;ANGPT2;SEMA5A
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.33966102607599014,1.0016197573123116,0.45970937912813736,0.8858358833107866,1.0,11/60,13.39%,FGFR4;PDGFRB;CHTF8;SMOC2;PARM1;HNRNPA1;FGF2;PARN;RGCC;FBXO4;TNKS2
prerank,defense response to protozoan (GO:0042832),-0.40356942487280545,-1.0014848340538693,0.48072562358276644,0.8660505765346551,1.0,5/12,21.28%,GBP4;GBP7;CD40;LYST;GBP6
prerank,mRNA modification (GO:0016556),0.41059571541611856,1.0011743429499398,0.4558359621451104,0.8863047977527863,1.0,8/22,18.89%,PUS3;NSUN2;METTL14;RPUSD2;WTAP;TRUB2;METTL3;TRUB1
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.44676202989900377,1.0010785599783218,0.4708904109589041,0.8858606185335163,1.0,4/13,17.38%,PLA2R1;SPRED3;SPRED1;ATM
prerank,positive regulation of DNA replication (GO:0045740),0.44130622528226443,1.0009614094896464,0.4743801652892562,0.8855085691417794,1.0,5/16,13.24%,GLI2;NPM2;EGFR;GLI1;EGF
prerank,regulation of mast cell degranulation (GO:0043304),0.44622376853383006,1.0006078757621717,0.46853146853146854,0.8857466752173356,1.0,2/14,7.20%,LYN;SPHK2
prerank,I-kappaB phosphorylation (GO:0007252),-0.42699502159530656,-1.0003749045984998,0.4872389791183295,0.8678356917457284,1.0,7/10,38.76%,TLR4;DAB2IP;CHUK;MAP3K7;ERC1;TLR2;TLR3
prerank,negative regulation of cell death (GO:0060548),0.32618669295501884,1.0002916860485396,0.4875,0.8858661403494227,1.0,21/88,18.20%,CCN2;CCN1;INPP5A;CSF1;MT3;CCN5;LRRK2;PARP16;CD200;CCN4;PRKN;FGF2;RAD18;IMPACT;NPAS2;TM7SF3;BMP4;AKT1;KANK2;BECN1;SOX11
prerank,response to estrogen (GO:0043627),-0.31745217532898,-1.0000090855200376,0.44744744744744747,0.8675500191011573,1.0,10/31,17.81%,CAV1;ESR1;TRIM24;TRIM25;NCOA4;ARID5A;EP300;SERPINB9;CITED2;KRT19
prerank,neuron maturation (GO:0042551),-0.35855379380442715,-0.9999690807553561,0.4748743718592965,0.86632646205728,1.0,8/18,22.38%,ADGRB3;B4GALT5;SCARF1;APP;ANKS1A;SRRM4;LGI4;RND1
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.36907221336597146,0.9999536361100415,0.45942028985507244,0.8860280713731338,1.0,6/36,9.94%,GAS6;CSF1;AXL;TSLP;PRKN;PARP14
prerank,protein complex oligomerization (GO:0051259),-0.2538670162773964,-0.9999338236944546,0.4700460829493088,0.8650732532119528,1.0,22/85,17.78%,LRRC8C;LRRC8D;LETM1;KCNC2;EHD4;CPSF7;ATL2;MAT2A;ELAVL1;PNPT1;AQP11;PDCD6IP;ADCY8;HOMER1;TMEM120A;UGDH;UPB1;CUTC;RBMX;MPP2;VSTM5;ECT2
prerank,protein localization to nucleus (GO:0034504),0.3151657059572606,0.9996769797194802,0.4827586206896552,0.8860589404954624,1.0,29/102,20.15%,COL1A1;RANBP17;NUP107;APPL2;FAM53C;PRICKLE1;PML;ARL2;HEATR3;CSE1L;PPP1R10;TOR1AIP1;YWHAE;PAF1;BANP;TSC2;NUP214;TOR1B;BMP4;PIKFYVE;AKT1;TOR1AIP2;PHB2;XPA;TPR;APPL1;KPNB1;ABCA7;HNRNPU
prerank,negative regulation of RNA metabolic process (GO:0051253),-0.36037977031531854,-0.9987332296080484,0.46475195822454307,0.8672300817966978,1.0,5/18,11.49%,ESR1;RPS13;PTBP2;PTBP3;TGFB1
prerank,positive regulation of mitochondrial fission (GO:0090141),0.424647496655739,0.9986802530147709,0.46915584415584416,0.887925162909008,1.0,4/18,13.02%,DCN;MCU;PRKN;MUL1
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.4157187756255892,-0.9983888969317831,0.4645308924485126,0.8668242659195657,1.0,3/10,14.93%,SHANK3;SYP;APP
prerank,positive regulation of ion transport (GO:0043270),0.3552205388747503,0.9982782958705463,0.47657295850066933,0.8882262990910399,1.0,4/48,6.11%,ACTN2;GDNF;MYLK;CCL4
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),-0.4201676043747429,-0.9972240247145151,0.4701834862385321,0.8688156680770568,1.0,4/10,10.23%,TBX1;LRP5;TGFBR2;PDGFA
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.3158385805951847,0.9971938089733423,0.4820574162679426,0.8902642112911706,1.0,30/104,22.90%,SLC8A1;KSR1;SLC8A3;CCNA2;CDK5RAP3;SRC;PARP16;MAP2K1;CCNK;TELO2;DDX3X;UVRAG;MNAT1;DUSP19;CNPPD1;CDK12;AKT1;CDKN2C;CCNT2;CDKN1B;HTT;ETAA1;SERTAD1;CCND2;TRIB1;CCNT1;TSG101;CCNG2;CDK7;SLC27A1
prerank,negative regulation of axon extension (GO:0030517),-0.32854957527856765,-0.9969603744549668,0.46788990825688076,0.8682891898556397,1.0,9/30,12.61%,SEMA6D;SEMA6A;MAP2;SEMA7A;DIP2B;SEMA5B;SEMA3G;SEMA3C;SEMA4B
prerank,mitochondrial translational termination (GO:0070126),-0.2582893893631482,-0.9966742241481855,0.4271356783919598,0.8677673637537275,1.0,34/88,32.16%,MRRF;MTRF1L;GFM2;MRPL46;MRPS18A;MRPS5;MRPL39;MRPS26;MRPS12;MRPL48;MRPL4;MRPL21;MRPL44;MRPS33;MRPL55;MRPL57;MRPS18B;MRPL42;MRPS10;MRPS21;MRPS7;MRPL34;MRPL19;MRPL15;MRPS22;MRPL38;MRPS31;MRPL12;MRPL28;MRPL43;MRPS14;MRPL54;MRPL2;AURKAIP1
prerank,bile acid metabolic process (GO:0008206),0.39370525738855455,0.9965886841108076,0.4635258358662614,0.891171396124771,1.0,3/27,7.22%,CYP7B1;SLC27A5;CYP27A1
prerank,regulation of interleukin-13 production (GO:0032656),-0.39203289442240824,-0.9965331436131488,0.4538834951456311,0.8668235520985516,1.0,3/13,11.31%,LEF1;TNFRSF21;PRKCZ
prerank,negative regulation of protein kinase activity (GO:0006469),0.31910592931811926,0.9965182136211045,0.4562043795620438,0.8906889191878036,1.0,7/88,4.30%,PDPK1;PPM1E;SLC8A1;SLC8A3;DTNBP1;PRKAG2;CDK5RAP3
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.39671448240753415,-0.9964942723291643,0.46774193548387094,0.8655530306805778,1.0,3/14,9.72%,ANK3;ATP1B1;WNK2
prerank,amyloid fibril formation (GO:1990000),0.3477657740130106,0.9962076907349775,0.4581673306772908,0.8908278672067539,1.0,9/51,13.17%,GSN;HSPG2;APOA1;CST3;SNCAIP;PRKN;GGA2;APH1B;USP9X
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),-0.4072266429067618,-0.9953830523052967,0.4373401534526854,0.8674032887753289,1.0,5/12,23.35%,PRKDC;CCND1;FBXO31;PLK3;SDE2
prerank,integrated stress response signaling (GO:0140467),0.4432039149875199,0.9953380668031545,0.46371681415929206,0.892271091304248,1.0,5/14,23.10%,NFE2L2;EIF2AK3;IMPACT;DDIT3;HSPA5
prerank,nuclear export (GO:0051168),0.3262221252528735,0.9952778558787139,0.4744897959183674,0.8917673175150431,1.0,15/80,14.57%,ATXN1;RANBP17;PHAX;U2AF1L4;THOC2;NUP42;HNRNPA1;XPO7;DDX39A;CSE1L;RAE1;MAGOHB;STRADA;NUP214;SRSF5
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),-0.3922487040795364,-0.994889086714465,0.5097560975609756,0.8675102556135594,1.0,6/14,35.14%,ECI2;AMACR;ACOX1;ACOX2;ACOXL;ACOT8
prerank,regulation of feeding behavior (GO:0060259),0.4654276545131588,0.9942047894350624,0.48148148148148145,0.8937810445820449,1.0,2/11,5.45%,LEPR;GNB3
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.37555446955593674,0.9937552001387675,0.4764705882352941,0.8942453207047095,1.0,7/35,8.90%,DLC1;KANK1;ITGA3;RIPOR2;ARHGAP35;EPHB2;SPRY2
prerank,indolalkylamine catabolic process (GO:0046218),0.4780496187527176,0.993593428171984,0.49646643109540634,0.8939866576071428,1.0,2/10,6.77%,TDO2;KYNU
prerank,copper ion transport (GO:0006825),0.46127617192668785,0.9931913860498068,0.5072992700729927,0.894310055616609,1.0,2/11,6.47%,STEAP3;SLC11A2
prerank,mitochondrial protein processing (GO:0034982),0.4585040107128221,0.9930401876741325,0.4879852125693161,0.8940413569855169,1.0,6/11,24.92%,PMPCB;IMMP1L;YME1L1;AFG3L2;STOML2;MIPEP
prerank,positive regulation of endocytosis (GO:0045807),0.34952444744604544,0.992698367487042,0.4714881780250348,0.8942421566894073,1.0,9/45,8.34%,LRP1;SERPINE1;APOE;VTN;CCL19;APPL2;AXL;CDC42;DAB2
prerank,prostanoid metabolic process (GO:0006692),0.4612482410583373,0.992281472589321,0.48704663212435234,0.8945801868949381,1.0,1/13,1.91%,PTGES
prerank,positive regulation of rRNA processing (GO:2000234),0.4734231209578663,0.992243996597265,0.46459412780656306,0.894022994664622,1.0,4/10,13.24%,BUD23;DIMT1;WDR43;TRMT112
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.45564573799460695,0.9921759084536999,0.48771929824561405,0.8935389677349497,1.0,4/12,10.76%,SFRP1;DAB2;NCOR1;NCOR2
prerank,body fluid secretion (GO:0007589),0.4414860165169662,0.9919848338141689,0.48080133555926546,0.8933389452790115,1.0,3/15,7.62%,SLC22A2;VIP;SLC22A4
prerank,negative regulation of apoptotic process (GO:0043066),0.28238001202971524,0.9918676644779444,0.5157680569684638,0.8929689157095378,1.0,73/444,14.89%,IGF1;FHL2;ANGPT1;GDNF;PIK3R1;IL31RA;BCL2;GRK5;SON;SH3RF1;ASCL1;YAP1;GAS6;APOE;CFLAR;NUPR1;MYO18A;NOTCH2;TXNDC5;TLE1;FSTL1;MT3;AXL;NTF3;RNF213;PHIP;LIG4;SFRP1;CTSH;PRKAA2;PDPN;TBX3;VIP;USP47;BFAR;ARHGAP10;SRC;DPEP1;TSLP;CD28;ARAF;OSR1;SLC30A10;DAB2;DNAJC3;EGFR;MAP4K4;SPRY2;PRKN;ITCH;BRAF;DDX3X;CLN3;ANXA5;YWHAE;NIBAN2;HMGN5;RIPK2;NOL3;VDAC1;IGBP1;HYPK;TAF9;HSPA9;ARF4;MERTK;DSTYK;MDK;HPN;FLNA;PLK2;GATA6;BMP4
prerank,PERK-mediated unfolded protein response (GO:0036499),0.47036537052685545,0.9911650370979191,0.46536412078152756,0.8940006007067012,1.0,4/10,23.10%,NFE2L2;EIF2AK3;DDIT3;HSPA5
prerank,receptor-mediated endocytosis (GO:0006898),0.30733343794335233,0.9906655557932881,0.5023041474654378,0.8946354734013644,1.0,26/132,13.35%,DNAJC6;COLEC12;SPARC;LRP1;GRK3;HSPG2;APOE;NEDD4;APOA1;LDLR;CXCL16;COLEC11;ADRB3;EPS15;DAB2;AP1G2;PICALM;IGF2R;MASP1;ADM;CLN3;LRP3;INSR;GRK4;WASF1;CTSL
prerank,protein modification process (GO:0036211),-0.25773904232545247,-0.9905105245276464,0.5097087378640777,0.8788279275943931,1.0,17/76,19.36%,ST3GAL6;ST8SIA4;YES1;STK38;UBA3;CHRM3;B4GALT7;MMP15;MAN2B1;UBE2D3;ATG3;UBE2S;PRKDC;RPN1;QPCT;CPE;PARP1
prerank,regulation of striated muscle contraction (GO:0006942),0.3894807811029093,0.9901159777067158,0.47192716236722304,0.8953275376332769,1.0,2/27,1.81%,SLC8A3;ATP1A2
prerank,eye photoreceptor cell differentiation (GO:0001754),0.45675082701641617,0.9899145588629268,0.46589018302828616,0.895165167263848,1.0,3/12,8.44%,NKD1;TULP1;DSCAM
prerank,detection of calcium ion (GO:0005513),-0.3986478075735045,-0.989855638541629,0.4584323040380047,0.8794211344402665,1.0,7/13,19.41%,SYT1;KCNMB2;CALM1;CALM3;CASQ2;RYR2;KCNIP2
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.40766324250122443,0.9898071492106038,0.49065420560747663,0.8947723840284956,1.0,6/20,18.02%,GSN;PLA2R1;RGCC;PDCD4;SFRP4;PRKCI
prerank,negative regulation of DNA binding (GO:0043392),-0.315787291238812,-0.9895002609877684,0.4479495268138801,0.8790088192186614,1.0,9/28,17.16%,LEF1;NFKBIA;KDM1A;HEY2;JAK2;JUN;HEY1;TFAP4;RSF1
prerank,negative regulation of interferon-beta production (GO:0032688),-0.4321463229353499,-0.9890014559419242,0.49770642201834864,0.8790928842364432,1.0,4/10,14.18%,SIRPA;YY1;REL;RELB
prerank,cellular calcium ion homeostasis (GO:0006874),0.30899158872827526,0.9889804736140988,0.4964871194379391,0.8961374058383953,1.0,22/133,12.16%,SLC24A3;SLC8A1;SLC8A3;BCL2;DMPK;CCL19;STIM1;ATP13A3;SLC24A1;MCU;CDH5;PML;SLC24A5;TMEM203;DRD3;CSRP3;MICU2;PDZD8;ANXA6;F2;CLN3;YWHAE
prerank,positive regulation of macrophage differentiation (GO:0045651),0.4715829904917367,0.9887495610316832,0.5124113475177305,0.896056952088859,1.0,5/11,19.34%,IL34;CSF1;LIF;PRKCA;HSF1
prerank,peptidyl-threonine modification (GO:0018210),0.3312852800957713,0.9885192059977868,0.4605263157894737,0.8959509613672778,1.0,18/66,18.49%,PDPK1;ROCK2;TGFBR1;ACVR1;LRRK2;MAP2K1;OXSR1;TTBK1;TBK1;WNK1;ACVR1B;MARK2;DYRK1A;DYRK1B;AKT1;CDK10;DYRK3;PRKCA
prerank,nucleoside phosphate catabolic process (GO:1901292),0.4476144220729238,0.9884862953298232,0.4879852125693161,0.8953836965530503,1.0,1/13,0.63%,ENPP1
prerank,methylguanosine-cap decapping (GO:0110156),-0.42135679053833947,-0.9884307294383685,0.5021645021645021,0.879325595893147,1.0,4/10,21.59%,EDC3;PNRC2;DCP2;DCPS
prerank,positive regulation of hormone secretion (GO:0046887),-0.36759933855949245,-0.9883415483026186,0.4837837837837838,0.87828641389187,1.0,10/17,45.90%,VAMP8;EDN1;SPP1;GRP;C1QTNF3;PLA2G3;RASL10B;TFR2;CYP19A1;HCAR2
prerank,glycerophospholipid metabolic process (GO:0006650),-0.26174435810732244,-0.9882913040640375,0.4811320754716981,0.8770885899077299,1.0,20/75,18.84%,GPCPD1;SERINC5;DGKH;CPNE3;PLA2G7;PLA1A;PIGP;PAFAH1B1;GPLD1;PLEK;PNPLA3;PIGB;PLA2G4C;CRLS1;PIGL;ABHD6;DPM2;SYNJ1;PIGV;PNPLA6
prerank,endothelial cell migration (GO:0043542),0.37023002961253154,0.9882385739014827,0.47960618846694797,0.8952929833573064,1.0,5/37,6.38%,NRP1;FSTL1;CYP1B1;CDH5;ADGRA2
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.45394949235551973,0.9881578448031451,0.4956369982547993,0.8948337923168934,1.0,2/13,5.01%,ABCA1;LDLR
prerank,protein localization to chromatin (GO:0071168),-0.3555981938654766,-0.9880074351755775,0.4595300261096606,0.876571795000771,1.0,10/18,28.23%,ESR1;TASOR;MCM8;LRWD1;SGF29;MSH2;RAD21;RUVBL2;PIH1D1;PLK1
prerank,negative regulation of hippo signaling (GO:0035331),0.45225076774180595,0.9879124411333318,0.4747292418772563,0.894796227189141,1.0,2/12,8.06%,WWC2;WTIP
prerank,regulation of complement activation (GO:0030449),0.36134854789942045,0.987839673794036,0.4812239221140473,0.8943124955109368,1.0,5/40,6.12%,SERPING1;VTN;CFH;C4B;C8G
prerank,striated muscle cell differentiation (GO:0051146),0.4254007074151853,0.9874900321186288,0.46405228758169936,0.8945300553923878,1.0,5/16,8.89%,SKI;SDC1;SIK1;BMP2;CBY1
prerank,negative regulation of cytokine production (GO:0001818),-0.22840935618043462,-0.9868032421045838,0.5348837209302325,0.8786021455927956,1.0,41/163,19.80%,LEF1;FN1;TMSB4X;IFIH1;CD34;THBS1;RPS6KA5;NAV3;OTUD7B;APOD;RNF125;CMKLR1;TRIB2;SIRPA;TRIM25;NLRC5;RPS6KA4;TNFRSF21;KLF4;TNFAIP3;PTPN22;INHBB;INHA;CEACAM1;SIGIRR;CUEDC2;PTPN6;SRGN;PTPRC;PCBP2;JAK3;HOMER3;N4BP1;INHBA;ZFPM1;TLR4;UFD1;TAX1BP1;ANXA1;DLL1;C1QBP
prerank,polarized epithelial cell differentiation (GO:0030859),-0.3966172456857482,-0.985859077251498,0.4597156398104265,0.8799613515039529,1.0,4/13,10.46%,MYO9A;OPHN1;SCRIB;MSN
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),0.44242832677618354,0.985813300866185,0.506108202443281,0.8980056382628313,1.0,3/16,3.68%,NOS1AP;APOE;NPR3
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.3562062136131966,0.9857466861320339,0.49359886201991465,0.8975446899666042,1.0,8/43,14.89%,TEAD1;SMAD3;NFIB;ATOH8;FGF2;REST;ETS1;BMP4
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.4175456732981698,0.9855890315439642,0.4855305466237942,0.8972751959813849,1.0,4/19,10.85%,PGM3;GFPT1;UAP1;RENBP
prerank,cardiac muscle cell action potential (GO:0086001),-0.3149439342805921,-0.9852639431881117,0.46875,0.8802319457541742,1.0,7/30,6.83%,KCNJ2;ATP1A1;SCN1A;KCND3;FGF12;KCNQ1;ATP1B1
prerank,male gonad development (GO:0008584),0.3700414845356248,0.9849368156819716,0.4964131994261119,0.8981878559623396,1.0,5/34,6.58%,AR;KIT;WNT4;LHCGR;NR5A1
prerank,DNA catabolic process (GO:0006308),0.4585061167499805,0.9848665206274749,0.4954296160877514,0.8977110447368893,1.0,2/11,10.44%,REXO4;DNASE1L1
prerank,lipoprotein catabolic process (GO:0042159),0.46513460644623295,0.984812633324612,0.47368421052631576,0.8971927722000966,1.0,3/11,6.13%,APOE;ABHD17C;LYPLAL1
prerank,cellular response to interleukin-12 (GO:0071349),-0.2804234874249052,-0.9845773150959503,0.4765625,0.8808744581317522,1.0,14/48,15.70%,PITPNA;PPIA;RAP1B;SIRPA;JAK2;MSN;LMNB1;ARF1;PAK2;TYK2;BOLA2;HNRNPA2B1;SNRPA1;RPLP0
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.38902258532329326,-0.9844159886171276,0.49271844660194175,0.8799880869809631,1.0,3/12,3.67%,PTPRJ;APOD;CBL
prerank,peptidyl-serine dephosphorylation (GO:0070262),-0.3801560226902248,-0.9836371322464195,0.46318289786223277,0.8808420084539547,1.0,5/14,16.67%,PPP2R2B;PPP1R15B;PPP2R2A;PPP2R2C;PPP1CA
prerank,cholesterol metabolic process (GO:0008203),0.33027570775780934,0.9835696998295042,0.4719387755102041,0.8996262105229379,1.0,12/68,15.73%,ABCA1;APOE;INSIG2;APOA1;MT3;MVK;CYP27A1;IDI1;LCAT;RXRA;OSBPL5;HMGCS1
prerank,regulation of neuron migration (GO:2001222),0.3889753799838245,0.9831849520304387,0.4928,0.8998989423742123,1.0,9/26,17.75%,PHACTR1;RAPGEF2;CAMK2B;NTNG2;COL3A1;MDK;PLXNB2;CX3CL1;NIPBL
prerank,maturation of SSU-rRNA (GO:0030490),-0.2998240866025508,-0.9830508108530935,0.48580441640378547,0.8811815103121212,1.0,9/34,21.20%,RPS14;RPS19;RIOK1;UTP4;LSM6;SNU13;RRP36;HELB;WDR46
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.32899202478459444,-0.9830476794317285,0.5028089887640449,0.8798769270251325,1.0,12/25,25.67%,HIPK2;RPS7;OPHN1;RPL11;HSP90AB1;TAF1;PSMF1;RPL5;RPL23;EFNA1;PRKCG;SGTA
prerank,positive regulation of immune system process (GO:0002684),-0.37439227466147357,-0.9829524877319817,0.4975369458128079,0.8788467698275904,1.0,3/16,9.51%,IL15;TGFB2;VEGFA
prerank,regulation of vasculature development (GO:1901342),-0.3329022141167167,-0.9824746948183466,0.4881656804733728,0.8788869728662029,1.0,9/26,11.43%,BMPER;WARS1;ERBB2;EMP2;HTATIP2;TSPAN12;PLXND1;VASH1;NF1
prerank,insulin secretion (GO:0030073),0.4162678882032127,0.982354635190718,0.4790322580645161,0.9013089412316401,1.0,5/19,16.07%,SLC30A8;NEUROD1;FAM3B;CYB5R4;MAFA
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.386568494017492,0.9822941704768507,0.48372781065088755,0.9007960990811875,1.0,9/26,21.28%,MAPKBP1;SIRT2;NMI;IRAK3;ITCH;MUL1;DHX58;TRIM21;TRIB1
prerank,positive regulation of viral process (GO:0048524),0.33574783706557587,0.9821950339609793,0.48745046235138706,0.9003962175024622,1.0,13/60,18.79%,POLR2D;AXL;KPNA6;CD28;POLR2C;DDX3X;LARP1;STAU1;NELFE;TBC1D20;KPNA2;PPIE;POLR2L
prerank,copper ion homeostasis (GO:0055070),-0.3683171668593127,-0.9821348644459383,0.4869109947643979,0.8785596824221182,1.0,9/17,27.14%,ATOX1;ARF1;ATP7A;SLC31A1;APP;CUTC;MT2A;SLC31A2;PRNP
prerank,neuron differentiation (GO:0030182),0.2991299326725745,0.9820387287530794,0.5218365061590146,0.9001307603572181,1.0,21/165,7.59%,PBX1;GLI2;RUNX1;WNT8B;FZD2;WNT4;ASCL1;RUNX2;TGFBR1;WNT6;NEUROD4;HS6ST1;NEUROD1;FZD1;THOC2;ATOH8;SMARCA1;WNT5B;USH2A;BRSK1;MAP2K1
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),-0.4247500633185954,-0.9819594559494469,0.47757847533632286,0.877734082234392,1.0,3/10,13.19%,LBP;IFI35;PTPN22
prerank,ear morphogenesis (GO:0042471),0.398751147815975,0.9819456991794524,0.49240121580547114,0.8997066190347499,1.0,4/20,8.61%,ZIC1;FGFR2;OSR1;EPHB2
prerank,positive regulation of cyclase activity (GO:0031281),-0.3788430260564969,-0.9818306421061038,0.47761194029850745,0.8768411795766181,1.0,6/14,15.08%,NOS3;NOS1;MAPK8;NF1;MAPK3;CACNA1D
prerank,mesoderm development (GO:0007498),-0.35422076755486576,-0.9812576858252984,0.46835443037974683,0.8771743943020822,1.0,12/18,30.61%,TIE1;TBX1;BMX;JAK2;VEGFA;BTK;HCK;MEST;MESD;TCF15;IKZF1;IKZF3
prerank,atrioventricular valve morphogenesis (GO:0003181),0.4087454749903452,0.9808681182145721,0.46915584415584416,0.9016131405232203,1.0,5/19,10.11%,BMPR1A;OLFM1;ACVR1;BMP2;SLIT3
prerank,protein import into nucleus (GO:0006606),0.33083164170625257,0.9805575989717901,0.5025773195876289,0.9017184831777362,1.0,19/66,18.83%,CBLB;RANBP17;NUP107;APPL2;FAM53C;PRICKLE1;KPNA6;HEATR3;CSE1L;PPP1R10;TSC2;NUP214;AKT1;KPNA2;KPNA1;PHB2;TPR;APPL1;KPNB1
prerank,regulation of cell development (GO:0060284),0.3558980520579041,0.9800822115546114,0.48169014084507045,0.9021598804791661,1.0,11/36,19.97%,ASCL1;YAP1;NOTCH2;HES7;ADGRA2;BHLHE41;AKT1;CX3CL1;WNT3;RHEB;YTHDF2
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.42181037271614746,0.9800699095394623,0.4975206611570248,0.9015466120358073,1.0,3/17,6.79%,ROCK2;CDH5;VCL
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.3581686848726652,-0.9799200392490651,0.4655581947743468,0.8796658541848646,1.0,10/19,27.14%,PTPRJ;KDR;GRM5;RYR2;PTPRC;FIS1;VCAM1;SELP;DMTN;PRNP
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.263187276979971,-0.9797388070030468,0.5041322314049587,0.878912973290297,1.0,20/65,23.95%,FHL1;CUL1;RBX1;FBXL7;AVEN;PSMF1;PSMB8;PSMA4;PSMB10;PSMB2;CHFR;PSMC4;VPS4A;PSMA6;PSMD9;PSMD11;PSMD5;NABP1;PSMA8;PSMB1
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.3121205079092581,0.9794048839639851,0.4963768115942029,0.9025861918826512,1.0,18/101,14.79%,SAMD4A;PLD1;DACT1;OGT;FGFR4;ASPH;CSF1;CPEB3;ATG10;AGTR1;CD28;METTL14;EIF6;DDX3X;BTRC;PLXNB2;NSUN5;NR1H3
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),-0.38853764417839654,-0.9793913877055977,0.5,0.8786362379541713,1.0,6/13,14.60%,GRIN2A;PERP;CASP8;CYFIP2;LGMN;BAK1
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.40339047848151194,0.9790764513501433,0.4720496894409938,0.9027596568542725,1.0,3/22,6.06%,RBP1;UBIAD1;ALDH1A2
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.37384445507429565,0.9786775998456828,0.5088235294117647,0.9030897089216037,1.0,4/33,10.16%,TEAD1;SMAD3;ATOH8;FGF2
prerank,muscle tissue morphogenesis (GO:0060415),0.4271502669286328,0.978450355336203,0.49193548387096775,0.9030598379416409,1.0,3/16,8.75%,TGFBR3;MYLK;BMP2
prerank,carnitine metabolic process (GO:0009437),0.4425073566352418,0.9784245184532947,0.49043478260869566,0.9024789971090138,1.0,7/12,30.21%,CPT1C;BBOX1;CPT1A;ACADM;CPT2;CPT1B;CRAT
prerank,positive regulation of vasculogenesis (GO:2001214),0.4697961058016174,0.9782920664505643,0.48633879781420764,0.902171777820318,1.0,2/10,4.33%,RIN2;RAPGEF2
prerank,response to tumor necrosis factor (GO:0034612),0.3132782649101892,0.9782697242890304,0.5099009900990099,0.901587366974386,1.0,10/91,8.17%,ADAMTS12;PID1;CCL19;SFRP1;CXCL16;ZFP36L1;CCL4;NFE2L2;NR1D1;AFF3
prerank,adipose tissue development (GO:0060612),0.4590089413320073,0.9782007341042792,0.5025728987993139,0.9011127481655529,1.0,5/11,15.71%,ARID5B;SH3PXD2B;PGRMC2;DGAT2;DYRK1B
prerank,negative regulation of ion transport (GO:0043271),0.3894360763523085,0.9778819732110886,0.4864864864864865,0.9012563090250647,1.0,7/24,13.46%,ACTN2;NEDD4;VIP;ADRA2A;CD33;WNK1;SYT11
prerank,transepithelial transport (GO:0070633),0.42929703563925337,0.9778270418114163,0.5049668874172185,0.9007539605893812,1.0,1/15,0.18%,SLC1A3
prerank,regulation of intracellular pH (GO:0051453),-0.30188366626671415,-0.9778099860588637,0.48125,0.8817867625855604,1.0,6/34,9.96%,SLC4A10;SLC9A2;SLC9A6;SLC4A8;SLC9A7;SLC26A6
prerank,histone monoubiquitination (GO:0010390),0.38588595600897446,0.9777412380796218,0.4869831546707504,0.9003088347448366,1.0,9/24,22.32%,ATXN7L3;BCOR;CUL4B;PAF1;RNF2;WAC;CDC73;LEO1;RNF20
prerank,regulation of viral transcription (GO:0046782),0.3617304702583135,0.9776605636689422,0.4930939226519337,0.8998950757302612,1.0,1/39,0.14%,POLR2D
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.42862474485314633,0.97741228174237,0.49185667752442996,0.8998540746770757,1.0,3/15,8.75%,GLI2;WNT6;BMP2
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.4206766691697219,0.9773899747096269,0.49756888168557534,0.8992727524098517,1.0,5/17,8.75%,BMPR1A;NOTCH2;ACVR1;RBPJ;BMP2
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.4708169253930911,0.9773026908092954,0.5212014134275619,0.898838483626452,1.0,3/11,6.31%,KANK1;PDPN;SRC
prerank,negative regulation of cilium assembly (GO:1902018),-0.40263077943418624,-0.977245080857636,0.5070754716981132,0.8820957909799221,1.0,4/12,10.94%,LIMK2;TBC1D30;CEP97;TESK1
prerank,positive regulation of programmed cell death (GO:0043068),0.2845624570745211,0.9771179898707166,0.5428571428571428,0.8986671504793089,1.0,52/272,16.01%,STK17B;DAPK2;DAPK1;OLFM1;PLEKHG2;GADD45B;TIAM2;PHLDA1;MOAP1;SOS2;FGD1;PDCD5;NEUROD1;ING3;RARG;SFRP1;FGD4;MAP3K20;CYP1B1;BCL6;LRRK2;ARHGEF17;ING5;SPHK2;ARHGEF18;STK4;BCL2L11;ARHGEF11;BMP2;AIFM1;FOXA1;APH1B;DDX3X;IGFBP3;SPDEF;ADAMTSL4;FGD3;REST;PLEKHN1;PAWR;IFIT2;AKAP13;MTCH2;MTCH1;BMP4;SUDS3;SFRP4;RBM5;NLRC4;ARHGEF19;CASP9;TRIO
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.44786209568852686,0.9760040564547172,0.4870848708487085,0.900684356976974,1.0,2/12,8.51%,PIK3R1;BCL2L11
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.3087998532048095,-0.9759092967154039,0.5078369905956113,0.8845658960545288,1.0,14/31,19.80%,DLG2;LIN7A;MYO9A;LRRC7;OPHN1;LIN7C;SCRIB;MSN;PDCD6IP;WDR1;ERBIN;SYNJ2BP;MTCL1;SH3BP1
prerank,potassium ion transport (GO:0006813),0.3057868130601995,0.9757524511467406,0.5093896713615024,0.9006991803905492,1.0,11/120,9.27%,SLC1A3;KCNK2;SLC24A3;NALCN;ATP1A2;SLC9A9;SLC24A1;KCNK7;KCNQ4;SLC9A5;KCNJ14
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.32194449263604524,0.9755067191483376,0.5114795918367347,0.9006734368137097,1.0,26/73,23.93%,IGF2;DNMT3A;POLR1G;SPHK2;MYO1C;KAT2B;RBBP7;BAZ1B;PHF1;PHF2;PPHLN1;GLMN;HDAC4;SF3B1;DNMT3B;POLR2L;POLR1F;JARID2;DNMT1;POLR1H;POLR1C;HDAC6;CTCF;HDAC5;PPM1D;TDG
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.4438675117650387,0.9754486296739066,0.4716666666666667,0.9001927935920917,1.0,2/13,4.87%,CBLB;KPNA6
prerank,membrane depolarization (GO:0051899),-0.3017361463801333,-0.9753842201651196,0.4857142857142857,0.8847047361348315,1.0,6/32,7.82%,CAV1;SCN1A;YWHAH;P2RX7;SCN3A;SCN2A
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.4470322441582205,0.9751265055664092,0.5085324232081911,0.9003379225112644,1.0,3/12,17.96%,IL12B;IL23A;IL18
prerank,negative regulation of B cell proliferation (GO:0030889),0.45561190428606446,0.9751028750522311,0.4906937394247039,0.8997694579395203,1.0,1/11,1.77%,LYN
prerank,cellular response to interleukin-2 (GO:0071352),-0.4023420143996727,-0.9750854556694559,0.48372093023255813,0.8829647896344072,1.0,5/11,28.72%,PTK2B;STAT5A;JAK3;IL2RG;SHC1
prerank,interleukin-2-mediated signaling pathway (GO:0038110),-0.4023420143996727,-0.9750854556694559,0.48372093023255813,0.8829647896344072,1.0,5/11,28.72%,PTK2B;STAT5A;JAK3;IL2RG;SHC1
prerank,plasma membrane organization (GO:0007009),-0.26488274399938244,-0.9749867926764268,0.5235849056603774,0.8819599388200492,1.0,15/61,13.61%,FNBP1L;CAVIN2;ANK3;AHNAK2;DYSF;SPTBN1;P2RX7;BIN3;PACSIN2;OSBPL2;DEGS1;UGCG;NSF;PACSIN1;ARV1
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.31682561995302994,-0.9744447522632966,0.484593837535014,0.8821717529216713,1.0,10/27,25.46%,PDE4D;CAMK2D;NOS1;CALM1;HPCA;AHNAK;CACNB3;FKBP1A;PLN;CALM2
prerank,positive regulation of translation (GO:0045727),0.3134588079091727,0.9743931836628833,0.5359712230215827,0.9008056158567351,1.0,10/94,10.98%,POLR2D;SAMD4A;PLD1;RPUSD4;CPEB3;CD28;METTL14;EIF6;CDC123;DDX3X
prerank,negative regulation of binding (GO:0051100),-0.24909000568453032,-0.9737978124762231,0.5478723404255319,0.8827436774808038,1.0,28/81,21.96%,LEF1;CAV1;ACTB;NFKBIA;KDM1A;SORL1;BTAF1;CTNNBIP1;JAK2;DISC1;GTF2F1;MAPK8;RALB;JUN;CARD16;PPP1CA;TFAP4;ZFPM1;RSF1;RACK1;CDKN1A;DVL1;EFHB;ITGB1BP1;HMGA2;ROCK1;STYX;GSK3B
prerank,acylglycerol biosynthetic process (GO:0046463),0.38883670143785687,0.9737510627799566,0.48536209553158705,0.9016865037014529,1.0,7/23,19.49%,AGMO;PLA2G4A;LPGAT1;MOGAT3;DGAT2;GK;LPIN3
prerank,hemidesmosome assembly (GO:0031581),-0.40508953813883547,-0.973732499889,0.5081206496519721,0.8816438961726936,1.0,2/11,3.29%,ITGA6;ITGB4
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.3004733707979045,-0.9735198687558594,0.5126582278481012,0.8809553394837686,1.0,19/34,22.00%,SEMA6A;KDR;NOTCH1;RAMP2;MT1G;FLT4;GAB1;VEGFA;PIK3CA;ERN1;DLL4;FLT1;VEGFC;ITGB1BP1;ANXA1;EGR3;DAB2IP;MAP2K3;VEGFD
prerank,vesicle cytoskeletal trafficking (GO:0099518),-0.2876071281797481,-0.973444922251865,0.4913494809688581,0.8798585322864095,1.0,11/39,21.94%,FNBP1L;PPFIA2;MYO1D;TANC2;PAFAH1B1;KIF1A;BICDL1;TRAK2;SYT4;MYO15A;HAP1
prerank,isotype switching (GO:0045190),0.4732223542786945,0.9734416508910299,0.5070422535211268,0.9017975979346254,1.0,2/10,6.84%,LIG4;BATF
prerank,intracellular cholesterol transport (GO:0032367),0.4266599733918808,0.9734404012748442,0.5082236842105263,0.9011723659308787,1.0,3/15,5.21%,ABCA1;LDLR;STAR
prerank,transition metal ion transport (GO:0000041),0.36353211426646254,0.9733242308208345,0.4884726224783862,0.9008260005745036,1.0,6/35,8.27%,CP;SLC30A8;MT3;HEPH;SLC11A2;SLC30A10
prerank,cranial nerve development (GO:0021545),0.4618575256813028,0.9731780125088999,0.4965156794425087,0.900523944494424,1.0,4/11,21.16%,SALL1;CHD7;CHRNB2;TIFAB
prerank,regulation of vesicle-mediated transport (GO:0060627),0.3110943243415976,0.9731336479965873,0.5166872682323856,0.9000012140574765,1.0,13/91,9.62%,NRP1;PLD1;SLC30A8;ATP9A;SRC;LRRK2;RAB25;MAP2K1;STON1;RNF139;PICALM;SNX12;ITGAV
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.29671787853292375,0.9730237162005506,0.5241844769403825,0.8996528595256642,1.0,27/158,15.04%,WLS;GJA1;PELI2;CFLAR;CCL19;EDAR;ROR1;RNF31;LPAR1;TLR6;PRKN;GPR89A;LTBR;SLC20A1;TMED4;CXXC5;CARD9;NEK6;TNIP2;IKBKE;TBK1;RIPK2;MUL1;FLNA;AKAP13;PLK2;TNFRSF1A
prerank,regulation of immune effector process (GO:0002697),0.35491214068834537,0.9728006828334331,0.5125348189415042,0.8995349479654252,1.0,5/41,6.12%,SERPING1;VTN;CFH;C4B;C8G
prerank,protein heterotetramerization (GO:0051290),-0.3869887178674001,-0.9725250573767452,0.48226950354609927,0.8811902800963894,1.0,7/13,27.85%,GRIN2B;CPSF7;HSD17B8;GRIN1;CBR4;CPSF6;PKD1
prerank,negative regulation of cell growth (GO:0030308),0.30581337718269486,0.9724660167628444,0.5307328605200946,0.8997188982012992,1.0,26/121,13.02%,GJA1;ENPP1;SMAD3;TSPYL2;MT3;SFRP1;PTPRS;BCL6;APBB2;PML;ULK2;SPHK2;STK11;RBBP7;SLIT3;FGF13;RNF6;DDX3X;JADE1;CGRRF1;ST7L;NME6;CDA;SIPA1;ACVR1B;MUL1
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.38675095668238246,-0.9720282496518287,0.49033816425120774,0.8812329269976685,1.0,4/13,6.98%,TMSB4X;NOS3;NOS1;PPARGC1A
prerank,negative regulation of protein ubiquitination (GO:0031397),-0.27354798555337784,-0.9716701934337962,0.5131086142322098,0.8809178607429454,1.0,20/50,28.68%,CAV1;IVNS1ABP;NXN;RPS3;CRY1;TAF1;MINAR1;TNFAIP3;USP4;N4BP1;VPS28;PRMT3;PRR7;ADGRB1;UBXN1;CAMLG;PRKCG;ISG15;BAG2;U2AF2
prerank,neuron projection development (GO:0031175),0.2935475153253441,0.9710780924183455,0.5249722530521642,0.9023560559170638,1.0,33/168,13.99%,NRK;GDNF;ADGRV1;LYN;GRXCR1;EPHA4;DOCK10;EPHA8;DTNBP1;VASH2;APOE;NEDD4;RAPGEF2;NTF3;CDK16;LRP12;CDC42;ATXN10;LRRK2;ALS2;EPHB2;MAP4K4;BLOC1S1;RYK;PTPRM;MANF;TAOK3;EPHB3;NRTN;GAS7;MARK2;PTEN;DLG4
prerank,brain morphogenesis (GO:0048854),-0.3968358058100182,-0.9708553273463848,0.4946695095948827,0.8819233183732744,1.0,2/12,8.63%,SHANK3;PAFAH1B1
prerank,insulin receptor signaling pathway (GO:0008286),0.3271090919623441,0.970792352465586,0.5086321381142098,0.9023970057386055,1.0,9/69,12.55%,ATP6V0A4;IGF2;PIK3R1;PHIP;FOXC2;ZNF106;ATP6V1E1;RHOQ;INSR
prerank,regulation of monocyte differentiation (GO:0045655),0.43319756970413226,0.970790433836566,0.5,0.901773154881673,1.0,3/14,5.78%,IL34;CSF1;ZFP36L1
prerank,dendrite morphogenesis (GO:0048813),0.3608841336626424,0.9706130960974183,0.50509461426492,0.9015838866028671,1.0,8/35,13.99%,PHACTR1;FARP1;DOCK10;CDC42;EPHB2;EPHB3;PTEN;DLG4
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.3936221312719659,-0.9705366816790869,0.5194174757281553,0.8814756901665349,1.0,4/12,13.10%,ANO1;GPLD1;ADCY8;CFTR
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.2869044551789319,0.9699838485904959,0.550755939524838,0.9024022041153859,1.0,35/234,13.79%,ADCY1;DDR2;CAMK1D;SMAD3;AR;PLPP3;NKX6-1;ARID5B;FZD2;KIT;CFLAR;SMO;IRAK2;CRTC3;ZIC2;NEUROD1;FZD1;SLCO3A1;ROR1;RNF31;TLR6;IRAK3;ANXA3;CD200;RAB7B;FOXA1;NFAM1;CARD9;RGCC;IKBKE;MAP3K13;RIPK2;MTPN;HDAC4;PTEN
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.3632570185335709,0.9698003968879464,0.49707602339181284,0.9021917031263607,1.0,5/33,8.36%,SERPINE1;LYN;EPHA8;CYP1B1;FOXC2
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.3232838740504256,0.9695884972724035,0.49747474747474746,0.9020537465450192,1.0,10/76,9.89%,NRP1;SEMA5A;CDC42EP4;SYNPO2;NTF3;DYNC1H1;CDC42;CARMIL1;NTRK3;SYNPO2L
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.43372374797208935,0.9694179817749032,0.5205930807248764,0.9018367680682143,1.0,6/13,12.48%,TGFBR3;BMPR1A;FGFR2;RBPJ;FGF2;GLI1
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.45461113669625586,0.9693365151285416,0.5088967971530249,0.9014029304253388,1.0,1/11,0.87%,ACTN2
prerank,diol metabolic process (GO:0034311),-0.35199495083814214,-0.9690783576355605,0.5144356955380578,0.8842365222967878,1.0,6/19,10.72%,NOS3;DEGS2;GCH1;NAAA;CALM1;SPR
prerank,protein localization to organelle (GO:0033365),0.3031763942505398,0.968966909161752,0.518058690744921,0.901677422420763,1.0,34/133,19.92%,COL1A1;OBSL1;TULP1;OPTN;TRAM2;LRRK2;WDR35;CYB5A;TULP3;CROCC;CSRP3;ARL1;DDX3X;TRAM1;TOR1AIP1;YWHAE;UBAC2;PAF1;BANP;TOR1B;MTCH2;BMP4;ARF6;PIKFYVE;LAMP2;AUP1;ZNF423;DCP1A;MICALL1;DDX1;XPA;ABCA7;CCDC47;EHD1
prerank,organic hydroxy compound transport (GO:0015850),0.36679053992301364,0.968958688109897,0.5154185022026432,0.9010743043129394,1.0,3/36,4.89%,RBP4;SLC27A5;NCOA2
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.44332438031060417,0.9689404752441778,0.5167548500881834,0.9004943886966711,1.0,5/13,21.72%,IRAK2;TNIP2;PIK3R4;EPG5;MYD88
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.40910688314446825,-0.9682304623838673,0.5368663594470046,0.8852749956199341,1.0,3/11,6.41%,ZFPM2;TGFB2;HEY2
prerank,cellular response to fluid shear stress (GO:0071498),0.4493938053225263,0.9676168211127025,0.5341506129597198,0.9030120840320175,1.0,2/12,6.96%,MTSS1;NFE2L2
prerank,regulation of calcium ion transmembrane transport (GO:1903169),-0.33477187180161916,-0.9674247827861128,0.5281501340482574,0.8862767990953857,1.0,8/23,14.78%,UBASH3B;PTK2B;DIAPH1;CAMK2D;NOS1;CASQ2;CBARP;CACNA2D1
prerank,cellular sodium ion homeostasis (GO:0006883),0.4262340473935067,0.967270972867638,0.5134680134680135,0.90323444714171,1.0,3/15,6.93%,SLC8A1;ATP1A2;ATP1B2
prerank,regulation of metal ion transport (GO:0010959),0.42417004633821254,0.9668585961700217,0.5159663865546219,0.9035318468293592,1.0,4/16,9.31%,BCL2;STIM1;SLC30A10;CAMK2B
prerank,peptidyl-lysine monomethylation (GO:0018026),0.47359560882062884,0.966669920753647,0.5141342756183745,0.9033722111251135,1.0,2/10,11.01%,SETD7;SETD4
prerank,regulation of lipid catabolic process (GO:0050994),-0.3444145660446313,-0.9661957312084529,0.5069252077562327,0.8884176933664586,1.0,2/19,8.61%,PDE3B;ALK
prerank,cellular response to hypoxia (GO:0071456),0.3025382499276301,0.9659737964708383,0.5087719298245614,0.9043553166116356,1.0,11/126,7.37%,PTGIS;RORA;SLC8A3;MT3;PSME4;SFRP1;CPEB1;EPAS1;ZFP36L1;NDRG1;SIRT2
prerank,hyaluronan metabolic process (GO:0030212),0.39011311258655534,0.965809971432497,0.4946727549467275,0.9041159697778911,1.0,4/23,10.70%,CEMIP;LYVE1;FGF2;ABCC5
prerank,defense response to Gram-positive bacterium (GO:0050830),-0.285313641912728,-0.9656036828339546,0.5231788079470199,0.8887516890614209,1.0,12/40,27.07%,PGLYRP1;RPL39;LBP;GBP4;GBP7;HMGB2;FGR;CHGA;GBP6;PPP1R11;MPEG1;STAB2
prerank,plasma membrane repair (GO:0001778),-0.38167014989935977,-0.9653964426943658,0.4797843665768194,0.8880144910466677,1.0,2/13,4.08%,AHNAK2;DYSF
prerank,positive regulation of macroautophagy (GO:0016239),0.3437019908568865,0.965000784097899,0.5173852573018081,0.9054172372028174,1.0,15/48,19.60%,DCN;OPTN;PRKAA2;TBK1;UVRAG;LARP1;VDAC1;RAB3GAP1;TSC2;SESN2;PIP4K2C;VPS13D;WAC;HTT;GPSM1
prerank,atrial cardiac muscle cell action potential (GO:0086014),0.4445292576962829,0.9649551519551102,0.49750415973377704,0.9048771528422551,1.0,2/13,6.66%,GJA1;CACNA1C
prerank,transcription by RNA polymerase I (GO:0006360),-0.2999706861154903,-0.9649017193498796,0.5,0.8880760487742133,1.0,9/34,13.80%,TAF1B;RRN3;TAF1;TBP;CAVIN1;GTF2H1;TAF1C;UBTF;MAPK3
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.33863314440474346,-0.9648838160701956,0.5273775216138329,0.886837596769293,1.0,4/22,8.16%,ESR1;MED1;MED4;SUB1
prerank,central nervous system myelination (GO:0022010),-0.40239450033156643,-0.9647220508049433,0.48936170212765956,0.886077077682596,1.0,4/11,19.40%,TENM4;B4GALT5;PLP1;CLU
prerank,oligosaccharide metabolic process (GO:0009311),0.34678909392029095,0.9646153024695473,0.5345557122708039,0.9050492315394857,1.0,5/46,6.86%,ST6GALNAC5;GAL3ST3;B3GALT1;ST3GAL3;B4GALT1
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.3228253535766077,0.9641602284258273,0.5498059508408797,0.9055022545361697,1.0,14/79,10.16%,ADAMTS12;SULF2;BMPR1A;SULF1;NEDD4;SMURF2;SKI;CASK;EMILIN1;BMP2;SPRY2;LEMD3;SMAD1;FGF2
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.376463216844092,0.9638157789350202,0.5101744186046512,0.9056875452879838,1.0,13/26,20.58%,EGFR;MTBP;DDX3X;RGCC;KMT2E;UBE2E2;AKT1;ADAMTS1;TFDP1;CDK10;LSM10;PLCB1;CCND2
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.27510353261088993,0.9636418743307102,0.5985699693564862,0.9054926421232488,1.0,85/417,16.67%,TCF7L2;RUNX1T1;ATXN1;NR2F2;SALL1;GLI3;ARID5B;ZEB1;NKX2-1;ARID4A;PRDM5;WNT4;FOXP2;ASCL1;RBFOX2;GAS6;RUNX2;LBH;MIDEAS;TLE1;IKZF4;SMURF2;IRF1;ZIC2;PRICKLE1;MT3;ZHX2;SFRP1;TBX3;BCL6;DKK3;USP47;BCOR;CBX3;ATOH8;PML;CEBPA;MBD2;SIRT2;ZBTB38;SMARCC2;NR1D1;RBPJ;NCOR1;ZMYND15;MTA3;SCML2;BMP2;ZBTB4;CBY1;NONO;EIF4A2;HEXIM2;GLIS2;PBXIP1;ZKSCAN3;NR1D2;MBD1;KDM5C;NCOR2;L3MBTL1;BHLHE41;REST;NIBAN2;PDCD4;BTRC;ZNF318;L3MBTL2;HDAC4;ZNF148;ZNF219;TWIST2;YAF2;GATA6;BMP4;SUDS3;FOXK2;CDKN1C;PSPC1;RIOX1;CBX5;SCMH1;COPS2;ZNF423;ATF5
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.32521160800596133,-0.9633979942504997,0.5,0.8884666592247334,1.0,6/23,15.95%,NMT2;FNTA;FNTB;CALM1;PDE6A;METAP2
prerank,nitric oxide metabolic process (GO:0046209),-0.3679638585244702,-0.9630840197256453,0.5037037037037037,0.8880722130438901,1.0,5/14,10.72%,NOS3;GCH1;NOS1;DDAH2;SPR
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),-0.249901450814637,-0.9630812129402987,0.5219512195121951,0.8868172639242164,1.0,28/78,24.70%,CAV1;RNF144B;CBFA2T3;RNF144A;RBX1;TRIB2;TAF1;GSK3A;HSPBP1;ZYG11B;RAD23A;COP1;RACK1;BBS7;DVL1;RNF14;UBQLN2;CLU;PLK3;DDRGK1;GSK3B;GABARAP;RCHY1;USP5;NUB1;CSNK1D;VCP;DDA1
prerank,regulation of DNA biosynthetic process (GO:2000278),0.3777368467751086,0.962894653999228,0.5244956772334294,0.9066116443064497,1.0,7/27,12.32%,FGFR4;PDGFRB;SMOC2;FGF2;RGCC;TERF2;NIBAN2
prerank,negative regulation of endothelial cell migration (GO:0010596),0.36122670794043793,0.9627599898499529,0.5170370370370371,0.906310442739557,1.0,10/36,11.88%,DCN;NR2F2;SP100;APOE;ANGPT2;ADAMTS9;FGF2;PTPRM;RGCC;DNAJA4
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),-0.23996879335847762,-0.962731795069773,0.5615763546798029,0.8865244942210782,1.0,23/93,20.21%,PDE4D;CAV1;FNIP2;NGF;BCAR3;TFRC;NOS1;PAK1;HSP90AB1;INPP5K;ATP2B4;VEGFA;DDIT4;TGFB1;NLRP2B;APP;TRIM6;TXN;RACK1;NCK2;CD44;PDCD10;HCLS1
prerank,urogenital system development (GO:0001655),0.4542619605059308,0.9624144829162239,0.5364120781527532,0.9065271945343509,1.0,4/11,16.71%,OSR1;EPHB2;EPHB3;SHH
prerank,fatty-acyl-CoA metabolic process (GO:0035337),-0.34191467846894136,-0.9620952431495098,0.4971751412429379,0.8869466973041531,1.0,8/20,26.09%,FAR2;PPT1;HSD17B8;PPT2;ACSL3;ACACA;SCD5;CBR4
prerank,positive regulation of protein catabolic process (GO:0045732),0.31399071181614985,0.962057921549642,0.5236318407960199,0.9067830618540142,1.0,16/84,15.20%,SH3D19;HECW2;DACT1;NKD1;APOE;NEDD4;SMURF2;VIP;SNX33;PRKN;ITCH;ADRA2A;SNX9;PLK2;HACE1;HUWE1
prerank,regulation of dendrite morphogenesis (GO:0048814),0.37086245306772053,0.9618664019057132,0.5067466266866567,0.9065998224199888,1.0,5/32,5.70%,HECW2;OBSL1;NEDD4;RAPGEF2;CUX2
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),0.4422636212680409,0.961638729663866,0.5097690941385435,0.9065024530631993,1.0,2/11,4.33%,LYN;RAPGEF2
prerank,regulation of anoikis (GO:2000209),0.39436072471197203,0.9615326805955442,0.5089141004862237,0.906123689986791,1.0,4/19,6.83%,BCL2;TLE1;SRC;SIK1
prerank,Notch signaling pathway (GO:0007219),0.33211868482998413,0.9610548550530943,0.5404312668463612,0.9066487477247114,1.0,13/59,10.92%,PBX1;GMDS;ASCL1;MAML3;NOTCH2;DTX4;TRAF7;RBPJ;BMP2;KAT2B;ITCH;MIB1;APH1B
prerank,rRNA modification (GO:0000154),0.3951215039045023,0.9609598051583867,0.513677811550152,0.9062373247642344,1.0,5/21,15.16%,BUD23;DIMT1;FTSJ3;TRMT112;NSUN4
prerank,regulation of macrophage activation (GO:0043030),0.36551038987297213,0.960876336409258,0.5161290322580645,0.9058354130914038,1.0,8/30,17.41%,IL31RA;MYO18A;CEBPA;TLR6;CD200;TNIP2;NR1H3;PJA2
prerank,histone H4 deacetylation (GO:0070933),0.4614345738712609,0.9607309113198822,0.5095320623916811,0.9055386448629174,1.0,6/10,25.04%,SIRT2;HDAC8;REST;HDAC4;SMARCAD1;HDAC1
prerank,sodium ion homeostasis (GO:0055078),0.3962767645974353,0.9605604273020131,0.5155763239875389,0.9053550580183097,1.0,3/21,6.93%,SLC8A1;ATP1A2;ATP1B2
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.3474953204480975,0.959917126274,0.5333333333333333,0.9062540711076386,1.0,13/49,14.60%,RUNX1;TNRC6B;MTURN;TNRC6A;SETD1A;KAT2B;RAB7B;EIF6;L3MBTL1;NFE2;KMT2E;KMT2A;WDR5
prerank,positive regulation of leukocyte migration (GO:0002687),0.3763633595613519,0.959696279910835,0.5287009063444109,0.9061636449322847,1.0,4/27,14.20%,IL6R;CSF1;MIA3;MDK
prerank,regulation of neuron death (GO:1901214),-0.24705216023715593,-0.9595729416751192,0.525,0.8924906587416872,1.0,12/82,10.38%,GRID2;MEF2C;CD34;EGLN3;EPHB1;SORL1;CDK5;GRIN2B;PPARGC1A;EGLN2;DDIT4;DCC
prerank,regulation of DNA replication (GO:0006275),0.33710667784279685,0.959208184450789,0.5242587601078167,0.9067191267230247,1.0,10/49,15.19%,GLI2;CCNA2;TSPYL2;NPM2;ZBTB38;EGFR;S100A11;GLI1;EGF;WAPL
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.40131861617142334,0.9591922659955348,0.5191986644407346,0.9061422680852339,1.0,6/18,14.89%,MAP2K1;NCOR1;EGFR;NCOR2;MYCN;BMP4
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.36466502503688353,0.9591852867150527,0.5252525252525253,0.9055442589354186,1.0,5/33,6.81%,RUNX1;IL34;CSF1;ZFP36L1;IL12B
prerank,protein localization to mitochondrion (GO:0070585),0.460161078167951,0.9590553983447939,0.5253940455341506,0.9052586805195768,1.0,4/11,16.32%,COX18;LRRK2;MTCH2;AKT1
prerank,regulation of BMP signaling pathway (GO:0030510),0.3244453629000558,0.9587788799735457,0.5544303797468354,0.9052547850123582,1.0,22/73,16.76%,BMPR1A;CCN1;ITGA3;FSTL1;TWSG1;SULF1;SMURF2;CDH5;ENG;SKI;CRB2;RBPJ;BMP2;LEMD3;SMAD1;FSTL3;BMP4;UBE2D1;SFRP4;SPART;ZNF423;DAND5
prerank,positive regulation of lipid kinase activity (GO:0090218),0.36991869499953955,0.9587580817349232,0.5374449339207048,0.9046921004503441,1.0,5/29,3.80%,EPHA8;KIT;PDGFRA;PDGFRB;CCL19
prerank,regulation of response to oxidative stress (GO:1902882),-0.4007974224873011,-0.9582875423692035,0.505938242280285,0.894681467724366,1.0,1/11,0.90%,MCTP1
prerank,regulation of cell cycle (GO:0051726),0.2785923049443457,0.9581395817754172,0.5917721518987342,0.9055245096566793,1.0,41/271,12.85%,TCF7L2;SMAD3;GRK5;SON;FGFR2;GADD45B;TGFBR1;NUPR1;SND1;NOTCH2;FBXL17;CDK5RAP3;TSPYL2;IRF1;LIN52;SFRP1;PCLAF;TBX3;MAP3K20;APBB2;PML;IL12B;SIK1;SIRT2;MAP2K1;FBXL3;CKS1B;LIN9;TTC28;BMP2;KAT2B;STK11;CDC123;NEK6;L3MBTL1;RGCC;FBXL12;NR4A1;PDCD4;MAP2K6;SIPA1
prerank,regulation of cell projection organization (GO:0031344),0.42853983662757544,0.9577927592799003,0.5,0.9057055456355397,1.0,4/13,13.26%,MACF1;CCL19;SPRY2;NTNG2
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.33666226297819907,0.9577329293404431,0.5273492286115007,0.9052372077552685,1.0,13/50,16.40%,SH3RF1;GAS6;RFFL;MT3;USP47;SRC;DPEP1;DDX3X;YWHAE;NOL3;IGBP1;AKT1;FNIP1
prerank,chromatin assembly (GO:0031497),-0.2856178842032067,-0.9576333414573547,0.5064102564102564,0.8951921451871677,1.0,16/38,29.46%,NAP1L4;SIRT1;NAP1L2;H3-3A;CHAF1A;NAA60;RSF1;HMGB2;NPM1;CDAN1;HMGA2;LIN54;ASF1A;GRWD1;H1-0;NAP1L3
prerank,response to alcohol (GO:0097305),0.3816685431397646,0.9571175446006973,0.5329341317365269,0.9060416478258422,1.0,6/27,10.11%,TGFBR3;TGFBR1;CCL19;HSD3B2;DRD3;SLIT3
prerank,antibacterial humoral response (GO:0019731),0.41456914348204554,0.9568103247570676,0.5208333333333334,0.9061674377204318,1.0,3/16,11.56%,WFDC3;CAMP;RNASE7
prerank,protein N-linked glycosylation (GO:0006487),0.31980265381165757,0.9566785471366419,0.538961038961039,0.9058448294753751,1.0,16/66,13.98%,PGM3;MAN1C1;MOGS;LMAN1;B4GALT1;STT3A;DERL3;DOLPP1;GFPT1;ALG5;UGGT2;ALG11;MGAT3;DDOST;ALG10B;ALG6
prerank,regulation of response to cytokine stimulus (GO:0060759),0.410918763993098,0.9565000517628407,0.528830313014827,0.9056751408773795,1.0,3/19,4.30%,RUNX1;IRAK2;APOA1
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.4536407375314111,0.9563485695846707,0.5379188712522046,0.9054594208874054,1.0,2/10,4.44%,PXYLP1;DSE
prerank,regulation of rRNA processing (GO:2000232),0.42085137787757504,0.9562370015513009,0.5131578947368421,0.9051025863394896,1.0,5/16,13.24%,BUD23;KAT2B;DIMT1;WDR43;TRMT112
prerank,response to cAMP (GO:0051591),-0.2924288904188176,-0.9562051120463496,0.5121951219512195,0.8979828096806831,1.0,9/37,13.10%,RAP1A;PDE2A;KCNQ1;AKAP6;RAP1B;INPP5K;SLC26A6;DGKQ;CFTR
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.3979114199386948,0.9560670206305636,0.5293185419968305,0.9049038446359365,1.0,4/21,6.66%,SLC8A1;ATP1A2;GSTM2;CACNA1C
prerank,chondroitin sulfate catabolic process (GO:0030207),0.4405840090737814,0.9558843616553624,0.5409252669039146,0.9047067271745318,1.0,3/13,8.04%,DCN;BGN;CSPG5
prerank,negative regulation of gene silencing by miRNA (GO:0060965),-0.3905377513599702,-0.9558015990031267,0.5112781954887218,0.8978509801507324,1.0,3/12,11.49%,ESR1;ELAVL1;TGFB1
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.3153845046210355,0.9550794417945225,0.5613810741687979,0.9059203951150786,1.0,11/76,11.48%,PTGIS;IRAK2;CDK5RAP3;CYP1B1;MTURN;IRAK3;ARRB1;CD200;COMMD1;ITCH;UFL1
prerank,regulation of TOR signaling (GO:0032006),0.3217452511493522,0.9548380091543903,0.5263157894736842,0.9058896509116651,1.0,21/67,20.58%,GAS6;NPRL3;UBR2;RFFL;PRKAA2;ARAF;SLC38A9;TELO2;FBXO9;LAMTOR2;RRAGD;TSC2;ITFG2;NPRL2;GOLPH3;FNIP1;SEH1L;DYRK3;RICTOR;RHEB;MLST8
prerank,sphingosine metabolic process (GO:0006670),-0.3623352062055013,-0.9548023847151728,0.5050251256281407,0.8993685955758058,1.0,4/17,10.37%,ACER3;ACER2;NAAA;SPTLC2
prerank,negative regulation of microtubule polymerization (GO:0031115),0.43619038864568604,0.9547362500593077,0.53,0.905512040289279,1.0,2/12,5.68%,EML2;CDH5
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.4263258741736526,0.9546010181339872,0.4898989898989899,0.9051951964735884,1.0,4/13,13.83%,GAS6;AXL;TSLP;TAF9
prerank,mitochondrial translation (GO:0032543),-0.24214834553409464,-0.9545214842623547,0.5581395348837209,0.8989096680925761,1.0,39/104,32.16%,MRRF;NOA1;MTRF1L;GFM2;MRPL46;MRPS18A;MRPS5;MRPL39;MRPS26;MRPS12;NDUFA7;MRPL48;MRPL4;MRPL21;FASTKD2;MRPL44;MRPS33;MRPL55;MRPL57;MRPS18B;MRPL42;MRPS10;MRPS21;MRPS7;MRPL34;MRPL19;MRPL15;MRPS22;GATC;MRPL38;MRPS31;MRPL12;MRPL28;MRPL43;MTIF3;MRPS14;MRPL54;MRPL2;AURKAIP1
prerank,monocarboxylic acid catabolic process (GO:0072329),0.38984479632109365,0.9543593556692891,0.5236593059936908,0.9051135730236065,1.0,7/21,23.12%,CYP26B1;HOGA1;NUDT19;LPIN3;LPIN2;FAH;LDHD
prerank,dendrite self-avoidance (GO:0070593),-0.35051522672853586,-0.9542893120469286,0.5060827250608273,0.8982935926962659,1.0,5/16,10.50%,BSG;CNTN4;CNTN6;ROBO4;EMB
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.2973355647908711,-0.9538516817923363,0.5299401197604791,0.8981770694248759,1.0,13/32,19.53%,KDR;THBS1;NOTCH1;JCAD;GATA2;VEGFA;KLF4;PTGS2;MAP3K3;DLL4;ITGB1BP1;ANXA1;PDCD10
prerank,early endosome to Golgi transport (GO:0034498),0.4373579860896254,0.9535560049289443,0.5173611111111112,0.9063208898197149,1.0,3/11,11.28%,LMAN1;RBSN;TRAPPC10
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.4441348540411828,0.9532351280309537,0.5303571428571429,0.9064555387092758,1.0,3/11,13.51%,PRKN;REST;P4HB
prerank,neurotransmitter transport (GO:0006836),0.3169420811482799,0.9527232390172491,0.5387547649301143,0.9070201711684145,1.0,12/73,13.18%,SLC1A3;GLUL;ATP1A2;SLC22A2;STXBP3;CASK;BRSK1;APBA1;SLC29A1;PPFIA3;STXBP1;SLC18A2
prerank,nuclear body organization (GO:0030575),0.4428891312990244,0.9526434706057897,0.5137614678899083,0.9066001266988475,1.0,5/12,17.94%,PML;USPL1;SERBP1;ETS1;DYRK3
prerank,neural tube development (GO:0021915),0.41636087692163126,0.9523000154669589,0.5141430948419301,0.9067970395762776,1.0,2/15,6.06%,DACT1;ALDH1A2
prerank,cellular response to cAMP (GO:0071320),-0.30557383747634725,-0.9516810922801259,0.528125,0.9025840755739435,1.0,8/30,13.10%,RAP1A;PDE2A;KCNQ1;AKAP6;RAP1B;INPP5K;SLC26A6;CFTR
prerank,chromatin disassembly (GO:0031498),0.42689190441660346,0.9514084097861667,0.5378151260504201,0.9076904897502971,1.0,6/14,23.32%,SMARCC2;NFE2;SMARCD2;SMARCB1;ARID2;SMARCE1
prerank,nucleosome disassembly (GO:0006337),0.42689190441660346,0.9514084097861667,0.5378151260504201,0.9076904897502971,1.0,6/14,23.32%,SMARCC2;NFE2;SMARCD2;SMARCB1;ARID2;SMARCE1
prerank,inner ear morphogenesis (GO:0042472),0.3904246182592296,0.9512947218919914,0.5144230769230769,0.9073606321712179,1.0,4/22,8.61%,ZIC1;FGFR2;TTC39C;EPHB2
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.3813044141779906,0.9510995149133601,0.5157232704402516,0.9072114707560239,1.0,1/22,1.07%,PPM1E
prerank,negative regulation of osteoblast differentiation (GO:0045668),-0.30601193897381607,-0.950438446097733,0.5335365853658537,0.9046081204686117,1.0,4/31,3.78%,CDK6;NOTCH1;RORB;LRP5
prerank,regulation of erythrocyte differentiation (GO:0045646),-0.27925838405950587,-0.9503555579783037,0.5416666666666666,0.9035583427967577,1.0,12/35,17.76%,CDK6;HOXA5;MED1;TAL1;ACVR2A;LDB1;HIF1A;PRKDC;INHBA;ZFPM1;FAM210B;HMGB2
prerank,nitric oxide biosynthetic process (GO:0006809),-0.3736560119711063,-0.9498545051258489,0.5287081339712919,0.9036358699852326,1.0,5/13,10.72%,NOS3;GCH1;NOS1;DDAH2;SPR
prerank,lysosome organization (GO:0007040),0.35346229219239667,0.9498287664115016,0.5249643366619116,0.9094822780888381,1.0,10/36,19.32%,ABCA1;LRRK2;GAA;ZKSCAN3;CLN3;HOOK2;TPCN2;HPS4;TMEM106B;SNAPIN
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.4434643644243388,0.9492044704314372,0.5299145299145299,0.9102931286249897,1.0,4/12,18.52%,CHAMP1;CENPC;SEH1L;BOD1
prerank,N-acetylneuraminate metabolic process (GO:0006054),-0.40828030967093815,-0.9489270021266513,0.5271493212669683,0.9048603780161772,1.0,1/10,0.97%,ST6GAL1
prerank,regulation of gene silencing by RNA (GO:0060966),0.33671771401216244,0.9487208244232793,0.5378378378378378,0.9101983254791235,1.0,7/50,11.57%,POLR2D;NUP107;NUP42;TNRC6A;POLR2C;NUP98;RAE1
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.33671771401216244,0.9487208244232793,0.5378378378378378,0.9101983254791235,1.0,7/50,11.57%,POLR2D;NUP107;NUP42;TNRC6A;POLR2C;NUP98;RAE1
prerank,protein N-linked glycosylation via asparagine (GO:0018279),-0.30625533657144244,-0.9484215321867139,0.5109034267912772,0.904961579769184,1.0,9/30,16.53%,ST6GAL1;FUT8;DPM1;UBE2J1;UGGT1;MGAT5;DPM3;RPN1;DPM2
prerank,vesicle transport along microtubule (GO:0047496),-0.32093610733431965,-0.9481807407280592,0.4763157894736842,0.9042831664077463,1.0,8/23,21.94%,KIFAP3;KIF13A;PAFAH1B1;KIF1A;BICDL1;TRAK2;KIF5A;HAP1
prerank,nucleotide-excision repair (GO:0006289),0.3012784421140378,0.9481664110833353,0.541371158392435,0.9108542457776231,1.0,13/101,12.95%,POLR2D;OGG1;LIG4;GTF2H5;CUL4B;POLL;COMMD1;POLR2C;ERCC8;FANCC;MNAT1;GPS1;COPS3
prerank,fatty acid transmembrane transport (GO:1902001),0.3955050731937253,0.94814794732319,0.5189274447949527,0.9102893453535534,1.0,3/19,5.19%,SLC27A5;PRKAG2;PRKAA2
prerank,neutrophil activation (GO:0042119),-0.38573057885125067,-0.9478399812182956,0.49074074074074076,0.9039991317852619,1.0,3/12,19.48%,IL15;FCER1G;PREX1
prerank,ureteric bud development (GO:0001657),-0.3555308893982314,-0.9478120403589639,0.5473684210526316,0.9028161336997294,1.0,3/17,2.74%,SLIT2;GPC3;SIX1
prerank,regulation of necroptotic process (GO:0060544),0.3815208977422543,0.9475055469312452,0.5419968304278923,0.911113050688509,1.0,3/23,3.51%,OGT;MLKL;CFLAR
prerank,negative regulation of interleukin-6 production (GO:0032715),0.3722185894213967,0.9474298943494778,0.5599393019726859,0.9106811976210181,1.0,7/27,17.51%,GAS6;IRAK3;ARRB1;CD200;SELENOS;SYT11;CX3CL1
prerank,carboxylic acid transport (GO:0046942),0.32807026125479744,0.9469137843839346,0.5365853658536586,0.9113156777224438,1.0,16/55,20.05%,SLC1A5;SLC16A12;SLC13A3;SLC6A9;SLC6A13;SLC38A6;CLN3;SLC16A3;SLC38A3;SLC7A6;SLC38A2;SLC16A2;SLC38A1;SLC25A29;SLC6A12;PSAP
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.35408485684943813,-0.9468021878271653,0.5331632653061225,0.9043534439572353,1.0,4/15,20.53%,RPS7;RPL11;RPL5;RPL23
prerank,negative regulation of autophagy (GO:0010507),0.3297197188098661,0.9459746233596383,0.5409836065573771,0.9128533523068977,1.0,8/54,10.15%,BCL2;LEPR;NUPR1;MT3;SNRNP70;LRRK2;SIRT2;ZKSCAN3
prerank,protein tetramerization (GO:0051262),-0.25400562882555144,-0.9459171511559255,0.5846774193548387,0.9056098112268659,1.0,26/67,26.42%,KCNJ2;B2M;GBP5;GRIN2B;CPSF7;OSBPL2;ACOT13;ALDOA;HSD17B8;HOMER1;AQP4;APIP;ALDH9A1;UPB1;CUTC;ACACB;GRIN1;HCN1;KCNC1;SOD2;ALDH1A3;ACACA;SHMT1;PKD2L1;CBR4;CPSF6
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.3561137544484525,0.9457912775133128,0.5339233038348082,0.9126829553301609,1.0,8/31,18.59%,LYN;CEBPB;GLMN;SDC4;ATM;SOX11;RC3H1;VTCN1
prerank,regulation of actin filament polymerization (GO:0030833),-0.24739466906653973,-0.9457013938107666,0.5965665236051502,0.9049244463403571,1.0,6/69,3.00%,SLIT2;BAIAP2L1;KANK3;ESAM;PTK2B;CYRIB
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.3873820926991579,0.9455818843730214,0.5313531353135313,0.9125841826541005,1.0,4/22,9.48%,LYN;APPL2;NR1D1;RAB7B
prerank,negative regulation of protein secretion (GO:0050709),0.3503965772329513,0.9450176170424467,0.5507246376811594,0.9132110712439977,1.0,12/38,18.59%,APOE;SFRP1;IL12B;DRD3;CD200;PRKN;ADRA2A;REST;SERGEF;NR1H3;RHBDF2;DPH3
prerank,protein import (GO:0017038),0.30545179920259113,0.9446662545713647,0.5509950248756219,0.9134099662805515,1.0,23/84,18.83%,RANBP17;NUP107;APOE;APPL2;FAM53C;PRICKLE1;SNX33;PXMP2;HEATR3;CSE1L;PPP1R10;PEX2;TSC2;TOMM22;ABCD2;NUP214;PEX11B;LAMP2;AKT1;PHB2;TPR;APPL1;KPNB1
prerank,interleukin-12-mediated signaling pathway (GO:0035722),-0.26946914629948604,-0.9443990820681224,0.5645756457564576,0.9071477231619602,1.0,13/46,15.70%,PITPNA;PPIA;RAP1B;JAK2;MSN;LMNB1;ARF1;PAK2;TYK2;BOLA2;HNRNPA2B1;SNRPA1;RPLP0
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.3075351244931657,0.9441990672617664,0.5401002506265664,0.9138903058096275,1.0,26/78,24.28%,NR2F2;CCNA2;CDK5RAP3;CEBPA;EGFR;CCNK;HEXIM2;INCA1;RGCC;MNAT1;CNPPD1;PTEN;CDKN1C;AKT1;CDKN2C;CCNT2;CDKN1B;SERTAD1;CCND2;CCNT1;CCNG2;CDK7;HEXIM1;CCNY;CCNE2;PKD2
prerank,response to ethanol (GO:0045471),-0.37863672754922995,-0.9438397527512292,0.5340314136125655,0.9073516851709318,1.0,5/14,7.48%,GRIN2A;GLRA1;GLRA2;GRIN2B;GRIN3A
prerank,apoptotic mitochondrial changes (GO:0008637),-0.29928384585104845,-0.9436186262083768,0.547550432276657,0.9067028191038001,1.0,13/32,23.99%,ERBB4;HK2;BBC3;BCL2L1;ATG3;BAK1;BIK;CLU;NDUFS1;FIS1;GGCT;SOD2;CCAR2
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.3440557719616552,0.9435835703278908,0.5455820476858345,0.9146941292626436,1.0,6/41,7.06%,DAGLA;ACSL1;PLA2G4A;CYP1B1;GSTM2;ALOXE3
prerank,negative regulation of kinase activity (GO:0033673),0.3175734494355188,0.9431001074202274,0.5301668806161746,0.9151796458024547,1.0,4/62,3.24%,PDPK1;PPM1E;DTNBP1;PRKAG2
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.3473286291137595,0.9430983282464007,0.5423476968796433,0.9145817928667286,1.0,10/37,16.55%,ADCY7;IL17D;APPL2;TLR6;CARD9;F2;PDCD4;ABCD2;CHID1;PLD4
prerank,regulation of oxidative phosphorylation (GO:0002082),0.4094398062199115,0.9428797802516914,0.5581395348837209,0.9144430391662713,1.0,2/16,5.33%,NUPR1;COX7A2
prerank,erythrocyte development (GO:0048821),-0.4104444008540883,-0.9427971561695185,0.5,0.90772591644955,1.0,4/10,24.35%,MED1;ALAS1;ALAS2;DMTN
prerank,lipoprotein biosynthetic process (GO:0042158),0.44111293915466754,0.9427322965957432,0.5152057245080501,0.9141491405507903,1.0,3/11,12.68%,APOE;ATG10;WIPI1
prerank,histone lysine methylation (GO:0034968),0.35352039775069605,0.9422936414310962,0.5466101694915254,0.9145196451305777,1.0,11/33,20.88%,PRDM5;WDR82;SMYD3;TRMT112;KMT2A;SETDB1;WDR5;SETD1B;CXXC1;RBBP5;N6AMT1
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),-0.33170739456222087,-0.9421546057712903,0.5478036175710594,0.9082160033142933,1.0,9/21,20.83%,SLIT2;CYRIB;TGFB2;ARHGAP25;SPRY4;CD2AP;SH3BP1;ARHGAP12;DAB2IP
prerank,aromatic amino acid family catabolic process (GO:0009074),0.41456179295874646,0.9421417800229005,0.5495934959349593,0.9142579012613918,1.0,2/15,6.77%,TDO2;KYNU
prerank,negative regulation of dephosphorylation (GO:0035305),-0.3417099080037896,-0.9416021086570184,0.5431034482758621,0.9085038653813806,1.0,6/18,27.26%,PPP1R16B;INPP5K;URI1;PPP1R35;MFHAS1;GPATCH2
prerank,ERAD pathway (GO:0036503),0.3069059306045392,0.9413633418308884,0.5694789081885856,0.9154725212612975,1.0,33/83,27.21%,ERLEC1;FAF2;DERL1;UBXN4;DERL3;UBE4B;RNF185;RNF139;ECPAS;PRKN;UGGT2;FOXRED2;RCN3;SELENOS;AMFR;TMUB1;AUP1;TMEM67;ERLIN1;CCDC47;JKAMP;BAG6;WFS1;HSPA5;ATXN3;ERLIN2;OS9;UBE2J2;FBXO2;FBXO17;DNAJB12;DNAJB9;TMUB2
prerank,positive regulation of protein-containing complex assembly (GO:0031334),-0.23107712606681866,-0.9413311553740092,0.6241610738255033,0.9080124091796921,1.0,21/113,11.49%,MPP7;UNC13B;FNIP2;PIEZO1;ESR1;TFRC;WARS1;RASIP1;FAF1;RBX1;GBP5;RPS3;MMP1;RAP1B;TAL1;VEGFA;GTF2H1;DDB2;SKAP1;PLEK;TGFB1
prerank,Rac protein signal transduction (GO:0016601),0.40097187293723485,0.9410092516714187,0.5466237942122186,0.9156474525237135,1.0,1/18,0.70%,RHOH
prerank,regulation of intracellular signal transduction (GO:1902531),0.26799673594136486,0.9409719311759576,0.6639511201629328,0.9151393615943737,1.0,65/420,12.49%,DAPK2;PDPK1;NRK;RHOH;PTPN13;LYN;ARHGAP6;SYDE2;DLC1;RHOD;WWC2;ARHGAP28;PLEKHG2;ARHGAP18;OPTN;PRKAG2;TIAM2;LBH;AKAP7;SOS2;ARHGAP29;FGD1;RFFL;ARHGAP21;FGD4;ARHGAP19;PRKAA2;ARHGAP32;ARHGAP10;CDC42;NUAK1;PML;LRRK2;FAM13A;ARHGEF17;ING5;SPHK2;GRM2;ARHGEF18;PPP1R13L;ARAF;ARHGAP35;MTA2;NTRK3;STK4;ARHGAP9;EGFR;ARHGEF11;MAP4K4;SYDE1;ITGAV;TELO2;STK11;RHOT1;RBBP7;TAOK3;CASTOR2;L3MBTL1;FBXO9;UFL1;FGD3;RHOQ;RCN3;ARHGAP5;FAM13B
prerank,NADH dehydrogenase complex assembly (GO:0010257),-0.26049200172792025,-0.940857714385463,0.5797101449275363,0.9068466922351511,1.0,23/56,28.83%,NDUFC1;NDUFAF2;NDUFA6;DMAC2;NDUFA5;TMEM126B;NDUFA7;NDUFA8;NDUFB7;NDUFA3;NDUFA10;NDUFAF8;NDUFS7;NDUFS1;NDUFS5;NDUFB3;NDUFAF3;DMAC1;NDUFAB1;NDUFB4;NDUFV2;NDUFAF7;NDUFV3
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),-0.26049200172792025,-0.940857714385463,0.5797101449275363,0.9068466922351511,1.0,23/56,28.83%,NDUFC1;NDUFAF2;NDUFA6;DMAC2;NDUFA5;TMEM126B;NDUFA7;NDUFA8;NDUFB7;NDUFA3;NDUFA10;NDUFAF8;NDUFS7;NDUFS1;NDUFS5;NDUFB3;NDUFAF3;DMAC1;NDUFAB1;NDUFB4;NDUFV2;NDUFAF7;NDUFV3
prerank,regulation of tube diameter (GO:0035296),0.4250415504796367,0.9405969651770214,0.533678756476684,0.9148315192969287,1.0,2/13,6.90%,ROCK2;AGTR1
prerank,vascular process in circulatory system (GO:0003018),0.4250415504796367,0.9405969651770214,0.533678756476684,0.9148315192969287,1.0,2/13,6.90%,ROCK2;AGTR1
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.3795949280391641,-0.9400379125045486,0.5303030303030303,0.9078414065483067,1.0,4/13,18.69%,SYT1;CACNA1H;STX1A;SYT4
prerank,macrophage migration (GO:1905517),-0.3652318020789189,-0.9397680796869259,0.5402843601895735,0.9072966987590021,1.0,3/13,23.02%,CKLF;EDNRB;CCL2
prerank,glycosaminoglycan metabolic process (GO:0030203),0.3251863772114634,0.9396372833501722,0.5570652173913043,0.9164518699663827,1.0,11/54,15.95%,GPC6;HSPG2;PXYLP1;HS6ST1;SDC1;EXT1;NDST1;GALNT5;SDC4;GNS;EXT2
prerank,amino acid transmembrane transport (GO:0003333),0.3368091027735353,0.9393617570400894,0.5341880341880342,0.9165054920301563,1.0,13/45,16.47%,SLC7A11;SLC6A13;SLC22A2;SLC7A13;SFXN2;SLC38A6;SLC22A4;SLC38A9;SLC38A3;SLC7A6;SLC38A10;SLC38A2;SLC16A2
prerank,negative regulation of synaptic transmission (GO:0050805),0.38123827856220704,0.9393360980104042,0.5378548895899053,0.9159675014243889,1.0,8/23,14.69%,SLC24A1;LRRK2;CBLN1;DRD3;STXBP1;SYT11;PTEN;PLK2
prerank,mammary gland development (GO:0030879),0.380182456897401,0.9390213147529783,0.5428571428571428,0.9161162704677532,1.0,4/21,7.95%,GLI2;WNT4;TBX3;ARHGAP35
prerank,negative regulation of DNA recombination (GO:0045910),0.3481108799205162,0.9383303040493991,0.5625879043600562,0.9170696680763825,1.0,8/43,18.79%,POLR2D;POLR2C;TERF2;RTEL1;SHLD3;SMCHD1;ATRX;POLR2L
prerank,positive regulation of developmental growth (GO:0048639),-0.270333501011588,-0.9380406912724794,0.5458015267175572,0.91060920181986,1.0,8/49,7.82%,SMURF1;SEMA7A;RIMS1;NGF;NEDD4L;RIMS2;SYT1;ITSN2
prerank,peptidyl-lysine modification (GO:0018205),0.30137049160985835,0.9377019588377837,0.5632603406326034,0.9179059865735871,1.0,24/99,20.24%,LOXL1;LOX;EYA1;NUP107;P3H3;NUP42;SIRT2;KAT2B;USPL1;TRPM4;BLOC1S1;NUP98;RAE1;HDAC4;SENP6;NUP214;SENP7;SEH1L;KAT5;TPR;SIRT5;SUMO1;AAAS;NSMCE2
prerank,negative regulation of developmental process (GO:0051093),0.3171592433977676,0.9374323244760744,0.5717981888745148,0.9179045543854619,1.0,10/69,9.32%,ROCK2;KANK1;IL17D;NFIB;GAS6;SFRP1;PTPRS;CST3;BMP2;PRKN
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.4461044159575248,0.9370478407810542,0.5469314079422383,0.9181699993534769,1.0,2/11,5.50%,NOS1AP;CACNB1
prerank,potassium ion transmembrane transport (GO:0071805),0.2901475820936309,0.9367033519980239,0.5853658536585366,0.9183306526112206,1.0,13/135,9.27%,SLC1A3;KCNK2;SLC24A3;NALCN;ATP1A2;KCNT2;SLC9A9;SLC24A1;KCNK7;ATP1B2;KCNQ4;SLC9A5;KCNJ14
prerank,vesicle transport along actin filament (GO:0030050),-0.3292735115581903,-0.9365946603050518,0.5580736543909348,0.9131721546163789,1.0,2/19,1.46%,FNBP1L;MYO1D
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.396842516216363,0.9365032778697042,0.5500821018062397,0.9181805843416381,1.0,5/18,10.90%,SRPX2;AKT3;FOXC2;FGF2;FGFBP1
prerank,regulation of interferon-gamma production (GO:0032649),-0.25119875405449454,-0.9363725258506683,0.5776892430278885,0.9125421761863264,1.0,15/71,19.92%,PDE4D;PDE4B;SLC7A5;CYRIB;SIRPA;SCRIB;PTPN22;INHA;INHBA;ZFPM1;TLR4;TXK;CD276;C1QBP;FZD5
prerank,negative regulation by host of viral process (GO:0044793),0.44322224295841406,0.9360845649999071,0.5528596187175043,0.9185312774703716,1.0,2/10,9.32%,CCNK;PRKN
prerank,regulation of T cell migration (GO:2000404),-0.3402982317720699,-0.9360347175857575,0.5824742268041238,0.9122056529352983,1.0,2/18,3.35%,LRCH1;APOD
prerank,peptidyl-serine modification (GO:0018209),0.28286175757253834,0.9355733110875479,0.618510158013544,0.9191024627571549,1.0,43/166,21.35%,PDPK1;ROCK2;CAMK1D;DMPK;MARK1;GAS6;TGFBR1;HPF1;ULK2;LRRK2;AKT3;EIF2AK3;BRSK1;MAST2;STK4;VRK3;TTBK1;NEK6;IKBKE;TBK1;TLK1;WNK1;MAP3K13;MARK2;PLK2;DYRK1A;DYRK1B;MAPKAPK2;AKT1;ATM;CDC7;DYRK3;PRKCI;CSNK1A1;PRKCA;PRKACA;RICTOR;CLSPN;SGK3;SGK2;PKN2;AURKA;PRKCB
prerank,regulation of T cell mediated immunity (GO:0002709),0.44785516232873607,0.9351272369348822,0.5575539568345323,0.9195222125675186,1.0,2/10,9.40%,ZBTB1;TRPM4
prerank,determination of left/right symmetry (GO:0007368),-0.27563336581178177,-0.9343196671566921,0.5770392749244713,0.9155251815503798,1.0,10/37,19.58%,NOTCH1;TBX1;ZIC3;GALNT11;DNAH11;STIL;ARL6;CITED2;BBS7;DLL1
prerank,positive regulation of autophagy (GO:0010508),0.302762528848943,0.9342772960872584,0.5759493670886076,0.9208613840518844,1.0,22/81,19.78%,DAPK1;DCN;OPTN;PRKAA2;LRRK2;PRKN;STK11;RNF152;UFL1;TBK1;LARP1;TSC2;PLK2;SESN2;NPRL2;KAT5;FOXO3;WAC;PHB2;HTT;GPSM1;TRIM21
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.3360320382486816,0.9340466959051289,0.552054794520548,0.9208024298419315,1.0,6/46,8.11%,PLD1;PLA2G4A;GPD1;AGPAT3;DDHD2;PLD2
prerank,response to interferon-alpha (GO:0035455),0.40028228325879234,0.9338442748485611,0.562396006655574,0.9206663876020351,1.0,2/16,4.70%,GAS6;AXL
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.38468775147910983,0.9333357994990503,0.5466237942122186,0.9212389274462427,1.0,6/22,16.48%,MAN1C1;RNF185;RNF139;UGGT2;AMFR;MAN1A2
prerank,synapse organization (GO:0050808),0.29368710802866493,0.9332050942181049,0.5760743321718932,0.9209310164725728,1.0,17/125,8.44%,GPC6;PDZRN3;FARP1;PPFIBP2;SLC8A3;OBSL1;UNC13C;CAST;NEDD4;PTPRS;MUSK;CACNB1;CDC42;APBB2;LRRK2;CBLN1;DSCAM
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.38997010715639435,0.9330117579267022,0.5538221528861155,0.9207716582496125,1.0,2/20,3.23%,GRK3;MGRN1
prerank,protein peptidyl-prolyl isomerization (GO:0000413),-0.33041160219372545,-0.9328883609442922,0.5490716180371353,0.9181162150075757,1.0,8/20,23.37%,PPIA;FKBP5;PPIG;PPID;PPIL1;FKBP1A;PPIB;PPIL6
prerank,peptidyl-asparagine modification (GO:0018196),-0.2996163759661237,-0.9325271093482772,0.5328947368421053,0.9178010438635756,1.0,9/31,16.53%,ST6GAL1;FUT8;DPM1;UBE2J1;UGGT1;MGAT5;DPM3;RPN1;DPM2
prerank,regulation of dendrite development (GO:0050773),0.34484022625101135,0.9325151426128918,0.5630252100840336,0.9212888876275497,1.0,4/37,4.26%,CAMK1D;HECW2;MARK1;NEDD4
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.3467215060427439,0.9323816475424638,0.5429403202328966,0.920989360880397,1.0,5/36,7.40%,GHR;LEPROT;KIT;CYP1B1;CENPJ
prerank,defense response to bacterium (GO:0042742),0.2915840713886296,0.9321956921387258,0.5714285714285714,0.9208081246319286,1.0,16/105,16.18%,COLEC12;SERPINE1;IL6R;OPTN;OAS2;WFDC3;IL12B;TLR6;CAMP;ANXA3;CEBPB;RNASE7;CXCL13;NLRC4;GSDMD;IL23A
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.3001255021701007,0.9316039206014574,0.5544554455445545,0.9215619452812159,1.0,11/84,11.94%,CELF2;RBFOX1;SON;RBFOX2;SF1;DDX17;HNRNPA1;NUP98;SMU1;WTAP;REST
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.3577148756976567,-0.9314222987923316,0.5605700712589073,0.9194592153954361,1.0,6/15,28.81%,SCYL2;HIP1R;UBQLN2;SNAP91;UNC119;BMP2K
prerank,positive regulation of growth (GO:0045927),0.31285607351467404,0.9313764371667209,0.5774111675126904,0.9214586429060788,1.0,23/64,23.38%,BCL2;TGFBR1;RFTN1;SFRP1;CXCL16;USP47;CDC42;INO80;EGFR;DDX3X;INSR;MTPN;HPN;AKT1;MMP14;TRIM32;PLCB1;DDX49;N6AMT1;EIF4G2;WFS1;EXOSC2;BRAT1
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.3625062035261255,0.9313010956995718,0.5518248175182482,0.9210427481375455,1.0,3/27,2.15%,DCN;BGN;PXYLP1
prerank,cellular response to oxygen-containing compound (GO:1901701),0.2713889692203979,0.930701007769814,0.6397905759162303,0.9217754755388383,1.0,41/291,13.53%,EPHA3;RORA;ROCK2;PID1;DAPK1;SERPINE1;LYN;TPM1;WNT8B;PDGFRA;WNT6;RAPGEF2;MTR;MT3;AXL;SFRP1;PTK7;IGFBP5;CPEB1;PDE3A;ZFP36L1;WNT5B;CPEB3;DPEP1;ERCC6L2;NR1D1;EGFR;RAPGEF1;SLC38A9;LAMTOR2;TNIP2;RRAGD;SLC5A5;IMPACT;SELENOS;PDCD4;PAF1;CD14;CHMP5;NCOA3;CXCL13
prerank,RNA processing (GO:0006396),0.28009497211935097,0.930661644110304,0.6266666666666667,0.9212780962488881,1.0,37/176,18.89%,CELF2;RBMS1;ATXN1;SON;DDX17;TUT7;RBMS2;HNRNPR;RBPMS;NONO;RNASEL;TENT4A;SMU1;DDX23;PRMT9;MAGOHB;TUT4;NOL3;SNRPD2;CDK12;TCERG1;SRSF5;AKAP8L;RBM39;RBM5;RNPC3;RBM6;GEMIN2;TENT4B;SYNCRIP;HNRNPC;PRPF6;SF3B2;SF3B1;METTL3;PRKACA;DICER1
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.3623984436610197,0.930544777570651,0.5493372606774669,0.920946176449705,1.0,9/31,13.48%,STXBP3;SYT9;ADRA2A;CACNA1G;REST;STXBP1;SYT11;SYT12;RAB3GAP1
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.39491531171258787,0.9299280442681896,0.5758620689655173,0.9217138738856125,1.0,3/19,8.81%,NRP1;SFRP1;MAP4K4
prerank,regulation of stem cell differentiation (GO:2000736),0.30576021916518165,0.9298629465601271,0.5891959798994975,0.9212537809322634,1.0,22/89,20.64%,GDNF;RUNX1;SP7;BMPR1A;YAP1;PDGFRA;PSME4;SETD1A;NSUN2;ITCH;KMT2A;TCF12;PSMB5;PSMC2;METTL3;PSMD1;PSMD4;PSME3;YTHDF2;HNRNPU;ZFP36L2;PSMA3
prerank,sensory perception of chemical stimulus (GO:0007606),0.40509936646039646,0.9298436576914257,0.5514834205933682,0.9207126709556355,1.0,1/15,3.29%,GNAS
prerank,chromosome condensation (GO:0030261),-0.2797158499067797,-0.9298025699669035,0.5454545454545454,0.9224340088303375,1.0,23/36,40.07%,MCPH1;NCAPD3;SMC4;TOP2A;GPER1;KMT5A;NCAPH;NCAPG;TTN;PLK1;SET;CDK1;H1-0;BANF2;NCAPG2;ERN2;NUSAP1;DFFB;SMC2;CSNK2A1;CSNK2A2;RB1;NCAPD2
prerank,regulation of muscle contraction (GO:0006937),0.3704481573664005,0.9296902663802971,0.5484848484848485,0.9204635140413115,1.0,6/26,10.48%,ATP1A2;TPM1;TNNT1;TNNC1;TNNT3;ANXA6
prerank,regulation of nucleocytoplasmic transport (GO:0046822),0.4216053610467061,0.9296658765510742,0.5512367491166078,0.9199268339507242,1.0,7/12,21.83%,NEDD4;IFI27;NUP214;BMP4;TPR;AAAS;RBM4
prerank,pulmonary valve morphogenesis (GO:0003184),0.40705267637288184,0.9295788720199185,0.5368782161234992,0.9195285266783813,1.0,2/17,3.81%,ROBO1;NOTCH2
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.3835017846606905,0.9287621520257643,0.5441640378548895,0.9207793437650211,1.0,1/23,0.20%,ATP6V0A4
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.36273619128342505,0.9286341872671292,0.5701219512195121,0.9204830053193789,1.0,4/26,8.85%,PDPK1;ZFP36L1;EGFR;STAT5B
prerank,response to reactive oxygen species (GO:0000302),-0.2607267495974528,-0.9285245769706159,0.6049382716049383,0.9245247814336804,1.0,21/54,22.43%,APOD;PTPRK;PXN;RPS3;HYAL1;MAPK8;SIRT1;JUN;APTX;MAPK3;HIF1A;PTPRN;ADAM9;GPX1;CAT;PDCD10;PLK3;CHUK;PRDX5;MAPK1;SOD2
prerank,positive regulation of cytokine production (GO:0001819),0.2672955318447818,0.9283175417836416,0.6391534391534391,0.9205980282298112,1.0,37/292,12.97%,CCBE1;RORA;ROCK2;SERPINE1;SULF2;RUNX1;PLA2R1;IL6R;IL17D;RFTN1;CCL19;SULF1;IRF1;CYP1B1;PIBF1;IL12B;BATF;TSLP;CD28;SPHK2;EIF2AK3;TLR6;CD200;POLR3A;RAB7B;ARNT;NFAM1;CARD9;SETD4;CEBPB;ADRA2A;RGCC;TBK1;EBI3;STAT6;RIPK2;CD14
prerank,negative regulation of lipid storage (GO:0010888),0.3853136122129062,0.92816824070883,0.5498338870431894,0.9203357108059733,1.0,4/19,9.62%,ABCA1;OSBPL8;ITGB3;ITGAV
prerank,negative regulation of viral life cycle (GO:1903901),0.4108434444845125,0.9279934455675224,0.5459016393442623,0.9201220545496118,1.0,1/15,1.20%,GSN
prerank,genitalia development (GO:0048806),0.43411455105336727,0.9279097606834433,0.5491525423728814,0.919745105099357,1.0,5/12,21.16%,TBX3;LHCGR;SHH;CHD7;TIFAB
prerank,neuron remodeling (GO:0016322),-0.3850114776843666,-0.9278250972015355,0.56,0.9250945379455627,1.0,5/10,22.38%,ADGRB3;SCARF1;APP;ANKS1A;RND1
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.36646449306704515,0.927813665826137,0.5623052959501558,0.9193673475252281,1.0,5/25,13.61%,ACTN2;SLC6A9;ATP1B2;WNK1;PIRT
prerank,regulation of actin nucleation (GO:0051125),0.42785440023268345,0.9278051142094369,0.5645161290322581,0.9188003438229355,1.0,2/12,9.05%,GSN;ARFIP2
prerank,intermediate filament organization (GO:0045109),0.40040185506329595,0.9275583268900108,0.5466893039049237,0.9187379602168256,1.0,4/17,15.84%,BFSP1;DES;KRT9;EPPK1
prerank,DNA double-strand break processing (GO:0000729),0.3858944078874858,0.927433929292174,0.5447019867549668,0.9184155150234713,1.0,12/18,30.64%,UBE2V2;RNF138;ATM;KAT5;EXD2;SMARCAD1;BRCA1;MRE11;RAD50;UBE2N;RBBP8;DNA2
prerank,protein homooligomerization (GO:0051260),0.28819535026422244,0.92685285466798,0.6033857315598549,0.919128888493616,1.0,15/114,10.53%,SLC1A5;TRPA1;SCARA5;MLKL;IKZF4;TDO2;APPL2;RNF213;ALDH1A2;ALS2;CBY1;ZBTB1;CLYBL;TRPM4;CARD9
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.3405901131232092,0.9263149822567173,0.5691176470588235,0.919745773524969,1.0,4/38,3.44%,NEDD9;EPHA4;IL34;GAS6
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.39809356303371707,-0.9262848133609799,0.5657276995305164,0.9278899711240154,1.0,5/10,25.87%,CALM1;CALM3;CBARP;FMR1;CRHR1
prerank,glycerophospholipid biosynthetic process (GO:0046474),-0.21676024542773656,-0.9261911243926295,0.6982758620689655,0.9269085772596158,1.0,48/172,18.61%,PIP5K1B;PLCG2;DGKB;INPP5D;BMX;DGKH;PIK3R6;CPNE3;LPCAT1;SLC44A5;MTMR2;INPP4B;PLEKHA3;MFSD2A;INPP5K;PLEKHA1;INPP5F;AGPAT1;PGS1;MTMR9;PIK3R3;PNPLA3;ARF1;PLA2G4C;ETNK1;SACM1L;DGKG;PCTP;DGKQ;CRLS1;PIK3R5;MTMR6;ARF3;MBOAT7;PIK3C2B;PTDSS1;LPCAT3;PIK3CA;RAB4A;AGPAT5;STARD7;PITPNM3;LPCAT2;DGKZ;PCYT1B;INPP5E;SELENOI;SYNJ1
prerank,lymphocyte differentiation (GO:0030098),0.3097962543925836,0.9261701266854729,0.5740498034076016,0.919469462137868,1.0,10/68,11.11%,RHOH;PBX1;LEPR;KIT;AXL;NHEJ1;GPR89A;GPR89B;NFAM1;IFNK
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.28755906301791984,0.9259483335747545,0.6069364161849711,0.9193581595794187,1.0,21/124,10.75%,GDNF;LYN;TPM1;EPHA8;DTNBP1;APOE;WDPCP;NEDD4;RAPGEF2;CDK16;LRP12;LIMA1;ATXN10;ATP1B2;RAB25;CARMIL1;ARFIP2;BLOC1S1;RYK;PTPRM;MANF
prerank,cellular transition metal ion homeostasis (GO:0046916),0.3010164119560608,0.9259260085221055,0.5984943538268507,0.9188333686938642,1.0,9/91,6.50%,BMP6;CP;SCARA5;SLC30A8;MT3;HEPH;CYBRD1;SLC11A2;ACO1
prerank,activation of GTPase activity (GO:0090630),0.30068907669241596,0.9257790982440752,0.5899632802937577,0.918563276436583,1.0,15/89,13.53%,RABGAP1L;TBC1D4;SYDE2;USP6NL;TIAM2;ARHGAP29;NTF3;ADPRH;NTRK3;SYDE1;TBC1D2B;TAX1BP3;ARHGEF10;SIPA1;CXCL13
prerank,regulation of lamellipodium assembly (GO:0010591),0.34617234892396787,0.9253021731017191,0.5796460176991151,0.9190193397476633,1.0,4/34,8.37%,AUTS2;PIK3R1;CDC42;CAPZB
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.285323563516253,0.9247257642598732,0.6084474885844748,0.9197547449392873,1.0,23/142,13.99%,ADRA1B;SLC8A1;SMAD3;ATP1A2;ADCY5;XCR1;PDGFRA;ACKR2;CCR9;BDKRB2;CACNA1C;AGTR1;LPAR1;DRD3;BCAP31;TRPM4;F2;CLN3;C1QTNF1;YWHAE;CXCR6;CXCL13;DLG4
prerank,piRNA metabolic process (GO:0034587),0.38561698537920436,0.9244056289126735,0.5636942675159236,0.9199227155802934,1.0,4/19,17.50%,TDRD1;PIWIL4;MYBL1;DDX4
prerank,nucleobase-containing compound catabolic process (GO:0034655),-0.2771242125279893,-0.9242636960451017,0.5825242718446602,0.9307120688863636,1.0,17/37,31.14%,ENTPD1;HNRNPD;PNPT1;ENTPD2;SUPV3L1;ENTPD6;ENTPD3;ADPRM;RNASEH1;DNASE1L2;NUDT16;PABPC4;NUDT9;ISG20;ENTPD5;NUDT1;RNASEH2B
prerank,cardiac myofibril assembly (GO:0055003),0.40090700513028954,0.924123389992854,0.5540983606557377,0.9199711170525053,1.0,3/15,3.56%,OBSL1;PDGFRA;PDGFRB
prerank,peptidyl-arginine modification (GO:0018195),0.40403999104962923,0.924084251756562,0.5518945634266886,0.9194759894397195,1.0,1/15,2.07%,ART4
prerank,microtubule anchoring (GO:0034453),0.4214354864715369,0.9233923743507996,0.5672413793103448,0.920410059675603,1.0,2/12,9.48%,DAG1;SAXO2
prerank,negative regulation of MAPK cascade (GO:0043409),0.2959925040381136,0.9233599477819561,0.5825242718446602,0.9199095451610256,1.0,18/87,15.73%,TIMP3;DAG1;LYN;APOE;FBLN1;CDK5RAP3;RANBP9;EMILIN1;IRAK3;EPHB2;SPRY2;SPRED3;IGBP1;CNKSR3;PTEN;BMP4;SPRED1;PIK3R2
prerank,response to hydroxyurea (GO:0072710),0.4310089020732563,0.9231531899780021,0.5633561643835616,0.9198139456654912,1.0,4/11,18.74%,DDI1;RTF2;TIMELESS;ATRX
prerank,positive regulation of cell-cell adhesion (GO:0022409),-0.2741464882585529,-0.9230923934617119,0.5659722222222222,0.9324774950042559,1.0,4/41,2.91%,PODXL;PIEZO1;ANK3;TJP1
prerank,neural crest cell development (GO:0014032),-0.27381437235068395,-0.9228492145300043,0.5947955390334573,0.9318909518246066,1.0,6/44,3.34%,SEMA6D;CDH2;SEMA6A;SEMA7A;ERBB4;TBX1
prerank,hyaluronan catabolic process (GO:0030214),0.3921111424413907,0.9226701429862887,0.565359477124183,0.9203496467946324,1.0,3/18,10.16%,CEMIP;LYVE1;FGF2
prerank,histone methylation (GO:0016571),-0.3045107923680241,-0.9223148568668663,0.5895953757225434,0.9320150265911618,1.0,6/26,14.47%,EZH2;PRMT7;SMYD2;SUV39H1;SMYD1;PRMT6
prerank,regulation of protein polymerization (GO:0032271),0.34311934606168326,0.9222063105054558,0.5601131541725601,0.9208166371285874,1.0,5/35,10.43%,ARHGAP28;PLEKHG2;ARHGAP18;ARL2;TTBK1
prerank,plasma membrane invagination (GO:0099024),0.352754050225283,0.9221848787673445,0.5318518518518518,0.9202923401209011,1.0,5/29,8.97%,GSN;CDC42;SNX33;GULP1;SNX18
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.4021186827960501,0.9215926549237153,0.559016393442623,0.9210089999495105,1.0,6/16,16.71%,GDNF;SALL1;BMP2;FGF2;BMP4;SHH
prerank,negative regulation of nervous system development (GO:0051961),-0.3369551664867758,-0.921572108430914,0.5471698113207547,0.932769505167534,1.0,3/17,5.60%,NOTCH1;B2M;SORL1
prerank,regulation of receptor internalization (GO:0002090),0.3415259442159876,0.9215534303530171,0.562962962962963,0.9205169732288822,1.0,9/35,14.94%,ANGPT1;NTF3;CD63;ARRB1;INSR;EGF;DLG4;RSPO1;SFRP4
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.3741666171607151,0.9214037537327666,0.5650793650793651,0.9202646857327035,1.0,9/22,23.90%,CCNK;CDK12;TCERG1;CCNT2;CDC73;LEO1;SCAF8;CCNT1;CDK13
prerank,aggrephagy (GO:0035973),0.3638465427160871,0.921402395264496,0.5639445300462249,0.919689434329203,1.0,5/27,12.46%,DYNLL1;DYNC1H1;WDR81;PRKN;DYNC1I2
prerank,cytosolic calcium ion transport (GO:0060401),0.3655458760011136,0.9212686109909485,0.5738461538461539,0.9194107400584869,1.0,4/28,9.91%,SLC8A1;MCU;CACNA1C;MICU2
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),-0.3635727703367506,-0.9212491662397334,0.5685785536159601,0.9324077506976018,1.0,5/13,21.57%,SRSF12;LSM2;PRPF31;USP4;CD2BP2
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.3599306718773605,0.9210181975278579,0.5539906103286385,0.9194020902131192,1.0,5/27,9.62%,ABCA1;CSF1;AGTR1;ITGB3;ITGAV
prerank,cellular response to gamma radiation (GO:0071480),0.3966233371421676,0.9209536334381349,0.553921568627451,0.9189777712789101,1.0,2/17,5.51%,YAP1;MAP3K20
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),-0.3144245868721694,-0.9208081917435738,0.5790960451977402,0.932336399570726,1.0,10/21,27.53%,MBOAT1;PLA1A;PLAAT3;LPCAT3;PLA2G4F;PLA2G4E;PLA2G4B;PLA2G5;LPCAT4;MBOAT2
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.3694156147500771,0.9203201539592741,0.5635528330781011,0.9198255352961411,1.0,2/24,7.67%,CEMIP;MYO1C
prerank,regulation of cellular component biogenesis (GO:0044087),0.3367935089946404,0.9197246103909725,0.5720524017467249,0.9205515478290399,1.0,6/39,9.36%,ROCK2;APOE;CCL19;RAPGEF2;SNCAIP;RAPGEF1
prerank,homotypic cell-cell adhesion (GO:0034109),0.34548965661881315,0.919475655017766,0.56973293768546,0.9205415768170089,1.0,11/39,15.81%,PLPP3;GNAS;PDGFRA;MYL12A;TLN1;STXBP3;VCL;ITGB3;STXBP1;FLNA;FIBP
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),-0.34890436032039723,-0.9192068150561029,0.5819070904645477,0.9351083587314376,1.0,5/16,18.79%,PIGP;PIGB;PIGL;DPM2;PIGV
prerank,histone H4-K5 acetylation (GO:0043981),0.4096050225043989,0.9191441304229463,0.5750421585160203,0.9201495448129093,1.0,7/15,24.63%,OGT;JADE1;WDR5;KANSL1;MEAF6;KANSL3;JADE2
prerank,histone H4-K8 acetylation (GO:0043982),0.4096050225043989,0.9191441304229463,0.5750421585160203,0.9201495448129093,1.0,7/15,24.63%,OGT;JADE1;WDR5;KANSL1;MEAF6;KANSL3;JADE2
prerank,pulmonary valve development (GO:0003177),0.39541409633232605,0.918960977381822,0.5572139303482587,0.9199482217551999,1.0,2/18,3.81%,ROBO1;NOTCH2
prerank,fatty acid transport (GO:0015908),0.39458012730426817,0.9188986602750518,0.5698234349919743,0.9195361193203441,1.0,2/17,3.47%,ACSL1;APOE
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.29993289298284176,0.9187146853087751,0.6061349693251534,0.9193719415467058,1.0,15/88,10.08%,SH3D19;DNAJC6;DTNBP1;TXNDC5;MYO1B;GOLGB1;MON2;ARFGEF2;EPS15;ARRB1;AP1G2;COMMD1;BLOC1S1;AP1M1;VPS35L
prerank,negative regulation of myotube differentiation (GO:0010832),-0.3696610710107562,-0.9186841908695006,0.5874439461883408,0.9352517549674522,1.0,2/12,2.63%,NOTCH1;CCN3
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.3221533776962355,0.917997864597633,0.5718194254445964,0.9203146550682579,1.0,5/49,6.31%,LDLRAD4;DACT1;PMEPA1;CDC42;SRC
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.3007686715718205,-0.9178905110254506,0.5649717514124294,0.9360815804909157,1.0,5/23,13.49%,ELOVL7;FAR2;ELOVL5;TECR;HACD2
prerank,cellular response to inorganic substance (GO:0071241),0.37686033332688845,0.9171857343151356,0.5463258785942492,0.9214309953495868,1.0,7/21,18.74%,MTR;MT3;DPEP1;DDI1;RTF2;TIMELESS;ATRX
prerank,amyloid-beta metabolic process (GO:0050435),0.40077016203045307,0.9171606829745427,0.5859766277128547,0.920913428412493,1.0,7/16,19.71%,APEH;APH1B;MGAT3;DYRK1A;PSEN2;ABCA7;IDE
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.2872663827717669,0.9170786903440983,0.6129032258064516,0.9205233565823757,1.0,11/124,6.15%,TCF7L2;PPP3CA;FZD2;WNT4;SMURF2;PRICKLE1;PSME4;FZD1;SFRP1;TNRC6B;CDC42
prerank,oligodendrocyte differentiation (GO:0048709),0.3833378277754881,0.9170782735190707,0.5467289719626168,0.9199530199302182,1.0,5/19,16.71%,SLC8A3;EIF2B4;NSUN5;EIF2B3;SHH
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.39798423005625266,-0.9169907913663825,0.5652173913043478,0.9371997106547796,1.0,3/10,14.14%,PRKG1;RDX;CEACAM1
prerank,phosphatidic acid metabolic process (GO:0046473),0.3269305663267622,0.9167508675460312,0.5718194254445964,0.920102171378001,1.0,6/48,8.11%,PLD1;PLA2G4A;GPD1;AGPAT3;DDHD2;PLD2
prerank,phosphate ion transmembrane transport (GO:0035435),-0.36666871131447504,-0.9167349193071602,0.5861297539149888,0.9366075080543581,1.0,4/12,15.86%,SLC37A3;SLC25A30;SLC25A11;XPR1
prerank,regulation of cell-substrate adhesion (GO:0010810),-0.2728557418197683,-0.9167086195797833,0.6130268199233716,0.9354476201105149,1.0,14/42,24.35%,NOTCH1;SPOCK1;FZD4;VIT;EMP2;JAK2;NF1;CORO1C;LIMS1;NDNF;CORO2B;MINK1;TBCD;DMTN
prerank,positive regulation of fat cell differentiation (GO:0045600),-0.26337274816116596,-0.9165864344356341,0.6254681647940075,0.934534226102272,1.0,6/47,4.35%,ZBTB16;CREB1;SIX1;PPARD;LRP5;CMKLR1
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.26515471436672494,0.9163995423249244,0.6758767268862912,0.9202893743210708,1.0,90/314,23.51%,SPSB1;TBL1XR1;HECW2;FBXO48;FBXL17;UBR2;FBXL19;NEDD4;RFFL;SMURF2;CDC20B;PSME4;FAF2;BFAR;DERL1;PML;CUL4B;UBXN4;NFE2L2;DERL3;UBE4B;CUL5;SIRT2;UBXN2B;UBE2U;FBXL3;RNF185;ARRB1;UBXN11;ECPAS;ANAPC5;PRKN;ITCH;IFI27;FOXRED2;FBXO9;KBTBD7;ERCC8;FBXO4;FBXL12;SELENOS;FEM1C;BTRC;TNFAIP1;APPBP2;AMFR;FBXO38;UBE2D1;HACE1;HUWE1;TMUB1;AUP1;NHLRC3;SPOP;UBR3;AMN1;PSMB5;PSMC2;KAT5;TMEM67;RNF34;PSMD1;ERLIN1;PSMD4;NSFL1C;PSME3;FBXL18;FEM1B;KCTD13;DCAF11;CDC23;PSMA3;ZSWIM8;DDIT3;UCHL1;AURKA;JKAMP;BIRC2;RNF216;BAG6;ANAPC4;KLHL20;WFS1;PSMA2;HSPA5;FBXW11;ATXN3;PSMC5;ERLIN2;ARMC8
prerank,DNA modification (GO:0006304),0.37716089707371064,0.916224133731285,0.5766062602965404,0.9201405773747203,1.0,4/22,12.17%,OGG1;NEIL1;MBD4;TERF2
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.3839217493798335,0.916181006104931,0.5573505654281099,0.9196551514374601,1.0,6/20,20.32%,WNT4;SIK1;NCOR1;CDA;GCK;BCKDK
prerank,heterochromatin organization (GO:0070828),-0.354194116886249,-0.9157284673709757,0.5655339805825242,0.9355556049203229,1.0,2/14,3.93%,MECOM;PRDM16
prerank,neuronal action potential (GO:0019228),-0.3109770063617463,-0.9156457269034185,0.592797783933518,0.9345580050916112,1.0,10/22,20.84%,ANK3;SCN1A;SCN3A;KCNMB2;SCN2A;KCNA2;CACNA1H;GPER1;MYH14;SCN8A
prerank,protein polymerization (GO:0051258),-0.2488544321448642,-0.9153747508632893,0.6311475409836066,0.9340416689263743,1.0,25/56,24.60%,COBL;DIAPH1;SPIRE1;DIAPH3;GPX4;JAK2;WASHC5;UBE2K;MSRB2;FAM107A;TPPP3;TTC17;TRPV4;CASQ2;ARL6;UBE2S;TRIM6;CORO7;PSTPIP1;PREX1;AIF1;CASQ1;CHMP4B;CHMP4A;MID1IP1
prerank,positive regulation of cell death (GO:0010942),0.31504151506671957,0.9153267185194535,0.5945945945945946,0.9209553320825689,1.0,8/59,9.03%,LRP1;EFNB2;SLC6A13;MT3;AXIN2;RARG;LRRK2;PICALM
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),-0.27799115210767855,-0.9150841767388005,0.5947712418300654,0.9335951498308653,1.0,8/35,10.07%,NLGN1;CDH12;ATP2C1;CDH6;CDH8;CDH9;CDH13;CDH10
prerank,mesenchyme morphogenesis (GO:0072132),-0.33817794482384766,-0.9149034824912399,0.5558441558441558,0.9328268704061888,1.0,5/17,6.42%,NOTCH1;NOS3;ACVRL1;TGFB2;TBX2
prerank,positive regulation of dephosphorylation (GO:0035306),-0.2872538168609674,-0.9148874967453099,0.5921450151057401,0.9316584072379248,1.0,8/27,11.49%,PPP1R16B;PPIA;PPP2R5A;SPPL3;CALM1;MTMR9;CALM3;TGFB1
prerank,central nervous system development (GO:0007417),0.2662166332798598,0.914808708733411,0.6733828207847296,0.9214773179798169,1.0,28/250,9.65%,EPHA7;ATXN1;GSN;PBX1;ARNT2;SLC8A3;HSPG2;ZIC1;PCDH18;SHROOM2;NKX2-1;NFIB;SMO;ZIC4;CDK5RAP3;SYNJ2;ZIC2;LIG4;TBX3;SMARCA1;ADGRA2;SH3GL1;NHEJ1;SETD1A;EEF1AKMT4-ECE2;PRKN;MARCKSL1;GLIS2
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.307156808841396,-0.9148049289243276,0.6046511627906976,0.9306483332467835,1.0,12/24,25.99%,ACKR3;KDM1A;TPT1;SIRT1;BCL2L1;CD44;CLU;TRIAP1;SNAI2;CCAR2;MIF;SNAI1
prerank,glycerol metabolic process (GO:0006071),-0.40118764190941153,-0.9147593748306113,0.5858823529411765,0.9295815884305048,1.0,6/10,37.71%,TPI1;TKFC;GOT1;COQ2;PDXP;PGP
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),-0.29916575076917035,-0.9145630169328889,0.6060606060606061,0.9288527121193508,1.0,4/25,6.57%,ANKRD13A;SDCBP;MTMR2;RIN3
prerank,clathrin-dependent endocytosis (GO:0072583),-0.30077773428968835,-0.9144676797195916,0.5940298507462687,0.9278615016811322,1.0,11/26,23.11%,FNBP1L;SGIP1;GAK;ITSN2;INPP5F;AP2A1;CLTB;DLL1;LMBRD1;SNAP91;AP2M1
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.433137618839457,0.9141220786789824,0.5706618962432916,0.9223704680207501,1.0,1/11,2.89%,PIGR
prerank,regulation of protein kinase A signaling (GO:0010738),0.3774592669197607,0.913991864592687,0.5652173913043478,0.9220859541916664,1.0,3/20,6.60%,ADGRV1;AKAP7;LRRK2
prerank,glucan biosynthetic process (GO:0009250),-0.3707021377911909,-0.9133665818652915,0.5847255369928401,0.9282761429049855,1.0,3/12,6.98%,GBE1;GYS1;UGP2
prerank,glycogen biosynthetic process (GO:0005978),-0.3707021377911909,-0.9133665818652915,0.5847255369928401,0.9282761429049855,1.0,3/12,6.98%,GBE1;GYS1;UGP2
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.39843608095664057,0.9132475978188442,0.5680379746835443,0.9231486368444255,1.0,3/15,10.16%,PDPK1;SMAD1;FGF2
prerank,cellular protein localization (GO:0034613),0.2675022654217286,0.912979059916646,0.6936842105263158,0.9231727422355649,1.0,52/285,16.17%,WLS;GJA1;FBLN5;RABGAP1L;TBC1D4;ANGPT1;USP6NL;SEC31A;SH3PXD2B;TMED1;VPS26C;AXIN2;RAB23;STXBP3;STX16;NPHP1;COX18;ARFGAP3;LRRK2;ADPRH;VCL;IFT27;CD63;RAB22A;CROCC;COPZ2;EGFR;ARFIP2;CSRP3;TBC1D2B;ARL1;GGA2;TMED4;LAMTOR2;TM9SF2;RRAGD;STXBP1;TLK1;COPA;WIPI1;RAP2A;USO1;ARF4;FLNA;SNX9;IFT22;ARF6;EPB41L3;STX1B;ARL5A;SNX31;RAB19
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.3941880302773284,0.9124537482121985,0.5584843492586491,0.9237572091598629,1.0,4/15,15.91%,FAF2;DERL1;SELENOS;AUP1
prerank,membrane lipid catabolic process (GO:0046466),-0.39219236031865595,-0.9122842863535358,0.5829596412556054,0.929836249594881,1.0,2/10,3.32%,ENPP2;PPT1
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.33674136541973626,0.9122164038948423,0.5780346820809249,0.9236899575693339,1.0,8/33,16.32%,AREG;TGFA;EPGN;HBEGF;ADRA2A;EGF;PDE6G;AKT1
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.39632595230075185,0.9119938611879915,0.5743243243243243,0.92360037565144,1.0,5/15,20.48%,ZFP36L1;BCL2L11;REST;HNRNPU;ZFP36L2
prerank,cellular response to DNA damage stimulus (GO:0006974),0.2650058530774683,0.9117492153868293,0.7004175365344467,0.9235507246376812,1.0,106/336,24.39%,LYN;BCL2;SETD7;YAP1;PDS5B;MOAP1;OGG1;PSME4;HPF1;PCLAF;BCL6;USP47;CBX3;INO80;PML;RAD51B;CUL4B;SPRTN;SMC5;BATF;TRIP12;REXO4;UBE2U;ZBTB38;BRSK1;UBA7;RECQL5;KMT5B;BCL2L11;ZBTB4;ZBTB1;CCNK;SMC6;POLE3;STK11;BAZ1B;PHF1;MRNIP;TAOK3;UFL1;IKBKE;ERCC8;RAD18;FANCC;MBD4;UVRAG;MNAT1;BOD1L1;MAP2K6;MTREX;USP10;TAF9;HMCES;RAD51D;UBE2E2;RTEL1;UBA6;MAPKAPK2;CASP9;CBX5;UBR5;XRCC2;TIMELESS;ATM;NIPBL;ALKBH1;ZBTB40;WAC;METTL3;XPA;ENDOV;RAD54L;NCOA6;SUMO1;RFC5;NRDE2;AATF;ETAA1;STK33;RBBP5;FAN1;USP3;UBE2T;MUTYH;DDIT3;RMI2;NSMCE4A;TAOK1;ERCC3;APLF;FANCA;XIAP;LIG1;BRCA1;MACROD1;BRAT1;VCPIP1;PPP1R15A;PSEN1;SETX;POLI;MSH6;NABP2;MAPK12;MASTL;MRE11
prerank,cellular response to heat (GO:0034605),0.3437560718987134,0.9115385583590945,0.5900439238653001,0.9234059962957208,1.0,1/35,0.14%,POLR2D
prerank,retinoic acid receptor signaling pathway (GO:0048384),0.44296615223620767,0.9113804427902376,0.5877342419080068,0.9231899802351704,1.0,4/10,15.02%,RARB;RARG;ACTN4;RXRA
prerank,regulation of tumor necrosis factor production (GO:0032680),0.28337174243448554,0.9107105801009958,0.6382730455075846,0.9240741198932583,1.0,14/112,13.46%,IGF1;GAS6;CCL19;OAS2;ARFGEF2;IL12B;SPHK2;IRAK3;EPHB2;SETD4;CD33;SELENOS;CD14;SYT11
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.37170883909458596,0.9105360502616048,0.5684713375796179,0.9239051305311687,1.0,3/21,4.91%,WNT8B;FZD2;FZD1
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.3851274829193939,0.9103004332886906,0.5950155763239875,0.9237946559363729,1.0,4/20,12.03%,PID1;DAB2;PICALM;RHOQ
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.3599899882819864,0.9101415927718304,0.5900900900900901,0.9235510345957408,1.0,9/26,16.32%,PYCR1;LRRK2;NFE2L2;PRKN;REST;NOL3;VNN1;BAG5;AKT1
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.38956522256604703,0.9101414721234852,0.5894039735099338,0.9229861715776394,1.0,4/17,8.83%,PBX1;MAML3;RBPJ;KAT2B
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.34287980225666626,0.9099982594605305,0.5742857142857143,0.9227092885410382,1.0,11/33,19.69%,MN1;APPL2;INO80;GLI1;PAF1;PTEN;CDC73;PHB2;APPL1;CDKN1B;PSME3
prerank,regulation of neuron apoptotic process (GO:0043523),0.2955863730517074,0.9098373614301017,0.6213592233009708,0.9225045222710822,1.0,8/96,5.01%,EPHA7;GDNF;BCL2;APOE;NUPR1;MT3;NTF3;LIG4
prerank,positive regulation of inflammatory response (GO:0050729),0.29450445377364165,0.909476274224122,0.6217228464419475,0.9227112435389636,1.0,20/86,17.96%,SERPINE1;OSMR;NUPR1;IL12B;CEBPA;AGTR1;TSLP;NMI;CCN4;SETD4;NAPEPLD;PDCD4;ETS1;MDK;TNFRSF1A;CD47;IL23A;CX3CL1;TNIP1;IL18
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.3610731002414957,0.9094489453481278,0.5822222222222222,0.9222069838291814,1.0,5/26,12.16%,ATP1A2;GSTM2;DRD3;ADRA2A;YWHAE
prerank,digestive tract morphogenesis (GO:0048546),0.42064292401968423,0.9092060086202927,0.5672131147540984,0.9221838693181582,1.0,6/14,18.20%,FGFR2;PDGFRA;EPHB3;GLI1;NIPBL;SOX11
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),-0.23999320127354726,-0.9088585862552065,0.6635071090047393,0.9373705123126842,1.0,26/76,24.70%,SMURF1;RNF144B;CBFA2T3;RNF144A;RBX1;TRIB2;TAF1;GSK3A;HSPBP1;ZYG11B;RAD23A;COP1;RACK1;BBS7;DVL1;RNF14;CLU;DDRGK1;GSK3B;GABARAP;RCHY1;USP5;NUB1;CSNK1D;VCP;DDA1
prerank,fatty acid oxidation (GO:0019395),-0.2500080060715002,-0.908586030741859,0.6622807017543859,0.9368222665807121,1.0,11/57,21.04%,ADIPOR2;PPARD;ECI2;ECHDC1;PPARGC1A;ACAD11;ABCD3;ACOX1;ABCD4;MTLN;ACAA2
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.38870344031264914,0.908212996729644,0.6040372670807453,0.9237348259366197,1.0,4/19,20.07%,APOE;COLQ;RAPSN;CHRNB2
prerank,cytokine-mediated signaling pathway (GO:0019221),0.2570181950926773,0.9071366469075977,0.7375886524822695,0.925441201882858,1.0,55/532,10.16%,GREM2;COL1A2;RORA;GHR;PIK3R1;IL31RA;BCL2;IL6R;LEPR;IL34;PELI2;OSMR;ZEB1;MMP2;KIT;SP100;YAP1;NUMBL;CCL19;IRAK2;CNN2;CSF1;NCAM1;APPL2;BRWD1;IRF1;EDAR;MT3;PSME4;OAS2;BCL6;CCL4;CDC42;SRC;PML;SDC1;IL12B;BATF;CEBPA;TSLP;IL13RA1;IL15RA;IRAK3;BCL2L11;MAP3K8;STAT5B;CNTFR;ACTN4;CAMK2B;RAPGEF1;LTBR;STAT2;RNASEL;IFI27;FGF2
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),-0.3795498465481773,-0.9071267276600937,0.5693069306930693,0.9392493545809149,1.0,2/11,5.92%,CAV1;PTPRT
prerank,gluconeogenesis (GO:0006094),0.3363135145188344,0.9070524767167963,0.594059405940594,0.9250370010772466,1.0,3/39,8.02%,RBP4;MDH2;ENO2
prerank,coenzyme A metabolic process (GO:0015936),0.4113494804611042,0.9067580553219006,0.5803108808290155,0.9251305212895112,1.0,8/14,30.12%,NUDT7;PANK1;COASY;SLC25A16;DCAKD;ACOT7;PANK2;ACLY
prerank,regulation of monocyte chemotaxis (GO:0090025),0.35954900882608043,0.9065903933425442,0.5907692307692308,0.9249166581783788,1.0,2/24,1.77%,SERPINE1;LYN
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.39881366804236473,0.9061382825207396,0.5676567656765676,0.9253670679453805,1.0,3/13,6.96%,PYCR1;LRRK2;NFE2L2
prerank,cellular senescence (GO:0090398),0.35874048811298476,0.9060786058257592,0.5705521472392638,0.9249380628493753,1.0,6/27,12.17%,TBX3;PML;SMC5;MAP2K1;SMC6;TERF2
prerank,inositol phosphate dephosphorylation (GO:0046855),0.42528590250785403,0.90593769193689,0.5746140651801029,0.9241252272960829,1.0,2/11,4.32%,INPP5A;SYNJ2
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.42528590250785403,0.90593769193689,0.5746140651801029,0.9241252272960829,1.0,2/11,4.32%,INPP5A;SYNJ2
prerank,muscle cell migration (GO:0014812),-0.39091525446854375,-0.9059276903335417,0.5976190476190476,0.9410368011240057,1.0,5/10,21.47%,CCN3;SIX1;ITGB1BP1;ROCK1;MEGF10
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.32155532168553425,-0.9058142135660839,0.5934343434343434,0.9401086421717733,1.0,8/19,18.32%,DLG2;CLIC4;LRRC7;SCRIB;PATJ;ERBIN;SYNJ2BP;MTCL1
prerank,regulation of response to external stimulus (GO:0032101),0.2823563979124356,0.9052957297449039,0.6578341013824884,0.9249525762747828,1.0,12/121,6.94%,ADAMTS12;AHSG;PTGES;CASP12;PDGFRA;EFNB2;APPL2;IRF1;BCL6;ADGRA2;AGTR1;GUCY2D
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.3425644475147453,-0.9051764898161135,0.5961995249406176,0.9405919852236582,1.0,7/15,25.82%,FAM98B;CLP1;ERN1;CSTF2;TSEN54;TSEN34;CPSF1
prerank,acetyl-CoA metabolic process (GO:0006084),0.3998413573168555,0.9050581864969484,0.5816666666666667,0.9248942084660796,1.0,3/15,5.14%,TDO2;MVK;NUDT7
prerank,mitotic chromosome condensation (GO:0007076),-0.3012194494435511,-0.905037868353402,0.5933147632311978,0.9397462577436385,1.0,17/26,40.07%,MCPH1;NCAPD3;SMC4;KMT5A;NCAPH;NCAPG;TTN;PLK1;SET;CDK1;NCAPG2;NUSAP1;SMC2;CSNK2A1;CSNK2A2;RB1;NCAPD2
prerank,regulation of cellular senescence (GO:2000772),-0.2923437377071445,-0.9046367952031052,0.6217008797653959,0.9396147596368818,1.0,8/28,15.46%,CDK6;B2M;PNPT1;VASH1;CGAS;SIRT1;ABI3;MAP3K3
prerank,Notch signaling involved in heart development (GO:0061314),-0.3854992879593419,-0.9045764069351957,0.5924170616113744,0.938560563576727,1.0,8/11,25.99%,NOTCH1;HEY2;GALNT11;HEY1;DLL4;HEYL;SNAI2;SNAI1
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.3037679437838288,0.904097630335475,0.6137566137566137,0.9263896627778704,1.0,14/65,14.13%,ERRFI1;AREG;TGFA;EPGN;CDC42;EPS15;EGFR;SPRY2;HBEGF;EPS15L1;PTPN3;EGF;MVP;PDE6G
prerank,Fc receptor signaling pathway (GO:0038093),0.2857742182407567,0.9040815761021253,0.6163895486935868,0.9258690648518313,1.0,7/110,4.77%,PDPK1;PIK3R1;LYN;PPP3CA;PIGR;KIT;PSME4
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.31420272564893653,0.9036634521377149,0.6155913978494624,0.9262156709490956,1.0,7/56,8.97%,ROCK2;SON;KIF20A;MYH10;EFHC1;SNX33;SNX18
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.36841488480864837,-0.9030709648016167,0.5751173708920188,0.9399476972639196,1.0,8/11,31.94%,CALM1;CALM3;CASQ2;FKBP1A;CALM2;SRI;FKBP1B;GSTO1
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.36841488480864837,-0.9030709648016167,0.5751173708920188,0.9399476972639196,1.0,8/11,31.94%,CALM1;CALM3;CASQ2;FKBP1A;CALM2;SRI;FKBP1B;GSTO1
prerank,response to zinc ion (GO:0010043),0.36425056525358074,0.9027861522689282,0.5810593900481541,0.9274768731077606,1.0,4/25,5.15%,PAM;SLC30A8;MT3;SLC30A2
prerank,response to unfolded protein (GO:0006986),0.3170892195622016,0.9025342941050338,0.6185852981969486,0.9274526346666135,1.0,18/48,24.70%,OPTN;DERL1;SERPINH1;PRKN;HSPB7;HSPA9;TM7SF3;TOR1B;TMBIM6;ERP44;HSPB2;HSF1;DDIT3;HSPA14;HSPA5;DNAJA1;HSPA4;BAG3
prerank,endocardial cushion morphogenesis (GO:0003203),-0.3271500377239266,-0.9023971045775383,0.5725190839694656,0.940468299234842,1.0,6/18,9.69%,NOTCH1;NOS3;ACVRL1;TGFB2;TBX2;TGFBR2
prerank,neuromuscular process (GO:0050905),0.3956677442180824,0.9023655178904195,0.6009771986970684,0.9272688732138805,1.0,1/16,0.51%,MYCBP2
prerank,positive regulation of telomerase activity (GO:0051973),-0.2847451878928399,-0.9022750651686419,0.6340694006309149,0.939590937971256,1.0,7/33,16.68%,NEK7;HSP90AB1;PKIB;KLF4;NVL;MAPK3;PNKP
prerank,glycosphingolipid metabolic process (GO:0006687),0.32677310199262904,0.9018875449015475,0.6141843971631206,0.9277170481434371,1.0,6/42,10.18%,ST6GALNAC5;ST3GAL5;LARGE1;SMPD2;B3GALNT1;ST6GALNAC6
prerank,vasoconstriction (GO:0042310),0.4217239152447152,0.9017139557406001,0.5769230769230769,0.9275327382678529,1.0,1/11,1.14%,SLC8A1
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.31862582503179304,0.9016513293573476,0.6024759284731774,0.9271051780230445,1.0,5/54,3.73%,PDPK1;ANGPT1;FGFR1;APOE;ANGPT2
prerank,cellular response to ATP (GO:0071318),-0.35385469615016213,-0.9016082941131718,0.5742092457420924,0.940076202782155,1.0,2/14,6.97%,P2RX7;TAF1
prerank,negative regulation of protein metabolic process (GO:0051248),0.3197798140749174,0.9015640975484954,0.5915875169606513,0.9267275295774832,1.0,12/48,16.75%,APOE;LDLR;SIRT2;IRAK3;EGFR;SNX12;ITGB3;ITGAV;BANP;FLNA;AGAP2;VBP1
prerank,negative regulation of protein transport (GO:0051224),0.36164284333944946,0.9015094875337567,0.5900900900900901,0.9262857315202229,1.0,9/25,22.56%,APOE;IL12B;DRD3;SNX12;SERGEF;RHBDF2;DPH3;RSAD2;CYP51A1
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.23272570569734377,-0.9013158180296524,0.6712962962962963,0.9395925597766394,1.0,26/73,30.04%,PTPRJ;IFIH1;THBS1;PLCG2;IL33;LBP;ARHGEF2;JAK2;APP;NOD2;PTPRC;TLR4;CD86;CLU;DHX9;FZD5;AGER;TWIST1;IFNGR1;MIF;TMEM106A;C1QTNF4;LPL;TLR1;IL1A;HSPB1
prerank,dendritic cell chemotaxis (GO:0002407),0.39342721560918503,0.9012135661750686,0.5735056542810986,0.9263481952829695,1.0,2/14,9.40%,CCL19;TRPM4
prerank,monocyte differentiation (GO:0030224),0.43283727669404337,0.901142693909397,0.5834829443447038,0.9259570728575647,1.0,1/10,1.75%,IL31RA
prerank,tryptophan catabolic process (GO:0006569),0.42035761209452865,0.901138332744483,0.5775862068965517,0.9254088513472641,1.0,2/11,6.77%,TDO2;KYNU
prerank,negative regulation of innate immune response (GO:0045824),0.3413422802151332,0.9006412546851913,0.6282420749279539,0.9259064553802827,1.0,11/34,20.22%,SERPING1;DCST1;NMI;IRAK3;STAT2;MUL1;DHX58;METTL3;TRIM21;YTHDF2;SUSD4
prerank,regulation of platelet activation (GO:0010543),0.37217556328082285,0.90060839035596,0.5773993808049536,0.925422116969055,1.0,6/21,12.06%,LYN;PDGFRA;APOE;PLA2G4A;F2;C1QTNF1
prerank,negative regulation of catabolic process (GO:0009895),0.3253217701274371,0.9002909905822405,0.6078697421981004,0.9255577848375679,1.0,12/47,16.24%,NUPR1;CST3;SIRT2;NCOR1;IRAK3;EGFR;SNX12;ADRA2A;BANP;HDAC4;FLNA;AGAP2
prerank,regulation of gene silencing by miRNA (GO:0060964),0.308901846793506,0.9002022695957536,0.6325224071702945,0.9251956189459123,1.0,8/62,11.57%,POLR2D;NUP107;NUP42;WTIP;TNRC6A;POLR2C;NUP98;RAE1
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.40370001599585326,0.9000237094041037,0.5959252971137521,0.9249958363455728,1.0,9/14,26.42%,CHKB;ETNK2;LPIN3;CEPT1;LPIN2;PCYT2;SLC27A1;PISD;LPIN1
prerank,neutral amino acid transport (GO:0015804),-0.294902963727063,-0.89997720787508,0.6274509803921569,0.9417184790452299,1.0,8/28,13.96%,SLC6A6;SLC7A5;SLC38A5;SLC1A1;SLC43A2;SLC36A4;SLC3A2;SLC1A4
prerank,positive regulation of neuron migration (GO:2001224),-0.37719877896743814,-0.8999266026992829,0.5925925925925926,0.9406734815737295,1.0,5/11,20.83%,SEMA6A;ARHGEF2;KIF20B;SHTN1;DAB2IP
prerank,cellular protein catabolic process (GO:0044257),0.3068713672643675,0.899592135361186,0.6059817945383615,0.9253248902551152,1.0,10/59,13.35%,ADAMTS12;CTSH;CTSF;CLPX;PRKN;CLPP;RSPRY1;CPA2;CTSZ;CTSL
prerank,positive regulation of interleukin-13 production (GO:0032736),0.4284049155256993,0.8988779957620019,0.573943661971831,0.9261969774831197,1.0,4/10,21.57%,TSLP;SPHK2;IL18;LGALS9
prerank,hemopoiesis (GO:0030097),0.2931085853839713,0.8986944725329805,0.6315136476426799,0.9260350988842273,1.0,12/87,6.86%,TGFBR3;RUNX1;PGM3;MFAP5;FGFR2;KIT;RUNX2;NOTCH2;SFRP1;ETV6;FUT10;CEBPA
prerank,positive regulation of ruffle assembly (GO:1900029),-0.353480890934038,-0.8978825416758465,0.6042154566744731,0.9446031599001913,1.0,2/13,7.20%,NLGN1;EPS8L2
prerank,actin filament-based transport (GO:0099515),0.36451393890639583,0.897713885161094,0.5945945945945946,0.9275041671060135,1.0,4/21,9.28%,SYNE2;MYO1B;MYO1C;ACTN4
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.32685907562895455,0.897494602574112,0.6229508196721312,0.9274106419773429,1.0,7/39,12.37%,BMP6;APOA1;BMP2;MYADM;MIA3;RGCC;WNK1
prerank,mitotic nuclear membrane organization (GO:0101024),-0.254122041297028,-0.8971261442695605,0.6730769230769231,0.9441401019428649,1.0,22/51,33.49%,NUP93;NUP35;NUP160;VRK1;PPP2R2A;RANGAP1;EMD;SEC13;NUP155;VPS4A;CCNB2;CHMP2B;NUP85;CHMP4B;CHMP4A;NUP43;CHMP4C;CDK1;NUP37;LBR;LEMD2;CC2D1B
prerank,mitotic nuclear membrane reassembly (GO:0007084),-0.254122041297028,-0.8971261442695605,0.6730769230769231,0.9441401019428649,1.0,22/51,33.49%,NUP93;NUP35;NUP160;VRK1;PPP2R2A;RANGAP1;EMD;SEC13;NUP155;VPS4A;CCNB2;CHMP2B;NUP85;CHMP4B;CHMP4A;NUP43;CHMP4C;CDK1;NUP37;LBR;LEMD2;CC2D1B
prerank,cellular response to interleukin-1 (GO:0071347),0.2713595734887077,0.8971162924963123,0.6451612903225806,0.9276472206046114,1.0,11/143,8.60%,ADAMTS12;PTGIS;PELI2;CCL19;IRAK2;PSME4;SFRP1;CCL4;NR1D1;IRAK3;MAP3K8
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.379984541439595,0.8966758500167857,0.6028257456828885,0.9280164016703571,1.0,8/19,23.42%,SREBF1;PRKN;VDAC1;HTT;ATP13A2;HAX1;HDAC6;SREBF2
prerank,cytoplasmic sequestering of protein (GO:0051220),0.4076129353493529,0.8966003735568635,0.5741056218057922,0.9276172860850033,1.0,3/13,15.02%,MDFI;FLNA;SUFU
prerank,tRNA export from nucleus (GO:0006409),-0.2776245541451061,-0.896282371041924,0.6296296296296297,0.943876809621949,1.0,11/32,22.14%,NUP93;NUP35;NUP153;NUP160;NUP54;SEC13;NUP155;RANBP2;NUP88;NUP62;NUP85
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.2776245541451061,-0.896282371041924,0.6296296296296297,0.943876809621949,1.0,11/32,22.14%,NUP93;NUP35;NUP153;NUP160;NUP54;SEC13;NUP155;RANBP2;NUP88;NUP62;NUP85
prerank,negative regulation of catalytic activity (GO:0043086),-0.30702492344454946,-0.8960041453296781,0.6149732620320856,0.9433530817872839,1.0,5/24,11.74%,NOTCH1;NOSIP;NOS1;TMBIM1;SIRT1
prerank,negative regulation of bone remodeling (GO:0046851),-0.3702926322946135,-0.8959480216016902,0.6227272727272727,0.9423127443893426,1.0,3/11,11.50%,UBASH3B;P2RX7;TNFAIP3
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.3398708052118138,-0.8956855702625843,0.6058201058201058,0.9418007725810297,1.0,7/16,26.03%,SHLD1;CGAS;PARPBP;POLQ;HELB;SHLD2;KLHL15
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),-0.3469122320872333,-0.8955518731812483,0.6096938775510204,0.9409347430643447,1.0,8/14,34.42%,RPS3;CD81;NECTIN2;CARD11;RAB29;IKBKG;TRAT1;CD226
prerank,negative regulation of cell adhesion (GO:0007162),0.3020814458474493,0.895240271076666,0.6201044386422977,0.9299395349344809,1.0,16/72,14.29%,PLXNA2;ANGPT1;SERPINE1;RIPOR2;SEMA5A;FBLN1;CYP1B1;DSCAM;EPHB2;MIA3;PLXNC1;SIPA1;DACT2;PLXNA1;MDK;PLXNB2
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.2921369511482971,0.8950762968548297,0.6372549019607843,0.9297284706811597,1.0,16/80,15.38%,DENND2A;BAIAP3;RHOBTB3;LMAN1;STX16;RBSN;DENND5A;GOSR2;HEATR5A;SNX12;RAB7B;ARL1;TRAPPC10;TMEM87B;BET1L;PIKFYVE
prerank,neuron fate commitment (GO:0048663),0.39816604678788803,0.8950609160762858,0.5927750410509032,0.9292127502716041,1.0,2/14,3.57%,ASCL1;TGFBR1
prerank,immunoglobulin mediated immune response (GO:0016064),0.4220328747775629,0.8948617767922233,0.5790378006872853,0.9290818628203744,1.0,2/10,10.53%,GAPT;CARD9
prerank,cardiac ventricle development (GO:0003231),-0.3099213665407256,-0.8945653649898682,0.6180371352785146,0.9422208041883193,1.0,9/20,21.70%,NOTCH1;PDE2A;HEY2;HES1;STRA6;HEY1;DLL4;HEYL;GJA5
prerank,sterol biosynthetic process (GO:0016126),0.3421319831699159,0.8944731977365713,0.6046852122986823,0.9293658175912939,1.0,5/33,9.33%,PRKAG2;INSIG2;APOA1;MVK;IDI1
prerank,response to thyroid hormone (GO:0097066),0.4127172437174357,0.8941707628632255,0.5735056542810986,0.9294352975428383,1.0,6/13,14.33%,THRB;CTSH;BRD8;KLF9;CTSL;HPN
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),-0.34660944511186753,-0.8941667179060291,0.5918367346938775,0.9420532073314055,1.0,11/16,43.72%,CADM1;PVR;RAET1E;NECTIN2;SLAMF6;CD226;CRTAM;CD160;KLRK1;LAMP1;AP1G1
prerank,negative regulation of protein localization to nucleus (GO:1900181),-0.32270471121571354,-0.8934334762628816,0.5979643765903307,0.9426798309623755,1.0,8/18,31.61%,OTUD7B;APOD;CABP1;FLCN;GSK3B;MFHAS1;LATS1;MDFIC
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.3402512684989544,0.893069711923679,0.5930735930735931,0.9311506521573453,1.0,6/33,11.48%,AR;RUNX1;NCOA2;SAFB2;RNF6;UFL1
prerank,regulation of neuron projection arborization (GO:0150011),-0.33797993720390485,-0.8927591531281305,0.5938242280285035,0.9431552672243169,1.0,4/15,7.78%,MYO9A;FZD4;NTNG1;MFSD2A
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),-0.3038910055237621,-0.8927446889273548,0.6424870466321243,0.9420205372136562,1.0,11/22,28.24%,MVB12B;VPS37B;VPS37A;RNF126;VPS28;VPS36;VPS4A;VPS37C;SNF8;MVB12A;UBAP1
prerank,inorganic ion transmembrane transport (GO:0098660),-0.35931581079084113,-0.8926481414367715,0.5825242718446602,0.9410992679765797,1.0,8/12,39.65%,ABCC9;CACNA1H;KCNJ8;ABCC8;PKD2L1;P2RX3;KCNJ11;RHAG
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.3722501330344673,0.8925186304149405,0.5961844197138315,0.9317152489968784,1.0,3/21,7.70%,MITF;MED14;MED16
prerank,inflammatory response (GO:0006954),0.26671754386271695,0.8920469943971282,0.6762114537444934,0.9321500818022886,1.0,34/195,16.06%,ADCY1;HSPG2;IL17D;XCR1;KIT;TPST1;CCL19;LTB4R;CCL4;BDKRB2;AGTR1;SCUBE1;TLR6;BMP2;ITCH;NFAM1;CDO1;LIAS;CEBPB;ADM;TNFAIP6;TBK1;FOLR2;RIPK2;CD14;NOX4;CXCL13;HDAC4;ADORA2A;VNN1;TNFRSF1A;NLRC4;MAPKAPK2;KLRG1
prerank,regulation of B cell proliferation (GO:0030888),-0.2606385371222689,-0.8920404459354505,0.6559139784946236,0.9413801286120239,1.0,11/44,17.03%,MEF2C;VAV3;CD38;TFRC;NFATC2;TNFRSF21;CD40;CD81;GPR183;PTPRC;CD320
prerank,establishment of epithelial cell polarity (GO:0090162),-0.3241269983670142,-0.8914997863641148,0.6063829787234043,0.9415306126806215,1.0,7/19,19.80%,CYTH3;MYO9A;OPHN1;MSN;CYTH1;CLASP1;SH3BP1
prerank,ganglioside biosynthetic process (GO:0001574),0.3914571348122987,0.8909662923361062,0.6070826306913997,0.9338349758750422,1.0,2/15,2.42%,ST6GALNAC5;ST3GAL5
prerank,negative regulation of growth (GO:0045926),0.2806441933945491,0.8907526317293981,0.6822977725674091,0.9337240842055167,1.0,24/121,13.02%,GJA1;ENPP1;SMAD3;NOTCH2;TSPYL2;MT3;SFRP1;BCL6;APBB2;PML;ING5;SPHK2;STK11;RBBP7;SLIT3;DDX3X;JADE1;CGRRF1;ST7L;NME6;CDA;SIPA1;ACVR1B;MUL1
prerank,positive regulation of defense response (GO:0031349),0.2858646560821842,0.8904446423664563,0.6721311475409836,0.9337787511362897,1.0,22/89,17.96%,SERPINE1;OPTN;IL12B;CEBPA;AGTR1;TSLP;NMI;CCN4;SETD4;IFNK;NAPEPLD;PDCD4;NPAS2;ETS1;MDK;RIOK3;TNFRSF1A;CD47;IL23A;CX3CL1;TNIP1;IL18
prerank,response to UV (GO:0009411),0.2919408175679673,0.8904003729343756,0.6610576923076923,0.9333163990899943,1.0,11/95,9.16%,MFAP4;NEDD4;PCLAF;USP47;INO80;SPRTN;IL12B;UBE4B;BRSK1;EGFR;ZBTB1
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.31902336180803387,0.8903830510177688,0.618978102189781,0.9328019109476351,1.0,6/44,8.95%,ROCK2;ZFP36L1;TNRC6B;CPEB3;TNRC6A;METTL14
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),0.4181575708972128,0.8902234512758772,0.6014760147601476,0.9325548779305453,1.0,3/11,8.75%,EFNB2;FRS2;BMP2
prerank,negative regulation of cell cycle (GO:0045786),0.29451082138416246,0.8902186826873754,0.6458598726114649,0.9320151365462309,1.0,17/73,15.85%,SMAD3;NR2F2;NUPR1;TSPYL2;CEBPA;BMP2;HEXIM2;INCA1;NR4A1;PDCD4;SIPA1;PTPN3;PTEN;BMP4;GAS1;CDKN1C;ZBTB17
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.2955801626679241,0.8901606494428329,0.6477419354838709,0.9315865892188396,1.0,18/72,24.39%,ENPP1;OGG1;GTF2H5;CUL4B;REXO4;DXO;DNASE1L1;DCP1A;DDX1;XPA;DICER1;RFC5;FAN1;EXD2;ERCC3;ERCC2;SPO11;MRE11
prerank,negative regulation of viral process (GO:0048525),-0.24434848200334325,-0.8900406286551792,0.7081545064377682,0.9439881762633034,1.0,21/57,29.87%,IFIH1;TRIM14;PPIA;SRPK1;FAM111A;TRIM11;TRIM6;N4BP1;TRIM62;OASL;PLSCR1;IFITM3;TRIM28;TRIM13;MID2;UBP1;ISG15;ISG20;TRIM35;IFIT1;ZC3HAV1
prerank,protein methylation (GO:0006479),-0.27010601061544637,-0.8900209767960664,0.6226415094339622,0.9428809612425008,1.0,9/40,19.14%,RAB6A;EZH2;SNRPB;PRMT7;ATPSCKMT;FAM98B;PRMT6;SNRPD3;PRMT3
prerank,negative regulation of TOR signaling (GO:0032007),0.3313453249203994,0.8898942569816684,0.6277695716395865,0.931575430609656,1.0,12/36,17.38%,NPRL3;UBR2;PRKAA2;STK11;RNF152;CASTOR2;TSC2;ITFG2;SESN2;NPRL2;FNIP1;ATM
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),-0.34269407466589036,-0.8898035212436781,0.6218905472636815,0.9422406511280581,1.0,6/15,21.94%,NGF;DDIT4;BCAR1;ZFYVE27;NTRK2;HAP1
prerank,skeletal muscle tissue development (GO:0007519),0.3398429080532453,0.8889638099680869,0.6070381231671554,0.932910896389166,1.0,5/32,9.65%,SVIL;CFLAR;MSC;SKI;CSRP3
prerank,negative regulation of inclusion body assembly (GO:0090084),-0.39003203934712793,-0.8888490174023236,0.6009501187648456,0.9433488324816747,1.0,4/10,23.24%,SORL1;DNAJB6;SACS;DNAJB1
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),-0.28089031950391197,-0.8887827135347977,0.671280276816609,0.9423574596281541,1.0,4/32,7.25%,RPS19;PGLYRP1;RPL39;RPL30
prerank,histone mRNA catabolic process (GO:0071044),0.3929247488971733,0.8886569637086189,0.6109271523178808,0.932974732929159,1.0,5/15,17.38%,TUT7;ERI1;TUT4;TENT4B;ATM
prerank,sodium ion export across plasma membrane (GO:0036376),0.4038101915689942,0.8884744208584794,0.6075731497418244,0.9327940525309104,1.0,2/13,6.93%,ATP1A2;ATP1B2
prerank,regulation of muscle cell differentiation (GO:0051147),0.34016914607058774,0.888306111105756,0.6194029850746269,0.9325748545266391,1.0,3/31,6.15%,IGF2;FGFR2;CDC42
prerank,axonal transport (GO:0098930),-0.2662295909416315,-0.8880641899514939,0.6655948553054662,0.9429502429299511,1.0,15/36,27.59%,RAB21;AP3B1;TMEM108;SYBU;PAFAH1B1;KIF1A;DCTN1;HIF1A;AP3S1;BLOC1S5;KIF4A;HAP1;KIF1B;AP3B2;SOD1
prerank,DNA methylation (GO:0006306),0.34778623349376886,0.887324636016263,0.5800933125972006,0.9340078270742831,1.0,10/23,24.63%,DNMT3A;SPOCD1;KMT2E;METTL4;DNMT3B;ATRX;N6AMT1;DNMT1;PPM1D;DMAP1
prerank,renal absorption (GO:0070293),0.4205017857248757,0.8871780994011689,0.5740740740740741,0.9337655578536681,1.0,1/10,1.20%,GSN
prerank,anterior/posterior pattern specification (GO:0009952),0.3088723853674698,0.886949698311153,0.6391891891891892,0.9336817897253704,1.0,9/53,15.00%,WLS;TGFBR1;SKI;HES7;BMP2;HOXC5;BHLHE41;ATP6AP2;HOXC4
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.3117506892958924,0.886488063687836,0.638095238095238,0.9340891356838538,1.0,10/57,12.67%,UACA;DAPK1;ASPH;PDCD5;BCAP31;TTBK1;CARD9;DDX3X;REST;RIPK2
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),-0.34796902596267293,-0.8864818933155545,0.6240601503759399,0.9455820966473961,1.0,7/14,28.81%,CPSF7;ERN1;CSTF2;CPSF1;CPSF6;CPSF4L;TUT1
prerank,regulation of protein binding (GO:0043393),0.2746892886325602,0.8864392384022018,0.6469893742621016,0.9336357449457999,1.0,22/114,15.16%,TCF7L2;LRP1;DACT1;VTN;RAPGEF2;DERL1;LRRK2;STK4;DAB2;BMP2;PRKN;TTBK1;NMD3;RIPK2;CTSZ;IFIT2;CFHR2;MARK2;HDAC4;AMFR;BMP4;TMBIM6
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.3140664926349286,0.8863479280079376,0.6293706293706294,0.933263636166234,1.0,2/48,0.72%,PDPK1;CEMIP
prerank,cellular response to exogenous dsRNA (GO:0071360),-0.3482255795086238,-0.886154115868259,0.6102941176470589,0.9452170676304312,1.0,4/12,11.84%,CAV1;IFIH1;CGAS;RALB
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),-0.3629751175426549,-0.8860072322142555,0.6037296037296037,0.9444396448415822,1.0,5/11,30.83%,PWP1;MTOR;SMARCA4;PIH1D1;IPPK
prerank,positive regulation of tumor necrosis factor production (GO:0032760),-0.23184582897452047,-0.8858374541087126,0.7192982456140351,0.9436581851391922,1.0,25/69,30.04%,PTPRJ;IFIH1;THBS1;PLCG2;IL33;LBP;ARHGEF2;JAK2;APP;NOD2;PTPRC;TLR4;CLU;DHX9;FZD5;AGER;TWIST1;IFNGR1;MIF;TMEM106A;C1QTNF4;LPL;TLR1;IL1A;HSPB1
prerank,kinetochore organization (GO:0051383),0.4055803362780437,0.8856753486658947,0.5986509274873525,0.9340740268313412,1.0,4/13,18.43%,CENPC;CENPH;POGZ;CENPA
prerank,positive regulation of protein deacetylation (GO:0090312),0.3953750044910395,0.8853803801533694,0.6212624584717608,0.9340816542441855,1.0,6/14,20.81%,NNMT;AKAP8L;DYRK1A;SAP30BP;NIPBL;BRMS1
prerank,polyol biosynthetic process (GO:0046173),-0.3317229930413502,-0.8853587224989371,0.6171284634760705,0.9436273625182536,1.0,4/16,11.02%,ACER3;IP6K1;ISYNA1;IPMK
prerank,negative regulation of anoikis (GO:2000811),0.3910501212929304,0.8853475748282557,0.6072664359861591,0.9336044352094397,1.0,3/14,6.31%,BCL2;TLE1;SRC
prerank,regulation of hippo signaling (GO:0035330),-0.3280192154524787,-0.8851767811112329,0.6148325358851675,0.942893753063551,1.0,3/17,5.06%,MOB3B;SCHIP1;CIT
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.2986416290055091,0.8849817263052423,0.6360153256704981,0.933792407061029,1.0,24/66,20.58%,DACT1;APPL2;INO80;EGFR;RBL2;DDX3X;JADE1;RGCC;KMT2E;PTEN;UBE2E2;AKT1;KANK2;ADAMTS1;CDK2AP2;TFDP1;CDKN2C;LSM10;MYO16;CDC73;APPL1;PSME3;PLCB1;CCND2
prerank,DNA replication-independent nucleosome assembly (GO:0006336),-0.2671982015737203,-0.8848544777258621,0.6523297491039427,0.9425200195864427,1.0,16/38,29.14%,HIRA;MIS18BP1;KNL1;H3-3A;RUVBL1;RSF1;NPM1;CENPI;CENPN;CABIN1;NASP;ASF1A;HAT1;ASF1B;HJURP;ITGB3BP
prerank,mesoderm formation (GO:0001707),0.3818288612168621,0.8847688861414238,0.6161137440758294,0.9336521811733358,1.0,3/17,9.58%,ITGA3;CRB2;ITGB3
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.365319817953812,0.8846315842675753,0.6194267515923567,0.9333831345444469,1.0,5/20,10.42%,TNRC6B;WTIP;HELZ;TNRC6A;EIF6
prerank,mRNA 3'-end processing (GO:0031124),0.295050515224486,0.8840384228107938,0.6594936708860759,0.9340321413508136,1.0,28/78,27.29%,POLR2D;U2AF1L4;THOC2;DDX39A;WDR33;MAGOHB;PAF1;SRSF5;PCF11;TENT4B;PAPOLG;CPSF2;CDC73;FIP1L1;LEO1;SCAF8;SRSF3;PAPOLA;NCBP2;CASC3;PAPOLB;SLU7;GRSF1;SSU72;AHCYL1;CDC40;NCBP1;PABPN1
prerank,acyl-CoA metabolic process (GO:0006637),0.33577332136005256,0.8838054371578413,0.6282420749279539,0.9339446184181642,1.0,8/35,17.18%,ACOT11;ACOT6;ACOT2;SUCLG2;ACSF2;HMGCS1;ACOT9;OXSM
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.379365205908372,0.883626945044833,0.6003236245954693,0.9337231228900111,1.0,7/18,16.32%,NFE2L2;NONO;PRKN;NOL3;VNN1;BAG5;AKT1
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.22101398533065614,-0.883495617737287,0.7570621468926554,0.9446024249339129,1.0,28/96,22.14%,NUP93;NUP35;NUP153;NUP160;EIF4E;NUP54;RBM8A;ALYREF;HHEX;CHTOP;HNRNPA2B1;YTHDC1;SRSF7;SEC13;SMG7;NUP155;DDX19B;RANBP2;GLE1;DHX38;NUP88;MCM3AP;THOC6;SRSF4;NUP62;SLBP;DDX25;NUP85
prerank,organelle disassembly (GO:1903008),-0.2760518358716827,-0.8830279344886265,0.689873417721519,0.9446059775675218,1.0,6/33,11.06%,VRK1;MRRF;TEX264;ULK1;GFM2;UBA5
prerank,tRNA transport (GO:0051031),-0.2643486805725675,-0.8826694012680836,0.7060702875399361,0.9443622370061642,1.0,11/35,22.14%,NUP93;NUP35;NUP153;NUP160;NUP54;SEC13;NUP155;RANBP2;NUP88;NUP62;NUP85
prerank,tryptophan metabolic process (GO:0006568),0.4142722014705149,0.882428946282677,0.5850694444444444,0.9356570455794356,1.0,2/11,6.77%,TDO2;KYNU
prerank,response to interferon-gamma (GO:0034341),0.29436406109922797,0.8823317960112507,0.6310935441370223,0.9353091515177281,1.0,6/67,6.77%,DAPK1;SP100;CCL19;CXCL16;CCL4;KYNU
prerank,metanephric mesenchyme development (GO:0072075),0.42163933850760327,0.882313942047221,0.6089285714285714,0.9348095441323071,1.0,5/10,24.84%,WNT4;OSR1;SHH;PKD2;STAT1
prerank,base conversion or substitution editing (GO:0016553),0.41142888833416297,0.8822043177080047,0.6043771043771043,0.9344819935299117,1.0,1/11,1.90%,A1CF
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.35052594973065354,0.8821588594177965,0.6188271604938271,0.9340299726938744,1.0,7/27,15.42%,FBXL17;PML;SIK1;FBXL3;FBXL12;PER3;RBM4B
prerank,protein maturation (GO:0051604),0.2856823040862456,0.8815285064741921,0.6520681265206812,0.9347209072827531,1.0,10/95,11.90%,CPXM2;OGT;AEBP1;CPXM1;MMEL1;ECE2;EEF1AKMT4-ECE2;LONP2;APH1B;CLN3
prerank,intracellular protein transport (GO:0006886),0.2545435593638325,0.8815005770685014,0.7387198321091291,0.9342380961750271,1.0,56/304,16.32%,WLS;RABGAP1L;TBC1D4;KIF13B;USP6NL;RANBP17;SEC31A;NUP107;APPL2;FAM53C;PRICKLE1;TMED1;VPS26C;RAB23;STXBP3;LMAN1;FUT10;STX16;COX18;ARFGAP3;ADPRH;TRARG1;LTBP2;NUP42;IFT27;MYO1C;RAB22A;COPZ2;ARFIP2;XPO7;KATNB1;HEATR3;TBC1D2B;ARL1;GGA2;TMED4;CSE1L;PPP1R10;STXBP1;TLK1;STRADA;COPA;USO1;TSC2;ARF4;NUP214;SNX9;IFT22;ARF6;LAMP2;STX1B;ARL5A;SNX31;RAB19;TECPR2;AKT1
prerank,ovarian follicle development (GO:0001541),0.4049525297108094,0.8811285281324336,0.6096256684491979,0.9344525009726616,1.0,4/13,11.09%,KIT;LHCGR;EIF2B4;CEBPB
prerank,ganglioside metabolic process (GO:0001573),0.364983905025289,0.8810197652470863,0.6277602523659306,0.934124344782885,1.0,2/20,2.42%,ST6GALNAC5;ST3GAL5
prerank,regulation of keratinocyte migration (GO:0051547),0.3956203462549037,0.8808160463294457,0.602112676056338,0.9339874133858944,1.0,5/12,15.84%,MAP4K4;MAPRE2;PTEN;ARF6;EPPK1
prerank,DNA replication checkpoint signaling (GO:0000076),-0.3253747416246091,-0.8807157798689611,0.6200527704485488,0.9477803578746072,1.0,9/16,40.74%,RAD17;TOPBP1;HUS1;HUS1B;CDC6;TICRR;RAD9A;RAD9B;CDT1
prerank,negative regulation of JNK cascade (GO:0046329),0.3348662441701272,0.8803940110719762,0.6283582089552239,0.9343101622809289,1.0,7/31,12.62%,DACT1;NCOR1;PRKN;ITCH;TAOK3;DUSP19;PDCD4
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.282188771707643,0.8801134830635897,0.6860321384425216,0.9343410303777724,1.0,27/95,23.15%,DYNLL1;NINL;CEP152;DYNC1H1;NPHP1;B9D1;ALMS1;CENPJ;FBF1;YWHAE;DYNC1I2;HAUS1;HAUS7;HAUS3;CEP164;CEP192;TMEM67;AHI1;ODF2;PRKACA;CEP250;KIF24;NDE1;HAUS5;HAUS6;TUBG1;SFI1
prerank,positive regulation of isotype switching (GO:0045830),-0.329986695044051,-0.8799098781399841,0.6273458445040214,0.9485753393804206,1.0,4/15,11.96%,TFRC;SHLD1;TGFB1;CD40
prerank,regulation of cellular component size (GO:0032535),-0.2775851558070698,-0.8798067898256279,0.659016393442623,0.9476964676724365,1.0,7/30,12.39%,VAV3;RDX;RAP1GAP2;RIN3;LARS1;MSN;MTOR
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.42334972875112337,0.8797803996550309,0.6126126126126126,0.9344773776371318,1.0,4/11,15.91%,DERL1;RNF185;UGGT2;AUP1
prerank,protein K63-linked deubiquitination (GO:0070536),-0.2759844724442419,-0.8797345819098331,0.6480938416422287,0.9467458828878279,1.0,10/31,27.61%,OTUD7B;OTUD7A;OTUD4;YOD1;TNFAIP3;BABAM1;BABAM2;USP7;OTUB2;USP33
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.347399107439651,0.8795768654043723,0.6021341463414634,0.9343329427320595,1.0,3/26,10.62%,HECW2;ANAPC5;NEK6
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.3846226764891023,0.879470617615602,0.6056338028169014,0.9340059937650455,1.0,4/15,15.04%,SMPD2;SPHK2;NSMAF;TNFRSF1A
prerank,positive regulation of cytokinesis (GO:0032467),-0.280966013168127,-0.879153948200035,0.6750788643533123,0.9469762455800305,1.0,10/32,18.72%,PKP4;CIT;KIF20B;CDC14A;CSPP1;GIPC1;KIF23;PRKCE;ECT2;CUL3
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.247356904329559,-0.8789135422302855,0.6937984496124031,0.9464777283033704,1.0,11/52,12.06%,PPP1R13B;YWHAH;YWHAQ;SAE1;GSK3A;ABLIM3;MAPK8;CASP8;YWHAG;BBC3;UBE2D3
prerank,amyloid precursor protein catabolic process (GO:0042987),-0.3432740170942037,-0.8788747556909242,0.5971223021582733,0.9454362759019426,1.0,3/14,9.59%,ADAM10;ABCG1;ADAM19
prerank,negative regulation of calcium ion transport (GO:0051926),0.3954704028706504,0.8788722259284688,0.6289517470881864,0.9346888544269844,1.0,4/15,15.16%,ATP1A2;ADRA2A;CD33;TMBIM6
prerank,positive regulation of lyase activity (GO:0051349),-0.33661768623151983,-0.8786614558237047,0.6246851385390428,0.9447938477079765,1.0,5/14,15.08%,NOS3;NOS1;NF1;ISCU;CACNA1D
prerank,regulation of protein localization (GO:0032880),0.302268124015056,0.8780952579261152,0.656498673740053,0.9356826463043768,1.0,9/58,11.48%,RABGAP1L;WDPCP;DZIP1L;VIP;AFDN;PICALM;ITGB3;PLEKHM2;UFL1
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.2922568353938386,0.8780176082750566,0.6696542893725992,0.9353034637665358,1.0,8/76,8.20%,ADRA1B;ACTN2;LTB4R;VIP;LHCGR;AGTR1;LPAR1;DRD3
prerank,organic substance transport (GO:0071702),0.27664771854682824,0.8776607117401257,0.6949352179034158,0.9354668241424624,1.0,20/121,14.21%,TXNIP;ARRDC4;ABCA1;ABCA9;LMAN2L;SLC22A2;APOA1;SLC35F3;TOM1;PLEKHA8;SLC22A4;MIA3;ABCB9;ARRDC2;SLC22A18;RCN3;SLC48A1;SLC18A2;ABCA3;ABCD2
prerank,inositol phosphate catabolic process (GO:0071545),0.40519770705221436,0.8773499071632953,0.6338983050847458,0.9355535146361055,1.0,2/12,4.32%,INPP5A;SYNJ2
prerank,positive regulation of myeloid cell differentiation (GO:0045639),-0.2624674377577366,-0.8772910718907717,0.6699029126213593,0.9469276739111638,1.0,10/33,17.76%,HOXA5;MED1;TAL1;FES;ACVR2A;HIF1A;PRKDC;INHBA;FAM210B;HMGB2
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.33365732717612484,-0.8769972105596127,0.654639175257732,0.9464758091947117,1.0,9/15,45.62%,CCT8;RUVBL1;RUVBL2;SHQ1;NHP2;CCT6A;NOP10;CCT7;CCT2
prerank,histone H2A ubiquitination (GO:0033522),0.37413581232607385,0.876892130841493,0.6006546644844517,0.935906761317616,1.0,3/17,6.57%,UBR2;BCOR;CUL4B
prerank,glycoprotein metabolic process (GO:0009100),0.3072881454473157,0.876871997461384,0.6657534246575343,0.9354006116591627,1.0,15/53,17.55%,GAL3ST2;PRKCSH;MAN1C1;LARGE1;ADAMTS9;NGLY1;ST6GALNAC6;GANAB;ENGASE;AGA;ERP44;GOLPH3;NEU4;MAN1A2;TNIP1
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.3078611911225788,0.8766510077803961,0.644718792866941,0.9353053504520192,1.0,10/50,12.97%,SASH1;CCL19;IL12B;NMI;EGFR;ACTN4;TRIP6;DDX3X;PDCD4;CD14
prerank,negative regulation of cholesterol transport (GO:0032375),0.42853555960077855,0.8763995181079006,0.5954063604240283,0.9352579626453431,1.0,10/10,57.17%,SHH;SREBF2;NFKB1;APOC1;APOC3;ABCG8;PLA2G10;APOA2;ABCG5;ABCA2
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.36179535257170164,-0.8759455183723972,0.6348195329087049,0.9478018565152992,1.0,4/11,19.01%,EGLN3;EGLN2;P4HA3;P3H2
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.33775976345432196,0.8754159227715407,0.6313432835820896,0.9366089562841284,1.0,5/31,15.26%,ARRDC4;GORASP1;BTRC;PTEN;DCUN1D2
prerank,oogenesis (GO:0048477),-0.32998051871804895,-0.8752631718402171,0.6269035532994924,0.9483064467804998,1.0,7/15,34.14%,FMN2;PTN;MEI4;TRIP13;KMT2D;PIWIL2;IHO1
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.34837315430703986,0.8751763105104831,0.6276923076923077,0.9365434196443742,1.0,6/27,14.89%,TNRC6B;MAP2K1;WTIP;EGFR;MYCN;BMP4
prerank,cellular response to hydrogen peroxide (GO:0070301),-0.2710602152779591,-0.8748080749932724,0.6869300911854104,0.9481710493239778,1.0,12/33,24.26%,NET1;RPS3;SIRPA;RHOB;PLEKHA1;TNFAIP3;SIRT1;SIGMAR1;ECT2;ANXA1;RNF112;MAPK7
prerank,morphogenesis of an epithelium (GO:0002009),0.3473995192278306,0.8747361667774558,0.620845921450151,0.9368692961339137,1.0,3/25,6.79%,DAG1;FGFR2;VCL
prerank,regulation of telomere capping (GO:1904353),-0.29142770920169203,-0.8742334642547297,0.6528189910979229,0.9484076736597048,1.0,8/23,24.24%,NEK7;PKIB;HNRNPD;MAPK3;PNKP;NBN;MAPK1;USP7
prerank,primary neural tube formation (GO:0014020),0.3356812929544392,0.873533408969447,0.6220588235294118,0.9387325193036756,1.0,7/30,14.29%,DLC1;PRICKLE1;MTHFR;SKI;LMO4;TSC2;PLXNB2
prerank,modulation by host of symbiont process (GO:0051851),-0.26853556301755566,-0.8732309891416806,0.6819571865443425,0.9496464804631509,1.0,8/31,16.95%,LEF1;CHD1;SNW1;INPP5K;CX3CR1;JUN;EP300;TFAP4
prerank,protein monoubiquitination (GO:0006513),0.32410733406429726,0.8728383607903251,0.6484593837535014,0.9395469754881014,1.0,14/36,22.32%,MGRN1;ATXN7L3;PRKN;RAD18;PAF1;KLHL12;HUWE1;UBE2R2;WAC;CDC73;TRIM21;UBE2T;LEO1;RNF20
prerank,eye photoreceptor cell development (GO:0042462),0.3838769626255536,0.8724161123923067,0.6152597402597403,0.9398345805463914,1.0,2/15,6.57%,TULP1;CRB2
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.347217881540217,-0.8721287578968506,0.6274038461538461,0.9509816950884465,1.0,3/12,20.57%,SKAP1;CD44;AGER
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.30584756451567974,0.8716175696784425,0.6517006802721088,0.9409358074450632,1.0,7/47,11.76%,PID1;PDGFRB;AGTR1;TLR6;SLC5A3;DCXR;F2
prerank,negative regulation of amyloid fibril formation (GO:1905907),0.40320169186403176,0.871366714217998,0.6073298429319371,0.9408662797004782,1.0,2/12,5.01%,APOE;LDLR
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),-0.35218198119361666,-0.8712533944579636,0.6271604938271605,0.9518810604260166,1.0,3/12,11.49%,ESR1;LIN28B;TGFB1
prerank,regulation of type I interferon production (GO:0032479),-0.221432692146228,-0.8705569003542036,0.7643979057591623,0.9523150073980542,1.0,20/84,19.40%,IFIH1;RNF125;LRRFIP1;POLR3H;TRIM25;NLRC5;TNFAIP3;CGAS;G3BP1;PTPN22;PRKDC;IRF5;PCBP2;EP300;DDX41;IRF8;POLR2E;UFD1;TAX1BP1;DHX9
prerank,embryonic appendage morphogenesis (GO:0035113),0.40595166449313436,0.8705249718353845,0.6044362292051756,0.9420659076148805,1.0,2/12,5.82%,CYP26B1;SKI
prerank,regulation of aerobic respiration (GO:1903715),-0.33087246570708306,-0.8701392433548112,0.6412213740458015,0.9521389967664927,1.0,3/15,11.81%,CBFA2T3;SLC25A33;ATP7A
prerank,positive regulation of cell adhesion (GO:0045785),0.2852626115951889,0.8699064319981857,0.6615776081424937,0.9427527694509692,1.0,11/74,9.62%,RHOD;TPM1;EPHA4;PPP3CA;ECM2;IL12B;AFDN;FOXC2;ARL2;RSU1;ITGAV
prerank,RNA transport (GO:0050658),0.2918661537578163,0.8694952312381111,0.6777493606138107,0.9429931514089405,1.0,12/71,14.57%,RBFOX1;RFTN1;U2AF1L4;SIDT1;ZFP36L1;THOC2;HNRNPA1;DDX39A;RAE1;MAGOHB;NUP214;SRSF5
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.22945643978834032,-0.8693447569445445,0.7252252252252253,0.9528222579997309,1.0,24/74,23.95%,NOTCH1;EGLN3;RBX1;EGLN2;VEGFA;PSMF1;PSMB8;PSMA4;PSMB10;HIF1A;PSMB2;HIGD1A;CUL2;EP300;CITED2;PSMC4;PSMA6;PSMD9;PSMD11;PSMD5;BACH1;VHL;PSMA8;PSMB1
prerank,mitotic recombination (GO:0006312),0.38591106340162346,0.8688269677897925,0.6112054329371817,0.9438105957822235,1.0,5/15,14.11%,DMC1;SMC5;SMC6;TEP1;RAD51D
prerank,icosanoid secretion (GO:0032309),-0.35466313916419234,-0.8686811518834892,0.6537530266343826,0.9532593018032598,1.0,7/12,31.30%,ABCC4;PNPLA8;ANXA1;NMUR2;PLA2G5;NOS2;ACE
prerank,outer dynein arm assembly (GO:0036158),0.38141760746196945,0.8685817224702823,0.587171052631579,0.9437245933424167,1.0,6/15,24.56%,DNAAF1;DNAAF5;DNAL1;DNAH8;ODAD4;ODAD1
prerank,regulation of TORC1 signaling (GO:1903432),0.32797330013831216,0.8684836244947989,0.6316568047337278,0.9433780859051133,1.0,12/33,20.41%,TELO2;STK11;RNF152;CASTOR2;RRAGD;ITFG2;SESN2;ATM;SEH1L;DYRK3;GPR137B;SZT2
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.3009927708872214,0.8683745520084843,0.6434316353887399,0.9430573837723656,1.0,15/51,18.89%,NRK;DTNBP1;NTF3;LRRK2;ALS2;MAP4K4;TAOK3;WASF1;GAS7;EPB41L3;TRIO;MYO16;BDNF;NYAP1;DICER1
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),-0.2727512833423781,-0.8682297323109344,0.6785714285714286,0.9531424465475198,1.0,12/29,28.15%,ELOVL7;PPT1;ELOVL5;TECR;HSD17B8;HACD2;PPT2;ACSL3;ACACA;SCD5;CBR4;ELOVL2
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.36494907922728487,0.8679988820083302,0.6179775280898876,0.943280169223589,1.0,2/17,9.91%,SERPINE1;CREB3
prerank,regulation of ATP biosynthetic process (GO:2001169),0.38267939626085057,0.8678766497592398,0.6408094435075885,0.9429846925278142,1.0,2/16,7.20%,PID1;SPHK2
prerank,phospholipid dephosphorylation (GO:0046839),0.31460655190274245,0.8677522527972036,0.6629213483146067,0.9426734096573665,1.0,6/37,10.53%,PLPP3;EPHX2;SYNJ2;MTMR3;MTMR7;PLPP5
prerank,endodermal cell differentiation (GO:0035987),0.32521190300492114,0.8668706271064537,0.6481751824817519,0.9439060953303399,1.0,9/31,18.31%,COL11A1;MMP2;VTN;ITGB5;ITGAV;PAF1;COL4A2;MMP14;CDC73
prerank,negative regulation of biosynthetic process (GO:0009890),0.37737234577909046,0.8663160707523876,0.6199677938808373,0.9444279162664176,1.0,4/16,14.21%,EMILIN1;SLC30A10;SLC18A2;ABCD2
prerank,detection of visible light (GO:0009584),0.38089004054046466,0.8662174728360634,0.6239600665557404,0.9440829629041575,1.0,1/16,2.64%,TULP1
prerank,protein polyubiquitination (GO:0000209),0.25219534303479313,0.8659697572029611,0.7987421383647799,0.9440576422720918,1.0,71/297,20.64%,SPSB1;HECW2;SASH1;BCL2;PELI2;FBXL17;UBR2;FBXL19;NEDD4;RFFL;SMURF2;PSME4;RNF213;BFAR;RNF31;UBE4B;TRIP12;UBE2U;FBXL3;UBE2V2;UBOX5;ANAPC5;FBXO28;PRKN;ITCH;IFI27;RNF6;RNF152;FBXO9;FBXO11;KBTBD7;ERCC8;FBXO4;FBXL12;BTRC;RNF217;MUL1;TNKS2;RNF19A;RC3H2;UBE2E2;AMFR;FBXO38;THOP1;UBE2D1;HACE1;HUWE1;DZIP3;NHLRC3;SPOP;UBR5;UBE2R2;UBE3B;UBE3A;PSMB5;RNF135;PSMC2;HERC6;UNKL;RC3H1;RNF34;PSMD1;TRIM32;PSMD4;PSME3;TRIM21;FBXL18;ARIH2;CDC23;UBE2T;PSMA3
prerank,positive regulation of dendritic spine development (GO:0060999),-0.3009192256325662,-0.8659254123486806,0.6657142857142857,0.9572717664357497,1.0,4/20,9.86%,SHANK3;NLGN1;LRP8;SHANK1
prerank,photoperiodism (GO:0009648),0.3421927357372056,0.8658651891380311,0.6394453004622496,0.9437311119585422,1.0,7/28,15.42%,FBXL17;PML;SIK1;FBXL3;FBXL12;PER3;RBM4B
prerank,positive regulation of T cell chemotaxis (GO:0010820),-0.3733257511333568,-0.8658330039850695,0.6431623931623932,0.9563723220249256,1.0,1/10,1.02%,ADAM10
prerank,DNA metabolic process (GO:0006259),0.2520516708978375,0.8655170027936759,0.7643312101910829,0.943849658726908,1.0,79/270,26.38%,TCF7L2;SP100;PDS5B;OGG1;PSME4;AXIN2;LIG4;NEIL1;INO80;RAD51B;DMC1;POLG;REXO4;UBE2U;TOP3B;TOP2B;POLL;RECQL5;KMT5B;UBE2V2;ZBTB1;POLE3;DNASE1L1;DNASE2;DDX23;RAD18;FANCC;MBD4;UVRAG;TERF2;MCM2;MNAT1;RAD51D;RTEL1;SMARCB1;XRCC2;LONP1;PRIMPOL;KPNA2;TIMELESS;ATM;CDC7;KAT5;ALKBH1;XPA;ENDOV;RAD54L;SUMO1;RFC5;FAN1;USP3;UBE2T;EXD2;MUTYH;CBS;RMI2;DNMT1;NSMCE4A;ERCC3;SMARCAD1;NOC3L;FANCA;LIG1;BRCA1;POLI;TDG;MSH6;NABP2;MRE11;POLE2;MCM6;HMGB3;MPG;ATRIP;RAD50;RPAIN;MMS19;UPF1;HMGB1
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.3561199219911665,-0.8649956778561737,0.6627634660421545,0.9571163274107796,1.0,7/12,40.04%,FOXP1;KLF4;TLR4;LPL;OAS3;MBP;TNF
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),-0.3514422544054582,-0.8646827876908808,0.6565420560747663,0.9567249265628177,1.0,2/11,11.53%,MSH3;ZRANB3
prerank,regulation of vasculogenesis (GO:2001212),0.38477510552702404,0.864322464202254,0.6347826086956522,0.9456166874024995,1.0,2/14,4.33%,RIN2;RAPGEF2
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.32125638736835327,0.8642100647493621,0.6690647482014388,0.945293846123728,1.0,5/38,5.05%,SERPINE1;SP100;CFLAR;RFFL;SFRP1
prerank,platelet aggregation (GO:0070527),0.33100323693439,0.8641401697311637,0.6385185185185185,0.944887054148764,1.0,10/33,15.81%,GNAS;PDGFRA;MYL12A;TLN1;STXBP3;VCL;ITGB3;STXBP1;FLNA;FIBP
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.31601675354094794,0.8639079051045491,0.6463932107496464,0.9447971597891256,1.0,14/41,20.10%,OGT;PRKAG2;NUP107;NUP42;EIF6;NUP98;RAE1;NUP214;LACC1;GCK;SEH1L;TPR;PRKAG1;AAAS
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.2844375805248736,0.8635442764941844,0.6654040404040404,0.9449732073482754,1.0,10/72,11.35%,RUNX1;GAS6;CFLAR;IRAK2;AXL;RNF31;TSLP;IRAK3;RNASEL;ABCE1
prerank,skeletal muscle contraction (GO:0003009),0.3690608463466211,0.8634156077163592,0.6389830508474577,0.944694405394317,1.0,3/19,10.12%,TNNT1;TNNC1;TNNT3
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.2768005476758055,-0.8633637874986694,0.6565096952908587,0.9585329726194759,1.0,13/27,25.99%,KDM1A;PTTG1IP;SMYD2;SIRT1;KMT5A;SPRED2;CD44;DDX5;MSX1;SNAI2;TWIST1;MIF;SNAI1
prerank,development of primary male sexual characteristics (GO:0046546),0.3221482424595114,0.863331038172656,0.6458036984352774,0.944332364985451,1.0,5/34,6.58%,AR;KIT;WNT4;LHCGR;NR5A1
prerank,response to acidic pH (GO:0010447),-0.34516946078571376,-0.8625200725228989,0.647450110864745,0.9593151217309044,1.0,5/13,26.08%,LGMN;GPR4;CTSS;RAB11FIP5;PKD2L1
prerank,cytoplasmic translational initiation (GO:0002183),0.37733648978834256,0.8623931949141657,0.6351791530944625,0.9457146425335831,1.0,8/17,23.86%,EIF4A2;EIF3A;EIF2S2;EIF2B3;EIF3I;RBM4;MCTS1;EIF2D
prerank,tube closure (GO:0060606),0.33073914939110155,0.8622071823039714,0.6444444444444445,0.9455359308646152,1.0,7/31,14.29%,DLC1;PRICKLE1;MTHFR;SKI;LMO4;TSC2;PLXNB2
prerank,regulation of regulated secretory pathway (GO:1903305),-0.26276838487384624,-0.8621403491359154,0.7129629629629629,0.959032876197379,1.0,13/34,23.10%,RIMS1;RAB27A;RIMS2;SYT1;SYT6;RAB15;RAB3A;SYT4;SYN1;RIMS3;SYT15;GSK3B;SYT5
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),-0.37433124074921953,-0.8618394463515869,0.6232876712328768,0.9585467508898328,1.0,3/10,10.46%,MYO9A;OPHN1;MSN
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.3303852382704322,0.8617649940975629,0.6475037821482602,0.945896742916887,1.0,3/30,4.50%,SLC27A5;ACSL1;ACOT2
prerank,DNA strand elongation (GO:0022616),-0.3071727650272583,-0.8617057980367826,0.672972972972973,0.9577507686396701,1.0,9/18,34.68%,DCLRE1B;GINS3;NBN;MCM3;GINS2;POLA1;POLD2;TERT;MCM7
prerank,positive regulation of leukocyte activation (GO:0002696),-0.3160273197786768,-0.8616083391530437,0.6536458333333334,0.9568625443033969,1.0,7/18,21.76%,THBS1;IL33;LBP;KARS1;CRLF2;TLR4;NECTIN2
prerank,negative regulation of lymphocyte migration (GO:2000402),-0.36214983571622883,-0.8614296195611726,0.6377777777777778,0.9561541662563571,1.0,2/10,3.35%,LRCH1;APOD
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",-0.27356540661566475,-0.8612616897142832,0.7092651757188498,0.9554508268237784,1.0,11/31,25.12%,EDC3;LSM2;LSM6;DIS3L2;EXOSC5;CNOT7;DCP2;CNOT8;DCPS;LSM7;EXOSC4
prerank,mitochondrion localization (GO:0051646),0.35688477504581617,0.8609849716169748,0.6266447368421053,0.9469195009585281,1.0,4/19,13.59%,MARK1;LRRK2;MUL1;MARK2
prerank,carboxylic acid metabolic process (GO:0019752),0.32906753569452607,0.8608920668340826,0.6510948905109489,0.946568069576322,1.0,5/33,11.07%,PTGIS;PLA2G4A;DDO;CYB5A;LIAS
prerank,regulation of defense response to virus by host (GO:0050691),-0.28047463192900934,-0.8604757915624175,0.685131195335277,0.9561601564714521,1.0,12/30,27.98%,TOMM70;AIM2;TNFAIP3;CGAS;PTPN22;TRIM6;DHX9;EIF2AK4;TRIM44;IFNLR1;LILRB1;TRAF3IP2
prerank,positive regulation of RNA splicing (GO:0033120),0.33566412548855906,0.8603163596535124,0.640502354788069,0.9471968965454529,1.0,6/29,15.60%,PIK3R1;HNRNPLL;RBM22;NUP98;DYRK1A;SLC38A2
prerank,toll-like receptor signaling pathway (GO:0002224),0.2780541341633518,0.8599539080126659,0.6902985074626866,0.947353031107474,1.0,24/84,22.12%,COLEC12;RFTN1;IRAK2;NMI;TLR6;IRAK3;TNIP2;RIPK2;CD14;CTSL;PIK3R4;UBE2D1;MAPKAPK2;TNIP1;EPG5;TLR5;SFTPA1;SFTPA2;TIRAP;LGALS9;MYD88;BIRC2;BIRC3;CNPY3
prerank,cellular response to starvation (GO:0009267),0.25934846946149215,0.8597154925557314,0.7431192660550459,0.9472611665426159,1.0,40/147,20.58%,PRKAG2;NPRL3;SFRP1;PRKAA2;NUAK1;LRRK2;SIK1;SREBF1;EIF2AK3;BRSK1;MTMR3;HNRNPA1;SLC38A9;ATP6V1E1;RNF152;CEBPB;CASTOR2;LAMTOR2;RRAGD;IMPACT;WIPI1;PIK3R4;ITFG2;SESN2;NPRL2;FADS1;LAMP2;TBL2;FNIP1;MAP1LC3A;SEH1L;FOXO3;BECN1;PRKAG1;RHEB;CARTPT;WDR45;SZT2;GCGR;MLST8
prerank,negative regulation of interleukin-10 production (GO:0032693),-0.31913661920965897,-0.8596227583777293,0.6641604010025063,0.9568904107391524,1.0,8/16,31.19%,TRIB2;TNFRSF21;JAK3;DLL1;AGER;VSIR;LILRB1;FCGR2B
prerank,response to exogenous dsRNA (GO:0043330),0.36610141239356286,0.8595257890135832,0.6386292834890965,0.9471118969706134,1.0,5/18,13.02%,COLEC12;RFTN1;IRAK3;IFNK;MUL1
prerank,positive regulation of glucose metabolic process (GO:0010907),0.3827615063154406,0.859482316118056,0.6375838926174496,0.9466663101333989,1.0,2/14,4.37%,NNMT;SLC45A3
prerank,carbohydrate transport (GO:0008643),-0.35775516381397704,-0.8590808617104226,0.675990675990676,0.9570092035357147,1.0,2/11,10.71%,SLC26A6;AQP11
prerank,cellular biogenic amine metabolic process (GO:0006576),-0.3516247472458065,-0.8584835468258311,0.640625,0.9572560646221754,1.0,3/12,13.55%,MAOA;ATP7A;DDC
prerank,response to steroid hormone (GO:0048545),0.3285806065068449,0.8580066366248427,0.6318114874815906,0.948986483960483,1.0,4/31,5.43%,AR;ATP1A2;YAP1;TFPI
prerank,negative regulation of leukocyte activation (GO:0002695),0.3801337656747911,0.8579334524587336,0.6221122112211221,0.9486153780742411,1.0,3/15,14.79%,IL31RA;CD200;NR1H3
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.260395077345406,-0.8578099095712765,0.7191358024691358,0.9576069355209748,1.0,16/38,28.83%,NDUFC1;NDUFA6;NDUFA5;NDUFA7;NDUFA8;NDUFB7;NDUFA3;NDUFA10;NDUFS7;NDUFS1;NDUFS5;NDUFB3;NDUFAB1;NDUFB4;NDUFV2;NDUFV3
prerank,glucose transmembrane transport (GO:1904659),-0.31929620551649385,-0.8577909128137183,0.6868131868131868,0.9565439883309845,1.0,2/18,2.87%,SLC2A1;PPARD
prerank,positive regulation of transporter activity (GO:0032411),0.39148212526583825,0.8574868326283701,0.6411149825783972,0.9489803929495156,1.0,6/13,20.46%,SYNGR3;KMT2A;NR1H3;RXRA;KCTD7;SGK2
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.22396383297028014,-0.8574510968945893,0.7723214285714286,0.956151035304737,1.0,10/73,9.51%,CAV1;FNIP2;NGF;BCAR3;TFRC;NOS1;PAK1;HSP90AB1;ATP2B4;VEGFA
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.4081005349689826,0.8573754634712754,0.6281138790035588,0.9486625112763403,1.0,3/10,10.78%,KLF15;PRKAA2;SETD5
prerank,regulation of early endosome to late endosome transport (GO:2000641),-0.309256232318727,-0.8573601446388218,0.6285714285714286,0.955253581049751,1.0,6/18,13.80%,RDX;MTMR2;DNAJC13;RAB21;MSN;MAPK3
prerank,miRNA mediated inhibition of translation (GO:0035278),-0.3494489414113816,-0.8560986789657807,0.6312217194570136,0.955845204657436,1.0,2/11,5.62%,TNRC6C;NOTCH4
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.3494489414113816,-0.8560986789657807,0.6312217194570136,0.955845204657436,1.0,2/11,5.62%,TNRC6C;NOTCH4
prerank,calcium import into the mitochondrion (GO:0036444),0.41067759168446405,0.856074492145704,0.6434782608695652,0.950691495046376,1.0,2/10,9.91%,MCU;MICU2
prerank,dephosphorylation (GO:0016311),0.2626513938902847,0.8559699659042609,0.7585394581861012,0.9503429519428996,1.0,28/147,17.52%,PPM1H;PPM1E;PTPN13;PLPP3;PXYLP1;PPP3CA;EPHX2;PTPN21;PTPRS;PTPN9;MTMR3;MTMR7;STK11;CTDSP2;PTPRM;PLPP5;PPP2R5D;BTRC;PTPN3;PTEN;PSPH;SDHAF2;PTPRA;ACP6;PPM1G;UBLCP1;DUSP4;DUSP12
prerank,cellular response to type I interferon (GO:0071357),0.3096013454406119,0.855921960965357,0.685595567867036,0.9493813361052016,1.0,11/41,21.72%,SP100;IRF1;OAS2;STAT2;RNASEL;IFI27;IFIT2;IRF2;RSAD2;IRF9;MYD88
prerank,type I interferon signaling pathway (GO:0060337),0.3096013454406119,0.855921960965357,0.685595567867036,0.9493813361052016,1.0,11/41,21.72%,SP100;IRF1;OAS2;STAT2;RNASEL;IFI27;IFIT2;IRF2;RSAD2;IRF9;MYD88
prerank,protein targeting to membrane (GO:0006612),-0.215783173329596,-0.8558861327580998,0.7860696517412935,0.9552415509486972,1.0,34/83,31.62%,ZDHHC2;SDCBP;RAB8B;RTP4;ZDHHC15;AQP11;ZDHHC14;VPS37B;PEX26;VPS37A;ARL6IP1;ATG3;ABCD3;ARL6;SGTB;PEX12;FIS1;VPS37C;ZDHHC18;CHMP4B;CHMP4A;PEX16;SGTA;PEX5;PXMP4;ZDHHC24;NACAD;SRPRA;GET3;ZDHHC22;SEC63;NCF1;ZDHHC6;ZDHHC12
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.3989750915038426,0.8557057807451673,0.630718954248366,0.949261158516981,1.0,5/12,13.35%,THRB;CTSH;BRD8;KLF9;CTSL
prerank,fatty acid biosynthetic process (GO:0006633),-0.22898352952311363,-0.855382108144925,0.7792207792207793,0.9552204549760035,1.0,22/63,28.26%,ELOVL7;ABHD2;ELOVL5;GPX4;DEGS1;TECR;HSD17B8;TECRL;HACD2;PTGS2;ABCD3;ACACA;LIPH;SCD5;NDUFAB1;HACD3;CBR4;LIPC;LPL;XBP1;ELOVL2;ALOX5
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.3771129278494938,0.8550283415408204,0.6281138790035588,0.9494697060854644,1.0,3/15,6.70%,ZFP36L1;TNRC6B;CPEB3
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.3771129278494938,0.8550283415408204,0.6281138790035588,0.9494697060854644,1.0,3/15,6.70%,ZFP36L1;TNRC6B;CPEB3
prerank,negative regulation of programmed necrotic cell death (GO:0062099),-0.3474042390307508,-0.8546732444035732,0.6519721577726219,0.9556818655479677,1.0,4/11,12.87%,YBX3;ARHGEF2;CASP8;SLC25A4
prerank,positive regulation of T cell mediated immunity (GO:0002711),-0.2886264743403117,-0.8543828740640406,0.6772334293948127,0.9552273774418933,1.0,7/22,23.25%,B2M;CYRIB;CD55;FZD5;TRAF2;MAP3K7;MALT1
prerank,DNA repair (GO:0006281),0.24916328934330806,0.8539151067586651,0.7892004153686397,0.9510505427083209,1.0,94/284,26.37%,EYA1;PDS5B;OGG1;PSME4;HPF1;LIG4;USP47;NEIL1;INO80;RAD51B;GTF2H5;CUL4B;SPRTN;ERCC6L2;REXO4;UBE2U;DCLRE1C;POLL;RECQL5;KMT5B;UBE2V2;MLH1;COMMD1;ZBTB1;ASCC3;WDR33;EXO5;BAZ1B;ACTR8;TENT4A;TDP2;ERCC8;DCLRE1A;RAD18;FANCC;MBD4;UVRAG;MNAT1;RAD51D;FANCE;FANCI;HUWE1;XRCC2;PRIMPOL;KPNA2;TIMELESS;ATM;KAT5;ALKBH1;DDX1;XPA;ENDOV;RAD54L;KDM4A;SUMO1;RFC5;UIMC1;FTO;BRCC3;FAN1;USP3;UBE2T;EXD2;MUTYH;RMI2;NSMCE4A;ERCC3;EME2;APLF;FANCA;CENPX;LIG1;BRCA1;ERCC2;ATXN3;VCPIP1;SETX;POLI;TDG;MSH6;NABP2;RAD51AP2;MRE11;POLE2;MPG;XRCC4;ATRIP;ABL1;RAD23B;RAD50;RPAIN;BAP1;MMS19;UPF1
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),-0.21568972512678236,-0.8537265910347285,0.7684210526315789,0.9555231982526616,1.0,30/85,25.42%,RNF144B;CBFA2T3;RNF144A;RBX1;TRIB2;ECSCR;TAF1;GSK3A;HSPBP1;TMTC3;ZYG11B;RAD23A;COP1;RACK1;BBS7;DVL1;RNF14;CLU;DAB2IP;DDRGK1;GSK3B;GABARAP;RCHY1;USP5;NUB1;CSNK1D;VCP;TREM2;DDA1;FMR1
prerank,mesonephric tubule development (GO:0072164),0.38056946272748937,0.8533217513327875,0.6328257191201354,0.9517014145113052,1.0,3/15,7.89%,SALL1;FGFR2;OSR1
prerank,myeloid cell differentiation (GO:0030099),-0.24633778646320018,-0.8531821733036498,0.7330827067669173,0.95561402884644,1.0,16/47,20.21%,ZBTB16;RPS14;RPS19;HIPK2;PTPN2;TAL1;JAK2;UBA5;INHA;PRKX;KAT6A;JAK3;INHBA;ZFPM1;ALAS2;HCLS1
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.25586526705130685,0.852899013876096,0.7427616926503341,0.9519885047906629,1.0,50/185,23.33%,HECW2;DYNLL1;NINL;CEP152;APPL2;PSME4;DYNC1H1;ZFP36L1;INO80;ZW10;ALMS1;NPM2;SIRT2;CENPJ;ANAPC5;NEK6;RGCC;YWHAE;DYNC1I2;BTRC;HAUS1;HAUS7;HAUS3;CEP164;CEP192;UBE2D1;PSMB5;PSMC2;KLHL18;PSMD1;ODF2;PRKACA;APPL1;PSMD4;PSME3;CDC23;ZFP36L2;PSMA3;CEP250;AURKA;ERCC3;NDE1;ANAPC4;HAUS5;HAUS6;TUBG1;PSMA2;ERCC2;SFI1;PSMC5
prerank,positive regulation of cartilage development (GO:0061036),-0.31133104546888535,-0.8527843095087341,0.6560693641618497,0.9553663629613418,1.0,3/17,5.23%,ZBTB16;ACVRL1;PKDCC
prerank,negative regulation of cytoskeleton organization (GO:0051494),0.33226055394551685,0.8514816071969437,0.6638054363376252,0.9541425889444541,1.0,5/29,9.40%,PLEKHH2;KANK1;LIMA1;PRKN;MYADM
prerank,lymphocyte migration (GO:0072676),-0.2672131506213082,-0.8514712854604197,0.6813880126182965,0.9571455810182778,1.0,5/32,10.46%,S1PR1;CCL14;RET;CKLF;MSN
prerank,intracellular sterol transport (GO:0032366),0.37902803610694347,0.851464924979437,0.6552287581699346,0.9536406571203361,1.0,2/13,5.21%,ABCA1;STAR
prerank,protein-DNA complex disassembly (GO:0032986),0.3713134039354177,0.8513501428643031,0.6530278232405892,0.9533309370173698,1.0,6/16,23.32%,SMARCC2;NFE2;SMARCD2;SMARCB1;ARID2;SMARCE1
prerank,histone acetylation (GO:0016573),-0.22546441473198942,-0.8513242994543159,0.78125,0.9563821568164835,1.0,18/69,18.75%,LEF1;JADE3;PHF20L1;TRIM16;KAT2A;TAF10;TADA2A;APBB1;PER1;RUVBL1;KAT6A;NAA60;EP300;MRGBP;BRCA2;SGF29;YEATS2;ZZZ3
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.2797871946044082,0.8509855989019881,0.7116788321167883,0.9529546451073737,1.0,11/78,13.73%,SEC24D;DYNLL1;SEC31A;CTSF;DYNC1H1;DCTN6;CAPZB;AP1M1;DYNC1I2;CTSL;SEC23A
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.2797871946044082,0.8509855989019881,0.7116788321167883,0.9529546451073737,1.0,11/78,13.73%,SEC24D;DYNLL1;SEC31A;CTSF;DYNC1H1;DCTN6;CAPZB;AP1M1;DYNC1I2;CTSL;SEC23A
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.3948674909432817,0.8508711377149633,0.6396551724137931,0.9526604537203719,1.0,4/11,20.22%,ARID1B;ZMIZ1;ELOF1;SERTAD1
prerank,positive regulation of T-helper cell differentiation (GO:0045624),-0.3297915849288253,-0.8507509402072067,0.659846547314578,0.9565898745421392,1.0,11/14,35.64%,PRKCZ;CD80;NFKBIZ;CD86;ANXA1;MALT1;RARA;NFKBID;NLRP3;SOCS5;MYB
prerank,embryonic axis specification (GO:0000578),-0.3327842305879516,-0.850639270759483,0.6876574307304786,0.9557371698850282,1.0,5/15,19.92%,COBL;TASOR;STIL;PTCH1;FZD5
prerank,regulation of T cell chemotaxis (GO:0010819),-0.3573096297189118,-0.8500735544742096,0.6775599128540305,0.9558183180351529,1.0,1/11,1.02%,ADAM10
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.29884383502952017,0.8500563298815633,0.6911357340720221,0.9536703101486879,1.0,9/48,10.33%,POLR1G;ARID1B;ATAD2B;SPHK2;MYO1C;ZMIZ1;KAT2B;BAZ1B;PHF2
prerank,positive regulation of ERAD pathway (GO:1904294),0.38986934051826544,0.8499489577116015,0.6552901023890785,0.9533479420529081,1.0,5/13,12.76%,NFE2L2;RNF185;BCAP31;TMEM259;RNFT1
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),-0.3640776232533525,-0.8496463279440484,0.6511111111111111,0.9555886263139749,1.0,7/10,55.05%,CCT8;CCT6A;CCT7;CCT2;TCP1;WRAP53;DKC1
prerank,cellular response to UV (GO:0034644),0.2819862572006628,0.8482811060713662,0.7052896725440806,0.9559771180474137,1.0,8/76,9.86%,MFAP4;MMP2;NEDD4;USP47;INO80;CUL4B;ZBTB1;STK11
prerank,phagosome-lysosome fusion (GO:0090385),0.41186699568543594,0.8482009395816053,0.6601423487544484,0.9556004862870482,1.0,3/10,15.38%,RAB7B;CLN3;PIKFYVE
prerank,non-motile cilium assembly (GO:1905515),-0.26243724711310024,-0.8478305167835487,0.7275747508305648,0.9583953834439858,1.0,9/30,26.41%,DISC1;TMEM216;DCTN1;FUZ;CCDC13;CSNK1D;VANGL2;GORAB;BBS10
prerank,mitochondrial transport (GO:0006839),0.2979096315096083,0.847529679123829,0.6779431664411367,0.9563472074820678,1.0,8/53,10.90%,BCL2;SLC25A24;TIMM17B;COX18;BCAP31;TIMM44;TIMM9;TSPO
prerank,'de novo' posttranslational protein folding (GO:0051084),-0.270578149950281,-0.8472511858219328,0.7074626865671642,0.9585754757946171,1.0,4/30,10.70%,HSPA8;UGGT1;GAK;DNAJB14
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.29480069760282085,0.8472241264470739,0.6969292389853138,0.9564189282036244,1.0,5/53,6.55%,XCR1;HTR1A;LHCGR;ADRB3;MTNR1A
prerank,regulation of astrocyte differentiation (GO:0048710),0.38494393178544467,0.8471584980783063,0.6235294117647059,0.9560168911914221,1.0,3/12,11.76%,EPHA4;BMP2;F2
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.33400121342393485,-0.8469900854399259,0.6748166259168704,0.9580360427297081,1.0,6/13,28.46%,SORL1;CD81;BRSK2;TMEM30A;GCC2;TMEM30B
prerank,regulation of microtubule nucleation (GO:0010968),0.406004103594927,0.8468146914789365,0.6618705035971223,0.9561212101238801,1.0,1/10,1.79%,EML2
prerank,regulation of mitotic cell cycle (GO:0007346),-0.20054021913438566,-0.8466879439251751,0.8823529411764706,0.9575493674250675,1.0,34/171,15.71%,AFAP1L2;CAV2;NEK7;IQGAP1;SDCBP;CUL1;BRINP3;EIF4E;MEIS2;ANGEL2;BRINP1;ANAPC16;ANAPC15;ANAPC7;TAL1;BORA;BTG2;SCRIB;KIF20B;TGFB1;BRINP2;LGMN;SIRT1;DYNLT3;PSMF1;USP22;THAP1;PSMB8;PSMA4;APP;PSMB10;PSMB2;UBE2S;BUB1B
prerank,positive regulation of TOR signaling (GO:0032008),0.30691057002947936,0.8462339232792315,0.6835443037974683,0.9567282455413362,1.0,12/40,20.58%,GAS6;SLC38A9;TELO2;LAMTOR2;RRAGD;GOLPH3;FNIP1;SEH1L;RICTOR;RHEB;GPR137B;MLST8
prerank,cellular response to leucine (GO:0071233),0.39007890642639836,0.8461133272895631,0.6052173913043478,0.9558886902510276,1.0,3/10,15.22%,UBR2;RRAGD;SESN2
prerank,response to leucine (GO:0043201),0.39007890642639836,0.8461133272895631,0.6052173913043478,0.9558886902510276,1.0,3/10,15.22%,UBR2;RRAGD;SESN2
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.2790005252887261,-0.8445472553944158,0.716931216931217,0.961028119876026,1.0,4/26,13.19%,CAV1;LBP;IFI35;PTPN22
prerank,regulation of mitochondrion organization (GO:0010821),0.30312770793302396,0.8440565788866633,0.6908602150537635,0.9592703797003708,1.0,8/47,13.09%,PID1;LRRK2;SREBF1;PRKN;STAT2;RHOT1;MUL1;VDAC1
prerank,regulation of DNA damage checkpoint (GO:2000001),-0.3619992065804644,-0.8439508402259341,0.6481069042316259,0.9611530176976427,1.0,6/10,38.16%,CRY1;WDR76;CCAR2;RPA2;THOC5;RFWD3
prerank,endocardial cushion development (GO:0003197),-0.2954273917563213,-0.8437503138401711,0.6815789473684211,0.9605191186203103,1.0,10/21,21.06%,NOTCH1;NOS3;ACVRL1;TGFB2;TBX2;HEY1;BMPR2;HEYL;CRELD1;FOXF1
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),-0.33386143329389295,-0.8434266722577665,0.6939759036144578,0.9601486579675204,1.0,5/13,29.55%,ANAPC15;CDK5RAP2;GEN1;LCMT1;DYNC1LI1
prerank,monocyte chemotaxis (GO:0002548),0.3122297447353639,0.8430789813909725,0.6631736526946108,0.9606112785625599,1.0,3/32,6.11%,IL6R;CCL19;CCL4
prerank,mitotic cell cycle phase transition (GO:0044772),0.25237472903918245,0.8428404615769698,0.8057080131723381,0.9605312387540353,1.0,53/204,23.15%,CDK14;DYNLL1;NINL;CCNA2;OPTN;CEP152;PHLDA1;FBXL17;ACVR1;DYNC1H1;CUL4B;ALMS1;CUL5;CENPJ;BRSK1;FBXL3;FBXL12;YWHAE;MNAT1;DYNC1I2;BTRC;HAUS1;ACVR1B;HAUS7;HAUS3;CEP164;PLK2;PHF8;CEP192;CDKN2C;CDC7;ODF2;PRKACA;CDKN1B;CACUL1;TAF2;CDC23;PLCB1;GSPT1;USP37;CCND2;CEP250;AURKA;NES;NDE1;EPS8;CCNG2;HAUS5;HAUS6;TUBG1;CDK7;FBXW11;SFI1
prerank,positive regulation of macrophage activation (GO:0043032),-0.31485315478044396,-0.8427277325666248,0.7022332506203474,0.9604693233093248,1.0,3/17,5.63%,THBS1;IL33;LBP
prerank,glycine transport (GO:0015816),0.40080561037948853,0.8415193329392322,0.6454545454545455,0.9625536320754547,1.0,3/10,18.99%,SLC6A9;SLC6A5;SLC25A38
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.31060296915771046,0.8409145387894695,0.6723891273247496,0.963158690031842,1.0,16/38,26.31%,LEPROT;LMAN1;LRRK2;RNF31;SREBF1;PRKN;HUWE1;RHOU;HPS4;ARIH2;HAX1;SREBF2;VPS11;UBE2J2;SH3GLB1;BAP1
prerank,fatty acid catabolic process (GO:0009062),0.28789425730382545,0.8407537549225493,0.7262210796915167,0.962909021131615,1.0,11/67,14.21%,PCCA;PCCB;NUDT7;ECHDC2;ECI1;MMUT;ABHD3;ECHS1;PEX2;DECR1;ABCD2
prerank,regulation of DNA metabolic process (GO:0051052),-0.24577207721081729,-0.840552100851671,0.7508771929824561,0.9639667467155175,1.0,12/44,20.88%,SUB1;POLH;ALYREF;HNRNPD;PDGFA;MPHOSPH8;NBN;YLPM1;PARG;WRNIP1;UBE2V1;HELB
prerank,negative regulation of DNA replication (GO:0008156),0.37124578909398886,0.8394224519827954,0.6638225255972696,0.9648704946515045,1.0,3/13,15.19%,TSPYL2;S100A11;WAPL
prerank,nuclear pore complex assembly (GO:0051292),-0.3524760475955768,-0.8393392962683818,0.6834061135371179,0.9653868292129164,1.0,2/10,4.51%,NUP93;NUP153
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),0.38290901138067784,0.838954534612225,0.641156462585034,0.9652232472664635,1.0,1/13,0.57%,ADCY1
prerank,neural tube closure (GO:0001843),0.3158620953626087,0.8387198908935823,0.6855072463768116,0.9651509553936802,1.0,7/34,14.29%,DLC1;PRICKLE1;MTHFR;SKI;LMO4;TSC2;PLXNB2
prerank,lysine catabolic process (GO:0006554),0.39111954681612615,0.838402446029592,0.6539162112932605,0.9647091758626413,1.0,2/12,8.29%,PHYKPL;ALDH7A1
prerank,lysine metabolic process (GO:0006553),0.39111954681612615,0.838402446029592,0.6539162112932605,0.9647091758626413,1.0,2/12,8.29%,PHYKPL;ALDH7A1
prerank,regulation of ATP metabolic process (GO:1903578),0.2933893946826878,0.8383691209743643,0.7028493894165536,0.964241109240276,1.0,15/54,20.10%,OGT;PRKAG2;NUP107;COX7A2;NUP42;SPHK2;EIF6;NUP98;RAE1;NUP214;GCK;SEH1L;TPR;PRKAG1;AAAS
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.3294226945632048,0.838305271561879,0.6764705882352942,0.9638263132935959,1.0,3/26,6.93%,ACTN2;NEDD4;ATP1B2
prerank,protein dephosphorylation (GO:0006470),0.2580167451470971,0.838108523798001,0.754325259515571,0.9636600735582191,1.0,26/135,17.52%,PPM1H;EYA2;PPM1E;PTPN13;EYA1;PPP3CA;PTPN21;PTPRS;PTPN9;MTMR3;MTMR7;RPAP2;STK11;CTDSP2;PTPRM;PPP2R5D;BTRC;PTPN3;PTEN;SDHAF2;PTPRA;TNS2;PPM1G;UBLCP1;DUSP4;DUSP12
prerank,positive regulation of organelle assembly (GO:1902117),0.30689111890327786,0.8380870020561979,0.6801112656467315,0.9631611759455523,1.0,12/44,20.66%,ASAP1;DYNC1H1;SDC1;ARHGAP35;CROCC;RAB3GAP1;SDC4;PIP4K2C;HTT;NUMA1;FSCN1;CEP120
prerank,placenta development (GO:0001890),-0.33361329229051284,-0.8378760216417642,0.6603325415676959,0.9672243583268576,1.0,6/12,30.93%,ADAM19;E2F7;PLAC1;SOD1;E2F8;PTK2
prerank,regulation of sister chromatid cohesion (GO:0007063),0.3849630106235066,0.8377963606820821,0.6570397111913358,0.9631595934224165,1.0,3/12,15.19%,AXIN2;HDAC8;WAPL
prerank,amide biosynthetic process (GO:0043604),0.294935526344957,0.8372733567584167,0.6880222841225627,0.9635957724347622,1.0,6/47,9.70%,PAM;SMPD2;ALOXE3;CERS6;CERS5;NMRAL1
prerank,protein localization to cilium (GO:0061512),0.32310901209938064,0.8371643324830547,0.6795422031473534,0.9632766132383117,1.0,11/32,25.67%,TULP1;WDR35;TULP3;INVS;ZNF423;EHD1;ODAD4;IFT140;TULP2;TTC21B;TCTN2
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.37701713631471423,0.8369472416773913,0.6584967320261438,0.9631338224424058,1.0,5/14,15.34%,ZEB1;OSR1;SPRY2;SPRED3;SPRED1
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.27354038830380145,0.8366691344595723,0.7146433041301627,0.9631311518787008,1.0,24/83,23.15%,DYNLL1;NINL;CEP152;DYNC1H1;ALMS1;CENPJ;YWHAE;DYNC1I2;HAUS1;HAUS7;HAUS3;CEP164;CEP192;ATF5;DYRK3;ODF2;PRKACA;CEP250;AURKA;NDE1;HAUS5;HAUS6;TUBG1;SFI1
prerank,regulation of protein dephosphorylation (GO:0035304),-0.24836679989847762,-0.8362778153931292,0.7582417582417582,0.9694790235673397,1.0,7/37,11.49%,PPP1R16B;PPIA;PPP2R5A;SPPL3;CALM1;CALM3;TGFB1
prerank,negative regulation of interleukin-12 production (GO:0032695),-0.31926345968662284,-0.8355792834942364,0.6733668341708543,0.9698373977091004,1.0,2/14,4.35%,THBS1;CMKLR1
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.3496720377253084,0.8346937047432986,0.6810897435897436,0.9662508034316375,1.0,7/20,24.47%,ZC3H7B;PRKRA;TSNAX;DICER1;AGO4;DROSHA;AGO3
prerank,mitochondrial translational elongation (GO:0070125),-0.2138357587733737,-0.83458830238556,0.8605769230769231,0.9708427504742447,1.0,32/88,32.16%,GFM2;MRPL46;MRPS18A;MRPS5;MRPL39;MRPS26;MRPS12;MRPL48;MRPL4;MRPL21;MRPL44;MRPS33;MRPL55;MRPL57;MRPS18B;MRPL42;MRPS10;MRPS21;MRPS7;MRPL34;MRPL19;MRPL15;MRPS22;MRPL38;MRPS31;MRPL12;MRPL28;MRPL43;MRPS14;MRPL54;MRPL2;AURKAIP1
prerank,interleukin-1-mediated signaling pathway (GO:0070498),-0.20906675363004107,-0.8345590815768859,0.8652849740932642,0.9698300403619992,1.0,38/94,31.88%,NOD1;RPS6KA5;CUL1;RBX1;ST18;NFKBIA;RPS6KA4;PSMF1;PSMB8;MAPK3;PSMA4;NOD2;PSMB10;PSMB2;MAP3K3;TAB1;PSMC4;PSMA6;PSMD9;PSMD11;PSMD5;UBE2V1;CHUK;PELI1;MAP3K7;PSMA8;PSMB1;EGR1;TRAF6;PSMD10;IL1A;IL1R2;SQSTM1;UBC;RPS27A;IKBKG;IL1R1;PSMC3
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.33639516822892207,0.833973302006564,0.6687402799377916,0.9670941464132526,1.0,9/22,19.92%,RAPGEF2;NTF3;ACAP2;NTRK3;RAPGEF1;WASF1;AKT1;BDNF;EHD1
prerank,protein modification by small protein removal (GO:0070646),0.24347449856715753,0.8338209985538888,0.8006362672322376,0.9668407797564005,1.0,70/252,23.49%,SMAD3;AR;OGT;CCNA2;TGFBR1;SMURF2;USP11;PSME4;USP47;USP20;INO80;USP35;USP24;USP48;KAT2B;SMAD1;PRKN;USPL1;RHOT1;ACTR8;OTULINL;TNIP2;USP30;USP9Y;GPS1;COPS3;USP32;USP10;USP9X;USP38;PTEN;SENP6;ADRM1;TADA3;SUDS3;UBE2D1;FOXK2;SENP8;SENP7;COPS2;PSMB5;PSMC2;TNIP1;BECN1;PSMD1;PSMD4;UIMC1;CLSPN;MDM4;PSME3;USP49;USP46;BRCC3;MBD6;USP37;USP3;PSMA3;ASXL2;UCHL1;STAMBPL1;ATXN7;SMAD2;BIRC2;BIRC3;ABRAXAS2;PSMA2;BRCA1;ATXN3;PSMC5;VCPIP1
prerank,sterol transport (GO:0015918),-0.29949372921489836,-0.8335862250595777,0.6900269541778976,0.9707780471843606,1.0,6/19,18.10%,CAV1;NPC2;OSBPL2;ARV1;OSBP;MSR1
prerank,protein localization to microtubule organizing center (GO:1905508),-0.31701727211011066,-0.8334125726184497,0.6868932038834952,0.9700753501146898,1.0,6/15,24.40%,CEP83;STIL;SPAG5;CEP131;CSNK1D;CCDC14
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.30864491941519767,-0.8334125488120167,0.7055837563451777,0.9690010695497787,1.0,8/17,30.71%,EMC3;EMC9;CAMLG;MMGT1;EMC4;SGTA;GET3;GET1
prerank,mammary gland epithelium development (GO:0061180),-0.31949131712870743,-0.8332381337125314,0.713216957605985,0.9682889658517306,1.0,4/14,10.09%,ERBB4;JAK2;ID2;SCRIB
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.35451556363759384,-0.8328584574380081,0.7040572792362768,0.9669275172408546,1.0,4/10,32.07%,VLDLR;AP2A1;AP2M1;MYLIP
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.35451556363759384,-0.8328584574380081,0.7040572792362768,0.9669275172408546,1.0,4/10,32.07%,VLDLR;AP2A1;AP2M1;MYLIP
prerank,negative regulation of B cell activation (GO:0050869),0.3451616353747059,0.8326909315143282,0.6614906832298136,0.9684093305011995,1.0,2/21,5.05%,LYN;SFRP1
prerank,membrane protein ectodomain proteolysis (GO:0006509),-0.2891136243268137,-0.8322299814267787,0.7146596858638743,0.9671294644176861,1.0,7/21,19.78%,ADAM10;SPPL3;BACE2;ADAM19;RBMX;ADAM9;APH1A
prerank,negative regulation of leukocyte migration (GO:0002686),-0.35722720308164474,-0.8320862217194337,0.6681922196796338,0.9663517739562864,1.0,1/10,0.43%,SLIT2
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.29896281418671183,-0.8311843959608576,0.680327868852459,0.9671217100417547,1.0,6/18,24.52%,NUP93;HHEX;DDX19B;MCM3AP;DDX25;POLDIP3
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.3325775811967526,0.8309999229010246,0.6716417910447762,0.9710514589620283,1.0,7/23,18.89%,REXO4;DNASE1L1;DNASE2;CECR2;KPNA1;KPNB1;DICER1
prerank,stress-activated MAPK cascade (GO:0051403),-0.22445886560935008,-0.8308551200353261,0.8149606299212598,0.9667192172909006,1.0,26/61,30.87%,NOD1;TNFRSF19;CUL1;MAPK10;MAPK8;MAPK3;MAP4K3;ARHGEF6;NOD2;TAB1;MAP3K11;UBE2V1;MAP2K3;CHUK;MAPK1;MINK1;MAP3K7;MAPK11;MAP2K4;TRAF6;GPS2;PTGER4;UBC;RPS27A;MAP3K10;IKBKG
prerank,mitochondrial gene expression (GO:0140053),-0.24737933971460763,-0.8308305524084093,0.7413793103448276,0.9657136409564245,1.0,12/42,20.17%,TFB2M;NOA1;GFM2;SLC25A33;MRPS18A;MRPS12;NDUFA7;FASTKD2;MRPL57;MRPS18B;MRPS21;MRPS7
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.24447729314141378,-0.8308107058192575,0.770764119601329,0.964702795258392,1.0,10/40,16.03%,SMURF1;PTK2B;HIPK2;RPS7;RPL11;TAF1;FOXF2;RPL5;RAD23A;GNA12
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.32675362599832175,0.8305042760437442,0.6825396825396826,0.9714448117845945,1.0,3/25,7.75%,SMAD3;NOS1AP;TLR6
prerank,positive regulation of erythrocyte differentiation (GO:0045648),-0.2700919079184591,-0.830402147969316,0.7032640949554896,0.9644749347573305,1.0,8/25,17.76%,MED1;TAL1;ACVR2A;HIF1A;PRKDC;INHBA;FAM210B;HMGB2
prerank,cell proliferation in forebrain (GO:0021846),0.400064276634561,0.8303576210165492,0.6678141135972461,0.9711973450202354,1.0,3/10,20.66%,NUMBL;AKNA;CEP120
prerank,atrial septum morphogenesis (GO:0060413),0.39591443499363954,0.8303032791683141,0.6482142857142857,0.970759015685835,1.0,2/10,4.67%,NOTCH2;ACVR1
prerank,production of siRNA involved in RNA interference (GO:0030422),0.39870285367353453,0.8302735659030579,0.6765734265734266,0.9702897835857528,1.0,4/10,22.16%,PRKRA;TSNAX;DICER1;DROSHA
prerank,cellular response to nutrient levels (GO:0031669),-0.22731159370373344,-0.8302215396924423,0.7950819672131147,0.9637809014349582,1.0,20/62,22.27%,HSPA8;MFSD2A;ULK1;CLEC16A;WDR45B;SIRT1;RALB;MTOR;FAM107A;ATG14;GAS2L1;INHBB;FOXO1;WIPI2;BMPR2;FLCN;VPS41;ATG7;NUPR2;ZFYVE1
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.27259366318016515,0.8300054813672685,0.7402912621359223,0.9702551796459503,1.0,11/79,13.73%,SEC24D;DYNLL1;SEC31A;CTSF;DYNC1H1;DCTN6;CAPZB;AP1M1;DYNC1I2;CTSL;SEC23A
prerank,regulation of mononuclear cell migration (GO:0071675),0.3284848565754442,0.829804440448068,0.661144578313253,0.9700836845096589,1.0,3/23,4.18%,LYN;IL34;CSF1
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),-0.21388909595836614,-0.8296703013667136,0.8252427184466019,0.9638344562220911,1.0,27/86,24.26%,EGLN3;KLF2;RBX1;EGLN2;VEGFA;PSMF1;PSMB8;PSMA4;PSMB10;HIF1A;PSMB2;HIGD1A;CUL2;EP300;PSMC4;PSMA6;PSMD9;PSMD11;PSMD5;BACH1;ATF3;ATF4;VHL;DNAJB1;PSMA8;PSMB1;MAPK7
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.377994214154779,0.8294603885189692,0.6700680272108843,0.9701910309687815,1.0,5/12,23.03%,RECQL5;NELFE;TCERG1;HNRNPU;HEXIM1
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.27459725962687936,0.8289472747098441,0.731016731016731,0.9706443315269575,1.0,26/69,27.21%,FAF2;DERL1;UBXN4;DERL3;UBE4B;RNF185;ECPAS;FOXRED2;SELENOS;AMFR;TMUB1;AUP1;TMEM67;ERLIN1;JKAMP;BAG6;WFS1;HSPA5;ERLIN2;OS9;UBE2J2;FBXO2;FBXO17;DNAJB12;DNAJB9;TMUB2
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.3613453544794295,0.8288818639839635,0.696078431372549,0.970234080377149,1.0,5/16,17.55%,TERF2;TNKS2;RTEL1;ATM;NAF1
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.3996875928025937,0.8288049619767416,0.6593001841620626,0.9698533560301935,1.0,5/10,25.74%,TLR6;MIA3;AKT1;MYD88;TICAM1
prerank,regulation of axon regeneration (GO:0048679),0.385575567861945,0.8287968370795548,0.672787979966611,0.9693430669686466,1.0,2/12,5.18%,EPHA4;PTPRS
prerank,positive regulation of catabolic process (GO:0009896),0.28086644400016925,0.8286464232046776,0.7280813214739518,0.9690920471957,1.0,6/65,5.56%,HECW2;DACT1;NKD1;NEDD4;SMURF2;VIP
prerank,establishment of protein localization to membrane (GO:0090150),0.2799620212639465,0.8284062806197762,0.7341115434500648,0.9690051009642939,1.0,17/66,18.02%,RFTN1;GORASP2;YIF1B;COX18;AFDN;MYO1C;EGFR;BRAF;VPS37D;GORASP1;RAB3GAP1;PARD3;PIKFYVE;NPC1;ZDHHC20;MICALL1;PRKCI
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.3312785943650864,0.8282523632752911,0.6885758998435054,0.968738109146688,1.0,10/25,23.90%,RECQL5;WDR43;CDK12;NELFE;TCERG1;CDC73;HNRNPU;LEO1;HEXIM1;CDK13
prerank,response to amino acid (GO:0043200),-0.2635950826577408,-0.8281398655637744,0.6985074626865672,0.9658536279852955,1.0,7/31,12.39%,SH3BP4;GLRA1;GLRA2;SPAAR;LARS1;IPO5;MTOR
prerank,negative regulation of intracellular protein transport (GO:0090317),0.3393008776290253,0.8276120633412382,0.6765163297045101,0.9693896760731583,1.0,4/22,6.60%,SP100;RAB23;LMAN1;LRRK2
prerank,cardiac cell development (GO:0055006),0.3847258629554867,0.8275593940734414,0.6950354609929078,0.9689636038091571,1.0,1/11,1.14%,SLC8A1
prerank,negative regulation of Notch signaling pathway (GO:0045746),-0.2686850362745948,-0.8275223535840132,0.7567567567567568,0.965962152239273,1.0,8/28,19.60%,NOTCH3;BEND6;GATA2;LFNG;HEY1;DLL4;DLL1;EGFL7
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.31592292828347046,-0.8273444488568721,0.6911764705882353,0.9652620972432351,1.0,1/15,0.27%,PRKCH
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.2839828944312548,0.8269136009466104,0.7330677290836654,0.9696520646559059,1.0,5/59,7.22%,CYP7B1;SLC27A5;ALDH1A2;HOGA1;CYP27A1
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.3226999689899461,0.8264431966257786,0.6941529235382309,0.9699868372284959,1.0,5/29,11.48%,RUNX1;YAP1;STRN3;FOXA1;UFL1
prerank,positive regulation of fatty acid oxidation (GO:0046321),-0.340197043174918,-0.8256511845475553,0.6931567328918322,0.9675051903160473,1.0,7/12,37.22%,PPARGC1A;MTLN;TWIST1;IRS2;MLYCD;NR4A3;PLIN5
prerank,positive regulation of triglyceride metabolic process (GO:0090208),0.35753648881118016,0.8249958834849235,0.6718213058419243,0.9721347170546114,1.0,3/16,7.36%,APOA1;LDLR;SREBF1
prerank,regulation of neurogenesis (GO:0050767),0.286427278207732,0.8247931710325149,0.7418478260869565,0.9720077099423281,1.0,7/55,6.12%,ASCL1;YAP1;NUMBL;APPL2;LIG4;SERPINF1;HES7
prerank,megakaryocyte differentiation (GO:0030219),-0.33379812566363914,-0.8247912713651928,0.6666666666666666,0.9681238849387828,1.0,4/11,17.09%,MED1;TAL1;UBA5;ZFPM1
prerank,positive regulation of macrophage chemotaxis (GO:0010759),0.36318738790465555,0.8242038051024261,0.684654300168634,0.9725654079472634,1.0,2/14,4.18%,IL34;CSF1
prerank,endoderm formation (GO:0001706),0.3049898421054493,0.8230475380560965,0.6681350954478708,0.9741779725474109,1.0,4/35,5.48%,COL11A1;MMP2;VTN;ITGB5
prerank,protein K48-linked ubiquitination (GO:0070936),0.2853760070716283,0.8226344459579734,0.7262872628726287,0.9744047920188478,1.0,20/54,20.63%,RFFL;BFAR;PRKN;ITCH;IFI27;RNF6;RNF152;KBTBD7;UBE2E2;AMFR;FBXO38;UBE2D1;HACE1;UBR5;UBE2R2;UBE3A;RNF34;TRIM32;ARIH2;UBE2T
prerank,clathrin coat assembly (GO:0048268),-0.31058152288918134,-0.8225514564536559,0.6887755102040817,0.971355034674535,1.0,2/15,6.51%,SGIP1;HIP1R
prerank,neurogenesis (GO:0022008),0.2959486876564633,0.8224325789747786,0.703601108033241,0.9742784713486621,1.0,8/43,10.17%,DAGLA;ASCL1;NEUROD1;THOC2;DCHS1;LPAR1;METTL14;RYK
prerank,regulation of viral release from host cell (GO:1902186),-0.291805530332913,-0.8223187364172986,0.7122093023255814,0.9707546205445304,1.0,10/21,29.20%,TRIM25;VPS37B;TRIM11;TRIM62;VPS4A;CHMP2B;TRIM28;TRIM13;MID2;TRIM35
prerank,cation transmembrane transport (GO:0098655),0.30001280419549536,0.821801626760602,0.7275204359673024,0.9748941678021755,1.0,4/44,5.38%,SLC7A2;ATP1A2;SLC6A9;SFXN2
prerank,erythrocyte differentiation (GO:0030218),0.29704750147532816,0.8216178619680787,0.7160664819944599,0.9747078791095767,1.0,4/44,4.30%,TGFBR3;LYN;KIT;CDK5RAP3
prerank,RNA export from nucleus (GO:0006405),-0.20592335606680784,-0.8211263946714094,0.906832298136646,0.9720145421135197,1.0,28/100,22.14%,NUP93;NUP35;NUP153;NUP160;EIF4E;NUP54;RBM8A;ALYREF;HHEX;CHTOP;HNRNPA2B1;YTHDC1;SRSF7;SEC13;SMG7;NUP155;DDX19B;RANBP2;GLE1;DHX38;NUP88;MCM3AP;THOC6;SRSF4;NUP62;SLBP;DDX25;NUP85
prerank,selective autophagy (GO:0061912),0.2860206725720833,0.8203397698236691,0.711139896373057,0.9764688374604354,1.0,14/56,18.44%,DYNLL1;DYNC1H1;ULK2;WDR81;PRKN;UFL1;USP30;DYNC1I2;UFC1;AUP1;ATM;BECN1;ATG2B;PHB2
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.3699962574830534,0.820329704025712,0.6897133220910624,0.9759607400933595,1.0,4/13,20.22%,ARID1B;ZMIZ1;ELOF1;SERTAD1
prerank,regulation of DNA recombination (GO:0000018),-0.2576950057275142,-0.8198232049465677,0.7539936102236422,0.9735183559460218,1.0,14/32,35.95%,KDM1A;MSH3;ALYREF;ZRANB3;RAD51;SHLD2;MSH2;RAD51AP1;H1-0;FIGNL1;IL7R;RPA2;SIRT6;IL4
prerank,positive regulation of DNA repair (GO:0045739),0.29229826059489294,0.8195420544583973,0.731638418079096,0.9768175375560502,1.0,2/46,1.57%,EYA2;EYA1
prerank,regulation of catecholamine secretion (GO:0050433),0.31987925173178355,0.8191085094107247,0.701780415430267,0.9770784619983364,1.0,8/29,20.07%,DTNBP1;SYT9;DRD3;PRKN;SYT11;SYT12;SYT13;CHRNB2
prerank,cardiac atrium morphogenesis (GO:0003209),-0.30300613741367144,-0.8188171033910068,0.7361809045226131,0.9743861917792511,1.0,6/16,17.36%,NOTCH1;TGFB2;HEY2;ZFPM1;DLL4;BMPR2
prerank,negative regulation of immune effector process (GO:0002698),-0.32186296580827545,-0.8187736590347774,0.687041564792176,0.9734191227339511,1.0,2/13,6.57%,RPS19;CD55
prerank,positive regulation of cholesterol efflux (GO:0010875),0.33833990554398724,0.8185124896567424,0.687797147385103,0.9776624673955033,1.0,3/21,4.30%,LRP1;APOE;APOA1
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),-0.23298989858809244,-0.8184551242168023,0.797153024911032,0.9730277230437889,1.0,12/48,16.61%,FNIP2;HIPK2;SNW1;CRIP1;DDIT4;SIRT1;BCL2L1;MCL1;BAK1;DYRK2;PRKDC;EP300
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.3887584671823652,0.8181010442493484,0.6906854130052724,0.9778998852092229,1.0,2/10,7.37%,CDC42;SIRT2
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.3674256676130796,0.8180999742372396,0.6851851851851852,0.9773788321790179,1.0,5/13,23.03%,RECQL5;NELFE;TCERG1;HNRNPU;HEXIM1
prerank,regulation of ERAD pathway (GO:1904292),0.3845026660015344,0.8178622512929481,0.6774193548387096,0.9772889725940371,1.0,5/11,23.17%,RNF185;TMEM259;RNFT1;BAG6;ATXN3
prerank,low-density lipoprotein particle remodeling (GO:0034374),-0.3408149652812964,-0.8175159482244235,0.7260579064587973,0.9737432198574054,1.0,2/11,8.30%,PLA2G7;ABCG1
prerank,positive regulation of mitotic cell cycle (GO:0045931),-0.27105346808354863,-0.8175037003072206,0.7130434782608696,0.9727254565198283,1.0,12/26,29.18%,EIF4E;MEIS2;TAL1;HES1;LGMN;USP22;APP;CUL3;RPS6KB1;DUSP3;TTL;USP2
prerank,B cell mediated immunity (GO:0019724),-0.3478622877137817,-0.8172479918941494,0.7030878859857482,0.9721915614331883,1.0,5/10,32.14%,FCER1G;CD27;MSH2;FCGR2B;TLR8
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.38502717391574204,0.8171806055025564,0.7,0.9780123786496524,1.0,1/11,1.77%,LYN
prerank,protein export from nucleus (GO:0006611),0.32070538003239196,0.8171021202894896,0.7113237639553429,0.9776273760470122,1.0,8/27,20.51%,RANBP17;NUP42;XPO7;CSE1L;STRADA;NUP214;TPR;CCHCR1
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.3760591281317171,0.8170368323006963,0.6892361111111112,0.9772276417854896,1.0,4/12,14.19%,RESF1;TET1;PPHLN1;SETDB1
prerank,sodium ion import across plasma membrane (GO:0098719),0.3559196087173531,0.8168176464199672,0.7003311258278145,0.9771115689799764,1.0,4/17,9.40%,SLC8A1;SLC9A9;SLC9A5;TRPM4
prerank,substantia nigra development (GO:0021762),0.3000648989314471,0.8165336939332783,0.7185714285714285,0.9770874601452587,1.0,10/37,14.90%,DYNLL1;CDC42;SIRT2;CKB;TTBK1;YWHAE;SYNGR3;ZNF148;MAOB;SUDS3
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.27969298913679325,0.8164520135679786,0.7437252311756936,0.9767134905393228,1.0,10/55,11.08%,BCL2;TGFBR1;NUPR1;PML;ING5;TRAF7;BCL2L11;BCAP31;LTBR;GSDME
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.32591621962619327,0.8164335618870627,0.7015625,0.9762314476294294,1.0,10/24,23.52%,LRRK2;PRKN;CREB3;SELENOS;NR1H3;TMBIM6;CREB3L1;OPA1;WFS1;TXNDC12
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.3452796949350201,0.8159284054772848,0.6935749588138386,0.9766059034043179,1.0,4/17,15.91%,FAF2;DERL1;SELENOS;AUP1
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.31774177681237464,0.815637666730588,0.6927899686520376,0.9766349454524832,1.0,3/26,7.75%,SMAD3;NOS1AP;TLR6
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.25006711890033345,0.8153783154349334,0.7889908256880734,0.9765825978900707,1.0,19/140,13.99%,ADRA1B;SLC8A1;ADCY5;XCR1;PDGFRA;ACKR2;CCR9;BDKRB2;CACNA1C;AGTR1;LPAR1;DRD3;BCAP31;TRPM4;P2RX5;C1QTNF1;CXCR6;CXCL13;DLG4
prerank,regulation of exosomal secretion (GO:1903541),0.33618622838772594,0.8146016457855517,0.6878048780487804,0.9774635490030547,1.0,4/19,13.90%,ATP9A;SDC1;PRKN;SDC4
prerank,water transport (GO:0006833),0.3718645161290619,0.814327066799449,0.6868686868686869,0.9774350370005941,1.0,2/12,8.37%,PDPN;AQP6
prerank,regulation of T cell differentiation in thymus (GO:0033081),0.3723116155818517,0.8141828788446964,0.6610738255033557,0.9771693232922939,1.0,4/13,16.71%,GLI2;VNN1;BMP4;SHH
prerank,phosphate ion transport (GO:0006817),-0.30600462083895563,-0.814007307240129,0.6926829268292682,0.9772413400330908,1.0,4/16,15.86%,SLC37A3;SLC25A30;SLC25A11;XPR1
prerank,response to lipid (GO:0033993),0.2540116413827089,0.8139554774473038,0.7848699763593381,0.9770474456732351,1.0,16/105,15.91%,RBP4;WNT8B;FGFR4;ASCL1;RARG;CTSH;STRN3;IRAK3;STAT5B;FOXA1;LIAS;GPX3;PAQR7;GATA6;RXRA;MAPKAPK2
prerank,receptor catabolic process (GO:0032801),-0.27217068558194984,-0.8132258092143653,0.7647058823529411,0.9776598125950116,1.0,7/24,15.09%,SMURF1;KIF16B;RNF43;TGFB1;LGMN;VLDLR;AP2A1
prerank,nucleotide-sugar metabolic process (GO:0009225),0.3803320055769892,0.8131807379285968,0.6982456140350877,0.97792466867956,1.0,3/12,8.21%,GMDS;SLC35A3;GFPT1
prerank,protein sumoylation (GO:0016925),-0.23273035579388968,-0.8131408054694875,0.8178438661710037,0.9767674662980359,1.0,13/49,17.88%,IFIH1;NUP93;NUP35;NUP153;NUP160;SAE1;NUP54;BCL11A;RANGAP1;NUP155;STX1A;RANBP2;NUP88
prerank,regulation of organelle assembly (GO:1902115),0.27086679077735537,0.8130520777177883,0.740880503144654,0.9776376346064058,1.0,14/73,15.46%,GSN;USP6NL;NPRL3;TBC1D19;ALMS1;ADPRH;CENPJ;MTMR3;TBC1D2B;SENP6;PLK2;TBC1D20;PIKFYVE;NPRL2
prerank,chromatin organization (GO:0006325),0.254073596447688,0.8128505444562524,0.7922535211267606,0.9774749057198213,1.0,24/132,14.19%,SETD7;BRWD1;NPM3;CBX3;INO80;SMARCA1;NPM2;DR1;SMARCC2;MTA2;TCF7L1;KDM5B;KAT2B;ZBTB1;FOXA1;BAZ1B;PHF1;KDM5C;SETD5;L3MBTL1;HDAC8;SMARCD2;HDAC4;SETDB1
prerank,protein autoprocessing (GO:0016540),0.35289436054263323,0.8127169336698047,0.6863057324840764,0.9771959251595127,1.0,4/17,20.01%,SPRTN;CTSL;CASP1;AFG3L2
prerank,positive regulation of locomotion (GO:0040017),-0.2612122984641832,-0.8122544050796076,0.7748538011695907,0.9774482966425854,1.0,5/27,11.49%,SPOCK2;THBS1;STX3;CAVIN1;TGFB1
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.3373704957842457,0.8120366725278669,0.7293233082706767,0.9778899654845802,1.0,10/22,27.44%,ERI3;FTSJ3;ERI1;EXOSC7;EXOSC2;NOP14;ERI2;EXOSC8;EXOSC9;KRI1
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.3761019734525245,0.8119197017477299,0.6863468634686347,0.9775880147417205,1.0,4/11,24.23%,NOS1AP;ALG10B;LRRC38;LRRC55
prerank,mitochondrial transcription (GO:0006390),0.3833870376137584,0.8118783314524488,0.6593001841620626,0.9771374684221514,1.0,4/10,17.92%,TFAM;POLRMT;TEFM;FOXO3
prerank,nonribosomal peptide biosynthetic process (GO:0019184),-0.3262478327722047,-0.8117848007816291,0.7054631828978623,0.9772559102624152,1.0,6/12,26.31%,GCLM;OPLAH;GCLC;GGT1;GGCT;GSS
prerank,regulation of histone deacetylation (GO:0031063),-0.32265245661627034,-0.8109537446821293,0.6990740740740741,0.9778119947925584,1.0,4/13,14.47%,CAMK2D;CTBP1;APLNR;PRMT6
prerank,positive regulation of cellular protein catabolic process (GO:1903364),0.3422227224284389,0.8109247204995429,0.7120253164556962,0.978307464611075,1.0,2/18,3.47%,DACT1;APOE
prerank,protein targeting (GO:0006605),-0.19631789278609887,-0.8108056405573394,0.910828025477707,0.9770584053199672,1.0,46/118,29.92%,NLGN1;RASSF9;ZDHHC2;SDCBP;TOMM70;SORL1;AP4E1;RPL11;AKAP6;RTP4;ZDHHC15;AQP11;ZDHHC14;VPS37B;VPS37A;ATG3;CDC37;GIPC1;ARL6;TOMM7;TRAK2;HOMER3;CACNG3;ZFAND2B;TOMM40;SPCS1;PEX12;FBXO7;FIS1;TIMM10;VPS37C;HAP1;GABARAP;ZDHHC18;PEX16;EDEM1;AIP;HACL1;ZDHHC24;NACAD;SRPRA;TIMM17A;TIMM22;SEC61G;ZDHHC22;SEC63
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.3766258468609688,0.8106876214611819,0.6771378708551483,0.9781866354036014,1.0,1/11,1.86%,BCL2
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.36946481998170067,0.8104659957969027,0.699825479930192,0.9780530981855041,1.0,5/13,28.02%,ETS1;MDK;NFAT5;RELA;IL6
prerank,pyrimidine nucleoside catabolic process (GO:0046135),-0.3457160837597158,-0.8104631799589043,0.7007125890736342,0.9766864033480844,1.0,4/10,17.65%,NT5E;NT5C1A;UPB1;NT5C
prerank,female gamete generation (GO:0007292),0.3122349970178777,0.810449755678018,0.7050359712230215,0.9775690472504934,1.0,11/29,24.42%,DMC1;DIAPH2;PARN;BMP15;USP9X;MDK;METTL3;GDF9;TOB2;SPO11;NANOS3
prerank,axon development (GO:0061564),0.26370987633624343,0.8102682683310504,0.7615480649188514,0.977379345850463,1.0,16/78,15.11%,NREP;FGFR2;VASH2;SEMA5A;MTR;BRSK1;ARHGAP35;PARD6B;EPHB2;RYK;EPHB3;SLITRK2;NTNG2;MARK2;LLGL1;PARD3
prerank,regulation of protein catabolic process (GO:0042176),0.26052191676319364,0.810216957955212,0.7783132530120482,0.9769527613391422,1.0,24/99,19.71%,HECW2;DACT1;NKD1;NEDD4;SMURF2;VIP;SIRT2;IRAK3;EGFR;SNX12;WDR91;PRKN;ITCH;BANP;FLNA;PLK2;HACE1;HUWE1;AGAP2;OAZ3;TRIM32;CDKN1B;MDM4;IDE
prerank,regulation of triglyceride biosynthetic process (GO:0010866),0.350802064467189,0.8099278252160311,0.697594501718213,0.9769354326024791,1.0,3/15,7.36%,LDLR;SIK1;SREBF1
prerank,regulation of myotube differentiation (GO:0010830),-0.2693707125127775,-0.8099057158358818,0.7584415584415585,0.9766335812610235,1.0,5/24,11.40%,PIEZO1;NOTCH1;CCN3;ATP11A;SMYD1
prerank,nucleoside catabolic process (GO:0009164),-0.3355164990299085,-0.8097898287004227,0.7089552238805971,0.9758038792856595,1.0,4/11,17.65%,NT5E;NT5C1A;UPB1;NT5C
prerank,negative regulation of neuron death (GO:1901215),0.2657458429061673,0.8097108369769753,0.7677261613691931,0.9768359771911802,1.0,14/93,11.94%,GDNF;BCL2;APOE;INPP5A;CSF1;MT3;NTF3;LIG4;LRRK2;SLC30A10;CD200;PRKN;CLN3;REST
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.3155286573263912,0.8096197380010675,0.7117117117117117,0.9764796588399982,1.0,1/29,1.53%,ARRDC4
prerank,negative regulation of interferon-gamma production (GO:0032689),0.322932755881401,0.8095140155157344,0.7178217821782178,0.9761471606497939,1.0,2/23,4.70%,GAS6;AXL
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.37454215320490625,0.8092904951217677,0.6790780141843972,0.9760360275048406,1.0,4/13,14.79%,NUPR1;EIF2AK3;MANF;NR1H3
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.35432799770986156,0.8092815823975353,0.7207678883071553,0.9755396350737342,1.0,4/15,10.16%,FGFR1;SEMA5A;SMOC2;FGF2
prerank,cellular response to dsRNA (GO:0071359),-0.30184278635647865,-0.8092155658097256,0.710997442455243,0.9757624562118032,1.0,6/15,19.40%,CAV1;IFIH1;CGAS;RALB;NPM1;DHX9
prerank,protein localization to Golgi apparatus (GO:0034067),0.32015190525648946,0.8089750932059615,0.6980854197349042,0.9755619397053656,1.0,8/27,17.90%,OBSL1;OPTN;ARL1;ARL5A;GOLPH3;VPS13D;VPS13C;TMED10
prerank,membrane raft organization (GO:0031579),0.3638513469095319,0.8087088840772214,0.7120689655172414,0.975504993362102,1.0,6/15,19.67%,RFTN1;MYADM;CLN3;NPC1;YJEFN3;ABCA7
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),0.38191324458336784,0.8084286789943942,0.6915077989601387,0.9754592672152737,1.0,3/11,11.94%,NONO;PRKN;REST
prerank,Rap protein signal transduction (GO:0032486),0.3863676501464919,0.8080016299852711,0.6733212341197822,0.9757131694218236,1.0,4/10,14.69%,RAPGEF2;RAPGEF1;RAP2A;PLK2
prerank,pore complex assembly (GO:0046931),0.33769546476234924,0.8078686107495504,0.7023622047244095,0.9754337893877163,1.0,4/19,10.95%,PLEKHA7;NUP107;AFDN;NUP98
prerank,pharyngeal system development (GO:0060037),0.35027974093841996,0.8077556538146927,0.6903225806451613,0.9751127835117477,1.0,2/15,3.57%,BMPR1A;TGFBR1
prerank,regulation of response to DNA damage stimulus (GO:2001020),-0.24514560598430346,-0.8073273655039752,0.8047945205479452,0.978249771785707,1.0,14/40,26.22%,CRY1;POLH;SMYD2;MCL1;WDR76;KMT5A;PARG;HMGA2;WRNIP1;UBE2V1;IER3;NSMCE1;FMR1;USP1
prerank,endodermal cell fate commitment (GO:0001711),-0.34449757270937387,-0.8073041212877633,0.6988505747126437,0.9772526663887312,1.0,2/10,9.50%,SOX17;RTF1
prerank,negative regulation of MAP kinase activity (GO:0043407),0.2876023829536891,0.8071353129967783,0.723463687150838,0.9757133084718019,1.0,8/44,14.89%,LYN;APOE;CDK5RAP3;IRAK3;SPRY2;DUSP19;PDCD4;BMP4
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.2947386625772219,0.8070649813014483,0.7240896358543417,0.9753294152504258,1.0,13/41,20.10%,OGT;PRKAG2;NUP107;NUP42;EIF6;NUP98;RAE1;NUP214;GCK;SEH1L;TPR;PRKAG1;AAAS
prerank,protein-containing complex subunit organization (GO:0043933),0.25545147619302055,0.8068803299646454,0.7954271961492179,0.9751737297958986,1.0,20/109,15.11%,TEAD1;MITF;LAMC1;YAP1;PML;CD247;ZW10;RANBP9;PARD6B;PICALM;TSPAN4;NUP98;FANCC;MNAT1;WASF1;KMT2A;LLGL1;DLG4;SNX9;PARD3
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.1941527437245006,-0.8064681320038637,0.9487179487179487,0.9777669041775099,1.0,44/146,23.95%,FHL1;CUL1;RBX1;FBXL7;KCNH5;AVEN;MECP2;RAB11A;TUBB4B;PRKAR2B;PAFAH1B1;YWHAG;RAD51C;ACTR1A;PSMF1;CEP70;CEP135;DCTN1;PSMB8;SDCCAG8;CETN2;CDK5RAP2;PSMA4;PSMB10;CEP57;PSMB2;CCND1;CEP43;CEP63;PSMC4;CLASP1;PSMA6;HAUS2;PSMD9;PSMD11;PSMD5;CENPF;DTL;HMMR;KIF14;CEP131;PSMA8;CSNK1D;PSMB1
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.30212005911372175,0.8063334184158897,0.7327327327327328,0.9756546720379699,1.0,14/32,24.99%,CDK5RAP3;BRSK1;MRNIP;TAOK3;ATM;UIMC1;CLSPN;BRCC3;TAOK1;TRIM39;BRCA1;MRE11;RINT1;CDC14B
prerank,arachidonate transport (GO:1903963),0.3930183431248978,0.8062640933332876,0.7031802120141343,0.9747674205746466,1.0,2/10,8.20%,BDKRB2;DRD3
prerank,arachidonic acid secretion (GO:0050482),0.3930183431248978,0.8062640933332876,0.7031802120141343,0.9747674205746466,1.0,2/10,8.20%,BDKRB2;DRD3
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.2468405776488316,0.8061008231422548,0.8221709006928406,0.9745531417627735,1.0,20/151,11.49%,PAM;GAL3ST2;PLPP3;APOE;SLC44A1;LARGE1;APOA1;GSTM4;PLA2G4A;GSTM2;SPHK2;CERS6;CERS5;MGST1;GSTT1;NMRAL1;CHKB;CDO1;KDSR;ABHD3
prerank,regulation of centriole replication (GO:0046599),0.34158833456377996,0.8060722488119174,0.6888168557536467,0.9740981360742376,1.0,5/18,14.69%,ALMS1;CENPJ;KAT2B;MDM1;PLK2
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.37723020260929496,0.8059975880278126,0.7101449275362319,0.9737296891502664,1.0,3/11,16.18%,IL12B;CARD9;IL23A
prerank,regulation of cytokine production (GO:0001817),0.24738646223087432,0.8050678451389813,0.7896592244418331,0.9748285196214708,1.0,24/126,16.55%,LYN;LGR4;PLA2R1;TWSG1;IGF2BP2;BCL6;IL12B;BATF;CD28;DTX4;MAST2;CCN4;NFAM1;CARD9;ADRA2A;RGCC;TBK1;SYT11;GLMN;ERMAP;ASB1;MAPKAPK2;CD47;PLD4
prerank,DNA alkylation (GO:0006305),0.33407899383308615,0.8047815187262387,0.7037643207855974,0.9742939719786756,1.0,8/19,24.63%,DNMT3A;SPOCD1;KMT2E;DNMT3B;ATRX;DNMT1;PPM1D;DMAP1
prerank,DNA methylation or demethylation (GO:0044728),0.33407899383308615,0.8047815187262387,0.7037643207855974,0.9742939719786756,1.0,8/19,24.63%,DNMT3A;SPOCD1;KMT2E;DNMT3B;ATRX;DNMT1;PPM1D;DMAP1
prerank,atrioventricular valve development (GO:0003171),0.3603875747188628,0.8039722037887315,0.6738410596026491,0.9751720781554322,1.0,4/14,10.11%,BMPR1A;ACVR1;BMP2;SLIT3
prerank,ncRNA catabolic process (GO:0034661),0.3106438510607035,0.8038404543268408,0.7228571428571429,0.9748867307291011,1.0,11/28,25.24%,SND1;PARN;EXOSC7;TUT4;MTREX;NUDT16L1;TENT4B;DIS3L;EXOSC2;XRN1;EXOSC8
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.2028432469056597,-0.8037302983614282,0.8743961352657005,0.9816003512910878,1.0,21/87,20.61%,FHL1;CDK6;CUL1;RBX1;FBXL7;AVEN;BRD7;KLF4;PSMF1;FAM107A;PSMB8;PSMA4;PSMB10;PSMB2;CDKN1A;PSMC4;PSMA6;E2F7;PSMD9;PSMD11;PSMD5
prerank,mRNA transport (GO:0051028),-0.20019635873760122,-0.8033032589633717,0.8816568047337278,0.981330665314991,1.0,28/101,22.14%,NUP93;NUP35;NUP153;NUP160;EIF4E;NUP54;RBM8A;ALYREF;HHEX;CHTOP;HNRNPA2B1;YTHDC1;SRSF7;SEC13;SMG7;NUP155;DDX19B;RANBP2;GLE1;DHX38;NUP88;MCM3AP;THOC6;SRSF4;NUP62;SLBP;DDX25;NUP85
prerank,regulation of chemokine production (GO:0032642),-0.24374590901354368,-0.8031358532844952,0.7685185185185185,0.9805936578783346,1.0,13/36,27.50%,IL33;FOXP1;SIGIRR;APP;HIF1A;TLR4;ACKR1;AGER;AIF1;SNAI2;TREM2;EGR1;LPL
prerank,regulation of programmed cell death (GO:0043067),0.24184801609762033,0.8028405414021389,0.8283752860411899,0.9760800290759399,1.0,13/161,9.32%,DAPK2;STEAP3;ACTN2;DAPK1;MOAP1;NTF3;RARG;BCL6;NDRG1;LRRK2;BCL2L11;ACTN4;PRKN
prerank,negative regulation of viral genome replication (GO:0045071),-0.23642678840590464,-0.8027717507533806,0.8247422680412371,0.9801745974386151,1.0,16/40,29.87%,IFIH1;INPP5K;SRPK1;TASOR;MPHOSPH8;FAM111A;TRIM6;N4BP1;HMGA2;OASL;PLSCR1;IFITM3;ISG15;ISG20;IFIT1;ZC3HAV1
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.33842412096450514,0.8027675179759293,0.7235387045813586,0.9757008421175515,1.0,4/20,12.03%,PID1;DAB2;PICALM;RHOQ
prerank,TOR signaling (GO:0031929),-0.2666687495342317,-0.8027542139273017,0.7811550151975684,0.9791858725769443,1.0,11/26,28.50%,PRR5L;CCDC88A;MTOR;RPS6;RPS6KB2;FLCN;EIF4EBP2;PRR5;RPS6KB1;CARD11;RHEBL1
prerank,cellular response to osmotic stress (GO:0071470),-0.28104679937744925,-0.8022887199207354,0.7688311688311689,0.9789752182427834,1.0,6/21,13.90%,LRRC8D;YBX3;ARHGEF2;SCN2A;RCSD1;TRPV4
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.33472032887718817,0.8021230123185263,0.71334431630972,0.9762997544829048,1.0,3/20,9.62%,BCL2;MOAP1;ITGAV
prerank,negative regulation of cation channel activity (GO:2001258),0.3195931322498925,0.8019111652070287,0.7179104477611941,0.9761453030115247,1.0,4/26,8.61%,SLC6A9;GSTM2;DRD3;EPHB2
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.27065569268179357,-0.8013891928814683,0.7528735632183908,0.979614932440021,1.0,6/23,12.41%,CBFA2T3;CRY1;GSK3A;PFKFB1;PLEK;GIT1
prerank,RNA polyadenylation (GO:0043631),0.316284397755381,0.8005681112255678,0.7257824143070045,0.9774074934017822,1.0,15/26,26.20%,WDR33;PAF1;PCF11;TENT4B;PAPOLG;CPSF2;CDC73;FIP1L1;LEO1;SCAF8;PAPOLA;PAPOLB;GRSF1;SSU72;AHCYL1
prerank,mRNA polyadenylation (GO:0006378),0.316284397755381,0.8005681112255678,0.7257824143070045,0.9774074934017822,1.0,15/26,26.20%,WDR33;PAF1;PCF11;TENT4B;PAPOLG;CPSF2;CDC73;FIP1L1;LEO1;SCAF8;PAPOLA;PAPOLB;GRSF1;SSU72;AHCYL1
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),-0.20507091777374675,-0.8001047371582987,0.8899521531100478,0.9808639925111998,1.0,31/87,29.24%,SDHAF3;NDUFC1;COX17;SLC25A33;NDUFAF2;NDUFA6;DMAC2;NDUFA5;SURF1;TMEM126B;NDUFA7;NDUFA8;COA3;NDUFB7;NDUFA3;NDUFA10;NDUFAF8;NDUFS7;NDUFS1;NDUFS5;NDUFB3;NDUFAF3;DMAC1;NDUFAB1;UQCRFS1;SDHAF1;NDUFB4;NDUFV2;NDUFAF7;NDUFV3;COA5
prerank,regulation of cytoplasmic translation (GO:2000765),-0.29412007642667926,-0.7996595735943489,0.7597087378640777,0.9805868415376459,1.0,7/14,25.42%,YBX3;UNK;DHX9;RBM24;CPEB2;PKM;FMR1
prerank,long-term memory (GO:0007616),0.3346144685609006,0.7994472067338299,0.7194127243066885,0.9788193581420211,1.0,3/19,6.70%,APOE;LDLR;CPEB3
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.34674777037640203,0.799430894777237,0.7142857142857143,0.9783460329167256,1.0,3/16,17.68%,LEPROT;CHMP5;TMEM50B
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.31356068131007087,0.7993621285001141,0.7147239263803681,0.9779633768611813,1.0,5/26,10.76%,SFRP1;STRN3;DAB2;NCOR1;NCOR2
prerank,translational termination (GO:0006415),-0.2049147315527183,-0.7993030820433055,0.9132947976878613,0.9801918603596412,1.0,24/95,21.01%,MRRF;MTRF1L;GFM2;MRPL46;MRPS18A;MRPS5;MRPL39;MRPS26;MRPS12;MRPL48;MRPL4;MRPL21;MRPL44;MRPS33;MRPL55;MRPL57;MRPS18B;MRPL42;MRPS10;MRPS21;MRPS7;MRPL34;MRPL19;MRPL15
prerank,"base-excision repair, gap-filling (GO:0006287)",0.29805218547708984,0.7983265970312554,0.7309941520467836,0.9792365159719213,1.0,5/35,12.07%,OGG1;NEIL1;POLG;POLL;MBD4
prerank,regulation of protein targeting to membrane (GO:0090313),0.311134275767178,0.7981973752193834,0.7219730941704036,0.9789611650516158,1.0,1/28,0.72%,CEMIP
prerank,regulation of cellular protein localization (GO:1903827),0.2851117536966989,0.7977636367896676,0.7423822714681441,0.9791478122574306,1.0,2/45,5.19%,GPC6;PRKAA2
prerank,positive regulation of interferon-beta production (GO:0032728),0.30291973383817644,0.7977577585567811,0.7369207772795217,0.9786530415908303,1.0,9/33,18.22%,IRF1;OAS2;POLR3A;DDX3X;TBK1;RIPK2;RIOK3;RNF135;DHX58
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.3606389902411563,0.7974678023663312,0.6907563025210084,0.9786508722907437,1.0,1/12,2.35%,ACSL1
prerank,phosphate-containing compound metabolic process (GO:0006796),0.23853775168101085,0.7969891099708968,0.8451472191930207,0.9789596964825599,1.0,19/198,9.78%,EPHA7;ENPP1;PLPP3;PXYLP1;ACYP2;PPP3CA;EPHX2;PFKFB4;PLCD1;INPP5A;PLA2G4A;LRRK2;PLCB4;SPHK2;GFPT1;EPHB2;INPP4A;XYLB;SLC20A1
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.3016479300909446,0.7969445347216693,0.7563527653213752,0.9785331785580462,1.0,2/32,4.79%,CDK14;CDK16
prerank,regulation of macrophage differentiation (GO:0045649),0.34843071782167184,0.7964028674329651,0.7114427860696517,0.978966013298745,1.0,2/15,4.18%,IL34;CSF1
prerank,endosome organization (GO:0007032),-0.2343259490280199,-0.796094527012752,0.8149466192170819,0.9847423170651215,1.0,9/41,16.17%,RAB27A;CLCN3;DNAJC13;ALS2CL;WASHC5;EXOC8;CORO1C;AKTIP;DNM1
prerank,cilium assembly (GO:0060271),0.2306247719236547,0.7957556742978263,0.8822314049586777,0.9795742710693064,1.0,43/297,14.91%,ASAP1;GSN;DYNLL1;PARVA;NINL;CEP152;WDPCP;DZIP1L;RAB23;CYS1;CPLANE1;DYNC1H1;PIBF1;NPHP1;TTC39C;B9D1;ALMS1;WDR35;IFT43;IFT27;CENPJ;DNAAF1;FBF1;CFAP46;TRIP11;IFT81;DYNC2I1;CFAP44;CFAP410;YWHAE;CCDC40;DYNC1I2;HAUS1;DYNLRB2;PTPDC1;ARF4;PTPN23;HAUS7;FLNA;HAUS3;CEP164;IFT22;CEP192
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.31592359157709654,0.7956140040294993,0.7389937106918238,0.9793004021238743,1.0,1/26,0.43%,FBN1
prerank,N-glycan processing (GO:0006491),0.33585345055348426,0.7954766166791907,0.7106598984771574,0.9790262937522722,1.0,2/18,2.63%,PRKCSH;MAN1C1
prerank,inositol phosphate biosynthetic process (GO:0032958),-0.33250771807076124,-0.7954631710278685,0.7322274881516587,0.9848073016631949,1.0,8/11,38.65%,IP6K1;IPMK;PPIP5K1;ITPKB;ITPKC;IPPK;IP6K3;PPIP5K2
prerank,positive regulation of embryonic development (GO:0040019),0.3347377665795419,0.7952265993685534,0.7032258064516129,0.978958286552301,1.0,4/19,12.32%,WNT4;OSR1;RBM19;NIBAN2
prerank,DNA replication initiation (GO:0006270),-0.23630185595248157,-0.7952047122968136,0.8244514106583072,0.984230053345463,1.0,15/37,34.68%,DBF4;TOPBP1;ORC4;POLE4;MCM8;LRWD1;MCM3;MCM5;ORC5;PRIM1;CDC6;POLA1;RPA2;CDC34;MCM7
prerank,regulation of chromatin binding (GO:0035561),-0.3392388797626126,-0.794246817432205,0.7451923076923077,0.984870789775503,1.0,3/10,24.44%,BTAF1;KDM4D;HMBOX1
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.31795405819639966,0.7938645334014558,0.721259842519685,0.9807782249401407,1.0,3/23,10.98%,UACA;NMI;DDX3X
prerank,positive regulation of cell division (GO:0051781),0.2976280099333002,0.7937839271583015,0.7450142450142451,0.9804126877339923,1.0,5/38,8.20%,SVIL;FGFR2;CDC42;SIRT2;DRD3
prerank,positive regulation of defense response to virus by host (GO:0002230),-0.2706832785775976,-0.7937457358997129,0.7728459530026109,0.9846907102094878,1.0,9/24,27.98%,TOMM70;AIM2;CGAS;PTPN22;TRIM6;EIF2AK4;TRIM44;LILRB1;TRAF3IP2
prerank,natural killer cell mediated cytotoxicity (GO:0042267),-0.29815783859377876,-0.7933211580504206,0.7518427518427518,0.9844014498983584,1.0,5/16,27.62%,TUBB4B;LYST;RAET1E;CEBPG;CORO1A
prerank,carbohydrate derivative catabolic process (GO:1901136),0.33602953187937445,0.7930825005612963,0.7262479871175523,0.9810677525708849,1.0,4/18,16.22%,ADAMTS9;NGLY1;BPGM;NEU4
prerank,stem cell development (GO:0048864),-0.2987287812321957,-0.7926262831916594,0.7702020202020202,0.9846417608120894,1.0,6/16,29.09%,CDH2;PTPRC;SOX8;SNAI2;NOLC1;WNT7A
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.3188409023280362,0.7924659110758525,0.722488038277512,0.9816254264856376,1.0,9/24,24.10%,SRC;HNRNPA1;TERF2;TNKS2;TENT4B;HNRNPC;HNRNPU;TNKS;XRN1
prerank,mucosal immune response (GO:0002385),0.3450887744430087,0.7923345301369907,0.7167235494880546,0.981343692883005,1.0,2/15,7.85%,PIGR;CAMP
prerank,negative regulation of extracellular matrix organization (GO:1903054),0.3821454554235882,0.7922092380645537,0.7071428571428572,0.981055495284987,1.0,3/10,6.63%,CHADL;CST3;EMILIN1
prerank,glutathione biosynthetic process (GO:0006750),-0.3300723581146755,-0.7921659945474325,0.7297921478060047,0.9843895954713345,1.0,6/11,26.31%,GCLM;OPLAH;GCLC;GGT1;GGCT;GSS
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.2606660579725781,0.7910941259632841,0.7817073170731708,0.9824217377683969,1.0,20/80,19.23%,PLPP3;ATP9A;ZW10;ARFGAP3;COPB1;COPZ2;KDELR3;ERGIC2;GOLPH3L;ERGIC3;UVRAG;COPA;ARF4;ERGIC1;GOLPH3;TAPBP;COPG1;TMED10;RER1;HTT
prerank,regulation of RNA metabolic process (GO:0051252),0.2707956744283976,0.7910435971345089,0.7626459143968871,0.982000438202103,1.0,6/59,5.58%,MITF;SON;HNRNPLL;IGF2BP2;OAS2;SNRNP70
prerank,dendritic cell migration (GO:0036336),0.337068462077243,0.7910199037492273,0.7149532710280374,0.9815360026359403,1.0,2/16,9.40%,CCL19;TRPM4
prerank,ncRNA export from nucleus (GO:0097064),-0.2355727656489272,-0.7906474656842742,0.8096774193548387,0.9859308937713902,1.0,12/36,22.14%,NUP93;NUP35;NUP153;NUP160;NUP54;SEC13;NUP155;RANBP2;NUP88;NPM1;NUP62;NUP85
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.2966801469170227,0.7897038338491628,0.7461858529819695,0.9832026440147327,1.0,15/33,20.58%,EGFR;DDX3X;RGCC;GLI1;PAF1;KMT2E;UBE2E2;AKT1;ADAMTS1;TFDP1;LSM10;CDC73;PHB2;PLCB1;CCND2
prerank,ribonucleoprotein complex assembly (GO:0022618),0.24442276716505365,0.7895088037036645,0.8315789473684211,0.9830209672772228,1.0,23/132,18.89%,POLR2D;CELF2;SF1;TRAF7;ERAL1;EIF6;EIF3A;EIF2S2;DDX23;NOL3;SNRPD2;SRSF5;RBM5;RRP7A;GEMIN2;PRPF6;NAF1;SF3B1;SRSF10;KHDC4;CDC73;DDX1;DICER1
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.33471292957816057,0.789366187750831,0.731418918918919,0.982768528868359,1.0,6/19,20.15%,SRC;HNRNPA1;TERF2;TENT4B;HNRNPC;HNRNPU
prerank,regulation of establishment of protein localization to telomere (GO:0070203),-0.3286808810602758,-0.7893348082989683,0.7534562211981567,0.9871194660476479,1.0,7/11,55.05%,CCT8;CCT6A;CCT7;CCT2;TCP1;WRAP53;DKC1
prerank,response to interferon-beta (GO:0035456),-0.270843191134517,-0.7888692902866652,0.7743732590529248,0.9868695536727607,1.0,8/22,28.44%,AIM2;PNPT1;UBE2K;UBE2G2;TRIM6;PLSCR1;IFITM3;IFNAR2
prerank,positive regulation of T cell activation (GO:0050870),0.2636831492503045,0.7888640772847757,0.7791005291005291,0.9831074474922805,1.0,6/62,9.16%,RHOH;CCL19;IL12B;CD28;ZMIZ1;ZBTB1
prerank,regulation of calcium ion import (GO:0090279),0.3231054164934445,0.7880655831784772,0.7236421725239617,0.9839395580092373,1.0,4/21,17.02%,PDGFRB;SPHK2;EGF;PSEN2
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.37713772200346085,0.788063028844965,0.7157534246575342,0.9834419454152821,1.0,2/10,10.17%,FZD1;RYK
prerank,snRNA 3'-end processing (GO:0034472),-0.2749143394509589,-0.7879598623196379,0.7700831024930748,0.9874377326160743,1.0,7/19,28.81%,INTS6;INTS8;EXOSC5;USB1;INTS1;EXOSC4;TUT1
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.3391649154233995,0.7878655251715181,0.753968253968254,0.983268878968237,1.0,3/16,9.94%,LEPROT;PIBF1;PARP14
prerank,telomere maintenance via telomere lengthening (GO:0010833),-0.24948191308678058,-0.7878180392534164,0.8103975535168195,0.9866784339090415,1.0,6/33,15.44%,ANKRD28;HSP90AB1;DCLRE1B;CTC1;ZBTB48;RAD51
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.36350776477281854,0.7872923104824122,0.7045454545454546,0.9836781342066345,1.0,3/12,17.96%,NUPR1;TTBK1;IL18
prerank,positive regulation of coagulation (GO:0050820),0.37606541772165175,0.7871411793106313,0.7150442477876107,0.9829416641837991,1.0,2/10,11.76%,SERPINE1;F2
prerank,positive regulation of hemostasis (GO:1900048),0.37606541772165175,0.7871411793106313,0.7150442477876107,0.9829416641837991,1.0,2/10,11.76%,SERPINE1;F2
prerank,T cell receptor signaling pathway (GO:0050852),0.23999450979375603,0.7871053889424667,0.8453488372093023,0.9825061698590185,1.0,9/138,7.09%,PDPK1;THEMIS;PIK3R1;FYB1;RFTN1;PSME4;CD247;RNF31;CD28
prerank,negative regulation of JUN kinase activity (GO:0043508),0.3719475276624856,0.7869320021972257,0.7415929203539823,0.9823432988728863,1.0,5/10,26.74%,DUSP19;PDCD4;AIDA;DNAJA1;HIPK3
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),-0.2512797510415675,-0.7868329639920103,0.7739938080495357,0.987270786943109,1.0,10/29,25.12%,EDC3;LSM2;LSM6;EXOSC5;CNOT7;DCP2;CNOT8;DCPS;LSM7;EXOSC4
prerank,gas transport (GO:0015669),-0.33901451354247186,-0.7868218063580086,0.7566371681415929,0.9862609765054691,1.0,2/10,8.56%,IPCEF1;CYGB
prerank,nerve growth factor signaling pathway (GO:0038180),0.3746018247576964,0.7867729654309165,0.7250922509225092,0.9821259791535076,1.0,3/10,9.36%,RAPGEF2;NTF3;RAPGEF1
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.28628343366412173,-0.7867048885548168,0.7696629213483146,0.9854419905222929,1.0,9/17,25.46%,INPP5K;CALM1;DDIT4;CALM3;DGKQ;SPRED2;PPEF2;DMTN;CALM2
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.25035761493342623,-0.7861181055886203,0.8132530120481928,0.9854440728630215,1.0,7/30,15.93%,CAV1;SRCIN1;PTPN2;INPP5F;PRKCZ;PTPN6;PTPRC
prerank,cellular respiration (GO:0045333),-0.23230975293100783,-0.7859772740982276,0.8166666666666667,0.98470375558339,1.0,17/41,25.88%,SLC25A13;PPARGC1A;MTFR1;UQCRH;NDUFA5;CYCS;SURF1;SDHB;MTFR2;MTLN;NDUFS7;NDUFS1;UQCR10;COQ10A;UQCRC1;ETFRF1;UQCRFS1
prerank,dendritic spine organization (GO:0097061),0.3098378313898484,0.7859752483008648,0.7239819004524887,0.9829707453414329,1.0,8/26,13.99%,DOCK10;ITGA3;CDC42;EPHB2;EPHB3;INSR;PTEN;DLG4
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.27795707774236705,-0.7849572532795657,0.7525252525252525,0.9853481393677733,1.0,8/18,32.98%,MECP2;RAB11A;RAD51C;CCND1;DTL;RCC2;CDK1;BRD4
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.31728157990720907,0.784858140533086,0.7602523659305994,0.9843499480762026,1.0,10/24,20.99%,CHD6;MT3;NFE2L2;RBPJ;CEBPB;SESN2;HSF1;MUC1;CREB3L1;DDIT3
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.3140684260652902,0.784627113270183,0.719551282051282,0.9837706965457531,1.0,4/23,9.86%,ZEB2;SLC2A10;DAB2;STK11
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.3140684260652902,0.784627113270183,0.719551282051282,0.9837706965457531,1.0,4/23,9.86%,ZEB2;SLC2A10;DAB2;STK11
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.3459060082686768,0.7845107446452673,0.7546218487394958,0.983449391401334,1.0,2/15,4.30%,APOE;APOA1
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.3739506288547649,0.7844050678072584,0.7076648841354723,0.9831263574732094,1.0,5/11,21.25%,RESF1;PPHLN1;SETDB1;TPR;DNMT1
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.3266326125751331,0.7840662790017163,0.7400950871632329,0.9831676533026169,1.0,7/20,22.93%,AMPD3;GART;AMPD2;PPAT;PFAS;ADSS1;ADSL
prerank,RNA splicing (GO:0008380),-0.19481450857025923,-0.7836763580368677,0.8802083333333334,0.9865411041663549,1.0,20/95,19.90%,MBNL1;IVNS1ABP;SNRPB;PPARGC1A;ZCRB1;SRPK1;RBM8A;SNRPD1;SNRNP40;LSM6;SNRPA1;SRSF7;MPHOSPH10;PPIG;SNRPD3;SNRPN;SF3B4;USB1;WDR83;SRSF4
prerank,regulation of cholesterol efflux (GO:0010874),0.30121063489815886,0.7836636790025937,0.7589285714285714,0.9833074306176526,1.0,9/30,19.67%,LRP1;APOE;APOA1;ABCA3;NR1H3;RXRA;SHH;YJEFN3;ABCA7
prerank,histone H3 deacetylation (GO:0070932),0.3417706428205323,0.7834615528744351,0.7110016420361248,0.9831490816530973,1.0,7/15,25.04%,SIRT2;HDAC8;HDAC4;ELK4;SMARCAD1;SFPQ;HDAC1
prerank,regulation of interleukin-10 production (GO:0032653),-0.2250081991159989,-0.783174361981421,0.8469387755102041,0.9863632654095544,1.0,10/44,20.57%,CD34;PLCG2;TRIB2;TNFRSF21;PRKCZ;NOD2;JAK3;TLR4;DLL1;AGER
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),0.3756335323675138,0.7830122995912671,0.7122557726465364,0.983407142791984,1.0,2/10,12.33%,OGT;SELENOS
prerank,positive regulation of double-strand break repair (GO:2000781),-0.23059587917812635,-0.7819497709150705,0.8279569892473119,0.9873741434430511,1.0,9/39,21.30%,SPIRE1;FMN2;SHLD1;KDM4D;PRKDC;SLF1;PNKP;PARP1;SHLD2
prerank,autophagosome organization (GO:1905037),0.2758399342073327,0.7814736041322682,0.7716643741403026,0.9854182512829177,1.0,15/50,22.93%,RAB23;ULK2;UBXN2B;EMC6;WIPI1;RAB19;MAP1LC3A;BECN1;ATG2B;NSFL1C;WDR45;ATP13A2;ATG9A;STX12;AMBRA1
prerank,positive regulation of superoxide anion generation (GO:0032930),-0.3021335005007053,-0.7812839332318956,0.7444168734491315,0.9874938460409994,1.0,11/13,52.49%,TGFB1;SOD1;MAPT;GSTP1;ITGB2;F2RL1;CD177;SYK;TYROBP;FPR2;CRP
prerank,rRNA transcription (GO:0009303),0.3375826805719351,0.7810905754202662,0.7347972972972973,0.9855504628636215,1.0,3/17,5.98%,POLR1G;BRF1;GTF3C1
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.3011097229210956,-0.780708915521136,0.7649880095923262,0.9873922503403866,1.0,6/14,25.82%,FAM98B;CLP1;CSTF2;TSEN54;TSEN34;CPSF1
prerank,response to glucocorticoid (GO:0051384),0.30453187993677616,0.7804323643408573,0.7496229260935143,0.9861012307358586,1.0,5/26,11.94%,HSD3B2;ZFP36L1;BCL2L11;SLIT3;REST
prerank,sister chromatid segregation (GO:0000819),0.3000104387201616,0.7803415169883051,0.7827380952380952,0.9857474674419513,1.0,10/31,22.73%,INO80;ZW10;TOP2B;CHAMP1;ZWINT;SGO1;CDCA8;DSN1;TUBG2;TUBG1
prerank,striated muscle cell development (GO:0055002),-0.30472690219224763,-0.7803190042619437,0.7576530612244898,0.9870302456998842,1.0,3/14,6.03%,TMOD2;PGM5;TMOD3
prerank,nucleoside phosphate biosynthetic process (GO:1901293),-0.30838119546237663,-0.7802879148777075,0.7755102040816326,0.9860628201560641,1.0,6/14,28.89%,ME1;AK5;AK7;PNP;AK3;NME2
prerank,positive regulation of transforming growth factor beta production (GO:0071636),0.3660629769696421,0.7800144070457304,0.7015706806282722,0.9857673315443395,1.0,4/11,14.75%,BMPR1A;CD200;GATA6;ATP6AP2
prerank,protein targeting to mitochondrion (GO:0006626),0.27376991493115244,0.7795808716409846,0.7927927927927928,0.9859982479704431,1.0,9/52,13.93%,TIMM17B;PMPCB;AIFM1;BCAP31;TIMM44;TIMM9;TSPO;IMMP1L;TOMM22
prerank,phosphatidylinositol metabolic process (GO:0046488),0.2463805021159761,0.7791164643583787,0.8238153098420413,0.9862718398246982,1.0,20/109,16.29%,PIK3R1;PTPN13;PDGFRB;PLCD1;SYNJ2;PLA2G4A;PLEKHA8;PLEKHA2;LPGAT1;MTMR3;INPP4A;MTMR7;FGF2;PI4KA;PIK3R4;PTEN;PGAP3;PIKFYVE;PIK3R2;PIP4K2C
prerank,glucose metabolic process (GO:0006006),0.2688166537228895,0.7790624874722779,0.7871222076215506,0.9858650953994862,1.0,6/58,11.21%,RBP4;MDH2;ENO2;GAA;DCXR;GALM
prerank,oligodendrocyte development (GO:0014003),-0.28933833649091434,-0.7787636110994255,0.7945544554455446,0.9875602344412875,1.0,4/15,14.74%,B4GALT5;EIF2B5;EIF2B1;PLP1
prerank,dendritic spine morphogenesis (GO:0060997),0.3393820129804895,0.7786886132189402,0.7274167987321711,0.9859899817492638,1.0,6/15,13.99%,DOCK10;CDC42;EPHB2;EPHB3;PTEN;DLG4
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.3613840527491875,0.7786106767547897,0.7508532423208191,0.9856347930344375,1.0,2/11,10.17%,FZD1;RYK
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.26469340918077655,0.7782033865757894,0.7945736434108527,0.985793825185211,1.0,9/69,9.32%,GDNF;BCL2;APOE;MT3;NTF3;LIG4;SLC30A10;NONO;PRKN
prerank,zymogen activation (GO:0031638),-0.2322739826049443,-0.7781652666608934,0.8438538205980066,0.9874798102591057,1.0,8/39,14.60%,GRIN2A;PERP;KLK2;PRSS12;CASP8;CYFIP2;LGMN;BAK1
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.2591305334165133,0.7779574960491472,0.8242894056847545,0.9856974234945644,1.0,11/76,12.97%,UACA;SASH1;CCL19;IL12B;NMI;EGFR;ACTN4;TRIP6;DDX3X;PDCD4;CD14
prerank,protein deubiquitination (GO:0016579),0.22777907957032512,0.7778732106963698,0.8807733619763695,0.9853424083249669,1.0,65/242,23.49%,SMAD3;AR;OGT;CCNA2;TGFBR1;SMURF2;USP11;PSME4;ATXN7L3;USP47;USP20;INO80;USP35;USP24;USP48;KAT2B;SMAD1;PRKN;RHOT1;ACTR8;OTULINL;TNIP2;USP30;USP9Y;USP32;USP10;USP9X;USP38;PTEN;ADRM1;TADA3;SUDS3;UBE2D1;FOXK2;SENP8;PSMB5;PSMC2;TNIP1;BECN1;PSMD1;PSMD4;UIMC1;CLSPN;MDM4;PSME3;USP49;USP46;BRCC3;MBD6;USP37;USP3;PSMA3;ASXL2;UCHL1;STAMBPL1;ATXN7;SMAD2;BIRC2;BIRC3;ABRAXAS2;PSMA2;BRCA1;ATXN3;PSMC5;VCPIP1
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.2967945530636492,0.777813053058293,0.7428139183055976,0.9849399023986222,1.0,2/29,3.44%,SERPINE1;GAS6
prerank,G1/S transition of mitotic cell cycle (GO:0000082),-0.19938793580726052,-0.7774709103691654,0.9,0.9875154583003991,1.0,26/83,24.43%,CDK6;CDK17;CUL1;USP29;EIF4E;CDK5;DBF4;DHFR;BCAT1;TYMS;NPAT;CCND1;CUL2;INHBA;E2F3;CDKN1A;CUL3;CDK18;HINFP;PLK3;BACH1;CDKN3;MAX;PIM2;NASP;RPS6KB1
prerank,regulation of viral entry into host cell (GO:0046596),-0.2516299404832542,-0.7773011282253693,0.8148148148148148,0.9867761262240244,1.0,8/30,18.25%,LY6E;TRIM14;HS3ST5;TRIM25;TRIM68;TRIM11;TRIM6;TRIM62
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.29805316004420346,0.7772921334382951,0.7589820359281437,0.985335029117819,1.0,5/31,10.60%,FGFR2;PDGFRA;TGFBR1;OSR1;DYNC2I1
prerank,cellular response to UV-A (GO:0071492),0.3627902190773979,0.7772330903831863,0.7125645438898451,0.9849415756116665,1.0,1/11,2.80%,MMP2
prerank,maintenance of protein location in nucleus (GO:0051457),-0.2747926127358108,-0.777147611449238,0.7780821917808219,0.9860195107853083,1.0,4/20,12.60%,SYNE1;SUN2;RANGAP1;MORC3
prerank,regulation of secretion (GO:0051046),-0.3135295351265389,-0.7764673632312913,0.7874720357941835,0.9860802351785324,1.0,4/13,12.77%,KCNQ1;SGK1;GPLD1;ERBB3
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.2647963187077338,0.7763114476416821,0.8030095759233926,0.9859202846240219,1.0,15/58,20.24%,LIG4;SMC5;DCLRE1C;POLL;UBE2V2;NHEJ1;ERCC8;DCLRE1A;UVRAG;ATM;KAT5;SUMO1;UIMC1;BRCC3;NSMCE2
prerank,positive regulation of vacuole organization (GO:0044090),0.3740300713307125,0.7762070869772374,0.7114093959731543,0.985569095869847,1.0,7/10,29.35%,RAB3GAP1;PIP4K2C;ANXA2;PIP4K2A;SH3GLB1;PIP4K2B;GRN
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.35934090471464675,0.7760875946684029,0.7160493827160493,0.9847647542913105,1.0,3/12,9.28%,KANK1;FBLN1;ACTN4
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.35934090471464675,0.7760875946684029,0.7160493827160493,0.9847647542913105,1.0,3/12,9.28%,KANK1;FBLN1;ACTN4
prerank,negative regulation of heart contraction (GO:0045822),0.36580928959849224,0.7760275889735089,0.7168141592920354,0.9843512677049973,1.0,1/11,1.81%,ATP1A2
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.29296305272858136,0.7759117584537143,0.7315634218289085,0.9840537861053035,1.0,11/29,22.70%,COPB1;COG8;COPZ2;GOSR2;TRAPPC10;COPA;GOLGA5;COPG1;TRAPPC3;COG2;NAPA
prerank,glutamine family amino acid catabolic process (GO:0009065),0.3511152427505199,0.7758645638662043,0.7209705372616985,0.9836294142032131,1.0,1/13,1.26%,GLUL
prerank,negative regulation of defense response to virus (GO:0050687),0.37894449306132255,0.775286448123669,0.7317073170731707,0.9840740652432215,1.0,2/10,13.02%,ITCH;MUL1
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.2996429707339262,0.7752352774939025,0.752906976744186,0.9836673187907026,1.0,12/30,26.31%,LEPROT;PDCD5;RNF31;HUWE1;RHOU;HPS4;ARIH2;SREBF2;VPS11;UBE2J2;SH3GLB1;BAP1
prerank,positive regulation of intracellular transport (GO:0032388),0.29070415361087987,0.7750745127587306,0.7824207492795389,0.9834340188806635,1.0,4/38,9.86%,ACTN2;NEDD4;DYNC1H1;STK11
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.31656150415903045,0.7748133919089871,0.7404580152671756,0.9833369886912497,1.0,2/21,1.65%,DCN;BGN
prerank,histone exchange (GO:0043486),-0.23076708683726466,-0.7745906499104651,0.8444444444444444,0.987999698043926,1.0,14/37,29.14%,MIS18BP1;KNL1;RUVBL1;RSF1;VPS72;NPM1;CENPI;RNF8;CENPN;ANP32E;ZNHIT1;NASP;HJURP;ITGB3BP
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.3463860431865812,0.7739909543536218,0.7269565217391304,0.9841877938666128,1.0,4/13,12.68%,ERLEC1;DERL3;BCAP31;UBAC2
prerank,regulation of amyloid fibril formation (GO:1905906),0.34335064593690434,0.7739613652822729,0.736318407960199,0.983740880271514,1.0,2/15,5.01%,APOE;LDLR
prerank,phosphatidylinositol dephosphorylation (GO:0046856),-0.2611144530186045,-0.7739574754972959,0.8366197183098592,0.9880257685539832,1.0,9/23,22.08%,MTMR2;INPP5K;INPP5F;MTMR9;SACM1L;MTMR6;INPP5B;SYNJ1;TPTE
prerank,regulation of centrosome cycle (GO:0046605),-0.2687399999314356,-0.7737497970822412,0.8028169014084507,0.987328060069687,1.0,8/21,29.11%,PDCD6IP;SIRT1;NPM1;CHMP2B;CEP131;CHMP4B;GEN1;CHMP4C
prerank,cellular response to calcium ion (GO:0071277),0.25808697008950143,0.7735989131757294,0.7951030927835051,0.9838301712055649,1.0,7/67,7.84%,ADCY1;ADGRV1;SLC25A24;PRKAA2;DPEP1;CPNE2;SYT9
prerank,serine family amino acid catabolic process (GO:0009071),-0.3397815014072836,-0.773508471879498,0.7543103448275862,0.9867084871226061,1.0,6/10,38.33%,GCSH;SHMT1;AMT;GLDC;DAO;THNSL2
prerank,positive regulation of peptidase activity (GO:0010952),0.32297740183870743,0.7735010604370274,0.7326892109500805,0.9835009727134558,1.0,6/20,24.23%,CTSH;APH1B;RCN3;PSME3;PRELID1;MAPK12
prerank,response to nutrient levels (GO:0031667),-0.28162697526126307,-0.7732636680699857,0.7755102040816326,0.9860803378311307,1.0,9/17,40.61%,ULK1;MTOR;FAM107A;ATF4;RPS6KB1;RPTOR;SCTR;CD68;UCN2
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.3328705209790192,0.7727156385969736,0.717391304347826,0.9842990515732993,1.0,3/15,10.53%,IL17D;TLR6;CARD9
prerank,regulation of cell division (GO:0051302),0.26046512549377937,0.7726085690860285,0.8097622027534418,0.9839810398712721,1.0,13/72,18.00%,TXNIP;FGFR2;KIF20A;EFHC1;MLLT3;SIRT2;UVRAG;NCOA3;PIK3R4;PLK2;CDK2AP2;SHH;BECN1
prerank,secondary alcohol biosynthetic process (GO:1902653),0.3000913417157438,0.7722192731599887,0.7677514792899408,0.9841002707321909,1.0,4/30,9.33%,INSIG2;APOA1;MVK;IDI1
prerank,positive regulation of lipid storage (GO:0010884),-0.2726067450251573,-0.7720570067655729,0.8,0.9869191088669826,1.0,7/21,27.50%,SCARB1;PLIN2;MSR1;OSBPL11;HILPDA;PLIN3;LPL
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.29762909473335974,-0.7719771125689333,0.7688442211055276,0.9860566457792348,1.0,4/14,13.19%,CD55;TGFBR2;CD81;PTPN22
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.2660911822211671,-0.7717217187741823,0.7845744680851063,0.9854594596351097,1.0,8/21,29.31%,MECP2;RAB11A;RAD51C;CCND1;NPM1;DTL;RCC2;CDK1
prerank,microtubule polymerization or depolymerization (GO:0031109),0.31361724600591434,0.7716827027308019,0.7578008915304606,0.9844752631800279,1.0,4/25,10.16%,NCKAP5;CENPJ;KATNB1;FGF13
prerank,synaptic vesicle membrane organization (GO:0048499),-0.27762893801467714,-0.7716239659888416,0.7449494949494949,0.9846090056411079,1.0,2/17,6.96%,STX3;SYP
prerank,positive regulation of positive chemotaxis (GO:0050927),-0.30081561832520937,-0.7714378206840058,0.7645631067961165,0.9839059428373723,1.0,6/15,23.54%,KDR;CDH13;VEGFA;VEGFC;VEGFD;F3
prerank,positive regulation of viral life cycle (GO:1903902),0.3155319111207426,0.771417397906122,0.7224806201550388,0.9844003013388852,1.0,6/22,21.87%,AXL;KPNA6;P4HB;KPNA2;LGALS9;TSG101
prerank,cellular response to interleukin-7 (GO:0098761),0.32876326950158397,0.7713427698840236,0.7491749174917491,0.983544960987098,1.0,3/17,8.85%,BRWD1;TSLP;STAT5B
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.32876326950158397,0.7713427698840236,0.7491749174917491,0.983544960987098,1.0,3/17,8.85%,BRWD1;TSLP;STAT5B
prerank,chemical homeostasis (GO:0048878),0.2642883450934912,0.7713088200593188,0.7976190476190477,0.9831156653855477,1.0,10/61,16.57%,ZBTB20;RBP1;CEBPA;TLCD1;NR1D2;DDX3X;WNK1;NR1H3;THADA;TENT4B
prerank,nuclear membrane reassembly (GO:0031468),-0.2169673146139102,-0.7712907331518809,0.8687258687258688,0.9831544755996781,1.0,16/54,25.02%,NUP93;NUP35;NUP160;VRK1;PPP2R2A;RANGAP1;EMD;SEC13;NUP155;VPS4A;CCNB2;CHMP2B;NUP85;CHMP4B;CHMP4A;NUP43
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.3430137602027945,0.771083250700798,0.7470686767169179,0.9829686711629583,1.0,4/15,16.32%,SLC45A3;PPM1K;ADM;AKT1
prerank,UV-damage excision repair (GO:0070914),0.3557786086870487,0.7699847147793468,0.7323943661971831,0.984241549859066,1.0,2/12,6.57%,INO80;CUL4B
prerank,regulation of establishment of planar polarity (GO:0090175),0.2512251809098123,0.7695234536179535,0.8315282791817088,0.9844836596130074,1.0,7/88,6.15%,DACT1;FZD2;SMURF2;PRICKLE1;PSME4;FZD1;CDC42
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.3046462711659361,-0.7695189910154262,0.7555012224938875,0.9849591112771837,1.0,7/13,34.41%,CPSF7;CSTF2;CPSF1;CPSF6;CPSF4L;TUT1;NUDT21
prerank,organonitrogen compound catabolic process (GO:1901565),0.2665119768965817,0.7695048493432618,0.8169209431345353,0.9840221387478343,1.0,7/57,10.85%,CPQ;GGACT;PLA2G4A;SMPD2;NAALADL1;CLPX;RENBP
prerank,gene silencing by miRNA (GO:0035195),0.2889550839893264,0.7694888902548817,0.7644508670520231,0.9835540544374056,1.0,11/32,24.62%,ZC3H7B;TNRC6B;WTIP;TNRC6A;EIF6;PRKRA;DICER1;AGO4;RBM4;AGO3;AJUBA
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.3394953535989583,0.7693843655070347,0.7356902356902357,0.9832548394966587,1.0,3/15,13.83%,BCL2;PRKN;TAF9
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.2745684917286038,-0.7688398974413553,0.7412398921832885,0.9850386282214143,1.0,4/18,13.49%,ELOVL7;ELOVL5;TECR;HACD2
prerank,positive regulation of cholesterol transport (GO:0032376),0.3037813645680983,0.768430167578857,0.753822629969419,0.9842879755473537,1.0,3/27,4.30%,LRP1;APOE;APOA1
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.3094337591498091,0.7684027212261398,0.7534039334341907,0.9838374782245959,1.0,3/25,8.51%,MOAP1;PDCD5;BCL2L11
prerank,cellular response to interferon-gamma (GO:0071346),0.24671777168889164,0.7680408945375813,0.8645962732919255,0.9839224240818981,1.0,8/88,6.42%,DAPK1;SP100;CCL19;NCAM1;IRF1;OAS2;CCL4;PML
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.24915442157231957,-0.7674754582027169,0.8353658536585366,0.9861599845729851,1.0,12/26,30.87%,IFIH1;NOD1;CASP8;TNFAIP3;NOD2;TAB1;UBE2V1;MAP3K7;TRAF6;UBC;RPS27A;IKBKG
prerank,epithelial cell differentiation (GO:0030855),0.25300254006061434,0.7674196193866983,0.8380024360535931,0.9844224675923656,1.0,12/88,14.89%,MAF;FGFR2;ASCL1;CNN3;FSTL1;SCUBE1;DAB2;GLI1;VDAC1;GSTK1;GATA6;BMP4
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.32324820917230157,0.7672525248850749,0.7504051863857374,0.9841940584837748,1.0,4/17,15.28%,LYN;CARD9;TAOK3;RNF13
prerank,ATP transport (GO:0015867),0.3692547511511991,0.7668581877601585,0.7385964912280701,0.9843361710999102,1.0,2/10,16.03%,SLC25A24;CD47
prerank,regulation of telomere maintenance (GO:0032204),0.30474933073365357,0.7667390222437185,0.7566302652106084,0.984032109026813,1.0,10/26,27.28%,PML;PPP1R10;HDAC8;TERF2;RTEL1;ATRX;MRE11;RAD50;UPF1;SMG1
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.2924955942568719,0.766623890657097,0.7664233576642335,0.9837193604831609,1.0,15/32,27.02%,SLC44A1;APOA1;CHKB;ABHD3;LCAT;SLC44A3;PCYT1A;PEMT;LPIN3;CEPT1;LPIN2;SLC27A1;SLC44A2;LPIN1;CSNK2B
prerank,positive regulation of immune effector process (GO:0002699),0.29813119961850526,0.7665184719316108,0.7665130568356375,0.9833904535060606,1.0,4/27,7.14%,MYO18A;APPL2;IL12B;DDX60
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.31733198901806803,0.7660981145108785,0.7739938080495357,0.9835740774065143,1.0,2/21,2.08%,LYN;RUNX1
prerank,regulation of tau-protein kinase activity (GO:1902947),-0.32939665627913445,-0.7659599894652057,0.7743362831858407,0.987520369102763,1.0,2/10,6.88%,SORL1;HSP90AB1
prerank,membrane protein proteolysis (GO:0033619),-0.22703125289824405,-0.7657885149003586,0.8738170347003155,0.986781679014838,1.0,11/37,19.78%,ADAM10;RET;SPPL3;BACE2;ADAM19;TGFB1;MBTPS2;RBMX;ADAM9;RHBDD1;APH1A
prerank,negative regulation of protein localization to membrane (GO:1905476),0.3115180967174744,0.765566478593972,0.773071104387292,0.983904576759333,1.0,4/24,12.03%,PID1;DAB2;PICALM;RHOQ
prerank,tricarboxylic acid metabolic process (GO:0072350),0.35340465977770863,0.7651478570542655,0.7363945578231292,0.9840763073697465,1.0,2/12,9.51%,ACO1;IDH2
prerank,fluid transport (GO:0042044),0.3474288623940681,0.7650063995248326,0.735144312393888,0.9838066363551952,1.0,2/12,8.37%,PDPN;AQP6
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.2792203858432626,-0.7649868167550815,0.8222222222222222,0.9869765427517636,1.0,5/16,21.30%,SHLD1;KDM4D;PRKDC;PNKP;SHLD2
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.3537953300592381,0.7643817148514279,0.7558139534883721,0.9842997997016188,1.0,7/12,28.49%,PCGF3;SMCHD1;METTL3;HNRNPU;BRCA1;LRIF1;RBM15
prerank,termination of RNA polymerase II transcription (GO:0006369),-0.2368007299909763,-0.7642823067923286,0.8226744186046512,0.9870274656374222,1.0,10/33,21.44%,SNRPB;CPSF7;CSTF3;CSTF1;CLP1;CSTF2;SNRPD3;MED18;SLBP;MAZ
prerank,cellular response to amino acid stimulus (GO:0071230),0.2908728275190269,0.7640751185406589,0.7820895522388059,0.9842994400719884,1.0,7/33,11.70%,UBR2;CPEB1;CPEB3;SLC38A9;CASTOR2;LAMTOR2;RRAGD
prerank,regulation of defense response to virus (GO:0050688),-0.2969317117363951,-0.7640703043701268,0.7749360613810742,0.986329261476031,1.0,5/14,25.30%,TNFAIP3;PCBP2;DHX9;C1QBP;IFNLR1
prerank,glutamate metabolic process (GO:0006536),0.32105991827669955,0.7637875680738317,0.7783094098883573,0.9842707362949528,1.0,2/19,8.63%,GLUL;ALDH18A1
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),-0.21095139290952142,-0.7632648222600807,0.8979591836734694,0.9865152816279246,1.0,24/57,30.28%,RAD17;FOXN3;TOPBP1;MDC1;HUS1;PRKDC;BABAM1;CCND1;FBXO31;NBN;CDKN1A;HMGA2;BABAM2;DTL;FANCD2;SDE2;ATF2;HUS1B;FZR1;PLK1;DONSON;CDK1;NEK11;TICRR
prerank,mitotic spindle assembly (GO:0090307),-0.2210073187624929,-0.7628795439806773,0.8861209964412812,0.9861148934247431,1.0,22/42,41.10%,KIF2A;STAG1;RAB11A;CCDC61;LSM14A;PRC1;KIF23;MISP;CLASP1;KIF4A;SPICE1;KIF11;TOGARAM2;WRAP73;MAP10;RACGAP1;STAG2;BCCIP;AURKB;CLASP2;TOGARAM1;KIFC2
prerank,regulation of urine volume (GO:0035809),0.37146249353686633,0.7627514465875134,0.7389770723104057,0.9853648467999417,1.0,2/10,11.10%,NPR3;ADM
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),-0.2695631404441221,-0.762744845215698,0.8224043715846995,0.9853346556489008,1.0,10/21,32.44%,RPS7;RPL11;RPL5;UBE2S;RPL23;FZR1;PLK1;BAG2;CDC20;UBE2C
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.20498959610205625,-0.7626292573296805,0.9137931034482759,0.9845328009730562,1.0,20/70,24.94%,B2M;VAMP8;NCF2;FCER1G;MFSD6;PSMF1;PSMB8;PSMA4;PSMB10;PSMB2;PSMC4;FCGR1A;PSMA6;PSMD9;PSMD11;PSMD5;CHUK;PSMA8;PSMB1;LNPEP
prerank,regulation of viral genome replication (GO:0045069),-0.2080792924161523,-0.762454107034066,0.8947368421052632,0.9837884570574575,1.0,20/56,29.87%,IFIH1;PPIA;PABPC1;SRPK1;ADAR;FAM111A;NR5A2;RAD23A;TRIM6;N4BP1;CNOT7;PPID;OASL;PLSCR1;IFITM3;HACD3;ISG15;ISG20;IFIT1;ZC3HAV1
prerank,cell cycle checkpoint signaling (GO:0000075),0.3425289632385849,0.762144067350393,0.7542955326460481,0.9858786337699187,1.0,5/12,24.19%,ZW10;ZWINT;PLK2;PRCC;NABP2
prerank,mitotic metaphase plate congression (GO:0007080),0.2688984930219793,0.7619020741247939,0.8220230473751601,0.9857886201296843,1.0,13/51,20.47%,PIBF1;SPDL1;ZW10;CHAMP1;CENPC;EML4;CHMP5;SEH1L;BECN1;BOD1;KPNB1;CDCA8;CDC23
prerank,endothelial tube morphogenesis (GO:0061154),-0.32795530433059544,-0.7618719900460401,0.7901498929336188,0.9836610926291108,1.0,2/10,7.70%,ACVRL1;RHOB
prerank,actin filament polymerization (GO:0030041),0.292448896815394,0.7613140070429628,0.7830609212481426,0.9861796068496538,1.0,3/29,6.19%,GSN;ARHGAP6;WASHC3
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.34225514371556987,0.7612861395835033,0.7416666666666667,0.9857393196243378,1.0,3/15,8.32%,APOA1;SLC45A3;LPGAT1
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),-0.20524654863904135,-0.7611891207005379,0.9140271493212669,0.9836629258209123,1.0,15/63,21.44%,CRADD;PLAGL1;CNOT6L;BTG2;RPL26;PRKDC;CCND1;EP300;FBXO31;CDKN1A;CNOT7;E2F7;TRIAP1;PLK3;CNOT8
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.3178367742629197,0.7602413632969647,0.7586750788643533,0.9868662278281486,1.0,3/19,9.31%,OBSL1;CUX2;CAMK2B
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.31735519276031454,0.7595360943901476,0.760586319218241,0.9874588011891137,1.0,2/17,8.32%,PLA2G4A;LPGAT1
prerank,protein deneddylation (GO:0000338),0.36544062436481717,0.7593876746440777,0.7448275862068966,0.9872156743339983,1.0,3/10,16.49%,GPS1;COPS3;COPS2
prerank,cellular defense response (GO:0006968),0.2769560016096385,0.7592735030163962,0.7970027247956403,0.986902978221459,1.0,3/40,5.27%,LSP1;RAB23;CCR9
prerank,cell cycle G1/S phase transition (GO:0044843),-0.20624993778912945,-0.7589600853809885,0.9190283400809717,0.9859892585632857,1.0,21/61,25.63%,CDK6;CUL1;USP29;EIF4E;DBF4;BCAT1;CCND1;CUL2;INHBA;E2F3;CDKN1A;CUL3;MAP3K11;HINFP;PLK3;CDKN3;MAX;PIM2;NASP;RPS6KB1;E2F1
prerank,negative regulation of telomere maintenance (GO:0032205),0.33377071380054996,0.7589038243942984,0.7529215358931552,0.9869869566015275,1.0,6/15,26.06%,TERF2;TNKS2;RTEL1;ATM;TNKS;RAD50
prerank,protein homotetramerization (GO:0051289),0.26813900725511164,0.75842940901565,0.810126582278481,0.9872246738962787,1.0,6/49,9.40%,TRPA1;TDO2;APPL2;ALDH1A2;CBY1;TRPM4
prerank,regulation of chromosome segregation (GO:0051983),0.32918679252208416,0.758289600887975,0.754071661237785,0.9869529687109105,1.0,5/16,21.23%,SMC5;SMC6;RAD18;NUMA1;RMI2
prerank,regulation of interleukin-1 production (GO:0032652),-0.2870599711672843,-0.7582075091902881,0.8062015503875969,0.9861280479325267,1.0,5/15,19.34%,SIRPA;FOXP1;CEACAM1;TLR4;ANXA1
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.3573731845054652,0.7580519275930774,0.7615780445969125,0.9868386582889446,1.0,5/12,24.20%,PIBF1;ERLIN1;BRCA1;ERLIN2;ACADVL
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.34134699413150404,0.757945502545385,0.7495741056218058,0.9865234511554569,1.0,3/13,12.03%,RAB23;LRRK2;RHOQ
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.2641423010079665,0.7578234850486097,0.7986577181208053,0.9862203985272338,1.0,6/54,9.32%,GAS6;CFLAR;RFFL;APOA1;RNF31;PRKN
prerank,regulation of mRNA catabolic process (GO:0061013),0.23623841350969005,0.7572885419177617,0.8686390532544379,0.9865343867071026,1.0,24/121,20.64%,SAMD4A;CSDC2;IGF2BP2;PSME4;ZFP36L1;EXOSC1;PARN;SERBP1;EXOSC7;RC3H2;NUP214;MAPKAPK2;AKT1;DCP1A;PSMB5;PSMC2;RC3H1;PSMD1;PRKCA;PSMD4;PSME3;YTHDF2;ZFP36L2;PSMA3
prerank,negative regulation of cell cycle process (GO:0010948),0.25891529740900454,0.7570633803976904,0.8284960422163589,0.9864165574342016,1.0,15/61,17.72%,TOM1L2;CBX3;RBBP7;PPP1R10;NME6;TERF2;L3MBTL2;YAF2;BMP4;WAPL;RNF2;CBX5;TFDP1;APAF1;CDC7
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.36137375775968245,0.75684324185636,0.7508650519031141,0.9857856234971627,1.0,3/10,13.78%,NUPR1;NCOR1;HDAC4
prerank,negative regulation of glycolytic process (GO:0045820),0.36137375775968245,0.75684324185636,0.7508650519031141,0.9857856234971627,1.0,3/10,13.78%,NUPR1;NCOR1;HDAC4
prerank,regulation of calcium ion transport (GO:0051924),0.26453365512968324,0.7562024892721053,0.8306451612903226,0.9862366023927791,1.0,10/54,16.89%,BCL2;MYLK;STIM1;CCL4;CAMK2B;ADRA2A;CD33;EGF;CASR;HRC
prerank,pre-miRNA processing (GO:0031054),0.34175726894267056,0.7560973228693133,0.7354409317803661,0.9859104549931861,1.0,7/14,24.47%,TUT7;TUT4;PRKRA;DICER1;AGO4;DROSHA;AGO3
prerank,endocytic recycling (GO:0032456),0.26943906043948307,0.7559547722209143,0.8283378746594006,0.985657926239883,1.0,12/50,17.24%,VPS26C;ACAP2;TRARG1;EPS15;SNX12;VPS35L;DENND1A;PTPN23;ARF6;SNX31;ANKRD50;MICALL1
prerank,secondary palate development (GO:0062009),0.3393681747119578,0.7554713074705393,0.7415540540540541,0.9859234236867154,1.0,1/14,1.00%,TGFBR3
prerank,positive regulation of viral genome replication (GO:0045070),-0.23927477178737325,-0.7553414845604797,0.8448844884488449,0.9893003091142207,1.0,9/29,20.11%,PPIA;PABPC1;SRPK1;ADAR;NR5A2;TOP2A;RAD23A;CNOT7;PPID
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.3336066152947845,0.7552302017240023,0.7579298831385642,0.9857787680981164,1.0,5/15,19.97%,DCST1;STAT2;MUL1;METTL3;YTHDF2
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.3588525253313073,0.7551974362395939,0.738898756660746,0.9853390158096316,1.0,2/10,8.39%,APOA1;IRAK3
prerank,import into nucleus (GO:0051170),0.24795175958389226,0.7551192153006775,0.847457627118644,0.9849846336777269,1.0,19/73,19.63%,RANBP17;NUP107;APPL2;FAM53C;PRICKLE1;HNRNPA1;HEATR3;CSE1L;PPP1R10;TSC2;SNRPD2;NUP214;GEMIN2;AKT1;PHB2;TPR;APPL1;KPNB1;BACH2
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.2183003505931795,0.754933992033575,0.9439834024896265,0.9847758619499933,1.0,95/341,23.62%,SPSB1;TBL1XR1;HECW2;DCST1;FBXL17;FBXL19;NEDD4;RFFL;SMURF2;PSME4;RNF213;BFAR;ZNRF3;PML;NFE2L2;UBE4B;TRIP12;SIRT2;UBXN2B;UBE2U;RNF185;UBR4;ARRB1;UBXN11;WDR81;ANAPC5;WDR91;PRKN;ITCH;IFI27;RNF6;MIB1;FBXO11;KBTBD7;ERCC8;VPS37D;FEM1C;BTRC;RNF217;COPS3;USP9X;TNFAIP1;RNF19A;RC3H2;PTPN23;APPBP2;ADRM1;AMFR;UBA6;UBE2D1;HACE1;HUWE1;RNF13;NHLRC3;SPOP;UBE2R2;UBR3;UBE3B;PSMB5;PSMC2;KAT5;RC3H1;RNF34;PSMD1;TRIM32;PSMD4;NSFL1C;PSME3;FEM1B;RNF11;KCTD13;ARIH2;DCAF11;CDC23;PSMA3;ZSWIM8;DDIT3;UCHL1;AURKA;FBXO10;BIRC2;TSG101;RNF216;RNF20;BAG6;ANAPC4;KLHL20;PSMA2;KLHL8;BIRC6;FBXW11;ATXN3;PSMC5;ARMC8;ELOC
prerank,heterotypic cell-cell adhesion (GO:0034113),0.2983677986743889,0.7548859924655166,0.7688679245283019,0.9843794197127279,1.0,4/25,9.62%,PARVA;CD200;ITGB3;ITGAV
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.32203988826335084,0.7544080274236964,0.7726523887973641,0.9846025998454708,1.0,4/18,14.40%,RNF185;RNF139;UGGT2;AMFR
prerank,negative regulation of activated T cell proliferation (GO:0046007),-0.3322728481965076,-0.7539939359054099,0.7849223946784922,0.990271373492119,1.0,2/10,10.09%,PRKAR1A;SCRIB
prerank,pattern recognition receptor signaling pathway (GO:0002221),-0.2039285642857342,-0.7537641500959744,0.9193548387096774,0.9896146050182406,1.0,11/56,18.63%,NOD1;PLCG2;LBP;CTSB;S100A1;LGMN;UNC93B1;NOD2;TAB1;TLR4;CTSS
prerank,positive regulation of reproductive process (GO:2000243),0.2815378941702574,0.7535034170799675,0.7751479289940828,0.9855145808548348,1.0,6/31,12.87%,SMURF2;VIP;PDE3A;SIRT2;SYDE1;ACVR1B
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.3037326874088308,0.7534151321146405,0.7936,0.9851707670035851,1.0,4/23,14.69%,CDK5RAP3;ZW10;ZWINT;PLK2
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),-0.2440513336335187,-0.7527160330533247,0.8459214501510574,0.9901328889394942,1.0,3/29,6.88%,ANKRD28;PPIA;HSP90AB1
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.2939842136368097,0.7525301316659726,0.7807807807807807,0.9860585815328573,1.0,4/29,11.78%,SYCE2;TEX12;MAJIN;STAG3
prerank,positive regulation of lymphocyte activation (GO:0051251),-0.2415932792691466,-0.7524599148439022,0.8643067846607669,0.9895310630753891,1.0,5/28,15.60%,CYRIB;SIRPA;SH3KBP1;NOD2;PRKDC
prerank,termination of RNA polymerase I transcription (GO:0006363),-0.2391499688530936,-0.752237642077016,0.8545994065281899,0.9888712236543782,1.0,6/30,10.92%,TAF1B;TBP;CAVIN1;GTF2H1;TAF1C;UBTF
prerank,negative regulation of interleukin-8 production (GO:0032717),0.3221889911246518,0.7517660619209671,0.7573149741824441,0.9867243545947434,1.0,5/17,13.00%,MAPKBP1;TLR6;ARRB1;CD33;SSC5D
prerank,regulation of RNA export from nucleus (GO:0046831),0.3525215826363413,0.7517520934931528,0.7614678899082569,0.9862733399536201,1.0,5/11,22.41%,NSUN2;AKAP8L;TPR;NRDE2;NCBP2
prerank,histone mRNA metabolic process (GO:0008334),0.2985141703194518,0.7515794551711168,0.7782945736434108,0.9860266203100099,1.0,12/27,26.97%,TUT7;ERI1;TUT4;TENT4B;ATM;LSM10;CPSF2;NCBP2;XRN1;SNRPE;UPF1;NCBP1
prerank,cilium organization (GO:0044782),0.2234409840018308,0.7512650824974151,0.919093851132686,0.9860200590949277,1.0,17/210,7.63%,ASAP1;GSN;DYNLL1;PARVA;WDPCP;DZIP1L;RAB23;CYS1;CPLANE1;PIBF1;TTC39C;B9D1;WDR35;IFT43;CENPJ;DNAAF1;FBF1
prerank,heme biosynthetic process (GO:0006783),-0.26044629037723177,-0.7512309319615328,0.8445040214477212,0.989268533931575,1.0,1/22,0.42%,ABCG2
prerank,zinc ion transmembrane transport (GO:0071577),0.3076073449074342,0.7511564285213752,0.7776049766718507,0.9857209522202344,1.0,9/22,24.06%,SLC30A8;SLC30A2;SLC30A10;SLC39A13;SLC39A1;SLC39A12;SLC39A6;SLC30A5;SLC30A4
prerank,cellular response to unfolded protein (GO:0034620),0.30003143039883023,0.7510048747504887,0.8012618296529969,0.9854689975074175,1.0,10/26,26.13%,OPTN;PRKN;HSPA9;TM7SF3;TMBIM6;HSF1;HSPA14;HSPA5;BAG3;ABCB10
prerank,response to estradiol (GO:0032355),0.2885151012006101,0.7503288352198818,0.7936046511627907,0.9859984616552809,1.0,6/31,10.00%,WNT8B;SFRP1;STRN3;EGFR;STAT5B;FOXA1
prerank,positive regulation of immune response (GO:0050778),-0.198175462511758,-0.7500965732091233,0.9201520912547528,0.9898908962293455,1.0,21/64,32.14%,IL15;TGFB2;GBP5;SKAP1;IFI35;SIRT1;CD81;KARS1;NOD2;PTPRC;DHX9;PLSCR1;EIF2AK4;POLR3C;SLC15A4;LILRB1;XBP1;NLRP3;SASH3;FCGR2B;TLR8
prerank,regulation of lymphocyte differentiation (GO:0045619),0.31897071567588275,0.7499360468301496,0.7814029363784666,0.9860860518079132,1.0,6/18,25.79%,ZFP36L1;METTL3;ZFP36L2;PRELID1;NCKAP1L;ABL1
prerank,mRNA export from nucleus (GO:0006406),0.24211432831938853,0.749269983578959,0.8703481392557023,0.9865966733805412,1.0,11/102,11.97%,POLR2D;NUP107;U2AF1L4;THOC2;NUP42;DDX39A;DDX19A;WDR33;NUP98;RAE1;MAGOHB
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.27949938910703487,-0.7491713703769063,0.8186528497409327,0.9901779123232731,1.0,3/17,11.31%,SLC7A5;FCER1G;PRKCZ
prerank,dicarboxylic acid metabolic process (GO:0043648),0.2605935475179841,0.7489644051445372,0.8186666666666667,0.9865757273501579,1.0,8/52,9.51%,MDH2;MDH1B;MTHFR;HOGA1;ALDH1L1;ALDH18A1;ADHFE1;IDH2
prerank,cellular response to molecule of bacterial origin (GO:0071219),-0.18734162306423227,-0.7488635277403732,0.9629629629629629,0.9896398454888032,1.0,20/95,20.83%,MEF2C;PDE4B;CYRIB;LBP;VIM;SIRPA;MAPK8;CX3CR1;TNFAIP3;CD80;GIT1;SBNO2;NOD2;CARD16;ADAM9;TLR4;HMGB2;CD86;FZD5;DAB2IP
prerank,positive regulation of cellular protein localization (GO:1903829),0.25650544608131537,0.7485137160052743,0.8315789473684211,0.986723787613955,1.0,23/69,23.48%,YAP1;CDK5RAP3;PRKAA2;SNX33;WWTR1;EIF2AK3;CROCC;SLC5A3;PRKN;F2;SYT11;SESN2;AKT1;LIF;TM9SF4;NUMA1;ABCA7;GPR137B;CEP250;GPD1L;CARD10;PARD6A;RANGRF
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.30505396524748307,0.7484562651112315,0.7725118483412322,0.986322642805323,1.0,3/22,12.75%,PDGFD;DDX3X;RAP2A
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.2367812563382225,0.7482341448525669,0.8797619047619047,0.9861792545309613,1.0,5/109,4.77%,PDPK1;PIK3R1;LYN;PPP3CA;PSME4
prerank,negative regulation of ATPase activity (GO:0032780),-0.2825612213484981,-0.7482320237706,0.8148148148148148,0.9895085120005205,1.0,5/16,29.52%,PXK;SIRT1;PLN;ATP5IF1;IFIT1
prerank,positive regulation of blood coagulation (GO:0030194),-0.2758753177841387,-0.7482184351514839,0.8161209068010076,0.9885611634953937,1.0,8/17,24.35%,THBS1;THBD;ANO6;ENPP4;ST3GAL4;F3;HPSE;DMTN
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.3200701020480567,0.7480989853448502,0.7401709401709402,0.9858974111624721,1.0,7/16,29.48%,RECQL5;MCM2;MCMDC2;MCM6;RECQL;RPA1;MCM4
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.3215095148173926,-0.7468587788322638,0.7743362831858407,0.9895339254402722,1.0,4/10,25.17%,EMC3;EMC9;MMGT1;EMC4
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.3200898295546733,0.7461225078380124,0.7847682119205298,0.9882940127463119,1.0,1/17,2.69%,NOS1AP
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.3320560536920707,0.7460872633139116,0.7595356550580431,0.9878695648647925,1.0,4/15,10.79%,TNRC6B;CPEB3;TNRC6A;TENT4A
prerank,protein hydroxylation (GO:0018126),0.3230476102831829,0.7458987280994933,0.7563451776649747,0.9876747229099143,1.0,3/15,13.83%,ASPH;P3H3;JMJD7
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.2898296025797627,0.7458747461161078,0.8133704735376045,0.9872393299182192,1.0,9/32,21.33%,EML2;CDH5;KATNB1;FGF13;DYRK1A;HDGFL3;CAMSAP1;ATXN7;TAOK1
prerank,purine nucleotide biosynthetic process (GO:0006164),0.34273662945293226,0.7450936296680243,0.7708703374777975,0.9879191733536393,1.0,7/12,28.42%,GART;AMPD2;PRPSAP2;PPAT;ADSL;PRPSAP1;ADA
prerank,regulation of phosphatase activity (GO:0010921),0.29532601684589055,0.7446364616047306,0.7832817337461301,0.9880906822060013,1.0,5/24,19.23%,CDK5RAP3;BMP2;PTPA;PPP1R26;HTT
prerank,regulation of gluconeogenesis (GO:0006111),0.29372764074198277,0.7444870971994201,0.7991004497751124,0.9878316473514055,1.0,3/27,6.83%,OGT;NNMT;SIK1
prerank,pyrimidine nucleoside metabolic process (GO:0006213),-0.28254962430320313,-0.7442334231358793,0.7979539641943734,0.9920744804926765,1.0,9/14,37.26%,NT5E;NT5C1A;UPB1;NT5C;UPP1;DPYS;DHODH;ERH;CAD
prerank,signal transduction by p53 class mediator (GO:0072331),-0.2354330932214606,-0.7436494264427511,0.8885630498533724,0.9918930258699769,1.0,2/30,1.35%,PPP1R13B;ACER2
prerank,chondroitin sulfate metabolic process (GO:0030204),0.286861406037119,0.7434446194139996,0.8222222222222222,0.9889031047876835,1.0,4/30,8.04%,DCN;BGN;DSE;CSPG5
prerank,actin crosslink formation (GO:0051764),-0.2994701539241279,-0.7432788524018844,0.8194774346793349,0.9914349019519434,1.0,3/12,13.21%,BAIAP2L1;GAS2;GAS2L1
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.3319483441156379,0.7430570516157988,0.7648054145516074,0.9889722157073579,1.0,2/13,5.08%,SP100;RAB23
prerank,positive regulation of interleukin-10 production (GO:0032733),0.28356281344144685,0.7430150515342315,0.8083832335329342,0.9885631011871965,1.0,4/30,7.09%,PIBF1;IL12B;TSLP;CD28
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.316762403182612,0.7428181292912207,0.7775947281713345,0.9883856031684126,1.0,1/18,1.86%,BCL2
prerank,myelin assembly (GO:0032288),0.3574499084767101,0.7426297513504828,0.7677642980935875,0.9881966704792238,1.0,4/10,18.89%,PMP22;EPB41L3;NCMAP;DICER1
prerank,ribosomal subunit export from nucleus (GO:0000054),0.3331977070070178,0.7421135375771635,0.773286467486819,0.9884675119314339,1.0,4/13,13.36%,EIF6;ABCE1;NMD3;SDAD1
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",-0.2712491321692156,-0.7420467564014083,0.8449612403100775,0.9921319059655668,1.0,4/16,19.40%,CELF4;RBM17;DDX5;DHX9
prerank,magnesium ion transport (GO:0015693),0.33181353621777887,0.7414823701354715,0.7696245733788396,0.9889037791085721,1.0,2/12,9.01%,SLC41A1;NIPAL4
prerank,positive regulation of macrophage migration (GO:1905523),0.31126715373546143,0.7412214888768252,0.7747163695299838,0.9888022588569845,1.0,2/19,4.18%,IL34;CSF1
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.2872680635720892,0.740184361240493,0.7907692307692308,0.9897967826525541,1.0,7/26,15.38%,SPHK2;TLR6;SLC30A10;SLC5A3;SLC18A2;ABCD2;PIKFYVE
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.3418389687182027,0.7401611979445099,0.7551724137931034,0.9893568038470221,1.0,1/12,1.86%,BCL2
prerank,ether lipid biosynthetic process (GO:0008611),0.3510117861663118,0.7399444850146685,0.7791741472172352,0.989198804400838,1.0,4/10,21.48%,PLA2G4A;PEX7;DHRS7B;PEDS1
prerank,regulation of glycogen metabolic process (GO:0070873),0.3544609089357782,0.7399225140244469,0.7823834196891192,0.9887667571271556,1.0,6/12,21.40%,PPP1R3C;PPP1R3D;AKT1;PPP1R3E;GCGR;RUBCNL
prerank,lysosome localization (GO:0032418),0.2755666275899428,0.7394399896805169,0.8335745296671491,0.9890181226837425,1.0,13/37,26.23%,KIT;BLOC1S1;PLEKHM1;PLEKHM2;TMEM106B;SNAPIN;DEF8;HDAC6;VPS33B;BLOC1S2;MAP6;RAB34;MYH9
prerank,double-strand break repair (GO:0006302),0.2200152739921531,0.7393578990615972,0.9060710194730813,0.9886650461682931,1.0,42/158,24.39%,EYA1;ZSWIM7;HPF1;LIG4;INO80;RAD51B;SMC5;DCLRE1C;POLL;RECQL5;UBE2V2;NHEJ1;SMC6;BAZ1B;ACTR8;TENT4A;TDP2;DCLRE1A;RAD51D;XRCC2;RNF138;KPNA2;AP5Z1;ATM;KAT5;DDX1;KDM4A;SUMO1;UIMC1;BRCC3;NSMCE2;FAN1;EXD2;EME2;APLF;SMARCAD1;BRCA1;SFPQ;SETX;NABP2;RAD51AP2;MRE11
prerank,regulation of phospholipid metabolic process (GO:1903725),0.3429451549502128,0.739259996968284,0.7527272727272727,0.9883450272646648,1.0,4/10,18.44%,GNB3;MTMR3;ABCA3;PHB2
prerank,peripheral nervous system development (GO:0007422),0.29980041397096535,0.7390603029969893,0.8033794162826421,0.988159986547517,1.0,3/23,7.01%,GDNF;NTF3;PMP22
prerank,nucleocytoplasmic transport (GO:0006913),0.2646797312018644,0.7389989480553597,0.8278335724533716,0.9877823402123787,1.0,8/40,20.10%,ATXN1;PHAX;HNRNPA1;NUP98;SNRPD2;GEMIN2;BACH2;AAAS
prerank,regulation of brown fat cell differentiation (GO:0090335),-0.27727270719116187,-0.738914257574156,0.8102564102564103,0.9952838385761703,1.0,3/16,13.52%,SIX1;SIRT1;PTGS2
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.35773881284286574,0.7385248729534195,0.7772020725388601,0.9880090698577904,1.0,3/10,19.35%,SP100;KAT5;MUC1
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.26929411483648613,0.7384494702742269,0.8271954674220963,0.9876429000029541,1.0,11/39,22.41%,PIK3R1;TTC7B;EFR3A;PI4KA;TMEM150A;PIK3R2;PIP4K2C;ITPKA;SOCS4;SOCS7;PIK3C2A
prerank,negative regulation of transferase activity (GO:0051348),0.2888767339411542,0.7378754047177953,0.7921092564491654,0.9880014994536476,1.0,7/28,20.15%,SRC;EIF4A2;BAG5;CDKN1C;NPRL2;CDKN1B;HNRNPU
prerank,regulation of platelet aggregation (GO:0090330),0.32104860961191317,0.7376002635123458,0.787828947368421,0.9878943140394733,1.0,5/17,19.60%,LYN;PDPN;C1QTNF1;PRKCA;ALOX12
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),-0.2496683620885475,-0.7375871498235166,0.8694444444444445,0.9961152897752211,1.0,1/24,0.42%,ABCG2
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.31272801933241523,0.737176396407053,0.8052373158756138,0.9880231997885653,1.0,4/18,11.94%,SFRP1;PRKN;ADRA2A;REST
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.32837197330264567,0.7371651030626507,0.7753743760399334,0.9875723856868506,1.0,3/15,11.81%,LARGE1;RENBP;MGAT3
prerank,ERBB2 signaling pathway (GO:0038128),0.2785331801005815,0.7366388044939376,0.8098802395209581,0.9878426538029536,1.0,6/31,13.24%,PIK3R1;SRC;CUL5;EGFR;HBEGF;EGF
prerank,positive regulation of interferon-alpha production (GO:0032727),-0.2692507005940327,-0.7366114862564141,0.8274932614555256,0.996423370665692,1.0,5/19,21.79%,IFIH1;IRF5;TLR4;DHX9;CHUK
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),-0.24348838734827505,-0.7365292777298915,0.8366197183098592,0.9955660234435199,1.0,3/25,10.70%,HSPA8;GAK;DNAJB14
prerank,release of cytochrome c from mitochondria (GO:0001836),0.32144235381825154,0.7363404875491759,0.8033613445378152,0.9878114175952426,1.0,1/17,1.86%,BCL2
prerank,positive regulation of myelination (GO:0031643),0.34353239551521636,0.7362086380573767,0.785472972972973,0.9875274538830991,1.0,4/11,18.89%,RNF10;PARD3;NCMAP;DICER1
prerank,hexose metabolic process (GO:0019318),-0.21914444141029335,-0.7359263814688581,0.902027027027027,0.9953993444821602,1.0,5/39,10.92%,PPARD;APOD;ALDOA;GDPGP1;SLC35A2
prerank,protein insertion into membrane (GO:0051205),0.2851534402562941,0.7352045186778055,0.8185840707964602,0.9884662757810558,1.0,5/32,11.43%,TRAM2;COX18;CYB5A;EGFR;TRAM1
prerank,response to UV-A (GO:0070141),0.32688228917957546,0.7351143374308926,0.7678275290215588,0.9881320543071763,1.0,2/14,8.59%,MMP2;EGFR
prerank,mitotic G2/M transition checkpoint (GO:0044818),-0.21465001434844988,-0.7350649035428776,0.8840579710144928,0.9955635446241541,1.0,19/43,30.28%,RAD17;FOXN3;TOPBP1;HUS1;BABAM1;NBN;CDKN1A;CHFR;HMGA2;BABAM2;DTL;NABP1;HUS1B;FZR1;PLK1;DONSON;CDK1;CDC6;TICRR
prerank,receptor internalization (GO:0031623),0.2680780322417567,0.7348990138030892,0.8391123439667129,0.9879769310410059,1.0,8/44,12.82%,LRP1;GRK3;NEDD4;DRD3;ARRB1;PICALM;ADM;GRK4
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.34638393074978674,0.7348803403409326,0.7843803056027164,0.9875405279896744,1.0,2/10,9.94%,PIBF1;PARP14
prerank,regulation of cholesterol storage (GO:0010885),0.3208451451324915,0.7348033908637397,0.7864406779661017,0.9871804713473031,1.0,1/15,1.73%,ABCA1
prerank,regulation of mRNA processing (GO:0050684),0.27873627376089827,0.7344441468199476,0.8204379562043795,0.987212183471788,1.0,14/32,27.29%,SON;ZFP36L1;SF1;SAFB2;RBM39;SRSF10;SRSF3;PAPOLA;METTL16;CWC22;CDK11B;AHCYL1;NCBP1;PABPN1
prerank,negative regulation of histone modification (GO:0031057),-0.284531006353069,-0.7336578169877069,0.8232558139534883,0.9963560086518728,1.0,6/14,28.27%,CTBP1;PRMT6;THAP7;TWIST1;AASS;SET
prerank,positive regulation of cell killing (GO:0031343),-0.2988580219679202,-0.7336216279295558,0.8270142180094787,0.9954457903341934,1.0,4/13,28.95%,MAPK8;DVL2;NOX1;NOS2
prerank,spinal cord development (GO:0021510),0.3386780169041339,0.7334558080005771,0.7538726333907056,0.9881399122779507,1.0,1/12,1.96%,GLI2
prerank,regulation of cilium movement (GO:0003352),0.350198496249292,0.7327355723726695,0.7609075043630017,0.9886962135317503,1.0,2/10,12.42%,DNAAF1;CCDC40
prerank,regulation of cellular response to stress (GO:0080135),0.23085186567193744,0.7325092470849682,0.9010856453558505,0.9885407860949603,1.0,29/115,20.58%,ROCK2;NUP107;NUPR1;NUAK1;NUP42;CAMK2B;PRKN;NEK6;MANF;NUP98;CEBPB;RAE1;CLN3;YWHAE;NPAS2;AMFR;NUP214;HSBP1;BAG5;SLC38A2;MAPKAPK2;CASP9;ATM;SEH1L;DYRK3;TPR;HSF1;AAAS;MLST8
prerank,very-low-density lipoprotein particle assembly (GO:0034379),-0.2918056123379619,-0.7324253803084924,0.8065268065268065,0.9960392684282061,1.0,3/12,22.63%,MFSD2A;LPCAT3;ACSL3
prerank,regulation of interleukin-6 production (GO:0032675),0.23354129643827715,0.7323824957130525,0.8923267326732673,0.9882663911699872,1.0,14/96,13.46%,IL6R;IL17D;GAS6;TSLP;SPHK2;TLR6;IRAK3;ARRB1;CD200;RAB7B;CARD9;SETD4;SELENOS;SYT11
prerank,regulation of inclusion body assembly (GO:0090083),0.3476535502855851,0.7320422443041041,0.78,0.9882622771271322,1.0,3/11,15.09%,SNCAIP;DNAJA4;BAG5
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.3182099521525391,0.7318212547614276,0.7864238410596026,0.9880991806061092,1.0,6/14,27.75%,MRNIP;TIMELESS;ARID2;FUS;MMS19;FANCB
prerank,rhodopsin mediated signaling pathway (GO:0016056),-0.3122785226439839,-0.7314127010590619,0.814385150812065,0.9963799633214754,1.0,4/10,33.84%,GNB1;PDE6A;PDE6B;SAG
prerank,cholesterol biosynthetic process (GO:0006695),0.2830406066857758,0.7313713337198171,0.8289085545722714,0.9882730919732297,1.0,4/31,9.33%,INSIG2;APOA1;MVK;IDI1
prerank,autophagy of peroxisome (GO:0030242),0.3320770672296145,0.7312219003818682,0.7877280265339967,0.9880150315040352,1.0,3/12,17.38%,USP30;PIK3R4;ATM
prerank,positive regulation of heart contraction (GO:0045823),0.30975809267875115,0.7309907622929764,0.7729468599033816,0.9878622626868626,1.0,3/19,11.10%,ATP1A2;TRPM4;ADM
prerank,regulation of neural precursor cell proliferation (GO:2000177),-0.25400573056015263,-0.7308798375915777,0.8696883852691218,0.996136827592112,1.0,13/22,34.51%,GATA2;KDM1A;TAFA1;ID2;DLL4;SHCBP1;TOX;PTPRZ1;FZD9;DISP3;NAP1L1;RASSF10;TRIM71
prerank,regulation of supramolecular fiber organization (GO:1902903),0.29612723192865975,0.7307279200404523,0.8024691358024691,0.9877733024491746,1.0,6/22,18.98%,AEBP1;APOE;ARL2;AKAP13;CAMSAP1;EFEMP2
prerank,cellular response to topologically incorrect protein (GO:0035967),0.27752430125648814,0.7301061062141089,0.8042168674698795,0.9881360471601358,1.0,11/31,24.70%,OPTN;PRKN;HSPA9;TM7SF3;TMBIM6;HSF1;HSPA14;HDAC6;HSPA5;ATXN3;BAG3
prerank,regulation of neurotransmitter secretion (GO:0046928),0.2732940832373968,0.7291801172879722,0.8258992805755395,0.9889436911154104,1.0,5/32,7.21%,DTNBP1;MCTP2;BAIAP3;LRRK2;SNCAIP
prerank,positive regulation of mitochondrion organization (GO:0010822),0.25457790582201206,0.7289063399737159,0.8505291005291006,0.9888405904126418,1.0,6/57,9.32%,DCN;MOAP1;PDCD5;MCU;BCL2L11;PRKN
prerank,regulation of chromosome organization (GO:0033044),0.3035539492153028,0.7288624050947285,0.8063492063492064,0.9884378765375674,1.0,6/22,21.69%,LIG4;HDAC8;TERF2;WAPL;RMI2;CENPV
prerank,lymphocyte proliferation (GO:0046651),-0.24706051198027523,-0.7287528741540563,0.847457627118644,0.9978474208163522,1.0,12/22,37.51%,MEF2C;MSN;CD40;PTPRC;PIK3CG;ELF4;FLT3;CR2;MS4A1;TNFRSF4;CD79A;LMBR1L
prerank,calcineurin-NFAT signaling cascade (GO:0033173),-0.3194543414893121,-0.7279170853134859,0.8113636363636364,0.9969935020696412,1.0,3/10,7.59%,NFATC2;NFATC3;NFATC1
prerank,calcineurin-mediated signaling (GO:0097720),-0.3194543414893121,-0.7279170853134859,0.8113636363636364,0.9969935020696412,1.0,3/10,7.59%,NFATC2;NFATC3;NFATC1
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.32544747196480484,0.7277355697257577,0.7920962199312714,0.9895077907375043,1.0,5/14,24.19%,TERF2;TNKS2;ATRX;TNKS;NABP2
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.2804751186363175,0.727608048854374,0.8164464023494861,0.9892216915445723,1.0,3/30,4.27%,SERPINE1;CFLAR;RFFL
prerank,positive regulation of JUN kinase activity (GO:0043507),0.29564198072311687,0.7269982703242485,0.8144,0.9895822680459495,1.0,4/23,12.36%,SASH1;TLR6;TAOK3;DUSP19
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.2347991171032599,-0.7264216528146897,0.887459807073955,0.9978697765195259,1.0,2/29,3.00%,CADM1;CYRIB
prerank,amyloid precursor protein metabolic process (GO:0042982),-0.2621168653925204,-0.7263406922767592,0.8444444444444444,0.9970087826561563,1.0,3/18,9.59%,ADAM10;ABCG1;ADAM19
prerank,vitamin D metabolic process (GO:0042359),-0.29511979345941797,-0.7262776857100303,0.8242280285035629,0.9961317765901795,1.0,2/13,11.56%,CUBN;LGMN
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.3368466433303613,0.7261914454223888,0.7839285714285714,0.9902624839275905,1.0,5/12,23.42%,H6PD;SREBF1;KPNB1;SEC14L2;SREBF2
prerank,DNA recombination (GO:0006310),0.27078167977929674,0.7257061043206541,0.8098693759071117,0.9904490767479488,1.0,15/37,28.42%,LIG4;RAD51B;DMC1;RECQL5;RAD51D;RTEL1;XRCC2;RAD54L;MRE11;HMGB3;RAD50;RPAIN;HMGB1;RECQL;RPA1
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.28913656976740676,0.7254008600654979,0.814388489208633,0.9903910081840371,1.0,6/25,22.45%,LEPROT;CHMP5;LAPTM4B;TMEM50B;RILP;SORT1
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.33016670334505965,0.7251845195963373,0.755877034358047,0.9902181337418939,1.0,3/13,12.32%,NEDD4;EMILIN1;NIBAN2
prerank,osteoclast differentiation (GO:0030316),0.29873712824335036,0.7249509073051584,0.7984496124031008,0.9900794373037116,1.0,5/22,17.06%,CSF1;SRC;EFNA2;OSTM1;GLO1
prerank,organic cation transport (GO:0015695),0.3108858016207441,0.7244954063763591,0.8129032258064516,0.9902312943855129,1.0,4/20,10.98%,SLC44A1;SLC22A2;SLC22A4;SLC22A18
prerank,lipid droplet formation (GO:0140042),-0.31608846308054506,-0.7244862376030977,0.8208232445520581,0.9973656346773817,1.0,6/10,37.21%,PLA2G4C;ZFYVE1;FITM2;CDS1;CDS2;BSCL2
prerank,regulation of mRNA metabolic process (GO:1903311),-0.3045021071994587,-0.7244046858024491,0.8271604938271605,0.9965140731336928,1.0,4/11,22.93%,SRPK1;PTCD2;DHX9;SRPK3
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.31963794733382195,0.7243885695648854,0.7794117647058824,0.9899058033659639,1.0,3/14,11.48%,BFAR;BCL2L11;UFL1
prerank,negative regulation of myoblast differentiation (GO:0045662),0.322758389658931,0.7242210208515293,0.7664359861591695,0.9896749744655766,1.0,2/13,5.51%,PRICKLE1;TBX3
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.2944189897642474,0.7239322115649108,0.8128930817610063,0.9896141274626951,1.0,6/22,19.01%,DYNLL1;CDA;BMP4;CDKN1C;CDKN2C;CDKN1B
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.22604680459382487,0.723446479428047,0.9124423963133641,0.9897998560070939,1.0,30/125,22.73%,DYNLL1;NUP107;EFHC1;DYNC1H1;SPC24;SPDL1;ZW10;DCTN6;PMF1;ZWINT;CENPC;NEK6;CENPH;NUP98;DYNC1I2;EML4;PLK2;SGO1;PTPA;SEH1L;CENPA;KPNB1;CDCA8;CENPM;DSN1;AURKA;TAOK1;NDE1;TUBG2;TUBG1
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.26441166139977523,-0.7232483683413926,0.8488063660477454,0.9970141518352297,1.0,2/17,4.12%,MEF2C;PRKG1
prerank,regulation of cell killing (GO:0031341),-0.2701744922874961,-0.7231430842424394,0.8605769230769231,0.9961830572233922,1.0,3/16,9.71%,TGFB2;CD55;MAPK8
prerank,negative regulation of cell communication (GO:0010648),-0.2510079265729832,-0.7230784738209676,0.8560411311053985,0.9953063755678314,1.0,2/21,4.48%,UBASH3B;GLRA1
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.2540264801734165,0.7229158029600322,0.8604026845637583,0.9900499574470996,1.0,6/45,9.31%,SP100;NCAM1;IRF1;OAS2;PML;CAMK2B
prerank,negative regulation of cellular senescence (GO:2000773),0.3235118848694124,0.7227586052948457,0.7755834829443446,0.9897912357457732,1.0,4/13,12.17%,AKT3;SLC30A10;ZKSCAN3;TERF2
prerank,DNA packaging (GO:0006323),0.31150942959453065,0.7225219033244081,0.8022690437601296,0.98964572210614,1.0,2/16,8.94%,CHAF1B;AIFM1
prerank,regulation of T cell proliferation (GO:0042129),-0.19253820475567568,-0.722348946009671,0.9407114624505929,0.9952434986690343,1.0,14/61,22.62%,SLC7A1;IL15;TFRC;TNFRSF21;CD80;PTPRC;JAK3;NCK2;PNP;CD86;ANXA1;CD276;AIF1;VCAM1
prerank,DNA damage checkpoint signaling (GO:0000077),-0.23429465258305032,-0.7218851010608277,0.8583569405099151,0.9948982840225714,1.0,12/28,34.66%,RAD17;RAD1;HUS1;NBN;CEP63;HINFP;E2F1;RHNO1;DONSON;RAD9A;DOT1L;FBXO6
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.31326350466897024,0.7216891431798284,0.805993690851735,0.9902987478045331,1.0,7/17,25.28%,IL12B;EBI3;IL18BP;IL18;BACH2;MYO1G;JAG1
prerank,regulation of cellular protein metabolic process (GO:0032268),0.2578037321140404,0.7215037463098477,0.8431635388739946,0.9900891781182499,1.0,10/47,17.92%,APOE;CSF1;AGTR1;WDR91;EIF2B4;MTPN;NR1H3;RBM4B;AKT1;FOXO3
prerank,regulation of protein-containing complex assembly (GO:0043254),0.22510413468326138,0.7214341193099167,0.899880810488677,0.989717168006202,1.0,7/110,6.31%,TRABD2B;GSN;ABCA1;APOE;CDH5;CDC42;SRC
prerank,positive regulation of interleukin-1 beta production (GO:0032731),-0.20782649911714177,-0.7211776623815263,0.9040590405904059,0.9948460567249587,1.0,20/45,32.82%,P2RX7;GBP5;AIM2;JAK2;TRIM16;CASP8;APP;NOD2;TLR4;FZD5;AGER;MALT1;TMEM106A;CD36;EGR1;LPL;NLRP3;HSPB1;TLR8;STAT3
prerank,cardiolipin metabolic process (GO:0032048),-0.2896793072573231,-0.7210578944835592,0.8392434988179669,0.9940550333429876,1.0,4/13,17.67%,PGS1;PNPLA8;CRLS1;PTPMT1
prerank,histone H3-K9 demethylation (GO:0033169),0.3456451313432243,0.720656580308535,0.7953410981697171,0.990267769679632,1.0,6/11,23.22%,KDM7A;PHF8;KDM3B;KDM4A;KDM4C;KDM3A
prerank,microvillus organization (GO:0032528),0.32816018039642936,0.7204741544349427,0.8044596912521441,0.9900556881850733,1.0,4/13,14.94%,RAPGEF2;MAP4K4;RAP2A;RAPGEF6
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.34422931854622624,0.7197982903887584,0.803921568627451,0.9904530710546562,1.0,2/10,5.54%,SERPINE1;CYP1B1
prerank,positive regulation of calcium ion transport (GO:0051928),0.2681645964371995,0.7197488696437307,0.8289855072463768,0.9900684447986617,1.0,5/36,11.46%,MYLK;PDGFRB;CCL4;SPHK2;P2RX5
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.3438938064634319,0.719741129516858,0.8102564102564103,0.9896199278342731,1.0,3/11,19.35%,SP100;KAT5;MUC1
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.2466903761974893,0.7195863776165109,0.8478835978835979,0.9893668210024873,1.0,9/59,16.32%,ROCK2;IRAK2;RNF31;TBK1;RIPK2;CD14;TNFRSF1A;PRDX4;AKT1
prerank,positive regulation of histone deacetylation (GO:0031065),-0.2916671960426592,-0.7193816928926146,0.8461538461538461,0.9950161907864626,1.0,3/12,13.51%,CTBP1;VEGFA;APLNR
prerank,peptidyl-lysine methylation (GO:0018022),0.2966845813739564,0.719090223862416,0.8269525267993875,0.989559512019294,1.0,5/26,16.47%,SETD7;SETD4;SMYD3;TRMT112;EEF2KMT
prerank,folic acid metabolic process (GO:0046655),0.3052792004899396,0.7189921080853652,0.8223684210526315,0.9892219040120662,1.0,3/18,12.63%,MTHFR;ALDH1L1;FOLR2
prerank,glutathione metabolic process (GO:0006749),0.268797619172869,0.7189615301848511,0.8102710413694721,0.9887984797919166,1.0,5/38,9.38%,CHAC2;GSTM4;GSTM2;DPEP1;GSTT1
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.25192912862845096,0.7184669039328819,0.8609986504723347,0.9889995880101378,1.0,16/50,24.01%,CCNA2;CDK5RAP3;CCNK;TTBK1;MNAT1;CNPPD1;CDKN1C;CDKN2C;CCNT2;CDKN1B;SERTAD1;CCND2;CCNT1;CCNG2;CDK7;CCNE2
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.2663662816609589,0.7184610729768323,0.8220946915351507,0.9885514039773086,1.0,7/36,13.47%,DACT1;NCOR1;PRKN;ITCH;TAOK3;DUSP19;IGBP1
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.29331900642882214,0.7184041247166307,0.8149847094801224,0.9881648682569276,1.0,3/22,8.20%,NOS1AP;CACNB1;DRD3
prerank,histone H2A monoubiquitination (GO:0035518),0.3046976626967816,0.7183011572854642,0.806930693069307,0.9878314854994379,1.0,3/17,8.77%,BCOR;CUL4B;PCGF3
prerank,translesion synthesis (GO:0019985),-0.20837991748637905,-0.7181501417250931,0.926923076923077,0.9954743644351403,1.0,15/42,30.76%,REV3L;TRIM25;POLH;POLN;UFD1;POLD4;POLK;DTL;RCHY1;FAAP20;VCP;ISG15;UBC;RPS27A;POLD2
prerank,tRNA 5'-leader removal (GO:0001682),0.33115542396907915,0.7178539890095964,0.800332778702163,0.9879901708287565,1.0,4/13,15.59%,RPP25L;PRORP;RPP30;RPP38
prerank,leukotriene metabolic process (GO:0006691),0.3059869941711836,0.7177171365824649,0.8104026845637584,0.9877019880643948,1.0,9/19,27.00%,PLA2G4A;DPEP1;DPEP2;MAPKAPK2;ALOX12;ALOX5AP;LTA4H;MGST3;MGST2
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.21640016059454065,0.7174907201754587,0.9488054607508533,0.9875545110532201,1.0,10/163,7.09%,PDPK1;THEMIS;PIK3R1;FYB1;BCL2;RFTN1;PSME4;CD247;RNF31;CD28
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.3089674473440131,0.7174815991977009,0.7834179357021996,0.9871119613319315,1.0,2/15,11.17%,RIPOR2;CD53
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.3434928195241704,0.7174683085699363,0.776735459662289,0.9866749465723414,1.0,4/10,21.44%,INO80;CDC7;ATRX;STOML2
prerank,regulation of protein metabolic process (GO:0051246),0.2584737515290164,0.7165693378229303,0.8649789029535865,0.9874138881442275,1.0,3/44,5.01%,ROCK2;APOE;LDLR
prerank,peroxisome organization (GO:0007031),0.28355080927177356,0.7163760251256708,0.8133748055987559,0.9872058053780897,1.0,8/25,21.50%,LONP2;PEX6;PEX2;ABCD2;PEX11B;SEC16B;PEX7;PEX1
prerank,response to ionizing radiation (GO:0010212),0.23568082154256467,0.7162844202593952,0.8871391076115486,0.9868568652842928,1.0,8/70,10.58%,EYA1;LIG4;IKBIP;INO80;BRSK1;NHEJ1;STK11;MRNIP
prerank,vitamin transport (GO:0051180),0.28149746605043824,0.7157797503404546,0.8520710059171598,0.9870424021653078,1.0,4/29,5.39%,SLC2A10;APOA1;SLC35F3;PDPN
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.30888206791207373,0.7157219298320079,0.8178807947019867,0.986660371801443,1.0,9/17,30.58%,DOLPP1;ALG6;DHDDS;SRD5A3;DPAGT1;MPDU1;ALG9;ALG2;ALG3
prerank,endoderm development (GO:0007492),0.3226535973106742,0.7154756956710208,0.8069565217391305,0.9865041520783056,1.0,1/13,2.67%,LAMC1
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.32771901271734755,0.7149984580905074,0.7969018932874354,0.9866728679303106,1.0,3/13,14.89%,NFIB;REST;BMP4
prerank,RNA biosynthetic process (GO:0032774),-0.22639177959127413,-0.714925810615182,0.8996960486322189,0.998300102437441,1.0,13/31,31.18%,TBP;TAF10;RSF1;HELB;TAF5;GTF2B;TAF4;TCEA2;PRIM1;TBPL1;SMN1;POLA1;TERT
prerank,cellular response to chemical stress (GO:0062197),0.23004972923812114,0.7147649347534815,0.9015795868772782,0.9865121413359799,1.0,23/96,20.79%,PYCR1;NUDT2;MT3;SLC25A24;PRKAA2;GPX8;LRRK2;NFE2L2;SIRT2;DDX3X;MGAT3;FANCC;SELENOS;GPX3;NOX4;SESN2;LONP1;ATM;FOXO3;SOD3;BRF2;ATP13A2;PRDX6
prerank,early endosome to late endosome transport (GO:0045022),0.2962257899156331,0.7147613553515748,0.805379746835443,0.9860655983359488,1.0,10/20,27.73%,WDR81;WDR91;PTPN23;HOOK2;BECN1;RILP;STX8;ANKRD27;HOOK1;RAB5A
prerank,negative regulation of platelet activation (GO:0010544),0.3112285188553789,0.7146426475306549,0.8145695364238411,0.9857582046830374,1.0,4/16,12.06%,PDGFRA;APOE;F2;C1QTNF1
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.3284137486794702,0.7144951684964834,0.7835051546391752,0.9854868052579691,1.0,3/13,8.46%,TNRC6B;CPEB3;TNRC6A
prerank,positive regulation of T cell migration (GO:2000406),-0.25172713859460194,-0.713975121898021,0.8886198547215496,0.9985312817162391,1.0,1/20,1.02%,ADAM10
prerank,microtubule nucleation (GO:0007020),0.30405543809221613,0.7139177718393719,0.8234349919743178,0.9857891143978432,1.0,6/20,22.73%,RANBP9;CENPJ;SLAIN2;NDE1;TUBG2;TUBG1
prerank,mRNA processing (GO:0006397),0.20765199235072687,0.7136727388492139,0.9716684155299056,0.9856476948044569,1.0,75/287,23.72%,POLR2D;SON;RBMXL2;U2AF1L4;SNRNP70;THOC2;GTF2H5;SF1;PNN;RBM22;HNRNPR;METTL14;HNRNPA1;NONO;DDX39A;RAVER2;POLR2C;WDR33;SMU1;DDX23;PRMT9;SUGP1;RBM19;MAGOHB;MNAT1;MTREX;SNRPD2;TCERG1;SRSF5;AKAP8L;PCF11;GPKOW;RBM5;RNPC3;RBM6;CMTR2;RBM4B;PSPC1;GEMIN2;LSM8;SRRM2;SYNCRIP;HNRNPC;PRPF6;RBM41;SF3B2;SF3B1;SRSF10;PPIE;CPSF2;METTL3;PRKACA;POLR2L;FIP1L1;USP49;HNRNPU;GCFC2;HNRNPH1;PPWD1;PRCC;SRSF3;ERCC3;PAPOLA;RBM4;IK;NCBP2;ESS2;CDK7;ZRSR2;SART1;ERCC2;PRPF8;SFPQ;CWC22;CASC3
prerank,positive regulation of transmembrane transport (GO:0034764),0.32233056879497657,0.7131270660369615,0.7986348122866894,0.9858760106040804,1.0,2/13,10.63%,ACSL1;BRAF
prerank,negative regulation of viral release from host cell (GO:1902187),0.3249580389524497,0.7130151755969564,0.8097643097643098,0.9855768133145241,1.0,4/13,19.78%,PML;TRIM32;TRIM26;TRIM21
prerank,mitochondrial RNA metabolic process (GO:0000959),-0.2742317080617602,-0.7130144235801497,0.8551068883610451,0.9986281468847567,1.0,4/14,15.04%,TFB2M;PNPT1;SLC25A33;FASTKD1
prerank,"DNA-templated transcription, termination (GO:0006353)",-0.19125218513189293,-0.7123511110356648,0.9796747967479674,0.9984160990261735,1.0,15/68,18.14%,TAF1B;SNRPB;TBP;CPSF7;CAVIN1;GTF2H1;TAF1C;CSTF3;CSTF1;UBTF;CLP1;CSTF2;SNRPD3;POLR2E;MED18
prerank,positive regulation of calcium-mediated signaling (GO:0050850),-0.2966836764429224,-0.7123257836415384,0.8542141230068337,0.9975079414147991,1.0,2/11,7.30%,PLCG2;CDH13
prerank,peptidyl-lysine acetylation (GO:0018394),0.33466706049741857,0.7119222619410069,0.7765567765567766,0.9865314583348548,1.0,5/10,24.13%,KAT2B;BLOC1S1;KAT5;BAG6;ESCO1
prerank,internal peptidyl-lysine acetylation (GO:0018393),-0.23583031058966514,-0.711132963748846,0.8875379939209727,0.9979630229208639,1.0,7/27,17.93%,PHF20L1;KAT2A;RUVBL1;KAT6A;EP300;MRGBP;SGF29
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.300812743956904,0.7110107904920898,0.8322981366459627,0.9872262141607184,1.0,2/17,8.32%,PLA2G4A;LPGAT1
prerank,neurotrophin signaling pathway (GO:0038179),0.29052589870550793,0.7104092960670065,0.8218954248366013,0.9875685103388255,1.0,4/21,9.36%,RAPGEF2;NTF3;FRS2;RAPGEF1
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.2834561612098551,0.7100109321736585,0.8476499189627229,0.987628145600834,1.0,2/24,3.47%,EPHA4;APOE
prerank,positive regulation of bone resorption (GO:0045780),-0.29752849892574595,-0.7096761075462327,0.8365384615384616,0.9986264505620295,1.0,2/11,11.79%,TNFRSF11A;SPP1
prerank,fatty acid beta-oxidation (GO:0006635),0.2475650637877771,0.7088784416911278,0.8783068783068783,0.9886018231819333,1.0,11/51,19.95%,IVD;ECHDC2;ECI1;ECHS1;PEX2;DECR1;ABCD2;ETFDH;DECR2;ETFA;ETFB
prerank,response to growth factor (GO:0070848),0.25995997895935186,0.7087368575295662,0.8647140864714087,0.9883183607939379,1.0,8/41,16.32%,BMPR1A;TGFBR1;ACVR1;SFRP1;STAT5B;ACVR1B;GATA6;AKT1
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.316739398436382,0.7079185152237243,0.8003300330033003,0.9884408825490315,1.0,2/15,9.55%,DTNBP1;BLOC1S1
prerank,anterograde synaptic vesicle transport (GO:0048490),0.316739398436382,0.7079185152237243,0.8003300330033003,0.9884408825490315,1.0,2/15,9.55%,DTNBP1;BLOC1S1
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.3066574484672282,0.7078076949951343,0.802653399668325,0.9881302170438111,1.0,4/17,22.45%,APOA1;NR1H3;LMF1;SORT1
prerank,pyrimidine-containing compound catabolic process (GO:0072529),0.3067665166186526,0.7077557771405406,0.8290322580645161,0.9877488636943701,1.0,2/16,4.55%,DPYSL3;DPYD
prerank,activation of phospholipase C activity (GO:0007202),0.27667044477468244,0.7076998894900598,0.8338414634146342,0.9873715422913644,1.0,3/29,8.59%,ARHGAP6;LPAR1;EGFR
prerank,regulation of store-operated calcium entry (GO:2001256),-0.30373146764852854,-0.7076438667965246,0.8407960199004975,0.9999457647770745,1.0,5/10,23.45%,HOMER1;HOMER3;EFHB;GRAMD2A;CASQ1
prerank,organophosphate biosynthetic process (GO:0090407),-0.21440592159736271,-0.707158416601562,0.9155405405405406,0.9995511106990339,1.0,11/37,26.00%,LPCAT1;MBOAT1;TPI1;IP6K1;IPMK;AGPAT5;GPHN;PPIP5K1;ITPKB;MOCS2;ITPKC
prerank,positive regulation of cell cycle phase transition (GO:1901989),-0.26827591601898165,-0.7063914655906253,0.8649350649350649,0.999438685691805,1.0,5/15,21.60%,PLCG2;EZH2;CUL3;NPM1;DDRGK1
prerank,negative regulation of response to stimulus (GO:0048585),0.2422863039069357,0.7060878940485216,0.8920377867746289,0.9888887672037551,1.0,13/60,14.79%,LYN;APOA1;APPL2;ACVR1;CASK;AKT3;SLC30A10;ZKSCAN3;IGFBP3;ADRA2A;TERF2;COL3A1;NR1H3
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.2897645683405147,0.7059341979813618,0.8138041733547352,0.9886415128571032,1.0,1/20,1.77%,LYN
prerank,response to cholesterol (GO:0070723),0.30319670946875316,0.7057857910673924,0.8240131578947368,0.9883627423641763,1.0,2/17,3.64%,TGFBR1;SMO
prerank,positive regulation of interleukin-6 production (GO:0032755),0.23376442509012907,0.7056991365576298,0.900516795865633,0.9880244507450193,1.0,8/68,11.01%,IL6R;IL17D;TSLP;SPHK2;TLR6;RAB7B;CARD9;SETD4
prerank,regulation of RNA splicing (GO:0043484),0.2363030549501939,0.7056933663493397,0.895618556701031,0.9875844364628764,1.0,13/69,15.60%,PIK3R1;SON;HNRNPLL;SNRNP70;SF1;RBM22;CLK4;RBM39;TMBIM6;METTL4;CLK3;DYRK1A;SLC38A2
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.3183791354887939,0.7055645002114803,0.810671256454389,0.9873014714191756,1.0,8/13,30.58%,ALG11;ALG6;SRD5A3;DPAGT1;MPDU1;ALG9;ALG2;ALG3
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.2852524055690683,-0.7048045248983722,0.849438202247191,1.0,1.0,8/12,55.05%,CCT8;GNL3;CCT6A;CCT7;CCT2;TCP1;WRAP53;DKC1
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.24150442088403162,0.7047571383492566,0.8953488372093024,0.987829668279541,1.0,17/62,21.17%,BCL2;SRC;LRRK2;NFE2L2;PRKN;CREB3;DDX3X;SELENOS;NOL3;VNN1;BAG5;TMBIM6;AKT1;TRIM32;CREB3L1;PPIF;OPA1
prerank,microvillus assembly (GO:0030033),0.31497769033535117,0.7046089931306974,0.8138747884940778,0.9875775994185245,1.0,4/14,14.94%,RAPGEF2;MAP4K4;RAP2A;RAPGEF6
prerank,glial cell differentiation (GO:0010001),0.2733444878257554,0.7044662791536765,0.8446455505279035,0.9872986920177982,1.0,2/28,3.18%,SLC8A3;NFIB
prerank,defense response to fungus (GO:0050832),-0.25676004402590347,-0.7044458450794963,0.8779220779220779,0.9997036538487897,1.0,2/17,11.17%,PLCG2;CX3CR1
prerank,negative regulation of organelle assembly (GO:1902116),0.2600416430782531,0.704178555301557,0.8531571218795888,0.9872117121694962,1.0,5/35,11.56%,YAP1;NUPR1;LRRK2;KAT2B;MDM1
prerank,fatty acid metabolic process (GO:0006631),0.22296136684607154,0.7032269137466833,0.9290085679314566,0.9879273735184314,1.0,25/115,22.97%,SLC27A5;ACSL1;ACOT11;ACOT6;CPT1C;ACOT2;ALOXE3;AASDH;PEX2;ACSF2;ACSF3;ABCD2;FASN;OXSM;ACADSB;NUDT19;CYP1A1;ACSL4;LPIN3;ALOX12;ALOX5AP;LPIN2;CPT1A;HPGD;ACADM
prerank,superoxide metabolic process (GO:0006801),-0.22706268881163003,-0.7028349133664266,0.9143730886850153,1.0,1.0,2/29,2.34%,SH3PXD2A;NOS3
prerank,calcium ion transport into cytosol (GO:0060402),0.29368125769780185,0.7021467239011066,0.8325358851674641,0.9888187706017941,1.0,2/21,6.66%,SLC8A1;CACNA1C
prerank,DNA-dependent DNA replication (GO:0006261),-0.16942245439468026,-0.7018883536843192,0.99375,1.0,1.0,39/128,30.76%,REV3L;DBF4;TOPBP1;ORC4;POLE4;PSMF1;POLB;PSMB8;PSMA4;MCM8;PSMB10;RAD51;PSMB2;MCMBP;LRWD1;GINS3;PNKP;PSMC4;MCM3;POLD4;PSMA6;PSMD9;PSMD11;PSMD5;WRNIP1;HELB;MCM5;PSMA8;PSMB1;ORC5;PRIM1;PSMD10;CDC6;GINS2;BAZ1A;POLA1;UBC;RPS27A;POLD2
prerank,regulation of translation (GO:0006417),0.21385072465807645,0.7015692437322301,0.9477196885428254,0.9890746696256506,1.0,28/173,18.51%,SAMD4A;DAPK1;PLD1;IGF2BP2;IGFBP5;CPEB3;CD28;EIF2AK3;RNF139;METTL14;EIF4A2;EIF6;EIF2B4;DDX3X;EIF5B;IMPACT;LARP1;MTPN;ENC1;PLXNB2;NSUN5;RBM4B;SYNCRIP;FOXO3;ALKBH1;METTL3;EIF3C;DDX1
prerank,regulation of T cell activation (GO:0050863),-0.20515194144372625,-0.701503774893369,0.9335548172757475,1.0,1.0,15/42,38.43%,CYRIB;SIRPA;KAT2A;PTPN22;JAK3;CCL2;LAX1;DUSP3;IL4I1;LAT;TNFSF8;PRKCQ;CRTAM;CCDC88B;TNFSF11
prerank,NIK/NF-kappaB signaling (GO:0038061),-0.18483666750536387,-0.7010792476984903,0.9586776859504132,0.9996644519607127,1.0,21/72,23.95%,CUL1;REL;CARD14;PSMF1;PSMB8;RELB;PSMA4;PSMB10;PSMB2;PSMC4;TNFRSF10B;PSMA6;PSMD9;PSMD11;PSMD5;TRAF2;CHUK;MAP3K7;MALT1;PSMA8;PSMB1
prerank,regulation of response to biotic stimulus (GO:0002831),0.2727440304028152,0.700938388983896,0.8586466165413534,0.9893944187233494,1.0,11/28,22.79%,APPL2;IRF1;GATA6;RNF135;CX3CL1;DHX58;APPL1;TIRAP;BIRC2;BIRC3;XIAP
prerank,autophagy of nucleus (GO:0044804),-0.2676629034401269,-0.7007624779861686,0.8439897698209718,0.9990394914915598,1.0,6/16,21.84%,ULK1;WDR45B;ATG3;WIPI2;ATG13;ATG7
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.2580114642867567,-0.7007495468603452,0.8746928746928747,0.9981227286989277,1.0,9/17,29.36%,KDM1A;PTTG1IP;SIRT1;CD44;SNAI2;TWIST1;MIF;SNAI1;PSMD10
prerank,peptidyl-proline modification (GO:0018208),-0.2323457966878586,-0.7003343633033281,0.9,0.9976322495570107,1.0,9/25,23.37%,PPIA;FKBP5;PPIG;P3H2;PPID;PPIL1;FKBP1A;PPIB;PPIL6
prerank,DNA integrity checkpoint signaling (GO:0031570),-0.21092387838973284,-0.6999390680848838,0.9287925696594427,0.9971038707437044,1.0,14/36,34.66%,RAD17;RAD1;HUS1;NBN;CEP63;HINFP;E2F1;RHNO1;HUS1B;DONSON;CDC6;RAD9A;DOT1L;FBXO6
prerank,positive regulation of cellular respiration (GO:1901857),0.32484783068820416,0.6998019550316269,0.7941176470588235,0.9903219192518261,1.0,1/11,3.58%,NUPR1
prerank,cellular response to reactive oxygen species (GO:0034614),0.238112912640877,0.6995541388634284,0.8758169934640523,0.9901743597510569,1.0,7/59,8.59%,TPM1;PDGFRA;CYP1B1;NFE2L2;ERCC6L2;OSER1;EGFR
prerank,phagolysosome assembly (GO:0001845),0.32251199441641637,0.6995019638076535,0.8200339558573854,0.9897910676521267,1.0,3/12,15.38%,RAB7B;CLN3;PIKFYVE
prerank,neutrophil mediated immunity (GO:0002446),0.19963431423559916,0.6980947976721837,0.9918781725888325,0.9910058937498126,1.0,70/432,16.20%,AMPD3;GSN;AHSG;PLD1;DYNLL1;CRISPLD2;PLEKHO2;PIGR;CLEC12A;CNN2;TXNDC5;FGL2;GALNS;IQGAP2;CTSH;FAF2;STXBP3;TOM1;DYNC1H1;CST3;PDXK;VCL;B4GALT1;KCMF1;TIMP2;CD63;CAMP;COPB1;SPTAN1;GAA;UBR4;DNAJC3;ANXA3;ARHGAP9;AGL;APEH;IGF2R;MGST1;S100A11;ITGAV;AP1M1;NFAM1;VPS35L;DNASE1L1;CARD9;DDX3X;TMEM179B;CD53;LAMTOR2;TNFAIP6;CD33;CDA;CTSZ;CD14;DDOST;KMT2E;MVP;FRK;ATP6AP2;VNN1;HUWE1;PRDX4;GNS;GSDMD;LAMP2;PYGB;AGA;ERP44;CD47;NHLRC3
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.24643376282652651,0.6980573588530269,0.8728813559322034,0.9906033913022624,1.0,8/47,13.47%,TGFBR3;MAP2K1;EGFR;MAP4K4;CARD9;TAOK3;RAP2A;IGBP1
prerank,protein K11-linked ubiquitination (GO:0070979),-0.22250876158358396,-0.6972451230800855,0.9207650273224044,0.9990101445122055,1.0,11/27,32.44%,UBE2H;ANAPC7;UBE2D3;UBE2B;UBE2S;RNF4;UBE2A;FZR1;ANAPC11;ANAPC13;UBE2C
prerank,base-excision repair (GO:0006284),0.24913310703780098,0.6970570107145573,0.8873435326842837,0.9913191864042921,1.0,12/48,23.93%,OGG1;USP47;NEIL1;POLG;POLL;MBD4;HUWE1;XPA;RFC5;MUTYH;LIG1;TDG
prerank,folic acid-containing compound metabolic process (GO:0006760),0.29160867499243925,0.6970309690857294,0.8396694214876033,0.9909009356276317,1.0,3/19,12.63%,MTHFR;ALDH1L1;FOLR2
prerank,negative regulation of DNA biosynthetic process (GO:2000279),-0.22223169414436253,-0.6969110675140494,0.9213483146067416,0.9984093997758269,1.0,7/30,21.71%,DACH1;ACVRL1;CTC1;BMPR2;CDKN1A;DCP2;TEN1
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",0.32985754170115666,0.696592880509028,0.8172231985940246,0.9909623964810693,1.0,1/10,4.42%,APPL2
prerank,positive regulation of interleukin-12 production (GO:0032735),0.26222658469336435,0.6962532378972344,0.8529411764705882,0.990895702569625,1.0,8/31,21.57%,CCL19;IL12B;RIPK2;MDK;IL23A;PLCB1;TIRAP;LGALS9
prerank,regulation of receptor recycling (GO:0001919),-0.2611222162206627,-0.6961541491692261,0.8571428571428571,0.9982732799042442,1.0,4/16,11.54%,INPP5F;KIF16B;SCRIB;NSF
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",-0.19313119188918582,-0.6959902024835443,0.9535864978902954,0.9975385462259689,1.0,12/54,21.44%,CRADD;PLAGL1;CNOT6L;BTG2;RPL26;EP300;CDKN1A;CNOT7;E2F7;TRIAP1;PLK3;CNOT8
prerank,positive regulation of mRNA processing (GO:0050685),-0.240914993181464,-0.6956448321447629,0.8853333333333333,0.9969713661236662,1.0,5/21,19.00%,CELF4;SNW1;THRAP3;RBMX;SF3B4
prerank,mitotic cytokinetic process (GO:1902410),0.2884382888217914,0.6954803222432088,0.8558692421991084,0.9913585512056152,1.0,3/20,13.15%,KIF20A;KLHDC8B;CHMP5
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.27475502446641625,0.6954147387494137,0.8569051580698835,0.990990224653648,1.0,5/28,15.04%,BCL2;MOAP1;DDX3X;CASP8AP2;TNFRSF1A
prerank,positive regulation of protein localization to cell surface (GO:2000010),-0.2763918943827258,-0.6953734433355105,0.8532338308457711,0.9963352234364142,1.0,2/13,6.88%,STX3;HSP90AB1
prerank,modification-dependent protein catabolic process (GO:0019941),0.2092469517938295,0.6950508932005725,0.9678848283499446,0.9909978147658531,1.0,41/193,18.73%,SPSB1;DCST1;NEDD4;RFFL;SMURF2;RNF213;BFAR;ZNRF3;UBE4B;TRIP12;RNF185;UBR4;ARRB1;WDR81;ANAPC5;WDR91;PRKN;ITCH;RNF6;MIB1;FBXO11;FEM1C;BTRC;RNF217;COPS3;RNF19A;RC3H2;ADRM1;AMFR;UBA6;UBE2D1;HACE1;RNF13;UBE2R2;UBR3;LONP1;UBE3B;PSMC2;RC3H1;RNF34;TRIM32
prerank,nucleobase-containing small molecule interconversion (GO:0015949),-0.22789738411068372,-0.6948911326463911,0.9221902017291066,0.995916360115857,1.0,9/27,28.89%,GSR;AK6;AK5;TYMS;AK7;DCTD;AK2;RRM1;NME2
prerank,reticulophagy (GO:0061709),0.32901999313300057,0.6936240379440596,0.8278829604130808,0.9922772648665101,1.0,4/12,18.09%,ULK2;UFL1;UFC1;ATG2B
prerank,establishment of protein localization to organelle (GO:0072594),0.23030485345994478,0.6931247162471276,0.9168797953964194,0.9924170853863273,1.0,16/72,18.83%,RANBP17;NUP107;APPL2;FAM53C;PRICKLE1;HEATR3;CSE1L;PPP1R10;TSC2;NUP214;LAMP2;AKT1;PHB2;TPR;APPL1;KPNB1
prerank,positive regulation of telomere maintenance (GO:0032206),-0.21554162677566774,-0.6930768953809808,0.9244712990936556,0.9968770391940456,1.0,9/31,22.34%,NEK7;PKIB;HNRNPD;MAPK3;HNRNPA2B1;PNKP;NBN;SLX4;MAPK1
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.20406437466021501,0.6929009471614131,0.9732905982905983,0.9922398947438796,1.0,62/241,23.72%,POLR2D;RBMXL2;U2AF1L4;SNRNP70;SF1;PNN;RBM22;HNRNPR;METTL14;HNRNPA1;NONO;DDX39A;RAVER2;POLR2C;WDR33;SMU1;DDX23;SUGP1;RBM19;MAGOHB;MTREX;SNRPD2;SRSF5;PCF11;GPKOW;RBM5;RNPC3;RBM6;RBM4B;PSPC1;LSM8;SRRM2;SYNCRIP;HNRNPC;PRPF6;RBM41;SF3B2;SF3B1;SRSF10;PPIE;CPSF2;METTL3;POLR2L;FIP1L1;USP49;HNRNPU;GCFC2;HNRNPH1;PPWD1;PRCC;SRSF3;PAPOLA;RBM4;IK;NCBP2;ESS2;ZRSR2;SART1;PRPF8;SFPQ;CWC22;CASC3
prerank,thymus development (GO:0048538),0.32280802224441824,0.6927499137331988,0.8330464716006885,0.9919665221715154,1.0,4/13,16.71%,TGFBR1;ZBTB1;EPHB3;SHH
prerank,mRNA catabolic process (GO:0006402),-0.19665417972848137,-0.6927471615209846,0.9471830985915493,0.9963044967338117,1.0,12/44,19.45%,PNPT1;LSM2;LSM6;THRAP3;SUPV3L1;DIS3L2;ERN1;NBAS;AGO1;RNH1;DDX5;DCP2
prerank,posttranscriptional regulation of gene expression (GO:0010608),-0.20263939046006285,-0.6927002504205503,0.9250936329588015,0.9954387999209613,1.0,8/45,14.93%,EIF4E;GRM5;LARP4;TDRD7;ATG14;PER1;YTHDC1;APP
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.2834379911649739,0.6919180801847908,0.8642611683848798,0.992510108410575,1.0,3/20,9.15%,BCL2;PML;BCAP31
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.23801578827708378,0.6918519204691533,0.9043250327653998,0.992138789113268,1.0,18/56,20.58%,RAD51B;EGFR;ANAPC5;DDX3X;RGCC;KMT2E;UBE2E2;AKT1;ADAMTS1;TFDP1;LSM10;CDC7;KLHL18;PHB2;NSMCE2;CDC23;PLCB1;CCND2
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.2703569885114535,0.6917907500467518,0.8551829268292683,0.9917573645072681,1.0,8/27,21.72%,IRAK2;TLR6;IRAK3;CD14;TNIP1;TLR5;TIRAP;MYD88
prerank,regulation of myelination (GO:0031641),-0.23031167549322262,-0.6914761562117623,0.9066265060240963,0.9957531155707365,1.0,4/25,11.15%,JAM2;TENM4;PTN;TNFRSF21
prerank,cellular component maintenance (GO:0043954),0.3244367366411619,0.6913542653401642,0.8333333333333334,0.9918317202684752,1.0,2/12,12.55%,ITGA3;INSR
prerank,protein alkylation (GO:0008213),-0.2374344119166531,-0.6909878576497642,0.8904494382022472,0.9953179607632605,1.0,11/22,42.60%,SNRPB;FAM98B;SNRPD3;PRMT3;LCMT1;CAMKMT;PRMT2;EEF1AKMT1;ETF1;EEF1AKMT2;FAM98A
prerank,protein-DNA complex assembly (GO:0065004),0.21743943943803007,0.6903446821383115,0.9413173652694611,0.9925267430717482,1.0,6/116,6.57%,TCF4;PSME4;CHAF1B;DMC1;GTF2H5;CUL4B
prerank,negative regulation of secretion (GO:0051048),-0.28880588545794406,-0.6897297537170681,0.8496583143507973,0.9956442964060053,1.0,2/10,12.77%,VAMP8;ERBB3
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.2848375586188595,0.6892898261286805,0.8516129032258064,0.9932990974812415,1.0,3/22,9.40%,APOA1;SPHK2;TRPM4
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.3003417981999538,0.6887143276119941,0.8282009724473258,0.9935312194447714,1.0,6/17,16.32%,NFE2L2;NOL3;P4HB;VNN1;BAG5;AKT1
prerank,protein targeting to peroxisome (GO:0006625),0.26595278477174955,0.6885863214852509,0.8748114630467572,0.9932356065992411,1.0,10/29,23.71%,PXMP2;LONP2;PEX6;PEX2;ABCD2;PEX11B;PEX7;ZFAND6;PEX1;ATAD1
prerank,regulation of cell aging (GO:0090342),0.32183608427030286,0.6881953156876724,0.8231173380035026,0.9932303814434308,1.0,2/11,10.62%,NUAK1;NEK6
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.2795671857886177,0.6881097461917739,0.8632218844984803,0.9928854020683794,1.0,3/22,12.37%,APOA1;MYADM;WNK1
prerank,negative regulation of centrosome duplication (GO:0010826),-0.2830345721870563,-0.6880767676035329,0.8598130841121495,0.9963166222800115,1.0,4/11,18.90%,RBM14;KAT2A;CDK5RAP2;NPM1
prerank,neutrophil degranulation (GO:0043312),0.19664539129429565,0.6870045413278638,0.9928861788617886,0.9936807437236767,1.0,68/425,16.20%,AMPD3;GSN;AHSG;PLD1;DYNLL1;CRISPLD2;PLEKHO2;PIGR;CLEC12A;CNN2;TXNDC5;FGL2;GALNS;IQGAP2;CTSH;FAF2;STXBP3;TOM1;DYNC1H1;CST3;PDXK;VCL;B4GALT1;KCMF1;TIMP2;CD63;CAMP;COPB1;SPTAN1;GAA;UBR4;DNAJC3;ANXA3;ARHGAP9;AGL;APEH;IGF2R;MGST1;S100A11;ITGAV;AP1M1;NFAM1;VPS35L;DNASE1L1;DDX3X;TMEM179B;CD53;LAMTOR2;TNFAIP6;CD33;CDA;CTSZ;CD14;DDOST;MVP;FRK;ATP6AP2;VNN1;HUWE1;PRDX4;GNS;GSDMD;LAMP2;PYGB;AGA;ERP44;CD47;NHLRC3
prerank,regulation of protein localization to centrosome (GO:1904779),-0.29378085613003735,-0.6866412331219955,0.8271028037383178,0.9967366951360292,1.0,1/10,1.66%,BICD1
prerank,neutrophil activation involved in immune response (GO:0002283),0.19619184835359718,0.6863522415214919,0.9928934010152284,0.9939745541608891,1.0,68/428,16.20%,AMPD3;GSN;AHSG;PLD1;DYNLL1;CRISPLD2;PLEKHO2;PIGR;CLEC12A;CNN2;TXNDC5;FGL2;GALNS;IQGAP2;CTSH;FAF2;STXBP3;TOM1;DYNC1H1;CST3;PDXK;VCL;B4GALT1;KCMF1;TIMP2;CD63;CAMP;COPB1;SPTAN1;GAA;UBR4;DNAJC3;ANXA3;ARHGAP9;AGL;APEH;IGF2R;MGST1;S100A11;ITGAV;AP1M1;NFAM1;VPS35L;DNASE1L1;DDX3X;TMEM179B;CD53;LAMTOR2;TNFAIP6;CD33;CDA;CTSZ;CD14;DDOST;MVP;FRK;ATP6AP2;VNN1;HUWE1;PRDX4;GNS;GSDMD;LAMP2;PYGB;AGA;ERP44;CD47;NHLRC3
prerank,mRNA methylation (GO:0080009),0.30387742242057414,0.6863070317896106,0.8367003367003367,0.9935818133290459,1.0,6/15,24.75%,NSUN2;METTL14;WTAP;METTL3;METTL16;PCIF1
prerank,endochondral bone morphogenesis (GO:0060350),-0.28611702239222814,-0.6861453442131821,0.8852040816326531,0.9962817768055666,1.0,1/11,0.57%,MEF2C
prerank,regulation of spindle organization (GO:0090224),0.2943200932538108,0.6860098288209711,0.8451400329489291,0.9934536097691518,1.0,5/18,19.33%,DYNC1H1;RAE1;SENP6;GNAI1;NUMA1
prerank,positive regulation of brown fat cell differentiation (GO:0090336),-0.27075617093105064,-0.6859467533297566,0.8896882494004796,0.995547801254489,1.0,2/13,13.52%,SIX1;PTGS2
prerank,regulation of dephosphorylation (GO:0035303),0.3024926617002323,0.685335141111847,0.838655462184874,0.9937642818526767,1.0,4/15,13.47%,CDK5RAP3;SRC;MTMR3;IGBP1
prerank,negative regulation of interleukin-17 production (GO:0032700),0.3202509720281276,0.6851203647569556,0.8173598553345389,0.9935463225216173,1.0,3/10,22.80%,IL12B;DDIT3;NCKAP1L
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.24282436197585452,0.6849013965726641,0.897196261682243,0.993353362202271,1.0,15/48,21.40%,OGT;PRKAG2;NUP107;NUP42;EIF6;NUP98;RAE1;NUP214;GCK;SEH1L;TPR;PRKAG1;AAAS;GCGR;RUBCNL
prerank,response to amino acid starvation (GO:1990928),0.22817238450542204,0.68455521703833,0.9300518134715026,0.993312492533162,1.0,19/72,21.57%,NPRL3;EIF2AK3;SLC38A9;ATP6V1E1;RNF152;CEBPB;CASTOR2;LAMTOR2;RRAGD;IMPACT;LARP1;ITFG2;SESN2;NPRL2;SEH1L;RHEB;SZT2;MLST8;ATP6V1B2
prerank,positive regulation of myoblast differentiation (GO:0045663),-0.25832124918457106,-0.6844464086205546,0.8325,0.9960269034941204,1.0,3/16,11.55%,MEF2C;SMYD1;RANBP3L
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.31225307553124904,0.6841892742129313,0.8091993185689949,0.9932707580301829,1.0,6/13,23.50%,BFAR;UFL1;ABCA7;WFS1;HSPA5;PPP1R15A
prerank,regulation of JUN kinase activity (GO:0043506),0.2556796348544459,0.6830946137802982,0.8859649122807017,0.9940582415884373,1.0,5/33,12.62%,SASH1;TLR6;TAOK3;DUSP19;PDCD4
prerank,mitotic spindle organization (GO:0007052),0.2101441890571278,0.6829291186061938,0.9594594594594594,0.9938014688357006,1.0,36/153,22.73%,DYNLL1;NUP107;EFHC1;DYNC1H1;SPC24;PIBF1;SPDL1;ZW10;DCTN6;PMF1;ZWINT;CENPC;NEK6;CENPH;NUP98;ARHGEF10;DYNC1I2;EML4;FLNA;PLK2;CEP192;SGO1;PTPA;SEH1L;CENPA;KPNB1;CDCA8;CENPM;AAAS;DSN1;AURKA;TAOK1;NDE1;ABRAXAS2;TUBG2;TUBG1
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.27874050982634696,0.6829221208038363,0.861904761904762,0.9933694254473769,1.0,5/22,17.38%,PLA2R1;CDK5RAP3;SPRED3;SPRED1;ATM
prerank,negative regulation of stem cell differentiation (GO:2000737),-0.2745500171871615,-0.6826769436847201,0.8654292343387471,0.9968208740297908,1.0,2/12,11.18%,NOTCH1;HES1
prerank,negative regulation of phagocytosis (GO:0050765),-0.24312409439048027,-0.6826136506609464,0.8740157480314961,0.9959572678528997,1.0,6/17,24.08%,DYSF;SIRPA;RACK1;CD300A;CD300LF;PLSCR1
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.24801550261862548,-0.6826013710760248,0.88,0.9950607051577508,1.0,9/18,38.18%,CCT8;RUVBL1;DCP2;RUVBL2;SHQ1;NHP2;CCT6A;EXOSC10;NOP10
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),-0.19958941777842773,-0.6818867128117867,0.9319727891156463,0.9948486021643139,1.0,17/42,35.23%,KDM1A;SHLD1;CGAS;RAD51;PARPBP;PARP1;POLQ;HELB;SHLD2;RAD51AP1;KLHL15;WDR48;FIGNL1;WAS;RPA2;SIRT6;RADX
prerank,DNA geometric change (GO:0032392),-0.23014308576132497,-0.6817968455330274,0.9016393442622951,0.9940359724822487,1.0,7/24,19.40%,ZRANB3;SUPV3L1;HNRNPA2B1;NBN;HMGB2;ANXA1;DHX9
prerank,protein K63-linked ubiquitination (GO:0070534),0.2456987707193891,0.6817222721141004,0.8917018284106891,0.9942408277877717,1.0,11/41,20.63%,NEDD4;BFAR;UBE2V2;PRKN;ITCH;RNF152;UBE2E2;RNF135;TRIM21;ARIH2;UBE2T
prerank,tRNA processing (GO:0008033),0.2373377180917649,0.6811676903815489,0.9106217616580311,0.9943885039627866,1.0,15/61,21.46%,PUS3;ADAT2;ZBTB8OS;NSUN2;ADAT1;TRMT9B;URM1;RPP30;ELP5;DTWD1;DDX1;ANKRD16;TRUB1;METTL1;SARS1
prerank,regulation of nervous system development (GO:0051960),0.24976886742807855,0.679871744331005,0.9049645390070922,0.995336876218084,1.0,9/37,19.97%,ASCL1;YAP1;HES7;SIRT2;BHLHE41;NSUN5;CX3CL1;WNT3;YTHDF2
prerank,phosphatidylglycerol metabolic process (GO:0046471),-0.22547530181956893,-0.6781140942183786,0.9034267912772586,0.9965153562706497,1.0,8/24,27.53%,LPCAT1;PGS1;PNPLA8;CRLS1;PLA2G4F;PLA2G4B;PLA2G5;LPCAT4
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),-0.2520510673831596,-0.6779894305664982,0.8693586698337292,0.995701806910087,1.0,6/15,27.02%,GBP5;NLRP2B;TLR4;TREM2;CPTP;CD36
prerank,myelination in peripheral nervous system (GO:0022011),0.30399101912251825,0.6764385561076018,0.835820895522388,0.9985946359637544,1.0,7/13,20.80%,SKI;SIRT2;ARHGEF10;PARD3;NCMAP;DICER1;PRX
prerank,organelle assembly (GO:0070925),0.19618863498263786,0.6764228101829591,0.9886714727085479,0.9981744464739435,1.0,75/385,20.29%,ASAP1;GSN;DYNLL1;PARVA;TMOD4;WDPCP;GORASP2;SH3PXD2B;DZIP1L;RAB23;CYS1;CPLANE1;DYNC1H1;PIBF1;INO80;ULK2;TTC39C;B9D1;WDR35;IFT43;UBXN2B;CENPJ;DNAAF1;FBF1;NCOR1;IFT81;MAPRE2;CENPC;DYNC2I1;NEK6;CFAP44;DDX3X;EMC6;CFAP410;VPS37D;WIPI1;HAUS1;GOLGA8B;CHMP5;PTPDC1;ABCA3;ARF4;SYNPO;PTPN23;HAUS7;FLNA;HAUS3;CEP164;PRRC2C;IFT74;POGZ;AUP1;RAB19;DZIP1;ABCB6;MAP1LC3A;INTU;PATL1;TMEM67;RAB32;RP2;BECN1;ATG2B;AHI1;RC3H1;CENPA;TTC36;HPS4;HYLS1;TMEM231;NSFL1C;EHD1;YTHDF2;WDR45;OCRL
prerank,negative regulation of lymphocyte activation (GO:0051250),-0.23134048851220163,-0.6758143818829605,0.9,0.9966655382656469,1.0,9/21,31.19%,TNFAIP3;PTPN22;JAK3;LST1;LAX1;DUSP3;IL4I1;FOXJ1;FCGR2B
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),-0.2566619296895825,-0.6755770603731635,0.8971291866028708,0.9959862794067846,1.0,8/14,31.21%,LIMS2;EMP2;LIMS1;ITGB1BP1;DMTN;PRKD1;BST1;PHACTR4
prerank,cochlea morphogenesis (GO:0090103),-0.28228975084949054,-0.6748058676767001,0.8725701943844493,0.9957824072323016,1.0,6/10,40.14%,TBX1;MYO3B;MYO3A;TBX18;HOXA1;PAX2
prerank,negative regulation of cell aging (GO:0090344),0.2917466895202164,0.674753489208939,0.8423817863397548,0.999471291596748,1.0,4/16,12.17%,AKT3;SLC30A10;ZKSCAN3;TERF2
prerank,monoacylglycerol metabolic process (GO:0046462),0.3028286983887241,0.6731087942290974,0.8583473861720068,1.0,1.0,3/13,14.60%,PLA2G4A;MOGAT3;DGAT2
prerank,pyroptosis (GO:0070269),-0.2639219863756902,-0.6729907682949858,0.8738095238095238,0.9965333973959777,1.0,5/15,23.90%,AIM2;CASP8;APIP;DHX9;TREM2
prerank,cytosolic transport (GO:0016482),0.21392386121719426,0.6728114296136603,0.9417360285374554,1.0,1.0,19/108,15.38%,DENND2A;BAIAP3;RHOBTB3;MON2;STX16;RBSN;DENND5A;EPS15;GOSR2;HEATR5A;WDR81;WDR91;ARL1;CLN3;TMEM87B;PTPN23;HOOK2;BET1L;PIKFYVE
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.28314214183750586,0.6727839841276256,0.8458961474036851,1.0,1.0,5/18,13.78%,FRS2;BMP2;BHLHE41;TMEM119;HDAC4
prerank,eosinophil chemotaxis (GO:0048245),0.2958863124394734,0.6726558928296147,0.8350340136054422,0.9994612148131357,1.0,2/14,17.51%,CCL4;CX3CL1
prerank,eosinophil migration (GO:0072677),0.2958863124394734,0.6726558928296147,0.8350340136054422,0.9994612148131357,1.0,2/14,17.51%,CCL4;CX3CL1
prerank,regulation of protein localization to Cajal body (GO:1904869),-0.2801004394224733,-0.672172838181034,0.8738532110091743,0.9954765490479832,1.0,11/11,72.02%,CCT8;CCT6A;CCT7;CCT2;LARP7;TCP1;DKC1;CCT4;CCT3;CCT5;MEPCE
prerank,positive regulation of protein localization to Cajal body (GO:1904871),-0.2801004394224733,-0.672172838181034,0.8738532110091743,0.9954765490479832,1.0,11/11,72.02%,CCT8;CCT6A;CCT7;CCT2;LARP7;TCP1;DKC1;CCT4;CCT3;CCT5;MEPCE
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),-0.23123449962295,-0.6714455672091614,0.9130434782608695,0.9951905988705847,1.0,8/22,27.02%,ERBB2;PWP1;UBTF;MTOR;UTP15;ATF4;SMARCA4;PIH1D1
prerank,sensory perception of taste (GO:0050909),-0.29104208327458714,-0.6709632592876142,0.876993166287016,0.9947177532004784,1.0,5/10,44.04%,PKD2L1;CD36;TAS1R1;TAS1R2;GNAT3
prerank,microtubule polymerization (GO:0046785),0.264234617564527,0.6708648394835502,0.8729689807976366,1.0,1.0,8/29,22.73%,RANBP9;CENPJ;FGF13;HDGFL3;SLAIN2;NDE1;TUBG2;TUBG1
prerank,double-strand break repair via break-induced replication (GO:0000727),0.3078581499397814,0.6708248276493959,0.8479427549194991,1.0,1.0,5/12,24.86%,MCM2;CDC7;GINS4;MCMDC2;MCM6
prerank,cilium-dependent cell motility (GO:0060285),0.27427779173145905,0.6705080067084288,0.8616352201257862,1.0,1.0,3/22,10.77%,EFHC1;DNAI3;CFAP44
prerank,pre-replicative complex assembly (GO:0036388),-0.1819156031981133,-0.6695714852867939,0.9641434262948207,0.9950235965194529,1.0,22/64,31.88%,ORC4;PSMF1;PSMB8;PSMA4;MCM8;PSMB10;PSMB2;PSMC4;MCM3;PSMA6;PSMD9;PSMD11;PSMD5;MCM5;PSMA8;PSMB1;ORC5;PSMD10;CDC6;UBC;RPS27A;PSMC3
prerank,snRNA processing (GO:0016180),-0.2495711564919464,-0.6694535138286708,0.9102902374670184,0.9942396694039627,1.0,6/16,33.28%,INTS6;INTS8;INTS1;INTS10;TUT1;INTS11
prerank,coenzyme A biosynthetic process (GO:0015937),0.31950264739918355,0.6685630503965203,0.831858407079646,1.0,1.0,6/11,28.20%,PANK1;COASY;SLC25A16;DCAKD;ACOT7;PANK2
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.31950264739918355,0.6685630503965203,0.831858407079646,1.0,1.0,6/11,28.20%,PANK1;COASY;SLC25A16;DCAKD;ACOT7;PANK2
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.31950264739918355,0.6685630503965203,0.831858407079646,1.0,1.0,6/11,28.20%,PANK1;COASY;SLC25A16;DCAKD;ACOT7;PANK2
prerank,protein deacylation (GO:0035601),0.2731994005355484,0.6685350936131977,0.8809523809523809,1.0,1.0,9/23,25.04%,ABHD17C;LYPLAL1;SIRT2;HDAC4;SIRT5;NOTUM;HDAC6;HDAC5;HDAC1
prerank,regulation of innate immune response (GO:0045088),0.22830858797954945,0.668364659435303,0.9354838709677419,1.0,1.0,17/57,22.79%,APPL2;IRF1;NMI;IRAK3;RNASEL;IFNK;ABCE1;MUL1;RIOK3;RNF135;DHX58;APPL1;TRIM21;TIRAP;BIRC2;BIRC3;XIAP
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),0.31052876298220267,0.6683054361473864,0.8281535648994516,1.0,1.0,3/11,14.79%,LDLR;SREBF1;NR1H3
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.31825231934956494,0.6682808389143947,0.8576576576576577,0.9991886623355042,1.0,6/10,31.64%,ASCC3;ALKBH1;FTO;MPG;ASCC2;ALKBH3
prerank,DNA dealkylation (GO:0035510),0.31825231934956494,0.6682808389143947,0.8576576576576577,0.9991886623355042,1.0,6/10,31.64%,ASCC3;ALKBH1;FTO;MPG;ASCC2;ALKBH3
prerank,glucose import (GO:0046323),0.2984446165173177,0.6681353958885944,0.8542024013722127,0.99889581693735,1.0,5/13,22.90%,SLC2A10;TRARG1;SLC2A4;SORT1;SLC27A1
prerank,regulation of response to stress (GO:0080134),-0.28540154187969324,-0.6681116871896837,0.8758949880668258,0.9945357856051351,1.0,3/10,21.53%,ADCY8;MLC1;CORO2B
prerank,nuclear membrane organization (GO:0071763),0.2791007719485948,0.6678082905825969,0.8690095846645367,0.9987844455906115,1.0,5/19,19.66%,UBXN2B;TOR1AIP1;TOR1B;AKAP8L;NSFL1C
prerank,positive regulation of protein acetylation (GO:1901985),0.30463234630618313,0.6677786600856421,0.8547297297297297,0.9983794364595806,1.0,4/12,21.33%,PRKAA2;DDX3X;KAT5;TAOK1
prerank,regulation of protein transport (GO:0051223),0.26105385655195534,0.6674463164953431,0.8888888888888888,0.9982901877861767,1.0,9/27,25.71%,DNAJC1;SNX12;LLGL1;RHBDF2;ATP13A2;LLGL2;DNAJA1;SCFD1;P3H1
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.2708630512751336,0.6669619983302051,0.8633633633633634,0.9983308591459318,1.0,6/25,17.81%,B3GALT1;B3GALNT1;EXT1;NDST1;EXT2;HS2ST1
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.29845181597309545,0.6654287056290369,0.8645484949832776,0.9994719979801302,1.0,5/16,19.20%,KAT2B;NAA40;NAA20;NAA80;NAA50
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),-0.20603890201212965,-0.6652769507356082,0.9477124183006536,0.9959945573463598,1.0,13/35,26.59%,ITGA1;HSP90AB1;PPP1R15B;CALM1;CALM3;MTOR;FKBP1A;CD300A;GSK3B;PPP1R11;PPP6R3;CALM2;PPP1R1B
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.3160090770139717,0.6649187906694848,0.8610603290676416,0.9995463243633019,1.0,4/10,18.28%,ERLEC1;DERL3;UBAC2;INSIG1
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.2873734382065252,0.663536472133112,0.8881469115191987,1.0,1.0,9/18,28.95%,EIF2AK3;WDR43;FLNA;PHF8;POLR2L;MAF1;HEATR1;SIRT7;LYAR
prerank,endoplasmic reticulum organization (GO:0007029),0.22095185343504,0.6629903420181184,0.9333333333333333,1.0,1.0,16/72,19.82%,LMAN2L;SEC31A;TRAM2;LMAN1;LRRK2;EIF2AK3;CYB5A;MIA3;TRAM1;TOR1B;TOR1AIP2;REEP4;SEC16B;MOSPD3;SMPD4;CCDC47
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.21188022795859002,0.6627384827147804,0.9572127139364304,1.0,1.0,19/88,20.64%,FBXO48;FBXL17;PSME4;CUL4B;CUL5;FBXL3;FBXO9;FBXO4;FBXL12;BTRC;FBXO38;AMN1;PSMB5;PSMC2;PSMD1;PSMD4;PSME3;FBXL18;PSMA3
prerank,motile cilium assembly (GO:0044458),0.3016733260576481,0.6627345171629571,0.8380634390651085,1.0,1.0,2/12,12.42%,DNAAF1;CCDC40
prerank,phospholipid metabolic process (GO:0006644),0.2206882531657843,0.6627257939937986,0.950507614213198,0.9995836180377482,1.0,5/71,6.05%,PLPP3;PLCD1;PLA2G4A;SMPD2;AGPAT3
prerank,regulation of sequestering of triglyceride (GO:0010889),-0.2546237968018011,-0.6624154138843988,0.9081885856079405,0.9975553363344838,1.0,9/15,40.09%,PLIN2;PNPLA2;OSBPL11;TREM2;PLIN3;LPL;FITM2;PLIN5;APOC4
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.21098588871429094,0.6621823415006891,0.9554216867469879,0.9992516000759059,1.0,5/104,6.92%,PDPK1;LYN;PSME4;SRC;KLRD1
prerank,cellular response to lectin (GO:1990858),0.21098588871429094,0.6621823415006891,0.9554216867469879,0.9992516000759059,1.0,5/104,6.92%,PDPK1;LYN;PSME4;SRC;KLRD1
prerank,nucleosome organization (GO:0034728),-0.18577599873444856,-0.6618734507092338,0.9878542510121457,0.9971168839729588,1.0,23/55,29.46%,NAP1L4;NAP1L2;H3-3A;CHAF1A;NAA60;RSF1;HMGB2;VPS72;NPM1;MCM3AP;RNF8;ANP32E;ZNHIT1;NASP;LIN54;ASF1A;SMARCA4;ARID1A;BPTF;SET;GRWD1;H1-0;NAP1L3
prerank,mitochondrion organization (GO:0007005),0.20201563168850645,0.661588948413781,0.9729425028184893,0.9993957126353021,1.0,36/165,20.39%,PID1;PYROXD2;COX7A2;MIGA2;TIMM17B;LRRK2;AKT3;AIFM1;WDR81;BCAP31;PRKN;TIMM44;RHOT1;TIMM9;TFAM;TSPO;NUBPL;POLRMT;USP30;SLC25A36;MUL1;IFIT2;RAB5IF;WASF1;TOMM22;FMC1;VPS13D;LONP1;VPS13C;RAB32;YME1L1;PHB2;SIRT5;AFG3L2;MTFP1;TOMM5
prerank,negative regulation of insulin secretion (GO:0046676),0.27933324809344173,0.6612986522735922,0.8764415156507414,0.999249844482524,1.0,4/17,11.94%,SFRP1;PRKN;ADRA2A;REST
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),-0.2129870021787032,-0.6608075401174709,0.9397590361445783,0.9970290631511327,1.0,14/28,39.79%,MAP2;GAS2L1;MAP1B;CLASP1;SKA3;PRUNE1;MAPRE1;STMN4;CAMSAP2;STMN1;MAPT;MAP1A;CLASP2;SKA1
prerank,metanephros development (GO:0001656),0.2628994568244332,0.6606946645409945,0.8670886075949367,0.9993482716304604,1.0,3/26,7.89%,GDNF;CTSH;OSR1
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.21011322469566188,0.6606850538148641,0.9530120481927711,0.9989231189904972,1.0,5/105,6.92%,PDPK1;LYN;PSME4;SRC;KLRD1
prerank,mitochondrion disassembly (GO:0061726),0.25039419232340376,0.6604753881056719,0.9115442278860569,0.9986945618872698,1.0,12/34,22.93%,ULK2;PRKN;USP30;WIPI1;MARK2;MAP1LC3A;BECN1;ATG2B;WDR45;ATG9A;FUNDC2;AMBRA1
prerank,nuclear envelope organization (GO:0006998),0.27816315264387825,0.6602421989512114,0.8672985781990521,0.9984706216805084,1.0,5/20,18.32%,DMPK;LEMD3;TOR1AIP1;TOR1B;REEP4
prerank,respiratory chain complex IV assembly (GO:0008535),0.2699207814146303,0.6595752085882906,0.8861386138613861,0.998661061751515,1.0,5/21,19.37%,COX18;COX10;COA6;PET100;FASTKD3
prerank,positive regulation of protein sumoylation (GO:0033235),-0.2827797334902684,-0.6591520990406706,0.883054892601432,0.9974743973535323,1.0,5/10,30.66%,SAE1;RWDD3;UBA2;GNL3;RASD2
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),-0.2430721095610935,-0.6583262436320991,0.9230769230769231,0.9973125734551284,1.0,7/16,32.50%,GSK3A;GPER1;ACP3;CHGA;NECAB2;GRP;SLC39A14
prerank,positive regulation of actin filament polymerization (GO:0030838),0.23616069094654726,0.6580677813054143,0.9112676056338028,0.9996789036223005,1.0,7/44,18.36%,GSN;CDC42EP4;CARMIL1;SNX9;ARF6;FCHSD2;CDC42EP3
prerank,regulation of interleukin-12 production (GO:0032655),0.22980394535843895,0.6579294966051706,0.9206989247311828,0.9993670330296608,1.0,9/47,16.18%,CCL19;PIBF1;IL12B;MAST2;IRAK3;RIPK2;MDK;CD47;IL23A
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.3074999353977812,0.657455669095855,0.8402903811252269,0.9993795580841057,1.0,3/12,13.79%,GORASP1;BTRC;PTEN
prerank,regulation of microtubule depolymerization (GO:0031114),-0.2200299080698503,-0.6574168348336668,0.9415384615384615,0.9971093768227576,1.0,5/25,18.88%,NAV3;ARHGEF2;TRPV4;MAP1B;CLASP1
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.2497881800942517,0.6572730040336766,0.8880918220946915,0.9991258331014455,1.0,9/31,18.31%,DACT1;RBL2;JADE1;PTEN;KANK2;CDK2AP2;CDKN2C;MYO16;CDC73
prerank,cellular response to superoxide (GO:0071451),-0.2878485334995514,-0.6572026206678327,0.8735083532219571,0.9963862409222851,1.0,5/10,27.59%,NOS3;ATP7A;SOD2;CCS;SOD1
prerank,L-serine metabolic process (GO:0006563),0.30331550967182264,0.6570523343625999,0.8642201834862385,0.9989115423821767,1.0,4/10,21.19%,PSPH;SERINC3;PHGDH;CBS
prerank,positive regulation of organelle organization (GO:0010638),-0.20147554240732699,-0.6560711172168899,0.9601226993865031,0.9963445134489847,1.0,9/32,23.90%,P2RX7;PPARGC1A;SORBS3;ADRB2;SYNJ1;ANXA1;RAB3GAP2;GSK3B;TREM2
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.26751878680125213,0.6553423446777641,0.8836140888208269,1.0,1.0,5/24,12.84%,IRAK2;AAMP;ITCH;RIPK2;MAP2K6
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.24934392357346435,-0.6545370428769937,0.9289340101522843,0.9966110233521083,1.0,4/14,21.76%,TFRC;SHLD1;SHLD2;NECTIN2
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.21260471933768438,-0.6544537843625868,0.9598765432098766,0.9957959871464948,1.0,13/27,41.60%,CYRIB;SIRPA;SKAP1;CD44;CCL2;TRAF6;HAS2;NR4A3;PRKCQ;CCDC88B;TNFSF11;TNF;ITGB2
prerank,positive regulation of interleukin-8 production (GO:0032757),0.22837812524334672,0.6543852696528228,0.9261285909712722,1.0,1.0,2/49,2.77%,SERPINE1;IL17D
prerank,response to peptide (GO:1901652),0.2541540817127552,0.6542529460758018,0.9073529411764706,1.0,1.0,7/33,15.70%,MMP2;STAT5B;STAT2;EIF2B4;STAT6;STAT4;EIF2B3
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.27793209693592014,0.6538221592204531,0.8802588996763754,1.0,1.0,1/18,1.77%,LYN
prerank,innate immune response (GO:0045087),0.19247063770482392,0.6530905482721302,0.9913232104121475,1.0,1.0,19/217,11.79%,MFAP4;COLEC12;LYN;SP100;WFDC3;CXCL16;COLEC11;SRC;PML;KYNU;KLRD1;CAMP;POLR3A;MASP1;IFI27;CARD9;DDX3X;RNASE7;TBK1
prerank,sensory perception of smell (GO:0007608),-0.27032513449439133,-0.6522659481272035,0.8953488372093024,0.9966017034608811,1.0,1/11,11.12%,ADCY3
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",-0.24564922762653263,-0.6518508561188805,0.9052369077306733,0.9960479813672294,1.0,6/15,30.83%,ZC3H12C;RNASEH1;NUDT16;POP7;RPP40;ZC3H12D
prerank,regulation of interferon-beta production (GO:0032648),0.23426312268928812,0.6518234761295684,0.9306930693069307,1.0,1.0,10/46,18.22%,IRF1;PTPRS;OAS2;POLR3A;DDX3X;TBK1;RIPK2;RIOK3;RNF135;DHX58
prerank,epidermal cell differentiation (GO:0009913),0.23787323945120756,0.6514082885254262,0.9213793103448276,1.0,1.0,12/41,26.38%,TXNIP;USH2A;KRT10;GLI1;GATA6;ST14;ERCC3;ERCC2;ACER1;HDAC1;JAG1;CASP3
prerank,regulation of telomerase activity (GO:0051972),-0.18709880852678837,-0.6512717917729809,0.9523809523809523,0.9956039227495471,1.0,7/45,16.68%,NEK7;HSP90AB1;PKIB;KLF4;NVL;MAPK3;PNKP
prerank,microtubule depolymerization (GO:0007019),0.28528677088296645,0.6511706782147666,0.8837579617834395,1.0,1.0,5/17,21.99%,NCKAP5;KATNB1;KIF19;KIF24;CCSAP
prerank,negative regulation of microtubule depolymerization (GO:0007026),-0.22586335047050707,-0.6510713329414889,0.9044943820224719,0.994850403249059,1.0,2/21,5.99%,NAV3;ARHGEF2
prerank,regulation of organelle organization (GO:0033043),0.21320074570637096,0.6508194613480499,0.9522058823529411,1.0,1.0,14/80,16.11%,ZEB2;USP6NL;LMAN1;RBSN;SYDE1;PRKN;RHOT1;NEXN;CLN3;MUL1;SYT11;MARK2;ARMH3;GOLPH3
prerank,response to light stimulus (GO:0009416),0.22705548507475737,0.6507090838049256,0.9277266754270697,1.0,1.0,7/55,12.95%,SLC24A1;PCLAF;SPRTN;UBE4B;BRSK1;ERCC8;COPS3
prerank,myelin maintenance (GO:0043217),0.31197414099990595,0.6506480483599787,0.851985559566787,1.0,1.0,4/10,20.80%,PTEN;ABCD2;EPB41L3;PRX
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.24304976401466388,0.65049050576987,0.9028985507246376,0.9998991618859308,1.0,7/38,16.32%,DAG1;DRD3;PHLPP2;MUL1;TSC2;PTEN;AKT1
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.17426955522547904,-0.6502225166691282,0.9918367346938776,0.9946113929519914,1.0,17/67,23.95%,B2M;VAMP8;NCF2;PSMF1;PSMB8;PSMA4;PSMB10;PSMB2;PSMC4;FCGR1A;PSMA6;PSMD9;PSMD11;PSMD5;CHUK;PSMA8;PSMB1
prerank,cellular lipid catabolic process (GO:0044242),0.2548087636411869,0.6501057592898902,0.9057750759878419,0.9998285700631506,1.0,10/27,27.00%,MT3;CYP1B1;SIRT2;NUDT19;SMPDL3B;LPIN3;LPIN2;LPIN1;PLBD2;MGST2
prerank,chaperone-mediated protein complex assembly (GO:0051131),-0.22951954754275183,-0.6498841014246968,0.9215189873417722,0.9939934240418116,1.0,4/20,19.40%,HSP90AB1;BBS12;PFDN6;CLU
prerank,regulation of myoblast differentiation (GO:0045661),0.24449812911021124,0.6493667893858122,0.9083969465648855,1.0,1.0,7/32,15.80%,RIPOR2;TBX3;ZFP36L1;IGFBP3;TRIP4;BMP4;LRRC8A
prerank,keratinocyte differentiation (GO:0030216),0.24993105863615753,0.649284081303211,0.8958944281524927,0.999704203782594,1.0,1/29,1.01%,TXNIP
prerank,autophagosome assembly (GO:0000045),0.22902892790104293,0.6491355012459974,0.936986301369863,0.9994058207988418,1.0,15/52,22.93%,RAB23;ULK2;UBXN2B;EMC6;WIPI1;RAB19;MAP1LC3A;BECN1;ATG2B;NSFL1C;WDR45;STX17;ATG9A;STX12;AMBRA1
prerank,nucleoside salvage (GO:0043174),0.3075765219706845,0.6488258024791915,0.8493647912885662,0.9992721456350522,1.0,3/10,17.30%,CDA;UPP2;DCK
prerank,hexose transmembrane transport (GO:0008645),0.26748666915349595,0.6485385455116582,0.8847926267281107,0.9990935564564203,1.0,5/21,17.56%,SLC2A10;SLC45A3;SLC5A3;SLC2A4;SLC2A8
prerank,regulation of DNA-dependent DNA replication (GO:0090329),-0.258044831166686,-0.6478232846598361,0.8921568627450981,0.9946056522135864,1.0,6/12,40.74%,NBN;WRNIP1;WDR18;TICRR;KAT7;CDT1
prerank,tRNA metabolic process (GO:0006399),-0.2359279876288085,-0.6475006909965637,0.9206798866855525,0.9939741793908292,1.0,4/17,15.63%,YARS2;KARS1;RPP21;FARS2
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.19913963082073632,0.6471350506991764,0.9863791146424518,0.9999437959476652,1.0,40/148,25.66%,PDPK1;PRKAG2;RFFL;CDK5RAP3;PRKAA2;NUAK1;PML;ING5;PPP1R13L;MTA2;STK11;RBBP7;L3MBTL1;MAP2K6;BANP;TAF9;AKT1;ATM;KAT5;RNF34;RICTOR;TAF2;RFC5;PRKAG1;MDM4;MLST8;AURKA;RMI2;MAPKAP1;MEAF6;BRCA1;HEXIM1;TAF4B;PRKAB2;MRE11;TAF15;PRKAG3;HDAC1;PIP4K2A;ATRIP
prerank,protein palmitoylation (GO:0018345),0.2491808123864924,0.6470350966472653,0.9159021406727829,0.9995995233512506,1.0,1/30,1.26%,GLUL
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.21001088833826817,0.6465589290287009,0.9754299754299754,0.9996000354634856,1.0,8/88,9.89%,TRABD2B;SMAD3;SYNPO2;CDH5;SDC1;EMILIN1;BCL2L11;SYNPO2L
prerank,myeloid cell development (GO:0061515),0.27955162643815556,0.6461800699221467,0.8949843260188087,0.9995097706883717,1.0,2/18,6.31%,KIT;SRC
prerank,cellular response to amino acid starvation (GO:0034198),0.21502401284431708,0.6459195081661676,0.9560723514211886,0.9993157591906335,1.0,18/71,21.57%,NPRL3;EIF2AK3;SLC38A9;ATP6V1E1;RNF152;CEBPB;CASTOR2;LAMTOR2;RRAGD;IMPACT;ITFG2;SESN2;NPRL2;SEH1L;RHEB;SZT2;MLST8;ATP6V1B2
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.27383106150405123,0.6455439502538255,0.8945634266886326,0.9992060722775806,1.0,6/17,21.66%,ARFIP2;DNAI3;WASF1;FCHSD2;CORO1B;BRK1
prerank,positive regulation of cilium assembly (GO:0045724),-0.22934029552625923,-0.6454599745155886,0.925207756232687,0.9945930677046111,1.0,6/18,26.21%,CCDC88A;KCTD17;CEP135;FUZ;HAP1;CCP110
prerank,positive regulation of keratinocyte migration (GO:0051549),0.2996301764896424,0.6454235334939524,0.8482142857142857,0.9988842150385943,1.0,3/10,15.36%,MAP4K4;MAPRE2;ARF6
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.24267914153164608,-0.6451468095748171,0.9214285714285714,0.9939532880127047,1.0,7/15,29.29%,RYR2;ZFAND2B;SPCS1;RAB3GAP2;EDEM1;SRPRA;SEC61G
prerank,regulation of multicellular organismal development (GO:2000026),-0.21256181663378176,-0.6443995486391633,0.9313984168865436,0.9936041276762722,1.0,4/25,11.69%,SOX17;SPAAR;PTN;KAT2A
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.2794678748642315,0.6442276054863231,0.8775510204081632,0.9995115334708468,1.0,7/17,23.42%,APOE;SREBF1;ERLIN1;KPNB1;SEC14L2;ERLIN2;SREBF2
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.29099162451901844,0.6437622524037345,0.858085808580858,0.9994715817928324,1.0,7/14,25.56%,ADK;GART;PPAT;PFAS;ADSS1;ADSL;LHPP
prerank,regulation of synapse maturation (GO:0090128),0.3117115928660358,0.6433289264105939,0.8634686346863468,0.9994268761530762,1.0,2/10,9.31%,ADGRL1;CAMK2B
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),-0.27295191345454245,-0.6431350674867623,0.8861047835990888,0.9936209812825861,1.0,6/10,37.81%,RUVBL1;ZNHIT3;RUVBL2;PIH1D1;SHQ1;PIH1D2
prerank,positive regulation of protein depolymerization (GO:1901881),0.3057422480207114,0.642599067049567,0.8701754385964913,0.9996411011232803,1.0,2/11,9.54%,SEMA5A;KATNB1
prerank,transcription by RNA polymerase III (GO:0006383),0.2530597726581055,0.6421971008928499,0.9170506912442397,0.9995733100031385,1.0,12/27,28.90%,BRF1;GTF3C1;SNAPC1;SNAPC5;SNAPC4;POLR2L;GTF3C3;ICE1;GTF3C5;ICE2;POLR3K;POLR3GL
prerank,positive regulation of interleukin-1 production (GO:0032732),-0.17851401543907078,-0.642087588881362,0.9776951672862454,0.9935215270481768,1.0,18/51,30.04%,P2RX7;GBP5;AIM2;JAK2;TRIM16;CASP8;APP;NOD2;TLR4;FZD5;AGER;MALT1;TMEM106A;CD36;EGR1;LPL;NLRP3;HSPB1
prerank,heterochromatin assembly (GO:0031507),-0.22633928799003103,-0.6418812868485173,0.9389920424403183,0.9927909660618359,1.0,5/20,14.36%,ZNFX1;BAZ2A;SUV39H1;SIRT1;H3-3A
prerank,cellular macromolecule catabolic process (GO:0044265),0.22422551667609694,0.6410676164120747,0.9335106382978723,1.0,1.0,9/49,16.22%,SND1;ADAMTS9;PRKN;NGLY1;DNASE1L1;EXOSC7;MTREX;RNASEH2C;NEU4
prerank,postreplication repair (GO:0006301),0.2295849081903615,0.640880178809888,0.9401595744680851,0.9998781044011786,1.0,7/45,13.01%,PCLAF;SPRTN;UBE2V2;ZBTB1;WDR33;RAD18;USP10
prerank,regulation of peptidase activity (GO:0052547),0.27091478447966744,0.6400512270331568,0.9037520391517129,1.0,1.0,7/19,25.04%,CTSH;CST3;RCN3;PSMA3;ATP13A2;MAPK12;HDAC1
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.2156096741616304,0.6396156994906466,0.9463350785340314,1.0,1.0,16/70,20.64%,RUNX1;YAP1;PSME4;SETD1A;ITCH;KMT2A;TCF12;PSMB5;PSMC2;METTL3;PSMD1;PSMD4;PSME3;YTHDF2;FOXC1;PSMA3
prerank,mitotic nuclear membrane disassembly (GO:0007077),-0.26754496686207907,-0.6393939692515375,0.9030837004405287,0.9936321043820315,1.0,6/12,29.31%,VRK1;CCNB2;CNEP1R1;CTDNEP1;PLK1;CDK1
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.21343146602702606,0.639342553363139,0.9632446134347274,0.9999148609902985,1.0,18/72,19.53%,SP100;NDRG1;PML;BATF;RBL2;RGCC;USP10;PLK2;CNOT3;SESN2;TFDP1;ATM;KAT5;CARM1;ATRX;CDKN1B;MUC1;MDM4
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.25802384994932237,0.6385991479111105,0.9003021148036254,1.0,1.0,4/24,10.34%,DNMT3A;RBBP7;PHF1;PPHLN1
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.23967049282992736,0.6384884093821744,0.9110473457675753,0.9997824860087995,1.0,9/33,18.31%,DACT1;RBL2;JADE1;PTEN;KANK2;CDK2AP2;CDKN2C;MYO16;CDC73
prerank,nuclear membrane disassembly (GO:0051081),-0.25678979866435314,-0.6383692394480486,0.9114219114219114,0.9934425111159233,1.0,7/14,29.31%,VRK1;DCTN1;CCNB2;CNEP1R1;CTDNEP1;PLK1;CDK1
prerank,regulation of interferon-alpha production (GO:0032647),0.26029515520853486,0.638129131088094,0.8911353032659409,0.9996650211642633,1.0,4/23,12.67%,PTPRS;DDX3X;TBK1;RIPK2
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.24886757119025227,-0.6374936761755,0.899749373433584,0.9922871274494727,1.0,7/13,34.04%,IL15;STAT5A;JAK3;IL2RG;SHC1;STAT3;GRB2
prerank,cellular response to interleukin-15 (GO:0071350),-0.24886757119025227,-0.6374936761755,0.899749373433584,0.9922871274494727,1.0,7/13,34.04%,IL15;STAT5A;JAK3;IL2RG;SHC1;STAT3;GRB2
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.2720754621002485,-0.6363053591703046,0.8886363636363637,0.992219127049475,1.0,3/10,26.23%,DLGAP2;BEGAIN;CACNG5
prerank,cell-cell junction maintenance (GO:0045217),-0.2631449286733386,-0.6357133568287211,0.9255813953488372,0.9917340108678171,1.0,1/11,2.91%,TJP1
prerank,maintenance of protein localization in organelle (GO:0072595),0.2678899839770747,0.6351713203740341,0.9058441558441559,1.0,1.0,8/19,28.51%,PML;ARL2;AKT1;HNRNPU;TAF8;HSPA5;HK1;TAPT1
prerank,GTP metabolic process (GO:0046039),0.27769443581069697,0.6349366313526762,0.8874388254486134,1.0,1.0,3/15,12.03%,RAB23;LRRK2;RHOQ
prerank,serine family amino acid metabolic process (GO:0009069),0.26963028789073107,0.6349353799982914,0.8752136752136752,1.0,1.0,5/16,24.07%,CDO1;PSPH;CBS;SARS1;SEPSECS
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.18553010099712888,0.6345614322898259,0.9926315789473684,1.0,1.0,66/264,23.90%,POLR2D;RBMXL2;U2AF1L4;SNRNP70;SF1;PNN;DDX17;RBM22;HNRNPR;METTL14;HNRNPA1;NONO;DDX39A;RAVER2;POLR2C;WDR33;SMU1;DDX23;SUGP1;RBM19;MAGOHB;MTREX;SNRPD2;SRSF5;PCF11;GPKOW;RBM5;RNPC3;RBM6;RBM4B;PSPC1;GEMIN2;LSM8;SRRM2;SYNCRIP;HNRNPC;PRPF6;RBM41;SF3B2;SF3B1;SRSF10;PPIE;CPSF2;METTL3;DDX1;POLR2L;FIP1L1;USP49;HNRNPU;GCFC2;HNRNPH1;PPWD1;PRCC;SRSF3;PAPOLA;RBM4;IK;NCBP2;ESS2;ZRSR2;SART1;PRPF8;SFPQ;CWC22;CASC3;CDK13
prerank,regulation of intracellular transport (GO:0032386),0.23753740204369786,0.6345204970815105,0.9275568181818182,1.0,1.0,13/38,25.25%,ATP9A;DYNC1H1;LRRK2;RNF139;NUP214;GAS1;NUMA1;AAAS;ATP13A2;RBM4;RINT1;TTC21B;SCFD1
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.2588777438561948,0.6341662816930782,0.9085072231139647,1.0,1.0,6/22,22.82%,PSME4;NFE2L2;ENC1;PSMB5;PSMA3;PSMA2
prerank,regulation of stem cell population maintenance (GO:2000036),0.2725840795397416,0.6341168670192843,0.9004893964110929,0.9999687129563349,1.0,5/18,14.96%,REST;WDR43;NCOA3;TAF5L;CNOT3
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.2602441982177711,0.6335695150764665,0.9092261904761905,1.0,1.0,8/23,26.15%,MYO10;DYNC1I2;HOOK2;MAP6D1;KIF1C;MAP6;KIF5C;HOOK1
prerank,intracellular lipid transport (GO:0032365),0.2620811252762689,0.6330668993057018,0.9227129337539433,0.9999918633631504,1.0,3/21,6.02%,PRKAG2;PRKAA2;PLEKHA8
prerank,nuclear transport (GO:0051169),-0.23331305193771437,-0.6319203510028782,0.9258312020460358,0.9933425842837748,1.0,8/16,38.55%,NXT2;PSIP1;NPM1;NUTF2;NXT1;RBM15B;HMGA1;XPO1
prerank,mitochondrial genome maintenance (GO:0000002),0.29652785084433986,0.6317152637329438,0.866779089376054,1.0,1.0,4/11,21.17%,AKT3;SLC25A36;LONP1;OPA1
prerank,cellular response to ionizing radiation (GO:0071479),0.22205855079563944,0.6314721014635595,0.9559834938101788,1.0,1.0,4/47,6.29%,YAP1;LIG4;MAP3K20;INO80
prerank,tetrahydrofolate metabolic process (GO:0046653),-0.2795997147112371,-0.6308456088725252,0.9099307159353349,0.9931822274986933,1.0,4/10,25.36%,DHFR;TYMS;MTHFD2;SHMT1
prerank,tRNA 5'-end processing (GO:0099116),0.2811699785044073,0.6308003890608125,0.8851132686084142,1.0,1.0,4/15,15.59%,RPP25L;PRORP;RPP30;RPP38
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.28283926464955844,0.630711205505969,0.8773747841105354,1.0,1.0,4/13,14.47%,ATG10;UBA7;SENP6;UBA6
prerank,lipid droplet organization (GO:0034389),-0.21814026889600094,-0.6296754978676524,0.9571428571428572,0.9930602894063195,1.0,11/22,37.22%,PPIA;PNPLA3;PLA2G4C;PPID;ZFYVE1;HILPDA;FITM2;CDS1;CDS2;BSCL2;PLIN5
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.2577625138353812,0.6285880127739438,0.9037854889589906,1.0,1.0,5/21,23.72%,NOS1AP;FLNA;SCN1B;SNTA1;ANK2
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.27268591467230807,0.627397645216952,0.8952536824877251,1.0,1.0,2/16,7.80%,SHOC1;TOP2B
prerank,myeloid dendritic cell activation (GO:0001773),-0.25676038343050367,-0.6272477667821611,0.9181141439205955,0.9937616617019114,1.0,2/12,9.69%,CAMK4;TGFBR2
prerank,negative regulation of macroautophagy (GO:0016242),0.24411872460138329,0.6268131888132888,0.9092307692307692,1.0,1.0,4/26,16.32%,NUPR1;LRRK2;TSC2;AKT1
prerank,glial cell development (GO:0021782),0.2538496025897347,0.626146146587171,0.91350531107739,1.0,1.0,8/25,19.07%,MT3;CSPG5;EIF2B4;MDK;NSUN5;EIF2B3;SOX11;MXRA8
prerank,cellular response to tumor necrosis factor (GO:0071356),0.1882108930491902,0.6250456318960512,0.9887892376681614,1.0,1.0,12/175,9.61%,ADAMTS12;PID1;CCL19;EDAR;PSME4;SFRP1;ZFP36L1;CCL4;NFE2L2;NR1D1;ACTN4;LTBR
prerank,regulation of B cell differentiation (GO:0045577),0.2613144884590147,0.6248058754446529,0.9141914191419142,1.0,1.0,2/17,5.78%,SFRP1;ZFP36L1
prerank,androgen metabolic process (GO:0008209),0.27238372146409506,0.6245337950849231,0.9030694668820679,1.0,1.0,2/18,7.55%,HSD3B2;SRD5A1
prerank,snRNA metabolic process (GO:0016073),-0.23181983655200172,-0.6236842739512174,0.9263157894736842,0.9950726801709684,1.0,7/17,33.28%,INTS6;INTS8;INTS1;INTS10;TUT1;ZCCHC8;INTS11
prerank,regulation of cell cycle phase transition (GO:1901987),-0.15922511894424476,-0.6228442730181266,1.0,0.9947093423833131,1.0,21/91,20.61%,CUL1;ANAPC16;TAF1;ANAPC15;ATP2B4;ANAPC7;DBF4;PSMF1;PSMB8;PSMA4;PSMB10;PSMB2;UBE2S;BUB1B;TFAP4;CDKN1A;PSMC4;PSMA6;PSMD9;PSMD11;PSMD5
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.241456223283502,0.6226200514846423,0.9053435114503817,1.0,1.0,4/28,9.32%,NUPR1;CDK5RAP3;RNF139;PRKN
prerank,glucose 6-phosphate metabolic process (GO:0051156),-0.21350598845710766,-0.6218903621875054,0.954177897574124,0.9944370076483013,1.0,2/21,5.77%,GPI;HK2
prerank,V(D)J recombination (GO:0033151),-0.25529055164550085,-0.6218293541301716,0.9105504587155964,0.9936065004681898,1.0,4/11,23.07%,TCF3;PRKDC;HMGB2;DCAF1
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",-0.21303207301144111,-0.6217612971343087,0.9555555555555556,0.9927892353996149,1.0,8/25,24.29%,HMGN1;ALYREF;LDB1;EAF2;ZNF326;EAF1;CCAR2;TCEA2
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.29980273293252324,0.6215570863282207,0.8958333333333334,1.0,1.0,1/10,4.37%,SLC45A3
prerank,mitochondrial fusion (GO:0008053),0.26532634203713984,0.621131449435506,0.9146341463414634,1.0,1.0,5/18,21.44%,MIGA2;USP30;AFG3L2;OPA1;STOML2
prerank,atrial septum development (GO:0003283),-0.2459259012638081,-0.6211241580454913,0.9218009478672986,0.9923103497927176,1.0,5/13,21.70%,TGFB2;HEY2;ZFPM1;BMPR2;GJA5
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.24633445031122744,-0.6205368854428363,0.927536231884058,0.9918154582781586,1.0,5/13,28.46%,SORL1;CD81;TMEM30A;EDEM1;TMEM30B
prerank,histone H4 acetylation (GO:0043967),0.2218866020550525,0.6203583754067451,0.9542395693135935,1.0,1.0,10/47,17.84%,OGT;ING3;BRD8;ING5;JADE1;KMT2A;WDR5;TADA3;MSL2;NAA40
prerank,global genome nucleotide-excision repair (GO:0070911),-0.20072547761132195,-0.6196655863548998,0.9667673716012085,0.9914492472398545,1.0,10/26,31.29%,RBX1;GTF2H1;DDB2;CETN2;PARP1;RNF111;CHD1L;UBC;RPS27A;XPC
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",-0.24170573497700892,-0.6195476329043103,0.926829268292683,0.9906660722270728,1.0,7/13,39.70%,NOL9;RPS21;RRS1;TSR1;RPP40;UTP20;NOP9
prerank,macroautophagy (GO:0016236),0.19440355485773428,0.6194890504945438,0.9825581395348837,1.0,1.0,34/118,25.59%,DYNLL1;PRKAG2;PRKAA2;SRC;ATG10;MTMR3;PRKN;PLEKHM1;VPS37D;CLN3;UVRAG;WIPI1;VDAC1;PIK3R4;TOMM22;LAMP2;MAP1LC3A;BECN1;EPG5;PRKAG1;ATG4B;TOMM5;STX17;ATP13A2;RUBCNL;LIX1;TSG101;AMBRA1;PRKAB2;VPS16;PRKAG3;CHMP2A;PIP4K2A;VPS33B
prerank,retinal metabolic process (GO:0042574),0.2860223804013783,0.6187223667104944,0.8941798941798942,1.0,1.0,1/12,5.54%,CYP1B1
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.23294884669923824,0.6186057552292742,0.9394387001477105,1.0,1.0,5/37,11.08%,BCL2;NUPR1;BCL2L11;BCAP31;GSDME
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.26043234741763777,0.6180487950027019,0.9125214408233276,1.0,1.0,4/18,18.59%,MIA3;WNK1;AKT1;VTCN1
prerank,mitotic DNA replication (GO:1902969),0.2896242736875964,0.616581182079223,0.8694158075601375,1.0,1.0,6/10,29.91%,MCM2;MCMDC2;LIG1;MCM6;MCM4;GINS1
prerank,regulation of nuclear division (GO:0051783),0.25525403100201616,0.615742884643579,0.9138461538461539,1.0,1.0,1/20,2.03%,OBSL1
prerank,apoptotic DNA fragmentation (GO:0006309),0.2610282866950446,0.6156372766931499,0.8950930626057529,1.0,1.0,5/16,18.89%,DNASE2;CECR2;KPNA1;KPNB1;DICER1
prerank,negative regulation of double-strand break repair (GO:2000780),0.23932431166883025,0.6155485427958906,0.9342105263157895,1.0,1.0,8/30,21.23%,OGG1;TRIP12;NUDT16L1;UBR5;SHLD3;SMCHD1;HSF1;RMI2
prerank,chemokine-mediated signaling pathway (GO:0070098),0.21893367523539353,0.6151465929105635,0.9593267882187938,1.0,1.0,5/42,13.53%,CCL19;CCL4;OXSR1;WNK1;CXCL13
prerank,negative regulation of signaling (GO:0023057),0.24862151608220717,0.6150590138436812,0.9228346456692913,1.0,1.0,5/25,17.97%,OPTN;ACVR1;IGFBP3;LIF;HHIP
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.265344999059226,0.6144571914962534,0.9033333333333333,1.0,1.0,6/16,26.37%,IRAK3;CLN3;INSR;GSPT1;HDAC6;UPF1
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.24572963823276273,-0.6141642294615398,0.9401913875598086,0.9928569485153853,1.0,7/13,40.32%,BOLA2;GLRX5;CIAO2B;CIAO2A;ISCA1;LTO1;ISCA2
prerank,proteasome assembly (GO:0043248),-0.2527861046585538,-0.6139767573706448,0.919047619047619,0.9921233985134266,1.0,6/11,34.80%,PSMD9;PSMD11;PSMD5;POMP;PSMD10;PSMD13
prerank,establishment of spindle localization (GO:0051293),0.27323773077779434,0.6139750500147492,0.8947368421052632,1.0,1.0,4/14,22.01%,DYNC1H1;LLGL1;KPNB1;LLGL2
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.22087760963781303,0.6136990863018807,0.9511228533685601,1.0,1.0,8/46,16.32%,TIMM17B;AIFM1;BCAP31;TIMM44;TIMM9;TSPO;TOMM22;AKT1
prerank,autophagy of mitochondrion (GO:0000422),0.22850103038440855,0.6121343878759594,0.9457478005865103,1.0,1.0,13/38,22.93%,ULK2;PRKN;USP30;WIPI1;MARK2;MAP1LC3A;BECN1;ATG2B;PHB2;WDR45;ATG9A;FUNDC2;AMBRA1
prerank,regulation of protein sumoylation (GO:0033233),-0.22201392299724446,-0.6120393027496782,0.9470899470899471,0.9923154956214132,1.0,8/17,30.66%,SAE1;RWDD3;EGR1;CAPN3;UBA2;GNL3;CTNNB1;RASD2
prerank,regulation of macroautophagy (GO:0016241),0.1945689514402645,0.6114786762729676,0.9853836784409257,1.0,1.0,25/105,21.57%,DCN;PRKAG2;NEDD4;PRKAA2;LRRK2;SLC38A9;ATP6V1E1;LAMTOR2;RRAGD;TBK1;CLN3;LARP1;TSC2;SESN2;AKT1;WAC;PRKACA;PRKAG1;GPSM1;RHEB;MLST8;ATP13A2;SNX6;UCHL1;ATP6V1B2
prerank,phosphatidylethanolamine metabolic process (GO:0046337),-0.20180792739093195,-0.610594028081474,0.9660056657223796,0.9922401498524034,1.0,9/27,25.78%,NAAA;PLAAT3;PNPLA8;ETNK1;SELENOI;PLA2G4E;CHKA;ABHD4;PLAAT1
prerank,positive regulation of interleukin-17 production (GO:0032740),0.24807397000019768,0.6100796265091946,0.9214743589743589,1.0,1.0,5/22,17.96%,RFTN1;IL12B;CARD9;IL23A;IL18
prerank,regulation of interleukin-8 production (GO:0032677),0.20243695069564108,0.610051432582762,0.973718791064389,1.0,1.0,8/69,13.00%,SERPINE1;IL17D;MAPKBP1;TLR6;ARRB1;CD33;CD14;SSC5D
prerank,natural killer cell mediated immunity (GO:0002228),0.2690764100821996,0.6099632893008122,0.9110738255033557,1.0,1.0,2/15,10.13%,KLRD1;PLEKHM2
prerank,spermatid development (GO:0007286),0.23442426929672025,0.6095942090047204,0.9466089466089466,1.0,1.0,3/32,12.26%,GALNTL5;ZMYND15;SYCP3
prerank,apoptotic nuclear changes (GO:0030262),0.23648533781867925,0.6088045316615188,0.9313572542901716,1.0,1.0,6/24,18.89%,CDK5RAP3;DNASE2;CECR2;KPNA1;KPNB1;DICER1
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.2621036276796958,-0.6080430997366902,0.9170616113744076,0.9927053926379906,1.0,5/10,31.19%,CX3CR1;CEACAM1;PTPRC;LILRB1;FCGR2B
prerank,protein-containing complex disassembly (GO:0032984),0.20973832807589846,0.6079541643196372,0.9671484888304862,1.0,1.0,14/54,21.87%,WNT8B;FZD2;FZD1;CLN3;UVRAG;LAMP2;MAP1LC3A;CSNK1A1;EPG5;FRAT1;STX17;RUBCNL;LIX1;TSG101
prerank,regulation of histone H3-K9 methylation (GO:0051570),-0.26156910642948134,-0.6073762251464444,0.9172259507829977,0.9921985141221706,1.0,2/10,11.74%,KDM1A;SIRT1
prerank,cellular response to arsenic-containing substance (GO:0071243),0.26953194284200244,0.6073738409309852,0.9115646258503401,1.0,1.0,4/15,20.93%,HNRNPA1;DDX3X;HSF1;PPIF
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.244330223817618,-0.6070892039796527,0.9268867924528302,0.9914920596891076,1.0,2/13,12.45%,CYRIB;PVR
prerank,interleukin-35-mediated signaling pathway (GO:0070757),0.28439716715951174,0.606845472277921,0.8974358974358975,1.0,1.0,6/11,30.79%,EBI3;STAT4;CANX;STAT1;IL6ST;IL12RB2
prerank,cell junction maintenance (GO:0034331),0.27380302191284944,0.6056659032075372,0.8978583196046128,1.0,1.0,2/14,9.40%,CBLN1;MYADM
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.27064527876130784,0.6051972935880632,0.9125214408233276,1.0,1.0,2/15,8.39%,APOA1;IRAK3
prerank,positive regulation of DNA recombination (GO:0045911),0.23634154023369763,0.6044488407545944,0.9370424597364568,1.0,1.0,10/27,27.75%,KMT5B;MRNIP;HMCES;SHLD3;TIMELESS;ARID2;ERCC2;FUS;MMS19;FANCB
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.2384410846960356,0.6043248587733718,0.9465408805031447,1.0,1.0,3/27,8.20%,AGTR1;LPAR1;DRD3
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.15499290021392753,-0.6030384284949054,0.9908256880733946,0.9927269663531492,1.0,33/84,35.80%,ANAPC16;ANAPC15;ANAPC7;PSMF1;PSMB8;PSMA4;PSMB10;PSMB2;UBE2S;BUB1B;FBXO31;PSMC4;CUL3;PSMA6;PSMD9;PSMD11;PSMD5;PSMA8;PSMB1;FZR1;PLK1;CDK1;PSMD10;UBC;RPS27A;CDC20;ANAPC11;PSMC3;UBE2C;PSMD13;SKP2;BUB3;ECRG4
prerank,positive regulation of cell cycle (GO:0045787),0.2022315323396307,0.6028123846379925,0.9735449735449735,1.0,1.0,15/62,21.05%,FGFR2;NUPR1;SMOC2;TBX3;EGFR;FOXA1;RGCC;AKT1;PRKCA;TRIM32;CDKN1B;HSF1;TRIM21;CCND2;PKN2
prerank,defense response to symbiont (GO:0140546),0.19292013317297252,0.6017784704716952,0.9858611825192802,1.0,1.0,14/92,17.16%,BCL2;MLKL;IRF1;OAS2;STAT2;RNASEL;IFI27;ABCE1;IFIT2;FLNA;SERINC3;IFI44L;TTC4;IRF2
prerank,defense response to virus (GO:0051607),0.1885950334657705,0.5996222076209519,0.9900990099009901,1.0,1.0,28/100,26.08%,BCL2;MLKL;IRF1;OAS2;STAT2;RNASEL;IFI27;ABCE1;IFIT2;FLNA;SERINC3;IFI44L;TTC4;IRF2;RNF135;PHB2;NDUFAF4;RSAD2;MYD88;AGBL5;ZBP1;ZDHHC1;PMAIP1;STAT1;FADD;MAVS;AKAP1;RELA
prerank,mitotic sister chromatid segregation (GO:0000070),0.1935523599700991,0.5995830870825859,0.9891696750902527,1.0,1.0,22/98,20.73%,PDS5B;PIBF1;INO80;SPDL1;ZW10;ZWINT;TENT4A;EML4;CHMP5;AKAP8L;PHF8;POGZ;SGO1;SEH1L;NIPBL;BECN1;BOD1;KPNB1;CDCA8;NAA50;CDC23;DSN1
prerank,protein acylation (GO:0043543),0.21746247147341186,0.599443479631861,0.9478260869565217,1.0,1.0,3/38,8.83%,GLUL;ING5;KAT2B
prerank,mRNA metabolic process (GO:0016071),0.1920288444625112,0.5981698421806111,0.9836683417085427,1.0,1.0,28/90,25.49%,SON;DXO;HNRNPR;NONO;PRMT9;TCERG1;SRSF5;AKAP8L;NUDT16L1;PCF11;GEMIN2;SF3B2;LSM10;METTL3;PRKACA;HSF1;YTHDF2;AGO4;ZFP36L2;NUDT12;NCBP2;PRPF8;SFPQ;METTL16;AGO3;SNRPE;CNOT10;RNASE4
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.22105621028849584,0.598050786769685,0.9588068181818182,1.0,1.0,3/39,6.57%,OGG1;GTF2H5;CUL4B
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.1952845447204938,0.5975735788428757,0.9877300613496932,1.0,1.0,6/85,6.15%,FZD2;SMURF2;PRICKLE1;PSME4;FZD1;CDC42
prerank,protein localization to centrosome (GO:0071539),0.2613689219201918,0.5966846054259204,0.9313725490196079,1.0,1.0,2/17,6.20%,GOLGB1;PIBF1
prerank,telomere maintenance (GO:0000723),0.20710630264498914,0.5964537576341847,0.9511173184357542,1.0,1.0,7/50,14.37%,SP100;SMC5;SMC6;TERF2;TEP1;RAD51D;RTEL1
prerank,protein catabolic process (GO:0030163),0.20237287626723055,0.5961867395548109,0.9813581890812251,1.0,1.0,7/59,9.85%,APOE;ADAMTS9;CUL4B;NR1D1;CLPX;PRKN;NGLY1
prerank,cellular response to leucine starvation (GO:1990253),0.28014643507632087,0.5951755906358993,0.9035714285714286,1.0,1.0,3/10,15.22%,RRAGD;IMPACT;SESN2
prerank,regulation of lysosomal lumen pH (GO:0035751),0.27109386729501905,0.5946012016587784,0.9036363636363637,1.0,1.0,3/12,14.75%,LRRK2;CLN3;ATP6AP2
prerank,Golgi to lysosome transport (GO:0090160),0.27868483791572995,0.5938269921340465,0.9055944055944056,1.0,1.0,2/11,11.90%,RBSN;CLN3
prerank,exit from mitosis (GO:0010458),-0.23584486109307254,-0.5928949049781355,0.9379652605459057,0.9968770806135275,1.0,4/12,32.44%,UBE2S;CLASP1;CHMP4B;UBE2C
prerank,regulation of lipid storage (GO:0010883),-0.20873643802673847,-0.592691061907621,0.9662337662337662,0.9961226194475886,1.0,7/22,27.50%,NFKBIA;PTPN2;SIRT1;HILPDA;ALKBH7;MEST;LPL
prerank,cellular response to estradiol stimulus (GO:0071392),-0.2168175476383768,-0.5919590722599063,0.9728997289972899,0.9956083277037503,1.0,2/18,5.60%,ESR1;NRIP1
prerank,mismatch repair (GO:0006298),-0.19262569110025418,-0.5909328897239894,0.9520958083832335,0.9952030253065773,1.0,10/27,34.31%,MSH3;PMS2;PMS1;POLD4;MSH2;EXO1;POLD2;XPC;RPA2;MLH3
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.2284707679236261,0.5904238216959602,0.9466666666666667,1.0,1.0,6/28,19.34%,KMT5B;MRNIP;NUDT16L1;SHLD3;SMCHD1;HSF1
prerank,negative regulation of T cell proliferation (GO:0042130),-0.18828011811486617,-0.5898481181431428,0.9884393063583815,0.9948349747343415,1.0,8/28,27.14%,PRKAR1A;SCRIB;TNFRSF21;CD80;CD86;LILRB1;IL4I1;PRNP
prerank,CENP-A containing nucleosome assembly (GO:0034080),-0.18959564242650442,-0.5882163424576514,0.9769736842105263,0.9938726427259299,1.0,10/29,29.14%,MIS18BP1;KNL1;RUVBL1;RSF1;NPM1;CENPI;CENPN;NASP;HJURP;ITGB3BP
prerank,CENP-A containing chromatin organization (GO:0061641),-0.18959564242650442,-0.5882163424576514,0.9769736842105263,0.9938726427259299,1.0,10/29,29.14%,MIS18BP1;KNL1;RUVBL1;RSF1;NPM1;CENPI;CENPN;NASP;HJURP;ITGB3BP
prerank,cilium movement (GO:0003341),0.20946459075376203,0.5865212481814285,0.9654696132596685,1.0,1.0,8/48,16.14%,CFAP73;DNAAF1;DNAI3;CCDC40;CABYR;CFAP53;DNAAF5;SPEF2
prerank,regulation of lymphocyte proliferation (GO:0050670),0.2528251111399609,0.5857875003558172,0.9087893864013267,1.0,1.0,5/16,25.88%,IL12B;SOX11;TNFSF9;AHR;TNFRSF1B
prerank,necroptotic process (GO:0070266),0.25253583323738144,0.5857842007458413,0.9290322580645162,1.0,1.0,2/16,12.97%,MLKL;CD14
prerank,toll-like receptor 4 signaling pathway (GO:0034142),-0.20766994018816196,-0.5848454902319122,0.962059620596206,0.9944945838766153,1.0,4/19,17.73%,LBP;PIK3AP1;PRKCE;TLR4
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.23149817426836988,0.5846397806553333,0.9398148148148148,1.0,1.0,5/28,12.84%,IRAK2;AAMP;ITCH;RIPK2;MAP2K6
prerank,positive regulation of type I interferon production (GO:0032481),-0.15582555666782966,-0.5840978071463854,1.0,0.9940182520214752,1.0,16/73,22.14%,IFIH1;TOMM70;LRRFIP1;POLR3H;CGAS;G3BP1;PTPN22;PRKDC;IRF5;EP300;DDX41;TLR4;POLR2E;DHX9;CHUK;CRCP
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.24419197825443223,0.5836329150269438,0.9365079365079365,1.0,1.0,5/18,18.73%,SFRP1;SKI;PEX2;CDC73;TRIM32
prerank,regulation of lipase activity (GO:0060191),0.2685836263184328,0.583355866794844,0.9242957746478874,1.0,1.0,13/13,73.16%,LMF1;PCSK5;FURIN;ANGPTL3;RHOA;SNCA;APOA2;ANGPTL8;PLIN5;RHOC;PCSK6;LPL;LIPC
prerank,regulation of oxidoreductase activity (GO:0051341),0.25964729819549415,0.5822928069436085,0.9178321678321678,1.0,1.0,1/13,4.57%,MT3
prerank,aromatic amino acid family metabolic process (GO:0009072),0.2814433486465956,0.5818364989721753,0.9045138888888888,1.0,1.0,1/10,6.77%,KYNU
prerank,cytoplasmic microtubule organization (GO:0031122),0.20424249936529376,0.5806566278546162,0.9720744680851063,1.0,1.0,3/54,5.66%,FIGN;CLIP4;DYNC1H1
prerank,receptor recycling (GO:0001881),-0.24725576614815448,-0.5802957772755969,0.9566265060240964,0.9947581558521312,1.0,3/10,20.90%,SORL1;LMTK2;EHD3
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.22496122281282396,0.579442636485185,0.9606060606060606,1.0,1.0,5/29,13.02%,DCST1;STAT2;RNASEL;ABCE1;MUL1
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.26200398659729307,0.5793405102618969,0.9168110918544194,1.0,1.0,2/13,12.22%,OAS2;EBI3
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.19576206731601925,0.5781569472184337,0.9815059445178336,1.0,1.0,17/73,20.64%,RUNX1;YAP1;PSME4;SETD1A;METTL14;ITCH;KMT2A;TCF12;PSMB5;PSMC2;METTL3;PSMD1;PSMD4;PSME3;YTHDF2;FOXC1;PSMA3
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.19553447817492756,0.5772928426831083,0.9775725593667546,1.0,1.0,22/61,29.39%,FGFR4;PRKAG2;PSME4;NCOR2;PSMB5;PSMC2;OAZ3;PSMD1;SIRT5;PSMD4;PSME3;PSMA3;PSMA2;PSMC5;PDK4;PSMB9;PSMD12;PSMB4;PANK2;PPARA;ODC1;PSMB7
prerank,dopaminergic neuron differentiation (GO:0071542),0.24613652417603993,0.5765591605562965,0.948220064724919,1.0,1.0,4/19,16.71%,FOXA1;RYK;MANF;SHH
prerank,RNA interference (GO:0016246),0.24586649112742767,0.575702023988428,0.9281150159744409,1.0,1.0,7/17,24.47%,PRKRA;TSNAX;DICER1;NRDE2;AGO4;DROSHA;AGO3
prerank,nucleotide metabolic process (GO:0009117),0.23621361066378552,0.5751247285965824,0.9528301886792453,1.0,1.0,9/23,26.28%,REXO2;CTPS2;AK8;DCK;NMNAT2;NUDT5;AK1;NMNAT1;CMPK1
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.20249202966797544,0.5747368491904646,0.9861111111111112,1.0,1.0,10/51,17.55%,SRC;HNRNPA1;PARN;FBXO4;TERF2;TNKS2;TENT4B;HNRNPC;ATM;NAF1
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.21542358934904,0.5746532636122943,0.966275659824047,1.0,1.0,9/36,17.72%,CBX3;RBBP7;L3MBTL2;YAF2;RNF2;CBX5;TFDP1;APAF1;CDC7
prerank,regulation of mitotic spindle assembly (GO:1901673),-0.2054699812120404,-0.57407220360415,0.9842105263157894,0.9964764205658446,1.0,6/19,29.11%,CEP97;PDCD6IP;CHMP2B;CHMP4B;PLK1;CHMP4C
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.27076885386163274,0.5739489402324254,0.9084249084249084,1.0,1.0,1/10,4.94%,KLF15
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.1920713832509819,-0.5739046968966187,0.9836956521739131,0.9957014410548533,1.0,9/22,31.29%,RBX1;GTF2H1;DDB2;CETN2;PARP1;CHD1L;UBC;RPS27A;XPC
prerank,carboxylic acid catabolic process (GO:0046395),0.2683784292799296,0.5732872900286904,0.9264214046822743,1.0,1.0,12/12,73.18%,RENBP;BCKDK;NAGK;GNPDA1;NPL;ACOT4;PON1;ACOT8;AMDHD2;GNPDA2;PON3;IL4I1
prerank,DNA conformation change (GO:0071103),0.24682768288999413,0.5726956460004301,0.9447154471544715,1.0,1.0,2/17,7.80%,TOP3B;TOP2B
prerank,ubiquinone biosynthetic process (GO:0006744),0.25438815677936777,0.5720345368504904,0.9455782312925171,1.0,1.0,4/15,19.52%,UBIAD1;COQ10B;NDUFA9;COQ7
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.27552426974295774,0.5719217814299523,0.9319371727748691,1.0,1.0,2/10,12.29%,TUT7;TUT4
prerank,centromere complex assembly (GO:0034508),-0.17621261010608463,-0.5718026016461203,0.9929078014184397,0.9957084898834435,1.0,12/36,29.14%,MIS18BP1;KNL1;RUVBL1;RSF1;NPM1;CENPI;CENPN;CENPF;NASP;HJURP;DLGAP5;ITGB3BP
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.2322661644695543,-0.5717938529858387,0.9413145539906104,0.994868681950668,1.0,11/11,76.80%,CAMK4;STAP1;ITGB2;F2RL1;CD177;TYROBP;SPI1;TICAM1;MAVS;STX4;ITGAM
prerank,Golgi to endosome transport (GO:0006895),0.24730890387739735,0.570521641965458,0.9514237855946399,1.0,1.0,6/16,22.59%,MON2;EPS15;WIPI1;VPS13C;SORT1;KLHL20
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.21795224763569415,0.5705155651323139,0.9618208516886931,1.0,1.0,5/31,12.71%,TIMM17B;AIFM1;TIMM44;PEX6;PEX2
prerank,regulation of biosynthetic process (GO:0009889),0.2664253743070417,0.5701765339613428,0.9215686274509803,1.0,1.0,2/11,15.38%,SPHK2;PIKFYVE
prerank,protein acetylation (GO:0006473),0.2219422745047694,0.569998971756397,0.9705014749262537,1.0,1.0,7/30,19.20%,ING5;KAT2B;BLOC1S1;KAT5;NAA40;NAA80;NAA50
prerank,peptidyl-methionine modification (GO:0018206),0.263285395796685,0.5699513225296344,0.9180887372013652,1.0,1.0,1/12,4.30%,APOA1
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.260360682065499,0.5689864102393373,0.9233644859813084,1.0,1.0,2/10,12.08%,SIRT2;IMPACT
prerank,sulfur amino acid catabolic process (GO:0000098),-0.2414524027538807,-0.5688517952558749,0.9492273730684326,0.9952257499980932,1.0,3/10,25.57%,BLMH;MPST;MTRR
prerank,DNA replication (GO:0006260),0.17933911433320077,0.568770035848073,0.9939686369119421,1.0,1.0,7/105,9.80%,RBMS1;PCLAF;ING5;POLG;POLL;RECQL5;POLE3
prerank,leukotriene biosynthetic process (GO:0019370),-0.2175870929884595,-0.5685128278071161,0.9627906976744186,0.9945301812884129,1.0,6/14,31.69%,GGT5;GGTA1;GGT1;PLA2G5;ALOX5;GGT7
prerank,signal peptide processing (GO:0006465),0.2623207244194953,0.5668279843290944,0.9189686924493554,1.0,1.0,6/11,31.43%,SEC11C;SEC11A;SPCS2;PCSK5;HM13;FURIN
prerank,cellular response to lipopolysaccharide (GO:0071222),0.17931557530496595,0.5668096015271968,0.9950738916256158,1.0,1.0,16/101,18.61%,SERPINE1;LYN;AXL;NR1D1;TNIP2;SELENOS;PDCD4;PAF1;CD14;CHMP5;CXCL13;NR1H3;IL18;CASP1;CDC73;TRIM41
prerank,metallo-sulfur cluster assembly (GO:0031163),0.23387189063791547,0.5654060328325676,0.9521604938271605,1.0,1.0,5/22,16.12%,IBA57;NUBPL;HSPA9;NFU1;LYRM4
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),-0.2339534422868091,-0.564132501916355,0.9603960396039604,0.9953524624482264,1.0,1/11,5.10%,TOMM70
prerank,histone deubiquitination (GO:0016578),0.2414957320555549,0.56352154111749,0.9531772575250836,1.0,1.0,6/18,21.32%,ATXN7L3;UIMC1;USP49;BRCC3;USP3;ATXN7
prerank,double-strand break repair via homologous recombination (GO:0000724),0.17830363502849472,0.5634196022767823,0.9936224489795918,1.0,1.0,32/95,27.75%,ZSWIM7;INO80;RAD51B;SMC5;POLL;RECQL5;SMC6;MCM2;RAD51D;XRCC2;RNF138;AP5Z1;CDC7;NIPBL;GINS4;RAD54L;MCMDC2;NSMCE2;FAN1;EXD2;BRCA1;SFPQ;NABP2;RAD51AP2;MRE11;MCM6;SWI5;RAD50;TONSL;UBE2N;RECQL;FANCB
prerank,cellular response to misfolded protein (GO:0071218),0.23482589081915575,0.5605255461232075,0.9388714733542319,1.0,1.0,4/20,15.91%,DERL1;RNF185;UGGT2;AUP1
prerank,tyrosine metabolic process (GO:0006570),0.26836158192090404,0.559265740162048,0.9215358931552587,1.0,1.0,11/11,73.18%,FAH;GSTZ1;TYR;HGD;TAT;PAH;TH;THAP4;IYD;DCT;IL4I1
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.23648802247390843,0.5592375390313564,0.9358552631578947,1.0,1.0,2/16,6.92%,IL12B;KLRD1
prerank,mitotic nuclear division (GO:0140014),0.1875819117425479,0.55729630381868,0.985897435897436,1.0,1.0,18/71,22.73%,PIBF1;INO80;ZW10;ZWINT;KLHDC8B;ARHGEF10;FLNA;CEP192;SGO1;KPNB1;CDCA8;AAAS;DSN1;NDE1;EPS8;ABRAXAS2;TUBG2;TUBG1
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.21728318423226997,0.5572338027966695,0.9617224880382775,1.0,1.0,4/27,12.65%,MAP3K20;MAP3K8;TNIP2;BTRC
prerank,regulation of interleukin-17 production (GO:0032660),0.20860746849042938,0.5564817439114063,0.974512743628186,1.0,1.0,8/31,22.80%,RFTN1;IL12B;CARD9;IL23A;IL18;DDIT3;MYD88;NCKAP1L
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.25886074459033664,0.5554739391304255,0.9281867145421903,1.0,1.0,3/12,17.30%,CDA;UPP2;DCK
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.24566454494203607,0.5539732338354634,0.9592529711375212,1.0,1.0,4/16,22.98%,RBM22;DDX23;NCBP2;SART1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.23071004509096243,-0.5535462270122041,0.9662162162162162,0.9982935939544165,1.0,4/11,22.33%,MBTPS2;ATF6B;ATF3;ATF4
prerank,spindle assembly (GO:0051225),0.18781377968382723,0.5532402442797587,0.9884763124199744,1.0,1.0,18/67,22.60%,PIBF1;INO80;NCOR1;MAPRE2;NEK6;ARHGEF10;HAUS1;GOLGA8B;HAUS7;FLNA;HAUS3;CEP192;KPNB1;NUMA1;AAAS;ABRAXAS2;HAUS5;HAUS6
prerank,organelle transport along microtubule (GO:0072384),0.21401719190925256,0.5531718951101304,0.9714285714285714,1.0,1.0,9/31,23.44%,ARHGAP21;CDC42;RHOT1;CLN3;COPG1;HTT;NDE1;FBXW11;TMEM201
prerank,protein import into peroxisome membrane (GO:0045046),-0.19197023783723202,-0.5530409416210152,0.9722222222222222,0.9976045879218379,1.0,8/22,26.77%,RAB8B;PEX26;ABCD3;PEX12;FIS1;PEX16;PEX5;PXMP4
prerank,axoneme assembly (GO:0035082),0.21286287916661928,0.5523215857770505,0.966275659824047,1.0,1.0,4/31,12.42%,SPAG1;DNAAF1;CFAP46;CCDC40
prerank,cellular response to virus (GO:0098586),0.20991413170319445,0.5515012956792518,0.9724349157733537,1.0,1.0,5/30,14.22%,CCL19;VWCE;DDX3X;GSDME;RIOK3
prerank,regulation of G0 to G1 transition (GO:0070316),0.2042376568094403,0.5508595203682185,0.9767441860465116,1.0,1.0,9/38,17.72%,CBX3;RBBP7;L3MBTL2;YAF2;RNF2;CBX5;TFDP1;APAF1;CDC7
prerank,telomere capping (GO:0016233),0.23627045109822434,0.5506500922761063,0.9490662139219015,1.0,1.0,3/16,12.17%,DCLRE1C;DCLRE1A;TERF2
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.25843271542897667,0.5504383510943656,0.9474605954465849,1.0,1.0,3/11,18.65%,CTPS2;DCK;SLC25A19
prerank,RNA catabolic process (GO:0006401),0.19648149056966813,0.5504135926672,0.9781420765027322,1.0,1.0,15/46,25.29%,SND1;DXO;EXOSC7;MTREX;NUDT16L1;RNASEH2C;METTL3;YTHDF2;AGO4;ZFP36L2;NUDT12;SIDT2;METTL16;AGO3;CNOT10
prerank,P-body assembly (GO:0033962),0.2551227052989038,0.5493953046106892,0.9354838709677419,1.0,1.0,3/12,18.30%,DYNC1H1;PATL1;RC3H1
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.24351263620637373,0.548823652052745,0.9443507588532883,1.0,1.0,3/15,11.99%,BAIAP3;CLN3;STXBP1
prerank,positive regulation of lipid catabolic process (GO:0050996),0.23042415710341968,0.5488234207461604,0.9557661927330173,1.0,1.0,2/19,14.21%,APOA1;ABCD2
prerank,midbody abscission (GO:0061952),0.23671229305792962,0.5486148669844882,0.9609022556390977,1.0,1.0,2/17,13.15%,KIF20A;CHMP5
prerank,regulation of autophagosome maturation (GO:1901096),0.2506212607184062,0.5483988192337996,0.9315789473684211,1.0,1.0,2/13,12.09%,CLN3;UVRAG
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.23381967419983268,0.5466499705165334,0.9640522875816994,1.0,1.0,2/17,6.92%,IL12B;KLRD1
prerank,negative regulation of gluconeogenesis (GO:0045721),-0.2167905398007839,-0.545728610858331,0.9792147806004619,0.9990539188671986,1.0,7/11,40.18%,CRY1;EP300;C1QTNF12;C1QTNF3;CLK2;PGP;ERFE
prerank,aerobic respiration (GO:0009060),0.22776463271554337,0.5456759830559893,0.9557377049180328,1.0,1.0,3/20,9.81%,MDH2;BLOC1S1;SDHC
prerank,mitochondrion transport along microtubule (GO:0047497),-0.21336360264307205,-0.5451900713794315,0.9578454332552693,0.9983777286106605,1.0,2/13,15.16%,SYBU;HIF1A
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.1887727811526312,0.5444271082886788,0.9863574351978172,1.0,1.0,7/53,13.65%,APOE;NUPR1;ARAF;COMMD1;PRKN;UFL1;GLMN
prerank,positive regulation of exosomal secretion (GO:1903543),-0.2072468733128405,-0.5438790912407151,0.9655172413793104,0.997922995659672,1.0,5/15,26.47%,SDCBP;PDCD6IP;VPS4A;SNF8;HGS
prerank,DNA synthesis involved in DNA repair (GO:0000731),-0.15853362190875211,-0.5422706255853473,1.0,0.9975811402041393,1.0,15/42,30.76%,TRIM25;POLH;SIRT1;POLN;POLD4;POLK;WRNIP1;DTL;FAAP20;VCP;ISG15;POLA1;UBC;RPS27A;POLD2
prerank,regulation of isotype switching (GO:0045191),-0.21135015898514567,-0.5418118895126027,0.9787234042553191,0.9968710951911628,1.0,4/14,25.33%,TFRC;SHLD1;SHLD2;SLC15A4
prerank,interstrand cross-link repair (GO:0036297),0.18722008639172594,0.5407597847142824,0.9854304635761589,1.0,1.0,15/53,25.66%,ERCC6L2;DCLRE1C;EXO5;DCLRE1A;FANCC;FANCE;FANCI;XPA;FAN1;UBE2T;FANCA;CENPX;MSH6;RAD51AP2;ATRIP
prerank,positive regulation of chemokine production (GO:0032722),0.19135367918631935,0.5401124299854038,0.99302649930265,1.0,1.0,3/44,10.98%,IL6R;TSLP;DDX3X
prerank,DNA duplex unwinding (GO:0032508),0.18844584587015795,0.5390277953141239,0.9958677685950413,1.0,1.0,18/50,28.42%,GTF2H5;CUL4B;RECQL5;ASCC3;MCM2;RTEL1;DDX1;XPA;MCMDC2;ERCC3;ERCC2;MRE11;MCM6;RAD23B;RAD50;RECQL;GTF2H2;RPA1
prerank,regulation of establishment of protein localization (GO:0070201),-0.21121899976169214,-0.5389808781162998,0.9795918367346939,0.9968452299069035,1.0,5/14,28.82%,GAPVD1;CEP135;CORO2B;TREM2;PTP4A3
prerank,chromatin remodeling at centromere (GO:0031055),-0.17137335860375272,-0.5387723747884156,0.9868421052631579,0.9960667914261127,1.0,10/31,29.14%,MIS18BP1;KNL1;RUVBL1;RSF1;NPM1;CENPI;CENPN;NASP;HJURP;ITGB3BP
prerank,serine family amino acid biosynthetic process (GO:0009070),0.2425501123958762,0.5386842875652152,0.9565217391304348,1.0,1.0,4/12,21.19%,PSPH;SERINC3;PHGDH;CBS
prerank,regulation of B cell activation (GO:0050864),0.2137451795421519,0.53802584292095,0.9626168224299065,1.0,1.0,3/25,11.59%,ZFP36L1;THEMIS2;TNIP2
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.18257948140567273,-0.5355934812097619,0.9857549857549858,0.9960865012690505,1.0,4/23,14.41%,RBX1;COPS7A;DDB2;CETN2
prerank,regulation of spindle assembly (GO:0090169),0.2140598879863722,0.5349658795751151,0.9711246200607903,1.0,1.0,7/25,21.99%,DYNC1H1;CHMP5;SENP6;TPR;NUMA1;HNRNPU;CCSAP
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.2327786499215071,0.5343167165819079,0.9681208053691275,1.0,1.0,16/16,76.75%,ETS1;MDK;NFAT5;RELA;IL6;IRAK1;FUT7;RHOA;ITGB2;SELE;TNF;FUT4;ALOX5;TRAF6;SELP;ST3GAL4
prerank,protein insertion into ER membrane (GO:0045048),0.19787131616301018,0.5326807529083761,0.9886524822695035,1.0,1.0,4/37,11.43%,TRAM2;CYB5A;EMC6;TRAM1
prerank,mitochondrial membrane organization (GO:0007006),0.19883333306685463,0.5293096727509085,0.9788199697428139,1.0,1.0,3/32,13.84%,BCL2;MICOS10;HSPA9
prerank,cellular response to oxygen levels (GO:0071453),-0.22245935597263194,-0.5283040638348321,0.9573560767590619,0.9972161002121248,1.0,10/10,77.77%,ATP6V0A2;PICK1;CCDC115;NDUFS2;TMEM199;ATP6V1A;ATP6AP1;ATP6V1G1;ATP6V0D1;CPEB4
prerank,regulation of mitochondrial translation (GO:0070129),-0.18291618341797736,-0.5280222059139361,0.9717223650385605,0.9964604744683145,1.0,9/21,34.89%,MALSU1;COA3;FASTKD2;C1QBP;NSUN3;TRMT10C;MTG2;NGRN;TSFM
prerank,programmed necrotic cell death (GO:0097300),0.22205248981905706,0.5271455808651123,0.9581320450885669,1.0,1.0,1/18,3.21%,MLKL
prerank,RNA 3'-end processing (GO:0031123),0.18005764224275553,0.5269724074295311,0.9974457215836526,1.0,1.0,16/69,22.41%,U2AF1L4;THOC2;TUT7;DDX39A;WDR33;TENT4A;MAGOHB;TUT4;SRSF5;PCF11;TENT4B;CPSF2;FIP1L1;SRSF3;PAPOLA;NCBP2
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.19542790296832122,0.526460365493986,0.9856115107913669,1.0,1.0,7/35,17.55%,HNRNPA1;PARN;FBXO4;TNKS2;RTEL1;ATM;NAF1
prerank,2-oxoglutarate metabolic process (GO:0006103),0.23955175616019764,0.5263520942143454,0.9541595925297114,1.0,1.0,4/13,22.01%,ADHFE1;IDH2;PHYH;L2HGDH
prerank,peroxisomal membrane transport (GO:0015919),0.20588197480416234,0.5246658214050818,0.9833836858006042,1.0,1.0,8/27,23.71%,PXMP2;PEX6;PEX2;ABCD2;PEX11B;PEX7;PEX1;ATAD1
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),-0.21703146102411366,-0.5238833983713237,0.9925925925925926,0.996635195821979,1.0,6/12,32.95%,PAICS;IMPDH1;ATIC;IMPDH2;ADSS2;GMPS
prerank,regulation of superoxide anion generation (GO:0032928),-0.20184364697315565,-0.5232484788425477,0.9922077922077922,0.9959495983775557,1.0,11/14,52.49%,TGFB1;SOD1;MAPT;GSTP1;ITGB2;F2RL1;CD177;SYK;TYROBP;FPR2;CRP
prerank,quinone biosynthetic process (GO:1901663),0.23705125513396225,0.5228683832401203,0.9688041594454073,1.0,1.0,2/14,9.89%,UBIAD1;COQ10B
prerank,organelle fusion (GO:0048284),0.2137750172757834,0.522658508700642,0.9787928221859706,1.0,1.0,6/22,25.22%,MIGA2;USP30;AFG3L2;OPA1;STX4;VPS11
prerank,regulation of exit from mitosis (GO:0007096),0.1956472090845413,0.5223496327925562,0.9824304538799414,1.0,1.0,13/38,27.45%,ZW10;NPM2;SIRT2;ANAPC5;RGCC;UBE2D1;PHB2;CDC23;ANAPC4;CDC14B;UBE2E1;ANAPC2;CDC16
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.2118337954971249,-0.5222341255093704,0.9763593380614657,0.9953617965985525,1.0,1/12,3.78%,STX3
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.24634385893415794,0.5215270484489546,0.9518900343642611,1.0,1.0,3/11,22.89%,PARN;TENT4B;EXOSC2
prerank,positive regulation of chromatin organization (GO:1905269),-0.2079685926902774,-0.5207631855151184,0.9575471698113207,0.9948983263295756,1.0,2/12,14.36%,TAL1;H3-3A
prerank,regulation of cell cycle process (GO:0010564),0.16704588785911983,0.519759863339375,0.9964028776978417,1.0,1.0,6/104,6.15%,OBSL1;SND1;KIF20A;SFRP1;DYNC1H1;CDC42
prerank,microtubule bundle formation (GO:0001578),0.18779572237780942,0.5189599302950779,0.9888111888111888,1.0,1.0,4/42,12.42%,NCKAP5;KIF20A;CFAP46;CCDC40
prerank,signal transduction in response to DNA damage (GO:0042770),0.1823701339118118,0.5178783133116286,0.9943582510578279,1.0,1.0,11/49,20.23%,MAP3K20;NDRG1;BATF;USP10;SESN2;CASP9;ATM;ATRX;CLSPN;MDM4;STK33
prerank,estrogen metabolic process (GO:0008210),0.22899724241325234,0.5177550318290401,0.952054794520548,1.0,1.0,1/15,5.54%,CYP1B1
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),0.2406943608633334,0.5176860994236546,0.9583333333333334,1.0,1.0,4/12,25.85%,UVRAG;INSR;SETX;JMJD4
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.21306406644481063,0.5155015825773758,0.962171052631579,1.0,1.0,8/20,25.73%,EGFR;TTBK1;RGCC;AKT1;CCND2;CCNY;PKD2;MAPRE3
prerank,T cell activation involved in immune response (GO:0002286),0.23598229816968724,0.5145628570812862,0.9606837606837607,1.0,1.0,3/12,19.43%,IFNK;MDK;ICAM1
prerank,hydrogen peroxide catabolic process (GO:0042744),0.24494460527272632,0.5135812843651958,0.9653379549393414,1.0,1.0,3/11,23.24%,GPX3;PRDX4;PXDN
prerank,replication fork processing (GO:0031297),0.18962757508320333,0.5129469879358277,0.9887323943661972,1.0,1.0,18/38,33.00%,BOD1L1;RTEL1;PRIMPOL;ATRX;ZGRF1;ETAA1;EXD2;EME2;CENPX;MRE11;TONSL;PCNA;DNA2;CDK9;DDX11;NUCKS1;THOC1;BLM
prerank,iron-sulfur cluster assembly (GO:0016226),0.20865593110930716,0.5123491951009026,0.9817629179331308,1.0,1.0,9/24,26.36%,IBA57;NUBPL;HSPA9;NFU1;LYRM4;GLRX3;NUBP2;NUBP1;MMS19
prerank,negative regulation by host of viral transcription (GO:0043922),0.23652332018940836,0.5114229073350411,0.9602076124567474,1.0,1.0,3/12,18.56%,CCL4;REST;POU2F3
prerank,intracellular protein transmembrane transport (GO:0065002),0.1836751956481447,0.5108369824183614,0.995768688293371,1.0,1.0,14/42,27.24%,TIMM17B;AIFM1;TIMM44;PEX6;PEX2;PEX7;SEC61A1;PEX1;HSPA5;PAM16;ROMO1;RTN2;DNLZ;DNAJC15
prerank,regulation of cellular amine metabolic process (GO:0033238),-0.14456764259633623,-0.508138778043803,1.0,0.996780604789002,1.0,12/50,23.95%,PSMF1;PSMB8;PSMA4;PSMB10;PSMB2;PSMC4;PSMA6;PSMD9;PSMD11;PSMD5;PSMA8;PSMB1
prerank,mitochondrion distribution (GO:0048311),0.235115220842193,0.5063878007667104,0.9639175257731959,1.0,1.0,1/12,6.60%,LRRK2
prerank,telomere organization (GO:0032200),-0.1463615064944237,-0.5060287390805476,1.0,0.9964074649094302,1.0,22/43,42.44%,DCLRE1B;CTC1;H3-3A;HUS1;PRKDC;NBN;PARP1;POLD4;HUS1B;APEX1;POLD2;TERT;RPA2;STN1;DOT1L;RECQL4;RIF1;LTO1;TERF2IP;ACD;TINF2;XRCC6
prerank,ubiquinone metabolic process (GO:0006743),0.22519331014567484,0.5051719632070942,0.9742710120068611,1.0,1.0,2/15,9.89%,UBIAD1;COQ10B
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.22738952215180097,0.5047551750787511,0.976027397260274,1.0,1.0,12/13,64.06%,SPHK2;ITGAM;STX4;KLRC2;GAB2;SYK;CD177;F2RL1;AP1G1;LAMP1;ITGB2;IL4
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.20746234988351217,0.5046027715093953,0.968895800933126,1.0,1.0,8/21,25.91%,PPP4R4;YWHAE;BOD1L1;PTPA;BOD1;PPP1R15A;MASTL;STYXL1
prerank,lipoxygenase pathway (GO:0019372),-0.19859173829093665,-0.5032604232891171,0.9902439024390244,0.9961272285511504,1.0,5/14,28.62%,GPX4;PTGS2;GPX1;ALOX5;PON3
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.21384735895440365,0.5031677260022388,0.9711864406779661,1.0,1.0,7/17,25.73%,EGFR;RGCC;AKT1;CCND2;CCNY;PKD2;MAPRE3
prerank,protein localization to phagophore assembly site (GO:0034497),0.2380180851486964,0.5023251391396556,0.9493670886075949,1.0,1.0,4/11,20.90%,WIPI1;WDR45;STX17;ATG9A
prerank,negative regulation of T cell activation (GO:0050868),0.18427691117143752,0.501919889645714,0.9941089837997055,1.0,1.0,4/35,13.90%,RIPOR2;CEBPB;GLMN;SDC4
prerank,positive regulation of mitochondrial translation (GO:0070131),0.22264343158688327,0.50063048223887,0.9712837837837838,1.0,1.0,3/14,19.37%,RPUSD4;TRUB2;FASTKD3
prerank,hydrogen peroxide metabolic process (GO:0042743),-0.18132155246914552,-0.4999037789441451,0.9802816901408451,0.9959105463769165,1.0,6/19,27.59%,ACOX1;GPX1;CAT;PRDX5;NOX1;SOD1
prerank,regulation of centrosome duplication (GO:0010824),0.1962950677504186,0.49747991693428334,0.983679525222552,1.0,1.0,6/30,20.66%,ALMS1;CENPJ;CHMP5;PLK2;TMEM67;CEP120
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.20213671835498703,0.49543561980569867,0.9839228295819936,1.0,1.0,5/20,21.91%,ZW10;ZWINT;ATM;TPR;IK
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.20213671835498703,0.49543561980569867,0.9839228295819936,1.0,1.0,5/20,21.91%,ZW10;ZWINT;ATM;TPR;IK
prerank,spindle assembly checkpoint signaling (GO:0071173),0.20213671835498703,0.49543561980569867,0.9839228295819936,1.0,1.0,5/20,21.91%,ZW10;ZWINT;ATM;TPR;IK
prerank,innate immune response in mucosa (GO:0002227),0.23401212337530947,0.4949036854737581,0.9740034662045061,1.0,1.0,1/10,7.85%,CAMP
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.21081254209312622,0.4942777673186787,0.9740680713128039,1.0,1.0,2/21,6.57%,GTF2H5;CUL4B
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.21081254209312622,0.4942777673186787,0.9740680713128039,1.0,1.0,2/21,6.57%,GTF2H5;CUL4B
prerank,telomere maintenance via telomerase (GO:0007004),-0.16209356137355568,-0.49397760385679,0.996996996996997,0.9961443678142832,1.0,2/28,6.88%,ANKRD28;HSP90AB1
prerank,negative regulation of establishment of protein localization (GO:1904950),-0.20838654483940966,-0.4924176399177284,0.9882352941176471,0.9955993832232092,1.0,5/10,38.02%,NDFIP2;CORO2B;WWP2;PPM1F;MAPT
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.19199269856973283,-0.491743500281365,0.9854721549636803,0.9948794151687225,1.0,6/14,27.09%,CARD14;TNFRSF10B;TRAF2;MAP3K7;MALT1;TRAF6
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.22036853866111905,0.4904681821824728,0.9735915492957746,1.0,1.0,3/14,16.32%,LONP2;ABCD2;AKT1
prerank,recombinational repair (GO:0000725),0.1581419696822467,0.48788595422020725,1.0,1.0,1.0,24/77,27.47%,ZSWIM7;INO80;RAD51B;SMC5;POLL;RECQL5;SMC6;RAD51D;XRCC2;RNF138;AP5Z1;NSMCE2;FAN1;EXD2;BRCA1;SFPQ;NABP2;RAD51AP2;MRE11;SWI5;RAD50;TONSL;UBE2N;RECQL
prerank,regulation of protein acetylation (GO:1901983),0.22028319403567836,0.48774342848340735,0.9740034662045061,1.0,1.0,3/12,21.33%,DDX3X;KAT5;TAOK1
prerank,negative regulation of translational initiation (GO:0045947),0.22093169261677548,0.48657219715001054,0.9807692307692307,1.0,1.0,13/13,77.92%,LARP1;TPR;RBM4;EIF3E;EIF2AK1;EIF4EBP1;AGO2;PAIP2;EIF4EBP3;PAIP2B;FMR1;EIF2AK4;EIF4EBP2
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.14834621014380073,-0.48639668283146054,0.9966101694915255,0.9949740453989082,1.0,12/37,34.18%,RBX1;GTF2H1;DDB2;PARP1;POLD4;POLK;CHD1L;UBC;RPS27A;POLD2;ERCC5;RPA2
prerank,positive regulation of establishment of protein localization (GO:1904951),-0.17474807285396327,-0.4848474503941756,0.997289972899729,0.9943943288653354,1.0,5/19,28.82%,CCT8;CEP135;CORO2B;TREM2;PTP4A3
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.18667331888285651,0.48432191502593946,0.9851190476190477,1.0,1.0,10/29,27.01%,TLR6;IKBKE;TBK1;CD14;UBE2D1;BIRC2;BIRC3;FADD;TICAM1;RIPK1
prerank,protein import into peroxisome matrix (GO:0016558),0.22244646529586515,0.4835983976765784,0.9757785467128027,1.0,1.0,4/12,21.50%,PEX6;PEX2;PEX7;PEX1
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.2124046757978047,0.4824006960740006,0.9755301794453507,1.0,1.0,5/14,27.72%,DDX60;DHX58;TLR5;ANKRD17;PUM1
prerank,superoxide anion generation (GO:0042554),0.2093648737892092,0.4809122202710377,0.991652754590985,1.0,1.0,3/13,19.60%,NOX4;NOX3;ALOX12
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.1953297581811107,0.48063033016274176,0.9919871794871795,1.0,1.0,5/21,21.91%,ZW10;ZWINT;ATM;TPR;IK
prerank,positive regulation of TORC1 signaling (GO:1904263),0.21017898045433486,0.48045659911649635,0.9853658536585366,1.0,1.0,4/16,20.27%,TELO2;RRAGD;SEH1L;GPR137B
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.18206495528915828,0.4800053458509394,0.9897058823529412,0.9999746143326202,1.0,6/32,17.55%,HNRNPA1;PARN;FBXO4;TNKS2;ATM;NAF1
prerank,N-terminal protein amino acid modification (GO:0031365),-0.19172394571804285,-0.478357266587954,0.9798994974874372,0.9945294445019578,1.0,7/14,40.78%,METAP2;NAA60;NAA15;AANAT;NTMT1;PDF;NAA11
prerank,regulation of mitotic spindle organization (GO:0060236),0.17823876601800148,0.4750714287158523,0.992816091954023,1.0,1.0,10/35,26.03%,DYNC1H1;RAE1;CHMP5;GNAI1;TPR;NUMA1;HNRNPU;CCSAP;CHMP2A;FSD1
prerank,negative regulation of phosphatase activity (GO:0010923),0.18827630708961185,0.47334920503904415,0.9863013698630136,1.0,1.0,9/25,25.91%,PPP4R4;BOD1L1;PTPA;BOD1;SEMA4D;PPP1R26;PPP1R15A;MASTL;STYXL1
prerank,protein localization to chromosome (GO:0034502),0.17682330225868279,0.4729284051912829,0.987012987012987,1.0,1.0,10/34,25.61%,MRNIP;TERF2;TNKS2;WAPL;CENPA;BOD1;ATRX;CTCF;TNKS;XRCC4
prerank,autophagosome maturation (GO:0097352),0.17643705339164578,0.46786704174813304,0.9899280575539569,1.0,1.0,11/32,25.59%,CLN3;UVRAG;LAMP2;MAP1LC3A;EPG5;STX17;RUBCNL;LIX1;TSG101;VPS16;VPS33B
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.17796012013583962,0.46505493238506834,0.9910313901345291,1.0,1.0,10/30,27.01%,TLR6;IKBKE;TBK1;CD14;UBE2D1;BIRC2;BIRC3;FADD;TICAM1;RIPK1
prerank,lymphocyte mediated immunity (GO:0002449),0.2159936652003432,0.4639846392261571,0.9836065573770492,1.0,1.0,1/12,6.92%,KLRD1
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.16106803847259832,0.4607073342886971,1.0,1.0,1.0,12/53,23.33%,PSME4;PPM1K;PSMB5;PSMC2;OAZ3;PSMD1;PSMD4;PSME3;BCKDK;PSMA3;PSMA2;PSMC5
prerank,regulation of hormone secretion (GO:0046883),0.20166079291697306,0.45207330349975,0.9934102141680395,1.0,1.0,4/15,22.73%,LIF;SOX11;SNX6;SCG5
prerank,regulation of double-strand break repair (GO:2000779),0.16566856832891402,0.45100478356621565,0.9955947136563876,1.0,1.0,6/39,17.12%,PML;TRIP12;MRNIP;RTEL1;UBR5;TIMELESS
prerank,negative regulation of T cell mediated immunity (GO:0002710),0.2121212434832379,0.4477509298527733,0.9837251356238698,1.0,1.0,1/11,6.92%,KLRD1
prerank,T cell homeostasis (GO:0043029),0.2078367049723005,0.44728757060321495,0.9835466179159049,1.0,1.0,4/10,24.90%,AKT1;NCKAP1L;PMAIP1;FADD
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.20594286699065825,0.4455965672298517,0.9842657342657343,1.0,1.0,4/12,22.49%,ANAPC5;NSMCE2;CDC23;ANAPC4
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.20594286699065825,0.4455965672298517,0.9842657342657343,1.0,1.0,4/12,22.49%,ANAPC5;NSMCE2;CDC23;ANAPC4
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.20594286699065825,0.4455965672298517,0.9842657342657343,1.0,1.0,4/12,22.49%,ANAPC5;NSMCE2;CDC23;ANAPC4
prerank,nucleotide biosynthetic process (GO:0009165),0.1847427539553086,0.4383646117509101,0.983633387888707,1.0,1.0,7/18,25.32%,GART;PRPSAP2;NMNAT2;PPAT;ADSL;NMNAT1;PRPSAP1
prerank,regulation of cellular amide metabolic process (GO:0034248),0.16789458336943633,0.434033874407626,0.9956458635703919,1.0,1.0,11/32,27.71%,PICALM;EIF2B4;MTPN;RBM4B;TMED10;FOXO3;NANOS3;PCIF1;ATXN2;METAP1;PRKCD
prerank,protein import into mitochondrial matrix (GO:0030150),0.18412366522578566,0.43050263776801295,0.9918962722852512,1.0,1.0,2/18,9.79%,TIMM17B;TIMM44
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.17974562708609965,0.42919103747657467,0.9983193277310924,1.0,1.0,3/18,19.37%,COX18;PET100;FASTKD3
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.15496667604836006,0.42503840280971755,1.0,1.0,1.0,9/40,22.68%,BOD1L1;RTEL1;PRIMPOL;TIMELESS;ATRX;ETAA1;EXD2;EME2;CENPX
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.1690561111387448,0.4246096070509647,0.9953703703703703,0.9999842139116573,1.0,10/25,29.26%,DDX23;GEMIN2;PRPF6;SF3B1;SRSF10;PRPF8;SLU7;TXNL4A;SCAF11;SF3B3
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.18150887361163004,0.42416669180248423,0.9952755905511811,0.9996366428864556,1.0,8/18,30.78%,POLE3;GINS4;MCMDC2;LIG1;MCM4;GINS1;PCNA;POLD3
prerank,homologous chromosome segregation (GO:0045143),0.17680825963695201,0.42341510368484647,0.9984615384615385,0.9993112793430238,1.0,3/20,16.34%,CENPC;MAJIN;SGO1
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.19705601617701143,0.4178056701425687,0.9931623931623932,0.9994155066191099,1.0,1/11,8.06%,WTIP
prerank,error-free translesion synthesis (GO:0070987),-0.1448365597020066,-0.4172326233098282,1.0,0.9991909190434892,1.0,7/22,34.18%,POLH;UFD1;RCHY1;VCP;UBC;RPS27A;RPA2
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.1609554616764533,0.4054500073453235,0.9984756097560976,0.9999842826805335,1.0,1/24,5.01%,LIG4
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.15979617421316158,0.4049180849317291,1.0,0.9996265035373526,1.0,7/29,23.01%,GTF2H5;CUL4B;MNAT1;XPA;ERCC3;CDK7;ERCC2
prerank,ESCRT complex disassembly (GO:1904896),0.19440085368150162,0.4044204225642369,0.9951456310679612,0.9988719874439018,1.0,10/10,80.57%,CHMP5;CHMP2A;IST1;CHMP7;CHMP1B;CHMP1A;VTA1;VPS4B;CHMP2B;VPS4A
prerank,ESCRT III complex disassembly (GO:1904903),0.19440085368150162,0.4044204225642369,0.9951456310679612,0.9988719874439018,1.0,10/10,80.57%,CHMP5;CHMP2A;IST1;CHMP7;CHMP1B;CHMP1A;VTA1;VPS4B;CHMP2B;VPS4A
prerank,rRNA catabolic process (GO:0016075),0.162531251011181,0.3735532840740227,1.0,1.0,1.0,6/16,27.34%,EXOSC7;DIS3L;EXOSC2;XRN1;EXOSC8;EXOSC9
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.16785938480853743,0.36261516160584945,1.0,1.0,1.0,11/11,83.23%,RC3H2;RC3H1;TNFSF4;SMAD7;ZC3H12A;TBX21;FOXP3;IL4;SOCS5;ANXA1;JAK3
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.13843540841412358,0.36044423003836656,0.9984939759036144,0.9996915940339617,1.0,8/27,25.49%,PARN;PCF11;RPP30;DICER1;TOE1;XRN1;LACTB2;RNASE4
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),0.16715837047266327,0.3573186835652255,0.9964788732394366,0.9993741133272136,1.0,10/10,83.29%,RC3H2;RC3H1;SMAD7;ZC3H12A;TBX21;FOXP3;IL4;NFKBID;MALT1;NFKBIZ
prerank,regulation of lymphocyte activation (GO:0051249),-0.1454125587721513,-0.35343672037601903,1.0,0.9998706380516966,1.0,4/12,35.27%,KAT2A;LAT;IKZF3;CRTAM
